Citrus Sinensis ID: 021441
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 312 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.932 | 0.314 | 0.416 | 2e-54 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.932 | 0.314 | 0.412 | 8e-54 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.935 | 0.428 | 0.380 | 2e-50 | |
| C0LGV0 | 895 | Probable LRR receptor-lik | no | no | 0.878 | 0.306 | 0.408 | 6e-50 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.897 | 0.394 | 0.386 | 2e-49 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.900 | 0.330 | 0.375 | 5e-49 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.926 | 0.379 | 0.357 | 1e-48 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.894 | 0.389 | 0.367 | 2e-48 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.884 | 0.423 | 0.381 | 2e-48 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.929 | 0.349 | 0.387 | 3e-48 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 213 bits (541), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 124/298 (41%), Positives = 178/298 (59%), Gaps = 7/298 (2%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLA 57
+E + LAT+ + K LIGEG FG VY+G L DG VA+K R TQ EF +E+ L+
Sbjct: 587 LEYIELATEKY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFDNELNLLS 644
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+IQH NLV LLGYC E + Q L+Y ++ NGS+ LYG R+ L++ RLSIALGAA
Sbjct: 645 AIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYG-EPAKRKILDWPTRLSIALGAA 703
Query: 118 KGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
+GLA+LH+ R V+H+D K++N+L+D AKVAD G + + + S +V
Sbjct: 704 RGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAG 763
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
+L E + ++ SEKSDV+SFGV LLE+VSGRE + P LVE + S +
Sbjct: 764 YLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYIRASKVD 823
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 294
+I+D + + E + +++ ++CL+P S RP M D+V EL+ L E N + M
Sbjct: 824 EIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYM 881
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 123/298 (41%), Positives = 179/298 (60%), Gaps = 7/298 (2%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLA 57
+E + AT+ + K LIGEG FG VY+G L DG VA+K R TQ EF +E+ L+
Sbjct: 588 LEYIEQATEQY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLS 645
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+IQH NLV LLGYC E + Q L+Y ++ NGS+ LYG + R+ L++ RLSIALGAA
Sbjct: 646 AIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEAS-KRKILDWPTRLSIALGAA 704
Query: 118 KGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
+GLA+LH+ R V+H+D K++N+L+D+ AKVAD G + + + S +V
Sbjct: 705 RGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAG 764
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
+L E + ++ SEKSDV+SFGV LLE+VSGRE + P LVE + S +
Sbjct: 765 YLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVD 824
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 294
+I+D + + E + +++ ++CL+P S RP M D+V EL+ L E N + M
Sbjct: 825 EIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYM 882
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 116/305 (38%), Positives = 178/305 (58%), Gaps = 13/305 (4%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
+ELS T FS+KNL+GEG FG VYKG+L DG VA+K+ +Q EF EV ++
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HR+LVTL+GYC + L+Y+Y+PN ++ HL+ P R + ++ R+ +A GAA+
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAGAAR 446
Query: 119 GLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTADEI 176
G+A+LH PR++H+D K++N+L+D F A VAD GL D+ S++V
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFG 506
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNSRDF 232
++A E + SEK+DVYS+GV LLEL++GR+ + P + LVE L+ + +
Sbjct: 507 YMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIEN 566
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 292
+++D RL F M ++ C+ S+ +RP MS VV LD TL++ ++T
Sbjct: 567 EEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATDITN 625
Query: 293 VMGEG 297
M G
Sbjct: 626 GMRPG 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 116/284 (40%), Positives = 173/284 (60%), Gaps = 10/284 (3%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 58
+E+ AT+NF K +IG G FG VY+G L DG VA+K R FI+EV L+
Sbjct: 599 KEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLSQ 656
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
I+H+NLV+ G+C E Q L+YEY+ GS++ HLYGP + R L + RL +A+ AAK
Sbjct: 657 IRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGP-RSKRHSLNWVSRLKVAVDAAK 715
Query: 119 GLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
GL +LH+ S PR++H+D K++N+L+D+D AKV+D GL + D + ++ V +
Sbjct: 716 GLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTAGY 775
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSRDFSNLL 236
L E + +EKSDVYSFGV LLEL+ GRE S S SPDS ++ N + +
Sbjct: 776 LDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ--AGAF 833
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+I+D+ L TF M++ + +RC+ + RPS+++V+T+L
Sbjct: 834 EIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKL 877
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 113/292 (38%), Positives = 173/292 (59%), Gaps = 12/292 (4%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCFLAS 58
EEL+ T+ FS N++GEG FG VYKG L DG LVA+K+ G +EF EV ++
Sbjct: 344 EELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISR 403
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HR+LV+L+GYC ++ + LIYEY+PN ++ HL+G R LE+ R+ IA+G+AK
Sbjct: 404 VHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG---KGRPVLEWARRVRIAIGSAK 460
Query: 119 GLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
GLA+LH P+++H+D K+AN+L+D++F A+VAD GL T S++V +
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTH-VSTRVMGTFGY 519
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNSRDFS 233
LA E + + +++SDV+SFGV LLEL++GR+ P + LVE L+ + +
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
+ +++D RL + + I+ C+ S +RP M VV LD D
Sbjct: 580 DFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 108/288 (37%), Positives = 167/288 (57%), Gaps = 7/288 (2%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLA 57
+ E+ ATKNF D IG G FG+VY+G L+DG L+AIK+ Q EF E+ L+
Sbjct: 510 LAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVMLS 569
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
++HR+LV+L+G+C E+N L+YEY+ NG++ HL+G + L +K RL +G+A
Sbjct: 570 RLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNL---PPLSWKQRLEACIGSA 626
Query: 118 KGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
+GL +LH+ S R ++H+D KT N+L+DE+F+AK++D GL D S+ V
Sbjct: 627 RGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFG 686
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
+L E ++ +EKSDVYSFGV L E V R + P +L E + + NL
Sbjct: 687 YLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLE 746
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
I+D L ++ E +E++ ++ +CL + RP M +V+ L+ L
Sbjct: 747 SIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVL 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 193 bits (491), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 109/305 (35%), Positives = 175/305 (57%), Gaps = 16/305 (5%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLAS 58
EEL +AT FSD+NL+GEG FG VYKG+L D +VA+K+ G +EF EV ++
Sbjct: 421 EELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVDTISR 480
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HRNL++++GYC N + LIY+Y+PN ++ HL+ L++ R+ IA GAA+
Sbjct: 481 VHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHA---AGTPGLDWATRVKIAAGAAR 537
Query: 119 GLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADE 175
GLA+LH PR++H+D K++N+L++ +F A V+D GL T + +++V
Sbjct: 538 GLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHI---TTRVMGTF 594
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNSRD 231
++A E + +EKSDV+SFGV LLEL++GR+ + P + LVE L+ N+ +
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654
Query: 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291
+ D +L + M I+ C+ S+ +RP MS +V D ++++
Sbjct: 655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTNG 714
Query: 292 TVMGE 296
+GE
Sbjct: 715 MRLGE 719
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 107/291 (36%), Positives = 171/291 (58%), Gaps = 12/291 (4%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
EELS AT FS+ NL+G+G FG V+KG+L++G VA+K+ +Q EF EV ++
Sbjct: 345 EELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGIISR 404
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HR+LV L+GYC + + L+YE++PN ++ HL+G R +E+ RL IA+G+AK
Sbjct: 405 VHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGK---GRPTMEWSSRLKIAVGSAK 461
Query: 119 GLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
GL++LH + +P+++H+D K +N+L+D F AKVAD GL T+ S++V +
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH-VSTRVMGTFGY 520
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNSRDFS 233
LA E + +EKSDV+SFGV LLEL++GR + + LV+ L+ +
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELG 580
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
N ++D++L + + E M + C+ ++ RRP M V L+ +
Sbjct: 581 NFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNI 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 110/288 (38%), Positives = 169/288 (58%), Gaps = 12/288 (4%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
EELS AT FS+ NL+G+G FG V+KG+L G VA+K+ Q EF EV ++
Sbjct: 271 EELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISR 330
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HR+LV+L+GYC + L+YE++PN ++ HL+G R +E+ RL IALG+AK
Sbjct: 331 VHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK---GRPTMEWSTRLKIALGSAK 387
Query: 119 GLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
GL++LH +P+++H+D K +N+L+D F AKVAD GL T+ S++V +
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH-VSTRVMGTFGY 446
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVE-LVQNSRDFS 233
LA E + +EKSDV+SFGV LLEL++GR +A++ DS D L+ + +
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ + D ++ + + E M + C+ S+ RRP MS +V L+
Sbjct: 507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 120/310 (38%), Positives = 168/310 (54%), Gaps = 20/310 (6%)
Query: 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQH 61
AT NF + IG G FG+VYKG L DG VA+K+ G P EF E+ L+ +H
Sbjct: 481 ATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKR--GNPKSQQGLAEFRTEIEMLSQFRH 538
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
R+LV+L+GYC ENN LIYEY+ NG+V HLYG S L +K RL I +GAA+GL
Sbjct: 539 RHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS---LTWKQRLEICIGAARGLH 595
Query: 122 HLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
+LH+ S V+H+D K+AN+L+DE+F+AKVAD GL D S+ V +L
Sbjct: 596 YLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDP 655
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
E ++ ++KSDVYSFGV L E++ R P +L E + L +I+D
Sbjct: 656 EYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIID 715
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL---------DKEMNLT 291
+ L + + +F + +CL RPSM DV+ L+ L + E N T
Sbjct: 716 QSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNST 775
Query: 292 TVMGEGTPTV 301
++GE P +
Sbjct: 776 NMIGELPPQI 785
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 312 | ||||||
| 255543513 | 381 | serine/threonine protein kinase, putativ | 1.0 | 0.818 | 0.804 | 1e-144 | |
| 224128800 | 311 | predicted protein [Populus trichocarpa] | 0.993 | 0.996 | 0.774 | 1e-141 | |
| 351727579 | 379 | protein kinase family protein [Glycine m | 1.0 | 0.823 | 0.788 | 1e-141 | |
| 356571643 | 379 | PREDICTED: probable receptor-like protei | 1.0 | 0.823 | 0.788 | 1e-140 | |
| 224069640 | 378 | predicted protein [Populus trichocarpa] | 0.996 | 0.822 | 0.762 | 1e-137 | |
| 388494484 | 380 | unknown [Lotus japonicus] | 1.0 | 0.821 | 0.766 | 1e-137 | |
| 225451635 | 381 | PREDICTED: nodulation receptor kinase [V | 1.0 | 0.818 | 0.750 | 1e-134 | |
| 147805741 | 414 | hypothetical protein VITISV_039777 [Viti | 1.0 | 0.753 | 0.750 | 1e-134 | |
| 357508461 | 379 | Nodulation receptor kinase [Medicago tru | 1.0 | 0.823 | 0.740 | 1e-134 | |
| 30688460 | 380 | protein kinase family protein [Arabidops | 0.996 | 0.818 | 0.712 | 1e-125 |
| >gi|255543513|ref|XP_002512819.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547830|gb|EEF49322.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-144, Method: Compositional matrix adjust.
Identities = 251/312 (80%), Positives = 280/312 (89%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
M+ELS ATKNF DKNLIG GKFGEVYKGLL DGMLVAIKKR GA +QEF+DEV +L+ IQ
Sbjct: 70 MDELSHATKNFVDKNLIGIGKFGEVYKGLLNDGMLVAIKKRSGASSQEFVDEVRYLSPIQ 129
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRN+VTLLGYCQENNLQFL+YEYIP+GSVS HLYGPSQ S KLEFKHRLSIALGAAKGL
Sbjct: 130 HRNIVTLLGYCQENNLQFLVYEYIPSGSVSSHLYGPSQFSDGKLEFKHRLSIALGAAKGL 189
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHSLSPR+VHKDFKTANVLVDE+FIAKVADAGL NFLGR DVAGPSSQVTADEIF A
Sbjct: 190 AHLHSLSPRLVHKDFKTANVLVDENFIAKVADAGLPNFLGRVDVAGPSSQVTADEIFQAP 249
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFRRFS+K DV+SFGVFLLEL+SGREA+ S SPDSSQ+LVE VQN++D+S ++D
Sbjct: 250 EVREFRRFSDKGDVFSFGVFLLELLSGREATESPSPDSSQNLVEWVQNTQDYSAFSSVVD 309
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
+RL + FT EGMEEFIQLI++CL+PSSERRPSMS VV ELDR L+KEM LTTVMGEGTPT
Sbjct: 310 QRLGTRFTAEGMEEFIQLIIQCLEPSSERRPSMSYVVMELDRILEKEMTLTTVMGEGTPT 369
Query: 301 VTLGSHLFRATK 312
VTLGS LF+A+K
Sbjct: 370 VTLGSQLFKASK 381
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128800|ref|XP_002320425.1| predicted protein [Populus trichocarpa] gi|222861198|gb|EEE98740.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1307), Expect = e-141, Method: Compositional matrix adjust.
Identities = 241/311 (77%), Positives = 283/311 (90%), Gaps = 1/311 (0%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEELSLATK FS+KNL+G GKFGEVYKGLL +GM+VAIKKRPGAP+ EF+DEV +L+ IQ
Sbjct: 1 MEELSLATKGFSEKNLMGFGKFGEVYKGLLNNGMVVAIKKRPGAPSPEFVDEVRYLSPIQ 60
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRNLVTLLGYCQEN+LQFL+YEYIP+GSVS HLYGP Q KLEFKHRLSIALGAAKGL
Sbjct: 61 HRNLVTLLGYCQENDLQFLVYEYIPSGSVSNHLYGPGQTLDGKLEFKHRLSIALGAAKGL 120
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHSLSPR+VHK+FKTANVLVDE+FIAKVADAGLRNFLG+ D+AGPS+QVT+DEIFLA
Sbjct: 121 AHLHSLSPRLVHKNFKTANVLVDENFIAKVADAGLRNFLGKVDIAGPSTQVTSDEIFLAP 180
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFRRFSEKSDV+SFGVFLLEL+SG+EA+ SP ++Q+LVE VQN++D++N I+D
Sbjct: 181 EVREFRRFSEKSDVFSFGVFLLELLSGKEAAEP-SPGTNQNLVEWVQNTQDYANFASIVD 239
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
+RL S+FT EGMEEFIQL++RC++PSSERRP+M+ VV ELDR ++KEMNLTTVMGEGTPT
Sbjct: 240 QRLGSSFTAEGMEEFIQLMLRCVEPSSERRPAMNYVVMELDRIIEKEMNLTTVMGEGTPT 299
Query: 301 VTLGSHLFRAT 311
VTLGSHLFR+
Sbjct: 300 VTLGSHLFRSA 310
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727579|ref|NP_001235374.1| protein kinase family protein [Glycine max] gi|223452478|gb|ACM89566.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-141, Method: Compositional matrix adjust.
Identities = 246/312 (78%), Positives = 276/312 (88%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR G +QEF+DEV +L+SI
Sbjct: 68 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVRYLSSIH 127
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRNLV+LLGYCQENNLQFLIYEY+PNGSVS HLYG Q R+KLEFKHRL IA GAAKGL
Sbjct: 128 HRNLVSLLGYCQENNLQFLIYEYVPNGSVSSHLYGAGQQPREKLEFKHRLPIAQGAAKGL 187
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHSLSPR+VHK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AG SSQV DEIFLAS
Sbjct: 188 AHLHSLSPRLVHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLAS 247
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFRRFSEKSDVYSFGVFLLEL+SG++A+ S PDS+Q+LVE V +++D + I+D
Sbjct: 248 EVREFRRFSEKSDVYSFGVFLLELLSGKQATESPFPDSNQNLVEWVLSNQDRGMMSYIID 307
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
RL S+FT EGMEE+I LI+RCLDPSSERRP+MS V EL R LDKEMNLTT+MGEGTPT
Sbjct: 308 RRLESSFTAEGMEEYIMLIIRCLDPSSERRPAMSYVEMELVRILDKEMNLTTIMGEGTPT 367
Query: 301 VTLGSHLFRATK 312
VTLGS LF++TK
Sbjct: 368 VTLGSQLFKSTK 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571643|ref|XP_003553985.1| PREDICTED: probable receptor-like protein kinase At1g30570-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1293), Expect = e-140, Method: Compositional matrix adjust.
Identities = 246/312 (78%), Positives = 275/312 (88%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR G +QEF+DEV +L+SI
Sbjct: 68 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVHYLSSIH 127
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRNLV+LLGYCQENNLQFLIYEY+PNGSVS HLYG Q ++KLEFKHRLSIA GAAKGL
Sbjct: 128 HRNLVSLLGYCQENNLQFLIYEYVPNGSVSSHLYGAGQNPQEKLEFKHRLSIAQGAAKGL 187
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHSLSPR+VHK+FKT NVLVDE+FIAKVADAGLRNFLGR D+AG SSQV DEIFLAS
Sbjct: 188 AHLHSLSPRLVHKNFKTTNVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLAS 247
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFRRFSEKSDVYSFGVFLLEL+SG+EA PDS+Q+LVE V +++D + I+D
Sbjct: 248 EVREFRRFSEKSDVYSFGVFLLELLSGKEAIEPPFPDSNQNLVEWVLSNQDRGMMSYIID 307
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
RL S+FT EGMEE+I LI+RCLDPSSERRP+MS V ELDR L+KEMNLTTVMGEGTPT
Sbjct: 308 RRLESSFTAEGMEEYILLIIRCLDPSSERRPAMSYVEMELDRILEKEMNLTTVMGEGTPT 367
Query: 301 VTLGSHLFRATK 312
VTLGS LF++TK
Sbjct: 368 VTLGSQLFKSTK 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069640|ref|XP_002303015.1| predicted protein [Populus trichocarpa] gi|222844741|gb|EEE82288.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1273), Expect = e-137, Method: Compositional matrix adjust.
Identities = 238/312 (76%), Positives = 278/312 (89%), Gaps = 1/312 (0%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEEL LATK FS+KNLIG GKFGEVYKGLL +GM+VAIKKRPGAP+ EF+DEV +L+SIQ
Sbjct: 68 MEELGLATKGFSEKNLIGLGKFGEVYKGLLNNGMIVAIKKRPGAPSPEFVDEVRYLSSIQ 127
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRNLVTLLGYCQENNLQFL+YEYI +GSVS HLYG Q KLEFK+RL IALGAAKGL
Sbjct: 128 HRNLVTLLGYCQENNLQFLVYEYISSGSVSNHLYGVGQTLEGKLEFKNRLPIALGAAKGL 187
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHS +PR++HK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AGPS+QVTADEIFLA
Sbjct: 188 AHLHSQTPRLLHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGPSTQVTADEIFLAP 247
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFR+FSEKSDV+SFGVFLLEL+SG+EA+ SP++SQ+LVE VQN++D++N I+D
Sbjct: 248 EVREFRQFSEKSDVFSFGVFLLELLSGKEATEP-SPETSQNLVEWVQNTQDYTNFSSIVD 306
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
RL S+FT EGMEEFIQL+++C++PSS+RRP MS VV ELDR L+KE NLTTVMGEGTPT
Sbjct: 307 HRLGSSFTAEGMEEFIQLMLQCVEPSSDRRPLMSYVVMELDRILEKERNLTTVMGEGTPT 366
Query: 301 VTLGSHLFRATK 312
VTLGS LFRAT+
Sbjct: 367 VTLGSQLFRATR 378
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388494484|gb|AFK35308.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1269), Expect = e-137, Method: Compositional matrix adjust.
Identities = 239/312 (76%), Positives = 276/312 (88%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEELSLATKNF+D NLIG+GKFGEVY GLLQDG+LVAIKKR G P+QEF+DEV +L+SIQ
Sbjct: 69 MEELSLATKNFNDGNLIGQGKFGEVYNGLLQDGVLVAIKKRFGTPSQEFVDEVRYLSSIQ 128
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRN+VTL+GYCQENNLQFLIYEY+PNGSVS HLYG Q S++KLEFK RLSIA GAAKGL
Sbjct: 129 HRNIVTLIGYCQENNLQFLIYEYVPNGSVSSHLYGAGQQSQEKLEFKLRLSIAQGAAKGL 188
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AH+HSLSPR+VHKDFKTANVLVDE+FIAKVADAGL++FLGR D+ G SSQV ADEIFLA
Sbjct: 189 AHIHSLSPRLVHKDFKTANVLVDENFIAKVADAGLKHFLGRVDIVGSSSQVAADEIFLAP 248
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFRRFSEKSDVYS+GVFLLEL+SG+EA+ S SPDS+ +LVE V ++D + KI+D
Sbjct: 249 EVREFRRFSEKSDVYSYGVFLLELLSGKEATESPSPDSNLNLVEWVLRNQDRHLMSKIID 308
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
RL S+FT EGME +I L++RCLD SSERRP+MS V TELDR L+KEMNLTT+MGEGTPT
Sbjct: 309 RRLESSFTAEGMEAYILLVIRCLDLSSERRPAMSYVETELDRILEKEMNLTTIMGEGTPT 368
Query: 301 VTLGSHLFRATK 312
VTLGS LF+ATK
Sbjct: 369 VTLGSQLFKATK 380
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451635|ref|XP_002277073.1| PREDICTED: nodulation receptor kinase [Vitis vinifera] gi|296082255|emb|CBI21260.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1247), Expect = e-134, Method: Compositional matrix adjust.
Identities = 235/313 (75%), Positives = 277/313 (88%), Gaps = 1/313 (0%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
M ELSLATKNFSD +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+
Sbjct: 69 MAELSLATKNFSDISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIE 128
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKG 119
HRNLVTLLGYCQEN QFLIYE+IP+GS+S +LYG +QVS++KLEFK+RL IALGAAKG
Sbjct: 129 HRNLVTLLGYCQENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKG 188
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
LAHLH+LSPR+VHKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA
Sbjct: 189 LAHLHTLSPRLVHKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLA 248
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
EV+EFRRFS+KSDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+ I+
Sbjct: 249 PEVREFRRFSDKSDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTII 308
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTP 299
D+RL + FT EGMEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE LTT++GEG P
Sbjct: 309 DQRLGNRFTAEGMEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIP 368
Query: 300 TVTLGSHLFRATK 312
V LGS LF+A+K
Sbjct: 369 NVILGSQLFKASK 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147805741|emb|CAN73905.1| hypothetical protein VITISV_039777 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1245), Expect = e-134, Method: Compositional matrix adjust.
Identities = 235/313 (75%), Positives = 277/313 (88%), Gaps = 1/313 (0%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
M ELSLATKNFSD +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+
Sbjct: 102 MAELSLATKNFSDISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIE 161
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKG 119
HRNLVTLLGYCQEN QFLIYE+IP+GS+S +LYG +QVS++KLEFK+RL IALGAAKG
Sbjct: 162 HRNLVTLLGYCQENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKG 221
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
LAHLH+LSPR+VHKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA
Sbjct: 222 LAHLHTLSPRLVHKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLA 281
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
EV+EFRRFS+KSDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+ I+
Sbjct: 282 PEVREFRRFSDKSDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTII 341
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTP 299
D+RL + FT EGMEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE LTT++GEG P
Sbjct: 342 DQRLGNRFTAEGMEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIP 401
Query: 300 TVTLGSHLFRATK 312
V LGS LF+A+K
Sbjct: 402 NVILGSQLFKASK 414
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357508461|ref|XP_003624519.1| Nodulation receptor kinase [Medicago truncatula] gi|355499534|gb|AES80737.1| Nodulation receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1243), Expect = e-134, Method: Compositional matrix adjust.
Identities = 231/312 (74%), Positives = 272/312 (87%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEELS ATKNF+DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G +QEF+DEV +L+SIQ
Sbjct: 68 MEELSHATKNFNDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGVTSQEFVDEVRYLSSIQ 127
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
HRNLVTL+GYCQENNLQFLIYEY+PNGSVS HLYG SQ R+KLEFKHRLSIA GAAKGL
Sbjct: 128 HRNLVTLIGYCQENNLQFLIYEYVPNGSVSSHLYGASQQPREKLEFKHRLSIAQGAAKGL 187
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
AHLHSLSPR+VHK+FKT+NVLVDE+FI+KVADAGLRNFL R ++ G SSQV DEIFLA
Sbjct: 188 AHLHSLSPRLVHKNFKTSNVLVDENFISKVADAGLRNFLARVEIVGTSSQVATDEIFLAP 247
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV+EFR+FSEKSD YSFGVFLLEL+SG+EA+ S P+++Q+LVE V ++++ S + I+D
Sbjct: 248 EVREFRQFSEKSDAYSFGVFLLELLSGKEATESPHPNTNQNLVESVLSNQNNSTMNTIID 307
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT 300
+R+ FT EGME +I L++RCLDPSSERRP+MS V ELDR ++KEMNLTT+MGE TPT
Sbjct: 308 QRMECRFTAEGMESYILLLIRCLDPSSERRPAMSYVEMELDRIIEKEMNLTTMMGERTPT 367
Query: 301 VTLGSHLFRATK 312
VTLGS LF++ K
Sbjct: 368 VTLGSQLFKSNK 379
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30688460|ref|NP_189304.2| protein kinase family protein [Arabidopsis thaliana] gi|332643680|gb|AEE77201.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1169), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/313 (71%), Positives = 272/313 (86%), Gaps = 2/313 (0%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEEL+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++EV +L+SI
Sbjct: 69 MEELAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIH 128
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKG 119
HRNLVTLLG+CQE+N QFL+YEY+PNGSVS HLYG +V +LEF+HRL+I++GAAKG
Sbjct: 129 HRNLVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKG 188
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
LAHLHSLSPR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS + AD+IFL+
Sbjct: 189 LAHLHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHIVADQIFLS 247
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
EV+EF+RFSEKSDVY+FGVFLLELVSGREAS S+Q LV+ +QN D++++ ++
Sbjct: 248 PEVQEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMI 307
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTP 299
DERL T+T EG+EE I L +RC+D SSE+RP+MS VVTEL+R LDKE++LTTVMGEGTP
Sbjct: 308 DERLGGTYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLTTVMGEGTP 367
Query: 300 TVTLGSHLFRATK 312
TVTLGS LF+ATK
Sbjct: 368 TVTLGSQLFKATK 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 312 | ||||||
| TAIR|locus:2090797 | 380 | AT3G26700 [Arabidopsis thalian | 0.996 | 0.818 | 0.658 | 6.5e-106 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.894 | 0.294 | 0.364 | 2.7e-42 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.894 | 0.292 | 0.354 | 1.6e-41 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.948 | 0.434 | 0.349 | 3.4e-41 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.894 | 0.325 | 0.349 | 3.9e-41 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.887 | 0.285 | 0.348 | 1.5e-40 | |
| TAIR|locus:2156549 | 895 | AT5G48740 [Arabidopsis thalian | 0.910 | 0.317 | 0.345 | 3.3e-40 | |
| TAIR|locus:2091980 | 432 | CDG1 "CONSTITUTIVE DIFFERENTIA | 0.910 | 0.657 | 0.369 | 5.3e-40 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.894 | 0.598 | 0.340 | 1.4e-39 | |
| UNIPROTKB|Q40234 | 321 | Pto "Pto disease resistance pr | 0.894 | 0.869 | 0.357 | 3.7e-39 |
| TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 206/313 (65%), Positives = 252/313 (80%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ 60
MEEL+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++EV +L+SI
Sbjct: 69 MEELAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIH 128
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIXXXXXXX 119
HRNLVTLLG+CQE+N QFL+YEY+PNGSVS HLYG +V +LEF+HRL+I
Sbjct: 129 HRNLVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKG 188
Query: 120 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
PR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS + AD+IFL+
Sbjct: 189 LAHLHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHIVADQIFLS 247
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKIL 239
EV+EF+RFSEKSDVY+FGVFLLELVSGREA V+ +QN D++++ ++
Sbjct: 248 PEVQEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMI 307
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTP 299
DERL T+T EG+EE I L +RC+D SSE+RP+MS VVTEL+R LDKE++LTTVMGEGTP
Sbjct: 308 DERLGGTYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLTTVMGEGTP 367
Query: 300 TVTLGSHLFRATK 312
TVTLGS LF+ATK
Sbjct: 368 TVTLGSQLFKATK 380
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 2.7e-42, P = 2.7e-42
Identities = 105/288 (36%), Positives = 160/288 (55%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
EELS T NFSD N +G G +G+VYKG L +G ++AIK+ Q EF E+ L+
Sbjct: 625 EELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSR 684
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
+ H+N+V LLG+C + Q L+YEYIPNGS+ L G + V KL++ RL I
Sbjct: 685 VHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGV---KLDWTRRLKIALGSGK 741
Query: 119 XXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
P ++H+D K+ N+L+DE AKVAD GL +G + A ++QV +
Sbjct: 742 GLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQVKGTMGY 801
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK 237
L E + +EKSDVY FGV +LEL++G+ ++ SR+ +L +
Sbjct: 802 LDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKM-DKSRNLYDLQE 860
Query: 238 ILDERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
+LD + N +G E+++ + ++C++P RP+MS+VV EL+ L
Sbjct: 861 LLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESIL 908
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 1.6e-41, P = 1.6e-41
Identities = 102/288 (35%), Positives = 159/288 (55%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
EEL T NFS+ N +G G +G+VY+G+L +G L+AIK+ Q EF E+ L+
Sbjct: 622 EELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSR 681
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
+ H+N+V LLG+C + N Q L+YEYI NGS+ L G S + +L++ RL I
Sbjct: 682 VHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGI---RLDWTRRLKIALGSGK 738
Query: 119 XXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
P ++H+D K+ N+L+DE+ AKVAD GL +G + ++QV +
Sbjct: 739 GLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQVKGTMGY 798
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK 237
L E + +EKSDVY FGV LLEL++GR ++ SR +L +
Sbjct: 799 LDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKM-NKSRSLYDLQE 857
Query: 238 ILDERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
+LD + ++ N +G E+++ L +RC++ RPSM +VV E++ +
Sbjct: 858 LLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENIM 905
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 3.4e-41, P = 3.4e-41
Identities = 108/309 (34%), Positives = 165/309 (53%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCFLAS 58
+ELS T FS+KNL+GEG FG VYKG+L DG VA+K K G+ + EF EV ++
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
+ HR+LVTL+GYC + L+Y+Y+PN ++ HL+ P R + ++ R+ +
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPG---RPVMTWETRVRVAAGAAR 446
Query: 119 XXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTADEI 176
PR++H+D K++N+L+D F A VAD GL D+ S++V
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFG 506
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVE----LVQNSRDF 232
++A E + SEK+DVYS+GV LLEL++GR+ VE L+ + +
Sbjct: 507 YMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIEN 566
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 292
+++D RL F M ++ C+ S+ +RP MS VV LD TL++ ++T
Sbjct: 567 EEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATDITN 625
Query: 293 VMGEGTPTV 301
M G V
Sbjct: 626 GMRPGQSQV 634
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 3.9e-41, P = 3.9e-41
Identities = 101/289 (34%), Positives = 161/289 (55%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA--PTQEFIDEVCFLAS 58
EE+ NFS N +G G +G+VYKG+L G L+AIK+ +PG+ EF E+ L+
Sbjct: 525 EEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKTEIELLSR 584
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
+ H+N+V LLG+C + Q L+YEYIPNGS+ L G S + +L++ RL I
Sbjct: 585 VHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGI---RLDWTRRLRIALGSGK 641
Query: 119 XXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
P ++H+D K++NVL+DE AKVAD GL + + A ++QV +
Sbjct: 642 GLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVEDAEKANVTAQVKGTMGY 701
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK 237
L E + +EKSDVY FGV +LEL++G+ +++ S++ +L
Sbjct: 702 LDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKM-NKSKNLYDLQD 760
Query: 238 ILDERLWSTFTN--EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
LD + +T +G E+++ + +RC+DP +RPSM++VV E++ +
Sbjct: 761 FLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENIM 809
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.5e-40, P = 1.5e-40
Identities = 99/284 (34%), Positives = 158/284 (55%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
EEL T NFS + +G G +G+VYKG+LQDG +VAIK+ TQ EF E+ L+
Sbjct: 629 EELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSR 688
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
+ H+NLV L+G+C E Q L+YEY+ NGS+ L G S ++ L++K RL +
Sbjct: 689 VHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGIT---LDWKRRLRVALGSAR 745
Query: 119 XXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
P ++H+D K+ N+L+DE+ AKVAD GL + S+QV +
Sbjct: 746 GLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGY 805
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK 237
L E ++ +EKSDVYSFGV ++EL++ ++ + + ++ DF L
Sbjct: 806 LDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRD 865
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+D L T + +++L ++C+D +++ RP+MS+VV E++
Sbjct: 866 KMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSEVVKEIE 909
|
|
| TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.3e-40, P = 3.3e-40
Identities = 101/292 (34%), Positives = 156/292 (53%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 58
+E+ AT+NF K +IG G FG VY+G L DG VA+K R FI+EV L+
Sbjct: 599 KEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLSQ 656
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 118
I+H+NLV+ G+C E Q L+YEY+ GS++ HLYGP R L + RL +
Sbjct: 657 IRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRS-KRHSLNWVSRLKVAVDAAK 715
Query: 119 XXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
PR++H+D K++N+L+D+D AKV+D GL + D + ++ V +
Sbjct: 716 GLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTAGY 775
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK 237
L E + +EKSDVYSFGV LLEL+ GRE V + + + +
Sbjct: 776 LDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ-AGAFE 834
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
I+D+ L TF M++ + +RC+ + RPS+++V+T+L +++
Sbjct: 835 IVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQLS 886
|
|
| TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 426 (155.0 bits), Expect = 5.3e-40, P = 5.3e-40
Identities = 110/298 (36%), Positives = 163/298 (54%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASI 59
EL++AT +F +++LIG G FG VYKG L G +A+K + Q EF+ EV L+ +
Sbjct: 66 ELAIATNSFRNESLIGRGGFGTVYKGRLSTGQNIAVKMLDQSGIQGDKEFLVEVLMLSLL 125
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 119
HRNLV L GYC E + + ++YEY+P GSV HLY S+ ++ L++K R+ I
Sbjct: 126 HHRNLVHLFGYCAEGDQRLVVYEYMPLGSVEDHLYDLSE-GQEALDWKTRMKIALGAAKG 184
Query: 120 XXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
P V+++D KT+N+L+D D+ K++D GL F D++ S++V +
Sbjct: 185 LAFLHNEAQPPVIYRDLKTSNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRVMGTHGYC 244
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD-FSN--L 235
A E + + KSD+YSFGV LLEL+SGR+A LV +R F N +
Sbjct: 245 APEYANTGKLTLKSDIYSFGVVLLELISGRKALMPSSECVGNQSRYLVHWARPLFLNGRI 304
Query: 236 LKILDERLWST--FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL----DRTLDKE 287
+I+D RL F+N + I++ CL + RPS+S VV L D T+ KE
Sbjct: 305 RQIVDPRLARKGGFSNILLYRGIEVAFLCLAEEANARPSISQVVECLKYIIDHTIRKE 362
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 1.4e-39, P = 1.4e-39
Identities = 97/285 (34%), Positives = 155/285 (54%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCFLA 57
+ +L +AT FS +N+IGEG +G VY+G L +G LVA+KK G +EF EV +
Sbjct: 147 LRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIG 206
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 117
++H+NLV LLGYC E + L+YEY+ NG++ L+G + L ++ R+ +
Sbjct: 207 HVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMK-HHGYLTWEARMKVLTGTS 265
Query: 118 XXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
P+VVH+D K++N+L+D+ F AK++D GL LG + +++V
Sbjct: 266 KALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLG-DGKSHVTTRVMGTFG 324
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 236
++A E +EKSDVYSFGV +LE ++GR+ VE ++ L
Sbjct: 325 YVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLE 384
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+++D + ++ + +RC+DP SE+RP MS VV L+
Sbjct: 385 EVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLE 429
|
|
| UNIPROTKB|Q40234 Pto "Pto disease resistance protein" [Solanum pimpinellifolium (taxid:4084)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.7e-39, P = 3.7e-39
Identities = 102/285 (35%), Positives = 149/285 (52%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASI 59
+L AT NF K LIG G FG+VYKG+L+DG VA+K+R +Q EF E+ L+
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 119
+H +LV+L+G+C E N LIY+Y+ NG++ HLYG S + + ++ RL I
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARG 151
Query: 120 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
++H+D K+ N+L+DE+F+ K+ D G+ D S+ V ++
Sbjct: 152 LHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKIL 239
E R +EKSDVYSFGV L E++ R A E S + L +I+
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
D L E + +F V+CL SSE RPSM DV+ +L+ L
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_XIV3031 | hypothetical protein (311 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 312 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 35/275 (12%)
Query: 17 IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 67
+GEG FGEVYKG L+ + VA+K + A Q EF+ E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
LG C E +++ EY+ G + +L + +R KL LS AL A+G+ +L S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKEFR 186
+H+D N LV E+ + K++D GL L D + I +A E +
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRWMAPESLKEG 178
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
+F+ KSDV+SFGV L E+ + S+++++E ++N RL
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLEYLKN-----------GYRLPQP 225
Query: 247 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 280
E L+++C E RP+ S++V L
Sbjct: 226 ---PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-48
Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 42/279 (15%)
Query: 17 IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 67
+GEG FGEVYKG L+ + VA+K + A Q EF+ E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
LG C E ++ EY+P G + +L + ++L LS AL A+G+ +L S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 183
+H+D N LV E+ + K++D GL L D +A E
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-----YKVKGGKLPIRWMAPESL 176
Query: 184 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
+ +F+ KSDV+SFGV L E+ + G E +S +++E ++ R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN---AEVLEYLKK-----------GYR 222
Query: 243 LWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 280
L E +L+++C E RP+ S++V L
Sbjct: 223 LPKP---PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-48
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 40/278 (14%)
Query: 17 IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTL 67
+GEG FGEVYKG L VA+K + GA +EF++E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
LG C + +++ EY+P G + L + +KL K L +AL AKG+ +L S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 183
VH+D N LV E+ + K++D GL + D + +A E
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPESL 176
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+ +F+ KSDV+SFGV L E+ + S+++++EL+++ RL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLELLED-----------GYRL 223
Query: 244 WSTFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTEL 280
E + + +L+++C E RP+ S++V +L
Sbjct: 224 ---PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-46
Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 15 NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 66
+GEG FGEVYKG L+ VA+K + A + +F+ E + + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 67 LLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
LLG C E +L+ EY+ G + + L K LS A+ AKG+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----L 178
L S + VH+D N LV ED + K++D G L R + +
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
A E + F+ KSDV+SFGV L E+ + G LS ++++E ++
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK--------- 222
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
RL +E +L++ C E RP+ S++V L+
Sbjct: 223 --GYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 63/268 (23%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
+GEG FG VY + G VAIK + + +E + E+ L + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
++ N +L+ EY GS+ L + + KL L I L +GL +LHS ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHSN--GII 114
Query: 132 HKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS 189
H+D K N+L+D D K+AD GL L + T ++A EV + +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT--PAYMAPEVLLGKGYYS 172
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
EKSD++S GV L E
Sbjct: 173 EKSDIWSLGVILYE---------------------------------------------- 186
Query: 250 EGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ E LI + L E+RPS +++
Sbjct: 187 --LPELKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 32/273 (11%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 65
+ +GEG FG+VY + G LVAIK + + + E+ L ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
L ++ + +L+ EY G + L R +L L +LHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHS 115
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
+VH+D K N+L+DED K+AD GL L + + T + ++A EV
Sbjct: 116 K--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPE--YMAPEVLLG 170
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNSRDFSNLLKILDERLW 244
+ + + D++S GV L EL++G+ P L+EL + KI +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFK---------KIGKPKPP 215
Query: 245 STFTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 276
+ E LI + L E+R + +
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-39
Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIK--KRPGAP---TQEFIDEVCFLASIQHRNLVTLLGY 70
+G G FG VYK + G +VA+K K+ Q E+ L + H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
++ + +L+ EY G + +L L IAL +GL +LHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN--GI 119
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEFRRFS 189
+H+D K N+L+DE+ + K+AD GL L ++ + ++A EV +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
K DV+S GV L EL++G+ S ++ D Q L L+ +
Sbjct: 178 PKVDVWSLGVILYELLTGK---PPFSGENILD-----QLQLIRRILGPPLEFDEP--KWS 227
Query: 250 EGMEEFIQLIVRCLDPSSERRPSMSDVV 277
G EE LI +CL+ +RP+ +++
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
IG+G+FG+V G + G VA+K K Q F+ E + +++H NLV LLG
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ N +++ EY+ GS+ +L R + +L AL +G+ +L V
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFV 124
Query: 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFR 186
H+D NVLV ED +AKV+D GL + D L A E +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGL----------AKEASQGQDSGKLPVKWTAPEALREK 174
Query: 187 RFSEKSDVYSFGVFLLELVS-GR 208
+FS KSDV+SFG+ L E+ S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 37/289 (12%)
Query: 15 NLIGEGKFGEVYKGLL-----QDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 65
+GEG FG+V G VA+K +F E+ L ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 66 TLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
G C+ +L+ LI EY+P+GS+ +L Q R ++ K L + KG+ +
Sbjct: 70 KYKGVCEKPGGRSLR-LIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDY 124
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASE 181
L S R +H+D N+LV+ + + K++D GL L + IF A E
Sbjct: 125 LGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+FS SDV+SFGV L EL + G S SP + + ++ ++ + ++L
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD---PSQSP--PAEFLRMIGIAQGQMIVTRLL- 236
Query: 241 ERLWSTFTNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
E L E + +E L+ C + + RPS +D++ +DR
Sbjct: 237 ELLKE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCFLASIQHRNLV 65
+ F+ + +G G FGEV++GL ++ + VAIK K Q +F EV L ++H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
+L C ++I E + GS+ L P Q L + +A A+G+A+L
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE 122
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 182
+H+D N+LV ED + KVAD GL + + DV S + +I + A E
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDK----KIPYKWTAPEA 175
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS 206
FS KSDV+SFG+ L E+ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-28
Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 26/267 (9%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
IG G+FG V+ G + VAIK R GA ++E FI+E + + H LV L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ L++E++ +G +S +L + R K + L + L +G+A+L S + V+H+D
Sbjct: 72 SPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRD 125
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 193
N LV E+ + KV+D G+ F+ D SS T + +S EV F ++S KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 194 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 253
V+SFGV + E+ S E + S+ ++VE + ++ RL S E M+
Sbjct: 184 VWSFGVLMWEVFS--EGKTPYENRSNSEVVE------TINAGFRLYKPRLASQSVYELMQ 235
Query: 254 EFIQLIVRCLDPSSERRPSMSDVVTEL 280
C E RPS S ++ +L
Sbjct: 236 H-------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 43/280 (15%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVT 66
F IG+G FGEVYK + G VAIK ++ I+E+ L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGL 120
G + + +++ E+ GS+ + + L+ + KGL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLK-------DLLK---STNQTLTESQIAYVCKELLKGL 111
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
+LHS ++H+D K AN+L+ D K+ D GL L T + + ++A
Sbjct: 112 EYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMAP 166
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
EV + + K+D++S G+ +EL G+ S L P + L ++ N L
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIATN--GPPGLRNP-- 220
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
WS EF + +CL + E+RP+ +L
Sbjct: 221 -EKWSD-------EFKDFLKKCLQKNPEKRPT----AEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 31/210 (14%)
Query: 15 NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFID----EVCFLASIQHRNLVTLL 68
L+G G FG VY L +D G L+A+K ++E ++ E+ L+S+QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 69 GYCQENNLQFL-IY-EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAK 118
G ++ L I+ EY+ GS+S + +G + +RQ LE
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE------------- 112
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
GLA+LHS +VH+D K AN+LVD D + K+AD G LG + + V ++
Sbjct: 113 GLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A EV + +D++S G ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASI 59
E L L K +G G+FGEV+ G VA+K +PG + E F+ E + +
Sbjct: 6 ESLKLERK-------LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL 58
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+H LV L C E +++ EY+ GS+ L +KL + +A A+G
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEG 115
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
+A+L S +H+D N+LV E+ + K+AD GL +++ D+ + A
Sbjct: 116 MAYLESR--NYIHRDLAARNILVGENLVCKIADFGL-------------ARLIEDDEYTA 160
Query: 180 SE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GR 208
E +K + RF+ KSDV+SFG+ L E+V+ GR
Sbjct: 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 31/273 (11%)
Query: 16 LIGEGKFGEVYKGLLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
IG+G FG+VYKG+L+ VA+K P ++F+ E L H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ +++ E +P GS+ L +L K L ++L AA G+ +L S + +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CI 115
Query: 132 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 189
H+D N LV E+ + K++D G+ G V+ Q+ + A E + R++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WTAPEALNYGRYT 173
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
+SDV+S+G+ L E S + P S Q +R+ E +
Sbjct: 174 SESDVWSYGILLWETFSL---GDTPYPGMSN------QQTRERI-------ESGYRMPAP 217
Query: 250 EGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ EE +L+++C E RPS S++ EL
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 17 IGEGKFGEVYKGLL------QDGMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVT 66
+GEG FG+V+ G D LVA+K K + ++F E L + QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVS-------RQKLEFKHRLSIALGAA 117
G C E + +++EY+ +G ++ L +GP +L L IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAG----PSSQ 170
G+ +L S VH+D T N LV D + K+ D G+ + TD V G P
Sbjct: 133 SGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
+ + I +R+F+ +SDV+SFGV L E+ +
Sbjct: 191 MPPESIM-------YRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FG V+ G + + VAIK R GA +++ FI+E + + H NLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
F++ EY+ NG + +L + + KL + L + + + +L S +H+D
Sbjct: 72 RPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRD 125
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 193
N LV ED + KV+D GL ++ D SSQ T + A EV ++ RFS KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 194 VYSFGVFLLELVSG 207
V+SFGV + E+ S
Sbjct: 184 VWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 31/213 (14%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 63
N+ +LIG G FG VYKGL L+ G VAIK K + + E+ L +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP---SQVSR---QKLEFKHRLSIALG 115
+V +G + ++ ++I EY NGS+ I +GP S V+ Q L+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ---------- 110
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175
GLA+LH V+H+D K AN+L +D + K+AD G+ L DV+ + V
Sbjct: 111 ---GLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTP 163
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV E S SD++S G ++EL++G
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 25/283 (8%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH-R 62
++ +GEG FGEVY +D LVA+K + F+ E+ LAS+ H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N+V L + Q+ +L+ EY+ GS+ L + L L I L +
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116
Query: 123 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 177
LHS ++H+D K N+L+D D + K+ D GL L + + + +
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 178 LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
+A EV S SD++S G+ L EL++G S+ + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
L L + L+ + L + R S S +
Sbjct: 235 LASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-24
Identities = 76/273 (27%), Positives = 130/273 (47%), Gaps = 34/273 (12%)
Query: 16 LIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 71
L+G+G FGEV+KG L+D VA+K + P + +F+ E L H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ +++ E +P G L + + +L+ K + AL AA G+A+L S +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCI 115
Query: 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 188
H+D N LV E+ + K++D G + R + G S +I + A E + R+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 189 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
S +SDV+S+G+ L E S G ++ +++ VE + R +
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--KGYR--------------MSC 215
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+ ++ +++ RC D E RP S++ EL
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 52/305 (17%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG-----MLVAIK----KRPGAPTQEFIDE 52
E+ L+ F ++ +GEG FG+VYKG L VAIK QEF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 101
++ +QH N+V LLG C + +++EY+ +G + L S S +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
L+ L IA+ A G+ +L S VH+D N LV E K++D GL +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 218
D S+ ++ E + +F+ +SD++SFGV L E+ S L P S
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF-----SYGLQPYYGFS 231
Query: 219 SQDLVELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
+Q+++E+++ SR LL ++ R+++ L++ C + RRP D
Sbjct: 232 NQEVIEMIR-SR---QLLPCPEDCPARVYA------------LMIECWNEIPARRPRFKD 275
Query: 276 VVTEL 280
+ T L
Sbjct: 276 IHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 2e-24
Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 43/281 (15%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEF-IDEVCFLASIQHRN 63
+ IG+G FG+VY DG L +K+ +E ++EV L + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR-----LSIALGAAK 118
++ +E ++ EY G +S + +QK E K L +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI------KKQKKEGKPFPEEQILDWFVQLCL 114
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
L +LHS +++H+D K N+ + + + K+ D G+ L T + T +L
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP--YYL 170
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
+ E+ + + ++ KSD++S G L EL + + P ++L+EL KI
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELAL---------KI 215
Query: 239 LD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L + S ++ E L+ L E RPS++ +
Sbjct: 216 LKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-24
Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 34/276 (12%)
Query: 14 KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
K+ +G G++GEVY+G+ + + VA+K K +EF+ E + I+H NLV LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
C ++I E++ G++ +L + +RQ++ L +A + + +L +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKN--F 125
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 189
+H+D N LV E+ + KVAD GL + G T A ++ + A E + +FS
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 183
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
KSDV++FGV L E+ A+ +SP DL S + ++L++ +
Sbjct: 184 IKSDVWAFGVLLWEI-----ATYGMSPYPGIDL----------SQVYELLEK----GYRM 224
Query: 250 EGME----EFIQLIVRCLDPSSERRPSMSDVVTELD 281
E E + +L+ C + RPS +++ +
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 43/281 (15%)
Query: 17 IGEGKFGEVYKGL-LQDG----MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G G FG VYKG+ + +G + VAIK + +E +DE +AS+ H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
LG C + +Q LI + +P G + ++ + + ++ L+ + AKG+++L
Sbjct: 75 LGICLSSQVQ-LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE-- 127
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLASEV 182
R+VH+D NVLV K+ D GL L + + A+ ++A E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALES 182
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
R ++ KSDV+S+GV + EL++ G + + + + +LL+ E
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-------------PAVEIPDLLEK-GE 228
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
RL + ++V+C +E RP+ +++ E +
Sbjct: 229 RLPQPPICT--IDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-24
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 15 NLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQEFIDEVCFL--ASI----QHRN 63
+IG G+FGEV +G L+ + VAIK + G+ ++ +D FL ASI H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPN 66
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
++ L G ++ +I EY+ NGS L + + K + + G A G+ +L
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGS----LDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 180
++ VH+D N+LV+ + + KV+D GL L ++ + +I + A
Sbjct: 123 SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKGGKIPIRWTAP 177
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS 206
E +R+F+ SDV+SFG+ + E++S
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-24
Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 21/279 (7%)
Query: 16 LIGEGKFGEVYK---GLLQD--GMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNLVTL 67
+G+G FG V LQD G +VA+KK + ++F E+ L S+QH N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 68 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
G C NL+ L+ EY+P GS+ +L Q R++L+ + L A KG+ +L
Sbjct: 71 KGVCYSAGRRNLR-LVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVK 183
S R VH+D T N+LV+ + K+ D GL L + + IF A E
Sbjct: 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+FS SDV+SFGV L EL + + S S + + + Q +L+++L
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN- 242
Query: 244 WSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 281
G E ++ C + +RPS S++ +++
Sbjct: 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 59/299 (19%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIK---KRPGAPTQ-EFIDEVCFLASI 59
N + +G G+FGEV+ + LV +K K Q EF E+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALG 115
H+N+V LLG C+E ++I EY G + L ++ L K ++++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175
A G+ HL + R VH+D N LV KV+ L S V E
Sbjct: 126 IALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSL------------SKDVYNSE 171
Query: 176 IF-----------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 224
+ LA E + FS KSDV+SFGV + E+ + E P E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL-----PFYGLSDEE 226
Query: 225 LVQNSRDFSNLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
++ + L + + RL+ +L+ RC + + RPS S++V+ L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLY------------KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLL 68
F +GEG +G VYK + + G +VAIK P QE I E+ L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 69 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
G Y + +L +++ EY GSVS + +++ + L + +I KGL +LHS
Sbjct: 65 GSYFKNTDL-WIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
+ +H+D K N+L++E+ AK+AD G+ L TD + V ++A EV +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRDFSNLLKILDERLWST 246
++ K+D++S G+ +E+ G+ S + P + + + S+ K WS
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSDPEK------WS- 226
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
EF + +CL E RPS
Sbjct: 227 ------PEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-23
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV++GL + VA+K +PG ++F+ E + ++H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+++ E + GS+ +L G + + L+ + +A A G+A+L + + +H+D
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 194
NVLV E+ I KVAD GL + D+ + A E + RFS KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 195 YSFGVFLLELVS-GR 208
+SFG+ L E+V+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 73/212 (34%), Positives = 111/212 (52%), Gaps = 18/212 (8%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75
IGEG+FG V +G G VA+K + Q F++E + + H+NLV LLG N
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 76 LQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133
L +++ E + G++ L G + VS +L L +L A+G+ +L S ++VH+
Sbjct: 73 L-YIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--KKLVHR 124
Query: 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 193
D N+LV ED +AKV+D GL +G V V + A E + ++FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKSD 179
Query: 194 VYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224
V+S+GV L E+ S GR +S ++ VE
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 17 IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 67
+GEG FG+V+ LL QD MLVA+K A Q+F E L +QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHL--YGP--------SQVSRQKLEFKHRLSIALGAA 117
G C E +++EY+ +G ++ L +GP V+ +L L+IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
G+ +L SL VH+D T N LV + + K+ D G+ + TD + +
Sbjct: 133 SGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS 215
+ E +R+F+ +SD++SFGV L E+ + G++ LS
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 17 IGEGKFGEVYK----GLL--QDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 66
IG+G FG V++ GLL + +VA+K + A +F E +A H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFK------------HR 109
LLG C L++EY+ G ++ L +S + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 110 LSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
L IA A G+A+ LS R VH+D T N LV E+ + K+AD GL + D S
Sbjct: 133 LCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
++ E + R++ +SDV+++GV L E+ S + P E++
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF-----SYGMQPYYGMAHEEVIYY 244
Query: 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
RD N+L D N +E + L+ C RPS + + L R
Sbjct: 245 VRD-GNVLSCPD--------NCPLELY-NLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 72/212 (33%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-KRPGAPTQEFIDEVCFLASI 59
M+EL L IG+G+FG+V G + G VA+K + A Q F+ E + +
Sbjct: 5 MKELKL-------LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQL 56
Query: 60 QHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+H NLV LLG +E +++ EY+ GS+ +L R L L +L +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 113
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIF 177
+ +L + + VH+D NVLV ED +AKV+D GL T D + TA E
Sbjct: 114 AMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE-- 169
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GR 208
++E ++FS KSDV+SFG+ L E+ S GR
Sbjct: 170 ---ALRE-KKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 17/219 (7%)
Query: 16 LIGEGKFGEVYKGL-LQDG----MLVAIK---KRPGAPT-QEFIDEVCFLASIQHRNLVT 66
L+G G FG V+KG+ + +G + VAIK R G T QE D + + S+ H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
LLG C +LQ L+ + P GS+ H+ + R L+ + L+ + AKG+ +L
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAKGMYYLEE- 127
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
R+VH++ N+L+ D I ++AD G+ + L D S+ ++A E F
Sbjct: 128 -HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 187 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224
R++ +SDV+S+GV + E++S G E + + P DL+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-21
Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 23/277 (8%)
Query: 17 IGEGKFGEV----YKGLLQD-GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLVTL 67
+GEG FG+V Y G +VA+K KR T + E+ L ++ H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 68 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G C E + LI EY+P GS+ +L + KL L A +G+A+LHS
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 184
+H+D NVL+D D + K+ D GL + + +F A E +
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERL 243
+FS SDV+SFGV L EL++ S SP ++++ Q L+++L+ +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+E L+ C + ++ RP+ ++ L
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 41/297 (13%)
Query: 17 IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 63
+GEG FG+V GL ++ VA+K T+ + I E+ + I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 112
++ LLG C ++ ++I EY G++ +L Y P+QV ++L FK +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
A A+G+ +L S + +H+D NVLV ED + K+AD GL + D ++
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A E R ++ +SDV+SFGV L E+ + SP + E
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF-----TLGGSPYPGVPVEE-------- 250
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
L K+L E + E ++ C +RP+ +V +LDR L N
Sbjct: 251 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-21
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 50/279 (17%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---------QEFIDEVCFLASIQHRNLV 65
++G+G +G VY GL G L+A+K+ + ++ +EV L S++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 117
LG C ++N + E++P GS+S ++ +GP + ++Q L+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ----VTA 173
G+A+LH+ VVH+D K NV++ + I K+ D G L + G S +
Sbjct: 114 -GVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
++A EV + KSD++S G + E+ +G+ +S+ ++ + + R
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAHR--- 224
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
L+ L + I + CL RPS
Sbjct: 225 GLMPRLPDSF--------SAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-21
Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 47/277 (16%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 63
+F N IG+G FG V+K + + D + A+K K +E IDE LA +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE---FKHRLSIALGAAKGL 120
++ + ++ EY NG + H Q R E ++ + I LG L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG------RTDVAGPSSQVTAD 174
AHLHS +++H+D K+ N+ +D K+ D G+ L T V P
Sbjct: 115 AHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP------- 165
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
+L+ E+ E + ++EKSDV++ GV L E +G+ P + + L+
Sbjct: 166 -YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH------PFDANNQGALI-------- 210
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
LKI+ + + ++ QLI +CL +RP
Sbjct: 211 -LKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-21
Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 10 NFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
+F +G+G +G VYK L D A+K+ ++ ++E+ LAS+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL--SIALGAAKGLA 121
+++ + N ++ EY P G +S S+ +++ + I + +GL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLS---KAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIF 177
LH +++H+D K+AN+L+ + + K+ D G L+ + +T + P +
Sbjct: 118 ALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP--------HY 167
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
+A EV + R +S KSD++S G L E+ + S QDL VQ +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA---PPFEARSMQDLRYKVQRGK------- 217
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ ++ ++ I L + RP+ +
Sbjct: 218 --YPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-21
Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 40/266 (15%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV+ G VAIK + G+ + E F+ E + +QH LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ ++I EY+ NGS+ L P + KL + +A A+G+A + + +H+D
Sbjct: 74 PI-YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN--YIHRD 127
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 188
+ AN+LV E K+AD GL + ++ TA E + A E + F
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 189 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
+ KSDV+SFG+ L E+V+ GR P E++QN ER +
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR------IPYPGMTNPEVIQNL-----------ERGYRMP 223
Query: 248 TNEGM-EEFIQLIVRCLDPSSERRPS 272
+ EE +L+ C E RP+
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 16 LIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQEFID---EVCFLASI-QHRNL 64
+GEG FG+V K VA+K + A ++ D E+ + I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIA 113
+ LLG C + +++ EY +G++ L + + L K +S A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
A+G+ L S + +H+D NVLV ED + K+AD GL + D ++
Sbjct: 139 YQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSSQDLVELVQNSRD 231
++A E R ++ +SDV+SFGV L E+ + G SP + EL + ++
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG-------SPYPGIPVEELFKLLKE 249
Query: 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
+++ T +E L+ C +RP+ +V +LDR L
Sbjct: 250 G----YRMEKPQNCT------QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 14 KNLIGEGKFGEVYKGLLQD----GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLV 65
IGEG+FG+VY+G+ + VA+K K +P ++F+ E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
L+G EN + +++ E P G + +L QV++ L+ + + + LA+L S
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 184
R VH+D NVLV K+ D GL +L S I ++A E
Sbjct: 126 K--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS--KGKLPIKWMAPESIN 181
Query: 185 FRRFSEKSDVYSFGVFLLELVS 206
FRRF+ SDV+ FGV + E++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV+ G VA+K +PG + E F++E + ++H LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ +++ EY+ GS+ L + L+ + + +A A G+A++ ++ +H+D
Sbjct: 74 PI-YIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 193
++AN+LV + + K+AD GL + D + Q I + A E + RF+ KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 194 VYSFGVFLLELVS-GR 208
V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-20
Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 26/238 (10%)
Query: 14 KNLIGEGKFGEVYKGL------LQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 64
K +GEG FG+V+ +D MLVA+K K P A ++F E L ++QH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV---------SRQKLEFKHRLSIA 113
V G C + + +++EY+ +G ++ L +GP + ++ +L L IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
A G+ +L S VH+D T N LV + + K+ D G+ + TD
Sbjct: 130 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230
++ E +R+F+ +SDV+SFGV L E+ + G++ LS +++E + R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 50/290 (17%)
Query: 14 KNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPG---APTQEFIDEVCFLASIQHRNLV 65
+ +IG G+FGEV++G+L+ + VAIK +PG Q+F+ E + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLSIALGAAKG 119
L G + +I EY+ NG++ +L + Q+ + + G A G
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL----------VGMLRGIAAG 119
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 176
+ +L ++ VH+D N+LV+ + KV+D GL L D + + +I
Sbjct: 120 MKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIR 175
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-- 234
+ A E +R+F+ SDV+SFG+ + E++S E + D SN
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----------------RPYWDMSNHE 218
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
++K +++ + QL+++C RRP D+V LD+ L
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 10 NFSDKNLIGEGKFGEVY------------KGLLQDGM-----LVAIKK-RPGAPT---QE 48
NF +K +GEG+FGEV+ K ++ LVA+K RP A ++
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 49 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPS 97
F+ EV L+ + N+ LLG C + +I EY+ NG ++ L
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 98 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157
+S L L +A A G+ +L SL+ VH+D T N LV +++ K+AD G+
Sbjct: 126 SLSFSTL-----LYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GRE 209
L +D + ++A E +F+ KSDV++FGV L E+++ RE
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-20
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV+ G + VA+K +PG Q F++E + ++QH LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
++I EY+ GS+ L K+ + + A+G+A++ +H+D
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRD 128
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 188
+ ANVLV E + K+AD GL + ++ TA E + A E F F
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 189 SEKSDVYSFGVFLLELVS 206
+ KSDV+SFG+ L E+V+
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-20
Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G+G FGEV+ G VAIK +PG + E F+ E + ++H LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ +++ EY+ GS+ L G + L + +A A G+A++ ++ VH+D
Sbjct: 74 PI-YIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 127
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 193
+ AN+LV E+ + KVAD GL + D + Q I + A E + RF+ KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 194 VYSFGVFLLELVS-GR 208
V+SFG+ L EL + GR
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 23/239 (9%)
Query: 10 NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQ 60
N K +GEG FG+V+ QD +LVA+K A ++F E L ++Q
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV------SRQKLEFKHRLSI 112
H ++V G C E + +++EY+ +G ++ L +GP V +L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
A A G+ +L S VH+D T N LV E+ + K+ D G+ + TD
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230
++ E +R+F+ +SDV+S GV L E+ + G++ L S+ +++E + R
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEVIECITQGR 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 15 NLIGEGKFGEVYKGLLQDGML-------VAIKK-RPGAPTQE---FIDEVCFLASIQHRN 63
N +G G FGEVY+G D + VA+K R GA QE F+ E +++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK--LEFKHRLSIALGAAKGLA 121
+V LLG C N Q++I E + G + +L L K L I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 122 HLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
+L + +H+D N LV E D + K+ D GL + ++D +
Sbjct: 121 YLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E +F+ +SDV+SFGV + E+++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 34/281 (12%)
Query: 16 LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 67
+IG G+FGEV +G L+ + VAIK T+ +F+ E + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
G ++ +I E++ NG++ L + + + + + G A G+ +L ++
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEI-FLASEVKE 184
VH+D N+LV+ + + KV+D GL FL +D SS I + A E
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 185 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+R+F+ SDV+S+G+ + E++S G + S+QD++ ++ D RL
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVINAIEQ-----------DYRL 230
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
+ QL++ C RP +V+ LD+ +
Sbjct: 231 PPPM--DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IGEG +G+VYK + G LVA+KK + G P I E+ L ++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNIVRLKE 65
Query: 70 Y---CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ ++ ++++EY+ + + + + ++ K +GL +LHS
Sbjct: 66 IVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQI--KC---YMKQLLEGLQYLHS- 118
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 181
++H+D K +N+L++ D + K+AD GL R + R + +T E+ L +
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGR 208
R+ + D++S G L EL G+
Sbjct: 178 -----RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 87/302 (28%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGM----LVAIK--KRPGAPTQ--EFIDEV 53
EL L+ F ++ +GE FG++YKG L GM LVAIK K P Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS------------R 101
+A + H N+V LLG + +++EY+ G + L S S +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
L+ L IA+ A G+ +L S VHKD N+L+ E K++D GL +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 218
D + ++ E + +FS SD++SFGV L E+ S L P S
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF-----SFGLQPYYGFS 231
Query: 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
+Q+++E+V+ R + R++S L+ C RRP D+ T
Sbjct: 232 NQEVIEMVRK-RQLLPCSEDCPPRMYS------------LMTECWQEGPSRRPRFKDIHT 278
Query: 279 EL 280
L
Sbjct: 279 RL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 14 KNLIGEGKFGEVYKGLLQDG-------MLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL 64
+L+ EG FG ++ G+L D + V K + Q + E C L + H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 65 VTLLGYCQEN-NLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALGAAKG 119
+ +L C E+ F++Y Y+ G++ + L G + Q L + + +A+ A G
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RN-FLGRTDVAGPSSQVTADEIF 177
+++LH V+HKD N ++DE+ K+ D L R+ F G + +
Sbjct: 130 MSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVS 206
L S V + +S SDV+SFGV L EL++
Sbjct: 188 LESLVNKE--YSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-19
Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FG V G + VAIK K EFI+E + + H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+++ EY+ NG + +L + ++ + L + +G+A+L S + +H+D
Sbjct: 72 RPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRD 125
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 193
N LVD+ KV+D GL ++ D SS + + + EV + +FS KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 194 VYSFGVFLLELVS 206
V++FGV + E+ S
Sbjct: 184 VWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEFIDE 52
E++L+T F ++ +GE +FG+VYKG L + VAIK K G +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 101
+ +QH N+V LLG + +I+ Y + + L S S +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
LE + I A G+ L S VVHKD T NVLV + K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 218
D +++ E + +FS SD++S+GV L E+ S L P S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF-----SYGLQPYCGYS 231
Query: 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
+QD++E+++N + +L D+ +T L++ C + RRP D+ +
Sbjct: 232 NQDVIEMIRNRQ----VLPCPDDCPAWVYT---------LMLECWNEFPSRRPRFKDIHS 278
Query: 279 EL 280
L
Sbjct: 279 RL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 71
IG G FGEV+ G L+ D VA+K R P +F+ E L H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ +++ E + G L + +L+ K + + AA G+ +L S +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLES--KHCI 116
Query: 132 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 189
H+D N LV E + K++D G+ G G Q+ + A E + R+S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK--WTAPEALNYGRYS 174
Query: 190 EKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 248
+SDV+SFG+ L E S G ++LS +++ +E Q R L +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--QGVR-----LPCPE-------- 219
Query: 249 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+ +L+ RC + +RPS S V EL
Sbjct: 220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 77/300 (25%), Positives = 133/300 (44%), Gaps = 55/300 (18%)
Query: 14 KNLIGEGKFGEVYKGLL-QDG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 65
+++IGEG FG+V K + +DG M AIK+ +++ F E+ L + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 114
LLG C+ +L EY P+G++ L + + + L + L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 166
A+G+ +L + +H+D N+LV E+++AK+AD GL + +GR V
Sbjct: 132 DVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
++A E + ++ SDV+S+GV L E+V S +P EL
Sbjct: 189 ----------WMAIESLNYSVYTTNSDVWSYGVLLWEIV-----SLGGTPYCGMTCAELY 233
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
+ L K L+ +E L+ +C RPS + ++ L+R L++
Sbjct: 234 EKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 45/220 (20%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-------------QEFIDEVCFLASIQH 61
LIG+G +G VY L + G ++A+K+ T + E+ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIA 113
N+V LG+ + EY+P GS+ + YG + Q LE
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------- 119
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
GLA+LHS ++H+D K N+LVD D I K++D G+ ++D + Q +
Sbjct: 120 -----GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMS 169
Query: 174 --DEIF-LASEVKEFRR--FSEKSDVYSFGVFLLELVSGR 208
+F +A EV +S K D++S G +LE+ +GR
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FG V+ G + + VAIK GA ++E FI+E + + H LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 75 NLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+++ E++ NG + +L G ++S+ L LS+ +G+ +L S +
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQG--KLSKDML-----LSMCQDVCEGMEYLERNS--FI 122
Query: 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 191
H+D N LV + KV+D G+ ++ D SS + EV F ++S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 192 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 251
SDV+SFGV + E+ + E S+ ++VE++ SR F ++ +L S E
Sbjct: 182 SDVWSFGVLMWEVFT--EGKMPFEKKSNYEVVEMI--SRGF----RLYRPKLASMTVYEV 233
Query: 252 MEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
M C E RP+ ++++ +
Sbjct: 234 M-------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK------------KRPGAPTQEFIDEVCFLASIQHR 62
LIG G FG VY G+ G L+A+K R + E+ L +QH
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGL 120
N+V LG + + + EY+P GSV+ L YG + + + + L KGL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL------GRTDVAGPSSQVTAD 174
+LH + ++H+D K AN+LVD K++D G+ L +T+ A PS Q +
Sbjct: 120 NYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV- 176
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV + ++ K+D++S G ++E+++G+
Sbjct: 177 -FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQE----FIDEVCFLASIQH 61
K F+D IG G FG VY ++ +VAIKK G + E I EV FL ++H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N + G + +L+ EY GS S L +V ++ L+ +I GA +GLA
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLA 129
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS +H+D K N+L+ E K+AD G + P++ ++A E
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLAD------FGSASLVSPANSFVGTPYWMAPE 181
Query: 182 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
V + ++ K DV+S G+ +EL + +++ S+ L + QN
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNDSP------- 232
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
+ +N+ + F + CL + RPS +++
Sbjct: 233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 64/308 (20%)
Query: 17 IGEGKFGEVYKGL------LQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 66
+GEG+FG+V K VA+K + A + E D E L + H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSR--------------QKLEFK 107
L G C ++ LI EY GS+ L GPS + + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 108 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167
+S A ++G+ +L + +VH+D NVLV E K++D GL + D
Sbjct: 128 DLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 226
S+ ++A E ++ +SDV+SFGV L E+V+ G ++P
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---------- 235
Query: 227 QNSRDFSNLLKILDERLWSTF-TNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVT 278
ERL++ T M EE L++ C ++RP+ +D+
Sbjct: 236 --------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
Query: 279 ELDRTLDK 286
EL++ + K
Sbjct: 282 ELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 77/268 (28%), Positives = 118/268 (44%), Gaps = 37/268 (13%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLLGYCQ 72
IG G +G+VYK + G LVAIK P +F E+ L +H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL---GAAKGLAHLHSLSPR 129
+ +++ EY GS+ +Y QV+R L L IA KGLA+LH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ-DIY---QVTRGPLS---ELQIAYVCRETLKGLAYLHET--G 121
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKE 184
+H+D K AN+L+ ED K+AD G+ L T +A S + A E+ + V+
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEV---AAVER 177
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ K D+++ G+ +EL + L P + L S+ K+ D+ W
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSNFPPPKLKDKEKW 232
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPS 272
S F I +CL ++RP+
Sbjct: 233 SP-------VFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G+G FGEV+ G VAIK +PG E F+ E + ++H LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ +++ E++ GS+ L + + L+ + +A A G+A++ ++ +H+D
Sbjct: 74 PI-YIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRD 127
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 193
+ AN+LV ++ + K+AD GL + D + Q I + A E + RF+ KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 194 VYSFGVFLLELVS-GR 208
V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 17 IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 63
+GEG FG+V K ++ + VA+K T+ + + E+ + I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 112
++ LLG C ++ ++I EY G++ +L Y ++V +++ FK +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
A+G+ +L S + +H+D NVLV E+ + K+AD GL + D ++
Sbjct: 143 TYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A E R ++ +SDV+SFGV + E+ + SP + E
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF-----TLGGSPYPGIPVEE-------- 247
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
L K+L E E ++ C RP+ +V +LDR L N
Sbjct: 248 --LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 31/270 (11%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLLG-Y 70
+G+G G VYK + G + A+KK +EF + E+ L S + +V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
+E + ++ EY+ GS++ L ++ L + IA KGL +LH+ +
Sbjct: 69 YKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR-HI 121
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 190
+H+D K +N+L++ K+AD G+ L T + T +++ E + +S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV--TYMSPERIQGESYSY 179
Query: 191 KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNE 250
+D++S G+ LLE G+ P EL+Q D L +S
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGPPPS--LPAEEFS----- 229
Query: 251 GMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
EF I CL ++RPS EL
Sbjct: 230 --PEFRDFISACLQKDPKKRPS----AAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 29/288 (10%)
Query: 13 DKNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 68
++N+I GK G YKG ++ I P+ E D + +QH N+V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLS 127
G C+ +LI+EYI ++S L S R+K IA+G AK L LH S
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK--------IAIGIAKALRFLHCRCS 801
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
P VV + +++D + L L SS ++A E +E +
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKD 854
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW--- 244
+EKSD+Y FG+ L+EL++G+ + + +VE + +L +D +
Sbjct: 855 ITEKSDIYGFGLILIELLTGK-SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 292
S NE + E + L + C RP +DV+ L+ + T
Sbjct: 914 SVNQNE-IVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLG 69
IGEG G V+K + G VA+KK G P Q + E+ L + QH +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHPYVVKLLD 66
Query: 70 YCQENNLQFLIYEYIPNG--SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
+ L+ EY+P+ V P ++ K + L KG+A++H+
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------KGVAYMHAN- 118
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEV 182
++H+D K AN+L+ D + K+AD GL + S QV A E+ +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA-- 175
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGR 208
R++ D+++ G EL++G
Sbjct: 176 ---RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
K FSD IG G FG VY +++ +VAIKK + Q+ I EV FL ++H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N + G + +L+ EY GS S L +V ++ L+ ++ GA +GLA
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS + ++H+D K N+L+ E + K+ D G + P++ ++A E
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181
Query: 182 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
V + ++ K DV+S G+ +EL + ++ L + QN
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNES------PA 233
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 294
L WS E F + CL + RP+ S+V+ + R + +E T +M
Sbjct: 234 LQSGHWS-------EYFRNFVDSCLQKIPQDRPT-SEVLLK-HRFVLRERPPTVIM 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 79/312 (25%), Positives = 138/312 (44%), Gaps = 45/312 (14%)
Query: 17 IGEGKFGEVYK----GLLQD----GMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 63
+GEG FG+V + G+ + + VA+K T + I E+ + I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GP------SQVSRQKLEFKHRLSI 112
++ LLG C + ++I EY G++ L GP ++V ++L FK +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
A A+G+ +L S R +H+D NVLV ED + K+AD GL + D +S
Sbjct: 140 AYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A E R ++ +SDV+SFG+ + E+ + + P
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------------V 242
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL----DKEM 288
L K+L E + E L+ C +RP+ +V LD+ L ++ +
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302
Query: 289 NLTTVMGEGTPT 300
+L+ + +P+
Sbjct: 303 DLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 14 KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLV 65
+++IGEG FG+V + +++ DG M AIK ++ +F E+ L + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 114
LLG C+ ++ EY P G++ L + + L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 166
A G+ +L + +H+D NVLV E+ +K+AD GL + +GR V
Sbjct: 127 DVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E + ++ KSDV+SFGV L E+VS
Sbjct: 184 ----------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 45/286 (15%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 60
NF + IG+G+F VYK + L DG +VA+KK Q+ + E+ L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
H N++ L ENN ++ E G +S + + ++ + + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA------D 174
H+HS R++H+D K ANV + + K+ D GL F SS+ TA
Sbjct: 120 EHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGT 169
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN--SR 230
+++ E ++ KSD++S G L E+ + + SP +L L +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSLCKKIEKC 223
Query: 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
D+ L +S EE L+ RC++P E+RP +S V
Sbjct: 224 DYPPLPA----DHYS-------EELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 16 LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 65
++G G FG VYKG+ + DG + VAIK P A +E +DE +A + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYVC 72
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C + +Q L+ + +P G + ++ + ++ ++ + L+ + AKG+++L
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSSQVTADEIFLASEVK 183
+ R+VH+D NVLV K+ D GL L T+ +V + L S +
Sbjct: 128 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 184 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
RRF+ +SDV+S+GV + EL++ G + + +R+ +LL+ ER
Sbjct: 186 --RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-------------AREIPDLLE-KGER 229
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
L ++ ++ ++V+C SE RP ++V E R
Sbjct: 230 L-PQPPICTIDVYM-IMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 37/279 (13%)
Query: 13 DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQE---FIDEVCFLASIQHRNLVTLL 68
++ ++G+G +G VY L + +AIK+ P ++ +E+ + ++HRN+V L
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 69 GYCQENNLQFLIY-EYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
G EN F I+ E +P GS+S L +GP + + Q + F + + +GL +LH
Sbjct: 72 GSDSENGF-FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH 125
Query: 125 SLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 182
++VH+D K NVLV+ + K++D G L + + T ++A EV
Sbjct: 126 DN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVI 181
Query: 183 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSL-SPDSSQDLVELVQNSRDFSNLLKILD 240
K R + +D++S G ++E+ +G+ L P ++ V + KI
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----------GMFKIHP 231
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279
E E I+RC +P ++R S D++ +
Sbjct: 232 E-----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFI----DEVCFLASIQHRNLVT 66
L+G G FG VY+GL L DG A+K+ G QE + E+ L+ +QH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLSIALGAAK 118
LG +E + ++ E +P GS++ L YG +RQ L
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------------L 113
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
GL +LH VH+D K AN+LVD + + K+AD G+ + A ++
Sbjct: 114 GLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWM 168
Query: 179 ASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 208
A EV + + +D++S G +LE+ +G+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 75/317 (23%), Positives = 138/317 (43%), Gaps = 54/317 (17%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----------------QEFIDEVCFLASI- 59
+GEG FG+V ++ + + + K +P P + + E+ + I
Sbjct: 20 LGEGCFGQV---VMAEAIGID-KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKH 108
+H+N++ LLG C ++ +++ EY G++ +L + ++ ++L FK
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 109 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
+S A A+G+ +L S + +H+D NVLV ED + K+AD GL + D +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+ ++A E R ++ +SDV+SFGV L E+ + SP + E
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF-----TLGGSPYPGIPVEE---- 244
Query: 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL---- 284
L K+L E E ++ C +RP+ +V +LDR L
Sbjct: 245 ------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
Query: 285 -DKEMNLTTVMGEGTPT 300
D+ ++L+ + +P
Sbjct: 299 TDEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 28/206 (13%)
Query: 16 LIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAPTQ--EFIDEVCFLASIQHRNLVT 66
++G G FG VYKG+ + +G + VAIK P EF+DE +AS+ H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C +Q L+ + +P+G + +++ + Q L L+ + AKG+ +L
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLAS 180
R+VH+D NVLV K+ D GL L G + AD ++A
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMAL 180
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS 206
E +R+F+ +SDV+S+GV + EL++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 16 LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 67
+IG G+FGEV G L+ + VAIK T+ +F+ E + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHS 125
G ++ ++ EY+ NGS+ L + +F + + G A G+ +L
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 182
+ VH+D N+LV+ + + KV+D GL L D + +I + A E
Sbjct: 125 MG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
+R+F+ SDV+S+G+ + E++S G + S+QD+++ ++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM---SNQDVIKAIEEGY----------- 226
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
RL + QL++ C RP +V+ LD+
Sbjct: 227 RLPAPMDCPAA--LHQLMLDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 25/267 (9%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
IG G VY + L + VAIK+ + E EV ++ H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 72 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
+ +L+ Y+ GS+ I R L+ ++ KGL +LHS
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSS---YPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRR- 187
+H+D K N+L+ ED K+AD G+ L G ++A EV E
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
+ K+D++SFG+ +EL +G S P + L+ +QN D +L D + +S
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQN--DPPSLETGADYKKYS-- 237
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMS 274
+ F ++I CL +RP+
Sbjct: 238 -----KSFRKMISLCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 9e-17
Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 58/299 (19%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNL 64
+ +GEG +G VYK + G +VA+KK R + + E+ L ++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V LL +L++EY L L SI +GLA+ H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFL--GRT---DVAGPSSQVT----AD 174
S R++H+D K N+L++ D + K+AD GL R F RT +V VT A
Sbjct: 116 S--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV------VTLWYRAP 167
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE---ASSSL-------------SPDS 218
EI L S + +S D++S G E+++G+ S + + +S
Sbjct: 168 EILLGS-----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL--DPSSERRPSMSD 275
+ +L F E++ EG I L+ + L +P +R S +
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG----IDLLSKMLQYNP--AKRISAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 31/276 (11%)
Query: 17 IGEGKFGEVYKGLLQDGMLVA---IKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 69
IG G FG+V G GM A +K+ R A E F+ EV + H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
C E+ L+ E+ P G + +L + Q + +A A GL LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--- 186
+H D N + D K+ D GL D +LA E+ E R
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 187 ----RFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNLLKILDE 241
++KS+++S GV + EL A+ PD S + +++ V +D +K+
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELF---TAADQPYPDLSDEQVLKQVVREQD----IKLPKP 233
Query: 242 RLWSTFTNEGMEEFIQLIVRC-LDPSSERRPSMSDV 276
+L ++ + + +++ C LDP E RP+ +V
Sbjct: 234 QLDLKYS----DRWYEVMQFCWLDP--ETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 17 IGEGKFGEVYKGLLQ--DG--MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 68
+G G FG V KG+ G + VA+K + A +EF+ E +A + H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G C+ L L+ E P G + +L ++ L +A A G+A+L S
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES--K 114
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEV 182
VH+D NVL+ AK++D G+ LG AG S A + A E
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG----AG-SDYYRATTAGRWPLKWYAPEC 169
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS 206
+ +FS KSDV+S+GV L E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 71/303 (23%)
Query: 14 KNLIGEGKFGEVY----KGLL---------QDG--MLVAIKK-RPGAPT---QEFIDEVC 54
K +GEG+FGEV+ +GL DG +LVA+K R +F+ E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------PSQVSR 101
++ +++ N++ LLG C ++ +I EY+ NG ++ L PS VS
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VSI 128
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
L L +A+ A G+ +L SL+ VH+D T N LV + K+AD G+ L
Sbjct: 129 ANL-----LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ 220
D + ++A E +F+ SDV++FGV L E+ + +E SL D
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239
Query: 221 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIVRCLDPSSER 269
++++N+ +F F N+G + ++ +L++RC +
Sbjct: 240 ---QVIENTGEF--------------FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD 282
Query: 270 RPS 272
RP+
Sbjct: 283 RPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 46/298 (15%)
Query: 5 SLATKNFSDKNLIGEGKFGEVYKGLL--QDG----MLVAIKKRPGAPTQE----FIDEVC 54
+ + + +G G FGEVY+GL +DG + VA+K P + +++ F+ E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHRLSI 112
++ H+N+V L+G E +F++ E + G + L P L K L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV----- 164
A AKG +L +H+D N L+ +AK+AD G+ + R
Sbjct: 122 ARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 165 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 222
A + E FL F+ K+DV+SFGV L E+ S G ++Q++
Sbjct: 180 RAMLPIKWMPPEAFLDG------IFTSKTDVWSFGVLLWEIFSLGYMPYPGR---TNQEV 230
Query: 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+E V RL G +++ C + E RP+ + ++ +
Sbjct: 231 MEFV-----------TGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 15 NLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLVT 66
++IGEG FG+V K ++ DG M AIK+ ++ +F E+ L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIALG 115
LLG C+ +L EY P+G++ L + + + L + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAGP 167
A+G+ +L + +H+D N+LV E+++AK+AD GL + +GR V
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E + ++ SDV+S+GV L E+VS
Sbjct: 177 ---------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 15 NLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVT 66
+IG+G FG VY G L D + A+K ++F+ E + H N+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 67 LLGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C + ++ Y+ +G + + + K + L AKG+ +L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVK 183
S + VH+D N ++DE F KVAD GL R+ + + ++A E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER- 242
+ ++F+ KSDV+SFGV L EL++ R A PD +S D + L L R
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT-RGAPP--YPDV---------DSFDITVYL--LQGRR 220
Query: 243 -LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
L + + + E +++ C P E RP+ S++V+ ++
Sbjct: 221 LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQE-----FIDEVCFLASIQHRNLV 65
+G G F Y+ ++ G L+A+K+ R + QE E+ +A + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIA--LGAAKGLA 121
+LG E++ L E++ GSVS + YG FK + I +GL+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLS 117
Query: 122 HLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP---SSQVTADEIF 177
+LH +++H+D K AN+L+D ++AD G L G Q+ F
Sbjct: 118 YLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA-AKGTGAGEFQGQLLGTIAF 174
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+A EV ++ DV+S G ++E+ + +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 78/316 (24%), Positives = 135/316 (42%), Gaps = 80/316 (25%)
Query: 14 KNLIGEGKFGEVY--------------------KGLLQDGMLVAIK-KRPGAPTQ---EF 49
K +GEG+FGEV+ KG +LVA+K RP A +F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDF 66
Query: 50 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--------GPSQVSR 101
+ EV L+ ++ N++ LLG C + + +I EY+ NG ++ L +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 102 QK------LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
+ + L +AL A G+ +L SL+ VH+D T N LV E+ K+AD G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG- 183
Query: 156 RNFLGRTDVAGPSSQVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 211
+ R AG ++ + ++A E +F+ SDV++FGV L E++ +
Sbjct: 184 ---MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE- 239
Query: 212 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIV 260
P ++++N+ +F F ++G + ++ +L++
Sbjct: 240 ---QPYGELTDEQVIENAGEF--------------FRDQGRQVYLFRPPPCPQGLYELML 282
Query: 261 RCLDPSSERRPSMSDV 276
+C RPS SD+
Sbjct: 283 QCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-16
Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
K F+D IG G FG VY ++ +VAIKK + Q+ I EV FL I+H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N + G + +L+ EY GS S L +V ++ L+ +I GA +GLA
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLA 139
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS + ++H+D K N+L+ E K+AD G +A P++ ++A E
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASIASPANSFVGTPYWMAPE 191
Query: 182 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
V + ++ K DV+S G+ +EL + +++ S+ L + QN
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES------PT 243
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
L WS + F + CL + RP+ +++ +
Sbjct: 244 LQSNEWSDY-------FRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-16
Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 25/276 (9%)
Query: 17 IGEGKFGEVY------KGLLQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 66
+GEG FG+V +G G VA+K +P + D E+ L ++ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 67 LLGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
G C E+ N LI E++P+GS+ +L P + K+ K +L A+ KG+ +L
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN--KINLKQQLKYAVQICKGMDYLG 126
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEV 182
S + VH+D NVLV+ + K+ D GL + TD + + D + A E
Sbjct: 127 S--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDE 241
+F SDV+SFGV L EL++ ++ S SP + ++ + L+++L+E
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSES--SPMTLFLKMIGPTHGQMTVTRLVRVLEE 241
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
EE QL+ +C + +R + +++
Sbjct: 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAP--TQEFIDEVCFL 56
L F ++G G FG VYKGL + +G + VAIK + +P +E +DE +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 57 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
AS+ + ++ LLG C + +Q LI + +P G + ++ + + + ++ L+ +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 118
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
AKG+ +L R+VH+D NVLV K+ D GL LG + +
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E R ++ +SDV+S+GV + EL++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 45/282 (15%)
Query: 16 LIGEGKFGEVYKG----LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G FG V +G + VA+K + +F+ E + S+ H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G + L ++ E P GS+ + L A+ A G+ +L S
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES 115
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEV 182
R +H+D N+L+ D K+ D GL L + + V +V + A E
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF--AWCAPES 171
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD- 240
R FS SDV+ FGV L E+ + G E + LS S +LK +D
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----------------SQILKKIDK 215
Query: 241 --ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
ERL ++ ++++C + RP+ + + L
Sbjct: 216 EGERL--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV+ VA+K +PG+ + E F+ E + ++QH LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ ++I E++ GS+ + + S+Q L + + A+G+A + + +H+D
Sbjct: 74 PI-YIITEFMAKGSL-LDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--YIHRD 127
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSD 193
+ AN+LV + K+AD GL + + A ++ + A E F F+ KSD
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--WTAPEAINFGSFTIKSD 185
Query: 194 VYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 252
V+SFG+ L+E+V+ GR +S +++ L+
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSN----------------PEVIRALERGYRMPRPENCP 229
Query: 253 EEFIQLIVRCLDPSSERRPS 272
EE +++RC E RP+
Sbjct: 230 EELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-16
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 17 IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVT 66
+G+G FG VY+GL + VAIK + EF++E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLY----------GPSQVSRQKLEFKHRLSIALGA 116
LLG ++ E + G + +L G + QK + +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
A G+A+L + + VH+D N +V ED K+ D G+ + TD +
Sbjct: 129 ADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E + F+ KSDV+SFGV L E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNLVTLLGY 70
IGEG +G VYK G +VAIKK + ++ + E+ L + H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
+ +L++E++ LY + ++ L S +GLA HS +
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGI 119
Query: 131 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 184
+H+D K N+L++ + + K+AD GL R+F + V + V A E+ L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGD---- 173
Query: 185 FRRFSEKSDVYSFGVFLLELVSGR 208
+ +S D++S G EL+S R
Sbjct: 174 -KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT----QEFIDEVCFLASIQHRN 63
F + IG G FG VY +VA+KK G T Q+ I EV FL ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+ G + + +L+ EY GS S L +V ++ L+ +I GA +GLA+L
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 182
HS + ++H+D K N+L+ E K+AD G + P++ ++A EV
Sbjct: 138 HSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASKSSPANSFVGTPYWMAPEVI 189
Query: 183 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+ ++ K DV+S G+ +EL + +++ S+ L + QN S L+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQND---SPTLQ--- 241
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+NE + F + CL + RP+ ++++
Sbjct: 242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIK---KRPG-APTQEFIDEVCFLASIQHRN 63
+ + + +GEG G V K L GM+ A+K P ++ + E+ S +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 64 LVTLLGYC---QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
+V G +++ + EY GS+ +Y + ++ K IA KGL
Sbjct: 61 IVKYYGAFLDESSSSIG-IAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
++LHS +++H+D K +N+L+ K+ D G+ L +AG T ++A
Sbjct: 119 SYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAG---TFTGTSFYMAP 172
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDLVELVQNSRDFSNL 235
E + + +S SDV+S G+ LLE+ R E L P +L+ + N +
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---IELLSYIVNMPNP--- 226
Query: 236 LKILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
++ DE WS EEF I +CL+ RRP+ D++
Sbjct: 227 -ELKDEPGNGIKWS-------EEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 10 NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
NF + IG G+F EVY+ L DG+ VA+KK + I E+ L + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
N++ E+N ++ E G +S H ++ +K +K+ + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
L H+HS RV+H+D K ANV + + K+ D GL F A S + +++
Sbjct: 119 LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E ++ KSD++S G L E+ + + SP + + +L K +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ------SP--------FYGDKMNLYSLCKKI 220
Query: 240 DERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++ + ++ EE QL+ C++P E+RP ++ V
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--------TQEFIDEVCFLASIQ 60
N+ L+G+G FG VY D G +A+K+ P P E+ L ++Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 61 HRNLVTLLGYCQENNLQFLIY-EYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLS 111
H +V G C ++ I+ EY+P GSV L YG + +RQ LE
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------ 115
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSS 169
G+ +LH S +VH+D K AN+L D K+ D G L + G S
Sbjct: 116 -------GVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
VT +++ EV + K+DV+S G ++E+++
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 15 NLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAP--TQEFID-----EVCFLASIQHRNLV 65
+GEG + VYK + G +VAIKK + G ++ I+ E+ L ++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 66 TLLG-YCQENNLQFLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
LL + ++N+ L++E+ I + S+ + P+ + S L
Sbjct: 66 GLLDVFGHKSNIN-LVFEFMETDLEKVIKDKSI---VLTPADIK----------SYMLMT 111
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---- 172
+GL +LHS ++H+D K N+L+ D + K+AD GL G + VT
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ + R + D++S G EL+
Sbjct: 170 APELLFGA-----RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-------HR 62
F +IGEG +G+VYK + G LVAIK ++ +E+ H
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEI--KEEYNILRKYSNHP 63
Query: 63 NLVTLLG-------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
N+ T G ++ L +L+ E GSV L + ++L+ + I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSV-TDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 171
+GLA+LH +V+H+D K N+L+ ++ K+ D G L + LGR + +
Sbjct: 122 TLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231
A E+ E + + +SDV+S G+ +EL G+ + P + L + R+
Sbjct: 180 MAPEVIACDEQPD-ASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFKIPRN 233
Query: 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
LK WS ++F I CL + E+RP M +++
Sbjct: 234 PPPTLK--SPENWS-------KKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IGEG +G VYKG + G +VA+KK G P+ I E+ L +QH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
+ + +LI+E++ S+ + Y S Q ++ + S +G+ HS R
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RR 121
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 185
V+H+D K N+L+D + K+AD GL G VT A E+ L S
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP---- 177
Query: 186 RRFSEKSDVYSFGVFLLELVSGR 208
R+S D++S G E+ + +
Sbjct: 178 -RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 6e-15
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 47/279 (16%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNL 64
+ + + IGEG GEVYK G VAIKK R +E I+E+ + +H N+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V + +++ EY+ GS++ + + ++ + +GL +LH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLA 179
S V+H+D K+ N+L+ +D K+AD G + R V G T ++A
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG-----TP--YWMA 184
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSRDFS 233
EV + + + K D++S G+ +E+ G P +++ + L +N +S
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-KNPEKWS 243
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
K +F+ +CL E+RPS
Sbjct: 244 PEFK----------------DFLN---KCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 84/298 (28%), Positives = 120/298 (40%), Gaps = 66/298 (22%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
NF IGEG +G VYK G +VA+KK G P+ I E+ L + H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 63 NLVTLLGYCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLS 111
N+V LL N +L++E++ P + + L K L
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL------------IKSYLF 107
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 171
L +GLA H S RV+H+D K N+L++ + K+AD GL G V
Sbjct: 108 QLL---QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 172 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227
T A EI L + +S D++S G E+V+ R +L P S E+ Q
Sbjct: 163 TLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR----ALFPGDS----EIDQ 209
Query: 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTELDRT 283
R F L DE +W T+ + ++ PS + R S VV LD
Sbjct: 210 LFRIF-RTLGTPDEVVWPGVTS--LPDY--------KPSFPKWARQDFSKVVPPLDED 256
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 75/286 (26%), Positives = 115/286 (40%), Gaps = 65/286 (22%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKKR----PGAPTQEFIDEVCFLASIQHRNLVTLL-GYC 71
+G+G FG+VYK ++ L A K ++F+ E+ L+ +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 72 QENNLQFLIYEYIPNGSV-SI-----HLYGPSQ---VSRQKLEFKHRLSIALGAAKGLAH 122
EN L LI E+ G++ SI Q V RQ LE L
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLE-------------ALNF 118
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFL 178
LHS +V+H+D K N+L+ D K+AD G+ T + T A E+ +
Sbjct: 119 LHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV-V 175
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
A E + + K+D++S G+ L+EL L+P LLKI
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---------------MRVLLKI 220
Query: 239 LDE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L WS+ F + CL + RP+ +++
Sbjct: 221 LKSEPPTLDQPSKWSS-------SFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 53/270 (19%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 17 IGEGKFGE--VYKGLLQDGMLVAIK----KRPGAPTQEF-IDEVCFLASIQHRNLVTLLG 69
+G+G FGE +Y+ +D LV K R + ++E+ L+ +QH N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--GAAKGLAHLHSLS 127
+ ++N + EY G++ + V ++ F+ + + ++++H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
++H+D KT N+ + + + K+ D G+ LG ++ + + V +++ E+ + +
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAET-VVGTPYYMSPELCQGVK 177
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
++ KSD+++ G L EL++ + + +P NL+ + + ++
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP----------------LNLVVKIVQGNYTPV 221
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ E I L+ L E+RP+ +V+
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 11 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 65
F+ IG+G FGEVYKG+ + +VAIK + ++ E+ L+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G + ++I EY+ GS ++ L P LE + +I KGL +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG-----PLEETYIATILREILKGLDYLHS 119
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
R +H+D K ANVL+ E K+AD G+ L TD + ++A EV +
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
+ K+D++S G+ +EL G +S L P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 43/232 (18%)
Query: 9 KNFSDKNLIGEGKFGEVY----KGLLQ-------------DGMLVAIKK-RPGA---PTQ 47
K + K +GEG+FGEV+ +G+ + +LVA+K R A
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 48 EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY------GPSQVSR 101
+F+ E+ ++ ++ N++ LL C ++ +I EY+ NG ++ L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
+ + + +A A G+ +L SL+ VH+D T N LV +++ K+AD G+ L
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 162 TD---VAG----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
D + G P ++ + I L +F+ SDV++FGV L E+++
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 6 LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQE---FIDEVCFLA 57
L K+ + ++G G+FGE+ +G L+ + VAI R G ++ F+ E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGA 116
H N+V L G N ++ EY+ NG++ L Q+ +L + + G
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGL 116
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
A G+ +L + VHK VLV+ D + K++ G R L + ++
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKIS--GFRR-LQEDKSEAIYTTMSGKSP 171
Query: 177 FL--ASEVKEFRRFSEKSDVYSFGVFLLELVS 206
L A E ++ FS SDV+SFG+ + E++S
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 52/281 (18%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
IG+G FG V K DG ++ K Q+ + EV L ++H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 71 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
N +++ EY G ++ L + R+ +E + I L H+
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 126 L---SPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 176
V+H+D K AN+ +D + K+ D GL + +T V P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP--------Y 175
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSN 234
+++ E + EKSD++S G + EL + P ++++ ++L ++ F
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------PPFTARNQLQLASKIKEGKFRR 229
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
+ L +I L+ ++RPS +
Sbjct: 230 IPYRYSSELNE------------VIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 10 NFSDKNLIGEGKFGEVY--KGLLQDGMLV----AIKKRPGAPTQEFIDEVCFLASIQHRN 63
+ IGEG FG++Y K V + K P + EV LA ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK---LEFKHRLSIALGAAKGL 120
+VT QEN F++ EY G + +++RQ+ LS + + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLM------KRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 121 AHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
H+H +++H+D K+ N+ + ++ +AK+ D G+ L D + +L+
Sbjct: 115 KHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLS 170
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVS 206
E+ + R ++ K+D++S G L EL +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 52/275 (18%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLLGYC 71
+G G G V K L + G ++A+K + + E+ L +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 72 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
N + EY+ GS+ I ++ + L IA+ KGL +LH ++
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE-KHKI 122
Query: 131 VHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+H+D K +N+LV+ K+ D G L N L +T V G SS ++A E +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-GTSS-------YMAPERIQGN 174
Query: 187 RFSEKSDVYSFGVFLLELVSGR--EASSSLSPDSSQDLVELVQNSRDFSNLLKILDE--- 241
+S KSD++S G+ L+EL +GR + PD F L I++E
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVNEPPP 222
Query: 242 RL----WSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
RL +S +F + CL RPS
Sbjct: 223 RLPSGKFS-------PDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 46/219 (21%)
Query: 15 NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFI-DEVCFLASIQHRNLVTLL 68
N IG G FG+VY + L G L+A+K + T + I DE+ L ++H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 69 G-------------YCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
G YC L + L + I + V I +Y + Q LE
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRVY-----TLQLLE--------- 110
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 173
GLA+LHS +VH+D K AN+ +D + + K+ D G L T G Q A
Sbjct: 111 ----GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 174 -DEIFLASEVKEFRRFSEK---SDVYSFGVFLLELVSGR 208
++A EV + +D++S G +LE+ +G+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 34/228 (14%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 69
++GEG +G V K + G +VAIKK + E + EV L ++H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ +L++EY+ ++ P + + S + +A+ HS
Sbjct: 68 AFRRKGRLYLVFEYVER---TLLELLEASPGGLPPDAVR-----SYIWQLLQAIAYCHSH 119
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 181
++H+D K N+LV E + K+ D G R R T A E+ +
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQN 228
+ + DV++ G + EL+ G L P DS D + L+Q
Sbjct: 178 -----NYGKPVDVWAIGCIMAELLDGE----PLFPGDSDIDQLYLIQK 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 65
F+ IG+G FGEVYK + + +VAIK ++ I+ E+ FL+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G + + ++I EY GS L P KL+ + I GL +LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG-----KLDETYIAFILREVLLGLEYLHE 116
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------- 176
+H+D K AN+L+ E+ K+AD G V+G Q+T+
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG---------VSG---QLTSTMSKRNTFVGTP 162
Query: 177 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
++A EV + + EK+D++S G+ +EL G S L P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 36/271 (13%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQH---RNLVTL 67
LIG G +G VY+G + G +VA+K P + EV L+ ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 68 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
G Y + L ++I EY GSV + + + K+ I L ++H +
Sbjct: 68 YGSYLKGPRL-WIIMEYAEGGSVR------TLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEF 185
V+H+D K AN+LV K+ D G+ L + S ++A EV E
Sbjct: 121 G--VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245
+ + K+D++S G+ + E+ +G S + + L+ + R L++ +S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPR--------LEDNGYS 228
Query: 246 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ EF+ CLD + R S ++
Sbjct: 229 KL----LREFVAA---CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)
Query: 17 IGEGKFGEVYK----GLLQDG--MLVAIKK-RPGA---PTQEFIDEVCFLASI-QHRNLV 65
+G G FG+V + GL + M VA+K +P A + + E+ ++ + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C +I EY G + L + L + LS + AKG+A L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 180
+ +H+D NVL+ I K+ D GL D+ S+ V L A
Sbjct: 160 KN--CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
E ++ +SDV+S+G+ L E+ S S+ P + +S+ F L+K
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS---LGSNPYPG-------MPVDSK-FYKLIKEGY 261
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ + ++ C D +RP+ +V
Sbjct: 262 RMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 47/233 (20%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE------FIDEVCFLAS 58
+F +IGEG F V + AIK KR +E I++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 59 IQHRNLVTLLGYCQ-ENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 115
H ++ L Q E NL + + EY PNG + I YG L+ K A
Sbjct: 59 NGHPGIIKLYYTFQDEENL-YFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAE 110
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV---- 171
L +LHS ++H+D K N+L+D+D K+ D G L +
Sbjct: 111 ILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 172 ----------------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
TA+ +++ E+ + + SD+++ G + ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAE--YVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 65
F+ IG+G FGEV+KG+ + +VAIK + ++ E+ L+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G ++ ++I EY+ GS ++ L P + ++ +I KGL +LHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
+ +H+D K ANVL+ E K+AD G+ L TD + ++A EV +
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
+ K+D++S G+ +EL G S L P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
NF + IG G+F EVY+ L D VA+KK Q+ + E+ L + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
N++ L E+N ++ E G +S + ++ ++ +K+ + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
+ H+HS RV+H+D K ANV + + K+ D GL F A S + +++
Sbjct: 119 VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E ++ KSD++S G L E+ ++L D + L FS KI
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM-------AALQSPFYGDKMNL------FSLCQKIE 221
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
T E+ +L+ C+ P ++RP + V
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 9e-13
Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLG-Y 70
L+G G +G+VYKG ++ G L AIK G +E E+ L HRN+ T G +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 71 CQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
++N + +L+ E+ GSV+ L ++ + K E+ + + +GL+HLH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQ 129
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 182
+V+H+D K NVL+ E+ K+ D G+ L RT G + ++A EV
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 185
Query: 183 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+ KSD++S G+ +E+ G + P + L+ R L
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--------LK 237
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ WS ++F I CL + +RP+ ++
Sbjct: 238 SKKWS-------KKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 31/270 (11%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG-YC 71
+G+G FG+VYK ++ G L A I+ + ++++ E+ LA+ H +V LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ L +I E+ P G+V + ++ R E + ++ I + L +LHS+ +++
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQV-ICRQMLEALQYLHSM--KII 132
Query: 132 HKDFKTANVLVDEDFIAKVADAGL--RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRR 187
H+D K NVL+ D K+AD G+ +N L R D + A E+ + +K+
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD-TP 191
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
+ K+D++S G+ L+E+ L+P + L+++ + S + WS
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK-----SEPPTLSQPSKWSM- 243
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
EF + LD E RPS + ++
Sbjct: 244 ------EFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 47/215 (21%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IGEG +G VYK G +VA+KK G P+ I E+ L + H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 70 YCQENNLQFLIYEYIPNG------SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
N +L++E++ S + P + + ++L +G+A+
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS----YLYQL------LQGIAYC 115
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RT---DVAGPSSQVT----A 173
H S RV+H+D K N+L+D + K+AD GL G RT +V VT A
Sbjct: 116 H--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV------VTLWYRA 167
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
EI L S R++S D++S G E+V+ R
Sbjct: 168 PEILLGS-----RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 33/273 (12%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 65
F+ IG+G FGEV+KG+ + +VAIK ++ I+ E+ L+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 66 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
G + ++I EY+ GS + + GP + K L KGL +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------KGLDYLH 118
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
S + +H+D K ANVL+ E K+AD G+ L TD + ++A EV +
Sbjct: 119 S--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ K+D++S G+ +EL G +S + P +L ++ +
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHP----------------MRVLFLIPKNNP 218
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
T T E + F + I CL+ RP+ +++
Sbjct: 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 36/255 (14%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 71
+G+G FG+VYK ++ ++A K ++E ++ E+ LAS H N+V LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 72 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
ENNL LI E+ G+V + L P + ++ K L + L +LH
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLHE--N 122
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 184
+++H+D K N+L D K+AD G+ + R D + A E+ + K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSR---DFSNL 235
R + K+DV+S G+ L+E+ L+P + + L Q SR +F +
Sbjct: 183 -RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241
Query: 236 LKILDER----LWST 246
LK E+ W+T
Sbjct: 242 LKKCLEKNVDARWTT 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 16 LIGEGKFGEVYKGLL--QDGML--VAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVT 66
++GEG+FG V +G L DG VA+K +EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 67 LLGYC-QENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIAL 114
L+G C + ++LQ +I ++ +G + L P ++ Q L L +
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-----LKFMV 120
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 174
A G+ +L + +H+D N ++ ED VAD GL + D
Sbjct: 121 DIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
++A E R ++ KSDV++FGV + E+ A+ +P V+N +
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEI-----ATRGQTPYPG------VENHEIYDY 227
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
L RL + ++E L+ C + RP+ + + L+ L
Sbjct: 228 LRH--GNRLKQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 49/282 (17%)
Query: 12 SDKNLIGEGKFGEVYKGLLQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLV 65
+D+N I +G F + V I+ K +E+ L I N++
Sbjct: 31 NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 66 TLLGY----CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ G+ + LI EY G + L + L FK +L +A+ KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLY 136
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+L+ + + +K+ + + LV E++ K+ GL L + P V F
Sbjct: 137 NLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILS----SPPFKNVNFMVYFSYKM 191
Query: 182 VKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI-L 239
+ + F ++ K D+YS GV L E+ +G+ +L +++++ +L+ N +N LK+ L
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIINK---NNSLKLPL 245
Query: 240 DERLWSTFTNEGMEEFIQLIV-RCLDPSSERRPSMSDVVTEL 280
D L I+ IV C S +RP++ +++ L
Sbjct: 246 DCPL-----------EIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 46/214 (21%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID--EVCFLASIQ-HRNLVTLLGY 70
+G+G FG VY + G LVAIK K+ +E ++ EV L + H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL-------SIALGAAKGLAHL 123
+EN+ + ++EY + +LY Q+ + + K + SI +GLAH+
Sbjct: 67 FRENDELYFVFEY-----MEGNLY---QLMKDR---KGKPFSESVIRSIIYQILQGLAHI 115
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL----RNFLGRTD-VAGPSSQVT----AD 174
H H+D K N+LV + K+AD GL R+ TD V+ T A
Sbjct: 116 HKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------TRWYRAP 167
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
EI L S +S D+++ G + EL + R
Sbjct: 168 EILLRSTS-----YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 17 IGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 66
+G+G FG VY KG+++D VAIK A + EF++E + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-----PSQVSRQKLEFKHRLSIALGAAKGLA 121
LLG + +I E + G + +L + + K + +A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+L++ + VH+D N +V EDF K+ D G+ + TD + +++ E
Sbjct: 134 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS 206
+ F+ SDV+SFGV L E+ +
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 49/168 (29%), Positives = 68/168 (40%), Gaps = 46/168 (27%)
Query: 15 NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNL 64
IGEG +G VYK L G VA+KK G P + E+ L ++ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63
Query: 65 VTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY---------GPSQ---VSRQKLEFK 107
V LL C L++E++ + Y P + RQ L
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLL--- 117
Query: 108 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
+G+ LH S R+VH+D K N+LV D K+AD GL
Sbjct: 118 ----------RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGL 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 32/164 (19%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
+GEG FGEVYK ++ G +VA+KK + G P E+ L ++H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 70 YCQENNLQFLIYEYIPNGS---VSIHLYGPSQVS---------RQKLEFKHRLSIALGAA 117
+ E S+++ P KL L
Sbjct: 75 ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 160
+G+ +LH ++H+D K AN+L+D I K+AD GL R + G
Sbjct: 126 EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 47/258 (18%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
F N IGEG +G VY+ G +VA+KK R G P + E+ L +++H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRH 65
Query: 62 RNLVTLLGYCQENNLQ--FLIYEYIPN--GSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
N+V L +L FL+ EY S+ ++ P S+ K + L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-------CLMLQLL 118
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--VT-- 172
+GL +LH ++H+D K +N+L+ + K+AD GL R + A P + VT
Sbjct: 119 RGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVVTLW 173
Query: 173 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS 229
A E+ L ++ D+++ G L EL++ + L P S+ + ++L+
Sbjct: 174 YRAPELLLGCTT-----YTTAIDMWAVGCILAELLAHK----PLLPGKSEIEQLDLI--- 221
Query: 230 RDFSNLLKILDERLWSTF 247
LL +E +W F
Sbjct: 222 ---IQLLGTPNESIWPGF 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 36/285 (12%)
Query: 17 IGEGKFGEVYKGLL-QDG---------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 66
+GEG+FG V +G L QD M +AI R + ++F+ E + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMR 64
Query: 67 LLGYCQENNLQ------FLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
L+G C + +I ++ +G + S LY Q L + + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
+ +L S +H+D N +++E+ VAD GL + D ++A
Sbjct: 125 MEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E R ++ KSDV+SFGV + E+ A+ +P V+NS + L +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI-----ATRGQTPYPG------VENSEIYDYLRQ-- 229
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
RL + ++ L+ C + + RPS + EL++ L
Sbjct: 230 GNRLKQ--PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 17 IGEGKFGEVYKG---LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR----NLVTLLG 69
+G G FG V KG + + + VAIK + DE+ A I H+ +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
C+ L L+ E G ++ L G +E H++S+ G+ +L
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG-- 113
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASE 181
VH+D NVL+ AK++D GL LG D S A + A E
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-----SYYKARSAGKWPLKWYAPE 168
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS 206
FR+FS +SDV+S+G+ + E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASI-QHRNLVTLLG 69
+G+G +G V+K + + +VA+KK A T Q E+ FL + H N+V LL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 70 -YCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSL 126
EN+ +L++EY+ +H V R LE H+ I K L ++HS
Sbjct: 75 VIKAENDKDIYLVFEYM---ETDLH-----AVIRANILEDVHKRYIMYQLLKALKYIHS- 125
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTAD----------E 175
V+H+D K +N+L++ D K+AD GL R+ P + V D E
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRAPE 182
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
I L S R+++ D++S G L E++ G+
Sbjct: 183 ILLGS-----TRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 17 IGEGKFGEVYKGLLQDGM---LVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 67
IGEG +G VYK +D + +A+KK G P+ I E+ L +QH N+V L
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRL 66
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
+L++EY+ + + H+ ++ K L L +G+A+ H S
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH--S 120
Query: 128 PRVVHKDFKTANVLVDEDFIA-KVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEV 182
RV+H+D K N+L+D A K+AD GL G VT A EI L S
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS-- 178
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGR 208
R +S D++S G E+V+ +
Sbjct: 179 ---RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
NF +GEG + VYKG + G +VA+K+ G P+ I E+ + ++H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+V L N L++EY+ + Y + R L+ S KG+A
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFL 178
H RV+H+D K N+L+++ K+AD GL G V S++V A ++ L
Sbjct: 117 HE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVVTLWYRAPDVLL 173
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
S R +S D++S G + E+++GR
Sbjct: 174 GS-----RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRN 63
+ ++G G FG V+ D LV IK+ P +E L + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
++ E+ ++ EY P G+++ ++ + L+ L + L H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 124 HSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182
H+ ++H+D KT N+L+D+ + K+ D G+ L A V +++ E+
Sbjct: 118 HT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
E + +++KSD+++ G L EL S + A + +L LV LKI+
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAF------EAANLPALV---------LKIMSGT 217
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279
++ ++ + QLI+ L+ +RP +S ++ +
Sbjct: 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 3e-11
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 45/223 (20%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRN 63
+ IG G +G V + + G VAIKK + ID E+ L ++H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 64 LVTLLGYCQENNLQFLIYEYIPN-GSVSI--HLYGP--SQV--SRQKLEFKHRLSIALGA 116
++ LL L + V I L +V S Q L H
Sbjct: 61 IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ------ 170
+GL +LHS + V+H+D K +N+LV+ + K+ D G L R +
Sbjct: 113 LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEY 166
Query: 171 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
VT A E+ L+S R+++ D++S G EL++ +
Sbjct: 167 VVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 47/294 (15%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-----APTQEFIDEVCFLASIQH 61
F+ ++G+G+FG V + L+ VA+K + +EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 62 RNLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHR 109
N++ L+G + + +I ++ +G + L P + Q L
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGP 167
+ + A G+ +L S +H+D N +++E+ VAD GL + D G
Sbjct: 116 VRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227
+S++ + L S ++ SDV++FGV + E+++ Q V+
Sbjct: 174 ASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMT-----------RGQTPYAGVE 220
Query: 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
NS ++ L+K RL + +E+ +L+ +C P + RPS + +L+
Sbjct: 221 NSEIYNYLIK--GNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 17 IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 66
+G+G FG VY+G +D VA+K + + EF++E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIALGAAKGLA 121
LLG + ++ E + +G + +L + R + + +A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+L++ + VH+D N +V DF K+ D G+ + TD + ++A E
Sbjct: 134 YLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS 206
+ F+ SD++SFGV L E+ S
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 33/291 (11%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIK-KRPGAPTQEFID-EVCFLA 57
+E L T + IG+G +G+VYK +DG L A+K P + E I+ E L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 58 SI-QHRNLVTLLG------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 110
S+ H N+V G L +L+ E GSV+ + G Q+L+
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICG-QRLDEAMIS 131
Query: 111 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 170
I GA GL HLH + R++H+D K N+L+ + K+ D G+ L T + +S
Sbjct: 132 YILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 171 VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
T A E+ +A E + + + DV+S G+ +EL G + P + L ++
Sbjct: 190 GTPFWMAPEV-IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIP 246
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+N +L W F I +CL E RPS++ ++
Sbjct: 247 RNPPP-----TLLHPEKWC-------RSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 39/273 (14%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 71
++G G +G+VYKG ++ G L AIK +E E+ L HRN+ T G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 72 -------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
++ L +L+ E+ GSV+ L ++ + K ++ + + +GLAHLH
Sbjct: 83 IKKSPPGHDDQL-WLVMEFCGAGSVT-DLVKNTKGNALKEDWIAYICREI--LRGLAHLH 138
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-- 182
+ +V+H+D K NVL+ E+ K+ D G+ L RT G + ++A EV
Sbjct: 139 A--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIA 194
Query: 183 ---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
+ +SD++S G+ +E+ G + P + L+ N L
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPPPKL 246
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
+ WS ++FI I CL + RPS
Sbjct: 247 KSKKWS-------KKFIDFIEGCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 40/166 (24%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IG+G FGEV+K + +VA+KK + G P + E+ L ++H N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 78
Query: 70 YC-----QENNLQ---FLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
C N + +L++E+ + N +V L S K K L+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL------SEIKKVMKMLLN-- 130
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 158
GL ++H +++H+D K AN+L+ +D I K+AD GL R F
Sbjct: 131 -----GLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+ N I EG +G VY+ + G +VA+KK + G P + E+ L +QH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKLQHP 64
Query: 63 NLVTLLGYCQE----NNLQ--FLIYEYIPNGSVSI--HLYGPSQVSRQKLEFKHRLSIAL 114
N+VT+ +E +NL +++ EY+ + S+ + P S K LS
Sbjct: 65 NIVTV----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS--- 117
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 171
G+AHLH ++H+D KT+N+L++ I K+ D GL R + P +Q V
Sbjct: 118 ----GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVV 168
Query: 172 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
T A E+ L + + +S D++S G EL++ +
Sbjct: 169 TLWYRAPELLLGA-----KEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 41/216 (18%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRN-LVTLL 68
IGEG +G+VYK G LVA+KK G P + E+ L + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRLL 67
Query: 69 G--YCQENN---LQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+ +E N +L++EY+ + + G + L K S KG+AH
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAH 125
Query: 123 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVAGPSSQVT-------- 172
H V+H+D K N+LVD+ + K+AD GL R F + P T
Sbjct: 126 CHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF------SIPVKSYTHEIVTLWY 177
Query: 173 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
A E+ L S +S D++S G E+
Sbjct: 178 RAPEVLLGS-----THYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G FGEV ++ G + A +KKR G Q ++E L + R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58
Query: 68 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
Y E L+ + G + H+Y V + A GL HLH
Sbjct: 59 -AYAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASEVKEF 185
R+V++D K NVL+D+ +++D GL G + G + ++A EV +
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----YMAPEVLQG 168
Query: 186 RRFSEKSDVYSFGVFLLELVSGR 208
+ D ++ G L E+++GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-10
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFI---DEVCFLASIQHRNLVTLLGYCQ 72
IG G +G+VYK + G L AIK P ++F E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 73 ENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
+ ++ E+ GS+ H+ GP +S ++ + R ++ +GL +LHS
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETL-----QGLYYLHSKGK-- 127
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--- 187
+H+D K AN+L+ ++ K+AD G+ + T +A S + ++A EV R
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFI-GTPYWMAPEVAAVERKGG 185
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSP 216
+++ D+++ G+ +EL + L P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEV----C---FLASIQ 60
N+ L+G G FGEVY D G +A+K+ P P +QE EV C L +++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 61 HRNLVTLLGYC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
H +V G C +E L + EY+P GS+ L ++ + + ++ I
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALT-ENVTRRYTRQIL--- 116
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADE 175
+G+++LHS +VH+D K AN+L D K+ D G + ++G VT
Sbjct: 117 -QGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
+++ EV + K+DV+S ++E+++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 17 IGEGKFGEVYKGLLQDGM---LVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 69
IG G FG+V G + G V +K+ R A QE F++E S+QH NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
C E L+ E+ P G + +L + + +A A GL HLH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNN 120
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF---------LAS 180
+H D N L+ D K+ D GL + + D VT D+++ L
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVD 175
Query: 181 EVKE---FRRFSEKSDVYSFGVFLLEL 204
EV +++S+V+S GV + EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 44/272 (16%)
Query: 14 KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLL 68
+ ++G G G VYK L ++A+K P T E + E+ L ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 69 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
G + EN + + E++ GS+ ++ P V + IA+ KGL +L SL
Sbjct: 66 GAFFVENRIS-ICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWSL- 114
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
+++H+D K +N+LV+ K+ D G+ L V + ++A E +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQ 169
Query: 188 FSEKSDVYSFGVFLLELVSGR-------EASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+ SDV+S G+ +EL GR + SL P ++L+Q I+D
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------LQLLQC---------IVD 214
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
E + E+F+ I +C+ + RP+
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 55/233 (23%)
Query: 15 NLIGEGKFGEVYKGL-LQDGMLVAIKK-------RPGAPTQEFIDEVCF----------L 56
+GEG +G+V K G +VAIKK ++ + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 57 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 113
I+H N++ L+ Y + ++I N + I +V + +L I
Sbjct: 75 NEIKHENIMGLVDVYVEG--------DFI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ--- 170
L GL LH +H+D AN+ ++ I K+AD GL G + S+
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 171 -----------VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
VT A E+ + +E ++ D++S G EL++G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAE-----KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
+G G +G+VYK L G L A IK PG E+ + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 73 ENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
++ EY GS+ H+ GP +S ++ + R ++ +GLA+LHS
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--- 187
+H+D K AN+L+ ++ K+AD G+ + T ++A EV +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
+++ D+++ G+ +EL + L P + L S+ K+ D+ WS+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHP-----MRALFLMSKSNFQPPKLKDKTKWSS- 239
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
F+++ L + ++RP+ ++T L
Sbjct: 240 ---TFHNFVKI---SLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 17 IGEGKFGEVYKGLLQ---DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 68
+G G FG V KG+ + VA+K A E + E + + + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSLS 127
G C+ + L+ E G ++ L V+ + + E H++S+ G+ +L +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEETN 115
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--------- 178
VH+D NVL+ AK++D GL S + ADE +
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGL------------SKALGADENYYKAKTHGKWP 161
Query: 179 ----ASEVKEFRRFSEKSDVYSFGVFLLELVS 206
A E + +FS KSDV+SFGV + E S
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 16/150 (10%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IGEG +G V+K ++ +VA+K+ G P+ E+C L ++H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
+ L++EY + Y S ++ + S KGLA H S
Sbjct: 67 VLHSDKKLTLVFEYCDQ---DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH--SHN 119
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGL-RNF 158
V+H+D K N+L++++ K+AD GL R F
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 46/254 (18%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 60
N+ L+G+G FG VY D G +A K+ P +P T + + E+ L ++Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 61 HRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRL 110
H +V G ++ + L EY+P GSV L YG + +RQ LE
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117
Query: 111 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-S 169
G+++LHS +VH+D K AN+L D K+ D G L ++G
Sbjct: 118 --------GMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR------EASSSL-----SPDS 218
VT +++ EV + K+DV+S G ++E+++ + EA +++ P +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 219 SQDLVELVQNSRDF 232
Q + +++RDF
Sbjct: 228 PQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 70/303 (23%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 69
L+GEG +G V K ++ G +VAIKK + + + E+ L ++H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 70 YCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ +L++E++ PNG L+ +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 175
G+ HS + ++H+D K N+LV + + K+ D G L A P T A
Sbjct: 112 GIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATR 164
Query: 176 IFLASE--VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
+ A E V + ++ D+++ G + E+++G L P S D+ +L +
Sbjct: 165 WYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTG----EPLFPGDS-DIDQLYHIIKCLG 218
Query: 234 NLLKILDE-----------RLWSTFTNEGME--------EFIQLIVRCLDPSSERRPSMS 274
NL+ E RL E +E + L +CL + RPS S
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 275 DVV 277
++
Sbjct: 279 QLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 72/296 (24%), Positives = 105/296 (35%), Gaps = 70/296 (23%)
Query: 16 LIGEGKFGEVYKGLL---QDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNL 64
+IG G FGEV+ L+ G + A+K KR E LA +
Sbjct: 8 VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRN--QIAHVRAERDILADADSPWI 63
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAH 122
V L Q+ +L+ EY+P G + L + + + R IA L A L
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFYIAELVLA--LDS 116
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------------------RNFLGRTD 163
+H L +H+D K N+L+D D K+AD GL F
Sbjct: 117 VHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 164 VAGPSSQV----------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 213
V + T D ++A EV + + D +S GV L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPD--YIAPEVLRGTPYGLECDWWSLGVILYEMLYGF----- 227
Query: 214 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 269
P S L E ++ L+ + S E I LI R L +R
Sbjct: 228 -PPFYSDTLQETYNKIINWKESLRFPPDPPVS-------PEAIDLICRLLCDPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 15 NLIGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 67
IGEG +G+VYK +D G LVA+KK + G P I E+ L + HRN+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNHRNIVNL 71
Query: 68 ----------LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
L + ++ +L++EY+ + L G + H S
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---- 173
+GL + H + +H+D K +N+L++ K+AD GL + +++V
Sbjct: 127 EGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 174 -DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E+ L E R+ DV+S G L EL + +
Sbjct: 185 PPELLLGEE-----RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 17 IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
IGEG FG K +L +DG IK K +E EV L++++H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLH 124
+EN +++ +Y G + + V Q L++ ++ +AL H+H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF------LGRTDVAGPSSQVTADEIFL 178
+++H+D K+ N+ + +D K+ D G+ L RT + P +L
Sbjct: 119 D--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP--------YYL 168
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 210
+ E+ E R ++ KSD+++ G L E+ + + A
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 67/271 (24%), Positives = 104/271 (38%), Gaps = 53/271 (19%)
Query: 17 IGEGKFGEVYK-GLLQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G FG+V G L A+K KR + E L+ I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--------G 119
Q +L+ EY P G + HL + A+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS-------------KEGRFSEERARFYAAEIVLA 105
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
L +LHSL ++++D K N+L+D D K+ D GL L + T + +LA
Sbjct: 106 LEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE--YLA 161
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
EV + + + D +S GV L E+++G+ P ++D E+ + KIL
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------PPFYAEDRKEIYE---------KIL 206
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
+ L F E LI L +R
Sbjct: 207 KDPL--RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 63/273 (23%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 64
K ++ IG+G G VY + + G VAIK+ P +E I +E+ + ++ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V L + +++ EY+ GS++ V+ ++ ++ + L LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
S +V+H+D K+ N+L+ D K+ D G + T S + ++A EV
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ + K D++S G+ +E+V G + +P + L+ + + N ERL
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PERLS 242
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ F + + RCL+ +RR S +++
Sbjct: 243 AVFRD--------FLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 63/274 (22%), Positives = 121/274 (44%), Gaps = 28/274 (10%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 64
K ++ IG+G G VY + + G VAIK+ P +E I +E+ + +H N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V L + +++ EY+ GS++ V+ ++ ++ + L LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
S +V+H+D K+ N+L+ D K+ D G + T S + ++A EV
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ + K D++S G+ +E+V G + +P + L+ + + N E+L
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
+ F + + RCL+ E+R S +++
Sbjct: 243 AIFRD--------FLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 60
N+ L+G+G FG VY D G +A+K+ P +P T + ++ E+ L ++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 61 HRNLVTLLGYC---QENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHR 109
H +V G E L + E++P GS+ L YG + +RQ LE
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILE---- 117
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS- 168
G+++LHS +VH+D K AN+L D K+ D G L ++G
Sbjct: 118 ---------GVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
VT +++ EV + K+D++S G ++E+++ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 5e-09
Identities = 61/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 64
K ++ IG+G G VY + + G VAI++ P +E I +E+ + ++ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V L + +++ EY+ GS++ V+ ++ ++ + L LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
S +V+H+D K+ N+L+ D K+ D G + T S + ++A EV
Sbjct: 134 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ + K D++S G+ +E++ G + +P + L+ + + N E+L
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 243
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ F + + RCLD E+R S +++
Sbjct: 244 AIFRD--------FLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 53/237 (22%), Positives = 107/237 (45%), Gaps = 21/237 (8%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
IGEG G V ++ G LVA+KK R + +EV + QH N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
+ +++ E++ G+++ V+ ++ + ++ L K L+ LH+ V+H
Sbjct: 88 VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIH 139
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 191
+D K+ ++L+ D K++D G F + P + + ++A E+ + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 192 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVE-----LVQNSRDFSNLLKILDERL 243
D++S G+ ++E+V G + P + ++ ++N S LK +RL
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 44/268 (16%)
Query: 16 LIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 67
++G+G FG+V+ KG Q + A+KK + +++ + +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Q F + EY+ G + H+ S K + A GL LHS
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQVTADEIFLASEVK 183
+V++D K N+L+D D K+AD G+ N LG +T + A EI L
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG---- 170
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
++++ D +SFGV L E++ G+ SP D EL Q+ R +D
Sbjct: 171 --QKYNTSVDWWSFGVLLYEMLIGQ------SPFHGHDEEELFQSIR--------MDNPC 214
Query: 244 WSTF-TNEGMEEFIQLIVRCLDPSSERR 270
+ + T E + ++L VR ERR
Sbjct: 215 YPRWLTREAKDILVKLFVR----EPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 61
F ++G+G FGEV ++ G + A IKKR G ++E L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
R +V+L + + L+ + G + H+Y + E + A GL
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLE 116
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 177
LH R+V++D K N+L+D+ +++D GL V P Q + +
Sbjct: 117 DLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGY 167
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+A EV + R++ D ++ G L E+++G+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGY 70
IG G FG V+ +DG VA+KK P + E+ L +H N+++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
Q ++ Y+ + L+ VS Q L H +GL +LHS +
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQILRGLKYLHS--AGI 124
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---------ADEIFLASE 181
+H+D K N+LV+ + + K+ D G L R + S +T A EI + S
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYRAPEILMGS- 179
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGR---EASS 212
R ++ D++S G EL+ R +A S
Sbjct: 180 ----RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 62/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI-DEVCFLASIQHRNL 64
K ++ IG+G G V+ + + G VAIK+ P +E I +E+ + +++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V L + F++ EY+ GS++ V+ ++ ++ + L LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
+ +V+H+D K+ NVL+ D K+ D G + T S + ++A EV
Sbjct: 133 A--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
+ + K D++S G+ +E+V G + +P + L+ + + N E+L
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
F + + RCL+ E+R S +++
Sbjct: 243 PIFRD--------FLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 47/282 (16%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEV-----CFLASIQHRNLVTLLGY 70
IG+G +G+V+K L ++G A+K P + +E+ A H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 71 CQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKG 119
+ +++ +L+ E GSV+ + + L+ R+ I A G
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVT-------DLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADE 175
L HLH + +H+D K N+L+ + K+ D G+ L T + +S T A E
Sbjct: 137 LQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235
+ +A E + + + DV+S G+ +EL G + L P + L ++ +N
Sbjct: 195 V-IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIPRNPPP---- 247
Query: 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ LWS EF I +CL E+RP++SD++
Sbjct: 248 -TLHQPELWSN-------EFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 17 IGEGKFGEVY---KGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTL 67
I +G +G V+ K D + AIK A + + E L+ Q +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 68 L-GYCQENNLQFLIYEYIPNGSVS--IHLYG--PSQVSRQKLEFKHRLSIALGAAKGLAH 122
+ + NL +L+ EY+P G ++ + G V+R + I L L +
Sbjct: 59 YYSFQGKKNL-YLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEY 108
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 176
LHS ++H+D K N+L+D + K+ D GL R + D ++
Sbjct: 109 LHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
++A EV + S+ D +S G L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 48/169 (28%)
Query: 17 IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTL 67
IG G +G VYK + DG AIKK G Q E+ L ++H N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 68 LGYCQENNLQ--FLIYEYIP------------NGSVSIHLYGPSQVSR---QKLEFKHRL 110
+ E+ + +L+++Y VSI PS V Q L
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP---PSMVKSLLWQILN----- 119
Query: 111 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL 155
G+ +LH S V+H+D K AN+LV E + K+ D GL
Sbjct: 120 --------GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 30/199 (15%)
Query: 96 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
++ ++ L + +S + A+G+ L S + +H+D N+L+ E+ + K+ D GL
Sbjct: 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGL 219
Query: 156 R-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+++ + D P + + IF + ++ +SDV+SFGV L E+ S
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFS-- 270
Query: 209 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 268
+S P VQ +F LK E E +++ C + E
Sbjct: 271 -LGASPYPG--------VQIDEEFCRRLK---EGTRMRAPEYATPEIYSIMLDCWHNNPE 318
Query: 269 RRPSMSDVVTELDRTLDKE 287
RP+ S++V L L +
Sbjct: 319 DRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 33/178 (18%)
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGP 167
IA+ +GL +L+++ R++H+D K +N+LV+ K+ D G L N + T V G
Sbjct: 108 IAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-GT 165
Query: 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDL 222
S+ +++ E + +++ KSDV+S G+ ++EL G+ D +
Sbjct: 166 ST-------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 223 VELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
++L+Q +I+ E RL S+ E + +F+ CL RP+ +
Sbjct: 219 LDLLQ---------QIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 39/277 (14%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIK--KRPGAPTQE---FIDEVCFLASIQ 60
K+F K+L+G G FGEV ++++ G + A+K K+ QE F +E + SI
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 61 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+ + L Y Q+ + +L+ EY P G + S ++R + +F ++ A
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL------SLLNRYEDQFDEDMAQFYLAELV 112
Query: 120 LAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
LA +HS+ VH+D K NVL+D K+AD G L + V + ++
Sbjct: 113 LA-IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD-YI 170
Query: 179 ASEVKEFRRFSEKS------DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
A EV K D +S GV E++ GR SP + N +F
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNF 224
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 269
LK ++ S +F+ LI L ER
Sbjct: 225 QRFLKFPEDPKVS-------SDFLDLIQSLLCGQKER 254
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 7 ATKNFSD---KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLAS 58
A K+ S+ N IG G G VYK + + G L A+K G ++ E+ L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 59 IQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQ----VSRQKLEFKHRLSIA 113
+ H N+V + +Q L+ E++ GS+ Q V+RQ L
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVARQILS-------- 179
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-----DVAGPS 168
G+A+LH +VH+D K +N+L++ K+AD G+ L +T G
Sbjct: 180 -----GIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ ++ + I +++ D++S GV +LE GR
Sbjct: 233 AYMSPERI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRN 63
+ + + IGEG +G V G+ VAIKK Q F + E+ L +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 64 LVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
++ +L + + + +++ E + LY + Q L H +
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-----DLY--KLIKTQHLSNDHIQYFLYQILR 117
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----- 172
GL ++HS + V+H+D K +N+L++ + K+ D GL R D + +T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD---HTGFLTEYVAT 172
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A EI L S + +++ D++S G L E++S R
Sbjct: 173 RWYRAPEIMLNS-----KGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 17 IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
+GEG + V+KG L + LVA+K+ GAP I EV L ++H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSP 128
+ L++EY+ + Y + + H + I L +GLA+ H
Sbjct: 72 IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH--RR 123
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKE 184
+V+H+D K N+L++E K+AD GL + VT ++ L S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS--- 180
Query: 185 FRRFSEKSDVYSFGVFLLELVSGR 208
+S + D++ G E+ SGR
Sbjct: 181 --EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 41/211 (19%)
Query: 17 IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
+GEG + VYKG L D LVA+K+ GAP I EV L ++H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71
Query: 70 YCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
L++EY+ + SI+++ Q L +GL
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL-------------RGLN 118
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIF 177
+ H +V+H+D K N+L++E K+AD GL + VT +I
Sbjct: 119 YCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
L S +S + D++ G E+ +GR
Sbjct: 177 LGST-----DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 52 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
E+ LA+ H +V + ++ LI EY G ++ + Q ++ L F+
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYEV 171
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 171
L LA S +++H+D K+AN+ + I K+ D G + +S
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
+LA E+ E +R+S+K+D++S GV L EL++
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 112 IALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAG 166
IA+ K L +LHS LS V+H+D K +NVL++ + K+ D G L + + +T AG
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ + I K + KSDV+S G+ ++EL +GR
Sbjct: 166 CKPYMAPERINPELNQKGY---DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 65/293 (22%)
Query: 17 IGEGKFGEVYKGL---LQDG--------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 65
+G+G F +++KG+ + D +L + K ++ F + ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LH 124
G C + ++ EY+ GS+ +L +K + +S L AK LA LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--------KKNKNLINISWKLEVAKQLAWALH 114
Query: 125 SLSPR-VVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 178
L + + H + NVL+ +ED G F+ +D G S V EI L
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREED-----RKTGNPPFIKLSD-PGISITVLPKEILLERI 168
Query: 179 ---ASE-VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
E ++ + S +D +SFG L E+ SG + ++ D
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQK 213
Query: 235 LLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
L+ ++R W+ E LI +C+D + RPS ++ +L+
Sbjct: 214 KLQFYEDRHQLPAPKWT--------ELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 40/273 (14%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNLVTLL 68
+G+G +G+V+ +D G +VA+K R ++EV L + + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLS 127
Q++ +L EY+P G L +S F + A+ A LH L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA------LHELG 121
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+H+D K N L+D K+ D GL + + + S V + + ++A EV +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPD-YMAPEVLRGK 173
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL---KILDERL 243
+ D +S G L E + G S +P+ + + NL + L +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------------WENLKYWKETLQRPV 221
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ +E LI + ++ S R S+ D+
Sbjct: 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI 254
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
IGEG G V + G VA+KK R + +EV + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
+ +++ E++ G+++ V+ ++ + ++ L + L++LH+ V+H
Sbjct: 90 VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 191
+D K+ ++L+ D K++D G F + P + + ++A EV + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 192 SDVYSFGVFLLELVSG 207
D++S G+ ++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 9 KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 60
K + + IG G G V Y +L+ VAIKK RP + E+ + +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 61 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
H+N++ LL + + +L+ YI + +L QV + +L+ + + G
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 138
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
+ HLHS ++H+D K +N++V D K+ D GL G + + P + A
Sbjct: 139 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
EV + E D++S G + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 16/243 (6%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
IGEG G V + G VA+K R + +EV + QH+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
+++ E++ G+++ VS+ +L + ++ + L +LHS V+H
Sbjct: 89 VGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG--VIH 140
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 192
+D K+ ++L+ D K++D G + + DV S V ++A EV + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198
Query: 193 DVYSFGVFLLELVSGREASSSLSPDSSQDLV--ELVQNSRDFSNLLKILDERLWSTFTNE 250
D++S G+ ++E+V G S SP + + ++ + +L + L T E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258
Query: 251 GME 253
E
Sbjct: 259 PQE 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 61/281 (21%), Positives = 119/281 (42%), Gaps = 44/281 (15%)
Query: 16 LIGEGKFGEVYKGLLQDG--MLVAIK-------------KRPGAPTQEFIDEVCFL-ASI 59
+G G FG VYK ++ L+A+K + + + EV + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+H N+V EN+ +++ + I + H + +Q+ + +I +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLA 125
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE---I 176
L +LH R+VH+D N+++ ED + D GL P S++T+ +
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGL------AKQKQPESKLTSVVGTIL 178
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNL 235
+ E+ + + EK+DV++FG L ++ +L P S +++ L ++ +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLA--TKIVEAV 229
Query: 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ L E ++S E+ +I CL P +E RP + V
Sbjct: 230 YEPLPEGMYS-------EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 22/147 (14%)
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 185
V+H+D K +N+L+D K+ D G+ L +T AG ++ + + I
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI---DPPDPN 192
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245
++ ++DV+S G+ L+EL +G+ P +F L KIL E S
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ------FP--------YKNCKTEFEVLTKILQEEPPS 238
Query: 246 TFTNEGME-EFIQLIVRCLDPSSERRP 271
NEG +F + CL +RP
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 69
+G G +G V + G+ VA+KK P Q I E+ L ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 70 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGL 120
+E N +L+ HL G + V QKL H + +GL
Sbjct: 84 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
++HS ++H+D K +N+ V+ED K+ D GL + A + A
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAP 186
Query: 181 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 208
E+ + +++ D++S G + EL++GR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 52/279 (18%)
Query: 17 IGEGKFGEVYKGLL---QDGMLVAIKK----------RPGAPTQEFIDEVCFLASIQHRN 63
+G+G +GEV L+ DG IKK R A E L+ ++H N
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAE-----QEAQLLSQLKHPN 60
Query: 64 LVTLLGYCQ-ENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKG 119
+V + E+ L +++ + G + L G Q +E+ ++++AL
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL----- 115
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 178
+LH ++H+D KT NV + I KV D G+ L + D+A S + ++
Sbjct: 116 -QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYM 169
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
+ E+ + ++ KSDV++ G + E+ + + A N++D ++L+
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAF----------------NAKDMNSLVYR 213
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ E + E +LI L E+RPS+ ++
Sbjct: 214 IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 67/286 (23%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQDGMLV----------AIKKRPGAPTQEFIDEVCFLASI 59
+F +IG+G FG+V +D + ++K + ++E L +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS---VRNVLNERRILQEL 57
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIALGA 116
H LV L Q+ +L+ + + G + HL QK++F + I
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQVKFWIC-EI 109
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
L +LHS ++H+D K N+L+DE + D + +++VT D +
Sbjct: 110 VLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI------------ATKVTPDTL 155
Query: 177 ---------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVE 224
++A EV + +S D +S GV E + G+ S Q +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAK 213
Query: 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
+ WST E I I + L+ ++R
Sbjct: 214 QETADVLYPA--------TWST-------EAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 9 KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 60
K + + IG G G V Y +L VAIKK RP + E+ + +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 61 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
H+N+++LL + + +L+ Y+ + +L QV + +L+ + + G
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 131
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
+ HLHS ++H+D K +N++V D K+ D GL G + + P + A
Sbjct: 132 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 186
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELV 205
EV + E D++S G + E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
+GEG + V+KG + LVA+K+ GAP I EV L +++H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSPR 129
L++EY+ + + +L L H + I + +GL++ H +
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH--KRK 123
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 185
++H+D K N+L++E K+AD GL + VT ++ L S
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST---- 179
Query: 186 RRFSEKSDVYSFGVFLLELVSGR 208
+S D++ G L E+ +GR
Sbjct: 180 -EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G FGEV ++ G L A +KKR G + + E LA + R +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG--YEGAMVEKRILAKVHSRFIVSL 58
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 125
Q L+ + G + H+Y V + F + A GL HLH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIY---NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVK 183
R++++D K NVL+D D +++D GL L G++ G + F+A E+
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG----FMAPELL 169
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGR 208
+ + D ++ GV L E+++ R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 47/222 (21%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 36 VAIKKRPGAPTQEFID---------EVCFLASIQHRNLVTLLGYCQENNLQFLI------ 80
V + +PG P + E L ++ H +++ + + ++
Sbjct: 82 VFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141
Query: 81 --YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138
Y Y+ S + + + +Q LE GL +LH+ R++H+D KT
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILE-------------GLRYLHAQ--RIIHRDVKTE 186
Query: 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEFRRFSEKSDVYSF 197
N+ +++ + D G F V P+ A + A EV +++ K+D++S
Sbjct: 187 NIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 198 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
G+ L E+++ S++ D E V++ S+LLKI+
Sbjct: 243 GIVLFEMLA---YPSTIFEDPPSTPEEYVKSCH--SHLLKII 279
|
Length = 357 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 16 LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEV------CFLASIQHRNLV 65
++G+G FG+V+ K D G L A+K A T + D V LA + H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
L Q +LI +++ G + L + + ++F + +AL L HLHS
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALA----LDHLHS 116
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
L ++++D K N+L+DE+ K+ D GL + S T + ++A EV
Sbjct: 117 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE--YMAPEVVNR 172
Query: 186 RRFSEKSDVYSFGVFLLELVSG 207
R ++ +D +SFGV + E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLV 65
+ IGEG G V G VA+KK R + +EV + QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
+ + +++ E++ G+++ V+ ++ + ++ L K L+ LH+
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKE 184
V+H+D K+ ++L+ D K++D G F + P + + ++A EV
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 185 FRRFSEKSDVYSFGVFLLELVSG 207
+ + D++S G+ ++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 16 LIGEGKFGEV----------YKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 65
L+G+G FG+V Y + V I K A T + E L + +H L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLT 58
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHL 123
+L Q + + EY+ G + HL SR+++ F + GA L +L
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHL------SRERV-FSEDRTRFYGAEIVSALDYL 111
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 183
HS ++V++D K N+++D+D K+ D GL G TD A + E +LA EV
Sbjct: 112 HS--GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPE-YLAPEVL 167
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGR 208
E + D + GV + E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 16 LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 67
+IG+G FG+V + + A+K K+ +E + L +++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Q + + + +YI G + HL Q R LE + R A A L +LHSL+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
+V++D K N+L+D + D GL + G +S +LA EV +
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+ D + G L E++ G L P S++ E+ N
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 33/214 (15%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 61
F ++G+G FGEV ++ G + A IKKR G ++E L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ +V L + + L+ + G + H+Y + E + L A GL
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLE 116
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVTAD 174
LH V++D K N+L+D+ +++D GL + GR G
Sbjct: 117 DLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG-------- 166
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV +R++ D + G + E++ G+
Sbjct: 167 --YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 27/155 (17%)
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 177
G+ LH ++H+D K N+L+D+ K+ D GL RN L G T D +
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG-----TPD--Y 159
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
LA E + SD +S G + E + G + +PD+ D
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD---------------N 204
Query: 238 ILDERL-WSTFTNEGME-EFIQLIVRCLDPSSERR 270
IL R+ W E E + LI R L +R
Sbjct: 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 10 NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHR 62
+F +G G FG V +KG + + +KKR Q E L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA- 121
+V ++ Q+ N + + E++ G + HL R+ F + ++ A LA
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYHAELVLAF 131
Query: 122 -HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
+LHS ++++D K N+L+D KV D G F + V + + +LA
Sbjct: 132 EYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFG---FAKK--VPDRTFTLCGTPEYLAP 184
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSG 207
EV + + + D ++ GV L E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 38/177 (21%)
Query: 64 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+T L C Q + + + EY+ G + + QV R K H + A A GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGRFKE--PHAVFYAAEIAIGLFF 116
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 171
LHS ++++D K NV++D + K+AD G+ + F G D
Sbjct: 117 LHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD-------- 166
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
++A E+ ++ + + D ++FGV L E+++G+ +P +D EL Q+
Sbjct: 167 -----YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELFQS 212
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 17 IGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFL---ASIQHRNLV 65
IGEG +G+V+K L G VA+K+ G P I EV L + +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67
Query: 66 TLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
L C +E L L++E++ + ++ +L +V + + + +G
Sbjct: 68 RLFDVCTVSRTDRETKLT-LVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRG 122
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR---NFLGRTDVAGPSSQVTADEI 176
L LHS RVVH+D K N+LV K+AD GL +F + A E+
Sbjct: 123 LDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
L S ++ D++S G E+ +
Sbjct: 181 LLQSS------YATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 36/200 (18%)
Query: 70 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 125
+C Q F + EY+ G + H+ + F + A GL LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVK 183
++++D K NVL+D+D K+AD G+ N G G +S ++A E+
Sbjct: 115 KG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEIL 168
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+ ++++E D +SFGV L E++ G+ SP +D EL + IL++R
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ------SPFHGEDEDELFDS---------ILNDRP 213
Query: 244 W--STFTNEGMEEFIQLIVR 261
+ E + +L R
Sbjct: 214 HFPRWISKEAKDCLSKLFER 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 34/155 (21%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQ-------HRNLVT 66
IGEG F EV K + G AIK + F +++V L IQ H N++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 67 LLGYCQENNLQFLIYEYIPNGSVS-------IHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
L+ ++++ G ++ ++LY + ++ L K S K
Sbjct: 63 LIE---------VLFD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154
L H+H + H+D K N+L+ +D I K+AD G
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIKDD-ILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 17 IGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLA--SI 59
+G G FG+V YK G L AIK A + I DEV F S
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIK----ALKKGDIIARDEVESLMCEKRIFETANSE 59
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+H LV L Q + + EY G + +H++ S + F A G
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVF-----YAACVVLG 113
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFL 178
L +LH ++V++D K N+L+D + K+AD GL + +G D +S FL
Sbjct: 114 LQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
A EV ++ D + GV + E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 7 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 65
K++ N+IG G FG VY+ + D VAIKK P Q E+ + ++ H N++
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINII 122
Query: 66 TLLGY----CQENNLQ--FL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--- 114
L Y C + N + FL + E+IP ++H Y +R H L + L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ---TVHKY-MKHYARN----NHALPLFLVKL 174
Query: 115 ---GAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG-LRNFL-GRTDVAGPS 168
+ LA++H S + H+D K N+L+D + K+ D G +N L G+ V+
Sbjct: 175 YSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 169 SQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227
S+ A E+ L + ++ D++S G + E++ G S S S LV ++Q
Sbjct: 233 SRFYRAPELMLGAT-----NYTTHIDLWSLGCIIAEMILGYPIFSGQS--SVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 44/160 (27%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
+GEG + VYKG + G LVA+K+ GAP I E L ++H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA-IREASLLKDLKHANIVTLHDI 71
Query: 71 CQENNLQFLIYEYI-----------PNG----SVSIHLYGPSQVSRQKLEFKHRLSIALG 115
L++EY+ G +V + L+ Q+ R
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF---QLLR-------------- 114
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
GLA+ H RV+H+D K N+L+ E K+AD GL
Sbjct: 115 ---GLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQHR 62
K + IG G G V G+ VA+KK RP + E+ L + H+
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 63 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N+++LL + + +L+ Y+ + +L QV +L+ + + G+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQMLCGIK 137
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
HLHS ++H+D K +N++V D K+ D GL + P + A E
Sbjct: 138 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP---YVVTRYYRAPE 192
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSG 207
V + E D++S G + ELV G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 16 LIGEGKFGEVYKGLLQD---GMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRN 63
L+G+G FG+V L+++ G A+K K A T + E L + +H
Sbjct: 2 LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPF 56
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 121
L L Q ++ + EY G + HL SR+++ F + GA L
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFHL------SRERV-FTEERARFYGAEIVSALE 109
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS VV++D K N+++D+D K+ D GL G +D A + E +LA E
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAPE 165
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGR 208
V E + D + GV + E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 16 LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 67
+IG+G FG+V + DG A+K K+ +E + L +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Q + + +++ G + HL Q R E + R A A L +LHS+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI- 115
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+V++D K N+L+D + D GL + + ++D ++ +LA EV +
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQ 171
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+ D + G L E++ G L P +D+ E+ N
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG------LPPFYCRDVAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 16/95 (16%)
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF--------LGRTDVAGPSSQV 171
LA H S ++H+D K+AN+L+ + + K+ D G +GRT P
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP---- 209
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E+ + +S+K+D++S GV L EL++
Sbjct: 210 ----YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 61
F ++G+G FGEV ++ G + A IKKR G ++E L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKG 119
R +V+L + + L+ + G + H+Y G ++ F A G
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCG 114
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVT 172
L LH R+V++D K N+L+D+ +++D GL GR G
Sbjct: 115 LEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG------ 166
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV + R++ D + G + E++ G+
Sbjct: 167 ----YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 16 LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 67
+IG+G FG+V + DG A+K K+ +E + L +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Q + + +Y+ G + HL Q R LE + R A A + +LHSL+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
++++D K N+L+D + D GL + +S +LA EV
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+ D + G L E++ G L P S+D+ ++ N
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRDVSQMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 16 LIGEGKFGE--VYKGLLQDGMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
++GEG FG + + + D + R + ++ E LA ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSLSP 128
+ + +++ EY G L ++ R KL F L + G+ H+H
Sbjct: 67 FEADGHLYIVMEYCDGGD----LMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHE--K 119
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 188
RV+H+D K+ N+ + ++ K+ D G L T + ++ E+ E +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 189 SEKSDVYSFGVFLLELVS 206
+ KSD++S G L EL +
Sbjct: 178 NNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 63/252 (25%), Positives = 99/252 (39%), Gaps = 29/252 (11%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAIK-------KRPGAPTQEFIDEVCF-LASIQHRNLVT 66
+IG G FGEVY D G + A+K K T + + L S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 67 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+ Y + L F I + + G + HL S ++ F + I LG L H+H
Sbjct: 61 CMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILG----LEHMH 114
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 183
+ VV++D K AN+L+DE +++D GL + P + V ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSR---DFSNLLKI 238
+ + +D +S G L +L+ G D + L FS L+
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 239 LDERLWSTFTNE 250
L E L N
Sbjct: 229 LLEGLLQRDVNR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 21/204 (10%)
Query: 17 IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 69
IG G FG+V + VA +K + Q EF+ + +QH N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLS 127
C E L++EY G + +L R Q L + +A A G+ H+H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKHN 119
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE-VKEFR 186
+H D N + D KV D G+ + D +LA E V EF
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 187 ------RFSEKSDVYSFGVFLLEL 204
++ S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G FGEV +++ G + A +KK+ G E+ L + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 68 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
Y E+ L+ + G + H+Y V + LE + + + G+ HLHS+
Sbjct: 59 -AYAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSM 114
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+V++D K NVL+D+ +++D GL L +Q ++A E+ +
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEE 169
Query: 187 RFSEKSDVYSFGVFLLELVSGR 208
+S D ++ G + E+V+GR
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
+GEG + VYKG+ + +G LVA+K G P I E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDI 71
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-FKHRLSIALGAAKGLAHLHSLSPR 129
++EY+ + P + + F +L +GLA++H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------LRGLAYIHG--QH 123
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 184
++H+D K N+L+ K+AD GL S VT D + A++
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD--- 180
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLS 215
+S D++ G +E++ G+ A +S
Sbjct: 181 ---YSSALDIWGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
LV L Q + FL+ EY+ G + H+ ++KL +H A L L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFL 112
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 182
H ++++D K NVL+D D K+ D G+ + LG D +S ++A E+
Sbjct: 113 HERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEI 167
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGR 208
+ D ++ GV + E+++GR
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 6 LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 59
L +F + +G G G V K GL+ L+ ++ +P Q I E+ L
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+V G + + E++ GS+ L + R E ++SIA+ +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAV--LRG 115
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
LA+L +++H+D K +N+LV+ K+ D G+ L + ++ +++
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E + +S +SD++S G+ L+EL GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 29/161 (18%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-------------EVCFLASIQHR 62
IGEG +G V+K ++ G +VAIKK F++ E+ L ++H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK--------FVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
NLV L+ + L++EY + ++ P V ++ I + +
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNF 115
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163
H + +H+D K N+L+ + K+ D G L
Sbjct: 116 CHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 42/263 (15%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVY-------------KGLLQDGMLVAIKKRPGAPTQEF 49
+L + ++F +IG G FGEV K L + M+ KR + F
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI----KRSDSAF--F 90
Query: 50 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KH 108
+E +A +V L Q++ +++ EY+P G + ++L + + F
Sbjct: 91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTA 149
Query: 109 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
+ +AL A +HS+ +H+D K N+L+D+ K+AD G + +
Sbjct: 150 EVVLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 169 SQV-TADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 223
+ V T D +++ EV + + + + D +S GVFL E++ G +P + LV
Sbjct: 202 TAVGTPD--YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD------TPFYADSLV 253
Query: 224 ELVQNSRDFSNLLKILDERLWST 246
D N L D+ S
Sbjct: 254 GTYSKIMDHKNSLTFPDDIEISK 276
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 6 LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 59
L +F + +G G G V+K GL+ L+ ++ +P Q I E+ L
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
+V G + + E++ GS+ L ++ Q L ++SIA+ KG
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSIAV--IKG 115
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
L +L +++H+D K +N+LV+ K+ D G+ L + ++ +++
Sbjct: 116 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E + +S +SD++S G+ L+E+ GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 31/180 (17%)
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
LS A+G+ L S VH+D NVL+ + I K+ D GL D+ S+
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSN 292
Query: 170 QVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 223
V+ FL A E ++ SDV+S+G+ L E+ S G + DS+
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348
Query: 224 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTEL 280
F N +K + +E ++V+C + E+RPS +SD+V L
Sbjct: 349 --------FYNKIK---SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 60/290 (20%)
Query: 17 IGEGKFGEVYKGLLQ-------------DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 63
+G+G F +YKG+L+ +++ + + F + ++ + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 64 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGL 120
LV L G C EN ++ EY+ G + + L+ + VS L L AK L
Sbjct: 63 LVKLYGVCVRDEN---IMVEEYVKFGPLDVFLHREKNNVS---------LHWKLDVAKQL 110
Query: 121 AH-LHSL-SPRVVHKDFKTANVLVDED--------FIAKVADAGLRNFLGRTDVAGPSSQ 170
A LH L ++VH + N+LV FI K++D G+ + +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPITVLSREERVERIP 169
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
A E + + ++K +SFG LLE+ S E P S+ E + +
Sbjct: 170 WIAPE-CIRNGQASLTIAADK---WSFGTTLLEICSNGEE-----PLSTLSSSEKERFYQ 220
Query: 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
D + L + D + N LI +C +RPS ++ +L
Sbjct: 221 D-QHRLPMPD---CAELAN--------LINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QE--FIDEVCFLASIQH 61
+F +G G FG V + G A+K A Q ++E L SI+H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
LV L G Q+++ +L+ EY+P G + HL + A L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----RKSGRFPEPVARFYAAQVVLALE 115
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRT-DVAGPSSQVTADEIFLA 179
+LHSL +V++D K N+L+D D K+ D G + GRT + G T + +LA
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG-----TPE--YLA 166
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSG 207
E+ + + + D ++ G+ + E+++G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 60/284 (21%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK--RPGAPT---QEFIDEVCFLASIQH 61
T + D +G G FG V Q G VAIKK +P + + E+ L ++H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 62 RNLVTLLG-YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 119
N+++L + + + E + +H L + +Q +++ +G
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-----FLYQILRG 120
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT------- 172
L ++HS VVH+D K +N+L++E+ K+ D GL Q+T
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI--------QDPQMTGYVSTRY 170
Query: 173 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
A EI L ++++ + D++S G E++ G+ L P +D V
Sbjct: 171 YRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGK----PLFP--GKDHVN------ 213
Query: 231 DFSNLLKIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
FS + +L + + +T +E F+Q + P E P
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSL-----PKREPVP 252
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 46/193 (23%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
F + H LV L Q + F + EY+ G + H+ ++KL +H +
Sbjct: 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSA 103
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 173
+ L +LH ++++D K NVL+D + K+ D G+ + L D +S
Sbjct: 104 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 158
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQNS 229
++A E+ + D ++ GV + E+++GR SS +PD QN+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNT 209
Query: 230 RDFSNLLKILDER 242
D+ L +++ E+
Sbjct: 210 EDY--LFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 14/145 (9%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
+GEG + VYKG + +G LVA+K + G P I E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
L++EY+ P + + ++ +GL+++H +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIHQ--RYI 124
Query: 131 VHKDFKTANVLVDEDFIAKVADAGL 155
+H+D K N+L+ + K+AD GL
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
IG+G FG+V DG A+K K+ + L +++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Q + + + +Y+ G + HL Q R E + R A A L +LHSL+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARF-YAAEIASALGYLHSLN 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--ADEIFLASEVKEF 185
++++D K N+L+D + D G L + + + T +LA EV
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+ + D + G L E++ G L P S+D E+ N
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDTAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
+G+G +G VYK L + G+ +A+K+ + + I E+ L +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
++ EY+ GS+ LY + E R I KGL L ++
Sbjct: 69 FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKE-EHNII 125
Query: 132 HKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
H+D K NVLV+ + K+ D G L L +T++ S A E + +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPT 183
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD---ERLW 244
++ +SDV+S G+ +LE+ GR P++ ++ F+ L I+D L
Sbjct: 184 YTVQSDVWSLGLSILEMALGR---YPYPPETYANI---------FAQLSAIVDGDPPTLP 231
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPS 272
S ++++ ++F+ CL+ RRP+
Sbjct: 232 SGYSDDA-QDFVAK---CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAP---TQEFIDEVCFLASIQHRNL 64
+ D +G G +G V L + G VAIKK RP + E+ L ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 65 VTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ LL + + +L +L+ ++ G+ L ++S +++F + K
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----AD 174
GL ++H+ ++H+D K N+ V+ED K+ D GL +TD VT A
Sbjct: 130 GLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E+ L + +++ D++S G + E+++G+
Sbjct: 185 EVIL-----NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 70 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
YC Q F + E++ G + H+ + + F A GL LHS
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKG 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
++++D K NV++D D K+AD G+ N G +S ++A E+ +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTPDYIAPEILQG 170
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
+++ D +SFGV L E++ G+ SP D EL ++ R
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ------SPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 36/202 (17%)
Query: 31 QDGMLVAIK-KRPGAPTQE-----FIDEVCFLASIQHRNLVTLL--GYCQENNLQFLIYE 82
G VAIK R AP +E F E A + H N+V LL G L F ++E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA------LGAAKGLAHLHSLSPRVVHKDFK 136
Y+P ++ R+ L L L LA H+ +VH+D K
Sbjct: 60 YVPGRTL-----------REVLAADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLK 106
Query: 137 TANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKEFRRF 188
N++V AKV D G+ L A ++ E+ + A E
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 189 SEKSDVYSFGVFLLELVSGREA 210
+ SD+Y++G+ LE ++G+
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 16/119 (13%)
Query: 95 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154
+ ++ L + + + AKG+ L S + +H+D N+L+ E+ + K+ D G
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 155 LR-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
L +++ + D P + + IF R ++ +SDV+SFGV L E+ S
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 35/144 (24%)
Query: 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHSLSPRVVHKDF 135
+ + EY+ G + H+ QV + FK H + A A GL LHS ++++D
Sbjct: 77 YFVMEYVNGGDLMYHI---QQVGK----FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDL 127
Query: 136 KTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKE 184
K NV++D + K+AD G+ R F G D ++A E+
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-------------YIAPEIIA 174
Query: 185 FRRFSEKSDVYSFGVFLLELVSGR 208
++ + + D ++FGV L E+++G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 59/223 (26%)
Query: 15 NLIGEGKFGEVYKGLLQD-GMLVAIKK--RPGAPTQEFID------EVCFLASIQHRNLV 65
+ +G G +G+V G VAIKK RP Q I E+ L + H N++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVS--------IHLYGP--SQVSR-QKLEFKHRLSIAL 114
LL + P S+ HL G + + + QKL H +
Sbjct: 78 GLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 174
+GL ++HS ++H+D K +N+ V+ED K+ D GL ++ T D
Sbjct: 126 QILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGL-------------ARHTDD 170
Query: 175 EI--------FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 208
E+ + A E+ + +++ D++S G + EL++G+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 11 FSDKNLI---GEGKFGEVYKGLLQDGML--VAIKK--RPGAPTQEFIDEVC----FLASI 59
+ D N I G G FG V ++ VAIK+ + Q+ +D V L I
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
H V L G ++ + +L+ E++ G L R+ F + + A
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFYAAQIV 141
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 178
L + S +V++D K N+L+D+D K+ D G + RT + + A EI L
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL 201
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
+ +D ++ G+F+ E++ G
Sbjct: 202 NVG------HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 16 LIGEGKFGEVYKGLLQDGM-LVAIKKRPGAPTQEFIDEVCF-----LASIQHRNLVTLLG 69
++GEG +G V K ++ +VAIKK + E + E L +++ N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
+ +L++EY+ + + P+ V +K+ S K + H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHK--ND 120
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 188
+VH+D K N+L+ + + K+ D G RN ++ ++ A + + E+ +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELLLGAPY 178
Query: 189 SEKSDVYSFGVFLLELVSGR 208
+ D++S G L EL G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 57/250 (22%), Positives = 106/250 (42%), Gaps = 31/250 (12%)
Query: 16 LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLA-----SIQHRN-LVTLL 68
++G+G FG+V L + G L A+K + D C + S+ + +T L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 69 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
C Q + F + E++ G + H+ Q SR+ E + R A L LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAA-EITSALMFLHDKG 116
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
++++D K NVL+D + K+AD G+ + T D ++A E+ +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD--YIAPEILQEML 172
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
+ D ++ GV L E++ G + ++ DL E + N DE ++ T+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH---APFEAENEDDLFEAILN-----------DEVVYPTW 218
Query: 248 TNEGMEEFIQ 257
++ + ++
Sbjct: 219 LSQDAVDILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 41/164 (25%)
Query: 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLHSLSPRVVHKDF 135
+ + EY+ G + H+ +Q +FK ++ A + GL LH ++++D
Sbjct: 77 YFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDL 127
Query: 136 KTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKE 184
K NV++D + K+AD G+ R F G D ++A E+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD-------------YIAPEIIA 174
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
++ + + D +++GV L E+++G+ P +D EL Q+
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ------PPFDGEDEDELFQS 212
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 45/218 (20%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASIQHRNLVTLLG- 69
IG G +G V + + G VAIKK P A PT + + E+ L +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 70 -----------YC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
Y E++L +I+ S Q L +H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIH------------------SDQPLTEEHIRYFLY 114
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--TDVAGPSSQVT 172
+GL ++HS V+H+D K +N+LV+ED ++ D G+ L T+ ++
Sbjct: 115 QLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 173 ADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGRE 209
A + A E+ ++ D++S G E++ R+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 61
F ++G+G FGEV ++ G + A IKKR G ++E L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLY--GPSQVSRQKLEFKHRLSIALGAAK 118
R +V+L Y E + I NG + H+Y G Q+ F A
Sbjct: 60 RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-----YAAELCC 113
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQV 171
GL L R+V++D K N+L+D+ +++D GL GR G
Sbjct: 114 GLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG----- 166
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV +++ D + G + E++ G+
Sbjct: 167 -----YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 30/188 (15%)
Query: 104 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 156
L+ + LS + AKG++ L S +H+D N+L+ I K+ D GL
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
N++ + + P + + IF ++ +SDV+S+G+ L E+ S SS P
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFS---LGSSPYP 318
Query: 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
D S K++ E E ++ C D +RP+ +
Sbjct: 319 GMPVD-----------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
Query: 277 VTELDRTL 284
V +++ L
Sbjct: 368 VQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 100 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 158
S Q L H S GL ++HS + V+H+D K N+LV+ D K+ D GL R F
Sbjct: 98 SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155
Query: 159 -LGRTDVAGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 208
+ AG ++ A + A E+ F+ +++ DV+S G L EL+ +
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 175
G+ HLHS ++H+D K +N++V D K+ D G L RT AG S +T
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVTR 181
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ A EV + E D++S G + E++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA-AKGLAH 122
LVTL Q + LI +Y+ G + HLY R+ + + + + L H
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFT-ESEVRVYIAEIVLALDH 120
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASE 181
LH L ++++D K N+L+D + + D GL + FL + S T + ++A E
Sbjct: 121 LHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE--YMAPE 176
Query: 182 V--KEFRRFSEKSDVYSFGVFLLELVSG 207
V + D +S GV EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAI----KKRPGAPTQEF--IDEVCFLASIQHRN--LVT 66
+IG G FGEVY D G + A+ KKR E ++E L+ + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 67 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+ Y + L F I + + G + HL S +++ F + I L GL H+H
Sbjct: 61 CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL----GLEHMH 114
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 183
+ VV++D K AN+L+DE +++D GL + P + V ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168
Query: 184 EFRRFSEKSDVYSFGVFLLELVSG 207
+ + +D +S G L +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 16 LIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQEFI---DEVC-------FLASIQHR 62
L+G+G FG+V L+++ G A+K +E I DEV L + +H
Sbjct: 2 LLGKGTFGKVI--LVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHP 55
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGL 120
L L Q ++ + EY G + HL S + F GA L
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 108
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
+LHS VV++D K N+++D+D K+ D GL G +D A + E +LA
Sbjct: 109 GYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAP 164
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGR 208
EV E + D + GV + E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLV 65
+ ++ +G G +G V + + G VAIKK RP F E+ A +R L
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP------FQSEI--FAKRAYREL- 65
Query: 66 TLLGYCQENNLQFLIYEYIP----NGSVSIHLYGP-SQVSRQKLEFKHRLS------IAL 114
TLL + Q N+ L+ + + +L P Q QK+ H LS +
Sbjct: 66 TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVY 124
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 172
GL ++HS ++H+D K N+ V+ED K+ D GL D VT
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW 179
Query: 173 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ L + +++ D++S G + E+++G+
Sbjct: 180 YRAPEVIL-----NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 37/165 (22%)
Query: 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 137
F + EY+ G + H+ Q S + + A GL LH ++++D K
Sbjct: 72 FFVMEYVNGGDLMFHI----QRSG-RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKL 124
Query: 138 ANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
NVL+D + K+AD G+ F G D ++A E+ ++
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-------------YIAPEILSYQ 171
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231
+ D ++ GV L E+++G+ SP D EL Q+ +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ------SPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 19/146 (13%)
Query: 12 SDKNLIGEGKFGEVYKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVT--L 67
S L+ G VY LL + + EV L + + L +
Sbjct: 1 SSIKLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV 58
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
L + + +L+ E+I ++ ++ + + IA A+ LA LH L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLD------------EVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 128 PRVV-HKDFKTANVLVDEDFIAKVAD 152
V+ H D N+LVD+ I + D
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIID 132
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 53 VCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
V F AS ++ + YC+ +L + E G +QV E+ +L
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQV----CEWFIQLL 116
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQ 170
+ G+ ++H R++H+D K N+ + + + K+ D G+ L G D+A +
Sbjct: 117 L------GVHYMHQ--RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TT 164
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 204
T +++ E + + + KSD++S G L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 49/219 (22%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEV 53
+ +L + +++ +IG G FGEV + + +L + + + F +E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSI 112
+A +V L Q++ +++ EY+P G + ++L V + +F + +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVL 153
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
AL A +HS+ ++H+D K N+L+D+ K+AD G + T + + V
Sbjct: 154 ALDA------IHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 173 ADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSG 207
+ +++ EV + + + + D +S GVFL E++ G
Sbjct: 206 TPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
LVTL Q LI +Y+ G + HLY S ++ F + I L L HL
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILA----LEHL 121
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 182
H L +V++D K N+L+D + + D GL + FL S T + ++A E+
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE--YMAPEI 177
Query: 183 KEFRRFSEKS-DVYSFGVFLLELVSG 207
+ K+ D +S G+ + EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNLVT 66
IG G +G VYK G VA+K G P + EV L ++ H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST-VREVALLKRLEAFDHPNIVR 66
Query: 67 LLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
L+ C +E + L++E++ + + +L +V L + + +GL
Sbjct: 67 LMDVCATSRTDRETKVT-LVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGL 121
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
LH+ +VH+D K N+LV K+AD GL
Sbjct: 122 DFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 17 IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 70
+G G +G VYK +DG A+K+ G + E+ L ++H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 71 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 127
+ +L+++Y + I + S+ +++ ++ + S+ G+ +LH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--A 126
Query: 128 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 176
V+H+D K AN+LV E K+AD G L D + A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
L + R +++ D+++ G EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 26/186 (13%)
Query: 104 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163
L + + + A G+ L S VH+D NVL+ E + K+ D GL D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----D 288
Query: 164 VAGPSSQVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218
+ S+ ++ FL A E ++ SDV+SFG+ L E+ + + P
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT---LGGTPYP-- 343
Query: 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278
EL N + F N +K ++ + E +Q +C + E RP S +V
Sbjct: 344 -----ELPMNEQ-FYNAIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVH 394
Query: 279 ELDRTL 284
+ L
Sbjct: 395 LVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEV 53
+ +L + +++ +IG G FGEV + + +L + + + F +E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSI 112
+A +V L Q++ +++ EY+P G + ++L V + F + +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVL 153
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGP 167
AL A +HS+ +H+D K N+L+D+ K+AD G + + R D A
Sbjct: 154 ALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
+ + E+ + + + + D +S GVFL E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 69/314 (21%), Positives = 113/314 (35%), Gaps = 61/314 (19%)
Query: 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLAS 58
L+L K F D + K LVA+KK + E+
Sbjct: 3 LTLIGKCFED------LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS---IAL- 114
+QH N++ + ++ +++ + GS L K F L IA
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL---------KTHFPEGLPELAIAFI 106
Query: 115 --GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-------RTDVA 165
L ++HS +H+ K +++L+ D KV +GLR + + V
Sbjct: 107 LKDVLNALDYIHSKG--FIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 166 GPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 223
+ +L+ EV + + ++EKSD+YS G+ EL +G + ++Q L+
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM--PATQMLL 220
Query: 224 E----LVQNSRDFSNLLKILDERLWSTFTNEG---------------MEEFIQLIVRCLD 264
E V D S D S +NE E F Q + CL
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280
Query: 265 PSSERRPSMSDVVT 278
E RPS S ++
Sbjct: 281 RDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 7e-04
Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 62/237 (26%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEF-------------------IDEVCFLA 57
IG G+FGEV+ LV K+ TQEF + EV +
Sbjct: 21 IGNGRFGEVF--------LVKHKR-----TQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 58 SIQHRNLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
++H+N+V + + N +++ E+ G +S ++ ++ K+E + I
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-GKIEEHAIVDITRQ 126
Query: 116 AAKGLAHLHSLS-----PRVVHKDFKTANVLVDEDF-----------------IAKVADA 153
LA+ H+L RV+H+D K N+ + IAK+ D
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 154 GLRNFLGRTDVAGPSSQVTADEIFLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 208
GL +G +A + + E+ E + + +KSD+++ G + EL SG+
Sbjct: 187 GLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ-KLEFKHRLSIA 113
F + H LV L Q + F + E++ G + H+ RQ KL +H +
Sbjct: 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------QRQRKLPEEHARFYS 102
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 172
+ L LH ++++D K NVL+D + K+ D G+ + + D +S
Sbjct: 103 AEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFC 157
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQN 228
++A E+ + D ++ GV + E+++GR S +PD QN
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QN 208
Query: 229 SRDFSNLLKILDER 242
+ D+ L +++ E+
Sbjct: 209 TEDY--LFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 16 LIGEGKFGEVY------------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 63
L+G+G FG+V +L+ ++VA + T+ + L + +H
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-----LQNSRHPF 56
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 121
L L Q ++ + EY G + HL S + F GA L
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALD 109
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS VV++D K N+++D+D K+ D GL G D A + E +LA E
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE-YLAPE 166
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGR 208
V E + D + GV + E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 17 IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 70
+G G +G VYK +DG A+K+ G + E+ L ++H N+++L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 71 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 127
+ +L+++Y + I + S+ +++ ++ + S+ G+ +LH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--A 126
Query: 128 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 176
V+H+D K AN+LV E K+AD G L D + A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
L + R +++ D+++ G EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 54/237 (22%)
Query: 17 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV--TLLGYC-- 71
IG+G FG+VY+ +D + A+K +E + + +I RN++ TLL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKV---LSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 72 --------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGAAKGLAH 122
Q ++ +L+ +Y+ G + HL + S + +F L +AL H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EH 111
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 171
LH +V++D K N+L+D + D GL F G T+ P +V
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP--EV 167
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
DE + +++ D +S GV + E+ G SP ++D ++ +N
Sbjct: 168 LLDE----------KGYTKHVDFWSLGVLVFEMCCG------WSPFYAEDTQQMYRN 208
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 16 LIGEGKFGEVYKGLLQD---GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVT 66
+G G FG V+ L++D A+K Q +E L + H ++
Sbjct: 8 TVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLH 124
L + +++ EY+P G + +L R F + + + L +LH
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYL-------RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 182
S +V++D K N+L+D++ K+ D G + RT + G T + +LA EV
Sbjct: 119 SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG-----TPE--YLAPEV 169
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSG 207
+ + ++ D ++ G+ + E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 48/185 (25%)
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DF---------IAKVADAGL 155
IA+ K L +L +++H+D K +N+L+D DF IAK DAG
Sbjct: 112 IAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 156 RNFLG--RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 213
R ++ R D S ++ +SDV+S G+ L E+ +G+
Sbjct: 171 RPYMAPERID----PSARDGYDV--------------RSDVWSLGITLYEVATGKFPYPK 212
Query: 214 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
+ Q L ++V+ IL F+ F+ I CL +RP
Sbjct: 213 WNSVFDQ-LTQVVKGDP------PILSNSEEREFS----PSFVNFINLCLIKDESKRPKY 261
Query: 274 SDVVT 278
+++
Sbjct: 262 KELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 17 IGEGKFGEV---YKGLLQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTL 67
+G G +G V Y L+ VA+KK P Q I E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 68 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L + +++ Y+ + L + V QKL +H + +GL ++HS
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK-EF 185
++H+D K +NV V+ED ++ D GL + D + A + A E+ +
Sbjct: 138 G--IIHRDLKPSNVAVNEDCELRILDFGLAR---QAD--DEMTGYVATRWYRAPEIMLNW 190
Query: 186 RRFSEKSDVYSFGVFLLELVSGR 208
+++ D++S G + EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 18/189 (9%)
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGA-AKGLA 121
LVTL Q + LI +YI G + HL Q+ FK + I G L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALE 119
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
HLH L ++++D K N+L+D + + D GL +V S E
Sbjct: 120 HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 182 VKEFRRFSEKS-DVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS-----RDFSN 234
V+ +K+ D +S GV + EL++G + +SQ ++ + S ++ S
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 235 LLKILDERL 243
L K + +RL
Sbjct: 238 LAKDIIQRL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTAD 174
A+G+ L S + +H+D N+L+ E+ + K+ D GL R+ D V S+++
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
++A E + ++ +SDV+SFGV L E+ S
Sbjct: 242 --WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIK--------KRPGAPTQEFIDEVCFLASI 59
++F +IG G FGEV L++ + A+K KR A T F +E L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNG 58
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA--LGAA 117
++ + TL Q+ N +L+ +Y G + L S+ + E R +A + A
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAI 115
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVT 172
+ LH VH+D K N+L+D + ++AD G + + ++ VA +
Sbjct: 116 DSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 224
+ EI A E + ++ + D +S GV + E++ G +P ++ LVE
Sbjct: 171 SPEILQAMEDGK-GKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 24/134 (17%)
Query: 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL---HSLSPRVVHKDFKTA 138
E++ GS+ L + R ++SIA+ +GL +L H ++H+D K +
Sbjct: 79 EHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREKHK----IMHRDVKPS 129
Query: 139 NVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 194
N+LV+ K+ D G L + + + V S +++ E + ++ +SD+
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--------YMSPERLQGTHYTVQSDI 181
Query: 195 YSFGVFLLELVSGR 208
+S G+ L+E+ GR
Sbjct: 182 WSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 16/112 (14%)
Query: 102 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------ 155
L+ L + A+G+ L S +H+D NVL+ + +AK+ D GL
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 156 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
N++ + + P + + IF ++ +SDV+S+G+ L E+ S
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 312 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.12 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.31 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.24 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.11 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.7 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.48 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.47 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.43 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.35 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.2 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 96.02 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.98 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.97 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.73 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=363.06 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=211.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC----CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCe-EEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 81 (312)
..+.+.++.||+|..|+||+|+ ..+++.+|+|.+. .....++.+|+++++.++||+|+.+||.|...+. ++++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3477788999999999999999 5578999999873 3344678999999999999999999999999984 99999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||++|+|+++.. ..+.+++.....++.++++||.|||.. .+||||||||+|+|++..|+|||||||.+.....
T Consensus 158 EYMDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhcCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999983 336689999999999999999999941 5699999999999999999999999999987754
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
. ......||..|||||.+.+..|+.++||||||++++||++|..||....+.. ..+-.+...+-.
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-----------~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-----------LDIFELLCAIVD 296 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-----------CCHHHHHHHHhc
Confidence 4 3456789999999999999999999999999999999999999998751111 111222222222
Q ss_pred hccccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+..|.+ +++++++|+..||++||.+||++.+|++|
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 223455665 88999999999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-54 Score=356.80 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=205.4
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
..+.|.+.+.||+|+||.|-+|. .++++.||||++... ....+.+|+++|++++||||+++++++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 35778899999999999999998 778999999975422 1234679999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC---CceEEee
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVAD 152 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~---~~vkl~D 152 (312)
..|+||||+.||.|.+++ ...+.+.+.....++.|++.|+.|||+ .||+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~v-----v~nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV-----VANKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHH-----HhccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999 455667777888999999999999999 779999999999999877 7899999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCC---CcccceehhHHHHHHHHhCCCCCCCCCCCC-hhhHHHHhhh
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLSPDS-SQDLVELVQN 228 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~vl~~l~tg~~pf~~~~~~~-~~~~~~~~~~ 228 (312)
||+|+..+...... ...||+.|.|||++.++.+ ..+.|||||||++|-+++|.+||++...+. ..+.+....
T Consensus 323 FGlAK~~g~~sfm~---TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~- 398 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMK---TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR- 398 (475)
T ss_pred cchhhccccceehh---hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc-
Confidence 99999987554433 3579999999999988764 347799999999999999999998765543 111111100
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+..-..++++..++|.+||..||++|||+.|+|+|
T Consensus 399 ------------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 ------------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 011112223456789999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=364.28 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=212.0
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.+|+..+.||+|+|..||.++. .+|+.||+|.++. ...+.+.+|+++.+.|+||||++++++|++.+.+|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999995 8899999997654 34567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|+|..++|..++ ..++.+++..+..+..||+.||.|||+ .+|+|||||..|+|++++.+|||+|||+|+....
T Consensus 98 ELC~~~sL~el~-----Krrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELL-----KRRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHH-----HhcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999988 466789999999999999999999999 6699999999999999999999999999998864
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.+ .......||+-|.|||++.....+..+||||+||+||-|++|.+||.+.+-.+. +..+...
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---y~~Ik~~------------ 233 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---YNKIKLN------------ 233 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH---HHHHHhc------------
Confidence 32 123456799999999999999999999999999999999999999987542221 2111111
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. -..|...+.+.++||.++|+.||.+|||++++|.|
T Consensus 234 ~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 E--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred C--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 12455667889999999999999999999999965
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=353.84 Aligned_cols=263 Identities=31% Similarity=0.492 Sum_probs=221.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC-eE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQ 77 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 77 (312)
+.+...+..+.+.||.|+||+||.+.++....||+|++.... ...+.+|+.+|.+++||||++|+|++.... .+
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 445566677788899999999999998855559999876544 458999999999999999999999999887 78
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEeCCCC-ceEEeeccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF-IAKVADAGL 155 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g-ivH~dikp~Nil~~~~~-~vkl~Dfg~ 155 (312)
++||||+++|+|..++... ....+++..+..++.||+.|+.|||+ ++ ||||||||+|+|++.++ ++||+|||+
T Consensus 116 ~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 9999999999999999432 35779999999999999999999999 77 99999999999999998 999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhh--hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++...... .......||..|+|||++. ...|+.++||||||+++|||+||..||.........
T Consensus 191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~------------- 255 (362)
T KOG0192|consen 191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA------------- 255 (362)
T ss_pred ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-------------
Confidence 98765432 2233468899999999999 568999999999999999999999999987652211
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
........+..++..+++.+..+|.+||..||..||++.+++..|+.+...-.
T Consensus 256 --~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 256 --SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred --HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11122333445566678899999999999999999999999999999987644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=338.01 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=209.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeee-eeeCC-eEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGY-CQENN-LQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~-~~~ 78 (312)
...+|++.++||.|+||.||+|. ..++..+|.|.++ ....+.+..|+.+|++|+||||++++++ +...+ .++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34579999999999999999999 6789999999755 2334568899999999999999999994 33333 489
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhc--CCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS--LSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~--~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|||+|..|+|+..+.... .....+++.+++.++.|++.||.++|. ..+-|+||||||.||+++.+|.|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999998885443 245679999999999999999999997 3334999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+.+...... ....+|||.||+||.+.+.+|+.+|||||+||++|||+.=..||.+. ....+...+
T Consensus 176 r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI---------- 240 (375)
T KOG0591|consen 176 RFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKI---------- 240 (375)
T ss_pred hHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHH----------
Confidence 987544322 34568999999999999999999999999999999999999999875 222333222
Q ss_pred HHhhhhccccCC-hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 237 KILDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 237 ~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
...-.+..| .-++.++..+|..|+..||+.||+...++..+..
T Consensus 241 ---~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 ---EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222233344 5567899999999999999999996655555444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=344.87 Aligned_cols=201 Identities=26% Similarity=0.456 Sum_probs=179.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..+|.+.+.||.|+|++||+|+ ..++..||||.+... ..+.+..|+++|+.++||||+.+++++...+.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 5789999999999999999999 556899999987665 3455778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC------CceEEeeccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED------FIAKVADAGL 155 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~------~~vkl~Dfg~ 155 (312)
|||.||+|.+++ .....+++.++..++.|++.||++||+ ++||||||||+|||++.. -.+||+|||.
T Consensus 89 EyC~gGDLs~yi-----~~~~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYI-----RRRGRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999 455689999999999999999999999 779999999999999875 4689999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCC
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~ 218 (312)
|+.+..+. ......|++.|||||++....|+.|+|+||+|+++|+|++|+.||...+..+
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99886443 2345679999999999999999999999999999999999999998766543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-52 Score=356.04 Aligned_cols=262 Identities=28% Similarity=0.479 Sum_probs=225.2
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCC--CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..+.+++++.||+|.||.||.+.++....||+|.+.. ...+.+.+|+.+|++|+|++|+++++++.....+|||
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 46677788889999999999999999998777899997665 4457899999999999999999999999998899999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+..|+|.+++.. ..+..+.....+.++.|||+|++||++ +++|||||.+.||||+++..+||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999954 245678889999999999999999999 669999999999999999999999999999554
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
+... .......-+..|.|||.+..+.++.+|||||||++||||+| |..||..++..+ ..+.+
T Consensus 355 d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~l 417 (468)
T KOG0197|consen 355 DDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELL 417 (468)
T ss_pred CCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHH
Confidence 4332 22334456667999999999999999999999999999999 788888766533 33334
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+...+-..|..+|+++.++|..||..+|++|||++.+...|+.+...
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 44555567888899999999999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=342.32 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=217.6
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
...++|++++.||+|+||+||+|+ .++++.||+|.++.. .......|..+|..++||+|++++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 457899999999999999999999 667999999965533 3456788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|+||+.||.|..++ ..+..+++..+..++..|+.||.|||+ +|||||||||+|||+|.+|+++|+|||+++.
T Consensus 102 lVld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 999999999999888 566789999999999999999999999 7799999999999999999999999999986
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......||+.|+|||++.+..|+..+|.||||+++|||++|..||...+.......+
T Consensus 175 ~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------------- 237 (357)
T KOG0598|consen 175 DLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------------- 237 (357)
T ss_pred cccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH---------------
Confidence 53332 2234478999999999999999999999999999999999999999875532221111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHHHHHHhccccccccc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTELDRTLDKEMNLTTVMGE 296 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~~ll~~l~~~~~~~~~~~~~~~~ 296 (312)
...+ ....+.-.+.+.++++.++|++||++|.. ..++.+.-+.-.-+.++|++++.-
T Consensus 238 ~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k 295 (357)
T KOG0598|consen 238 LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAK 295 (357)
T ss_pred hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhc
Confidence 1111 12233335678999999999999999974 233333444455567788877653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-52 Score=354.72 Aligned_cols=267 Identities=19% Similarity=0.256 Sum_probs=223.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (312)
..+|.+++.||+|+|++|++|+ ..+++.||||++.. .....+..|-+.|..| .||.|++++-.|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4789999999999999999999 67899999996543 3345577888999999 89999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|+||+++|+|.++| ...+.+++.....++.+|+.||.|||+ +|||||||||+|||+|.+|+++|+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i-----~K~Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLI-----KKYGSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHH-----HHhCcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999 455778999999999999999999999 77999999999999999999999999999887
Q ss_pred cCCCcC-----------CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 160 GRTDVA-----------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 160 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
...... .....++||..|.+||++..+..+..+|||||||++|+|+.|.+||....+--....+..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 542211 1124578999999999999999999999999999999999999999876643222222111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCCCcc
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTV 301 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~ 301 (312)
.-.++.+.++.+.+||.++|..||.+|+|++++-+| .+.+.++|..+-+..+|..
T Consensus 303 ---------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H---pFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 303 ---------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH---PFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred ---------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC---cccccCChhhhhhcCCCcc
Confidence 124666667899999999999999999999877765 4667778888666555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=330.93 Aligned_cols=260 Identities=19% Similarity=0.283 Sum_probs=207.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+.|+.+.++|+|+||.||+++ ..+|+.||||++..... .-..+|+++|++++|+|++.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578899999999999999999 66899999998765443 335789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
||+..-|.++- .....++...+..++.|++.|+.|+|+ ++++||||||+|||++.+|.+||||||.|+....
T Consensus 82 ~~dhTvL~eLe-----~~p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVLHELE-----RYPNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHHHHHH-----hccCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 99884444333 345668899999999999999999999 6699999999999999999999999999988753
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh-hhHHhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-LLKILD 240 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 240 (312)
.......++.|..|+|||++-| ..|+.+.||||+||++.||++|.+.|.+.++. ++++.+....-++.. ...+..
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHhc
Confidence 2334567889999999999998 57999999999999999999999999886554 444433333222111 111111
Q ss_pred hhc---------------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERL---------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... .+.--+..+.-+.+++++||.+||.+|++-++++.|
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 100 011112334578999999999999999999999964
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=349.98 Aligned_cols=278 Identities=22% Similarity=0.277 Sum_probs=230.4
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+..++|.+++.||+|+||.||+|+ ..+|..+|+|+++... ...+..|-.+|...++|+||++|..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3456899999999999999999999 6689999999876543 34577788899888999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||++||++..++ .....+++..+..++.+++.|+..+|+ .|+|||||||+|+|||..|++||+|||+++
T Consensus 217 YLiMEylPGGD~mTLL-----~~~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL-----MRKDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHH-----HhcCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999888 566789999999999999999999999 669999999999999999999999999986
Q ss_pred cccCCC--------------------cCCC-------------------------CccccCcccccchhhhhhcCCCccc
Q 021441 158 FLGRTD--------------------VAGP-------------------------SSQVTADEIFLASEVKEFRRFSEKS 192 (312)
Q Consensus 158 ~~~~~~--------------------~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~s 192 (312)
...... .... .-..+|||.|+|||++.++.|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 542200 0000 0034699999999999999999999
Q ss_pred ceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC
Q 021441 193 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272 (312)
Q Consensus 193 DiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 272 (312)
|.||||||||||+.|.+||...++.+....+..++....+ ......+++.+|||.+|+. ||++|..
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999999987776554444333322221 1122234789999999999 9999998
Q ss_pred HHHHHHHHHHHHHHhcccccccccCCCcccc
Q 021441 273 MSDVVTELDRTLDKEMNLTTVMGEGTPTVTL 303 (312)
Q Consensus 273 ~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~ 303 (312)
...+-+.-..-..+.++|+.+.++++|-++.
T Consensus 436 ~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~ 466 (550)
T KOG0605|consen 436 SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQ 466 (550)
T ss_pred cccHHHHhcCCccccCCcchhhcCCCCCCCC
Confidence 7777777777888899999999999876554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=314.55 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=212.2
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|...+.||+|.||.||+|+ ..+++.||||++.... .....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578899999999999999999 7789999999765433 3457899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|++. +|...+. .+...+....+..++.++++|++|||. +.|+||||||.|+|++.+|.+||+|||+|+.++..
T Consensus 82 fm~t-dLe~vIk----d~~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK----DKNIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc----ccccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9977 8888883 345678889999999999999999999 77999999999999999999999999999998765
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhhhhhHH
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFSNLLKI 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 238 (312)
....+ ..+.|..|+|||++.|. .|+...||||.||++.||+-|.+-|.+.++-+....+......+ +|.++...
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 44433 33788999999998876 58999999999999999999998888766544444333332222 33333222
Q ss_pred hhh--------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
-+. ..........+++..+|+.+||..||.+|+|++++++|
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 11111333445778999999999999999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=334.77 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=207.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCC--eEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 82 (312)
.++...+.||+|+||.||++. .+++...|+|...... .+.+.+|+.+|+.++||||++++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457889999999999999999 4558899999766554 455899999999999999999999854444 6899999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a~~~~~ 161 (312)
|+++|+|.+++.+. ...+++..+..+..|++.||.|||+ +||+|+||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~----g~~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY----GGKLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999422 2268999999999999999999998 78999999999999999 79999999999887653
Q ss_pred -CCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 162 -TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 162 -~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
...........||+.|+|||++... ..+.++|||||||++.||+||..||... ...... +..+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~-------------~~~ig 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEA-------------LLLIG 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHH-------------HHHHh
Confidence 2222334456799999999999953 2345999999999999999999999864 111111 11111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.....+.++...+++.++++.+|+.+||++||||+++|+|---..+.
T Consensus 237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 22222367777889999999999999999999999999886544433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=331.51 Aligned_cols=285 Identities=24% Similarity=0.294 Sum_probs=225.7
Q ss_pred HhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.|....+.|++.+.||.|..+.||+|+ ..++..||||+++-+ ..+.+.+|+..++.++||||+.++..|.....+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 466778999999999999999999999 667899999987643 246788999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||+||.+|++.+++... -...+++..+..+.+++++||.|||+ +|.||||||+.|||++.+|.|+|+|||.+.
T Consensus 100 WvVmpfMa~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred EEeehhhcCCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeee
Confidence 9999999999999999533 34558999999999999999999999 779999999999999999999999999877
Q ss_pred cccCCC-cCCCC-ccccCcccccchhhhhh--cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 158 FLGRTD-VAGPS-SQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 158 ~~~~~~-~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
.+.... ..... ....++++|+|||++.. ..|+.|+||||||++..||.+|..||....+.. .+...+++.++..
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQNDPPTL 252 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCCCCCc
Confidence 765433 11112 45679999999999553 479999999999999999999999998866532 2334444444322
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHHHHhcccccccccCCC
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLDKEMNLTTVMGEGTP 299 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~~~~~~~~~~~~~~~~ 299 (312)
. ....+ .+.....+..+++++..||..||++|||+++++.| +...........+++..++|
T Consensus 253 ~-t~~~~----~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~ 315 (516)
T KOG0582|consen 253 L-TSGLD----KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPP 315 (516)
T ss_pred c-cccCC----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCc
Confidence 2 11111 11122233579999999999999999999999954 55555555555555554444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=341.82 Aligned_cols=249 Identities=22% Similarity=0.381 Sum_probs=211.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
....|....+||+|+.|.||.|. ..+++.||+|.+. ....+-+..|+.+|+..+|+||+.+++.|...+.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 35678889999999999999998 6678899999654 2334557899999999999999999999988899999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|++||+|.+.+ ....+++..+..++..++.||+|||. +||+|||||.+|||++.+|.+||+|||.+..+...
T Consensus 351 ym~ggsLTDvV------t~~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVV------TKTRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhh------hcccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999988 34458899999999999999999999 78999999999999999999999999998877544
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. .+...+||++|+|||++..+.|+++.||||||++++||+-|.+||-...+ ...++.+..+..
T Consensus 423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAlyLIa~ng~------------ 486 (550)
T KOG0578|consen 423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNGT------------ 486 (550)
T ss_pred cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHHHHhhcCC------------
Confidence 32 35567899999999999999999999999999999999999999975332 222232222221
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+..++..|++|+.+||..|+++|++|.|||+|
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223566677899999999999999999999999976
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=338.66 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=211.7
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhH--HHHHHHHHhcCC-CccceeeeeeeeeCC-eE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQE--FIDEVCFLASIQ-HRNLVTLLGYCQENN-LQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~ 77 (312)
....++|+++++||.|+||.||+|+ ..++..||||..+.. .-++ -.+|+.-|++++ ||||+++.+++.++. .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3456899999999999999999999 667899999975533 2233 357999999998 999999999998887 99
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|||||+. +|.+++. ..+..+++..+..|+.||++||+|+|. +|+.|||+||+|||++....+||+|||+|+
T Consensus 86 ~fVfE~Md~-NLYqLmK----~R~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMK----DRNRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhhhh-hHHHHHh----hcCCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEeccccccc
Confidence 999999976 8888884 346789999999999999999999999 779999999999999998999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... ..+...++.|..|+|||++... .|+.+.||||+||||+|+++=++.|.+..+.+....+-.+...+......
T Consensus 159 ev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 7643 3346678899999999997655 57999999999999999999999999866544333332222222222111
Q ss_pred H------Hhhhhc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 237 K------ILDERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 237 ~------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
. ...-+. ......+.+.+..++|.+|+..||.+||||.++++|-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1 111111 1112233678999999999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=335.86 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=206.6
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--------ChhHHHHHHHHHhcCC-CccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 75 (312)
...++|.+.+.||+|+||+|+.+. ..++..||+|+++.. ....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346799999999999999999998 567899999976553 2345668999999998 999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeecc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG 154 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg 154 (312)
.+|+||||+.||+|.+.+. ....+.+..+..++.|+++|++|+|+ +||+||||||+||+++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999993 35678889999999999999999999 779999999999999999 999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcC-C-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-F-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
+++... ..........|++.|+|||++.+.. | +.++||||+|+++|-|++|..||.+... ......+
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~ki------ 235 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRKI------ 235 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHHH------
Confidence 999874 2223355668999999999999988 8 5889999999999999999999987332 1111111
Q ss_pred hhhhHHhhhhccccCChHH-HHHHHHHHHHhcCCCCCCCCCHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVV 277 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (312)
... ...++... +.++++++.+||..||.+|+|+.+++
T Consensus 236 ------~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 ------RKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------hcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 12244444 78999999999999999999999999
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=337.28 Aligned_cols=266 Identities=22% Similarity=0.377 Sum_probs=207.9
Q ss_pred hhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ 72 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 72 (312)
|.++.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 678889999999999999999999963 234679999876432 24578899999999 8999999999886
Q ss_pred eC-CeEEEEEEeccCCcccccccCcccc----------------------------------------------------
Q 021441 73 EN-NLQFLIYEYIPNGSVSIHLYGPSQV---------------------------------------------------- 99 (312)
Q Consensus 73 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------------------- 99 (312)
.. ..+|+||||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4579999999999998887432100
Q ss_pred -----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCc
Q 021441 100 -----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 174 (312)
Q Consensus 100 -----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~ 174 (312)
....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++...............++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 02346778889999999999999999 77999999999999999999999999998765332221122233455
Q ss_pred ccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHH
Q 021441 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 253 (312)
Q Consensus 175 ~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (312)
..|+|||++.+..++.++|||||||++|||++ |..||....... ........ ......+...++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~-------------~~~~~~~~~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKD-------------GTRMRAPENATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhc-------------CCCCCCCCCCCH
Confidence 67999999999999999999999999999997 999997644321 11111111 111122344567
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 254 EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.+.+++.+||..||.+|||+.++++.|+.++.+
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=328.40 Aligned_cols=279 Identities=44% Similarity=0.737 Sum_probs=225.6
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCC-eE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQ 77 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 77 (312)
+++.-+.++|.-...||+|+||.||++...+++.||||...... ..+|..|++++.+++|||+++++|||.+.+ ..
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 46677889999999999999999999998777899999876654 457999999999999999999999999988 59
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeecccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
++|+||+++|+|.+++...... .++|..+.+|+.++|.||+|||.... .|+|||||++|||+|.+.++||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence 9999999999999999654321 78999999999999999999998422 5999999999999999999999999999
Q ss_pred ccccCCCcCCCCccc-cCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
...+.. ....... .||..|+|||+...+..+.++||||||++|.|++||..+.....+.....+............+
T Consensus 225 ~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 225 KLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred ccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 655431 1111222 7888899999999888999999999999999999999887754422222222222222222256
Q ss_pred hHHhhhhcc-ccCCh-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 236 LKILDERLW-STFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 236 ~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
..++++++. ..... .....+..+..+|++.+|.+||++.++++.|+.+..
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 777787765 44443 455678999999999999999999999998865553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=329.28 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=208.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (312)
.+.|+.+++||+|+||.||+|+ ..+++.||+|++.-+. .....+|+.+|++|+||||+++.+..... +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4678889999999999999999 7789999999754333 34567999999999999999999998766 78999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|+|||+. +|.-++. ...-.+++..+.-++.|++.||.|+|. +||+|||||.+|||+|++|.+||+|||+|+.+
T Consensus 196 VFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999988 6665552 234578899999999999999999999 88999999999999999999999999999977
Q ss_pred cCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh--
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL-- 236 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (312)
...... .....+.|..|+|||++.|. .|+.+.|+||.||||.||+.|++.|.+.++.+....+..+-..+....+.
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 543322 24455789999999999986 58999999999999999999999999877665555444433322211111
Q ss_pred HH-----hh-----hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KI-----LD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~-----~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+. .. .+...+.....+....+|+..+|..||.+|.||.++|.+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 00 000111123334678999999999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=336.89 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=208.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChh-----HHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|.+.+.||+|+||+||+++ ..+.+.||+|.+.+..+. .+.+|+++++.++||||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 579999999999999999999 667899999987655444 48899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.| +|..++ .....++++.+..++.+++.||.|||+ ++|.|||+||+||+++..|.+|+||||+|+.....
T Consensus 82 ~a~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 898888 455678999999999999999999999 67999999999999999999999999999987543
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. .......||+.|+|||++.+..|+..+|+|||||++|||++|++||.... ...+...+ ..+.
T Consensus 154 t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I------------~~d~ 216 (808)
T KOG0597|consen 154 T--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSI------------LKDP 216 (808)
T ss_pred c--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHH------------hcCC
Confidence 2 23456789999999999999999999999999999999999999996522 12222111 1111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ..+...+..+.+++..+|.+||.+|.|..+++.|
T Consensus 217 v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 V--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 2345677899999999999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=331.43 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=210.9
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
....|+..+.||.|.||.||+|. ..+++.||+|+++-+. .+.+.+|+.+|..++++||.++|+.+..+..+|++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34678889999999999999999 6689999999876443 356788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||.||++.+.+. ....+++..+..++++++.||.|+|. .+.+|||||+.||+++.+|.+|++|||.+.....
T Consensus 91 ey~~gGsv~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLK-----SGNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhc-----cCCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999983 33444777778899999999999999 7799999999999999999999999999887765
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.... .....||+.|||||++.+..|+.++||||||++.+||++|.+|+....+..... .+..
T Consensus 164 ~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk 225 (467)
T KOG0201|consen 164 TVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPK 225 (467)
T ss_pred hhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccC
Confidence 4433 366789999999999999999999999999999999999999999877632211 1122
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..++.+...+++.+++|+..||++||+.||+|.+||.|
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22233444666789999999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=338.38 Aligned_cols=245 Identities=23% Similarity=0.307 Sum_probs=212.0
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.-|++++.||.|+.|.|-+|+ ..+|+.+|||++... ....+.+|+-+|+.+.|||++++|+++.+..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457889999999999999999 678999999987655 2345889999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++|-|.+++ ...+.+++.....+++||+.|+.|+|. -+|+|||+||+|+|+|..+++||+|||+|..-..
T Consensus 92 Eyv~gGELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999998 566778899999999999999999999 5599999999999999999999999999987655
Q ss_pred CCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
+... ....|++.|.+||++.|..| +.++||||.|||+|.|+||+.||.+. ....+...++.
T Consensus 165 gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~------------ 226 (786)
T KOG0588|consen 165 GKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQR------------ 226 (786)
T ss_pred Cccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHc------------
Confidence 4433 34578999999999999999 88999999999999999999999842 22222222221
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...+.|.+++.+.++|+.+||..||++|+|.+++++|-
T Consensus 227 --G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 --GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 22457788889999999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=308.42 Aligned_cols=235 Identities=22% Similarity=0.334 Sum_probs=203.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++++.||.|+||+|.+++ ..++..||+|.+..... +...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 45789999999999999999999 56789999998765432 446779999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||.+||-|..++ ....++++..+..++.+|+.||+|||+ .+|++||+||+|||+|.+|.+||+|||.|+..
T Consensus 122 vmeyv~GGElFS~L-----rk~~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYL-----RKSGRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHH-----HhcCCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999998 455679999999999999999999999 66999999999999999999999999999875
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... .....||+.|+|||++.+++|+.++|.||||+++|||+.|..||....+.... .+++
T Consensus 195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY---------------~KI~ 254 (355)
T KOG0616|consen 195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY---------------EKIL 254 (355)
T ss_pred cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH---------------HHHH
Confidence 432 45578999999999999999999999999999999999999999876652221 2222
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCC
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (312)
...+ .+|.-.+.++++|+.++|+.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222 3566667899999999999999999
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=316.61 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=208.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeee-----CCe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (312)
...|..++.||.|+||.|+.|. ..+++.||+|++.+ ....+..+|+++|+.++|+||+.+.+++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3566668999999999999998 66889999998652 233567889999999999999999999854 356
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+|+|+|+. +|...+ ..++.+....+..++.|++.||.|+|+ .+++|||+||.|++++.++.+||+|||+|
T Consensus 101 vYiV~elMet-DL~~ii-----k~~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQII-----KSQQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHhh-HHHHHH-----HcCccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCEEeccccce
Confidence 8999999954 888888 345558899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhh-hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+..........-..++.|..|+|||++. ...|+.+.||||.||++.||++|+..|.+.+..+...++......+....+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9876543333446678999999999865 457999999999999999999999999986654444433333222222221
Q ss_pred hHHh--------------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKIL--------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+. ....+...-++..+...+|+.+||..||.+|+|++|+|+|
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 1111122223556789999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=332.10 Aligned_cols=264 Identities=28% Similarity=0.429 Sum_probs=218.3
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
++|.+..+...+.+.||+|.||+||+++|.. .||||.++.+. .+.|..|+.++++-+|.||+-|.|++...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5788888999999999999999999999873 38999866443 3568999999999999999999999998876
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+|..+|+|.+|..+++ .....+++.....|+.|++.|+.|||. ++|||+|||..|||+.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccce
Confidence 89999999999999984 455788999999999999999999999 88999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
................+...|+|||++.- .+|+..+||||||||+|||++|..||.....+.+...+-.....++
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd-- 613 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD-- 613 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc--
Confidence 87655433333444567778999999874 4689999999999999999999999995443332211111110111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
......++++++++|+..||++++++||.+.+|+..|+.++..
T Consensus 614 ----------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 ----------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ----------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1223455678999999999999999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=309.95 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=208.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeee--eCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 79 (312)
.+.|+.+..|++|+||.||+|+ .++++.||+|+++.+.. -...+|+.+|.+++||||+.+-.+.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4678899999999999999999 66899999998765432 24689999999999999999988764 3457899
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|||||+. +|..++. ...+++....+.-+..|++.|++|||. +.|+|||||++|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d----~m~q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLME----TMKQPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHH----hccCCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999987 8887773 234678888999999999999999999 77999999999999999999999999999988
Q ss_pred cCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---hhhh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNL 235 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~ 235 (312)
+.. .......+.|..|+|||++.|. .|+.+.||||+|||+.||+++++.|.+..+.+....+......+. |...
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 654 2334567889999999998876 589999999999999999999999998766554444433322221 1111
Q ss_pred hH--H---------hhhhccccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LK--I---------LDERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~--~---------~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. . ....+...+... .++.-.+|+..+|..||.+|.||++.|.|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 10 0 011112222222 45788999999999999999999999976
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=318.56 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=201.1
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----------------hhHHHHHHHHHhcCCCccceeee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----------------TQEFIDEVCFLASIQHRNLVTLL 68 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~ 68 (312)
..++|++++.||+|.||.|-+|+ ..+++.||||++.... .+.+.+|+.+|++|+||||++++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35789999999999999999999 5578999999755321 24688999999999999999999
Q ss_pred eeeee--CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 69 GYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 69 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
.+..+ ...+|+|+|||..|.+..-- .....+.+.+++.++++++.||.|||. +||+||||||+|+|++.+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCC
Confidence 99865 46789999999887775332 122238899999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCC---CCccccCcccccchhhhhhc---CC-CcccceehhHHHHHHHHhCCCCCCCCCCCCh
Q 021441 147 IAKVADAGLRNFLGRTDVAG---PSSQVTADEIFLASEVKEFR---RF-SEKSDVYSFGVFLLELVSGREASSSLSPDSS 219 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~ 219 (312)
+|||+|||.+.....+.... ......||+.|+|||...+. .+ +.+.||||+|++||.|+.|..||.+....+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 99999999988764332111 12236799999999998873 33 678999999999999999999997644321
Q ss_pred hhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
+ ..+++..++.....++..+++++||.+||.+||+.|++..++..|.
T Consensus 327 --l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 --L------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --H------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 1222333332333334568899999999999999999999987765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=343.48 Aligned_cols=269 Identities=28% Similarity=0.439 Sum_probs=228.5
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
.+...+.++.+.||+|+||+||+|... ..+.||||.++.... .+|.+|++++..++||||++++|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455677788999999999999999832 357899998776544 4699999999999999999999999999
Q ss_pred CeEEEEEEeccCCcccccccCccccc---------ccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVS---------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
+.+|+|+|||..|+|.+|+....... ..+++....+.|+.||+.|+.||.+ +.+|||||-.+|+||.++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGEN 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceeccc
Confidence 99999999999999999996533221 3348889999999999999999999 669999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~ 224 (312)
..|||+|||+++..-..++........-+.+|||||.+..+.|+.+|||||+||+|||+++ |..||.+..+++..+.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i- 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI- 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-
Confidence 9999999999998877776666656667789999999999999999999999999999998 88999887765443322
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
..+.....|.++|.++.+||..||+.+|.+||++.|+-..|+.+........
T Consensus 719 ---------------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 719 ---------------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred ---------------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence 1222245678888999999999999999999999999999999987654433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=333.02 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=219.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++++.||+|+||+|+++. ..+++.||||.++ .+..+....|..++... +||.++.++.+|+...++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 567899999999999999999999 6678899999654 44456677788888877 599999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.||++..+. ....+++..+..++..|+.||.|||+ +|||+||||.+|||+|.+|.+||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999965444 44678999999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..-.. ....+...||+.|+|||++.+..|+.+.|.|||||+||||+.|..||.+.++++..+.+. +
T Consensus 517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---~--------- 582 (694)
T KOG0694|consen 517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---N--------- 582 (694)
T ss_pred ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---c---------
Confidence 65422 224567889999999999999999999999999999999999999999876654433221 1
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHHHHHHhccccccccc
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVTELDRTLDKEMNLTTVMGE 296 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~--~~ll~~l~~~~~~~~~~~~~~~~ 296 (312)
. ...+|..++.+..++++++|.++|++|..+ .+.-+...+-+.++++|+++...
T Consensus 583 ---d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r 638 (694)
T KOG0694|consen 583 ---D--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNR 638 (694)
T ss_pred ---C--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhc
Confidence 1 124677778899999999999999999866 33334445566677777776654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=329.03 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=207.6
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-C-----CceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-Q-----DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGY 70 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~-----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~ 70 (312)
+.|.+..++|++.+.||+|+||.||+|.. . +...||+|.+.... ...+.+|+.+++.+ +|+||++++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 34667788999999999999999999873 2 23579999876432 23577899999999 89999999999
Q ss_pred eeeCCeEEEEEEeccCCcccccccCccc----------------------------------------------------
Q 021441 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQ---------------------------------------------------- 98 (312)
Q Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 98 (312)
+......|+||||+++++|.+++.....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 9999999999999999999887742110
Q ss_pred -------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 99 -------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 99 -------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
.....+++..+..++.|++.||.|||+ +||+||||||+||++++++.++|+|||+++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 012346788899999999999999999 77999999999999999999999999998765433221
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..... .....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~-------------~~~~~ 333 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMV-------------KRGYQ 333 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHH-------------HcccC
Confidence 11122234556999999998899999999999999999997 9999976443211 11111 11111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
...+...++++.+++.+||..||.+|||+.++++.|++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1122334578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=319.61 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=202.2
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-----------------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccc
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-----------------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNL 64 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i 64 (312)
+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+|+.++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45678999999999999999999742 234699998765432 357889999999999999
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCcc--------------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021441 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS--------------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130 (312)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~gi 130 (312)
+++++++...+..|+||||+.+++|.+++.... ......+++..+..++.|++.||.|||+ .||
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNF 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCc
Confidence 999999999889999999999999988774321 0112346778889999999999999999 779
Q ss_pred EecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh--CC
Q 021441 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GR 208 (312)
Q Consensus 131 vH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t--g~ 208 (312)
+|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999876543322222233345677999999998899999999999999999987 56
Q ss_pred CCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 209 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 209 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.||.............. .............+..+++.+.+++.+||..||++|||+.++.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGE---------FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHH---------HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67766443221111000 00000001111223345678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=317.90 Aligned_cols=263 Identities=19% Similarity=0.238 Sum_probs=199.9
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|+||.||+++. .+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999994 46888999975432 23457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.++++..+. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776544 223457888999999999999999999 77999999999999999999999999998875432
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh--
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD-- 240 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 240 (312)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||...................+.........
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 211 12234578889999999988999999999999999999999999986543221111111110000000000000
Q ss_pred -------hh------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 -------ER------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 -------~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+. .........+.++.+++.+||+.||++|||++++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0001112245789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=328.43 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=206.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.+.+..++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+|+.++..+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3556677999999999999999999963 235689999875432 24577899999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-----------------------------------------------------
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ----------------------------------------------------- 98 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 98 (312)
...+..|+||||+++|+|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999877742110
Q ss_pred -----------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 99 -----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 99 -----------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
.....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 011246788899999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
...........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...... .
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~-------------~ 331 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI-------------K 331 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH-------------H
Confidence 322112222334556999999999999999999999999999998 888987643321 111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.......+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111122333457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=315.66 Aligned_cols=249 Identities=18% Similarity=0.292 Sum_probs=199.8
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+.+++.++|++|+++++++...+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999998 5678999999765322 1346789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999877632 122357888999999999999999999 77999999999999999999999999998765332
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. .....++..|+|||++.+..++.++|||||||++|+|++|..||............... . ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------~-~~ 219 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------V-KE 219 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH------------h-hc
Confidence 21 22345788899999999999999999999999999999999999875443211111100 0 01
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
....++...++++.+|+.+||+.||.+||+ ++++++|
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 112234455678999999999999999997 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=321.63 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=204.8
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+..++|++.+.||+|+||.||++. ..++..+|+|...... ...+.+|+++++.++||||+++++++...+..|+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999999 4468889999766442 24578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. ++|+|+||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998883 334578899999999999999999972 359999999999999999999999999987653
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh----------
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---------- 230 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 230 (312)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||......+. ........
T Consensus 156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccc
Confidence 321 2334678889999999999999999999999999999999999975432211 11110000
Q ss_pred -----------------------hhhhhhH-HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 231 -----------------------DFSNLLK-ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 231 -----------------------~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
....... +.............++++.+||.+||+.||++|||+.++++|-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000 1111111111223567899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=320.32 Aligned_cols=242 Identities=21% Similarity=0.265 Sum_probs=199.7
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999 446889999976432 2345778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999998883 34467888889999999999999999 7799999999999999999999999999876532
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
. .....+++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. ..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~------------~~ 213 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKIL------------AG 213 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH------------hC
Confidence 2 123457888999999999999999999999999999999999997643221 111111 00
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
...++...+..+.++|.+||+.||.+||+ ++++++|
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 --KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11233444578999999999999999995 8888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=317.05 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=198.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||.|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4689999999999999999998 457889999976532 23457789999999999999999999999889999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+++.. ....++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9976 77776631 23346788899999999999999999 77999999999999999999999999998764322
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH---
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI--- 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (312)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+...........+........
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 21 1223456788999999876 45899999999999999999999999765433222211111111110000000
Q ss_pred ------hhhh----ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 ------LDER----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ------~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+. .........++++.+++.+||..||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0001112345688999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=313.67 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=207.2
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc-----eEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG-----MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|... .+ ..+++|....... ..+.+|+.++..++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34578999999999999999999843 22 5799998764432 35778999999999999999999999888
Q ss_pred eEEEEEEeccCCcccccccCccccc-----------ccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVS-----------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 144 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~ 144 (312)
..|++|||+++++|.+++....... ...+++..+..++.|++.||.|||+ +|++|+||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcC
Confidence 9999999999999988885322111 1457888899999999999999999 77999999999999999
Q ss_pred CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHH
Q 021441 145 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 223 (312)
Q Consensus 145 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~ 223 (312)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~ 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VI 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence 99999999999876543322222233345677999999988889999999999999999998 999997644321 11
Q ss_pred HHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 224 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
. .+........+..+++++.+++.+||+.||.+||++.+++++|+.
T Consensus 237 ~-------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 E-------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 111122223455667899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=321.80 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=213.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe-EEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 80 (312)
.++|..++.+|.|+||.+++++ ..+++.|++|.+.-.. .....+|..+++++.||||+.+.+.+..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4789999999999999999999 5567899999765332 3456789999999999999999999988887 9999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|+||+||++.+.+.. .+...++++.+..|+.|++.|+.|||+ +.|+|||||+.|||++.++.|+|+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~---~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKE---QKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999843 335778999999999999999999998 779999999999999999999999999999876
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .......||+.|+.||++.+.+|+.++|||||||++|||++-+++|...+.... . ..+.
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i-------------~ki~ 219 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I-------------LKIN 219 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H-------------HHHh
Confidence 443 234557899999999999999999999999999999999999999987553221 1 1112
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+..++.+++.+|..||..+|+.||++.+||.+
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222455777888999999999999999999999999976
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=323.69 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=201.2
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
...++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 345789999999999999999999 45688999997643 23346788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+.+++|.+.+. ....++...+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++..
T Consensus 95 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 95 FLLEFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEcCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 9999999999988883 34457888889999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... ....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~----------- 228 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKIL----------- 228 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHHh-----------
Confidence 53321 2345788899999999999999999999999999999999999754321 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
... ..++...+..+.+++.+||+.||.+||+ +++++.|
T Consensus 229 -~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 -AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 1233345578999999999999999997 6888866
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=295.27 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=208.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeC-----
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN----- 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 74 (312)
+-++.++|++.+.||+|+|+-||+++ ..+++.||+|++... ..+...+|++..++++|||+++++++....
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34678999999999999999999999 778899999976544 345678899999999999999999886433
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|++++|...|+|.+.+.... ..+..+++..++.|+.++++||.+||.....+.||||||.||+++.++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 34899999999999988885432 24557899999999999999999999954459999999999999999999999999
Q ss_pred ccccccCCCcCCC-------CccccCcccccchhhhhhcC---CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHH
Q 021441 155 LRNFLGRTDVAGP-------SSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 224 (312)
Q Consensus 155 ~a~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~ 224 (312)
.++.......... -..-..|..|+|||++.-+. .++++|||||||++|.|++|..||+........-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-- 252 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-- 252 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence 9876543221111 11224677799999987554 58899999999999999999999975433211100
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
..+.....-......+++.+.++|..||+.||.+||++.+++.+++.+.
T Consensus 253 -----------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 -----------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0011111111122226789999999999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=321.50 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=201.3
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+..|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999994 46889999976532 2345778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999883 34457888899999999999999999 7799999999999999999999999999876533
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||......+.......... ....
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~ 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE---------TLQR 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc---------cccC
Confidence 22345678889999999999999999999999999999999999976443221111110000 0000
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........++++.+++.+||..+|.+||++.+++.|
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=309.16 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=196.7
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeee----CCeEEEEEEec
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIYEYI 84 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 84 (312)
..|++|+++.||++... ++.||+|.+.... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 67899999999999984 7899999876432 2456689999999999999999999876 45689999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|.+++. ....+++.....++.+++.||.|||.. .+++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHh-----hCCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999983 334678888999999999999999973 268999999999999999999999999987653221
Q ss_pred CCCCccccCcccccchhhhhh--cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 165 AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
....++..|+|||++.+ ..++.++|||||||++|||++|..||......+ ..... ....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i------------~~~~ 238 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI------------INKN 238 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH------------HhcC
Confidence 22356778999999976 678999999999999999999999998643211 11111 0111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
.....+...++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112234456788999999999999999999999999998875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=319.11 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=194.6
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 557889999976532 2234677999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 9988873 34567889999999999999999999 779999999999999999999999999987532211 12
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ . ...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~------------~--~~~~ 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM------------E--EIRF 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHc------------C--CCCC
Confidence 23346888999999999999999999999999999999999999753321 11111100 0 1123
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
+...++++.++|.+||..||++|| ++.++++|
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 445567899999999999999999 79998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=309.64 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCC-----eEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 83 (312)
.|.-.+.+|.|+||.||.|. ..+++.+|||+.-.+.. .-.+|+.+|+.++||||+++.-+|.... .+.+||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 46678999999999999999 56689999997644333 2357999999999999999988775432 34589999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg~a~~~~~~ 162 (312)
++. +|...+.... ..+..++...+.-+..|+++||+|||. .||+||||||+|+|+|.+ |.+||||||.|+....+
T Consensus 104 mP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 987 8887774321 234567777888899999999999999 679999999999999976 89999999999998766
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH---
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI--- 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (312)
..+ ..+..|..|+|||++.|. .|+.+.||||.||||.||+-|++.|.+.+..+....+...-..+....+..+
T Consensus 180 epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 180 EPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 543 446678889999998875 6899999999999999999999999985443322222222222222221111
Q ss_pred --------hhhhcccc-CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 --------LDERLWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 --------~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+....+.. +....++++.+|+.++|..+|.+|.++.+++.|
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11122222 455566899999999999999999999999965
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=307.97 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=208.3
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|.+..++|++.++||+|++|.||+|...++..|++|..... ..+.+.+|+.+++.++|+||+++++.+...+..|++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 45678899999999999999999999777778999976543 3457888999999999999999999999888999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999888432 23457788889999999999999999 7799999999999999999999999999987644
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||...+..++.++|||||||++|+|++ |..||........ .......
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~----------- 220 (261)
T cd05072 156 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRG----------- 220 (261)
T ss_pred Ccee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcC-----------
Confidence 3221 1122334567999999998889999999999999999998 9999976432211 1111110
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.........+.++.+++.+||..+|++||+++++++.|+++
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 --YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112233457899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=303.79 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=204.8
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCcc-ceeeeeeeeeCC------
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRN-LVTLLGYCQENN------ 75 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------ 75 (312)
..|..+++||+|+||+||.|+ ..+|+.||+|++.-. ......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 457788999999999999999 667899999975432 3456789999999999999 999999998776
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+++|+||++. +|..++...... ....+...+..++.|++.||+|||+ +||+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~-~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKK-PQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 887777322211 1456678899999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---h
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---D 231 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~ 231 (312)
|+....... ......+|..|+|||++.|. .|+...||||+||+++||+++...|.+..+.+....+......+ .
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 986643322 23445688889999999988 68999999999999999999999999877643333333332222 2
Q ss_pred hhhhhHHhhhhc-ccc------CC---hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 FSNLLKILDERL-WST------FT---NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 ~~~~~~~~~~~~-~~~------~~---~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
|.......+... +.. .. .....+..+++.+||..+|.+|.|+..+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222222111110 000 11 1112478999999999999999999999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=317.55 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=207.4
Q ss_pred hhHHhcCCCcccccccCcceEEEeeee-C-----CceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLL-Q-----DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ 72 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~-----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 72 (312)
|.++.++|++.+.||+|+||.||+|.. . +++.||+|.+.... ...+.+|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 678889999999999999999999962 2 24689999876432 23466799999999 7999999999876
Q ss_pred e-CCeEEEEEEeccCCcccccccCcccc----------------------------------------------------
Q 021441 73 E-NNLQFLIYEYIPNGSVSIHLYGPSQV---------------------------------------------------- 99 (312)
Q Consensus 73 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------------------- 99 (312)
. ...++++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 45688999999999998877432110
Q ss_pred ----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcc
Q 021441 100 ----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175 (312)
Q Consensus 100 ----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~ 175 (312)
....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++................++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 01357888999999999999999999 779999999999999999999999999998754332222222334556
Q ss_pred cccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHH
Q 021441 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEE 254 (312)
Q Consensus 176 ~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (312)
.|+|||++.+..++.++|||||||++|+|++ |..||......+. ..... ........+...+++
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~~ 304 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRL-------------KEGTRMRAPEYATPE 304 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHH-------------hccCCCCCCccCCHH
Confidence 7999999999999999999999999999998 9999976432211 11111 111111223344578
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 255 FIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+.+++.+||+.+|++||++.+++++|++++..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.38 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=209.0
Q ss_pred HhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|.+.+.||+|+||.||++.. .++..+++|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467899999999999999999973 234568999876543 24578899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCccc--------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceE
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ--------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vk 149 (312)
|+||||+++++|.+++..... .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEE
Confidence 999999999999888843211 122358899999999999999999999 7799999999999999999999
Q ss_pred EeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhh
Q 021441 150 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ....+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~~ 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECITQ 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc
Confidence 999999876543332222233345667999999998889999999999999999998 899987544211 1111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
. .....+...+.++.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 238 ~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 G-------------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred C-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 011122334568999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=309.72 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=205.5
Q ss_pred HhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+|+++++.++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4678999999999999999999842 24789999876443 2467889999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcc---------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPS---------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI 147 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~ 147 (312)
.|+||||+++++|.+++.... ......+++..+..++.|++.|+.+||+ +|++|+||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCe
Confidence 999999999999998885432 1123457788899999999999999999 77999999999999999999
Q ss_pred eEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHh
Q 021441 148 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 148 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~ 226 (312)
++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999876533322222233345667999999999999999999999999999998 999987544321 11111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
. .......+...+..+.+++.+||..||.+||++.++++.|+
T Consensus 238 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 11112223345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=305.87 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=208.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
|.+...+|.+.+.||+|++|.||++. .++++.+++|...... ...+.+|+++++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 34566789999999999999999998 4468889999876543 34678899999999999999999999988899999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||++++++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 81 TEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999887321 23457888899999999999999999 779999999999999999999999999987664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 156 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~------------- 218 (263)
T cd05052 156 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL------------- 218 (263)
T ss_pred cceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------
Confidence 332111 112223456999999999999999999999999999998 89998754321 111111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
........+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234445568899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=322.23 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=211.8
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+.|+++.+....++-||+|+.|.||+++.+ ++.||||+.+... ..+++.|++|+||||+.|.|+|.....+||||
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 346777777788899999999999999987 5679999765432 34688899999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||..|-|...+ .....+.......|..+|+.|+.|||. +.|||||||.=||||+.+..|||+|||.++....
T Consensus 192 EfCa~GqL~~VL-----ka~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 192 EFCAQGQLYEVL-----KAGRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eccccccHHHHH-----hccCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999998 455667788889999999999999999 6699999999999999999999999999887644
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
. .+.-.+.||..|||||++...+.++|+||||||||||||+||..||.+.+...+.. .+-..
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------------GVGsN 326 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------------GVGSN 326 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE---------------eccCC
Confidence 3 23334678889999999999999999999999999999999999998755332111 01112
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.+....|..+|+-|+-||++||+..|.+||++.+++.||+=.
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 223346777888999999999999999999999999999743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=309.44 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=207.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
..+|++.+.||+|.||.|-+|. ...++.||||.+..+.. -.+.+|+++++.|+||||+++|.+|.+.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3579999999999999999998 67899999997654432 2478899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||..+|.|.+++ .....+++.....+++||++|+.|+|. ++++|||||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 456778999999999999999999999 779999999999999999999999999999886
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ..+.|++.|.+||+++|.+| ++..|-||||+++|-|+.|..||.+.+. ..++.. +
T Consensus 205 ~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQ-------------I 265 (668)
T KOG0611|consen 205 DKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQ-------------I 265 (668)
T ss_pred cccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHH-------------h
Confidence 65543 34678999999999999999 8899999999999999999999987542 111111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...-+.+ +.-|.+..-||+.||..||++|-|+.++..|-
T Consensus 266 s~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hcccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111111 11135678899999999999999999998874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=316.25 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=201.8
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+..++|++.+.||+|+||.||++.. .++..+|+|...... ...+.+|+++++.++||||+++++++...+..|+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 4568999999999999999999994 468889999765432 24578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++. ....++...+..++.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998883 334578888999999999999999972 369999999999999999999999999987553
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh------------
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN------------ 228 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~------------ 228 (312)
... .....++..|+|||++.+..++.++|+|||||++|+|++|..||.................
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 221 2234577889999999988899999999999999999999999976433211111000000
Q ss_pred -------------hhhhh---hhhHHhhhhccccC-ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 -------------SRDFS---NLLKILDERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 -------------~~~~~---~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+.. .............. ....++++.+|+.+||..||++|||+.+++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000 00000000000111 11235689999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.95 Aligned_cols=246 Identities=19% Similarity=0.261 Sum_probs=201.2
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CC-ceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QD-GMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~-~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
.+..++|++.+.||+|+||.||+|.. .+ +..||+|.+.. .....+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 34567899999999999999999983 33 36899997532 233567789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++
T Consensus 106 ~~lv~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 999999999999998883 34567889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+.
T Consensus 179 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i~--------- 241 (340)
T PTZ00426 179 KVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKIL--------- 241 (340)
T ss_pred eecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHHh---------
Confidence 765322 223468888999999998889999999999999999999999997643211 111111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.. ...++...++.+.++|.+||+.||++|+ +++++++|
T Consensus 242 ---~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 ---EG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---cC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 10 0123444557889999999999999995 88888876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=306.27 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=203.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||++..+ .+..||+|....... ..+.+|+.++..++||||+++++++...+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 35678999999999999999999732 356899998765432 3577899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++.. ....+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999988842 22457889999999999999999999 779999999999999999999999999876
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... .......++..|+|||.+.+..++.++|||||||++|++++ |..||....... .....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---------- 221 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV---------- 221 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----------
Confidence 5422211 11112234567999999999999999999999999999775 999997654321 11111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
........+..++..+.+++.+||..+|.+||++.++++.|..+
T Consensus 222 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 ---EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111223455667899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=324.06 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=204.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--hHHHHHHHHHhcCC-C-----ccceeeeeeeeeCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQ-H-----RNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv 80 (312)
+|.+.+.||+|+||.|.+|. .++++.||||++++... .+...|+.+|..++ | -|+++++++|...+++|+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 78999999999999999998 66899999999876644 45667899999886 3 3799999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC--CceEEeecccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNF 158 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~--~~vkl~Dfg~a~~ 158 (312)
+|.+.. +|.+++. .+....++...+..++.||+.||.+||+ .||||+||||+|||+.+- ..||++|||.|..
T Consensus 267 fELL~~-NLYellK---~n~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLK---NNKFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999955 9999994 3455678999999999999999999999 669999999999999643 3899999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..+... .+.-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+..+.+....+..+.+.++...+...
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 655432 456677899999999999999999999999999999999999886654443333322222221111000
Q ss_pred ---------------------------------------hhhhcc-------ccCChHHHHHHHHHHHHhcCCCCCCCCC
Q 021441 239 ---------------------------------------LDERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPS 272 (312)
Q Consensus 239 ---------------------------------------~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt 272 (312)
.+.+.. ..........+.+++.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000000 0011123367899999999999999999
Q ss_pred HHHHHHH
Q 021441 273 MSDVVTE 279 (312)
Q Consensus 273 ~~~ll~~ 279 (312)
+.++|.|
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999976
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=305.04 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=208.0
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|++..++|++.+.||+|++|.||++...+++.||+|..... ....+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45677899999999999999999999766778999987643 3456888999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++... ....+++..+..++.|++.||.+||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999888422 23457899999999999999999999 7799999999999999999999999999887653
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
..... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ......
T Consensus 156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~------------- 218 (261)
T cd05068 156 DIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVD------------- 218 (261)
T ss_pred Ccccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH-------------
Confidence 22111 111222346999999998889999999999999999999 999997643211 111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.......+...++.+.+++.+||+.||.+||++.++++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111122334557899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=319.00 Aligned_cols=262 Identities=18% Similarity=0.289 Sum_probs=194.3
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC-----CeEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (312)
+|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58899999999999999999 557899999976532 234577899999999999999999987543 2479
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 47777762 33457889999999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCc-CCCCccccCcccccchhhhhh--cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 159 LGRTDV-AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 159 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||..................+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 111233468888999999876 57899999999999999999999999764432211111111110000000
Q ss_pred -----------hHHhhhhccc---cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 -----------LKILDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 -----------~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......... ......++++.+++.+||+.||++|||++++++|
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 0111234678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=289.54 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=210.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
...++|++.+.||.|.||.||+|+ .+++-.||+|.+.. ....++.+|+++-..|+||||.++|++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 457899999999999999999999 66788899996543 33456889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+++||...|.+...+... ....+++.....++.|++.||.|+|. ++++||||||+|+|++..+.+|++|||-+..
T Consensus 99 LilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999998888422 34567788889999999999999999 7899999999999999999999999998765
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
-. ........||..|.+||...+..++...|+|++|++.||++.|.+||......+ .++.+...
T Consensus 174 ~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k~--------- 237 (281)
T KOG0580|consen 174 AP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRKV--------- 237 (281)
T ss_pred cC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHHc---------
Confidence 43 233455679999999999999999999999999999999999999998765322 22222211
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+|..++.+..|+|.+|+..+|.+|.+..++++|
T Consensus 238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123456667889999999999999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=312.03 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=194.4
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999994 468899999865322 2356789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+++. .....++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVHT-DLCQYMD----KHPGGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCCc-CHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9965 6655552 223457788899999999999999999 77999999999999999999999999998754322
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh--hhhh---hhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ--NSRD---FSNLL 236 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~--~~~~---~~~~~ 236 (312)
. .......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ...... ..+. +....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccchh
Confidence 1 112234567889999998764 5788999999999999999999999864332111 111100 0000 00000
Q ss_pred H--Hhh-hhccccCC---------hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 K--ILD-ERLWSTFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~--~~~-~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ... .......+ ...++++.+++.+||+.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 000 00000000 0123578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.59 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=208.3
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCC----hhHHHHHHHHHhcCC-Cccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~ 71 (312)
.|.+..++|++.+.||+|+||.||.|... .+..||+|.+.... ...+.+|+.+++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 56778899999999999999999999732 23479999876433 245788999999996 99999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-----------------------------------------------------
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ----------------------------------------------------- 98 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 98 (312)
......|+||||+++++|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999877642110
Q ss_pred --------------------------------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 021441 99 --------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV 140 (312)
Q Consensus 99 --------------------------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Ni 140 (312)
.....+++..+..++.|++.||.|||+ ++++|+||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhE
Confidence 001246778888999999999999999 7799999999999
Q ss_pred EeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCCh
Q 021441 141 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 219 (312)
Q Consensus 141 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~ 219 (312)
+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999876543322222222345567999999998899999999999999999997 9999876432211
Q ss_pred hhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
..... ........+...+.++.+++.+||+.||++|||+.++.+.|++++.
T Consensus 349 --~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNKI-------------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHH-------------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111 1111122334556789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=304.84 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=207.8
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
....+|++.+.||.|+||.||+|....++.+++|.+.... ...+..|+.+++.++|+||+++++++......|+|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4567899999999999999999997668899999876543 3567889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999998432 23457888999999999999999999 77999999999999999999999999998766433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... .....++..|+|||...+..++.++||||||+++|+|++ |..||......+. .... ..
T Consensus 158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~-------------~~ 219 (261)
T cd05148 158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI-------------TA 219 (261)
T ss_pred ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH-------------Hh
Confidence 221 123345567999999988889999999999999999998 8999976442111 1111 11
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......+...++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111123344567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=307.31 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=209.7
Q ss_pred HhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|.+.+.||+|+||.||++... ++..+++|....... ..+.+|+.+++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4567999999999999999999732 345689998765543 4578899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
++||||+++++|.+++..... .....+++..+..++.|++.||+|||+ +|++|+||||+||+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCC
Confidence 999999999999998853211 122347889999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~ 237 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC 237 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 999999999876543332222233445677999999999999999999999999999999 999986644321 1111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.........+...+..+.+++.+||..||.+|||+.++++.|+++.+.
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 -------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111222334457899999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=320.23 Aligned_cols=250 Identities=24% Similarity=0.288 Sum_probs=201.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999 44788999997653 23345778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++. ....++...+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLI-----RKDVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999998883 33567889999999999999999999 7799999999999999999999999999876543
Q ss_pred CC---------------------------cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCC
Q 021441 162 TD---------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 214 (312)
Q Consensus 162 ~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~ 214 (312)
.. .........+++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001123345888999999999999999999999999999999999999765
Q ss_pred CCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 021441 215 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE 279 (312)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~~ll~~ 279 (312)
.... ....+.. + ...........+++++.++|.+||. ||.+||+ +.++++|
T Consensus 234 ~~~~---~~~~i~~---~-------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE---TYNKIIN---W-------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH---HHHHHhc---c-------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4211 1111110 0 0001111111246789999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.45 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=197.0
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
...+|++.+.||+|+||.||+|. ..+++.||+|... ...+.+|+.+++.++||||+++++++......++|+|++.
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 34689999999999999999999 5678899999653 3456789999999999999999999999999999999996
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 167 -~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 167 -TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 47766662 23457888899999999999999999 779999999999999999999999999986543221 1
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCC-----hhhHHHHhhhh---h-hh----
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----SQDLVELVQNS---R-DF---- 232 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~-----~~~~~~~~~~~---~-~~---- 232 (312)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ........... + .+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 11223468889999999999999999999999999999999998875432211 11111111110 0 00
Q ss_pred -hhhhHHh----hh--hcc-----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 -SNLLKIL----DE--RLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 -~~~~~~~----~~--~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+.... .. ... .......+.++.++|.+||..||++|||++++++|
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 00 000 00112346789999999999999999999999964
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=302.75 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=204.9
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.+..++|++.+.||+|+||.||+|...+...|++|...... ...+.+|+.+++.++||||+++++.+.. ...|+|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 35567899999999999999999986655679999876433 3568889999999999999999988754 45799999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++... ....+++..+..++.|++.||.|+|+ +|++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999888421 23456888999999999999999999 77999999999999999999999999998766443
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... ......++..|+|||+..+..++.++|||||||++|+|++ |..||....... .......
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~~~------------- 218 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER------------- 218 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhc-------------
Confidence 321 1122345567999999988889999999999999999999 888887543211 1111100
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
......+...+..+.+++.+||+.||++||++.++++.|+..+
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0011223445678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.85 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=209.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCc-eEEEEEeCCC---CChhHHHHHHHHHhcCC-Cccceeeeee-eee---C--
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGY-CQE---N-- 74 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~---~-- 74 (312)
+..-++++.+.|.+|+|+.||+|....+ ..||+|+.-. .....+.+|+++|+.|. |+|||.++|. ... .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4456778899999999999999995544 8999996432 23356889999999995 9999999993 221 1
Q ss_pred -CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 75 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 75 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
-.++++||||.|+.|.+++... ....+.+..+++|+.|++.|+++||.....|||||||-+|||++.+|+.|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~R---lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTR---LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHH---HhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 2467999999999999999533 334589999999999999999999997677999999999999999999999999
Q ss_pred cccccccCCCcC-CC------CccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHH
Q 021441 154 GLRNFLGRTDVA-GP------SSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 223 (312)
Q Consensus 154 g~a~~~~~~~~~-~~------~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~ 223 (312)
|.+.-....... .. .-..-.|+.|+|||.+. +...++|+|||||||+||.|++...||+......
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----- 265 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----- 265 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence 998754322210 00 11223778899999854 5678999999999999999999999998753322
Q ss_pred HHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 021441 224 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 293 (312)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~ 293 (312)
++.......-.+.+++.+.+||..||+.||.+||++-+++..+..+.+......+.
T Consensus 266 --------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 266 --------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred --------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 12222222233567789999999999999999999999999999999876544433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=309.02 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=192.9
Q ss_pred cCCCcccccccCcceEEEeeee-C-CceEEEEEeCCCC-----ChhHHHHHHHHHhcC---CCccceeeeeeee-----e
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-Q-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQ-----E 73 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 73 (312)
++|++.+.||+|+||.||+|.. . +++.||+|.+... ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999984 3 4678999975432 223456677777665 6999999999875 2
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
....++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 77777632 123457889999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--- 230 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--- 230 (312)
|++...... .......++..|+|||.+.+..++.++|||||||++|+|++|..||......+...........+
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 998765432 12234457888999999998899999999999999999999999998754332221111110000
Q ss_pred hhhhhhHHhh-------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKILD-------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+........ ...........++.+.+++.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000000 000011122345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.62 Aligned_cols=269 Identities=27% Similarity=0.433 Sum_probs=210.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC--------CceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|.+..++|.+.+.||+|+||.||++... +...+|+|...... ...+..|+++++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 35566789999999999999999999732 23569999876542 23577799999999 7999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++......|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~ 169 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAAR 169 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHH
Confidence 99999999999999999999988853211 112357888999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~- 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 99999999999999999876543222211222234457999999998889999999999999999998 8888865332
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
....... ........+...+.++.+++.+||..+|.+|||+.++++.|++++....+
T Consensus 249 --~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 249 --EELFKLL-------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred --HHHHHHH-------------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 1111111 11111233445567899999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=301.81 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=201.1
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.++|++.+.||+|+||.||++.++.+..+++|..... ....+.+|+.+++.++||||+++++++......|+||||++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4678999999999999999999777778999976543 34578889999999999999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999988732 22357889999999999999999999 77999999999999999999999999998765332211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ....+... ..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~-------------~~ 219 (256)
T cd05114 157 S-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRG-------------FR 219 (256)
T ss_pred c-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-------------CC
Confidence 1 112234457999999998889999999999999999999 899997644211 11111110 01
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...+...+..+.+++.+||..||.+||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 112223346799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=317.22 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=194.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..++|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+++++.++|+||+++++++...+.+|+||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 35678899999999999999998 4568899999865432 245788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.... ......+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus 152 e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 152 EFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred ecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999886433 23466778899999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
... ......++..|+|||++.. ...+.++|||||||++|+|++|..||...............
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---------- 288 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---------- 288 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----------
Confidence 221 1223467888999998743 23456899999999999999999999743322211111100
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+...+.++.++|.+||..||++|||+.++++|
T Consensus 289 ---~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 ---CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111122344556789999999999999999999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.35 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=200.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
..+..++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34556789999999999999999998 556889999976431 22346789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||.+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 999999999999998873 2346788888999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhc----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
......... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+....
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~-- 263 (370)
T cd05596 190 MKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMDHK-- 263 (370)
T ss_pred eeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HHHHHHcCC--
Confidence 765432211 12334688899999998754 37889999999999999999999997644211 111111000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
...........+.++.++|.+||+.+|.+ |+++.+++.|
T Consensus 264 --------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 --------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00000111234678999999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=306.58 Aligned_cols=264 Identities=28% Similarity=0.463 Sum_probs=209.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
++.+..++|++.+.||+|+||.||++... ....+++|....... ..+.+|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 46677889999999999999999999843 236799997764322 3477899999999 799999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCcc-----------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV 140 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Ni 140 (312)
...+..|++|||+.+++|..++.... ......+++..+..++.|++.||.|||+ +|++|+||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeE
Confidence 99889999999999999988874321 0123467889999999999999999999 7799999999999
Q ss_pred EeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCCh
Q 021441 141 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 219 (312)
Q Consensus 141 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~ 219 (312)
+++.++.++|+|||.+................++..|+|||...+..++.++|||||||++|+|++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999887654322221222234456999999988889999999999999999997 9999875432211
Q ss_pred hhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
... .........+...+.++.+++.+||..||.+|||+.++++.|+.++
T Consensus 244 ---~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ---FKL-------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHH-------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 1111112234445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=302.97 Aligned_cols=276 Identities=21% Similarity=0.218 Sum_probs=221.0
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+..+.|++++.||.|.-|+||+|. ..++..+|+|.+.+... .+...|.+||..++||.++.+|..++.....
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3556788999999999999999999 55679999998775543 3466799999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|||||+||+|..+. ..+....+++..+..++..++.||+|||- -|||.|||||+||||-++|++-|+||.++.
T Consensus 153 cl~meyCpGGdL~~Lr---qkQp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLR---QKQPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHH---hhCCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 9999999999998877 34566789999999999999999999999 559999999999999999999999999864
Q ss_pred cccCC----------------------------C-----c---------------------CCCCccccCcccccchhhh
Q 021441 158 FLGRT----------------------------D-----V---------------------AGPSSQVTADEIFLASEVK 183 (312)
Q Consensus 158 ~~~~~----------------------------~-----~---------------------~~~~~~~~~~~~y~aPE~~ 183 (312)
..... . . .......+||..|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 43110 0 0 0011234699999999999
Q ss_pred hhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhc
Q 021441 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL 263 (312)
Q Consensus 184 ~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 263 (312)
.|..-+.++|.|+|||++|||++|.-||.+.+..+. +.. ++...+.......++..++|||+++|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHH-------------HhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999999998765432 222 22222222223356688999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHHHHHHhcccccccccCCCc
Q 021441 264 DPSSERRPS-MSDVVTELDRTLDKEMNLTTVMGEGTPT 300 (312)
Q Consensus 264 ~~dp~~Rpt-~~~ll~~l~~~~~~~~~~~~~~~~~~~~ 300 (312)
.+||++|.. ...+.+.-+.-+.++++|+=+....||-
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999985 4455555566788899999555555544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=320.43 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=197.4
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999 456889999986532 2234678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999998883 33458899999999999999999999 7799999999999999999999999999875432
Q ss_pred CCcCC------------------------------------CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHH
Q 021441 162 TDVAG------------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 205 (312)
Q Consensus 162 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~ 205 (312)
..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 001235888999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 021441 206 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE 279 (312)
Q Consensus 206 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~ 279 (312)
+|..||........ ...+... ............++++.++|.+|+. +|.+|++ +.+++.|
T Consensus 234 ~G~~Pf~~~~~~~~---~~~i~~~----------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQET---YRKIINW----------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHH---HHHHHcC----------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999976442211 1111000 0000000111345789999999996 9999997 8888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=313.59 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=197.0
Q ss_pred CCCcccccccCcceEEEeeee----CCceEEEEEeCCCC-------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+|++.+.||+|+||.||++.. .+++.||+|.+... ....+..|+.+++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999974 35788999976431 224567799999999 589999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999988873 34567889999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
........ ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.............. .
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~-------- 222 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--R-------- 222 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--H--------
Confidence 65332211 122346888999999998764 78899999999999999999999975433221111100 0
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
+.. ....++...++.+.+++.+||+.||++|| +++++++|
T Consensus 223 -~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 223 -ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 11223444567899999999999999999 77788876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=315.14 Aligned_cols=239 Identities=23% Similarity=0.264 Sum_probs=193.5
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999 456889999976532 2234667999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 9987772 33467889999999999999999999 779999999999999999999999999987532211 11
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....++..|+|||++.+..++.++|||||||++|+|++|..||...+.... ..... .. ...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~~------------~~--~~~~ 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL------------ME--EIRF 214 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHh------------cC--CCCC
Confidence 2234578889999999999999999999999999999999999976432211 11100 00 0123
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
+...++++.++|.+||+.||.+|+ ++.++++|
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 445567899999999999999998 88888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=305.66 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=203.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
|.+..++|++.+.||+|+||.||.+... .+..||+|...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 5677899999999999999999998742 35679999875432 2347789999999999999999999998
Q ss_pred CCeEEEEEEeccCCcccccccCcccc-----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
....++||||+++++|.+++...... .....++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCE
Confidence 88999999999999999887432111 12335678888999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~ 227 (312)
+|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH
Confidence 9999999876543322211222234567999999998889999999999999999999 78888754321 1111111
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.......+...++.+.+++.+||+.||++|||+.+++++|+
T Consensus 236 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111233445678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=310.30 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=191.4
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.++..++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999 45688999997643 2234567899999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 88883 33457888999999999999999999 779999999999999999999999999987542221 1223
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...+++.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ... ...++.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~------------~~~--~~~~~~ 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKI------------LQE--PLRFPD 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHH------------HcC--CCCCCC
Confidence 346888999999999999999999999999999999999999753321 111111 011 123445
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPS---MSDVVTE 279 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~ 279 (312)
..++++.+++.+||..||.+||+ +.+++.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 56678999999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=301.35 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=205.5
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|++..++|++.++||+|+||.||+|...+++.+|+|.+.... ...+.+|+.+++.++|+||+++++++. .+..|++|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 466788999999999999999999997778899999766433 467889999999999999999998874 45689999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999998887322 23457888899999999999999999 6799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .... .
T Consensus 155 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~-------------~ 217 (260)
T cd05067 155 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNL-------------E 217 (260)
T ss_pred CCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH-------------H
Confidence 2211 1112234567999999998889999999999999999999 9999976442211 1111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111112233445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=326.36 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=201.0
Q ss_pred cCCCcccccccCcceEEEeee-eCC-ceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQD-GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~-~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
..|.+.+.||.|++|.||+|. ..+ ++.|++|....... ..+..|+.+++.++||||+++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 448999999999999999998 334 67888886543332 3466799999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999987763221 123457888899999999999999999 779999999999999999999999999998764433
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... +.. ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~------------~~~-~~ 287 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ------------VLY-GK 287 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHh-CC
Confidence 222233456888999999999999999999999999999999999999753321 11110 001 11
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+..++.++.++|.+||..||++||++.+++.+
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 112334456789999999999999999999998754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=301.38 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=204.1
Q ss_pred HhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
..++|++.+.||+|+||.||+|.+. +...+++|...... ...+.+|+.+++.++||||+++++.+...+..|
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3578999999999999999999853 24579999866433 235778999999999999999999999989999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++|||+++++|.+++.. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++..
T Consensus 82 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 82 IITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999988842 22367889999999999999999999 7799999999999999999999999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..............++..|+|||...+..++.++||||||+++|+|++ |..||....... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~--------- 223 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVED--------- 223 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHc---------
Confidence 752221111122334567999999998899999999999999999998 999986543221 1111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......+...++.+.+++.+||+.+|++||++.+++++|+++
T Consensus 224 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 ----GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011122334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=300.88 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=204.9
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|.+..++|++.+.||+|+||.||+|....+..+++|..... ....+.+|+.++++++|++++++++++.. ...|++|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 45677899999999999999999999777778999976543 34568899999999999999999998754 5679999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++... ....+++..+..++.+++.||.|||+ +|++|+||||+||++++++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999888432 23457889999999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
..... .....++..|+|||...+..++.++|+||||+++|+|++ |..||......+ ..... .
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~-------------~ 217 (260)
T cd05070 155 NEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV-------------E 217 (260)
T ss_pred ccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-------------H
Confidence 32111 112234556999999988889999999999999999999 889997543211 11111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...+..+.+++.+||..||.+|||+.++++.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111122334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=309.52 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=204.4
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc----eEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~----~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+...+|++.+.||+|+||.||+|.+. ++ ..||+|...... ...+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34678999999999999999999843 33 348999875432 24577899999999999999999998765 4
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++++|+.+++|.+++.. ....++...+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 VQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred ceeeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccc
Confidence 6799999999999988842 23457788889999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.................+..|+|||.+.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~-------- 225 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE-------- 225 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh--------
Confidence 87653322222222234567999999999999999999999999999997 999997543211 111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.......+..++.++.+++.+||..||.+||++.+++..+..+.++..
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 226 -----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 111111223345678999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=304.86 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=206.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
|++..++|++.+.||+|+||.||++... ++..+++|....... ..+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567889999999999999999999843 246899998764432 357789999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCcccc-----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
....|+||||+++++|.+++...... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCE
Confidence 99999999999999999888532211 12346788899999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~ 227 (312)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~- 234 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV- 234 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH-
Confidence 9999999876654332222233345667999999988889999999999999999998 9999975433211 1111
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
........+...+.++.+++.+||..+|++|||+.++++.|+
T Consensus 235 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 ------------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111112234445688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.99 Aligned_cols=250 Identities=21% Similarity=0.260 Sum_probs=194.9
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.|++++.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68899999999999999998 557889999986532 22457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ....+++..+..++.|++.||.|||. .||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999988883 33457888889999999999999999 77999999999999999999999999987543110
Q ss_pred CcC---------------------------------------------CCCccccCcccccchhhhhhcCCCcccceehh
Q 021441 163 DVA---------------------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 197 (312)
Q Consensus 163 ~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 197 (312)
... .......||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 00112458889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHh--cCCCCCCCCCHHH
Q 021441 198 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRC--LDPSSERRPSMSD 275 (312)
Q Consensus 198 G~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~--l~~dp~~Rpt~~~ 275 (312)
||++|||++|..||.......... ..... ............++++.++|.+| +..+|..|+++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~--~i~~~-----------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL--KVINW-----------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH--HHHcc-----------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999997654322111 11100 00000111123457889999984 4556666999999
Q ss_pred HHHH
Q 021441 276 VVTE 279 (312)
Q Consensus 276 ll~~ 279 (312)
++.|
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.41 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=194.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999998 557889999976432 2245678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999998883 33557888899999999999999999 7799999999999999999999999999864321
Q ss_pred CCcC------------C---------------------------------CCccccCcccccchhhhhhcCCCcccceeh
Q 021441 162 TDVA------------G---------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYS 196 (312)
Q Consensus 162 ~~~~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 196 (312)
.... . ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0 000135888999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCC---CCH
Q 021441 197 FGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSM 273 (312)
Q Consensus 197 lG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---pt~ 273 (312)
|||++|||++|..||........ ...+... . ...........+.++.++|.+||. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~---~~~i~~~---~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET---YRKIINW---R-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH---HHHHHcc---C-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999976443111 1111100 0 000000111245789999999997 77765 599
Q ss_pred HHHHHH
Q 021441 274 SDVVTE 279 (312)
Q Consensus 274 ~~ll~~ 279 (312)
.+++.|
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=313.62 Aligned_cols=239 Identities=22% Similarity=0.267 Sum_probs=194.0
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999 556889999976532 2345678999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|...+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 9987772 33467889999999999999999999 779999999999999999999999999987532211 11
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ....+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~~~--------------~~~~~ 214 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILM--------------EDIKF 214 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHhcc--------------CCccC
Confidence 233467888999999999999999999999999999999999997543211 1111100 01123
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
+...++++.+++.+||..||++|+ ++.++++|
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 445567899999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=301.17 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=201.5
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..++|++.+.||+|+||.||.+.+..+..+|+|.+.... .+.+.+|+.+++.++||||+++++++......|+||||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 356799999999999999999987666679999766433 356889999999999999999999998888899999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999988732 22357889999999999999999999 7799999999999999999999999999876543221
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......++..|+|||...+..++.++|||||||++|+|++ |..||....... ......+. .
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~-------------~ 218 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQG-------------L 218 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcC-------------C
Confidence 1 1112234556999999998889999999999999999998 999987544321 11111110 0
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
....+...++.+.+++.+||+.||.+||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11122233578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=320.73 Aligned_cols=250 Identities=23% Similarity=0.259 Sum_probs=196.8
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.+|++++.||+|+||.||+|+ ..+++.||+|.+... ....+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999 556899999986532 2345778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999883 33457888888999999999999999 7799999999999999999999999999753311
Q ss_pred CCc-----------------------------------------CCCCccccCcccccchhhhhhcCCCcccceehhHHH
Q 021441 162 TDV-----------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF 200 (312)
Q Consensus 162 ~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~v 200 (312)
... ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 000112358889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC---CHHHHH
Q 021441 201 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP---SMSDVV 277 (312)
Q Consensus 201 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll 277 (312)
+|+|++|..||.......... ..... ............++++.++|.+|+ .+|.+|+ ++.+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~---~i~~~----------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL---KVINW----------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH---HHhcc----------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999997654321111 11000 000001112234577899999977 5999999 899998
Q ss_pred HH
Q 021441 278 TE 279 (312)
Q Consensus 278 ~~ 279 (312)
.|
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 77
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=304.14 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=202.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|++.+.||+|+||.||+|.. ..+..+++|....... ..+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 457889999999999999999973 2457899998764332 3577899999999999999999999998899
Q ss_pred EEEEEeccCCcccccccCccc------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCC
Confidence 999999999999888742211 112346788889999999999999999 779999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~ 224 (312)
+.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||...... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence 9999999999876543322222223334566999999998889999999999999999998 98898654321 1111
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
... .......+..+++.+.+++.+||+.||++||++.+++++|..
T Consensus 238 ~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVR-------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH-------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 111122334456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=299.79 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=201.4
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
..+|++.+.||+|+||.||++.++++..+++|.+... ....+.+|+++++.++||||+++++++...+..|+||||++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4678999999999999999999776778999986543 34567889999999999999999999998889999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.++........
T Consensus 83 ~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999988832 22357889999999999999999999 77999999999999999999999999998765432211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .... .....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~-------------~~~~~ 219 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESV-------------SAGYR 219 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHH-------------HcCCc
Confidence 1111223346999999999999999999999999999999 8999975433211 1111 11111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=311.87 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=192.8
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHH---hcCCCccceeeeeeeeeCCeEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFL---ASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
|++.+.||+|+||.||+|. ..+++.||+|.+... ....+..|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6789999999999999998 556889999976432 223455565554 466799999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|...+. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999987762 2457889999999999999999999 779999999999999999999999999886532
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||........ ...+. .
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i~------------~ 215 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSIV------------N 215 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH------------h
Confidence 211 122345678889999999999999999999999999999999999976432111 11110 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
. ....+...++++.++|.+||+.||.+|| ++.++++|
T Consensus 216 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 216 D--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 1123444567899999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=306.64 Aligned_cols=269 Identities=25% Similarity=0.445 Sum_probs=211.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee--------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|.+..++|.+.+.||+|+||.||+++. .++..+++|...... ...+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3667789999999999999999999963 124579999875432 24578899999999 7999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
.+......|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~ 166 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAAR 166 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccc
Confidence 99999999999999999999988853211 112357788899999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999887644332222222344567999999998889999999999999999998 78888654321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
...... ........+..++.++.+++.+||..+|.+|||+.++++.|++++.-..|
T Consensus 247 ---~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 ---ELFKLL-------------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ---HHHHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 111111 11111223445567899999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=315.72 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=198.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
..+..++|++.+.||+|+||.||++. ..+++.+|+|.+.. .....+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44556899999999999999999999 45688999997642 123346789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999998883 2346788899999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcC----CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+....
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~~~~i~~~~-- 263 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---TYSKIMDHK-- 263 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC--
Confidence 86543221 1123456888999999987653 7889999999999999999999997643211 111110000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
...........++.+.+++.+||..++.+ |+++.++++|
T Consensus 264 --------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 --------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00001111234678999999999865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=327.27 Aligned_cols=256 Identities=19% Similarity=0.299 Sum_probs=203.6
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC---
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN--- 75 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (312)
....++|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3456899999999999999999998 5578999999765332 234677899999999999999987764322
Q ss_pred -----eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEE
Q 021441 76 -----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 150 (312)
Q Consensus 76 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl 150 (312)
.+++||||+.+++|.+++.... .....+++..+..++.|++.||.|+|+ +||+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999998874322 123467888999999999999999999 77999999999999999999999
Q ss_pred eeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 151 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~---- 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKT---- 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----
Confidence 9999988764433222334456888999999999999999999999999999999999999753321 111100
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+...++++.+++.+||..||.+||++.+++.+
T Consensus 258 ---------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 ---------LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111123445566889999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=323.92 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=194.4
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeC--------CeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN--------NLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~ 77 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ....+|+.+++.++||||+++++++... ..+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 34689999999999999999998 4568899999775432 3346799999999999999998876432 246
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeecccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLR 156 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a 156 (312)
++||||+++ ++.+++.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 799999976 5655542211 234567889999999999999999999 7799999999999999665 7999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+...... ......+++.|+|||++.+. .|+.++|||||||++|+|++|.+||.+................+.....
T Consensus 219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8654322 12234568889999998765 6899999999999999999999999865433221111111111100000
Q ss_pred hH------------HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LK------------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. .....+...++...++++.+||.+||..||.+|||+.+++.|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000111112333456789999999999999999999999966
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=297.45 Aligned_cols=245 Identities=28% Similarity=0.447 Sum_probs=194.4
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
+.||+|+||.||+|. ..+++.+|+|...... ...+.+|+++++.++||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999998 4568899999765432 34578899999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 988732 23357888999999999999999999 779999999999999999999999999987654322111111
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCC
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 248 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (312)
....+..|+|||.+.+..++.++|+|||||++|+|++ |..||........ .... ........+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~~~-------------~~~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---REAI-------------EQGVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HHHH-------------HcCCCCCCc
Confidence 2223456999999998889999999999999999998 8888865432111 1100 111112233
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 249 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
...+..+.+++.+||..||++|||+.++++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.77 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=194.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|++... ....+..|..++..++|++|+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999998 556889999987532 2245677999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999998883 34568899999999999999999999 7799999999999999999999999999875432
Q ss_pred CCcC---------------------------------CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC
Q 021441 162 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 162 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~ 208 (312)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0011236889999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCC--hHHHHHHHHHHHHhcCCCCC---CCCCHHHHHHH
Q 021441 209 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSE---RRPSMSDVVTE 279 (312)
Q Consensus 209 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~---~Rpt~~~ll~~ 279 (312)
.||........ ...+.... .. ..++ ...++++.++|.+|+. +|. .||+++++++|
T Consensus 234 ~Pf~~~~~~~~---~~~i~~~~----------~~--~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQET---YKKVMNWK----------ET--LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHH---HHHHHcCc----------Cc--ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 99976443211 11111100 00 0011 1234678999998664 444 46899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=304.71 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=203.5
Q ss_pred HhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
...+|++.+.||+|+||.||++... .++.||+|....... ..+.+|..++..++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4567889999999999999999842 247899998775433 346789999999999999999999999889
Q ss_pred EEEEEEeccCCcccccccCcc-----------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 77 QFLIYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
.++++||+.+++|..++.... ......+++..+..++.|++.||.|+|+ +|++|+||||+||+++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCC
Confidence 999999999999988874211 0112347788899999999999999999 779999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~ 224 (312)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIE 237 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence 9999999999876543332222223345667999999988889999999999999999998 88888654321 1111
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.+. .......+..+++.+.+++.+||+.+|.+||++.+++..|+.
T Consensus 238 ~i~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR-------------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-------------cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 111122345566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=300.73 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=201.3
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cce----EEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|++.+.||+|+||.||++.+. +++ .+++|....... .++..|+.++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 34578999999999999999999853 333 578887654322 345667778899999999999998754 45
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++++||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred cEEEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 7889999999999988842 23457889999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~------ 227 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDLLEKG------ 227 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC------
Confidence 76543332222333446667999999998899999999999999999998 9999976543211 1111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.....+..++.++.+++.+||..||++|||+.++++.|..+.++
T Consensus 228 -------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 228 -------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111222346789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=318.69 Aligned_cols=249 Identities=21% Similarity=0.257 Sum_probs=194.0
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.|++++.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68899999999999999999 556889999987542 22457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999988873 23457888899999999999999999 77999999999999999999999999997533110
Q ss_pred Cc---------------------------------------------CCCCccccCcccccchhhhhhcCCCcccceehh
Q 021441 163 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 197 (312)
Q Consensus 163 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 197 (312)
.. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 000112358889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC---HH
Q 021441 198 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MS 274 (312)
Q Consensus 198 G~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~ 274 (312)
||++|+|++|..||......... ...... ............++++.++|.+|+ .+|.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~--~~i~~~-----------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ--MKVINW-----------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH--HHHHcc-----------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999764432111 111000 000001111234578899998876 59999987 77
Q ss_pred HHHHH
Q 021441 275 DVVTE 279 (312)
Q Consensus 275 ~ll~~ 279 (312)
+++.|
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 77765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=291.23 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=202.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|.+.+.||+|.|+.|+++. ..+|+.+|+|+++ ....+.+.+|+.+-+.|+||||+++.+.+......|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 5789999999999999999998 6678889988644 334567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~Dfg~a~~ 158 (312)
|++.|++|..-+ ..+--+++..+..++.||+.+|.|+|. +||||||+||.|+++- .+.-+||+|||+|..
T Consensus 90 e~m~G~dl~~eI-----V~R~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDI-----VAREFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999987665 233556788888999999999999999 7799999999999994 455789999999988
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
...+. .-....||+.|+|||++...+|+.++||||.|+++|-++.|.+||.+.+.... ++.+....
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl---ye~I~~g~-------- 228 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YEQIKAGA-------- 228 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH---HHHHhccc--------
Confidence 76332 23456799999999999999999999999999999999999999987443222 22111110
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......=..++++.++|+.+||..||.+|+|+.|.|.|
T Consensus 229 --yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 --YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 000111122334688999999999999999999988764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=301.78 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=202.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|.+.+.||+|++|.||+|... .+..|++|...... ...+..|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45678999999999999999999843 46789999776443 235788999999999999999999998888
Q ss_pred eEEEEEEeccCCcccccccCccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEE
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKV 150 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl 150 (312)
..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .++|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEe
Confidence 89999999999999988843221 122357889999999999999999999 7799999999999998765 6899
Q ss_pred eeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhh
Q 021441 151 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~-- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFVT-- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 99999887633222111112223456999999998899999999999999999997 999997644321 111111
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.......+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus 236 -----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11112234445678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=302.07 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=203.9
Q ss_pred CCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
+|++.+.||+|+||.||+|... ....+++|.+..... ..+.+|+.+++.++||||+++++.+...+..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5788999999999999999742 225688887654432 357789999999999999999999998889999
Q ss_pred EEEeccCCcccccccCccc-------------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 021441 80 IYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV 140 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Ni 140 (312)
++||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheE
Confidence 9999999999887643210 112357788999999999999999999 7799999999999
Q ss_pred EeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCCh
Q 021441 141 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 219 (312)
Q Consensus 141 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~ 219 (312)
++++++.++|+|||++................++..|+|||...+..++.++||||||+++|+|++ |..||.......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~- 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER- 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 999999999999999876533322111222344567999999988889999999999999999998 999996543211
Q ss_pred hhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.... .........+...+.++.+++.+||+.||++||++.++++.|++++.+
T Consensus 238 --~~~~-------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 --LFNL-------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHH-------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 111111223444567899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.20 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=207.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCC-Cccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQ-HRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~ 71 (312)
+|++..++|.+.+.||+|+||.||+|.+. .++.||+|.+..... ..+.+|+.++..+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 47778889999999999999999999843 346799998764422 35778999999997 99999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-----------------------------------------------------
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ----------------------------------------------------- 98 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 98 (312)
...+..|+||||+.+++|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 998899999999999999888743210
Q ss_pred ----------------------------------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 99 ----------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 99 ----------------------------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
.....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcc
Confidence 011235667788899999999999998 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999876533221111222345667999999998889999999999999999998 88898654321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
+. ..... ........+...+.++.+++.+||..+|.+||++.+++..|+.++
T Consensus 349 ~~--~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ--FYNAI-------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH--HHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 11111 111112233445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=315.84 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=216.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC--Cc---eEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ--DG---MLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~---~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (312)
.|++..++..+.++||+|+||.||++... ++ ..||+|.... +...++.+|..+++.++||||+++||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 57777788888999999999999999833 22 2389997653 2235688999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
.....+|+|||+|.||+|.+++. .....++......++.+.+.||+|||+ ++++||||-.+|+|++.++.+||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~----k~~~~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLK----KNKKSLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999993 223368899999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||+++..... .........+..|+|||.+....|+.++|||||||++||+++ |..||.+....+....
T Consensus 305 DFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k-------- 374 (474)
T KOG0194|consen 305 DFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK-------- 374 (474)
T ss_pred ccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH--------
Confidence 99998765311 111223356678999999999999999999999999999999 7889987654322111
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
+.........+...|.++..++.+||..||++||++.++.+.++.+......
T Consensus 375 -------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 -------IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1122333345556678999999999999999999999999999999987654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=298.56 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=207.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|++..++|++.+.||+|+||.||++..++++.+++|.+... ....+.+|+.+++.++|+||+++++++......|+||
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 46778999999999999999999999766788999977643 3467889999999999999999999998888899999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... ....+++..+..++.+++.|+.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999888432 23457889999999999999999999 7799999999999999999999999999876643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .......
T Consensus 156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~------------- 218 (261)
T cd05034 156 DEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE------------- 218 (261)
T ss_pred hhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-------------
Confidence 2111 1112223456999999998889999999999999999998 99999654321 1111110
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...+.++.+++.+||..+|++||++.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011112233345789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=315.25 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=196.9
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-----eEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (312)
+|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 57889999999999999999 457899999987542 2245778999999999999999999987765 789
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|+||+.+ +|...+ .....++...+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKII-----VSPQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999975 666665 234567889999999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .......++..|+|||++.+.. ++.++|||||||++|+|++|..||..................+....+..
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 533221 1122345677899999998754 79999999999999999999999987554322221111111111111000
Q ss_pred -------Hh-hhhc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 -------IL-DERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 -------~~-~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+ .... ........++++.++|.+||..||++|||+.+++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0000 001222335789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=303.16 Aligned_cols=249 Identities=19% Similarity=0.286 Sum_probs=199.3
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48889999999999999999 4568899999765422 2345679999999999999999999999889999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998777321 23457889999999999999999999 77999999999999999999999999998765322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. .....++..|+|||++.+..++.++||||+||++|+|++|..||............ ...+. .
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~------------~~~~~-~ 219 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV------------ERRVK-E 219 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH------------HHHhh-h
Confidence 21 12335778899999999888999999999999999999999999864432111100 00001 0
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.....+...++.+.+++.+||+.||.+|| ++.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11223444567899999999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=304.80 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=206.0
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
++.+..++|.+.+.||+|+||.||++.. ..+..+|+|.+.... ...+.+|+.+++++ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3556678899999999999999999973 134579999776432 24577899999999 799999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
...+..|+||||+.+++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEEC
Confidence 9999999999999999999888321 12337899999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .....
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~---- 257 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI---- 257 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----
Confidence 9999876543322111222335567999999998899999999999999999998 9999876443211 11111
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
........+...++++.+++.+||+.+|++|||+.++++.|+++
T Consensus 258 ---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 ---------KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111122333457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=300.98 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=201.5
Q ss_pred CCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (312)
.|++.+.||+|+||.||++.. .+++.||+|...... ...+.+|+.+++.++||||+++++++... ...|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 349999999999999988652 356789999876432 34577899999999999999999987653 4679
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++|||+.+++|.+++. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999998882 2347899999999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCcCC-CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
........ ......++..|+|||...+..++.++|||||||++|+|++|..||......... ................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhh
Confidence 64322111 112223455699999998888999999999999999999999998654322110 0100000011111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
..........+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11222222234456689999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=310.25 Aligned_cols=240 Identities=20% Similarity=0.275 Sum_probs=192.9
Q ss_pred ccccccCcceEEEeeee----CCceEEEEEeCCCC-------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 14 KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++.||+|+||.||++.. .+++.||+|.+... ....+..|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999984 35788999976432 12346679999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++. ....+....+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999988872 33456778888899999999999999 77999999999999999999999999998754222
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. .......++..|+|||++.+..++.++|||||||++|+|++|..||....... .... +...
T Consensus 154 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~~------------~~~~- 215 (323)
T cd05584 154 G--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TIDK------------ILKG- 215 (323)
T ss_pred C--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHHH------------HHcC-
Confidence 1 11223467888999999998889999999999999999999999997643211 1111 1111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
....+...++++.++|.+||+.||++|| +++++++|
T Consensus 216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1123444567899999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=310.85 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=194.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCC-ccceeeeeeeeeCCeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (312)
+|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+..|..++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999998 44678899997643 233456778888888876 56888999999889999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999988873 33457888899999999999999999 7799999999999999999999999999864321
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~------------~ 216 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIME------------H 216 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHc------------C
Confidence 11 1122345788999999999999999999999999999999999999754321 11111110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~ 279 (312)
...++...++++.+++.+||..||.+|++. +++++|
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112344456789999999999999999986 566655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=304.04 Aligned_cols=266 Identities=27% Similarity=0.454 Sum_probs=208.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC--------CceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|.+..++|.+.+.||+|+||.||++... ....+|+|....... ..+..|+.+++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 45677889999999999999999999731 245789997664332 3567899999999 6999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++...+..|++|||+++++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccce
Confidence 99988889999999999999988843211 122457888899999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||.++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999976643322211222234456999999998889999999999999999999 88898654322
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
. ...... .......+...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 244 ~---~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 E---LFKLLR-------------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred H---HHHHHH-------------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1 111111 1111223444567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=297.01 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=203.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|.+..++|++.+.||+|++|.||++....+..+++|..... ....+.+|+.+++.++|+|++++++++.. ...|+||
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 34566789999999999999999999666667999976543 23567889999999999999999988754 4678999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 80 EFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999888432 23346888899999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||...+..++.++||||||+++|+|++ |..||....... ..... .
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~-------------~ 217 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV-------------E 217 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-------------H
Confidence 3211 1122335567999999998889999999999999999999 899997643211 11111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...+..+.+++.+||..||.+||+++++++.|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=307.91 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=189.1
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhc-CCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... .......|..++.. .+||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999 456888999976532 22344556666654 4799999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 99988873 33467888999999999999999999 779999999999999999999999999987543222 2
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~--------------~~~~ 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILN--------------DRPH 214 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc--------------CCCC
Confidence 233456888999999999999999999999999999999999999764321 11111111 0112
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~-~ll~~ 279 (312)
++...+.++.+++.+||..||.+||++. ++++|
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3444567899999999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=296.56 Aligned_cols=256 Identities=24% Similarity=0.439 Sum_probs=205.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|++..++|++.+.||+|+||.||++....+..+++|...... .+.+.+|+.+++.++|+||+++++.+.. ...|++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 567889999999999999999999996667789999765433 3567889999999999999999999877 6789999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... .....++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999888432 23456788889999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||++.+..++.++|+|||||++|+|++ |..||........ .....
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~------------- 217 (260)
T cd05073 155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALE------------- 217 (260)
T ss_pred CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh-------------
Confidence 2211 1122234556999999998889999999999999999998 9999976432111 11111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111112233455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=298.08 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=199.4
Q ss_pred CCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe-----
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL----- 76 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 76 (312)
|++.+.||+|+||.||.|... .+..+|+|.+.... ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999843 24679999765432 2357789999999999999999998765443
Q ss_pred -EEEEEEeccCCcccccccCccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 77 -QFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 77 -~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
.++++||+++++|..++..... .....+++..+..++.|++.||.|||+ +|++|+||||+||++++++.++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCcc
Confidence 6899999999999877743211 123467889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
.++................+..|+|||.+.+..++.++|||||||++|||++ |..||....... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~------ 229 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR------ 229 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH------
Confidence 9887644332222222334567999999988889999999999999999999 888886543211 111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.......+...++++.+++.+||+.||.+|||+.+++++|+++
T Consensus 230 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111223445567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=312.33 Aligned_cols=240 Identities=23% Similarity=0.271 Sum_probs=192.9
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++. ..+++.||+|.+... ....+..|+.++..++||||+++++++...+..|+||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 557889999976532 2234567889999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|..++ .....+++..+..++.|++.||.|||+. +||+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l-----~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 998777 2344678899999999999999999962 469999999999999999999999999987532211 11
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....++..|+|||++.+..++.++|||||||++|+|++|..||....... ....... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~i~~------------~--~~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILM------------E--EIRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHHHhc------------C--CCCC
Confidence 223458888999999999999999999999999999999999997543211 1111100 0 1123
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
+...++++.+++.+||+.||++|+ ++.++++|
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 344567899999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=308.98 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=204.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQ 72 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 72 (312)
|.+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 677889999999999999999999973 246789999876432 23577899999999 6899999999876
Q ss_pred eC-CeEEEEEEeccCCcccccccCccc-----------------------------------------------------
Q 021441 73 EN-NLQFLIYEYIPNGSVSIHLYGPSQ----------------------------------------------------- 98 (312)
Q Consensus 73 ~~-~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 98 (312)
.. ...++||||+++++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 467899999999999888743110
Q ss_pred ---------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 99 ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 99 ---------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 001235777888999999999999999 779999999999999999999999999987653322211122
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCC
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 248 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (312)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....... .......+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~-------------~~~~~~~~ 304 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK-------------EGTRMRAP 304 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHh-------------ccCCCCCC
Confidence 2334556999999998899999999999999999997 899987643221 1111111 11111122
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 249 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
...++++.+++.+||..||++|||+.+++++|+.+++.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 23446799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=305.81 Aligned_cols=267 Identities=26% Similarity=0.444 Sum_probs=209.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC--------CceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
+|++...+|++.+.||+|+||.||.|... .+..+|+|...... ...+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 57788889999999999999999999731 12368999776432 34678899999999 7999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++......|+++||+.+++|.+++..... .....+++..+..++.|++.||.|||. +|++|+||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~ 163 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAAR 163 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccc
Confidence 99988899999999999999988743211 123357788889999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999876543322211222233456999999998899999999999999999998 88888654321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
...... ........+...+.++.+++.+||..+|.+|||+.++++.|+.+....
T Consensus 244 ---~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ---ELFKLL-------------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111 111112233445578999999999999999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=297.74 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=200.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
++|.+.+.||+|++|.||.+. ..+++.+++|...... ...+.+|+++++.++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999998 4568899999754321 2356779999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|+||+++++|.+.+. ....++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLK-----AYGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999988873 33457788889999999999999999 77999999999999999999999999998765
Q ss_pred cCCCcCCC-CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
........ .....++..|+|||...+..++.++||||||+++|+|++|+.||........ . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~------------~~~ 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I------------FKI 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H------------HHH
Confidence 43211111 1234566789999999998899999999999999999999999975432110 0 000
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+...++.+.+++.+||..+|.+|||+.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111123444556789999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=308.69 Aligned_cols=239 Identities=19% Similarity=0.271 Sum_probs=191.2
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998 456789999976532 223456788888765 799999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 99987773 33457888899999999999999999 779999999999999999999999999987542221 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ....+.. .. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~~------------~~--~~ 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESILH------------DD--VL 214 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHHc------------CC--CC
Confidence 1233457888999999999899999999999999999999999997644221 1111111 00 11
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRP-------SMSDVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rp-------t~~~ll~~ 279 (312)
.+...++++.+++.+||+.||++|| +++++++|
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2333457899999999999999999 78888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.42 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=197.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++|+||+++++++......|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999998 557889999976532 2345778899999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR----YEDQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999988832 22467889999999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhh------hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.... ......+++.|+|||++. +..++.++|||||||++|+|++|..||........ ...+....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~~~~----- 225 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNNIMNFQ----- 225 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHHHHcCC-----
Confidence 3211 122335788899999987 45678899999999999999999999976432111 11110000
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........++++.+++.+||. ||.+|||+.+++.|
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 -----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000001112345789999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=297.85 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=196.0
Q ss_pred CCcccccccCcceEEEeeeeCC-c--eEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------Ce
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQD-G--MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL 76 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~-~--~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 76 (312)
|.+.+.||+|+||.||++.... + ..+|+|..... ....+.+|..+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999998543 3 36899976543 234577899999999999999999976432 24
Q ss_pred EEEEEEeccCCcccccccCcc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+++|||+.+++|..++.... ......+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCc
Confidence 689999999999987763221 1233457889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+.................+..|+|||...+..++.++|||||||++|+|++ |..||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~----- 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLRQG----- 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcC-----
Confidence 887644322111222234567999999998889999999999999999999 78898764321 111111111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.....+...++.+.+++.+||..||++|||+.++++.|+++
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 --------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122334557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=299.31 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=202.9
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCce----EEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|++.+.||+|+||.||+|.+ .+++ .||+|....... ..+.+|..++..++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 3467899999999999999999984 3333 589997654332 3567789999999999999999998754 5
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++++|+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||++++++.++|+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCce
Confidence 6799999999999888832 23457889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+...............++..|+|||...+..++.++|||||||++|||++ |..||....... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~--------- 224 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLL--------- 224 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---------
Confidence 87643322212222334567999999998899999999999999999998 899986543211 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+...+.++.+++.+||..||++||++.++++.|+.+..+.
T Consensus 225 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 225 ----EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111223345578999999999999999999999999998887655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.99 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=202.6
Q ss_pred HhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|.+.++||+|+||.||++.. .++..+++|....... ..+.+|+++++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 457889999999999999999963 2356789997665432 4678899999999999999999999998899
Q ss_pred EEEEEeccCCcccccccCccc----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI 147 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~ 147 (312)
|++|||+.+++|.+++..... .....+++..+..++.|++.|++|||+ +|++|+||||+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCC
Confidence 999999999999988843211 112347889999999999999999999 77999999999999999999
Q ss_pred eEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHh
Q 021441 148 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 148 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~ 226 (312)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~ 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IECI 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHHH
Confidence 99999999875543222122223334567999999999999999999999999999998 8999865432211 1111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
. .......+..+++.+.+++.+||..||++||++.++++.|+
T Consensus 238 ~-------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 11111223345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=307.79 Aligned_cols=246 Identities=19% Similarity=0.271 Sum_probs=191.9
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999998 456889999976532 223467788898888 699999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++ .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~~-----~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHM-----QRQRKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 9998777 234568899999999999999999999 77999999999999999999999999998643211 11
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh--hHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
......++..|+|||++.+..++.++|+|||||++|+|++|..||......... ..... ..+.+.. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~-~~ 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY---------LFQVILE-KQ 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH---------HHHHHHc-CC
Confidence 223346788899999999999999999999999999999999999743221100 00000 0000000 01
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPS------MSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt------~~~ll~~ 279 (312)
...+...+.++.+++.+||+.||.+|++ ++++++|
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1234455678999999999999999997 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=300.66 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=193.2
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||+|+||.||++. ..+++.||+|.+.... ...+..|+.+++.++|+||+++.+++......|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999998 4568899999865322 23456799999999999999999999998899999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
...+.... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 87763321 133467899999999999999999999 7799999999999999999999999999876543221 122
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...++..|+|||++.+..++.++|||||||++|+|++|..||............. . ..... ....+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~--~---------~~~~~--~~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--Q---------RILND--SVTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--H---------hhccc--CCCCcc
Confidence 3467788999999999999999999999999999999999997644321111000 0 00001 112334
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
..++.+.+++.+||+.||++|| +++++++|
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 4567899999999999999999 67778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=308.90 Aligned_cols=233 Identities=21% Similarity=0.301 Sum_probs=187.2
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+.. .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999 45688999997653 2234556788888766 699999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 99988772 33467889999999999999999999 779999999999999999999999999987532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~------------~--~~~ 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILN------------D--EVV 214 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhc------------C--CCC
Confidence 223346888999999999989999999999999999999999999764321 11111111 0 012
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSM 273 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (312)
.+...++++.+++.+||+.||.+||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 333456789999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=305.93 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=197.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||++. ..+++.+|+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4679999999999999999998 446788999976532 22356789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+.+. .....++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||.+......
T Consensus 85 ~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMD----DCGNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9976 6666552 123446788889999999999999999 77999999999999999999999999998754322
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH---
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI--- 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (312)
.. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+...........+........
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 TK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred cc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 21 12223467789999998754 5789999999999999999999999875543322222111111100000000
Q ss_pred -----hhhhcc-----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 -----LDERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 -----~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... .......++++.++|.+||..||.+|||+.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 01112345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=297.62 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=204.0
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 689999999999999999999 456889999965421 1235778999999999999999999999989999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++.... .....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999987773221 123457888899999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......+.. .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~------------~ 223 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQ------------C 223 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhc------------C
Confidence 221 1122356778999999998889999999999999999999999986533211 111111110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......+...+..+.+++.+||..+|++||++.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011112234557899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=315.52 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=194.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+..|..++..++||+|+++++.+...+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999998 55688999997642 22345677999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999998883 34567889999999999999999999 7799999999999999999999999999875432
Q ss_pred CCcC---------------------------------CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC
Q 021441 162 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 162 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~ 208 (312)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011235888999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 021441 209 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE 279 (312)
Q Consensus 209 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~ 279 (312)
.||........ ...+... ............++++.++|.+|+. ||.+|++ ++++++|
T Consensus 234 ~Pf~~~~~~~~---~~~i~~~----------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQET---YRKVMNW----------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHH---HHHHHcC----------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99976543211 1111100 0000000011235788999999874 9999986 4555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=295.54 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=202.2
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeee-eCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 81 (312)
|.+..++|++.+.||+|+||.||++... +..+++|...... ...+.+|+.+++.++|++++++++++. ..+..|++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4566789999999999999999999865 6779999876543 346888999999999999999999764 456789999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... ....+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 80 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred ECCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999887421 22347788999999999999999999 7799999999999999999999999999875432
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. .....+..|+|||+..+..++.++|||||||++|+|++ |..||...... ...... .
T Consensus 155 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~-------------~ 213 (256)
T cd05082 155 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV-------------E 213 (256)
T ss_pred cC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------h
Confidence 21 12233456999999998889999999999999999997 99998653321 111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.......+...++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111233445567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=306.93 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=190.7
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999 556889999976532 123466788887776 799999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 99987762 33568899999999999999999999 779999999999999999999999999987532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||............. ...+...+.. ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~i~~-~~~~ 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQVILE-KQIR 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc-------HHHHHHHHhc-CCCC
Confidence 2233567888999999999999999999999999999999999996432211100000 0000000000 1122
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~------~~ll~~ 279 (312)
++...+.++.+++.+||+.||.+||++ .++++|
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 445556789999999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=311.35 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=193.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-----
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN----- 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (312)
..++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35889999999999999999998 456889999986532 2345778999999999999999999886432
Q ss_pred -eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..|+||||+.+ ++...+ ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVI-------HMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHH-------hccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 444443 1236778888999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh-
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS- 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 233 (312)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...+..............+...
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 987543221 1233467888999999999999999999999999999999999998654321111000000000000
Q ss_pred --h----hhHHhhhh-c-----------------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 234 --N----LLKILDER-L-----------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 234 --~----~~~~~~~~-~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
. ........ . ........++++.++|.+||..||++|||+.|++.|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 00000000 0 0001112246789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.67 Aligned_cols=248 Identities=22% Similarity=0.278 Sum_probs=209.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (312)
.+.|++.+.||.|.||.||.+. ..+++.+|+|.+..... ..+.+|+.+|+.+. ||||+.+++.+.....+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4579999999999999999999 55699999997654332 57899999999998 9999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC----CceEEeeccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGL 155 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~----~~vkl~Dfg~ 155 (312)
|||++.||.|.+.+... .+++..+..++.|++.++.|||. .|++||||||+|+++... +.++++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998432 28899999999999999999999 779999999999999643 4799999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+..... ........||+.|+|||++.+..|+..+||||+|+++|.|++|..||...+.......+ .....
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--~~~~~----- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--LRGDF----- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--HcCCC-----
Confidence 998765 23456678999999999999999999999999999999999999999986654333211 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......-..+++.++++|..|+..||.+|+|+.++|+|
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222334446789999999999999999999999996
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=300.60 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=202.1
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-----------------CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccc
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-----------------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNL 64 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i 64 (312)
++.++|++.+.||+|+||.||++... ++..+|+|...... ...+.+|+.+++.++|+||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 45678999999999999999998532 24568999876432 2457889999999999999
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCccc------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
+++++++...+..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChh
Confidence 9999999998899999999999999888754221 112346778899999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh--CCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSP 216 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t--g~~pf~~~~~ 216 (312)
||+++.++.++|+|||++.................+..|++||...+..++.++|+|||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999876543322222222334567999999888889999999999999999998 7788865443
Q ss_pred CChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
........ ..+ ...........+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTG-----EFF----RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHH-----HHH----hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 22111000 000 000001111223345578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=300.84 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=205.2
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
|++..++|++.+.||+|+||.||+|..+ .+..||+|....... ..+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 5677899999999999999999998632 245799997654432 346778999999999999999999998
Q ss_pred CCeEEEEEEeccCCcccccccCccc-----ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
....|+||||+++++|.+++..... ..........+..++.|++.||.|||+ +|++|+||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcE
Confidence 8899999999999999999853211 112345667788999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~ 227 (312)
+|+|||+++...............++..|+|||...+..++.++|+|||||++|+|++ |..||....... ......
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM 235 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9999999876543332222222234566999999998889999999999999999998 788886543211 111110
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
.......+...++.+.+++.+||+.||++|||+.++++.|++.+
T Consensus 236 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -------------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00111223344578999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=313.64 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=199.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
.+.+..++|++.+.||+|+||.||+|. ..+++.+|+|.+... ....+.+|..+++.++||||+++++.+....
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 355667899999999999999999999 456889999976431 2234678899999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+++++|.+++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999998873 2346788888999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcC----CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
+......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.. .....+....
T Consensus 189 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~- 263 (371)
T cd05622 189 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHK- 263 (371)
T ss_pred eeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCC-
Confidence 8765432211 122446888999999987643 788999999999999999999999764321 1111111100
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTEL 280 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~l 280 (312)
...........+..+.++|.+||..++.+ |++++++++|.
T Consensus 264 ---------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 ---------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00001112245678999999999844443 78999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=302.52 Aligned_cols=263 Identities=27% Similarity=0.459 Sum_probs=204.7
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc--eEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~--~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|..+ ++ ..+++|...... ...+.+|++++.++ +|+||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 34578999999999999999999843 34 346777655432 23577899999999 899999999999999999
Q ss_pred EEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
|+||||+++++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENY 161 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCC
Confidence 999999999999988843211 112357889999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|+| |..||......+ ....
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~ 235 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK 235 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHH
Confidence 99999999986432111 1111223456999999988889999999999999999998 999997543321 1111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
. ........+...++++.+++.+||+.+|++||++++++..|+.++.+...
T Consensus 236 ~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 236 L-------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred H-------------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 1 11111123334457899999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=300.51 Aligned_cols=248 Identities=31% Similarity=0.529 Sum_probs=192.3
Q ss_pred CcccccccCcceEEEeeeeC-----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 12 SDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++.+.||.|.||.||+|.+. .+..|++|.+.... ...+.+|++.++.++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999854 36789999885533 3568889999999999999999999998888999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++... ....+++..+..++.|++.||.|||+ ++++|++|+++||+++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 99999999998432 24568899999999999999999999 67999999999999999999999999998776322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
..............|+|||.+.+..++.++||||||+++|||++ |..||..... ......+ ..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~-------------~~ 220 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL-------------KQ 220 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH-------------HT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc-------------cc
Confidence 22222233345667999999999999999999999999999999 6788866532 1111111 11
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
......+..++..+.++|.+||..||.+|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112234445567899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=307.02 Aligned_cols=239 Identities=22% Similarity=0.311 Sum_probs=188.9
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... .......|..++... +||+|+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999 456889999976532 233455677777654 899999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 99988772 33457888899999999999999999 779999999999999999999999999986432111 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~--------------~~~ 214 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVD--------------TPH 214 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC--------------CCC
Confidence 223446788999999999999999999999999999999999999754321 111111100 112
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~-~ll~~ 279 (312)
.+...+.++.+++.+||..||++||++. ++++|
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 3334557899999999999999999984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=295.85 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=205.5
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh--hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
|.+..++|++.+.||.|+||.||.+... ++.+++|....... ..+.+|+.+++.++|+||+++++++......|+||
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 3456789999999999999999999865 67899998766543 56888999999999999999999999888999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 80 EYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999888322 22357899999999999999999999 7799999999999999999999999999877632
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...... .
T Consensus 155 ~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~-------------~ 213 (256)
T cd05039 155 GQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV-------------E 213 (256)
T ss_pred ccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-------------h
Confidence 221 2233456999999988889999999999999999997 99998654321 111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+...++.+.+++.+||+.+|++|||+.++++.|++
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111122334456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=331.44 Aligned_cols=265 Identities=28% Similarity=0.441 Sum_probs=222.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC--Cc----eEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ--DG----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~----~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++.++.+.||+|+||.||.+... .+ ..||+|.+.... ..+|.+|..+++.++||||++++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44667788999999999999999833 23 359999776553 356899999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccc--cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
..++++|||.+|+|..++...... ....+.....+.++.|||+|..||++ +++|||||..+|+|++....|||+||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999654221 24567889999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
|+|+.+...+........+-+..|||||.+....++.++|||||||++||++| |..||....+.+....
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---------- 916 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---------- 916 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----------
Confidence 99997666555544444455668999999999999999999999999999999 8899988665433221
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
..... +-+.|..+|+.+.++|.+||+.+|++||++..+++.+..+.+...
T Consensus 917 -----~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 917 -----VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -----HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11222 456788888999999999999999999999999999998887654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=299.72 Aligned_cols=269 Identities=26% Similarity=0.380 Sum_probs=201.9
Q ss_pred hcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeC--Ce
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 76 (312)
.+.|++++.||+|+||.||++.. .++..|++|.+.... ...+.+|+.+++.+.||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 46689999999999999999973 357889999876442 34578899999999999999999988764 56
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCccc
Confidence 8999999999999988732 22357889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
......... .......++..|+|||...+..++.++|||||||++|+|+++..|+........... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI-GPTHGQMTVTRL 235 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc-ccccccccHHHH
Confidence 876433211 111233456679999999888899999999999999999998776543211100000 000000000111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
............+...++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111112223444568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=297.93 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=206.8
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCC-----ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeee-C
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-N 74 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 74 (312)
.+..++|++.+.||+|+||.||.|.... +..|++|.+.... ...+.+|+.+++.++|+||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4567899999999999999999998544 6789999765432 2346789999999999999999998765 4
Q ss_pred CeEEEEEEeccCCcccccccCcccc---cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
...+++++|+.+++|.+++...... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEEC
Confidence 6678999999999998887432111 12457899999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||...... ........
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-- 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLKD-- 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHHc--
Confidence 9999876543322111222334566999999998889999999999999999999 99999754321 11111111
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
......+..+++++.+++.+||..||++|||+.++++.|+.+..+
T Consensus 235 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111112333457899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=301.03 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=203.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCC-----------------ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccc
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNL 64 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i 64 (312)
+..++|++.+.||+|+||.||+|.... +..+|+|.+.... ...+.+|+.++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 346789999999999999999987331 2458999876543 3457789999999999999
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCccc------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
+++++++...+..+++||++.+++|..++..... .....+++..++.++.|++.||.|||+ +|++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchh
Confidence 9999999998899999999999999988843321 112368899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh--CCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSP 216 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t--g~~pf~~~~~ 216 (312)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876544332222333445667999999998889999999999999999998 6778765432
Q ss_pred CChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
... ...... .............+...++++.+++.+||..||++|||+.++++.|+
T Consensus 240 ~~~---~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQV---IENAGH------FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHH---HHHHHh------ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111 111100 00000111111223344578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=312.61 Aligned_cols=262 Identities=20% Similarity=0.223 Sum_probs=200.1
Q ss_pred hcCCCcccccccCcceEEEeeeeC---CceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..+|++.+.||+|+||.||++... ++..|++|..... ....+|+.+++.++||||+++++++......|+|||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 457999999999999999999732 4578999977543 34568999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+ +|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++........
T Consensus 169 ~~-~l~~~l-----~~~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 169 KC-DLFTYV-----DRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred CC-CHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 64 676666 234567899999999999999999999 7799999999999999999999999999876654332
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh-HHHHhhhhhh----hh-----h
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRD----FS-----N 234 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~----~~-----~ 234 (312)
........++..|+|||++.+..|+.++|||||||++|+|++|..||.......... +......... +. .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 222334568899999999999999999999999999999999999997654433221 1111111000 00 0
Q ss_pred hhHH---hhhhcccc--CC-----hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKI---LDERLWST--FT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~---~~~~~~~~--~~-----~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+... ........ .+ ...+.++.++|.+||..||++|||+.+++.|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000 00 1234678999999999999999999999987
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=298.72 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=201.2
Q ss_pred hcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeee--CCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (312)
.++|++.+.||+|+||.||.+.. .+++.|++|.+..... ..+.+|+.+++.++||||+++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999873 2477899998765543 357789999999999999999998643 3468
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|+||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 999999999999988832 23457888999999999999999999 779999999999999999999999999988
Q ss_pred cccCCCcCC-CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh----hhh
Q 021441 158 FLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS----RDF 232 (312)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~----~~~ 232 (312)
......... .......+..|+|||...+..++.++|||||||++|||++|..|+....... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF----MRMMGNDKQGQMIV 232 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh----hhhcccccccccch
Confidence 764322111 1111223445999999998889999999999999999999887764432110 0000000 000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
..+............+...+.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111112222222223445567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.40 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=193.7
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+|++.+.||+|+||.||+|. ..+++.||+|.+... .......|..++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999998 446789999976532 122355677777776 5899999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|...+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999988772 33457888999999999999999999 7799999999999999999999999999875322
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~------------~ 216 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIME------------H 216 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHh------------C
Confidence 11 1123346788899999999999999999999999999999999999764321 11111110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~ 279 (312)
...++...++++.+++.+||+.||.+|++. .++++|
T Consensus 217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 112344556789999999999999999985 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=298.08 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=197.9
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhH-----HHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQE-----FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~-----~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
|++.+.||+|+||.||++. ..+++.+|+|.+....... ..+|+.+++.++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6789999999999999999 5567789999877665543 234889999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+++|.+++. ....++...+..++.|++.||.+||+ +|++|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred cccccccccc-----cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc--ccc
Confidence 9999998883 45667899999999999999999999 77999999999999999999999999998754 111
Q ss_pred CCCCccccCcccccchhhhh-hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 165 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
........++..|+|||+.. +..++.++|+||||+++|+|++|..||................... . ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~----~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----L----PSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----H----HHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----c----cccc
Confidence 22234456778899999998 7888999999999999999999999998651111111111100000 0 0000
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......++.+.+++.+||+.||++||++.+++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001112789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=305.22 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=189.2
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhc-CCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... .......|..++.. ++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999 456789999976532 23345567777765 4899999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 99988883 33457888899999999999999999 779999999999999999999999999987532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~--------------~~~ 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRMD--------------NPC 214 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC--------------CCC
Confidence 123345788899999999989999999999999999999999999764321 111111100 011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~-~ll~~ 279 (312)
.+...+.++.+++.+||..||++||++. +++.|
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 2334557899999999999999999997 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=293.61 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=194.0
Q ss_pred cccccCcceEEEeeee---CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLL---QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
++||+|+||.||+|.+ .++..+|+|.+.... ...+..|+.+++.++||||+++++++.. ...++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 3689999999999963 357889999875432 2457789999999999999999998764 466899999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC-
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA- 165 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~- 165 (312)
++|.+++. ....+++..+..++.|++.||.|+|+ +|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 80 GPLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99998883 33457889999999999999999999 77999999999999999999999999998766433211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......++..|+|||.+....++.++|+|||||++|||++ |..||...... .....+. ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~-------------~~~~ 216 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE-------------SGER 216 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-------------CCCC
Confidence 11112233467999999988888999999999999999998 99999764332 1111111 1111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
...+...++++.++|.+||+.||++||++.++...|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 234445668899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.76 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=191.6
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+..|..++..+ +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998 446789999976532 234566788888877 699999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 99988772 33468899999999999999999999 779999999999999999999999999886532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. . ...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~------------~--~~~ 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILE------------D--EVR 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHc------------C--CCC
Confidence 122345788899999999999999999999999999999999999754321 11111111 0 112
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~ 279 (312)
.+...++.+.++|.+||..||.+||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 334456789999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=297.20 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=213.8
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+-|.++++||+|+||.||+|. ..+|+.+|||..+.+ ..+++.+|+.++.++++|+++++||.+..+..+|+|||||.-
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 446788999999999999998 668999999988755 457899999999999999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
|++++.++ ..++.+.+..+..++++.+.||.|||.+. -+|||||..|||++.+|..||+|||.+-.+..+- .
T Consensus 113 GSiSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 113 GSISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred CcHHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 99999994 45678999999999999999999999954 8999999999999999999999999987664432 2
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......||+.|+|||++..-.|+.++||||||++..||.-|++||.+..+......+ . ..++....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---P-----------T~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---P-----------TKPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---c-----------CCCCCCCC
Confidence 234567999999999999999999999999999999999999999886653221111 0 12333345
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.|..+++++.+++++||.++|++|-|+..|++|
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 677888999999999999999999999999876
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=301.15 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=201.4
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCC---------------ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCcccee
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQD---------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT 66 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~ 66 (312)
+..++|++.+.||+|+||.||++.... ...||+|...... ...+.+|+++++.++|+|+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 346799999999999999999987431 2358999876542 235778999999999999999
Q ss_pred eeeeeeeCCeEEEEEEeccCCcccccccCccc-------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 021441 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 139 (312)
Q Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~N 139 (312)
+++++...+..|+||||+.+++|.+++..... .....+++..++.++.|++.||.|||+ +|++|+||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhh
Confidence 99999998999999999999999888743210 111246788899999999999999999 779999999999
Q ss_pred eEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh--CCCCCCCCCCC
Q 021441 140 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPD 217 (312)
Q Consensus 140 il~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t--g~~pf~~~~~~ 217 (312)
|+++.++.++|+|||++................++..|+|||...+..++.++|+|||||++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876543322222223344567999999988889999999999999999998 66777654332
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.... .... .............+...++.+.+++.+||..||++||++.++++.|+
T Consensus 240 ~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIE---NTGE------FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHHH------hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 0000 00000111112223344578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.05 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=189.1
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+.+|..++..+ +||+|+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999 556789999987543 223467788888887 699999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+ .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~-----~~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHM-----QRQRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 9998777 233468899999999999999999999 779999999999999999999999999987532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||............... ...... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~~-~~~~ 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVILE-KPIR 221 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHHh-CCCC
Confidence 223346788899999999999999999999999999999999999754332211111000 000000 1122
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
.+...+..+.+++.+||+.||.+|+++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 4445567899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=299.79 Aligned_cols=261 Identities=22% Similarity=0.283 Sum_probs=191.4
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcC---CCccceeeeeeeee-----CC
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQE-----NN 75 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 75 (312)
+|++.+.||+|+||.||+|. ..+++.||+|.+... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58899999999999999998 557889999976532 123455677777665 69999999998754 24
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..+++||++.+ +|.+++.. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK---VPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999976 77666632 123457899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DF 232 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~ 232 (312)
+....... ......++..|+|||++.+..++.++|||||||++|+|++|..||..................+ .+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 87654221 1223456778999999998899999999999999999999999997644322111111110000 00
Q ss_pred hhhhHH----h---hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKI----L---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~----~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... . ............++++.+++.+||..||++|||+.+++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0 0000111223445788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=298.77 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=203.3
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|... ++..+|+|.+.... ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 34678999999999999999999842 46789999876543 245778999999999999999999999888
Q ss_pred eEEEEEEeccCCcccccccCccc-----------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQ-----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
..|++|||+++++|.+++..... .....+++..++.++.|++.||.|||+ +|++|+||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHh
Confidence 99999999999999888843211 112346788889999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||.+.................+..|+|||...+..++.++|||||||++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322222222334556999999998999999999999999999997 88888654321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
+ ...... ... ....+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~---~~~~~~------------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E---VIYYVR------------DGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---HHHHHh------------cCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 111111 011 111233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=294.69 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=205.5
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCC----ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
.+..++|++.+.||+|+||.||+|...+ ...+++|...... .+.+.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 4567889999999999999999998432 3468999766443 24578899999999999999999988764 5
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++.. ....+++..+..++.+++.||.|||+ +|++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence 7899999999999998832 23357889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ....+
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~------- 223 (270)
T cd05056 155 RYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIEN------- 223 (270)
T ss_pred eeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHc-------
Confidence 7654332111 112234456999999988889999999999999999996 99999765432111 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
......+...+..+.+++.+||..+|.+|||+.++++.|+++.++.
T Consensus 224 ------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 224 ------GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111234455678999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=292.00 Aligned_cols=247 Identities=20% Similarity=0.319 Sum_probs=199.2
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+|++.+.||+|+||.||++. ..+++.+++|.+... ....+.+|+.+++.++|+||+++++.+...+..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58899999999999999999 456889999975432 2345778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|.+++.. .....++...+..++.|++.||.+||+ +|++|+||||+||+++.++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999887732 123456888899999999999999999 7799999999999999999999999999876543221
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
......++..|+|||+..+..++.++|+||||+++|+|++|..||...... ...... .....
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~-------------~~~~~ 217 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKV-------------CQGSY 217 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHH-------------hcCCC
Confidence 122345777899999999888999999999999999999999999753321 111111 11111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+..++..+.+++.+||+.||.+|||+.+++..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22344456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=291.31 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=205.2
Q ss_pred cCCCcccccccCcceEEEeeeeC-CceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|++|.||+|... +++.+++|.+.. .....+.+|++++++++|++++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999954 788999996542 12356788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|..++.... .....++...+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999988774321 123457889999999999999999999 7799999999999999999999999999876533
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ....... ...
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-------------~~~ 222 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-------------IEK 222 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhh-------------hhc
Confidence 221 112234677799999999888999999999999999999999999654321 1111110 011
Q ss_pred hccccCCh-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 242 RLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 242 ~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
......+. ..+..+.++|.+||..+|++|||+.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11112222 45578999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=306.68 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=185.7
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHH-HHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+.... ...+..|. .+++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999 4467889999765321 12333343 356778999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+. ....+....+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 99988873 33456788888899999999999999 779999999999999999999999999987542211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~------------~~--~~~ 214 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNIL------------NK--PLQ 214 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHH------------hC--CcC
Confidence 233456888999999999999999999999999999999999999754321 1111111 11 012
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (312)
.....++.+.+++.+||+.||.+|+++.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 233456789999999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=296.95 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=198.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||+|+||.||++. ..+++.+|+|..... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45789999999999999999999 456889999976543 23456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ....+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999998873 33457888999999999999999999 77999999999999999999999999998765322
Q ss_pred CcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 163 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
. .......++..|+|||.+. ...++.++|+|||||++|+|++|..||............. . ...
T Consensus 160 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~---~-~~~------- 226 (267)
T cd06646 160 I--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS---K-SNF------- 226 (267)
T ss_pred c--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee---c-CCC-------
Confidence 1 1122345677899999975 3447889999999999999999999986543221110000 0 000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
... .......++..+.+++.+||..||++|||++++++++
T Consensus 227 ~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0011223457899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=295.40 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=189.2
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||+|+||.||++. ..+++.||+|.+.... ......|+++++.++||||+++++++......|+||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998 4568999999765321 22345689999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 8777321 23347788889999999999999999 7799999999999999999999999999876543221 12
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...++..|+|||++.+..++.++|+|||||++|+|++|..||.......... ..... ...... .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~---------~~~~~~-~~~~~ 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRR---------TLEDEV-KFEHQ 220 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHH---------hhcccc-ccccc
Confidence 3457778999999998899999999999999999999999997543221111 00000 001110 01112
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
..++++.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 34678999999999999999999977663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.73 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=201.6
Q ss_pred cCCCcccccccCcceEEEeeeeC-Cc--eEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~--~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (312)
++|++.+.||+|+||.||+|... ++ ..+++|...... ...+.+|+.++.++ +||||+++++++...+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57999999999999999999843 33 346888766432 24577899999999 799999999999998899999
Q ss_pred EEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceE
Q 021441 81 YEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vk 149 (312)
+||+++++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEE
Confidence 999999999888843211 112357888999999999999999999 7799999999999999999999
Q ss_pred EeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhh
Q 021441 150 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|+|||++........ ......+..|+|||...+..++.++|||||||++|+|++ |..||....... ....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~--- 230 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEK--- 230 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---
Confidence 999999864321110 111122446999999998889999999999999999997 999997644211 1111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.........+..+++.+.+++.+||+.+|.+||+++++++.|+.+.+..
T Consensus 231 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 ----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111112233445678999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.90 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=185.5
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHH-HHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.||+|.+... ....+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999 457899999986532 1223444444 56778999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 99988772 34567888899999999999999999 779999999999999999999999999986532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~------------~--~~~ 214 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILN------------K--PLR 214 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHHc------------C--CCC
Confidence 233446788999999999999999999999999999999999999764321 11111111 0 012
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
.+...++.+.++|.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2334467899999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=307.14 Aligned_cols=236 Identities=22% Similarity=0.264 Sum_probs=189.7
Q ss_pred ccccccCcceEEEeeee----CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 14 KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
++.||+|+||.||++.. .+++.||+|.+... ....+..|+++++.++||||+++++++...+..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999873 35789999976532 2234567999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+++|.+++. ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 81 RGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 9999988872 34457899999999999999999999 779999999999999999999999999987643321
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+. .. .
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~------------~~--~ 214 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMIL------------KA--K 214 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHH------------cC--C
Confidence 1122345788899999999888999999999999999999999999764321 1111110 00 1
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (312)
...+...++++.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1234445678999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=290.57 Aligned_cols=249 Identities=32% Similarity=0.511 Sum_probs=201.5
Q ss_pred cccccCcceEEEeeeeC-C---ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|... . +..+++|...... ...+.+|+.+++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999944 3 7889999876543 35678899999999999999999999998899999999999
Q ss_pred CcccccccCcccc----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 87 GSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 87 ~~L~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
++|.+++...... ....+++..+..++.|++.||.+||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999988432110 13668999999999999999999999 77999999999999999999999999999876544
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
..........++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~-------------~ 222 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR-------------K 222 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH-------------c
Confidence 32222334456778999999998889999999999999999999 699997753211 111111 1
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
......+...+.++.+++.+||..||.+|||+.+++++|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122344555788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=292.09 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=200.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||++. ..+++.|++|.+.. .....+.+|+++++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 57889999999999999998 45688999997543 2345677899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++... ....++...+..++.+++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999888432 23567888899999999999999999 779999999999999999999999999987664332
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.. .....++..|+|||+..+..++.++|+|||||++|+|++|..||...... ...... ....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~-------------~~~~ 217 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI-------------IRGV 217 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-------------HcCC
Confidence 11 12234677899999999888999999999999999999999999754421 111110 1111
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 122333556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.09 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=198.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.|++.+.||+|+||.||++. ..+++.||+|.+.... ...+..|+.+++.++|++|+.+++.+...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47788999999999999998 5578899999764321 2346679999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++.. .....++...+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999887732 122357888899999999999999999 77999999999999999999999999998754322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. .....++..|+|||++.+..++.++|||||||++|+|++|..||............... . . .
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---------~---~-~ 219 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---------V---K-E 219 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---------h---h-h
Confidence 21 12335788899999999889999999999999999999999999764432211111000 0 0 0
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
.....+...++++.+++.+||+.||++||| ++++++|
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 011233345578999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=292.84 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=201.5
Q ss_pred HhcCCCcccccccCcceEEEeeeeC-Cc---eEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ-DG---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
..++|+..+.||+|+||.||+|... ++ ..+++|...... ...+..|+++++.++||||+++.+++...+..|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4568899999999999999999843 33 379999875442 245778999999999999999999999989999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+.+++|.+++.. ....+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++++|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999888732 23457888899999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCcCC-CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~--------- 224 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIN--------- 224 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHh---------
Confidence 64322111 1111223446999999998889999999999999999997 99999754321 1111111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.......+...+..+.+++.+||..+|++||++.++++.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 ----DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111112334457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=295.44 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=195.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|+||.||++. ..+++.||+|...... ...+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 478899999999999999998 5578899999765332 24577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|..+. .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999886432 35677888999999999999999 779999999999999999999999999987654321
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||............... .........
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~ 217 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL--------LQCIVDEDP 217 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH--------HHHHhccCC
Confidence 22346777899999999889999999999999999999999999764322211100000 000000000
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........++++.+++.+||..||++||++++++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011122245689999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=303.20 Aligned_cols=238 Identities=20% Similarity=0.286 Sum_probs=190.3
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+|++.+.||+|+||.||+|. ..+++.||+|++... ....+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47888999999999999998 556889999976532 2234667888888775 578888999999888999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999988872 33458889999999999999999999 7799999999999999999999999999875422
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. .......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~------------~~ 216 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM------------EH 216 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH------------hC
Confidence 21 1122345788899999999999999999999999999999999999764321 1111111 10
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (312)
....+...++++.+++.+||..||.+|++.
T Consensus 217 --~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 --NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 112334456789999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=299.52 Aligned_cols=263 Identities=20% Similarity=0.276 Sum_probs=196.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5789999999999999999998 446889999976432 23456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|..++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+......
T Consensus 85 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLDK-DLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cccc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9975 77766632 23457788999999999999999999 77999999999999999999999999998754322
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+...........+...........
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 11 11223457789999998764 4788999999999999999999999765432211111111000000000000000
Q ss_pred -------------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 -------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........++++.++|.+||..||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00001122345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=288.98 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=193.7
Q ss_pred cccccCcceEEEeeee-CC---ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLL-QD---GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~-~~---~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
++||+|+||.||+|.. .. +..+++|....... ..+.+|+.+++.+.|+||+++++++.. ...++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 4799999999999973 22 26899998765443 457789999999999999999998764 467999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|.+++. ....+++..+..++.|++.||.|||. .|++|+||||+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99998883 23367899999999999999999999 779999999999999999999999999988764332211
Q ss_pred C-CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 167 P-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 167 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+.. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~-------------~~~ 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES-------------GER 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc-------------CCc
Confidence 1 111223456999999998899999999999999999998 99999764321 11111111 111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
...+...+..+.+++.+||..+|.+||++.++++.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 123344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=288.69 Aligned_cols=245 Identities=24% Similarity=0.404 Sum_probs=193.1
Q ss_pred ccccCcceEEEeeeeC---CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCc
Q 021441 16 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS 88 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (312)
.||+|+||.||++.+. ++..||+|....... ..+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999998743 356799998765432 457789999999999999999998764 46799999999999
Q ss_pred ccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC-C
Q 021441 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG-P 167 (312)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~-~ 167 (312)
|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.......... .
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9988732 23467899999999999999999999 779999999999999999999999999987653322111 1
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... .......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~-------------~~~~~~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI-------------EQGKRLD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH-------------HCCCCCC
Confidence 111223457999999988889999999999999999996 9999976543211 1111 1111123
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.+...++++.+++.+||..||++||++.++.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3445568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=307.00 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=193.5
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------ 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 74 (312)
..++|++.+.||+|+||.||++. ..+++.+|+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 46899999999999999999998 456889999976532 224567899999999999999999987543
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+.+ ++...+ ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 554444 1246788888999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh----h
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS----R 230 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~----~ 230 (312)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||......... ....... +
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 239 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW--NKVIEQLGTPCP 239 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence 987653321 123346788899999999999999999999999999999999999764321111 1000000 0
Q ss_pred hh-h----hhhHHhhh---------------hc---cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DF-S----NLLKILDE---------------RL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~-~----~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. . ........ .. ........+.++.++|.+||+.||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0 00000000 00 001112234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=287.89 Aligned_cols=245 Identities=28% Similarity=0.495 Sum_probs=195.2
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCccc
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS 90 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (312)
++||+|++|.||++....++.|++|....... ..+.+|+++++.++|+||+++++++......|+||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999965588999997665433 36788999999999999999999999999999999999999998
Q ss_pred ccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCcc
Q 021441 91 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 170 (312)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 170 (312)
+++.. ....++...+..++.+++.+|.|||+ ++++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 88732 22356788899999999999999999 7799999999999999999999999999876543221111112
Q ss_pred ccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 171 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...+..|+|||.+.+..++.++|+|||||++|+|++ |..||.......... .. ........+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~~-------------~~~~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---RI-------------ESGYRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---HH-------------hcCCCCCCCc
Confidence 223456999999998889999999999999999999 888886654321111 11 1111112233
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
..+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 44678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=291.74 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=201.9
Q ss_pred HhcCCCcccccccCcceEEEeeeeC-C---ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
..++|++.+.||+|+||.||+|... + +..+++|.+.... ...+.+|+.+++.++||||+++++++...+..|
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3568999999999999999999842 2 3479999876433 245788999999999999999999999888999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++.. ....+++..+..++.|++.||.+||+ .|++|+||||+||+++.++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 82 IVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999988842 22457888899999999999999999 7799999999999999999999999999886
Q ss_pred ccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... ........+..|+|||.+.+..++.++|+|||||++|++++ |..||......+. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~------- 225 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEG------- 225 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCC-------
Confidence 6432211 11111223456999999998889999999999999999886 9999976543211 1111110
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.....+...++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=312.82 Aligned_cols=262 Identities=18% Similarity=0.205 Sum_probs=195.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
..+|.+.+.||+|+||.||++. ..+++.||+|... ...+.+|+.++++++|+||+++++++...+..++|||++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 4579999999999999999999 4467889999543 2345789999999999999999999999999999999996
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+++.........
T Consensus 244 ~~L~~~l~----~~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLG----ARLRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 47766662 123468899999999999999999999 779999999999999999999999999987654322221
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCC-----hhhHHHHhhhhh----hhh----
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----SQDLVELVQNSR----DFS---- 233 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~-----~~~~~~~~~~~~----~~~---- 233 (312)
......+|..|+|||++.+..++.++|||||||++|||++|..|+....... .......+.... .+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2223468889999999999999999999999999999999887653322111 111222221110 000
Q ss_pred -hhhHHhhhh----ccccC-------ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 -NLLKILDER----LWSTF-------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 -~~~~~~~~~----~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+....... ..... ....+.++.+||.+||+.||.+|||+.|+|+|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 00000 01233578999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.44 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=193.5
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------ 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 74 (312)
..++|++.+.||+|+||.||.+. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999998 456888999986532 234577899999999999999999887533
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+.+ ++...+. ..++...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 5554441 236778888999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh--hh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DF 232 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~ 232 (312)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...+..............+ .+
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 987653321 1223457888999999999999999999999999999999999997654322111110000000 00
Q ss_pred -hhh----hHHhhhhc------------------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 -SNL----LKILDERL------------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 -~~~----~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+ ......+. ........++++.++|.+||..||.+|||+.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000 000111123578999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.60 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=192.1
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
...+|++.+.||+|+||.||+|.. .+++.||+|..... ....|+.+++.++||||+++++++......|+|||++.
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 346799999999999999999994 46788999975433 23568999999999999999999999999999999996
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+ +|.+++. .....+++..+..++.|++.||.|||. +||+||||||+||+++.++.++|+|||++.......
T Consensus 141 ~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 141 S-DLYTYLT----KRSRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred C-cHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 5 6666663 233567899999999999999999999 779999999999999999999999999987533221
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH--------HHHhhh----hhhhh
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL--------VELVQN----SRDFS 233 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~--------~~~~~~----~~~~~ 233 (312)
......++..|+|||++.+..++.++|||||||++|+|+++..|+....+...... ...... ...+.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 12234578889999999999999999999999999999986655433222221110 000000 00000
Q ss_pred -----hh-hHHhhhhcc-----c----cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 -----NL-LKILDERLW-----S----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 -----~~-~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ......... . ....+.+.++.++|.+||+.||.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 000000000 0 0011234567889999999999999999999976
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=292.32 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=204.7
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc----eEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG----MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~----~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+...+|++.+.||+|+||.||+|... ++ ..+++|....... ..+.+|+.++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 34578999999999999999999843 33 3689997665432 457789999999999999999999887 67
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++||||+.+++|.+++.. ....+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||.+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred eEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCccc
Confidence 8999999999999988832 23457899999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.................+..|+|||.+....++.++|+|||||++|++++ |..||......+ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~------- 226 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEK------- 226 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhC-------
Confidence 87653322211122223457999999988889999999999999999998 999997643221 1111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
......+...+.++.+++.+||..||.+||++.++++.|++++++.
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 227 ------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 1111223334467899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.61 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=199.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|+||.||++. ..++..+++|....... ..+.+|+++++.++||||+++++.+...+..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999998 45678899997654422 3477899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. ....++...+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLK-----KAGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998883 335578889999999999999999962 369999999999999999999999999886543221
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh------------
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD------------ 231 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------ 231 (312)
.....++..|+|||...+..++.++|+|||||++|+|++|..||....................
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 2234577789999999888899999999999999999999999965432211111100000000
Q ss_pred -----hhhhhHHhh---hhccccCC-hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 -----FSNLLKILD---ERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 -----~~~~~~~~~---~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+ .......+ ...+.++.+++.+||..||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00011111 1245679999999999999999999999977
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=305.57 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=192.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC------C
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 5789999999999999999998 5578899999875432 23466899999999999999999887533 3
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|++++++ +++|..++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 468999988 668877662 2457889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.......................
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8765332 223457888999999877 4679999999999999999999999976432211111111000000000
Q ss_pred hhHHhh-------hhc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKILD-------ERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~~~-------~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+.. ... ........++.+.+++.+||..||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 000111223568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=286.61 Aligned_cols=244 Identities=29% Similarity=0.492 Sum_probs=194.9
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCccc
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS 90 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (312)
+.||+|+||.||++...+++.+|+|....... ..+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999976788899998765433 35778999999999999999999999988999999999999998
Q ss_pred ccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCcc
Q 021441 91 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 170 (312)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 170 (312)
+++.. ....+++..+..++.+++.+|.|+|+ +|++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 88732 22346789999999999999999999 77999999999999999999999999998754332211 1112
Q ss_pred ccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 171 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...+..|+|||++.+..++.++||||||+++|+|++ |..||........ ..... .......+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~-------------~~~~~~~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVE-------------KGYRMSCPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHH-------------cCCCCCCCC
Confidence 233456999999998889999999999999999998 9999976432211 11111 111112333
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
..+.++.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 45678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=291.78 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=205.1
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|++|.||++. ..+++.+++|.+... ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578999999999999999999 457889999965432 2245778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++.... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999988774221 123467889999999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.... .....++..|+|||...+..++.++|+||||+++|+|++|..||...... ......... ..
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------------~~ 223 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE------------QC 223 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh------------cC
Confidence 3211 12335677899999999888999999999999999999999999653321 111111111 00
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
..........++.+.+++.+||..||++|||+.++++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111122345678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.64 Aligned_cols=267 Identities=20% Similarity=0.204 Sum_probs=206.2
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999998 4568899999865431 245788999999999999999999999999999999
Q ss_pred EeccCCcccccccCccc------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 82 EYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
||++|++|.+++..... ......+...+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999888743110 112334567788999999999999999 7799999999999999999999999999
Q ss_pred cccccCCC----------------cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCCh
Q 021441 156 RNFLGRTD----------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS 219 (312)
Q Consensus 156 a~~~~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~ 219 (312)
+....... .........||+.|+|||.+.+..++.++|||||||++|+|+||..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 87652110 00111234688999999999999999999999999999999999999976332111
Q ss_pred hhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHHhcccc
Q 021441 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~~ll~~l~~~~~~~~~~~ 291 (312)
... .... .+.. .......++.+.+++.+||..||++|+ +++++++.|+..+.....+.
T Consensus 240 ~~~----~~i~---------~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~ 298 (932)
T PRK13184 240 SYR----DVIL---------SPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT 298 (932)
T ss_pred hhh----hhcc---------Chhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence 100 0000 0000 001123456789999999999999995 67788888998887654443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.81 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=200.5
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
...+|++.+.||+|++|.||++. ..+++.+++|...... ...+.+|+.+++.+.|+||+++++.+......|+|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 35789999999999999999998 4568899999765432 3457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ...++...+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999998872 2346788889999999999999999 77999999999999999999999999988765332
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|..||........ ....... ..
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~~------------~~ 233 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN------------GT 233 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhcC------------CC
Confidence 21 12234577789999999988889999999999999999999999976443211 1111100 00
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...+..+.+++.+||..||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111234455789999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=291.33 Aligned_cols=254 Identities=25% Similarity=0.460 Sum_probs=199.9
Q ss_pred hcCCCcccccccCcceEEEeeeeC-Cc---eEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DG---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
...|++.+.||+|+||.||+|... ++ ..|++|...... ...+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 456889999999999999999843 33 469999876542 2467889999999999999999999999889999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 83 ITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999988732 23457888999999999999999999 77999999999999999999999999998765
Q ss_pred cCCCcCCCCc---cccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 160 GRTDVAGPSS---QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 160 ~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.......... ....+..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~------- 226 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQ------- 226 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc-------
Confidence 4322111111 1112346999999998899999999999999999886 9999976442211 111110
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112334557899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=305.30 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=198.1
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCC-----CCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (312)
.+..+.|+++++||+|+.+.||+|...+.+-||+|+.. ....+-+..|++.|.+| .|.+|+++|||-...+.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 45678899999999999999999997777778888543 33445688999999999 5899999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|||+-+. +|..++... ....+...+..++.|++.++.++|+ .||||.||||.|+++-. |.+||+|||+|..
T Consensus 437 mvmE~Gd~-DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecccc-cHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 99998754 888888322 1222324788999999999999999 67999999999999864 6899999999998
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCC-----------CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRF-----------SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----------~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
............-.||.-||+||.+....+ +.+||||||||++|+|++|+.||..... .
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~----- 578 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q----- 578 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H-----
Confidence 876655555555679999999999876543 4689999999999999999999965221 1
Q ss_pred hhhhhhhhhHHhhhhc---cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 228 NSRDFSNLLKILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+..+..+.++.. ++..+... ++.++++.||.+||.+|||+.+||+|
T Consensus 579 ----~aKl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 ----IAKLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122233333322 22233322 39999999999999999999999975
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=289.07 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=199.9
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
..+|++.+.||+|+||.||++.+..++.+++|...... ...+.+|+++++.++||+++++++++......|+||||+.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46789999999999999999987667789999876432 3578899999999999999999999998889999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++.. ....+++..+..++.+++.++.+||+ +|++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999888732 22356788899999999999999999 77999999999999999999999999998765432211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
. ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ..... .....
T Consensus 157 ~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~-------------~~~~~ 219 (256)
T cd05112 157 S-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI-------------NAGFR 219 (256)
T ss_pred c-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH-------------hCCCC
Confidence 1 112234457999999998889999999999999999998 999997543211 11111 00001
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...+...++.+.+++.+||..+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111222357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=291.57 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+|++.+.||+|+||.||++...+++.+|+|.+.... ...+.+|+.+++.++|+||+++++++...+..|++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588999999999999999997778899999754321 13467899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
+||+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999998883 23457788889999999999999999 679999999999999999999999999987653
Q ss_pred CCCc----CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 161 RTDV----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 161 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||......... .... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~-~-------- 222 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FYIG-A-------- 222 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HHhh-h--------
Confidence 2111 11122345777899999999888999999999999999999999999754322111 0000 0
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+..++.++.++|.+||..+|.+||++.+++.+
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 223 ---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011122344456789999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=290.17 Aligned_cols=250 Identities=29% Similarity=0.473 Sum_probs=200.1
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.+..++|++.+.||+|+||.||.+.. +++.+++|..... ....+.+|+.+++.++|||++++++++... ..|+||||
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cccHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 45668899999999999999999875 4677999987654 345688899999999999999999998765 47999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999888432 23357888899999999999999999 779999999999999999999999999987543221
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ..... ...
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~-------------~~~ 213 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECV-------------EKG 213 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH-------------hCC
Confidence 12233456999999988889999999999999999997 999997644221 11111 111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.....+...++.+.+++.+||+.+|.+||++.++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112233456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.27 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=200.7
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+.+..+.+.|++++.||.|+||.||++.. .+++.+++|....... ..+.+|+.+++.++||||+++++.+...+..
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 34455678899999999999999999994 4688999998765443 3567799999999999999999999998999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|..++.. ....+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEEEecCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999877632 23457889999999999999999999 779999999999999999999999999876
Q ss_pred cccCCCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||........ ........
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~-- 231 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSE-- 231 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHHHhcCC--
Confidence 543221 11233456778999998753 3467899999999999999999999976432111 11110000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+..++.++.+++.+||..||++||++++++++
T Consensus 232 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 ---------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111233445689999999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=294.33 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=194.7
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58899999999999999998 456889999976432 234578899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+ +|.+++... .....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LSM-DLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CCC-CHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 974 776666321 123467899999999999999999999 779999999999999999999999999987653321
Q ss_pred cCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-----hhhh----
Q 021441 164 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-----RDFS---- 233 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----~~~~---- 233 (312)
. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ........ ..+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 1 11223456779999998765 468899999999999999999999976432211 11111000 0000
Q ss_pred --hhhHHh---hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 --NLLKIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 --~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... ............++++.++|.+||..||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0000011122345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=293.92 Aligned_cols=249 Identities=19% Similarity=0.285 Sum_probs=196.9
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.|+..+.||+|+||.||.+. ..+++.+|+|.+.... ...+.+|+.+++.++|++|+++++.+...+..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47788999999999999998 4578899999765332 2346779999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++... ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998777321 23458899999999999999999999 77999999999999999999999999988654322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||............ ..... ..
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~~---------~~- 220 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVL---------ET- 220 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhhh---------cc-
Confidence 1 112335778899999999888999999999999999999999999764322111110 00000 00
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
....+...+.++.+++.+||+.||++||+ +.+++.+
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01233445578899999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=289.50 Aligned_cols=247 Identities=25% Similarity=0.443 Sum_probs=198.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------------hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------------QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+|.+.+.||+|++|.||.|. ..+++.+++|.+..... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47889999999999999998 44678899996543211 346789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++|+||+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999988883 33457788889999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCc----CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDV----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~------ 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFKI------ 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHHH------
Confidence 77642211 111223456778999999998889999999999999999999999997643211 01000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+...++.+.++|.+||+.||.+||++.+++++
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 -------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -------hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0011223445566889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.14 Aligned_cols=262 Identities=17% Similarity=0.232 Sum_probs=188.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCC------ccceeeeeeeeeC-C
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQH------RNLVTLLGYCQEN-N 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~ 75 (312)
...++|++.+.||+|+||.||+|. ..+++.||+|++... .......|+.+++.+.| .+++.+++++... .
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 345789999999999999999998 456889999987543 22345567777766644 4588888888654 5
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---------
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF--------- 146 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~--------- 146 (312)
..|+||+++ +++|.+++. ....+++..+..++.|++.||.|||.. .||+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCccccccccc
Confidence 788999988 557776662 334678889999999999999999961 3799999999999998765
Q ss_pred -------ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCCh
Q 021441 147 -------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS 219 (312)
Q Consensus 147 -------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~ 219 (312)
.+||+|||.+..... ......+|..|+|||++.+..|+.++|||||||++|||++|..||......+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998754221 12345688899999999999999999999999999999999999976543222
Q ss_pred hhHHHHhhh-hh-hhh---------hhhHHh-------hhh----ccc-c-C-ChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 220 QDLVELVQN-SR-DFS---------NLLKIL-------DER----LWS-T-F-TNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 220 ~~~~~~~~~-~~-~~~---------~~~~~~-------~~~----~~~-~-~-~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
......... .+ .+. .+.... .+. ... . . .....+.+.+||.+||..||.+|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 211111100 00 000 000000 000 000 0 0 000135688999999999999999999
Q ss_pred HHHHH
Q 021441 275 DVVTE 279 (312)
Q Consensus 275 ~ll~~ 279 (312)
|+|+|
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99975
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=303.12 Aligned_cols=234 Identities=21% Similarity=0.279 Sum_probs=184.6
Q ss_pred cccccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHH-HHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999994 568899999765321 223444443 57788999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+. ....++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 99987762 33457788888999999999999999 779999999999999999999999999987532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+. .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~------------~~--~~~ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNIL------------HK--PLQ 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHh------------cC--CCC
Confidence 223446788899999999889999999999999999999999999764321 1111111 11 112
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
.+...+..+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3344557899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=292.93 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=199.0
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
...++|++.+.||+|+||.||.|. ..+++.|++|...... ...+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 345789999999999999999998 5568899999765433 234678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus 86 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998873 34467899999999999999999999 6799999999999999999999999999876532
Q ss_pred CCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.. .......++..|+|||++. ...++.++|+|||||++|+|++|..||....+..... .......
T Consensus 159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~~~~~~~-------- 226 (267)
T cd06645 159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMTKSNF-------- 226 (267)
T ss_pred cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--hhhccCC--------
Confidence 21 1223446778899999975 4457889999999999999999999986543221110 0000000
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ......++..+.+++.+||..||++|||++++++|
T Consensus 227 -~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 -QPPK-LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -CCCc-ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00111245678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=294.78 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=203.6
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCce----EEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|+..+.||+|+||.||++.+ .++. .+|+|....... ..+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3467889999999999999999984 3343 578897665432 2567899999999999999999998754 4
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++++|+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred ceeeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccc
Confidence 6789999999999888732 23357788899999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~~------- 226 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLEK------- 226 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHC-------
Confidence 86643322212222334567999999998899999999999999999997 8899865432111 111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
......+...+.++.+++.+||..+|++||++.++++.|+.+.+......
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (303)
T cd05110 227 ------GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYL 276 (303)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhhe
Confidence 11111222344678999999999999999999999999999877655443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=290.83 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=200.4
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||.|++|.||++. ..+++.+++|...... ...+.+|+.+++.++|+||+++++++......|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 478999999999999999999 4468899999865432 24577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999988832 267889999999999999999999 779999999999999999999999999988765432
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....... ..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~-------------~~ 214 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIPK-------------NN 214 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhhh-------------cC
Confidence 12233456777999999998889999999999999999999999997644211 1111110 01
Q ss_pred cccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+.. .+.++.+++.+||..||++|||+++++.+
T Consensus 215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111222 55789999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=295.64 Aligned_cols=263 Identities=19% Similarity=0.282 Sum_probs=186.4
Q ss_pred ccccccCcceEEEeeeeC---CceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeee--CCeEEEEEEeccCC
Q 021441 14 KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNG 87 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 87 (312)
.++||+|+||.||+|... +++.+|+|.+.... .....+|+.+++.++||||+++++++.. ....|++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 468999999999999843 46789999876543 3467889999999999999999998854 4567999999965
Q ss_pred cccccccCcc----cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----CCCCceEEeeccccccc
Q 021441 88 SVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFL 159 (312)
Q Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~----~~~~~vkl~Dfg~a~~~ 159 (312)
+|.+++.... ......++...+..++.|++.||.|||+ +||+||||||+||++ +.++.+||+|||++...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 6655542111 1122357889999999999999999999 779999999999999 46679999999999765
Q ss_pred cCCCc-CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCCh-------hhHHHHhhh--
Q 021441 160 GRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-------QDLVELVQN-- 228 (312)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~-------~~~~~~~~~-- 228 (312)
..... ........+|..|+|||++.+. .++.++||||+||++|+|++|..||........ .........
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 43221 1112334678889999998874 579999999999999999999999975432211 111111000
Q ss_pred h---hhhhhh---------hHHhhhhcc---------ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 S---RDFSNL---------LKILDERLW---------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~---~~~~~~---------~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ..+... ......... .......+.++.++|.+||..||.+|||++++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 000000000 00001112468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=293.60 Aligned_cols=269 Identities=28% Similarity=0.398 Sum_probs=204.5
Q ss_pred hcCCCcccccccCcceEEEeeeeC-----CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeee--CCe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE--NNL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 76 (312)
.+.|++.+.||+|+||.||++... ++..+|+|.+..... ..+.+|+++++.+.|+||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 567899999999999999999843 367899998765433 468889999999999999999999877 557
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 8999999999999988832 22358889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
......... ........+..|++||...+..++.++|||||||++|+|++|..||............. .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHH
Confidence 876532211 11112234456999999988889999999999999999999999986543221110000 0000001111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
............+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111122212222344557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=300.03 Aligned_cols=252 Identities=23% Similarity=0.257 Sum_probs=194.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.||+|.+.. .....+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 579999999999999999999 55688999998653 22344678899999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999988832 23457888899999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---~~~i~~~~------ 224 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHK------ 224 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH---HHHHHcCC------
Confidence 2211 1223457888999999874 3468899999999999999999999975432111 11110000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
............++++.+++.+||..++.+ |+++.++++|
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 ---EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000001112235678999999988654443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=289.26 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=203.4
Q ss_pred hcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.++|++.+.||+|++|.||++... +++.+++|.+.... ...+.+|+.+++.++|+||+++++++......|+++||+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 478999999999999999999954 47889999876443 5678899999999999999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++.. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999988732 23567899999999999999999999 7799999999999999999999999999887643321
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (312)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .... ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---~~~~-----------~~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---MIPN-----------KPPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---hhcc-----------CCCCCC
Confidence 1223346778999999998899999999999999999999999997644321110 0000 000011
Q ss_pred cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 246 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+..++.++.+++.+||+.||.+|||+.+++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 2233455789999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=289.79 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=193.0
Q ss_pred cccccCcceEEEeeeeC-Cc--eEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~-~~--~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||++... ++ ..+++|...... ...+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999843 33 356888766432 24577899999999 799999999999998899999999999
Q ss_pred CcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 87 GSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 87 ~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
++|.+++..... .....+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCC
Confidence 999988743211 112347889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~-------- 224 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-------- 224 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH--------
Confidence 75332111 1111223456999999988889999999999999999997 999996543211 11111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
........+...+.++.+++.+||+.||.+|||+.+++..|++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111233344578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=289.27 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=201.0
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++.+.||+|++|.||+|.. .+++.+++|.+... ....+.+|+.+++.++||||+++++.+.....+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 47899999999999999999984 46788999976543 345688899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++.. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999988732 22467889999999999999999999 779999999999999999999999999987654321
Q ss_pred cCCCCccccCcccccchhhhhhc---CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 164 VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.......... .......
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~~~~~---------- 221 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LISKSNF---------- 221 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccC----------
Confidence 112234566779999999877 78899999999999999999999997644221111 0000000
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+.++.+++.+||..||.+|||+++++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111234456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=289.54 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=189.0
Q ss_pred cccccCcceEEEeeeeC---CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++... ++..+++|....... ..+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999743 346799997654322 35778999999999999999999998888899999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++...........++..+..++.|++.|+.|||+ +|++|+||||+||+++.++.++|+|||.+...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99988853322223345677788899999999999999 7799999999999999999999999999875433322222
Q ss_pred CccccCcccccchhhhhhc-------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 168 SSQVTADEIFLASEVKEFR-------RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~-------~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.....++..|+|||++.+. .++.++|||||||++|+|++ |..||.......... ..... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~-~~~------- 228 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--YTVRE-QQL------- 228 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHhhc-ccC-------
Confidence 2233456779999998643 35789999999999999996 999997644322111 00000 000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
...........++.+.+++.+|| .+|++|||+++++..|.
T Consensus 229 -~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 -KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00001122234567899999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=292.35 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=196.9
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+-|++.+.||+|+||.||++.. .++..+++|.+..... ..+.+|+++++.++||||+++++.+......|+|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 4478899999999999999994 4578889998754432 45678999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|..++.. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~- 157 (282)
T cd06643 85 AGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 157 (282)
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence 99999877632 23457889999999999999999999 779999999999999999999999999987653221
Q ss_pred CCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 165 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.......++..|+|||++. +..++.++|+|||||++|+|++|..||........ ........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~---------- 224 (282)
T cd06643 158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE---------- 224 (282)
T ss_pred -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhcC----------
Confidence 1223345777899999974 34577899999999999999999999976432111 11110000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
......+..++.++.++|.+||+.||.+||++.+++.+-
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 225 --PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 001122334567899999999999999999999887653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.02 Aligned_cols=234 Identities=20% Similarity=0.267 Sum_probs=185.1
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHH-HHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|. ..+++.+|+|.+... ....+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999998 557889999976532 1233444544 56778999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|...+ .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l-----~~~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHL-----QRERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 9998777 234567889999999999999999999 779999999999999999999999999986532211 1
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||...+... ...... ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~------------~~~--~~ 214 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNIL------------HKP--LV 214 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHH------------cCC--cc
Confidence 2234468888999999999999999999999999999999999997643211 111111 000 11
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
.....+..+.+++.+||..||.+||++.
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 2233457789999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=289.52 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=188.0
Q ss_pred cccccCcceEEEeeeeC---CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++... ....+++|....... ..+.+|+..++.++|+||+++++.+......|+||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46999999999999732 345788887654332 34678999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++...........++.....++.|++.||+|||+ +||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99998854432223445677888999999999999999 7799999999999999999999999999865433221111
Q ss_pred CccccCcccccchhhhhh-------cCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 168 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.....++..|+|||+... ..++.++|||||||++|+|++ |..||....+.+ ...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~~-------- 228 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVVREQDI-------- 228 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhhccCc--------
Confidence 222334566999999753 346789999999999999999 788887543221 11111111000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
.......+...++.+.+++..|| .||++|||++++++.|
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 -KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00011223345577889999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=286.94 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=197.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee-CCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 82 (312)
+|++.+.||.|++|.||++. ..+++.+++|.+... ....+.+|+++++.++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999 456788999976432 22457789999999999999999988764 446899999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++.. .....+++..+..++.+++.++.+||+ +|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999888842 123457889999999999999999999 77999999999999999999999999998766432
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||+..+..++.++|+|||||++|+|++|..||...+.. ....... ..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~-------------~~ 217 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRII-------------EG 217 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH-------------hc
Confidence 21 223345677899999999888999999999999999999999998753321 1111000 01
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...++++.+++.+||+.||++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122344566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=292.26 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=198.8
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++++.||+|+||.||++.. .+++.+|+|.+.... ...+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4789999999999999999994 478899999765332 24677899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|..++.... ....+++..+..++.+++.||.|||.. .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988874321 123678999999999999999999951 479999999999999999999999999987653221
Q ss_pred cCCCCccccCcccccchhhhhhcC------CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRR------FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||............ ..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------~~ 221 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------------SA 221 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH------------HH
Confidence 22234666799999986543 478999999999999999999999754322111111 11
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+.. ......+..+++++.++|.+||..+|.+||++.+++.+
T Consensus 222 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred Hhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 11223445567889999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.37 Aligned_cols=243 Identities=30% Similarity=0.450 Sum_probs=202.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+-|..++.||.|+||.||.|+ ..+.+.||||+..-... .++.+|+..|+.+.|||++.+-|+|.....-|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 457788999999999999999 66788999997543322 35788999999999999999999999888889999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||-| +..+++ ....+++.+..+..|+.+.+.||+|||+ .+.||||||..|||+++.|.|||+|||.|....
T Consensus 106 EYClG-SAsDll----eVhkKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLL----EVHKKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHhc-cHHHHH----HHHhccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 99976 777777 2445678889999999999999999999 559999999999999999999999999886542
Q ss_pred CCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
+...++|||+|+|||++.. +.|+-++||||||+++.|+.-.++|+..++... .+..+
T Consensus 178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---------------ALYHI 237 (948)
T KOG0577|consen 178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------------ALYHI 237 (948)
T ss_pred -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---------------HHHHH
Confidence 3456789999999999775 468999999999999999999999976654321 12222
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.-+..+......+++.|+.|+..||++-|++|||.++++.|
T Consensus 238 AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 238 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22222334567788999999999999999999999998876
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.90 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=197.4
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|++|.||++.. .+++.|++|.+... ....+.+|+.+++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999984 46889999975422 22456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|..++. ....+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988877662 33457899999999999999999999 77999999999999999999999999998876433
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh-hhhHHhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILD 240 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 240 (312)
... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+...... ....... .......
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR--KTLGDLIPRHQQIFS 229 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHhCCCChHHhhhcc
Confidence 211 122345677999999876 457899999999999999999999998655432211111 1000000 0000000
Q ss_pred ----------hhcc-----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ----------ERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ----------~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+... .......+..+.+++.+||..||++|||+.+++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 00012335789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=293.79 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=193.9
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||+|.. .+++.+++|.+... ....+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999994 56889999976532 224567899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+ +|.+++. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFD----SCNGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 6665552 123457899999999999999999999 779999999999999999999999999987653322
Q ss_pred cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh------hhhhhhh
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS------RDFSNLL 236 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~ 236 (312)
. ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||....... .....+... ..+....
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhh
Confidence 1 112234567899999987754 6899999999999999999999865433221 111111000 0000010
Q ss_pred HHhhhh---------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDER---------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+.. .+.......++++.+++.+||..||.+|||+++++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 0011223356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=288.86 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=195.3
Q ss_pred cccccCcceEEEeeeeCC-------ceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 15 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+.||+|+||.||++.... ++.+++|.+... ....+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998432 257899976433 345678899999999999999999999988899999999
Q ss_pred ccCCcccccccCcccc--cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-----ceEEeecccc
Q 021441 84 IPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-----IAKVADAGLR 156 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-----~vkl~Dfg~a 156 (312)
+++++|.+++...... ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++++|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999888532211 22446788899999999999999998 7799999999999999887 8999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.................+..|+|||.+.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~--------- 226 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV--------- 226 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---------
Confidence 76543332222223344567999999998889999999999999999998 999997543211 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
........+...++.+.+++.+||..+|.+||++.++++.|+
T Consensus 227 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 ----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111112234455688999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=286.84 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=201.0
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
...|+..+.||.|+||.||.|.. .+++.+|+|...... ...+.+|+.+++.+.||||+++++.+..+...|+|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35688899999999999999984 468899999765432 2457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++. ...++...+..++.|++.||.++|+ ++++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998873 2346788888999999999999999 77999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||...+..++.++|+|||||++|+|++|..||.......... .. ...
T Consensus 155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~-------------~~~ 216 (277)
T cd06640 155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---LI-------------PKN 216 (277)
T ss_pred cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---hh-------------hcC
Confidence 21 1222346677999999998889999999999999999999999997644321110 00 111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+.+++.+||..+|++||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1223445567889999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=291.84 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=201.8
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+..++|++.+.||+|+||.||++. ..+++.+|+|..... ....+.+|+++++.++||||+++++.+...+..|+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 356789999999999999999999 446888999965432 235678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++. ....+++..+..++.+++.+|.|||+. .+++|+||+|+||++++++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 82 MEFMDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EecCCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999988872 234578899999999999999999962 469999999999999999999999999876542
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh-hhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (312)
... .....++..|+|||++.+..++.++|+|||||++|+|++|..||............ .... .....+.
T Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~ 226 (284)
T cd06620 156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD-----PMGILDLLQQIV 226 (284)
T ss_pred hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh-----hhHHHHHHHHHh
Confidence 221 22346778899999998888999999999999999999999999865432110000 0000 0001111
Q ss_pred hhhccccCC-hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 240 DERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 240 ~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
... ....+ ...+.++.+++.+||+.||.+|||+.+++.+.
T Consensus 227 ~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 11111 22557899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=297.33 Aligned_cols=252 Identities=21% Similarity=0.229 Sum_probs=195.0
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.+|+|.+... ....+..|..++..++|++|+++++.+......|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999 446788999986532 2234677888999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++.. ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999988832 23457888899999999999999999 7799999999999999999999999999875432
Q ss_pred CCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~~----- 225 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHKE----- 225 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---HHHHHhCCCc-----
Confidence 211 11223468889999999863 457889999999999999999999997543211 1111111000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
..........+++++.+++.+|+..++.+ |+++.++++|
T Consensus 226 ----~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 ----RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00011122345678999999999765554 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=294.45 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=200.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||+|++|.||++. ..+++.||+|.+... ....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 35889999999999999999999 457889999976432 23456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ...++...+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999998872 2346788899999999999999999 77999999999999999999999999998765332
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||...+..++.++|+|||||++|+|++|..||.......... .... ...
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~~~~------------~~~ 232 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIAT------------NGT 232 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--eecc------------CCC
Confidence 21 1223456778999999998889999999999999999999999997643321110 0000 000
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...+..+.+++.+||..||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234455778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=297.50 Aligned_cols=260 Identities=17% Similarity=0.191 Sum_probs=191.6
Q ss_pred cccccccC--cceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 13 DKNLIGEG--KFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 13 ~~~~lg~G--~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
++++||+| +|++||++. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 57889999 688999998 5678999999876432 234667999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|.+++... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999888321 22347888999999999999999999 7799999999999999999999999986543321110
Q ss_pred -----CCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-hhhhhhh
Q 021441 165 -----AGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFSNLL 236 (312)
Q Consensus 165 -----~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (312)
........++..|+|||++.+. .++.++|||||||++|+|++|..||......... ....... +......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcccccccc
Confidence 0111223456679999999763 5899999999999999999999999754322111 1100000 0000000
Q ss_pred H------------------------------HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 K------------------------------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~------------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ..............++++.+++.+||+.||++|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 000000011222345789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=288.86 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=196.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcC-CCccceeeeeeeeeC------Ce
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN------NL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~ 76 (312)
+...|++.+.||+|+||.||.+. ..+++.+|+|..... ....+..|+.+++.+ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 46779999999999999999998 556889999976433 345678899999998 699999999998653 45
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 79999999999999888421 23457888999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
....... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.......... ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~---~~~---- 229 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---LIP---- 229 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HHh----
Confidence 7653221 12233457778999999863 357889999999999999999999996543211110 000
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
............+.++.+++.+||..||.+|||+.+++.|
T Consensus 230 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 --------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0001111222345789999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=300.59 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=183.3
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC---CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
||+|+||.||+|. ..+++.||+|.+... .......|..++... +||||+++++++......|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998 456889999986532 112334456666554 699999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 99987772 34567889999999999999999999 779999999999999999999999999987542221 1
Q ss_pred CCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccc
Q 021441 167 PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (312)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...... .....+.... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~~~----------~~~-- 216 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAFGK----------VRF-- 216 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHcCC----------CCC--
Confidence 12344688889999998765 4799999999999999999999999764321 1111111000 000
Q ss_pred cCChHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 021441 246 TFTNEGMEEFIQLIVRCLDPSSERRP----SMSDVVTE 279 (312)
Q Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rp----t~~~ll~~ 279 (312)
-....++++.+++.+||+.||.+|| ++.++++|
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0112457889999999999999998 56676654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=298.64 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=194.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||+++ ..+++.||+|.+... ....+.+|..++..++|++|+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999 456788999976531 2234677889999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|..++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999988832 23457888899999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~------ 224 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHE------ 224 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHHHHcCC------
Confidence 2211 1223458889999999876 457889999999999999999999997543211 111111000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
............++++.+++.+||..++.+ |++++++++|
T Consensus 225 ---~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ---ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000011112234678999999999876654 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=294.88 Aligned_cols=251 Identities=21% Similarity=0.248 Sum_probs=199.4
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|++|.||+|.. .+++.+|+|.+.... ...+..|+++++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999994 458899999765432 235778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++.. .....+++..+..++.|++.||.|||. .|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999988732 223567888999999999999999999 6799999999999999999999999999775432
Q ss_pred CCcC---------------------------CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCC
Q 021441 162 TDVA---------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 214 (312)
Q Consensus 162 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~ 214 (312)
.... .......++..|+|||+..+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1100 0111235677899999999888999999999999999999999999764
Q ss_pred CCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 021441 215 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS----MSDVVTE 279 (312)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~~ll~~ 279 (312)
..... ..... ............++.+.+++.+||..||++||| +++++.|
T Consensus 236 ~~~~~--~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDET--FSNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHHH--HHHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 43211 11111 111111111224678999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.79 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=201.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|+.+ +.+.+++|....... ..+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 34578999999999999999999843 246799997654332 46788999999999999999999999888
Q ss_pred eEEEEEEeccCCcccccccCcccc----cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
..|+||||+++++|.+++...... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEc
Confidence 899999999999999888432211 11257899999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||.+......... ......++..|+|||...+..++.++||||||+++|+|++ |..||....... ......
T Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~--- 232 (275)
T cd05046 160 LLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ--- 232 (275)
T ss_pred ccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH---
Confidence 99988654322211 1122234566999999988888999999999999999998 788986543221 111111
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
........+...+..+.+++.+||+.||.+|||+.+++..|.
T Consensus 233 ---------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111123345578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=284.68 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||.|+||.||.++ ..+++.+++|..... ....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999998 556888999965432 234577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++... ....++...+..++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999888422 13457889999999999999999999 679999999999999999999999999987654332
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......++..|.|||...+..++.++|+|||||++|+|++|..||...... ....... . ..
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~------------~-~~ 217 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIV------------Q-GN 217 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH------------c-CC
Confidence 1 223345778899999998888899999999999999999999999653321 1111110 0 11
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
....+...+.++.+++.+||..+|.+||++.++++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122344567899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.29 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=201.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
+|+..+.||+|++|.||.+. ..+++.+++|.+.... ...+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999998 5678899999765332 2457889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeecccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNF 158 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~ 158 (312)
|+||+.+++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999998883 23457888999999999999999999 7799999999999998776 699999999876
Q ss_pred ccCCCcC--CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... .......++..|+|||...+..++.++|+|||||++|+|++|..||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 221 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------------ 221 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------------
Confidence 6433211 11223456778999999988889999999999999999999999997543322111110
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+...++++.+++.+||..+|.+|||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111111233455566889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=285.77 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=194.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--------ChhHHHHHHHHHhcCCCccceeeeeeeee--CCeE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ 77 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (312)
.+|++.+.||+|+||.||++. ..+++.|++|..... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999998 456889999975422 12346779999999999999999998865 3567
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++++||+++++|.+++. ....++......++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK-----AYGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999998883 23447788888999999999999998 779999999999999999999999999987
Q ss_pred cccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||........ . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~------------~ 219 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---I------------F 219 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---H------------H
Confidence 6532111 1111223467789999999988899999999999999999999999975432110 0 0
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+...++.+.+++ +||..+|++||++++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 220 KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00111112234445567888888 6888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.14 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=199.1
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|++|.||++. ..+++.+|+|.+... ....+.+|+++++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999 446889999976432 2355778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999988883 33567889999999999999999999 7799999999999999999999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... ..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~------------~~ 213 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKIL------------EG 213 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh------------cC
Confidence 3 23345777899999998888899999999999999999999999764421 1111110 00
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
....+...+..+.+++.+||..||.+|+ ++++++.|
T Consensus 214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1123334467899999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.25 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=196.9
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee--CCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 76 (312)
....++|++++.||+|+||.||+|. ..++..+++|.+... ....+..|+.++..++||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3456799999999999999999999 456788999976532 23457889999999999999999998854 456
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC-----CCeEecCCCCCceEeCC-------
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-----PRVVHKDFKTANVLVDE------- 144 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-----~givH~dikp~Nil~~~------- 144 (312)
+|+||||+.+++|..++.... .....+++..++.|+.||+.||.|||..+ ++|+|+||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 899999999999998884321 12346889999999999999999999843 45999999999999964
Q ss_pred ----------CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCC
Q 021441 145 ----------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASS 212 (312)
Q Consensus 145 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~ 212 (312)
.+.++|+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3358999999987654322 12334688899999998653 47899999999999999999999997
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... .......+...+ .......+.++.+||..||..+|.+||++.++|.+
T Consensus 245 ~~~~--~~qli~~lk~~p--------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KANN--FSQLISELKRGP--------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cCCc--HHHHHHHHhcCC--------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5332 111111111110 00112235789999999999999999999999964
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=291.73 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=199.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+.++|++.+.||.|+||.||++.. .+++.+++|....... ..+..|+++++.++||||+++++.+......|+|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 357899999999999999999994 4688999997654433 357789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999888732 23458889999999999999999999 77999999999999999999999999987654322
Q ss_pred CcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
. .......++..|+|||.+.. ..++.++|+|||||++|+|++|..||....... ........
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-------- 223 (280)
T cd06611 157 L--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKILKS-------- 223 (280)
T ss_pred c--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHHhcC--------
Confidence 1 11223457778999999753 346779999999999999999999997643221 11111110
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+..++.++.+++.+||..||.+||++.+++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000111233456789999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=293.31 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=200.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||.|++|.||++. ..+++.|++|.+... ....+.+|+.+++.++||||+++++++......|+|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 44679999999999999999998 557889999976433 23467789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|..++. ...+++..+..++.+++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999998772 2347889999999999999999999 77999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........ ....... ..
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~------------~~ 232 (296)
T cd06655 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATN------------GT 232 (296)
T ss_pred cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc------------CC
Confidence 21 12234567789999999988899999999999999999999999976443111 1110000 00
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+..+++.+.++|.+||..||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111233455789999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.95 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=203.4
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCccc
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS 90 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (312)
=.||+|.||+||-++ ..++..+|||.++.... +.+.+|+.+-+.++|.||++++|.+..++++-+.||..+||+|+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999 56788999998876544 34778999999999999999999999999999999999999999
Q ss_pred ccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEEeeccccccccCCCcCCCCc
Q 021441 91 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
+++... +..-.-++.++..+.+||++||.|||. +.|||||||-+|++++ -+|.+||+|||.+++...- +....
T Consensus 661 sLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 661 SLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 998532 222233678888999999999999999 6699999999999996 6889999999999887543 23355
Q ss_pred cccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 170 QVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.+.||..|||||++..+ .|+.++|||||||++.||.||++||-......... .+.--....+..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------------FkVGmyKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------------FKVGMYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------------hhhcceecCCCC
Confidence 67899999999998865 58999999999999999999999998765433221 111122334568
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
|.+++.+.+.+|.+|+..||.+||+|.++|.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8889999999999999999999999999984
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=289.96 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=199.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.+.|+..+.||+|+||.||++. ..+++.||+|...... ...+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3567788999999999999998 4567889999865332 2457889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ...+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLK------PGPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999988772 2457888899999999999999999 77999999999999999999999999998765432
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... . ....
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~-------------~~~~ 216 (277)
T cd06642 155 QI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L-------------IPKN 216 (277)
T ss_pred ch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h-------------hhcC
Confidence 21 1122346677999999998889999999999999999999999987543321110 0 0111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+.+++.+||..+|.+||++.+++.|
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122333456789999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=283.59 Aligned_cols=248 Identities=30% Similarity=0.498 Sum_probs=197.8
Q ss_pred CCcccccccCcceEEEeeeeC-Cc----eEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ-DG----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~----~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+++.+.||.|+||.||++... .+ ..+|+|...... ...+..|+.+++.++|+||+++++++...+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999954 23 789999876554 346788999999999999999999999989999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|++++++|.+++... ....+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999888321 11127899999999999999999999 7799999999999999999999999999877654
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
....... ...++..|+|||...+..++.++|+|||||++|+|++ |..||...... .......
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~------------- 218 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK------------- 218 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh-------------
Confidence 4222111 2235678999999988889999999999999999998 78888653221 1111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
.......+...+.++.+++.+||+.||++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223344567899999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=291.36 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=198.9
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcC-CCccceeeeeeee-----eC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGYCQ-----EN 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~ 74 (312)
+....++|++.+.||+|+||.||++. ..+++.+++|...... ...+..|+.+++.+ +||||+++++++. .+
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 44467899999999999999999998 4567899999865432 35677899999998 6999999999874 34
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+++++|.+++.... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEccCC
Confidence 56899999999999988764321 123457888899999999999999999 679999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
.+........ ......++..|+|||++.. ..++.++|||||||++|+|++|..||........ .......
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~~~~~- 244 (286)
T cd06638 170 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFKIPRN- 244 (286)
T ss_pred ceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhhcccc-
Confidence 9876543221 1223457788999999753 4478899999999999999999999976432111 0000000
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
.......+...+.++.++|.+||..||++|||+.+++++.
T Consensus 245 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 -----------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000112223346799999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=283.90 Aligned_cols=249 Identities=25% Similarity=0.457 Sum_probs=189.0
Q ss_pred cccccCcceEEEeeeeC----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeee-eCCeEEEEEEecc
Q 021441 15 NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIP 85 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 85 (312)
+.||+|+||.||+|... ....+|+|...... ...+.+|+.+++.++||||+++++++. ..+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999732 24679999765322 246778999999999999999999775 4556789999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++... .....+..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999888421 2334667778899999999999999 77999999999999999999999999998755332111
Q ss_pred --CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhC-CCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 166 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 166 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.......++..|+|||...+..++.++|||||||++|+|++| ..||..... ......... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~-------------~ 218 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQ-------------G 218 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc-------------C
Confidence 111123345679999999888899999999999999999995 556654321 111111100 0
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
.....+...++.+.+++.+||..+|++||++.+++..|+++..
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0111223345789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.47 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=197.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcC-CCccceeeeeeeee------
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE------ 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------ 73 (312)
.......|++.+.||.|+||.||++. ..+++.+++|..... ....+..|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34466899999999999999999999 456889999976543 334577888888888 69999999999853
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
....|++|||+.+++|.+++... ....+++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 45789999999999998887421 23346788889999999999999999 67999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|++....... .......++..|+|||.+. ...++.++|+|||||++|+|++|..||.......... ..
T Consensus 166 g~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~-- 238 (282)
T cd06636 166 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LI-- 238 (282)
T ss_pred cchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hH--
Confidence 9987553221 1223345777899999875 3457889999999999999999999997543211110 00
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
............++.++.++|.+||..||.+|||+.+++++
T Consensus 239 ----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ----------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 01111111223456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=282.49 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=194.5
Q ss_pred cccccCcceEEEeeeeCC--c--eEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|++|.||++.+.+ + ..+|+|.+..... ..+.+|+.+++.++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998532 2 3689998766544 457789999999999999999999888 788999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC-
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA- 165 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~- 165 (312)
++|.+.+.... ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99998884321 1457899999999999999999999 77999999999999999999999999998876542211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ ....... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~------------~~~~ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK------------EGER 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh------------cCCc
Confidence 11122345667999999998899999999999999999998 999996543321 1111110 0011
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
...+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=280.11 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=221.9
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|.+++.||+|.||+|.+++ ..+++.||+|+++.+.. ..-..|..+|+..+||.+..+.-.|+.++.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 345789999999999999999999 77899999998765532 22355889999999999999998999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||..||.|.-++ .....+++.....+...|++||.|||+ ++||.||||.+|+++|.+|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchh
Confidence 999999999998777 345667888888999999999999999 7799999999999999999999999999875
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
-- ..........||+.|+|||++..+.|+.+.|.|.+|++||||++|..||...+......++...
T Consensus 318 ~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------ 383 (516)
T KOG0690|consen 318 EI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------ 383 (516)
T ss_pred cc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------------
Confidence 32 2233455678999999999999999999999999999999999999999876654333322110
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHhcccccccc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTELDRTLDKEMNLTTVMG 295 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--t~~~ll~~l~~~~~~~~~~~~~~~ 295 (312)
.-.+|..++++.+.|+..+|.+||.+|. ..+++.+..+.-+...++|.++..
T Consensus 384 -----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~ 437 (516)
T KOG0690|consen 384 -----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR 437 (516)
T ss_pred -----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH
Confidence 0135666678999999999999999996 667888888888888888887654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=286.76 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=200.5
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+|++.+.||.|+||.||+|.. .+++.+++|.+... ....+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 588999999999999999994 46889999976532 23567889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|..++. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999998883 23467889999999999999999999 67999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-------------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------------
Confidence 2 12234566779999999988899999999999999999999999987654322211111110
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVT 278 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~--~~ll~ 278 (312)
.....+...+.++.++|.+||..||.+||++ +++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1123445556899999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=283.92 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=198.6
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|+||.+|.+. ..+++.|++|.+... ....+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58999999999999999998 556889999975422 234678899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+.+.. .....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999887732 122356788899999999999999999 779999999999999999999999999987654322
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......++..|+|||+..+..++.++|+|||||++|+|++|..||...... ..... ... ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~------------~~~-~~ 217 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLK------------IIR-GS 217 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHHH------------Hhc-CC
Confidence 1 112234667799999999888999999999999999999999998653211 11100 000 11
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+...+.++.++|.+||+.+|.+||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122344556789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=310.15 Aligned_cols=270 Identities=25% Similarity=0.446 Sum_probs=226.7
Q ss_pred HhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
.....++.+.||.|.||.|++++.+ ....||||.++.. ...+|..|..+|-+++||||+++.|+......+.
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 3445678899999999999999843 2457999987654 3456899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|.|||++|+|+.|++. +...+....+..+++.|+.|+.||.+++ +|||||...|||++.+-..|++|||+++.
T Consensus 707 IiTEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEhhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999953 3355788888899999999999999955 99999999999999999999999999998
Q ss_pred ccCCC-cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
..+.. ..........+.+|.|||.+....++.+|||||+|+||||.++ |..||+++++++...
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk--------------- 845 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK--------------- 845 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH---------------
Confidence 75543 2233333456678999999999999999999999999999665 999999988754332
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCC
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGT 298 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~ 298 (312)
.++...+-.-|.++|..|.+||..||++|-.+||++.+++.+|+.++.++........+.+
T Consensus 846 -aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~ 906 (996)
T KOG0196|consen 846 -AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESP 906 (996)
T ss_pred -HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCC
Confidence 2344444456788899999999999999999999999999999999998877666555443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=293.09 Aligned_cols=263 Identities=19% Similarity=0.282 Sum_probs=185.8
Q ss_pred ccccccCcceEEEeeeeC---CceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeee--CCeEEEEEEeccCC
Q 021441 14 KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNG 87 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 87 (312)
..+||+|+||.||+|... ++..||+|.+.... ...+.+|+.+++.++||||+++++++.. ....|+||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 367999999999999843 45789999776543 3467889999999999999999998853 4577999999976
Q ss_pred cccccccCc----ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----CCCCceEEeeccccccc
Q 021441 88 SVSIHLYGP----SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFL 159 (312)
Q Consensus 88 ~L~~~~~~~----~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~----~~~~~vkl~Dfg~a~~~ 159 (312)
+|.+++... .......+++..+..++.|++.||.|||+ .||+|+||||+||++ +.++.++|+|||++...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 555554211 11123357888899999999999999999 779999999999999 56779999999999865
Q ss_pred cCCCc-CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCCh-------hhHHHHhhh--
Q 021441 160 GRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-------QDLVELVQN-- 228 (312)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~-------~~~~~~~~~-- 228 (312)
..... ........++..|+|||++.+. .++.++|||||||++|+|+||..||........ .........
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 1112334577889999998774 479999999999999999999999975432211 000000000
Q ss_pred ---hhhhhh---------hhHHhhhh---------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 ---SRDFSN---------LLKILDER---------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ---~~~~~~---------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+.. ........ ............+.+++.+||..||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000000 0000111123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=285.45 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=196.3
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-------------hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-------------TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+|.+.+.||+|++|.||++. ..+++.+|+|.+.... .+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 57889999999999999998 4468899999754211 134677999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..++||||+++++|.+++. ....++...+..++.|++.||.+||+ ++++|+||+|+||+++.++.++++|||.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLR-----TYGRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999998883 23467888899999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcC--CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~---- 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLGNKR---- 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhhccc----
Confidence 87654322111222345677899999988765 7899999999999999999999996432211 000000000
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
............++..+.+++.+||..||.+|||+.+++.|
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111112223456789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=288.94 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=198.5
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|++|.||+|.. .+++.|++|.+... ....+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4789999999999999999984 46889999976432 23567899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.++++..+. .....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLE-----ASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776555 233457889999999999999999999 77999999999999999999999999998776543
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh-hh----
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-LL---- 236 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~---- 236 (312)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+. ............. ..
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHhhhcc
Confidence 32 122234567779999999888 789999999999999999999999976433211 1111000000000 00
Q ss_pred -----------HHhhh-hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 -----------KILDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 -----------~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... ......+..++.++.++|.+||..+|++|||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00011222346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=292.07 Aligned_cols=266 Identities=19% Similarity=0.223 Sum_probs=202.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
++|++.+.||+|+||.||++. ..+++.|++|.+.... ...+.+|+++++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478999999999999999998 4467889999765432 235678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.++....
T Consensus 81 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999998883 33457888899999999999999999 7799999999999999999999999998764211
Q ss_pred CCc-------------CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 162 TDV-------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 162 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~ 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVIS 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 000 00011234567799999998888999999999999999999999999754321 11111100
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccc
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMG 295 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~ 295 (312)
. ...........+.++.++|.+||+.||++||+..++++.|+.-......+.+...
T Consensus 231 ~-----------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~ 286 (305)
T cd05609 231 D-----------DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR 286 (305)
T ss_pred c-----------ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhh
Confidence 0 0001111123457899999999999999999976666666654434444444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=283.42 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=202.0
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||.|++|.||+|. ..++..+++|.+... ....+.+|+++++.++|+||+++++.+......|+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 579999999999999999999 446788999976533 235678899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++.... ....+++..+..++.|++.||.+||+ +|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999998884221 12457888999999999999999999 779999999999999999999999999987765432
Q ss_pred cC--CCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 164 VA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 164 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. .......++..|+|||.+... .++.++|+|||||++|+|++|..||.......... .......
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~~~---------- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LTLQNDP---------- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HHhcCCC----------
Confidence 22 122344577889999998876 67999999999999999999999997654322111 1111100
Q ss_pred hhcccc-CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... .....++++.+++.+||..||++||++.+++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 112456789999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=282.85 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=194.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--------ChhHHHHHHHHHhcCCCccceeeeeeeeeC--CeE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ 77 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (312)
.+|++.+.||+|+||.||.+. ..+++.|++|..... ....+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999998 456889999975321 123567799999999999999999988653 467
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|++|||+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999998873 23446788889999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
........ .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~-~~------------ 219 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--A-IF------------ 219 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--H-HH------------
Confidence 65322111 11223357778999999988889999999999999999999999997532111 0 00
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+...+..+.+++.+||. +|++||++++++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 220 KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011111123455566789999999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=284.98 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=198.8
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|++|.||++.. .+++.+++|.+.... ...+.+|+++++.++||||+++++.+...+..|+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4788999999999999999994 468889999765442 24577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++... ...++...+..++.|++.|+.|+|+. .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999888321 25678899999999999999999971 359999999999999999999999999886653221
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ....++..|+|||...+..++.++|+|||||++|+|++|..||.......... .... ...... .
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~---------~~~~~~-~ 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELL---------QYIVNE-P 220 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHH---------HHHhcC-C
Confidence 1 11556777999999999999999999999999999999999997643211110 1000 000111 1
Q ss_pred cccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+.. .++++.++|.+||..||++|||+.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1122222 56789999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=282.99 Aligned_cols=245 Identities=25% Similarity=0.423 Sum_probs=198.0
Q ss_pred CCCcccccccCcceEEEeeeeC-CceEEEEEeCCCC--------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+|+..+.||+|++|.||+|... +++.|++|.+... ....+.+|+.+++.++|+||+++++++......|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999954 7889999964322 234678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
+||+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999998883 23457788899999999999999999 779999999999999999999999999987654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......++..|++||.+.... ++.++|+|||||++|+|++|..||....... .... . .
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~------------~ 215 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFK-I------------G 215 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHH-H------------H
Confidence 332 123345677899999988776 8999999999999999999999997644211 1110 0 0
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+...++++.+++.+||..+|.+||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1011122344456789999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=282.87 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=198.3
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
+....+.......||+|+||.||++. ..++..|++|....... ..+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34455666667899999999999998 55678899997665433 357889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCccccccccc--CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeecccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKL--EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLR 156 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~--~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a 156 (312)
|+||+++++|.+++... ...+ +...+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||.+
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999888422 1223 677888899999999999999 77999999999999986 679999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcC--CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
........ ......++..|+|||++.+.. ++.++|+||||+++|+|++|..||............
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~----------- 223 (268)
T cd06624 157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK----------- 223 (268)
T ss_pred eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-----------
Confidence 76543221 122234677899999987654 788999999999999999999999754321111000
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+...++++.+++.+||..+|.+|||+.+++.|
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 ---VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000011123444556789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=296.71 Aligned_cols=266 Identities=28% Similarity=0.399 Sum_probs=218.0
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+++.+...++++||+|.||.|.++....+.+||+|++..... .+|.+|+++|.+|+||||+.++|+|...+.++++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 456678889999999999999999987789999998876543 5689999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
+||++.|+|-.|+..... ....-....+|+.||++|++||.+.+ +|||||.+.|+|++.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999843321 22344555679999999999999954 9999999999999999999999999999776
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh--CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.++.....+...-+.+|+|+|.+.-+.++.+||+|+||+++||+++ ...||+..++++..+...... ..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~---------~~ 759 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF---------RD 759 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc---------CC
Confidence 6665555556667789999999999999999999999999999876 778998876544322111111 11
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
-........|.-++..+.++|.+||+.|-++||+++++-.+|.+..
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1122233456667789999999999999999999999999887653
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=287.87 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=197.6
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||+|.. .+++.|++|...... ...+.+|+.+++.++||||+++++++......|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999994 568899999765332 35678899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+ +++|.+++.. ....+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD----EERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 8899888732 22558899999999999999999999 679999999999999999999999999987664332
Q ss_pred cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh--h---hhhhhh-
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--R---DFSNLL- 236 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~---~~~~~~- 236 (312)
. .......++..|+|||.+.+.. ++.++|||||||++|+|++|..||....+... ........ + .+....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ--LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH--HHHHHHHcCCCChHHHhhccC
Confidence 1 1122345777899999987654 58999999999999999999888865433211 11111100 0 000000
Q ss_pred -----HHhhh----hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 -----KILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 -----~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... ........+.++.+.+++.+||+.||++|||+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00011112345789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=305.15 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=203.3
Q ss_pred hcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCC---CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.+-+.|++.||.|+||.||+|..+ ++-..|-|.+.. +..+++.-|+++|..++||+|+++++.|...+.+|++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345678999999999999999944 444455665443 3445677799999999999999999999988999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
|.||.++..+.. -...+.+..+..++.|++.||.|||+ +.|||||||..|||++-+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred cCCchHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 999999888842 34568899999999999999999999 77999999999999999999999999988765332
Q ss_pred cCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 164 VAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
......+.||++|+|||++. ..+|+.++||||||+++.||..+.+|.....+. +.+.++
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------------RVllKi 247 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------RVLLKI 247 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------------HHHHHH
Confidence 22345578999999999854 457999999999999999999999997765432 223333
Q ss_pred hhh-hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... +.....|..++..|.|++.+||.+||..||++.++++|
T Consensus 248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 222 22334677788999999999999999999999998865
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=282.67 Aligned_cols=236 Identities=19% Similarity=0.375 Sum_probs=183.0
Q ss_pred cccccCcceEEEeeeeCC-------------ceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 15 NLIGEGKFGEVYKGLLQD-------------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+.||+|+||.||.+.... ...+++|....... ..+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998421 23588897665433 35677889999999999999999999888899
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc-------eEEe
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-------AKVA 151 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~-------vkl~ 151 (312)
+||||+.+++|..++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999877632 23457888999999999999999999 77999999999999987664 8999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhh-hcCCCcccceehhHHHHHHHH-hCCCCCCCCCCCChhhHHHHhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELV-SGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~vl~~l~-tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... ..
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~--- 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---FY--- 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH---HH---
Confidence 99987654221 2234566799999886 466899999999999999998 5888876533211110 00
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
... .......++++.++|.+||+.||.+||++.+++.++
T Consensus 223 ----------~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 ----------EGQ--CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------hcC--ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 011112246789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=282.70 Aligned_cols=255 Identities=21% Similarity=0.389 Sum_probs=196.2
Q ss_pred CCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC------
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------ 75 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (312)
|++.+.||+|+||.||+|... +++.+|+|.+.... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999732 46889999765432 235778999999999999999999875432
Q ss_pred eEEEEEEeccCCcccccccCcc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..+++++|+.+++|..++.... ......++...+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECccc
Confidence 2478899999999877763221 1122357888899999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
.+................++..|++||...+..++.++|||||||++|+|++ |..||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~--- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIKGN--- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHcCC---
Confidence 9886643332222233345567999999998889999999999999999999 88888754331 1111111100
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
....+...++.+.+++.+||+.+|.+||++.+++..|+++
T Consensus 233 ----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112233457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=285.61 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=189.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHH-HhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|+||.||++. ..+++.||+|...... ...+..|+.. ++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478999999999999999999 4568999999765432 2234455554 566689999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+ + +++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMDT-SLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhcc-cHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9975 6766653221 123568899999999999999999998 5 799999999999999999999999999876533
Q ss_pred CCcCCCCccccCcccccchhhhhh----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... .....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~------------- 219 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ------------- 219 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH-------------
Confidence 21 1122346677999998865 456889999999999999999999996532211 11000
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.............+++++.++|.+||..+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011100011112345789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=297.29 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=216.7
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCC---c--eEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQD---G--MLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~--~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
+++..+..++.+.||.|.||.||.+...+ | -.||||..+. +..+.|..|..+++.++||||++++|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 34455566678899999999999998432 2 2478885443 3457799999999999999999999999875
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..|+|||.++-|-|.+++ +.+...++..+..-++.|++.||+|||+ +.+|||||-..|||++....|||+|||
T Consensus 464 -P~WivmEL~~~GELr~yL----q~nk~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYL----QQNKDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -ceeEEEecccchhHHHHH----HhccccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccc
Confidence 689999999999999998 3456678889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+++......+.. .+...-+..|+|||.++..+++.+||||-||+.|||+++ |..||.+..+.+...
T Consensus 537 LSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------------ 603 (974)
T KOG4257|consen 537 LSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------------ 603 (974)
T ss_pred hhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------------
Confidence 999887655433 334555667999999999999999999999999999887 889998866544322
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.++..-+...|+++|+.+..|+.+||..||.+||++.++...|..++.+
T Consensus 604 ----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 604 ----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2233334457888889999999999999999999999999999998874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.18 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=195.1
Q ss_pred CCCcccccccCcceEEEeeee-C--CceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-Q--DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~--~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (312)
+|.+.+.||+|++|.||+|.. . +++.||+|.+... ....+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 588999999999999999994 3 4789999976652 235677899999999999999999999887 7899
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC----CCceEEeecc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAG 154 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~----~~~vkl~Dfg 154 (312)
+||||+.+ ++.+++..........++...+..++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999976 55554432222223467889999999999999999999 77999999999999999 9999999999
Q ss_pred ccccccCCCc-CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChh-------hHHHH
Q 021441 155 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-------DLVEL 225 (312)
Q Consensus 155 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~-------~~~~~ 225 (312)
++........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886643322 1112233567779999988764 4789999999999999999999999875543310 00000
Q ss_pred hhhhh-----------hhhhhhHHhhhhccccCC-----------hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 226 VQNSR-----------DFSNLLKILDERLWSTFT-----------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 226 ~~~~~-----------~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... .........+......++ ...+.++.+++.+||..||++|||+.+++.|
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 000000000000000011 1234578999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=280.17 Aligned_cols=246 Identities=23% Similarity=0.391 Sum_probs=198.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||++. ..+++.+++|.+... ....+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58899999999999999998 456889999976433 234678899999999999999999999988999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+++++|.+++... ....+++..+..++.+++.+|.|||+ +|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999888421 23447888999999999999999999 7799999999999998654 6799999998876433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. .....++..|+|||...+..++.++|+||||+++|+|++|..||....... ...... ..
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~-------------~~ 216 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM-------------SG 216 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH-------------hc
Confidence 21 223456778999999998888999999999999999999999997543211 111110 11
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...+.++.+++.+||..||.+|||+.+++.+
T Consensus 217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122334456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=283.75 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=197.2
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC--hhHHHHHHHHHhcC-CCccceeeeeeeeeCC------e
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGYCQENN------L 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~ 76 (312)
..++|++.+.||+|++|.||+|.. .+++.+++|...... ...+.+|+.+++.+ .|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 468999999999999999999994 467889999765443 35678899999998 7999999999986544 4
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++.... .....++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 899999999999988874321 123567889999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhc-----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ........
T Consensus 161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~--- 233 (275)
T cd06608 161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFKIPRN--- 233 (275)
T ss_pred eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHHhhcc---
Confidence 7653322 112234577789999997643 46788999999999999999999997533211 11111000
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+..+++++.+++.+||..||++|||+.+++++
T Consensus 234 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 ---------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000011123356789999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.64 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=198.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+-|++.+.||+|+||.||++. ..+++.+|+|...... ...+.+|+.++..++||||+++++.+..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347788999999999999998 4568899999765332 24577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. ...+++..+..++.+++.++.+||+ +|++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999988872 2357888999999999999999999 779999999999999999999999999987654322
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.. .....++..|+|||...+..++.++|+|||||++|+|++|..||........ .... ....
T Consensus 156 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~-------------~~~~ 217 (277)
T cd06641 156 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLI-------------PKNN 217 (277)
T ss_pred hh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHH-------------hcCC
Confidence 11 1223466779999999888889999999999999999999999975432111 1110 1111
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+.++.+++.+||..+|.+||++.+++.|
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122344456789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=281.75 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=199.9
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee--CCeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (312)
+|++.+.||.|+||.||++. ..+++.+++|...... ...+..|+.+++.++|+||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999998 5567889999764322 2457779999999999999999997753 45679999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC---CCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~---~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
||+++++|.+++.... .....+++..+..++.|++.||.+||.. +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999988884321 1245678899999999999999999922 17799999999999999999999999999887
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~------------- 221 (265)
T cd08217 160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK------------- 221 (265)
T ss_pred ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH-------------
Confidence 6543321 1223567789999999988899999999999999999999999976441 111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+...+.++.+++.+||..+|.+|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112233455666889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=287.91 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=194.9
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+|++.+.||+|++|.||+|. ..+++.|++|.+..... ..+..|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 58889999999999999998 44688999997654322 3456799999999999999999999998999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+ +++|.+++... ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88998888321 1368899999999999999999999 779999999999999999999999999987764
Q ss_pred CCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhh---
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFS--- 233 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~--- 233 (312)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....+.............+ .+.
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 4321 1222345667999999865 356899999999999999999987776544322111110000000 000
Q ss_pred hhhHHhhhhc-----cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......... ........+.++.++|.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 011123345789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=286.88 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=198.4
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcC-CCccceeeeeeeeeC-----
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN----- 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----- 74 (312)
+.-..++|.+.+.||+|+||.||++. ..+++.+|+|..... ....+.+|+.++..+ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 34456889999999999999999999 456889999987543 335677889999988 799999999998643
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+..|+||||+++++|.+++.... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 35899999999999988774321 123457889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc-----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
.+......... .....++..|+|||.+... .++.++|||||||++|+|++|..||........ .......
T Consensus 174 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~~ 248 (291)
T cd06639 174 VSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKIPRN 248 (291)
T ss_pred cchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHHhcC
Confidence 98765432211 2233567789999997643 367899999999999999999999976442111 1101000
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ......+...+..+.++|.+||+.||++||++.++++|
T Consensus 249 ~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 P-----------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred C-----------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00011223344679999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.51 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|++|.||+|.. .+++.+++|...... ...+.+|+.++..++|+||+++++++......|+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4688999999999999999994 468999999866543 45688899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~-~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
+++++|.+++. ....++...+..++.|++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999883 23567899999999999999999997 54 999999999999999999999999998766433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............... ...
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------~~~ 218 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------------CDG 218 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-------------hcC
Confidence 211 12345677899999999888899999999999999999999999776531211111111 111
Q ss_pred ccccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11223333 56789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=274.07 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=199.2
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-------Ch----hHHHHHHHHHhcC-CCccceeeeeeeeeCC
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-------PT----QEFIDEVCFLASI-QHRNLVTLLGYCQENN 75 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-------~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 75 (312)
..|.-.+.||.|..+.|-++. ..+++.+|+|++... .. +.-.+|+.+|+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 567788999999999998887 667888999964321 12 2345689999998 6999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+++|+|.|+.|.|.+++ ...-.+++....+|++|+..|+.|||. +.||||||||+|||++++.+++|+|||.
T Consensus 97 F~FlVFdl~prGELFDyL-----ts~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL-----TSKVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHh-----hhheeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999 455678899999999999999999999 5599999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
++.+..+.. .....||+.|+|||.+.-+ .|+...|+||+|++||-++.|.+||.....
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------------- 233 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------------- 233 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------------
Confidence 998876543 3456799999999987643 578889999999999999999999975221
Q ss_pred hhhhhhhHHh-hhh--ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFSNLLKIL-DER--LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..++..+ ... ..+..=.+.+...++||++||+.||++|.|++|+|.|
T Consensus 234 ---mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ---MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0111111 111 1122223455788999999999999999999999976
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=287.03 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=196.5
Q ss_pred hcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (312)
.++|++.+.||+|+||.||+|... +++.+++|.+.... ...+.+|+.++..++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999954 68889999765322 22456799999999999999999998776 78999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|+||+.+ +|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+...
T Consensus 84 v~e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 84 VMEYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EehhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9999975 77776632 22357899999999999999999999 77999999999999999999999999998876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---hh--
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FS-- 233 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~-- 233 (312)
..... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...............-..+. +.
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 157 GSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 54321 122234567799999987654 58899999999999999999999986543222111111000000 00
Q ss_pred -hhh--------HHhhhhccccCChH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 -NLL--------KILDERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 -~~~--------~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+. ..........++.. .++.+.++|.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00000111112222 46789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=286.10 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=193.1
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|++|.||++.. .+++.||+|...... ...+.+|+++++.++|+||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999994 468899999764322 2346789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9986 78776632 22357888999999999999999999 77999999999999999999999999998654221
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hh---hhhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SR---DFSNLL 236 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~---~~~~~~ 236 (312)
.. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||....... ......... .. .+....
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhh
Confidence 11 11222356779999998764 57899999999999999999999997654211 111111100 00 000000
Q ss_pred HH----------hhhhccccCChHHH--HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KI----------LDERLWSTFTNEGM--EEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~----------~~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. .............. .++.+++.+||..||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00000000001112 678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=286.06 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCe-----
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL----- 76 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 76 (312)
++|++.+.||+|+||.||++. ..+++.||+|..... ....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999 456889999975432 2245778999999995 6999999998876554
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeeccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGL 155 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~ 155 (312)
.|+||||+.+ +|..++..........+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 7999999986 67766643222223567899999999999999999999 77999999999999998 88999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hhh-
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SRD- 231 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~- 231 (312)
+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.... ....... .+.
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (295)
T cd07837 158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTE 233 (295)
T ss_pred ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 8765322111 112245667999998865 4568999999999999999999999976443221 1111110 000
Q ss_pred --hhhhhHHhh--------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 --FSNLLKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 --~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+........ +..........++++.++|.+||..||.+||++.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 000001112345789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=286.30 Aligned_cols=269 Identities=22% Similarity=0.347 Sum_probs=208.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|.+.+.||+|+||.||++. ..+++.+++|.+... ....+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 35789999999999999999998 456788999976432 23457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ...++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999998873 2346788889999999999999999 77999999999999999999999999988765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||.+.+..++.++|+|||||++|++++|..||............ .. ...
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--~~------------~~~ 232 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT------------NGT 232 (293)
T ss_pred cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--hc------------CCC
Confidence 21 122345777899999998888899999999999999999999999764332111000 00 000
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCCCcccccc
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGS 305 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (312)
.....+...+..+.+++.+||..+|++||++.+++.|- -+.........+|....+.
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~------~~~~~~~~~~~~~~~~~~~ 289 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP------FLKIAKPLSSLTPLIAAAK 289 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH------HHhcCcccccccchHHHhh
Confidence 01112233456799999999999999999999999763 2233334445555555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.89 Aligned_cols=268 Identities=15% Similarity=0.219 Sum_probs=187.3
Q ss_pred hcCCCcccccccCcceEEEeeeeC--CceEEEEE------------------eCCC--CChhHHHHHHHHHhcCCCccce
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIK------------------KRPG--APTQEFIDEVCFLASIQHRNLV 65 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK------------------~~~~--~~~~~~~~e~~~l~~l~h~~i~ 65 (312)
.++|++++.||+|+||.||++..+ .+...+.| .... .....+.+|+.+++.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998732 12111111 1111 1123567899999999999999
Q ss_pred eeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
++++++...+..|+|++++.+ ++..++...............+..++.|++.||.|||+ +||+||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCC
Confidence 999999999999999999865 56555532211112223456677899999999999999 779999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCC-CCCCCCCChhhHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVE 224 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~p-f~~~~~~~~~~~~~ 224 (312)
+.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++|..+ |.............
T Consensus 304 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999876433211 12234688899999999999999999999999999999998764 44333222222222
Q ss_pred Hhhhhh----hhh----hhhHHhhhhccc----cC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 225 LVQNSR----DFS----NLLKILDERLWS----TF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 225 ~~~~~~----~~~----~~~~~~~~~~~~----~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+.... .+. .+...+...... .. ....+.++.++|.+||..||.+|||+.|+++|
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 221100 000 011111100000 00 01124578889999999999999999999975
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=286.92 Aligned_cols=260 Identities=20% Similarity=0.324 Sum_probs=196.3
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|+||.||+|.. .+++.+|+|..... ....+.+|+++++.++||||+++++++...+..|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4789999999999999999995 46889999975432 23457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.++++..+.. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988877652 23347899999999999999999999 77999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh-hH---
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL-LK--- 237 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 237 (312)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|..||....... ...........+... ..
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID--QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH--HHHHHHHHhCCCchhhHHHhc
Confidence 21 11223467789999998764 46889999999999999999999997543211 111111100000000 00
Q ss_pred ---Hhhhh---------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ---ILDER---------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ---~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... .........+..+.+++.+||..+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 0001122446789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=297.77 Aligned_cols=274 Identities=25% Similarity=0.411 Sum_probs=233.6
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCC-ceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+.|++...+.+...+||.|.||.||.+.|+. .--||+|.++.+ ..++|.+|..+++.++|||+++++|+|......|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 4688888888999999999999999999764 456899987665 4578999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
||.|||..|+|.++++ ..++..++.-..+.++.||.+|+.||.. +.+|||||-..|+|+.++..||++|||+++.
T Consensus 340 IiTEfM~yGNLLdYLR---ecnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLR---ECNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHH---HhchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999994 3455667778888999999999999999 7799999999999999999999999999998
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
+....+..+. ...-+..|.|||.+..+.++.++|||+||++|||+.| |-.||.+.+- ..+..
T Consensus 415 MtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYG 477 (1157)
T ss_pred hcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHHH
Confidence 8655444332 2334567999999999999999999999999999998 7788887553 33444
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccC
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEG 297 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~ 297 (312)
.++...+-+.+..+++...+||..||+.+|.+||++.|+-+.+|.++.+..-++.+.-+.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keL 537 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKEL 537 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHH
Confidence 556666667888899999999999999999999999999999999997766555554443
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.11 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=185.4
Q ss_pred ccccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHHHHhc---CCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 16 LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLAS---IQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.||+|+||.||++.. .+++.+|+|...... .....+|..+++. ..||+|+.+++++...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999994 568899999764321 1123344433333 468999999999998889999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999988772 33458899999999999999999999 779999999999999999999999999986543221
Q ss_pred CCCccccCcccccchhhhh-hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.....++..|+|||... +..++.++|+|||||++|+|++|..||.............. .....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------------~~~~~ 215 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------------TLTVN 215 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH--------------hhcCC
Confidence 22345788899999986 45679999999999999999999999976543222111100 00111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
...+...++++.++|.+||+.||++|| +++++++|
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 234455668899999999999999999 59998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=280.49 Aligned_cols=235 Identities=24% Similarity=0.440 Sum_probs=185.4
Q ss_pred cccccCcceEEEeeeeC-Cc----------eEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 15 NLIGEGKFGEVYKGLLQ-DG----------MLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~-~~----------~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+.||+|+||.||++... ++ ..+++|...... ...+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999954 33 357888755443 4678889999999999999999999887 6789999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-------ceEEeecc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-------IAKVADAG 154 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-------~vkl~Dfg 154 (312)
||+++++|.+++... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||
T Consensus 80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999888422 2257888899999999999999998 7799999999999999888 89999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
.+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. ..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~-- 222 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQ-- 222 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cC--
Confidence 9876543 1123345569999998877 68999999999999999999 577787654322111110 00
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
...+......+.+++.+||..+|.+|||+.++++.|
T Consensus 223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 -------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 001111126899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=277.80 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=204.0
Q ss_pred CCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (312)
+|.+.+.||+|++|.||.+... +++.+++|...... .+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5788899999999999999944 78899999766544 46688899999999999999999999888 8899999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|++.+++|.+++. ....+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999998883 23378899999999999999999999 7799999999999999999999999999887655
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
...........++..|+|||...+..++.++|+||||+++|+|++|..||...... .... ......
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~------------~~~~~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAAL------------YKIGSS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHH------------Hhcccc
Confidence 43221233445777899999999888999999999999999999999999765511 1101 011111
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+...+..+.+++.+||..||.+||++.+++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 12233444556899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=287.43 Aligned_cols=247 Identities=18% Similarity=0.306 Sum_probs=195.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+.|.....||+|+||.||++. ..++..||+|.+.... ...+.+|+.+++.++|+||+++++.+...+..|+||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 455667889999999999998 4568899999765432 345778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|.+++. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVT------HTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999988772 2346788899999999999999999 6799999999999999999999999999875532221
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ......
T Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~- 238 (292)
T cd06658 174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD---------NLPPRV- 238 (292)
T ss_pred --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------cCCCcc-
Confidence 1223456778999999988889999999999999999999999997543211 1111110 000000
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+..+.+++.+||..||.+|||+++++++
T Consensus 239 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112235678999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.80 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=191.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||++. ..+++.|++|.+.... ...+.+|+.+++.++|+||+++++++......|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4789999999999999999998 4568899999765332 2356789999999999999999999999889999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ ++.+.+. .....+....+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMHT-DLAQYMI----QHPGGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred cccC-CHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9965 6655542 122346677788899999999999999 67999999999999999999999999998754322
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh-hhhh----hh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFSN----LL 236 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~----~~ 236 (312)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...... ............ +... ..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhh
Confidence 11 12223457789999998764 4788999999999999999999999764431 111111111000 0000 00
Q ss_pred H------Hhhhh--------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 K------ILDER--------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~------~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ..... .+... ..+..+.+++.+|+..||++|||+.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRL--SRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhcccc--CCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00000 00000 114678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=279.70 Aligned_cols=240 Identities=20% Similarity=0.257 Sum_probs=192.8
Q ss_pred cccCcceEEEeeee-CCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~~-~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||.|++|.||++.. .+++.+++|.+... ....+.+|+.+++.++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999994 45889999976532 234578899999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++. ....++...+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILR-----DRGLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 98883 23457888899999999999999999 779999999999999999999999999987764332 112
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...++..|++||.+.+..++.++|+||||+++|+|++|..||......... .... +.........+.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~------------~~~~~~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IYND------------ILKGNGKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HHHH------------HhccCCCCCCCc
Confidence 235677799999998888999999999999999999999999876532111 1111 111111122333
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
..++++.++|.+||..||++||+ +.++++|
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 44678999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=281.76 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=206.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCC--Cc----cceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ--HR----NLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~--h~----~i~~~~~~~~~~~~~~ 78 (312)
..+|++...+|+|.||.|-.+. ..++..||+|++.... .+...-|+++|.++. .| .++++.+||.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 5789999999999999999998 4557899999876543 345667899999983 23 3788889999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC--------------
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------------- 144 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-------------- 144 (312)
+|+|.+ |-++.+++. .++..+++...+..++.|+++++++||+ .+++|.||||+||++..
T Consensus 168 ivfell-G~S~~dFlk---~N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLK---ENNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhc---cCCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 558889983 3456778999999999999999999999 66999999999999932
Q ss_pred ------CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCC
Q 021441 145 ------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218 (312)
Q Consensus 145 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~ 218 (312)
+..|+++|||.|+...+. .+..+.|..|+|||++.|-+++.++||||+||||+|++||...|.+-++.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 346999999999865433 356788889999999999999999999999999999999999999877666
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhh------hc-----------------------cccCChHHHHHHHHHHHHhcCCCCCC
Q 021441 219 SQDLVELVQNSRDFSNLLKILDE------RL-----------------------WSTFTNEGMEEFIQLIVRCLDPSSER 269 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~------~~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~ 269 (312)
...+.+.+.+..+...+.+.... ++ ..........+|.||+.+||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 66666665554333333222000 00 00001112256999999999999999
Q ss_pred CCCHHHHHHH
Q 021441 270 RPSMSDVVTE 279 (312)
Q Consensus 270 Rpt~~~ll~~ 279 (312)
|+|+.|+|.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=292.62 Aligned_cols=268 Identities=21% Similarity=0.322 Sum_probs=195.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeC-----CeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (312)
.++|++.+.||+|+||.||++. ..+++.||+|..... ....+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4789999999999999999998 557889999986532 234567899999999999999999887543 357
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|+||+.+ ++...+ ....+++..+..++.|++.||.+||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~------~~~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLI------KTQHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 666555 23457888999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCC-CCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDVAG-PSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..................+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654322111 1223456788999998765 45789999999999999999999999754321111111000111100111
Q ss_pred hHHhhhh---------c-----cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHH
Q 021441 236 LKILDER---------L-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTL 284 (312)
Q Consensus 236 ~~~~~~~---------~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~ 284 (312)
..+.... . ........++++.+++.+||+.||++|||+.++++| ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 0 000112235679999999999999999999999988 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=282.15 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=196.9
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeee--CCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (312)
++|+..+.||.|++|.||++.. .+++.+|+|.+.... ...+.+|+++++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999994 568899999765432 3457889999999999999999998854 34689999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++.... .....++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999987763211 133457888899999999999999999 7799999999999999999999999999865432
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCC--ChhhHHHHhhhhhhhhhhhHHh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD--SSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.. .....++..|+|||...+..++.++|||||||++|+|++|..||...... .............. .. .
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PE----L 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-hh----h
Confidence 21 12334566799999999889999999999999999999999999865321 11111111111000 00 0
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... .......++.+.+++.+||..||++|||+.+++.+
T Consensus 229 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 01112345789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=285.88 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=194.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||.|++|.||+|. ..+++.|++|.+.... ...+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58899999999999999998 4468899999765332 24578899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+. ++|..++... ....+++..+..++.|++.||.|||. .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 4777666321 23457889999999999999999999 779999999999999999999999999987654322
Q ss_pred cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh-hhh----hhH
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FSN----LLK 237 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~----~~~ 237 (312)
. ......++..|+|||.+.+.. ++.++|||||||++|+|+||..||....... ........... ... ...
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 1 112223566799999887655 5889999999999999999999997643221 11111111100 000 000
Q ss_pred H------hh---hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 I------LD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~------~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. .. ...........+.++.++|.+||+.||.+|||+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00 000001112245678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=316.67 Aligned_cols=281 Identities=23% Similarity=0.262 Sum_probs=225.0
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
.+.++..++|.+++.||.|+||.|.+++ ..+++.||+|+++. ....-|..|-.+|..-+.+-|+.++-.|++.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3566778999999999999999999999 67899999997654 3344577888888888899999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
.++|+||||++||+|..++. ....+++.++..+...|+.||..+|++| +|||||||+|||+|.+|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999998882 3336899999999999999999999955 9999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
.+-.....+.. .....+|||.|.+||++.. +.|+...|.||+||++|||++|.-||....-.+.+..+
T Consensus 221 sClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI------ 293 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI------ 293 (1317)
T ss_pred hHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH------
Confidence 98877643322 2344589999999999764 45899999999999999999999999764332222111
Q ss_pred hhhhhhhHHhhhhccccCC--hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCCCcccccce
Q 021441 230 RDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 306 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (312)
....-...+| ..++++.++||.+.+ -+|+.|..-..+-++-...+..+..|+......+|.++..+-
T Consensus 294 ---------m~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 294 ---------MNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred ---------hchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 1111112233 446789999998765 578888885555555556788899999998888888776543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=281.36 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=195.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.|++.+.||+|+||.||+|. ..+++.+++|.+... ....+.+|+.+++.+. |||++++++++......|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999 457889999976532 2345778999998886 999999999999989999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++. ...+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMK------AGPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHH------ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999988872 1257889999999999999999999 7799999999999999999999999999877654
Q ss_pred CCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......... ......
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~----------- 217 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIPKS----------- 217 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hccccC-----------
Confidence 331 12233577789999998754 4689999999999999999999999764322110 000000
Q ss_pred hhccccCCh-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+. ..+.++.+++.+||+.||.+||++.+++.+
T Consensus 218 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 --KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0011111 145789999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.30 Aligned_cols=258 Identities=15% Similarity=0.169 Sum_probs=182.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-C---ceEEEEEeCCCCChh--------------HHHHHHHHHhcCCCccceee
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAPTQ--------------EFIDEVCFLASIQHRNLVTL 67 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~~--------------~~~~e~~~l~~l~h~~i~~~ 67 (312)
+..++|++.+.||+|+||.||+|... + +..+++|........ ....+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 45678999999999999999999844 3 456677753322111 11122334556689999999
Q ss_pred eeeeeeCC----eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC
Q 021441 68 LGYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 143 (312)
Q Consensus 68 ~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~ 143 (312)
++++.... ..+++++++.. ++.+.+. .....+...+..++.|++.||.|||+ ++|+||||||+||+++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEc
Confidence 98765443 34677887644 4444441 12234677788999999999999999 7799999999999999
Q ss_pred CCCceEEeeccccccccCCCc-----CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCC
Q 021441 144 EDFIAKVADAGLRNFLGRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218 (312)
Q Consensus 144 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~ 218 (312)
.++.++|+|||+++....... ........+|+.|+|||+..+..++.++|||||||++|+|++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999987643211 111223468899999999999999999999999999999999999998753322
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
........ .+ ...+.... ......++++.+++..||+.+|++||++.++++.+
T Consensus 241 ~~~~~~~~----~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKC----DF--IKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHH----HH--HHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11110000 00 00000111 11223457899999999999999999999999876
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=279.35 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=184.1
Q ss_pred cccccCcceEEEeeeeCC---ceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 15 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.||+|+||.||++...+ ...+++|..... ....+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997332 345667765433 2346788999999999999999999999988999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++..... .....+...+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99988843221 12345677788899999999999999 7799999999999999999999999998754322221112
Q ss_pred CccccCcccccchhhhhh-------cCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 168 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.....++..|+|||+... ..++.++|||||||++|+|++ |..||......+.. ...... ... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~~-~~~----~~- 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL--NHVIKD-QQV----KL- 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHhh-ccc----cc-
Confidence 223456778999998753 235778999999999999997 56677654321111 111110 000 00
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.........++.+.+++..|| .+|.+||+++++++.|.
T Consensus 230 ---~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 ---FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 011223335578899999999 78999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=287.12 Aligned_cols=247 Identities=20% Similarity=0.299 Sum_probs=196.4
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCC---CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..|.....||+|+||.||.+. ..+++.|++|.+.. .....+.+|+.++..++||||+++++.+......|+|+||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 445566789999999999998 45688999997643 23346778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|..++ ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++........
T Consensus 101 ~~~~L~~~~------~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHH------hhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999998766 22457888999999999999999999 6799999999999999999999999999875533221
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ......... ...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~-----------~~~ 236 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSP-----------PPK 236 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhccC-----------CCC
Confidence 1223457778999999998889999999999999999999999997543211 111111100 000
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......++.+.+++.+||..+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11122345679999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.00 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=193.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------ 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 74 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 46889999999999999999999 557889999987532 224567899999999999999999987543
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+.+ +|.+.+. ..++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 6666551 126788889999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
.+........ .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+..............+ ...
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 239 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP-SDE 239 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC-CHH
Confidence 9876543221 222346778999999999999999999999999999999999997643211111100000000 000
Q ss_pred hhH-----------------------Hhhhhcc----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLK-----------------------ILDERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~-----------------------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+.. ....... ...+...++++.++|.+||..||++|||+.++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000 00022345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.30 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=190.2
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||+|+||.||+|. ..+++.+++|.+... ....+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998 446889999976432 223456799999999999999999999998999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 9888432 12357889999999999999999999 779999999999999999999999999887654321 122
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...++..|+|||...+..++.++|+|||||++|+|++|..||............. ... . ......+.
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~----------~-~~~~~~~~ 219 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRT----------L-EMAVEYPD 219 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcc----------c-cccccCCc
Confidence 2345667999999988889999999999999999999999997654321111110 000 0 00112334
Q ss_pred HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
..++++.++|.+||+.||++|| ++.+++.|
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 4467899999999999999999 67777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.38 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=194.4
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (312)
..++|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+.+++.++|+||+++++++... +..|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35789999999999999999999 4568899999764322 22456799999999999999999998654 4689
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+..
T Consensus 85 lv~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 99999975 67666632 23567889999999999999999999 7799999999999999999999999999887
Q ss_pred ccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---hhh
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSN 234 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~ 234 (312)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..............+. +..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 158 YGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 643321 1122234667999999876 4578999999999999999999999986543322211111100000 000
Q ss_pred hhHH-------hhhhccc---cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKI-------LDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~-------~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ....... ......++++.++|.+||..||++|||+.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000000 0011235778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=281.19 Aligned_cols=235 Identities=20% Similarity=0.374 Sum_probs=182.5
Q ss_pred ccccCcceEEEeeeeCC-------------------------ceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceee
Q 021441 16 LIGEGKFGEVYKGLLQD-------------------------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTL 67 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~ 67 (312)
.||+|+||.||++.... ...+++|.+..... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999987311 13588887765433 356778889999999999999
Q ss_pred eeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-
Q 021441 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF- 146 (312)
Q Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~- 146 (312)
++++......|+||||+++++|..++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCc
Confidence 9999999999999999999999888732 23457888899999999999999999 7799999999999997654
Q ss_pred ------ceEEeeccccccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHH-hCCCCCCCCCCCC
Q 021441 147 ------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELV-SGREASSSLSPDS 218 (312)
Q Consensus 147 ------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~-tg~~pf~~~~~~~ 218 (312)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999987543221 12245567999998875 45799999999999999985 6899987654322
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
... ..... ...+...++++.++|.+||..+|++|||+.++++.|
T Consensus 230 ~~~---~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KER---FYEKK---------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---HHHhc---------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 11000 011222235789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=278.14 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=197.0
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|.+.+.||+|++|.||.+. ..+++.+++|.+.... ...+..|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 58899999999999999998 4468899999755332 34678899999999999999999999988999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. ....+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHh-----hcCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999998883 33446788889999999999999999 779999999999999999999999999988764432
Q ss_pred cCCC--CccccCcccccchhhhhhcC---CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 164 VAGP--SSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 164 ~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||........ .... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~-~~~---------- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFH-VGA---------- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHH-Hhc----------
Confidence 2111 11345677899999988776 78999999999999999999999975432111 1110 000
Q ss_pred hhhhccccCCh--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTN--EGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+. ..++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 222 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 222 ---GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00111222 225778999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=283.28 Aligned_cols=237 Identities=22% Similarity=0.380 Sum_probs=184.3
Q ss_pred cccccCcceEEEeeeeC-C-------ceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 15 NLIGEGKFGEVYKGLLQ-D-------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~-~-------~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+.||+|+||.||++... . ...+++|....... +.+.+|..+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999843 2 23478887654332 4577899999999999999999999998889999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc--------eEEeeccc
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------AKVADAGL 155 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~--------vkl~Dfg~ 155 (312)
+.+++|..++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999988842 22357888899999999999999999 77999999999999987765 69999998
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCC-CCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++|. .||........ ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~------- 218 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFY------- 218 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHH-------
Confidence 765432 1223566779999998864 4799999999999999999985 55544322110 0000
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.. ....+...+.++.+++.+||+.||++|||++++++.|+
T Consensus 219 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ------ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11233333468999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=275.55 Aligned_cols=275 Identities=21% Similarity=0.286 Sum_probs=205.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCC----ceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee-CCe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQD----GMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~----~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 76 (312)
...|+.+++||+|.||.||+|. .++ .+.+|||.+..+ ......+|+.+++.++|||++.+..++.. ...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4679999999999999999996 332 237899987655 23457899999999999999999999876 778
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC----CceEEee
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVAD 152 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~----~~vkl~D 152 (312)
+|+++||.+. +|...+..........++...+..|+.||+.|+.|||+ +=|+||||||.||++..+ |.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999987 77777765544455678999999999999999999999 669999999999999888 8999999
Q ss_pred ccccccccCCC-cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCC-------CChhhHH
Q 021441 153 AGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSP-------DSSQDLV 223 (312)
Q Consensus 153 fg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~-------~~~~~~~ 223 (312)
||+++.+...- ........+.|..|+|||++.|.. |+.+.||||+||++.||+|-.+.|..... ...+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875432 222344567889999999998865 89999999999999999999988876432 1122222
Q ss_pred HHhh--hh---hhhhhh---------hHHhhhhccccC-ChH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 224 ELVQ--NS---RDFSNL---------LKILDERLWSTF-TNE-------GMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 224 ~~~~--~~---~~~~~~---------~~~~~~~~~~~~-~~~-------~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.+.. .. ..|..+ ......+.+... ... -++...+|+.+||..||.+|+|+++++++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 2111 00 111111 111111111111 000 1134789999999999999999999998865
Q ss_pred HHHH
Q 021441 282 RTLD 285 (312)
Q Consensus 282 ~~~~ 285 (312)
...+
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 5443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=285.09 Aligned_cols=268 Identities=20% Similarity=0.275 Sum_probs=214.8
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
+.+.+..+.|+.-+.||.|+||.|+-++ ..+|+.||+|++..... .....|-.+|.+++.+.|+.+--.|...
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 3456677889999999999999999999 66899999997654433 2356788999999999999998889999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+.+|+||..|.||+|.-++++. ....+++..+..++.+|+.||.+||. .+||.||+||+|||+|+.|+++|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999999998543 34679999999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+|..+..+... ...+||..|||||++....|+.+.|.|||||++|+|+.|+.||.......... .
T Consensus 333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e------------E 397 (591)
T KOG0986|consen 333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE------------E 397 (591)
T ss_pred eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH------------H
Confidence 99988665433 22378999999999999999999999999999999999999997543322111 1
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHHHHHHhcccccc
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTELDRTLDKEMNLTTV 293 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~l~~~~~~~~~~~~~ 293 (312)
+.+... ....+++...+++.+++....|.+||++|..- +++.+ .-+.+.+||..+
T Consensus 398 vdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~---HpfFk~lnw~rl 457 (591)
T KOG0986|consen 398 VDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE---HPFFKDLNWRRL 457 (591)
T ss_pred HHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh---CcccccCCHhHH
Confidence 111111 11234667777899999999999999999643 34433 344445555543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.38 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=196.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee----CCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 77 (312)
.++|++.+.||+|++|.||++. ..+++.|++|.+... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3789999999999999999998 556889999976532 23456789999999999999999988753 3568
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+ +|..++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLMES-DLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhhh-hHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 999999964 7877772 33458899999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcC--CCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..............+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 11223467778999999865 4578999999999999999999999976543221111111101110000
Q ss_pred h-----------hHHhhhh---ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 L-----------LKILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~-----------~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....... .+.......++++.++|.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0000000 0011112346789999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.37 Aligned_cols=245 Identities=28% Similarity=0.403 Sum_probs=192.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..+.|.+.+.||+|+||.||++. ..+++.|++|.+.... ...+.+|+++++.++||||+++++++......|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 45679999999999999999998 4468899999764321 1357789999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|+||+.+ ++.+++. .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~g-~l~~~~~----~~~~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCLG-SASDILE----VHKKPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhCC-CHHHHHH----HcccCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 9999976 5555442 123457889999999999999999999 77999999999999999999999999988654
Q ss_pred cCCCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
... ....++..|+|||++. ...++.++||||||+++|+|++|..||........ .....
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~~--------- 227 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA--------- 227 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHHh---------
Confidence 322 2234666799999874 35578899999999999999999999865432110 00000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+++.+.+++.+||..||++||++.+++.+
T Consensus 228 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 ---QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011111223356789999999999999999999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=273.60 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=199.9
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
+|++.+.||+|++|.||++.. .+++.+++|...... ...+.+|+.+++.++|++++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 478899999999999999995 468899999876543 3568889999999999999999999999899999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++... ...+++..+..++.|++.+|.+||. +|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999888321 1467899999999999999999999 7799999999999999999999999999877654321
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (312)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...... .... ....
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-------------~~~~ 215 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---KIAT-------------NGPP 215 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHh-------------cCCC
Confidence 233456777999999998888999999999999999999999997643211111 0000 0011
Q ss_pred cC--ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 246 TF--TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 246 ~~--~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ...++..+.+++.+||+.||++|||+.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 12225789999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=277.63 Aligned_cols=244 Identities=20% Similarity=0.205 Sum_probs=189.7
Q ss_pred hcCCCccccc--ccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLI--GEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~l--g~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|.+.+.+ |+|+||.||++. ..++..+++|.......... |......+ +||||+++++.+...+..|+||||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 4677777777 999999999998 55688899998765433222 22222222 699999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+......
T Consensus 91 ~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 91 IKDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99999999883 23378899999999999999999999 6799999999999999998 9999999998765322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
....++..|+|||++.+..++.++|+||||+++|+|++|..||.......... .. +.....
T Consensus 164 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-~~----------~~~~~~-- 224 (267)
T PHA03390 164 ------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL-ES----------LLKRQQ-- 224 (267)
T ss_pred ------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH-HH----------HHHhhc--
Confidence 12346778999999998899999999999999999999999998544322110 00 000000
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~~ll~~ 279 (312)
.........++.+.++|.+||+.||.+||+ ++++++|
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 011223345678999999999999999996 5888854
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.49 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=192.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|+..+.||+|+||.||++. ..+++.+|+|.+.... ...+.+|+.++.++. |+||+++++++......+++|
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 3577888999999999999998 4568899999765432 245678999999985 999999999999888899999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.. ++.++...........+++..+..++.+++.||+|||+. .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99865 443322100111235678899999999999999999962 3799999999999999999999999999876533
Q ss_pred CCcCCCCccccCcccccchhhhhhc---CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||..... ............
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~-------- 227 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD-------- 227 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC--------
Confidence 22 11223567779999998876 589999999999999999999999975431 000000000000
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+.........++.++.+++.+||..||++|||+.+++.+
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112223456789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=278.53 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=196.2
Q ss_pred CCCcccccccCcceEEEeeeeC--CceEEEEEeCCCC-------------ChhHHHHHHHHHhc-CCCccceeeeeeeee
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA-------------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQE 73 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-------------~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 73 (312)
+|++.+.||+|+||.||.+... .++.+++|.+... ....+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 5889999999999999999954 4688999965321 11335667777765 689999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
.+..|++|||+++++|.+.+.... .....++...++.++.|++.+|.|||+. +|++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999987763211 1234578889999999999999999952 56999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~------ 226 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LATKIV------ 226 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHHHHh------
Confidence 9987654332 2234457778999999998889999999999999999999999996533211 111110
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
.....+......++++.+++.+||..||.+||++.++.++++
T Consensus 227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111234578999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=277.19 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=196.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--------ChhHHHHHHHHHhcCCCccceeeeeeeeeC--CeE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ 77 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (312)
.+|++.+.||+|+||.||++. ..+++.+++|..... ....+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 578999999999999999998 456889999975321 123577899999999999999999998654 467
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++++||+++++|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.++
T Consensus 82 ~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999988873 23446788889999999999999998 779999999999999999999999999987
Q ss_pred cccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
........ .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-------------~~ 219 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A-------------IF 219 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H-------------HH
Confidence 65321111 11123457778999999998888999999999999999999999997542211 0 11
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+...++.+.+++.+||. +|..||++.+++.|
T Consensus 220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111112234566677889999999999 57999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.67 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=197.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC-----Ce
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (312)
.++|.+.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4689999999999999999998 557889999976532 234567899999999999999999987543 34
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 47776662 33468899999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+....................
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7654322 11223356778999998865 45889999999999999999999999764322111111111000000000
Q ss_pred -----------hHHhhhhc---cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHH
Q 021441 236 -----------LKILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRT 283 (312)
Q Consensus 236 -----------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~ 283 (312)
.+...... ........++++.++|.+||+.||++|||++++++| ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 001122456789999999999999999999999988 6654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=270.29 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=193.8
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (312)
...++.++++.||+|+.|.||+++ ..++...|+|..... ...++...+.++.... .|+|++++|+|..+..+++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 345667778999999999999999 557899999975443 3345666667666653 7999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
-||.|.. .+..++. ....++++..+-.+...+++||.||... +||+|||+||+|||+|+.|++||||||++-+.
T Consensus 169 cMelMs~-C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 169 CMELMST-CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHH-HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeeccccccee
Confidence 9998854 3444442 2345688888889999999999999973 67999999999999999999999999998776
Q ss_pred cCCCcCCCCccccCcccccchhhhhhc---CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.+.. ......|-+.|+|||.+... .|+.++||||||++++||.||..||.....+ +..+.
T Consensus 243 vdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--------------Fe~lt 305 (391)
T KOG0983|consen 243 VDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--------------FEVLT 305 (391)
T ss_pred eccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--------------HHHHH
Confidence 5433 23344566679999997754 5899999999999999999999999874432 22233
Q ss_pred HHhhhhcc-ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLW-STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.++..... -......++++.+++..||.+|+.+||...+|++|
T Consensus 306 kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 33222110 11122256899999999999999999999999976
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=288.70 Aligned_cols=264 Identities=22% Similarity=0.343 Sum_probs=194.7
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC-----CChhHHHHHHHHHhcC-CCccceeeeeeeeeC--CeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN--NLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 77 (312)
..++|++.+.||+|+||.||+|.. .+++.+++|.+.. .....+.+|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 357899999999999999999984 4688999997642 2234567899999999 999999999988643 467
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+ +|..++. . ..+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~~-~L~~~~~-----~-~~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYMET-DLHAVIR-----A-NILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEeccccc-CHHHHHh-----c-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 999999975 7877762 1 256778888899999999999999 779999999999999999999999999988
Q ss_pred cccCCCcC---CCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh-
Q 021441 158 FLGRTDVA---GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF- 232 (312)
Q Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 232 (312)
........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 76433221 12223457788999998765 45688999999999999999999999764432211111110000000
Q ss_pred --hh--------hhHHhhh---hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 --SN--------LLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 --~~--------~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ....... ..........+.++.++|.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 0000000 00011122256789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=279.05 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=200.8
Q ss_pred HhcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
..+.|++.+.||+|++|.||.+... +++.+++|.+.... ...+.+|+++++.++|+|++++++.+......|+++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3567899999999999999999954 68889999876544 45678899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+++|.+++... ...++...+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999998321 1368889999999999999999999 779999999999999999999999999876543221
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ ...... ....
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~~~-----------~~~~ 234 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLITT-----------KGIP 234 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-----------cCCC
Confidence 1 11223456679999999888899999999999999999999999975332211 110000 0000
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......++..+.++|.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111122355789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=277.43 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=197.0
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|+||.||++. ..++..+++|.+... ....+.+|+.+++.++|+||+++++.+......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58889999999999999999 446788999976432 335677899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+++++|.+++.. .....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999888732 122356889999999999999999999 7799999999999999886 4699999998766432
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......++..|+|||...+..++.++|+||||+++|+|++|..||...... ..... ....
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~------------~~~~- 217 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLK------------ICQG- 217 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH------------Hhcc-
Confidence 21 122235777899999998888999999999999999999999999653311 11110 0001
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+.++.+++.+||..+|++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112233445789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.23 Aligned_cols=244 Identities=21% Similarity=0.268 Sum_probs=205.4
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.=|.+.+.||+|.|..|-+|+ .-+|.+||+|+++.... ..+.+|+..++.++||||+++|.+......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 347788999999999999998 56799999998766544 457889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE-eCCCCceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL-VDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil-~~~~~~vkl~Dfg~a~~~~~ 161 (312)
+-++|+|.+++.. ....+.+.....++.||+.|+.|+|++- +|||||||+|+. +..-|-|||.|||.+..+..
T Consensus 98 LGD~GDl~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999943 3456788999999999999999999954 999999999975 47789999999999988765
Q ss_pred CCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
+... ....|+..|-|||++.|..| -++.||||||+++|-|++|..||....+.+...++. +
T Consensus 172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------D 233 (864)
T KOG4717|consen 172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------D 233 (864)
T ss_pred cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------c
Confidence 5432 33467788999999999999 567999999999999999999998766544322221 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
+.-..|.-++.+.++||..||..||.+|.+.+++..
T Consensus 234 --CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 --CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 112467777899999999999999999999988764
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=283.66 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=191.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC-----
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN----- 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 45789999999999999999999 4468899999754321 234567999999999999999999876543
Q ss_pred ---eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEee
Q 021441 76 ---LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD 152 (312)
Q Consensus 76 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~D 152 (312)
..|+||||+.+ ++...+. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLS----NKNVKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEECc
Confidence 45999999975 6665552 122357899999999999999999999 6799999999999999999999999
Q ss_pred ccccccccCCCcC--CCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 153 AGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 153 fg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
||.+......... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..................
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9998765432211 1112234667799999987654 688999999999999999999999764432211111111100
Q ss_pred hhhh---hh---------------hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFS---NL---------------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~---~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... .. ......... +...++.+.++|.+||..||.+|||++++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00 000000000 00113567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.03 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=195.8
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+|++.+.||.|++|.||+|.. .+++.|++|..... ....+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588999999999999999994 46889999976533 2345678999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+ +|.+++.... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 86 7776663221 13457899999999999999999999 6799999999999999999999999999876533211
Q ss_pred CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh-hh
Q 021441 165 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD-ER 242 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (312)
......++..|++||.+.+. .++.++|+|||||++|+|++|..||...+..+...........+.......... +.
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11223456779999998764 468899999999999999999999987554322111111100000000000000 00
Q ss_pred -----------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 -----------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+.++.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011112335788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.75 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=193.4
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
|++.+.||.|++|.||++. ..+++.|++|.+... ....+.+|+.+++.++|||++++++++...+..|+++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6788999999999999998 457889999976532 2245778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
. ++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 4787777321 11357899999999999999999999 6799999999999999999999999999876532211
Q ss_pred CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh--hh---hhhhhHH
Q 021441 165 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD---FSNLLKI 238 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~---~~~~~~~ 238 (312)
. .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.... ........ +. +......
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 1 1122346779999987765 468899999999999999999999976443211 11111110 00 0000000
Q ss_pred ------h---hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 ------L---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ------~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ............++.+.+++.+||+.||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000011123345789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=278.00 Aligned_cols=257 Identities=20% Similarity=0.248 Sum_probs=189.7
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCC-CccceeeeeeeeeC--CeEEEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYE 82 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 82 (312)
|++.+.||+|+||.||++. ..+++.+|+|...... .....+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999998 4568899999765432 123356888888885 99999999999877 88999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. +.++|+|||.+......
T Consensus 81 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9976 66666522 22457899999999999999999999 77999999999999999 99999999998765432
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+.............. ........
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA-EVLKKFRK 228 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH-HHHHhhcc
Confidence 21 122346778999998654 45688999999999999999999999765432211111111110000 00000000
Q ss_pred h--c-----------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 R--L-----------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~--~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. . ........+.++.++|.+||+.||++|||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0 001122456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=281.32 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=192.1
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||.|++|.||++.. .+++.|++|..... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999994 46889999976432 22457789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a~~~~~ 161 (312)
|+.+ ++.+++.. ......++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9965 66655522 122335778888999999999999999 77999999999999985 56799999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hh---hhhh-
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SR---DFSN- 234 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~---~~~~- 234 (312)
.... .....++..|+|||.+.+. .++.++|||||||++|+|+||..||...+..+ ........ .+ .+..
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred Cccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhcccc
Confidence 2111 1223456779999998764 47889999999999999999999997644321 11111100 00 0000
Q ss_pred --hhH--Hhhhhc----cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 --LLK--ILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 --~~~--~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+.. ...+.. ........++++.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 000122345779999999999999999999999974
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=274.23 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=202.2
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|.+.+.||.|++|.||++.. .+++.+++|..... ....+.+|+++++.++|+|++++.+.+......++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999994 46889999976543 334578899999999999999999999998999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++.... .....++...+..++.+++.||.+||+ +|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999988884321 123668899999999999999999999 779999999999999999999999999987664432
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.......++..|+|||...+..++.++|+||+|+++++|++|..||....... ..... ....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~-------------~~~~ 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI-------------LKGQ 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH-------------hcCC
Confidence 11223457778999999998889999999999999999999999996544211 11110 1111
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+...+.++.+++.+||..+|++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122344556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=275.34 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=201.1
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||++. ..+++.+++|..... ....+.+|+.+++.++|+||+++++++......|+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999998 456788999976532 234567899999999999999999999988999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++.... .....+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999988874322 123567888999999999999999999 779999999999999999999999999987765431
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.....++..|++||...+..++.++|+||||+++|+|++|..||...+... .... .....
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~-------------~~~~~ 217 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK-------------VQRGK 217 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-------------HhcCC
Confidence 222346678999999998889999999999999999999999997644211 1110 11122
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+...+.++.+++.+||..+|.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 233444566889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=272.62 Aligned_cols=245 Identities=28% Similarity=0.468 Sum_probs=200.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
+|++.+.||+|++|.||++. ..+++.|++|...... ...+.+|++++..++|+|++++++++...+..|++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58899999999999999998 4467889999765543 24578899999999999999999999998999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. ....+++..+..++.|++.+|.+||+ +|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999998883 33567899999999999999999999 779999999999999999999999999988765433
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.. .....++..|+|||...+..++.++|+||||+++|+|++|..||....... ...... ...
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~~~--------------~~~ 215 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRIV--------------QDD 215 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHh--------------ccC
Confidence 21 233456778999999988888999999999999999999999997543211 100000 011
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+...++.+.+++.+||..+|++|||+.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 123344556789999999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=280.09 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=196.2
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
|++.+.||+|++|.||++. ..+++.+++|...... ...+.+|+.+++.++|+||+++++++......|+|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999998 4568899999765433 246778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+ ++.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 76 77666632 22467889999999999999999999 679999999999999999999999999987664432
Q ss_pred CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh---hhhhhhhHHhh
Q 021441 165 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS---RDFSNLLKILD 240 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 240 (312)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+........... ..+........
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 111223466679999998876 6799999999999999999999999765432211111100000 00000000000
Q ss_pred h----------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 E----------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ..........+.++.++|.+||..||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00011223456889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=295.21 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=210.8
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCC----ceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
.+..++.+++++||+|+||.|+++.|.. -..||+|++... ..++|.+|+.+|.+++|+|++++||+..+ ..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 3456777889999999999999999763 246999987654 34679999999999999999999999987 56
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
..+|+|+++.|+|.+.+.. .....+.......++.||+.|+.||.. +++||||+-..|+++-....|||+|||+.
T Consensus 185 ~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccce
Confidence 7799999999999999954 245667888899999999999999999 88999999999999998999999999999
Q ss_pred ccccCCCcCCCC-ccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 157 NFLGRTDVAGPS-SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 157 ~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+.++..+..+.. ........|+|||.+....++.+||+|++|+++|||+| |..||.+.....
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------------- 323 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------------- 323 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------
Confidence 998776544332 22234556999999999999999999999999999998 778988765432
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
+++.++.+-.-.-+..+++++.+++.+||..+|++|||+..+.+.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2222333333455777889999999999999999999999998544
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=279.06 Aligned_cols=246 Identities=19% Similarity=0.304 Sum_probs=195.5
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.|...+.||+|++|.||++. ..+++.+++|..... ....+.+|+.+++.++||||+++++++...+..|+++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 56667899999999999998 456888999976432 23457789999999999999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|.+++.. ..++...+..++.|++.||++||+ +|++|+||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999988732 457888899999999999999999 7799999999999999999999999998765433211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (312)
......++..|+|||...+..++.++|+|||||++|+|++|..||...... .......... ....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~~-----------~~~~ 235 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDNL-----------PPKL 235 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhcC-----------CCCC
Confidence 112234677899999998888999999999999999999999999753321 1111111100 0001
Q ss_pred cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 246 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+...+..+.+++.+||..+|++|||+.+++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1122245789999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=281.50 Aligned_cols=266 Identities=22% Similarity=0.269 Sum_probs=194.0
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC----
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN---- 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (312)
...++|++.+.||+|++|.||++.. .+++.|++|.+.... ...+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4568899999999999999999994 468899999764322 235677999999999999999999886544
Q ss_pred ------eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceE
Q 021441 76 ------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 76 ------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vk 149 (312)
..|+|+||+.+ ++..++. .....+++..+..++.|++.||+|||+ +||+|+||||+||++++++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLE----SGLVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEE
Confidence 78999999987 5555442 123467899999999999999999999 7799999999999999999999
Q ss_pred EeeccccccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 150 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|+|||.+......... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.................
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999998766433211 11122345679999988654 468899999999999999999999975443221111111100
Q ss_pred hhhhhhhhHHhhh-------------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDE-------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+........... +.........+..+.+++.+||..||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000000000000 00000112245789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=319.49 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=203.7
Q ss_pred CCCcccccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++....+||.|.||.||-|. ..+|...|+|.+.- .....+.+|..++..++|||++++||+-.+...++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 44557789999999999999 67899999995332 2234578899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
|.+|+|.+.+ ......++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll-----~~gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLL-----EHGRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHH-----HhcchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999998 344456777788899999999999999 679999999999999999999999999998775432
Q ss_pred --cCCCCccccCcccccchhhhhhcC---CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 164 --VAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 164 --~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..+......||+.|||||++.+.. -.-+.||||||||..||+||+.||...+.. |.-+.+.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------------~aIMy~V 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------------WAIMYHV 1454 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------------hHHHhHH
Confidence 122234567999999999998754 356899999999999999999999876543 1112222
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...-.+.+|..++.+-+++|.+||..||.+|.++.+|++|
T Consensus 1455 -~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 -AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1222345677788999999999999999999999988876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=275.14 Aligned_cols=240 Identities=20% Similarity=0.222 Sum_probs=184.4
Q ss_pred cccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHH-HhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|++|.||+|. ..+++.||+|....... ..+..|..+ ....+|+|++++++++...+..|+|+||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999998 45688999998754321 123334443 3445899999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|..++. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99998883 33457889999999999999999999 6799999999999999999999999998875432
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ .......
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~----------~~~~~~~ 215 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNILSR----------RINWPEE 215 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhc----------ccCCCCc
Confidence 123346677999999998888999999999999999999999997543211 11111000 0001111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
....+++++.+++.+||..||++||++.++.+.|
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 2234567899999999999999999775444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=286.27 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=193.7
Q ss_pred hcCCC-cccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----------------hHHHHHHHHHhcCCCccceeee
Q 021441 8 TKNFS-DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----------------QEFIDEVCFLASIQHRNLVTLL 68 (312)
Q Consensus 8 ~~~y~-~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~ 68 (312)
.++|. +.+.||+|+||.||+|. ..+++.||+|....... ..+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35564 56789999999999998 45688999997543322 1367899999999999999999
Q ss_pred eeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
+++......|+||||+.+ +|.+++. ....++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMAS-DLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEecccc-CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCE
Confidence 999999999999999975 7777772 34457889999999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCc------------CCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCC
Q 021441 149 KVADAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLS 215 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~ 215 (312)
+|+|||.+........ ........++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541110 11112223567799999987654 6899999999999999999999998654
Q ss_pred CCChhhHHHHhhhhhhhhhhhHHhh-----------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 216 PDSSQDLVELVQNSRDFSNLLKILD-----------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+...........+.......... +..........++++.+++.+||+.||++|||+++++.+
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 3221111111000000000000000 000001112335778999999999999999999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.30 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=188.9
Q ss_pred ccccccC--cceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 14 KNLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
...||.| +||.||++.. .+++.||+|...... .+.+.+|+.+++.++||||+++++++...+..|+|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3456766 8999999984 578999999865332 2456788899999999999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc-
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV- 164 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~- 164 (312)
++++.+++... ....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998887432 12347888889999999999999998 7799999999999999999999999986543321110
Q ss_pred ----CCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh--hhh---
Q 021441 165 ----AGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFS--- 233 (312)
Q Consensus 165 ----~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~--- 233 (312)
........++..|+|||++.+. .++.++|||||||++|+|++|..||........ ......... ++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 0111122345569999998764 468899999999999999999999976542211 111110000 000
Q ss_pred ------h-------hh--------------HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 ------N-------LL--------------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ------~-------~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. .. ...............++.+.+++.+||..||++|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 0000111112234456789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=275.38 Aligned_cols=239 Identities=21% Similarity=0.286 Sum_probs=185.2
Q ss_pred ccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHH---HHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 16 LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEV---CFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 16 ~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.||+|+||.||++. ..+++.||+|.+..... .....|. ..++...||+|+++++++......|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998 45688999997654321 1123333 34444579999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
+++|..++. ....+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999988772 33468899999999999999999999 779999999999999999999999999987553221
Q ss_pred CCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.....++..|+|||.+.+. .++.++||||+||++|+|++|..||............... ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------~~~~ 215 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------------LTMA 215 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--------------hccC
Confidence 1233577889999998754 5899999999999999999999999765332221111000 0011
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
...+...+.++.+++.+||..+|.+|| ++.+++++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 223344567899999999999999999 99999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=279.20 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=205.0
Q ss_pred CCCcccccccCcceEEEeeee----CCceEEEEEeCCCC-------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+|++.+.||+|++|.||++.. .+++.+|+|.+... ....+..|+.++..+ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999873 24678999976532 224467899999999 599999999999998999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|.+.+. ....+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999988873 23457888899999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcC--CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
........ ......++..|+|||...+.. .+.++|+||||+++|+|++|..||........... ....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~------- 223 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE--ISRR------- 223 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH--HHHH-------
Confidence 65432211 122234677899999987765 68899999999999999999999964322111110 0000
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccccccccc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 296 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~ 296 (312)
.... ....+...+..+.+++.+||+.||++|||+.++.+.|+...-+...++.....
T Consensus 224 --~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 224 --ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred --HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 0000 11233345578999999999999999999998888888777666666555433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.08 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=195.7
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..|...+.||+|+||.||++. ..++..+++|...... ...+.+|+.+++.++|||++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 457889999999999999999 4568899999764321 235778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+ ++.+.+. .....+++..+..++.+++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99976 6655552 223457889999999999999999999 7799999999999999999999999998765432
Q ss_pred CCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||........ ... +
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~------------~ 236 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH------------I 236 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHH------------H
Confidence 22335677799999974 35678899999999999999999999865322111 100 1
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.............++.+.+++.+||+.+|.+||++.+++.+.-.....
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 111111122334557899999999999999999999999886654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=279.66 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=200.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (312)
++|.+.+.||+|++|.||++. ..+++.+++|..... ....+..|.++++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999 447889999976542 2245778899999998 99999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
||++.+++|.+++. ....+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999998883 33468999999999999999999999 779999999999999999999999999987664
Q ss_pred CCCcC------------------CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH
Q 021441 161 RTDVA------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 222 (312)
Q Consensus 161 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~ 222 (312)
..... .......++..|+|||...+..++.++|+||||++++++++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 33211 112233467789999999888889999999999999999999999986542111
Q ss_pred HHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 021441 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM----SDVVTE 279 (312)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~----~~ll~~ 279 (312)
.... . ......+...++.+.+++.+||+.||.+||++ ++++.|
T Consensus 231 ~~~~------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 FQKI------------L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH------------H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0000 0 11122344456789999999999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=286.06 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=198.6
Q ss_pred CCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-----eEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (312)
+|++.+.||.|++|.||+|.. .+++.+++|.+... ....+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999994 45889999976543 2356788999999999999999999987764 789
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++|+|+.+ +|.+++. ....+++..+..++.+++.||.+||+ +|++|+||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~~-~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999975 7777762 33468899999999999999999999 7799999999999999999999999999887
Q ss_pred ccCCCcC-CCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh--
Q 021441 159 LGRTDVA-GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-- 234 (312)
Q Consensus 159 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 234 (312)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..............+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6543210 112334567789999999888 789999999999999999999999987653221111111100000000
Q ss_pred ------hhHHhh------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 ------LLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ------~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... ...........+.++.++|.+||..||.+|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000111122346789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.88 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=205.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
...|.+.+.||+|.|+.|.+++ .-++..||||.+++... ..+.+|+.+++.++||||++++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4678999999999999999999 55788999998765433 44788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.++.+.+++. +........+..++.|+++|++|||+ +.|||||||++|++++.+.++||+|||.+..+..
T Consensus 135 eya~~ge~~~yl~-----~~gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLV-----KHGRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHH-----hcccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999993 44455568888999999999999999 7799999999999999999999999999998864
Q ss_pred CCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .....|++.|.|||++.|..| ++.+|+||+|+++|-|+.|.+||.+..-.+..... +.
T Consensus 208 ~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~ 269 (596)
T KOG0586|consen 208 GLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LR 269 (596)
T ss_pred ccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------ee
Confidence 433 344678889999999999998 88999999999999999999999875432221111 01
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ...++-.++.+..++|+++|..+|.+|++.+++..+
T Consensus 270 g--k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 G--KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e--eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 112344445688999999999999999999998865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=247.54 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=204.7
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.+|.-.++||+|.||+||+++ +.+.+.||+|... ....+...+|+++++.++|.||++++++......+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356778999999999999999 7788999999643 2344678999999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
||.. +|..+.- .....++.+.+..++.|++.||.++|+ +.+.|||+||+|++++.+|++|++|||+++.++..
T Consensus 82 ~cdq-dlkkyfd----slng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HhhH-HHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9966 7766652 345678899999999999999999999 55999999999999999999999999999987644
Q ss_pred CcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCC-CCCCCCCCCChhhHHHHhhh---hhhhhhhhH
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQN---SRDFSNLLK 237 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~-~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~ 237 (312)
.. ..+....|..|++|.++.|.. |+.+.|+||-||++.|+.... +.|.+.+-.+....+..... ..+|..+.+
T Consensus 155 vr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 32 234456788999999988765 799999999999999999854 44665443333222222222 234444544
Q ss_pred HhhhhccccCC---------hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+...++.++ +.....-++++++.|.-+|.+|+++++.++|
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 44443333332 3333456899999999999999999998875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=276.31 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=193.5
Q ss_pred CCcccccccCcceEEEeeeeC-CceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC--CeEEEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIYE 82 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (312)
|++.+.||+|++|.||++... +++.+++|.+... ....+.+|+.+++.++|+|++++++++... +..|+|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999944 5889999987544 234577899999999999999999999887 78999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+++.. ....+++..+..++.|++.||++||+ .|++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 77777632 22467899999999999999999999 77999999999999999999999999998876443
Q ss_pred CcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhhhhhHH
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFSNLLKI 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 238 (312)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||................... .+......
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 211 11223456679999987654 57899999999999999999999997654322111111000000 00000000
Q ss_pred -----------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 -----------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.............++.+.+++.+||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=276.87 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=189.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+-|...+.||+|+||.||+|. ..+++.+++|.+.... ...+.+|+.+++.++|||++++++++......|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 346677889999999999998 4568899999765321 135678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+ ++.+++. .....+++..+..++.|++.++.|||+ +|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 101 e~~~~-~l~~~l~----~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 101 EYCLG-SASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred ecCCC-CHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 99975 5555552 223457888999999999999999999 7799999999999999999999999998764321
Q ss_pred CCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.....++..|+|||++. +..++.++|||||||++|+|++|..||.......... ....
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~----------- 234 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ----------- 234 (313)
T ss_pred ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHh-----------
Confidence 22345677899999974 3557889999999999999999999987643211111 0000
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........++..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 --~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 --NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111222344679999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.45 Aligned_cols=260 Identities=19% Similarity=0.193 Sum_probs=188.2
Q ss_pred CcccccccCcceEEEeeeeCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 12 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
.+.+.+|.|+++.|+.... +++.||+|.+... ....+.+|+.+++.++|+||+++++++......|++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444455554444444433 5889999976433 234678899999999999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc--
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-- 164 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~-- 164 (312)
++|.+++... ....+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++++|||.+........
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999888422 22457788899999999999999999 7799999999999999999999999998865532211
Q ss_pred ---CCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh-------
Q 021441 165 ---AGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------- 232 (312)
Q Consensus 165 ---~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 232 (312)
........++..|+|||++.+. .++.++|+|||||++|+|++|..||....... ............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 1112333466679999998764 57899999999999999999999998643221 111111100000
Q ss_pred h----hhh--------HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 S----NLL--------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~----~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ... ...............+.++.+++.+||..||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000 0000011112234455789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.21 Aligned_cols=262 Identities=20% Similarity=0.305 Sum_probs=193.5
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC---
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--- 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 74 (312)
+....++|++.+.||+|+||.||++. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 33456899999999999999999998 5578899999875432 24567899999999999999999987543
Q ss_pred ---CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 75 ---NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 75 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
...|++++++ +++|.+++. ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 668876662 2347888999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||++...... .....++..|+|||...+ ..++.++|||||||++|+|++|..||...................
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754322 223456778999999876 467889999999999999999999997644322111111100000
Q ss_pred hhhh-----------hhHHhhhh---ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSN-----------LLKILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~-----------~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ........ .........++++.++|.+||..||.+||++.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000000 0001111235678999999999999999999999977
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=273.79 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=191.7
Q ss_pred CCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC-----hhHHHHHHHHHhcC---CCccceeeeeeeeeCCe-----
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASI---QHRNLVTLLGYCQENNL----- 76 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 76 (312)
|++.+.||+|+||.||++..+ +++.+|+|...... ...+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999954 58899999765321 23455677766655 59999999999987766
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++||++.+ +|.+++... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 677766321 12357889999999999999999999 67999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFS 233 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~ 233 (312)
........ .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......+............ .+.
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 76543321 122346777999999999899999999999999999999999987644322111111000000 000
Q ss_pred hh----h---HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NL----L---KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~----~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. . ...............++.+.+++.+||..||.+||++.+++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0 0000011112223456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=281.73 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=190.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC-------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------- 74 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 74 (312)
.++|++.+.||+|++|.||+|. ..+++.+++|.+... ....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5799999999999999999999 446888999975322 123567899999999999999999887433
Q ss_pred -CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 75 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 75 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
..+|+|+||+.+ ++...+. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~----~~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE----NPSVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh----ccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999976 5554442 223468899999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcCCC---------CccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHH
Q 021441 154 GLRNFLGRTDVAGP---------SSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 223 (312)
Q Consensus 154 g~a~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~ 223 (312)
|++........... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99876543221111 1122456779999988764 4789999999999999999999999764432221111
Q ss_pred HHhhhhh---hhh---hhhHHhhhhccccC-------ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 224 ELVQNSR---DFS---NLLKILDERLWSTF-------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 224 ~~~~~~~---~~~---~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... .+. .............. .....+.+.+++.+||..||++|||+.+++.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1110000 000 00000000000000 01122578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=313.83 Aligned_cols=267 Identities=26% Similarity=0.447 Sum_probs=200.9
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.|...+.||+|+||.||+|.. .+++.||+|.+..... ....|++.+++++||||+++++++......|+||||++++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 4577788999999999999994 5788999998764332 2245688999999999999999999998999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
+|.+++. .+++..+..++.|++.|++|||.. ..+++||||||+||+++.++..++. |+.+.....
T Consensus 769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9998882 367888999999999999999942 2679999999999999998887775 554432211
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc--
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW-- 244 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (312)
.....++..|+|||++.+..++.++|||||||++|||+||+.||........ ......+............++...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC-cHHHHHHHhcCccchhheeCccccCC
Confidence 1122567789999999999999999999999999999999999954322211 111111111000011111122211
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccccc
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 292 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~ 292 (312)
.........++.+++.+||+.||++|||+.++++.|+++......+..
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~ 960 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccccc
Confidence 122334456788999999999999999999999999998876555443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=271.91 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=190.0
Q ss_pred cccCcceEEEeeeeC-CceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||.|+||.||++... +++.+++|.+.... ...+.+|+.+++.++||||+++++.+......|+++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999954 58899999875432 24577889999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc-----
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV----- 164 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~----- 164 (312)
.+++. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLE-----NVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 88883 22367889999999999999999999 7799999999999999999999999999876533211
Q ss_pred -CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 165 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
........++..|+|||......++.++|+||||+++|+|++|..||........ ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~------------~~- 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNILN------------GK- 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhc------------CC-
Confidence 1122334566779999999888889999999999999999999999976442211 111100 00
Q ss_pred cccCChH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 244 WSTFTNE--GMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 244 ~~~~~~~--~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
...+.. .+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus 218 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 -IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 011111 3578999999999999999999955544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=274.99 Aligned_cols=244 Identities=19% Similarity=0.332 Sum_probs=192.4
Q ss_pred CcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 12 SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
.....||+|+||.||++. ..+++.+++|...... ...+.+|+.+++.++|+||+++++.+......|+||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 345679999999999998 4578899999764322 245778999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++. ...+++..+..++.|++.+++|||+ +|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 103 ~L~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~ 172 (292)
T cd06657 103 ALTDIVT------HTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 172 (292)
T ss_pred cHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cc
Confidence 9988762 2346888899999999999999999 779999999999999999999999999876553221 11
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....++..|+|||...+..++.++|+||||+++|+|++|..||........ ...... ..... ...
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~---------~~~~~--~~~ 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD---------NLPPK--LKN 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh---------hCCcc--cCC
Confidence 2234567789999999888889999999999999999999999975332111 111100 00000 011
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+..+.+++.+||..||.+||++.+++.+
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=276.53 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=191.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.+.|...+.||+|++|.||++. ..+++.+++|..... ....+.+|+++++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3457788999999999999999 446788999975421 123567899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+ ++.+.+. .....++...+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~-~l~~~~~----~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCLG-SASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccCC-CHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999975 6655552 123447888999999999999999999 779999999999999999999999999886543
Q ss_pred CCCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----------- 227 (308)
T cd06634 167 P------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA----------- 227 (308)
T ss_pred C------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHh-----------
Confidence 2 123356678999999753 45788999999999999999999998654321111 0000
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
............+..+.++|.+||..+|.+||++.+++.+--
T Consensus 228 --~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 228 --QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111111122345578999999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=287.24 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=193.8
Q ss_pred CcccccccCcceEEEeeee-CCceEEE---EE--eCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCC--eEEEEE
Q 021441 12 SDKNLIGEGKFGEVYKGLL-QDGMLVA---IK--KRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIY 81 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~-~~~~~va---iK--~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 81 (312)
++-..||+|+|-+||+|.. .+|..|| +| .+... ..+.+..|+.+|+.|+||||+++|+++.+.. .+.+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 6678899999999999994 4565555 22 12222 3367899999999999999999999987654 477899
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~~~~ 160 (312)
|.+.+|+|..+. ......+...+..|++||++||.|||++..+|+|||||.+||||+ ..|.|||+|+|+|+...
T Consensus 123 EL~TSGtLr~Y~-----kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYR-----KKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHH-----HHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999888 455668889999999999999999999888899999999999997 56899999999999765
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .....|||.|||||+.. ..|++..||||||+.|.||+|+..||..-.+.. +.+..+........+.++.
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~- 269 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVK- 269 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccC-
Confidence 432 23368999999999998 889999999999999999999999998755432 1222222111111111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+++++||.+||.. .++|+|+.|||.+
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 26789999999999 9999999999954
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.35 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=193.6
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeee-CCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 77 (312)
-...++|++.+.||.|+||.||++. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3457889999999999999999998 55788999997542 223567789999999999999999998865 4578
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+++||+. ++|..++. ...++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELLG-TDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehhc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 99999984 57776662 2346778888899999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh--hhh-
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFS- 233 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~- 233 (312)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||................... .+.
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54221 122345677999998765 568999999999999999999999997654321111111000000 000
Q ss_pred -----hhhHH---hhhh---ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 -----NLLKI---LDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 -----~~~~~---~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... .... .........++.+.++|.+||..+|++|||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000 0001112345789999999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=279.74 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=189.7
Q ss_pred CCCcccccccCcceEEEeeee-CC--ceEEEEEeCCCC-----ChhHHHHHHHHHhcC-CCccceeeeeeeee----CCe
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QD--GMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNL 76 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~--~~~vaiK~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 76 (312)
+|++.+.||+|+||.||++.. .+ +..||+|.+... ....+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588899999999999999994 34 778999976532 234567899999998 59999999987532 245
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|++++++. ++|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999886 47777762 34567899999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcC--CCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 157 NFLGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
......... .......++..|+|||+..+ ..++.++|||||||++|+|++|..||..................+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 765432211 11223457888999998776 467999999999999999999999997644221111111000000000
Q ss_pred hhhHHhh--------------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILD--------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+..... ...........+..+.+++.+||+.||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000001112235689999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=289.44 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=206.0
Q ss_pred CcccccccCcceEEEeee-eCCceEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeC------CeEEEE
Q 021441 12 SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLI 80 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv 80 (312)
...+.||+|+||.||+++ ..+|+.||+|.++. ...+...+|++++++++|+||++.+++-... ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 446889999999999999 77899999997665 3446678999999999999999999875433 345799
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC--C--ceEEeecccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--F--IAKVADAGLR 156 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~--~--~vkl~Dfg~a 156 (312)
||||.||+|...+..+ .+...+++..++.++.+++.||.|||+ +||+||||||.||++-.. | ..||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999655 456778999999999999999999999 779999999999998432 3 5699999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh--hHHHHhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSRDFS 233 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~ 233 (312)
+...++. ......||+.|++||++.. +.|+...|.|||||++|+++||..||......... ..+......+.-.
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9887655 3455789999999999994 78899999999999999999999999765443211 1111111111100
Q ss_pred --hhhHHhhh--------hccccCChHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHh
Q 021441 234 --NLLKILDE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTELDRTLDKE 287 (312)
Q Consensus 234 --~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--t~~~ll~~l~~~~~~~ 287 (312)
...+.... +............+..++..+|..+|++|- ...+....+..+++..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 00000000 111223344456788899999999999998 7778888888877664
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.89 Aligned_cols=261 Identities=17% Similarity=0.256 Sum_probs=190.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeC---------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--------- 74 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 74 (312)
..+|++.+.||.|+||.||+|. ..+++.|++|.+... ....+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4789999999999999999998 556889999976443 234577899999999999999999776543
Q ss_pred -----CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCce
Q 021441 75 -----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIA 148 (312)
Q Consensus 75 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~v 148 (312)
...|+||||+.+ +|.+++. ...+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLE------QGPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceE
Confidence 357899999975 7776662 2357889999999999999999999 67999999999999974 5578
Q ss_pred EEeeccccccccCCCc-CCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 149 KVADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
+++|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~ 232 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLIL 232 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH
Confidence 9999999876532211 111223356778999998754 45788999999999999999999999765432111 1111
Q ss_pred hhhhh-----hhh----hhHHhh-hhcc-----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 227 QNSRD-----FSN----LLKILD-ERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 227 ~~~~~-----~~~----~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+. ... ...... .... .......+.++.+++.+||..||.+|||+.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 10000 000 000000 0000 01112345788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.67 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=211.2
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcC-CCccceeeeeeeee-----C
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE-----N 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~ 74 (312)
.....+.+++.+.||.|.+|.||+++ .++++..|+|+.... ..+++..|.++++.. .|||++.+|+++.. +
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34456788999999999999999999 667888888876544 446677888899887 69999999999853 5
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+.+|+|||||.+|+..+++.+.. ...+.+..+.-|++.++.||.|||. +.++|||||-.|||++.++.|||+|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEEeeee
Confidence 68999999999999999996543 6778899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc-----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
.+.....+. .......||+.|+|||++... .|+..+|+||||++..||.-|.+|+.++.+.-. +..+.++
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--LF~IpRN- 243 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPRN- 243 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--hccCCCC-
Confidence 998875543 334567899999999997754 477899999999999999999999988765321 1111122
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
++....-+..+++++.++|..||.+|.++||+..++++|
T Consensus 244 -----------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 -----------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 122233467788999999999999999999999999865
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.29 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=193.0
Q ss_pred CCCcccccccCcceEEEeeee----CCceEEEEEeCCCC-------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+|++.+.||+|+||.||.|.. .+++.||+|.+... ....+.+|+.+++.+ +|++|+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 588999999999999999984 36788999976532 224567899999999 589999999999998899
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|+||+++++|.+++. ....++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999998873 33457788889999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
........ ......++..|+|||...+. .++.++||||||+++|+|++|..||............ ...
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~------- 223 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRR------- 223 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHH-------
Confidence 65432211 12234567789999998753 4678999999999999999999999643221111100 000
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.... ....+...+..+.+++.+||..||.+|| ++.+++.+
T Consensus 224 ---~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 224 ---ILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---hhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 1123344567899999999999999997 66777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.01 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=192.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-----
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN----- 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (312)
..++|++.+.||+|+||.||++. ..+++.||+|..... ....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 36789999999999999999998 557889999976432 1235778999999999999999999886543
Q ss_pred -eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..++|||++ +++|..++. ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 668877762 2457889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh--h
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--D 231 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~ 231 (312)
.+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||................... .
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98765322 122355677999999876 357889999999999999999999998644321111110000000 0
Q ss_pred hh---------hhhHHhh---hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 FS---------NLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 ~~---------~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+. .....+. ...........+.++.++|.+||..||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000 000011122345678999999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.78 Aligned_cols=254 Identities=19% Similarity=0.304 Sum_probs=192.4
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeeeeCCe
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNL 76 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (312)
.+.+..++|++.+.||+|++|.||+|... +++.||+|.+.... ...+..|+.++... .||||+++++++.....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34567789999999999999999999955 48899999875432 23455667666666 59999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|++|||+.+ ++..++.. ....+++..+..++.|++.|+.|||+. .|++|+||+|+||+++.++.++|+|||.+
T Consensus 89 ~~~v~e~~~~-~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 89 VFICMELMST-CLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred EEEEeeccCc-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccc
Confidence 9999999855 56555521 223678888999999999999999962 37999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcC----CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... .......
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~------ 231 (296)
T cd06618 163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI------ 231 (296)
T ss_pred hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH------
Confidence 76543221 12224566799999987654 788999999999999999999999653211 1111100
Q ss_pred hhhhHHhhhh-ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDER-LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ........+++++.+++.+||..||.+||++.+++.+
T Consensus 232 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 232 ------LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------hcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0001111345789999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=261.99 Aligned_cols=252 Identities=17% Similarity=0.208 Sum_probs=195.1
Q ss_pred hcCCCc-ccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeee----CCeEEEE
Q 021441 8 TKNFSD-KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNLQFLI 80 (312)
Q Consensus 8 ~~~y~~-~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv 80 (312)
.++|++ .+.||-|-.|.|..+. ..+++++|+|.+... ....+|+++--.. .||||+.+++++.+ ...+.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 456655 4789999999999998 668999999987543 3345666644444 69999999999854 4578899
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~ 157 (312)
||.++||.|..++. ......+.+..+..|++||+.|+.|||+++ |.||||||+|+|.+. +..+||+|||.|+
T Consensus 138 mE~meGGeLfsriq---~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 138 MECMEGGELFSRIQ---DRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eecccchHHHHHHH---HcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccccc
Confidence 99999999999883 334466899999999999999999999965 999999999999964 5589999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh-HHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (312)
....... .....-|+.|.|||++....|+...|+||+|++||-|+.|.+||.+........ +...+...
T Consensus 213 ~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g------- 282 (400)
T KOG0604|consen 213 ETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG------- 282 (400)
T ss_pred ccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc-------
Confidence 7653222 222356788999999999999999999999999999999999998766533221 11111110
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........=..++++.+++|+.+|+.+|++|.|+.++++|
T Consensus 283 ---qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 ---QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0011111224456889999999999999999999998875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.31 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=192.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe----
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL---- 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 76 (312)
..++|++.+.||+|++|.||++.. .+++.||+|.+... ....+.+|+.+++.++||||+++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357899999999999999999994 46889999986532 22446679999999999999999988765543
Q ss_pred --EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 77 --QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 77 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
.|+|+||+ +++|.+++. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 558887772 2457889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
.+...... .....++..|+|||...+. .++.++|||||||++|+|++|..||..................+...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98765432 2233567779999998754 56889999999999999999999997644321111110000000000
Q ss_pred hhh-----------HHhhhhcc---ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLL-----------KILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~-----------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ........ .......++++.++|.+||..||++|||+.+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 00000000 00111235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=262.57 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=198.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeC-----CCCChhHHHHHHHHHhcCCCccceeeeeeeee--------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE-------- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 73 (312)
...|+-..+||+|.||.||+|+ .+++++||+|+. ++.-.....+|+.+|..+.|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3567778899999999999999 567888999853 22233567899999999999999999888732
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
...+|+||.+|+. +|.-++. .....++...+..++.+++.||.|+|. +.|+|||+||.|++++.+|.++|+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEeecc
Confidence 3458999999987 6655552 334678899999999999999999999 56999999999999999999999999
Q ss_pred cccccccCCCcCC--CCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 154 GLRNFLGRTDVAG--PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 154 g~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|+++.+....... .....+.|..|++||.+.|. .|+++.|||+-||+|.+|+|+.+.+.+.++.....++..+-...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997764433221 12233578899999998886 58999999999999999999999998877655544443322211
Q ss_pred ---hhhhh-----hHHhhhh-ccccCChHH---------HHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 231 ---DFSNL-----LKILDER-LWSTFTNEG---------MEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 231 ---~~~~~-----~~~~~~~-~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
-|.+. .+.++.. +....-..+ .++..+|+.++|..||.+|+++++++.|-
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111 1111100 100000000 14788999999999999999999988763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=270.49 Aligned_cols=273 Identities=26% Similarity=0.385 Sum_probs=214.8
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC--CCccceeeeeeeeeCC----eEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQENN----LQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~ 81 (312)
.+..++.+.+|+|.||.||+|... ++.||||+++......+..|-++++.. +|+||++|++.-.... .+|+|+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 456678899999999999999976 588999999999999999999988875 7999999998876554 789999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-------~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+|.+.|+|.+++ ....++|....+++..++.||+|||+- ..+|+|||||..||||.+|++..|+|||
T Consensus 288 ~fh~kGsL~dyL------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYL------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHH------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999 455689999999999999999999963 3459999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcC-CC-----cccceehhHHHHHHHHhCCCCCCC-CCCCChhhHHHHhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-----EKSDVYSFGVFLLELVSGREASSS-LSPDSSQDLVELVQ 227 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~sDiwslG~vl~~l~tg~~pf~~-~~~~~~~~~~~~~~ 227 (312)
+|..+..+...+....-+||.+|||||++.|.. .. .+.||||+|.|||||++.-.-+.. ..+.-...+...+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999887655444444468999999999998642 22 258999999999999996654432 12221222233344
Q ss_pred hhhhhhhhhHH-hhhhccccCChHH-----HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 228 NSRDFSNLLKI-LDERLWSTFTNEG-----MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
+.+.+..+... +..+.++.++..+ ..-+++.+..||+.||+-|.|+.-+-+.+.++..-.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 44444444332 2333334444333 367999999999999999999999999988887543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=271.63 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=194.4
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
|++.+.||+|.+|.||++. ..+++.+++|...... ...+..|+.+++.++|+|++++++++......++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 6778899999999999999 4468899999765432 245678999999999999999999999889999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+ +|.+++... ...+++..+..++.+++.||.+||+ +|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 75 888888321 1468899999999999999999999 7799999999999999999999999999876543221
Q ss_pred CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhhhhhHH--
Q 021441 165 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFSNLLKI-- 238 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 238 (312)
.......+..|+|||.+.+. .++.++|+|||||++|+|++|..||...+............... .+......
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 11222345679999998776 78999999999999999999999997644321111110000000 00000000
Q ss_pred -------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 -------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.............+..+.+++.+||..||++||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000001112235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=279.14 Aligned_cols=261 Identities=20% Similarity=0.333 Sum_probs=191.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------C
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 75 (312)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4689999999999999999998 456889999976532 224577899999999999999999988654 2
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+|+||+.. ++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999864 554433 2357788899999999999999999 6799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-hhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFS 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~ 233 (312)
+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ ........ .+..
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGP 236 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 8754321 122355677999999876 4578999999999999999999999976432111 11111000 0000
Q ss_pred hhhHHh---------h--hhc-c---ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHHH
Q 021441 234 NLLKIL---------D--ERL-W---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD 285 (312)
Q Consensus 234 ~~~~~~---------~--~~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~~ 285 (312)
...... . +.. . .......+.++.++|.+||+.||++||++.+++.| ++...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000 0 000 0 00011234678999999999999999999999976 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=267.36 Aligned_cols=248 Identities=18% Similarity=0.263 Sum_probs=191.3
Q ss_pred CCCcccccccCcceEEEeeeeC-CceEEEEEeCCC--------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+|.+.+.||+|+||.||++... .+..+++|.... ........|..+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999843 333344443221 1223456788999999999999999999988889999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
+||+++++|.+++.... .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999988774321 233568899999999999999999999 77999999999999975 569999999887653
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||..... ....... .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~-------------~ 218 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRI-------------V 218 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH-------------H
Confidence 3221 12234567779999999888889999999999999999999999964321 1111100 0
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+...+.++.++|.+||+.||++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111122345566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.60 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=191.6
Q ss_pred CCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh----hHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEec
Q 021441 11 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
|++.+.||+|++|.||+|.. .+++.+++|.+..... ....+|+..++.+. |+||+++++++...+..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67889999999999999995 4578899997654322 23456888999998 999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
+++|.+.+... ....+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 66887776321 12467899999999999999999999 7799999999999999999999999999876543221
Q ss_pred CCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh-hhhhh--hhhhhHH--
Q 021441 165 AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-QNSRD--FSNLLKI-- 238 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~--~~~~~~~-- 238 (312)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..||............... ..... +......
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 123456778999998754 45789999999999999999999999765432221111100 00000 0000000
Q ss_pred -hhhhc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 -LDERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 -~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... ........+.++.+++.+||..||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000 000111124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=263.72 Aligned_cols=236 Identities=24% Similarity=0.310 Sum_probs=190.3
Q ss_pred cccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 17 IGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 17 lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
||.|++|.||.+.. .+++.+++|.+.... ...+..|+.+++.++|+||+++++.+......|+|||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999994 458899999765432 23677899999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 169 (312)
.+++. ....+++..+..++.|++.||.++|+ .+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 98883 33357889999999999999999999 779999999999999999999999999987654332 1123
Q ss_pred cccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
...++..|++||...+...+.++|+||||+++|+|++|..||...+. ........ . .....+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~------------~--~~~~~~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL------------K--DPLRFPE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh------------c--CCCCCCC
Confidence 34567779999999888889999999999999999999999976443 11111111 0 1122344
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPSM---SDVVT 278 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~---~~ll~ 278 (312)
..+..+.+++.+||..||++||++ +++++
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 446789999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.84 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.++|.+...+|.|+|+.|-.+. ..+++..++|++... ..+..+|+.++... +||||+++.+.+.+....|+|||.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 5788999999999999998887 667888999988766 34445667666555 79999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe-CCCCceEEeeccccccccCCCc
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~-~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
|+-+.+.+. ...... ..+..|+.+|+.|+.|||. +|++|||+||+|||+ +..++++|+|||.++.....
T Consensus 400 g~ell~ri~-----~~~~~~-~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 400 GGELLRRIR-----SKPEFC-SEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccHHHHHHH-----hcchhH-HHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 988877773 222222 5667799999999999999 789999999999999 58999999999998766433
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.....-|..|.|||+.....|++++|+||||+++|+|++|..||...... ......+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~---------------- 528 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQM---------------- 528 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcC----------------
Confidence 11123455699999999999999999999999999999999999875543 111111111
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+...+++..++|+.+||+.||.+|+++.+++.|
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22336667899999999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=258.86 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=197.3
Q ss_pred ccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccCCc
Q 021441 14 KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS 88 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (312)
.+.||+|+|+.|--+. ..++..||+|++.+. .+..+.+|++++..+ .|+||++++++|.+....|+|||-+.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999888 778999999987654 346788999999999 59999999999999999999999999999
Q ss_pred ccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEeeccccccccCCCcC
Q 021441 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~Dfg~a~~~~~~~~~ 165 (312)
|..++ ..+..+++..+.++..+|+.||.+||. +||.|||+||+|||..... -||||||.+..........
T Consensus 163 lLshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHI-----QKRKHFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99998 566778999999999999999999999 8899999999999997654 5799999987765433222
Q ss_pred CCC-----ccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh-hhh
Q 021441 166 GPS-----SQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FSN 234 (312)
Q Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 234 (312)
.+. ....|+..|||||++.- ..|+.+.|.||||+|+|-|+.|.+||.+.+..+ .-+...+.... -..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--CGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--CGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--CCccCCCccHHHHHH
Confidence 111 12247778999998542 358999999999999999999999999866532 11111110000 001
Q ss_pred hhHHhhhhccccCCh----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 235 LLKILDERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
+.+.+-+.. -++|. .++.+.+++++.+|..|+.+|.++..++.
T Consensus 314 LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 LFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111 22332 34578899999999999999999999887
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.63 Aligned_cols=267 Identities=30% Similarity=0.447 Sum_probs=214.7
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC----C----ceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ----D----GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|++..++..+.+.||+|.||.|+++... . ...||+|...... .+.+..|+++++.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 36667777788889999999999999722 1 4579999766443 35688899999999 5999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCcc---------cccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPS---------QVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~--~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++...+.+++|+||+..|+|.+++.... .... ..+.....+.++.||+.|++||++ .+++|||+-.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaR 447 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAAR 447 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhh
Confidence 9999999999999999999999986443 1111 238889999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCC-CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP 216 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~ 216 (312)
||+++.+..+||+|||+++......... ..+...-+..|+|||.+....|+.+|||||||++||||+| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999998655443322 1111113456999999999999999999999999999998 8889976321
Q ss_pred CChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
. ..+.+.+....+...|..+++++.++|+.||+.+|++||++.++.+.++..+..
T Consensus 528 ~---------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T---------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 111223344444566777789999999999999999999999999999997654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=294.23 Aligned_cols=143 Identities=27% Similarity=0.315 Sum_probs=126.9
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+..|+.++..++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999994 468899999875432 24577899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|||+.+++|.+++. ....+++..+..++.||+.||.|||. +||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~-----~~~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998883 23457788899999999999999999 779999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.01 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=177.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeC---------
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--------- 74 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 74 (312)
.+|+.++.||+|+||.||+|+ .-+|+.||||+++-.. ...+.+|+..|.+++||||++++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 467889999999999999999 4479999999876543 24578899999999999999987643110
Q ss_pred --------------------------------------------------------------------------------
Q 021441 75 -------------------------------------------------------------------------------- 74 (312)
Q Consensus 75 -------------------------------------------------------------------------------- 74 (312)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh
Q 021441 75 ------------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124 (312)
Q Consensus 75 ------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH 124 (312)
..+||=||||+..++.+++.. +...-.....++++++|++||+|+|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHH
Confidence 012444555544444444411 1010135667899999999999999
Q ss_pred cCCCCeEecCCCCCceEeCCCCceEEeecccccccc----------------CCCcCCCCccccCcccccchhhhhhcC-
Q 021441 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG----------------RTDVAGPSSQVTADEIFLASEVKEFRR- 187 (312)
Q Consensus 125 ~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~- 187 (312)
+ .|+|||||||.|||++.++.|||+|||+|+... ............||..|.|||++.+..
T Consensus 715 ~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 D--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred h--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 779999999999999999999999999998721 011222344567999999999988765
Q ss_pred --CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc--ccCChHHHHHHHHHHHHhc
Q 021441 188 --FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCL 263 (312)
Q Consensus 188 --~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l 263 (312)
|+.|+||||||+|+|||+. ||.+.- +....+.+.. +.... ..+..+-.+.-..+|..|+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa~iL~~LR---------~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSM-----ERASILTNLR---------KGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchH-----HHHHHHHhcc---------cCCCCCCcccccccchHHHHHHHHHh
Confidence 9999999999999999986 465421 1111111111 11111 1223333356688999999
Q ss_pred CCCCCCCCCHHHHHH
Q 021441 264 DPSSERRPSMSDVVT 278 (312)
Q Consensus 264 ~~dp~~Rpt~~~ll~ 278 (312)
+.||.+||||.|||.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=260.94 Aligned_cols=219 Identities=17% Similarity=0.185 Sum_probs=174.4
Q ss_pred CcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcccccccCccc
Q 021441 20 GKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ 98 (312)
Q Consensus 20 G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 98 (312)
|.+|.||+|. ..+++.||+|.+.... ....|...+....||||+++++++......|+||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS---- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH----
Confidence 8899999999 5578899999876543 23345555555679999999999999999999999999999988873
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCccccc
Q 021441 99 VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178 (312)
Q Consensus 99 ~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~ 178 (312)
....+++..+..++.|++.||.|+|+ +|++|+||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 78 -~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 78 -KFLNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred -HhcCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 23457889999999999999999999 779999999999999999999999999876554321 1223455699
Q ss_pred chhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHH
Q 021441 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL 258 (312)
Q Consensus 179 aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (312)
|||...+..++.++|+||+||++|+|++|..||....... ........+...++.+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHHHH
Confidence 9999988889999999999999999999998875321100 0000012334455789999
Q ss_pred HHHhcCCCCCCCCCH
Q 021441 259 IVRCLDPSSERRPSM 273 (312)
Q Consensus 259 i~~~l~~dp~~Rpt~ 273 (312)
+.+||+.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=269.01 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=204.5
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--hHHHHHHHHHhcCC------CccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQ------HRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 76 (312)
+...+|.+....|+|-||+|..|. ...++.||||++.+... ..-.+|+++|++|+ --|+++++..|...++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 345789999999999999999999 44577999999876654 45688999999995 2479999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGL 155 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~ 155 (312)
+|+|+|.+.- +|.+.+.... ....+.+..+..++.|+..||.+|-. .||+|.||||+||||+++. .+||||||.
T Consensus 509 LClVFE~Lsl-NLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 509 LCLVFEPLSL-NLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eEEEehhhhc-hHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCcc
Confidence 9999998844 8888885443 23456778899999999999999999 8899999999999998765 569999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
|....... ...+..+..|.|||++.|..|+...|+||.||+|||++||+..|++.++.+-..+...+...-+...+
T Consensus 584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 88765443 33455677899999999999999999999999999999999999987755433322222221111111
Q ss_pred hH------Hhhh--------------------------------hc-----cccCChHHHHHHHHHHHHhcCCCCCCCCC
Q 021441 236 LK------ILDE--------------------------------RL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPS 272 (312)
Q Consensus 236 ~~------~~~~--------------------------------~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 272 (312)
.+ ..+. .+ .+.-......+|.+|+.+||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00 0000 00 11111223367999999999999999999
Q ss_pred HHHHHHH
Q 021441 273 MSDVVTE 279 (312)
Q Consensus 273 ~~~ll~~ 279 (312)
..++|.|
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=258.97 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=192.9
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcCC-----C---ccceeeeeeee---
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-----H---RNLVTLLGYCQ--- 72 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~--- 72 (312)
...+|.+.++||+|.|++||+|. ..+.+.||+|+.+.. ..+...+|+++|+.+. | .+|+++++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 45789999999999999999998 566889999986644 3466789999999873 2 46999999985
Q ss_pred -eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC------
Q 021441 73 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED------ 145 (312)
Q Consensus 73 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~------ 145 (312)
++.++|+|+|++ |.+|..+|. ....+.++...+..|+.||+.||.|||.- .||||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~---~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIK---YSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHH---HhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccchhh
Confidence 456899999999 567777773 34557789999999999999999999973 789999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 021441 146 -------------------------------------------------------------------------------- 145 (312)
Q Consensus 146 -------------------------------------------------------------------------------- 145 (312)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 021441 146 -------------------------------------------------------------------------------- 145 (312)
Q Consensus 146 -------------------------------------------------------------------------------- 145 (312)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCCh------
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS------ 219 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~------ 219 (312)
-.+||+|||.|...... ......|..|+|||++.|..|+..+||||++|++|||+||...|........
T Consensus 391 i~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred eeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 01444445444443211 1223466789999999999999999999999999999999999976443321
Q ss_pred -hhHHHHhhhhhhhhh--------------------------hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC
Q 021441 220 -QDLVELVQNSRDFSN--------------------------LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272 (312)
Q Consensus 220 -~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 272 (312)
...+..+...+...- +..++.. +-.++.+...++.+|+.-||.++|++|||
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e--KY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE--KYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHH--HhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 111111111111100 1111111 12456677789999999999999999999
Q ss_pred HHHHHHH
Q 021441 273 MSDVVTE 279 (312)
Q Consensus 273 ~~~ll~~ 279 (312)
|.++|+|
T Consensus 544 A~~cl~h 550 (590)
T KOG1290|consen 544 AAQCLKH 550 (590)
T ss_pred HHHHhcC
Confidence 9999965
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.93 Aligned_cols=241 Identities=21% Similarity=0.274 Sum_probs=196.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChh------HHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ------EFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~------~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+...+|.++..||+|+||.|.++. ..+.+.||||++..+..- --.-|-.+|... +-|.+++++.+++.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 445789999999999999999998 557889999987655432 123355555554 468999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.||+|.-.+ ..-..+.+..+..++..|+-||.+||+ +||+.||||.+|+++|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999998887 344567788889999999999999999 889999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
.---. ..+.....||+.|+|||++...+|+.++|.||+|+++|||+.|+.||.+.++++....+.
T Consensus 499 Eni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~------------- 563 (683)
T KOG0696|consen 499 ENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM------------- 563 (683)
T ss_pred ccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------------
Confidence 53221 223445679999999999999999999999999999999999999998765533222111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 272 (312)
+.. -.+|...+.+..++....|.+.|.+|..
T Consensus 564 --ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 --EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 2367777889999999999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.48 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=199.7
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEe--CCCCChh--------HHHHHHHHHhcCCCccceeeeeeeee-C
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQ--------EFIDEVCFLASIQHRNLVTLLGYCQE-N 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~--~~~~~~~--------~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 74 (312)
..++|-++.+||.|+|+.||+|. ...++.||+|+ ++..+.+ ...+|..+-+.|+||.|+++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 35788899999999999999999 55678899996 3333332 24678889999999999999999864 4
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEe
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVA 151 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~ 151 (312)
...|-|+|||+|.+|+-++ .....+++..+..|+.||+.||.||.....+|+|-||||.|||+- ..|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYL-----KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYL-----KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHH-----HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 5678999999999999887 345678899999999999999999998877899999999999994 56899999
Q ss_pred eccccccccCCCcC-----CCCccccCcccccchhhhhhc----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH
Q 021441 152 DAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 222 (312)
Q Consensus 152 Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~ 222 (312)
|||+++........ ...+...||..|++||.+--. ..+.+.||||+|+++|++++|..||...-.......
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999998765433 224566799999999986543 358899999999999999999999986433221111
Q ss_pred HHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
...+.+. ..+....-+.++.+..++|++||...-++|....+|..
T Consensus 696 eNTIlkA-----------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKA-----------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcc-----------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111 01111122344578999999999999999999888764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=275.82 Aligned_cols=267 Identities=18% Similarity=0.182 Sum_probs=171.3
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CC----ceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeee------eee
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QD----GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGY------CQE 73 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~----~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~ 73 (312)
.+..++|.+.+.||+|+||.||+|.. .+ +..||+|........+...... +....+.++..++.. ...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhhchhhHHHHHHhhhccccccc
Confidence 34668999999999999999999994 45 6899999876543332222212 222222333322221 234
Q ss_pred CCeEEEEEEeccCCcccccccCcccc---------------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQV---------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
....|+|+||+.+++|.+++...... .........+..++.|++.||.|||+ +||+||||||+
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDLKP~ 284 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDVKPQ 284 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcCCHH
Confidence 56789999999999998877432100 00111234566799999999999999 77999999999
Q ss_pred ceEeCC-CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcC----------------------CCccccee
Q 021441 139 NVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----------------------FSEKSDVY 195 (312)
Q Consensus 139 Nil~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~sDiw 195 (312)
|||++. ++.+||+|||+++...... ........+++.|+|||.+.... ++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 5799999999997654322 12233456788899999764332 33456999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-hhhhhhhHHhhhhcccc------CChHHHHHHHHHHHHhcCCCCC
Q 021441 196 SFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFSNLLKILDERLWST------FTNEGMEEFIQLIVRCLDPSSE 268 (312)
Q Consensus 196 slG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~ 268 (312)
||||++|||+++..|+.. ....+...+... ................+ .........++||.+||..||+
T Consensus 364 SlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999997766432 111111111111 11111111111110000 0011123466999999999999
Q ss_pred CCCCHHHHHHH
Q 021441 269 RRPSMSDVVTE 279 (312)
Q Consensus 269 ~Rpt~~~ll~~ 279 (312)
+|||+.++|+|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=254.68 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=193.2
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeeeeeeCCeEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (312)
.+..++.+.++.||.|+||+|++-. ..+|+..|+|.+..... .++..|.+...+- +.|+|+++||.....+.-|
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 4556677778999999999999998 56799999997654332 4566676655544 6899999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+-||+|+- +++.+-..-.......+++..+-.|....+.||.||... ..|+|||+||+|||++..|.+||||||.+-.
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHh
Confidence 99999965 665443221223445678888888888999999999963 4699999999999999999999999999766
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+.... ......|-..|+|||.+... .|+.+||+||||++|||+.||..||..... ..++..+.....++..
T Consensus 218 Lv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdpp~l--- 290 (361)
T KOG1006|consen 218 LVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDPPIL--- 290 (361)
T ss_pred HHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCCCee---
Confidence 54322 22334566679999997644 589999999999999999999999976443 1111222221111100
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+..+|.-||.+|-..||...+|+++
T Consensus 291 ------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 ------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0111223356789999999999999999999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=268.29 Aligned_cols=279 Identities=22% Similarity=0.256 Sum_probs=205.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
...-|..++.||-|+||.|.+++ ..+...||+|.+... ....+..|-.||..-+.+-|+++|-.|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34557778999999999999998 666788999965433 22346678889999899999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||+|++||++..++. .-..+.+..+..++..+.+|+.+.|.. |+|||||||+|||||.+|++||+|||+++.+
T Consensus 707 VMdYIPGGDmMSLLI-----rmgIFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI-----RMGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEeccCCccHHHHHH-----HhccCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeeccccccc
Confidence 999999999988883 345688888999999999999999994 5999999999999999999999999998765
Q ss_pred cCCCcC----------------------------------------CCCccccCcccccchhhhhhcCCCcccceehhHH
Q 021441 160 GRTDVA----------------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGV 199 (312)
Q Consensus 160 ~~~~~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 199 (312)
..+... ...-..+||+-|+|||++....|+..+|.||.|+
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 321100 0011456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 200 FLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 200 vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
|||||+.|..||...++.+.+..+..+++. +. .....+++.+..++|.++. .+++.|..-...=+.
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~------l~-------~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~v 925 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWRNF------LH-------IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQV 925 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehhhc------cc-------cccccccCHHHHHHHHHHh-cChhhhhcccchhhh
Confidence 999999999999988877665544333322 11 1234555567777776532 345555432222122
Q ss_pred HHHHHHHhcccccccccCCCcccccce
Q 021441 280 LDRTLDKEMNLTTVMGEGTPTVTLGSH 306 (312)
Q Consensus 280 l~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (312)
-..-+.+.+.++++.....|=+..-++
T Consensus 926 KaHpfFkgIDfsslRkq~ApYIP~ItH 952 (1034)
T KOG0608|consen 926 KAHPFFKGIDFSSLRKQRAPYIPRITH 952 (1034)
T ss_pred hcCccccccchHhhhhccCCcCccccC
Confidence 222334445555544444444443333
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.96 Aligned_cols=264 Identities=15% Similarity=0.200 Sum_probs=215.4
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCce-EEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGM-LVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+...+++++..||-|+||+|-+++.+... .+|+|+++.. ..+.+..|-.+|..++.|.|+++|..|.++..+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 45678888999999999999999955433 4888865543 2345777899999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++||-|-||.+...+ ..+..++..+...++.-+++|+.|||. +|||.|||||+|++++.+|-+||.|||.|+.
T Consensus 497 mLmEaClGGElWTiL-----rdRg~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 497 MLMEACLGGELWTIL-----RDRGSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhHHhhcCchhhhhh-----hhcCCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHH
Confidence 999999999999888 466778889999999999999999999 7799999999999999999999999999998
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.+.+. ....+.||+.|.|||++..+.-+.++|.||||+++|||++|.+||.+.++......+
T Consensus 570 i~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I--------------- 631 (732)
T KOG0614|consen 570 IGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI--------------- 631 (732)
T ss_pred hccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---------------
Confidence 86554 344568999999999999999999999999999999999999999987654333222
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHHHHHHhccccccc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS--MSDVVTELDRTLDKEMNLTTVM 294 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt--~~~ll~~l~~~~~~~~~~~~~~ 294 (312)
++.--...+|..++....++|+++-+.+|.+|.. ...+-+.-...-..+++|.-+.
T Consensus 632 LkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 632 LKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred HhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 2222223456666778899999999999999986 4444444444445566666543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=238.10 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=198.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCC-CccceeeeeeeeeC--CeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 82 (312)
..++|++.+++|.|.|+.||.+. ..++++++||++++.....+.+|+++|..+. ||||++++++..+. ...-+++|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46899999999999999999998 6678899999999999999999999999996 99999999998654 44578999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg~a~~~~~ 161 (312)
|..+.+...+. +.++...+..++.+++.||.|+|+ .||.|||+||.|+++|.. ..++|+|+|+|.+...
T Consensus 116 ~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99887665443 445667788899999999999999 669999999999999964 4789999999988754
Q ss_pred CCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh--hhhhhhhh----
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV--QNSRDFSN---- 234 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~---- 234 (312)
+.. ..--..+..|..||++-. ..|+.+-|+|||||++..|+..+.||-..... .+++..+. .....+..
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHH
Confidence 432 223356777999998654 45788999999999999999999998653322 22223222 11111111
Q ss_pred --------hhHHhh---hhcc-----ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 --------LLKILD---ERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 --------~~~~~~---~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...++. ...| ++.....+++..+++.++|+.|.++|+|+.|++.|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111111 1111 12223335789999999999999999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=263.22 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred ccccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 14 KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
-+.||+|.||+||-++ .++|+.||+|.+++ ...+.+..|+.+|..+.||.|+.+...++....+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 3789999999999999 66899999997543 3446788999999999999999999999999999999999966
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccccccCCCc
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++.+.+... ....+++..-..++.||+.||.|||. ++|+|+||||+|+|+.. -.++||||||.|+.++....
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 555555332 34567888888999999999999999 77999999999999964 34899999999999876554
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
. ...+||+.|+|||++..+.|+..-||||.|+++|--++|..||...++... .+ +++. -+..+..|
T Consensus 723 R---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QI---QNAa------FMyPp~PW 788 (888)
T KOG4236|consen 723 R---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QI---QNAA------FMYPPNPW 788 (888)
T ss_pred h---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hh---hccc------cccCCCch
Confidence 3 336799999999999999999999999999999999999999987544322 11 1111 11122223
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+. +.+..|||..+|+..-++|.+....+.|
T Consensus 789 ~ei----s~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 SEI----SPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hhc----CHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 333 3567899999999999999998876654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=253.93 Aligned_cols=260 Identities=24% Similarity=0.441 Sum_probs=202.8
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhc--CCCccceeeeeeeeeC----CeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQEN----NLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~ 81 (312)
.++.++.+.||+|.||.||+++|+ |+.||+|++.......+.+|.++++. ++|+||..|++.--.+ .++|+|.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 467788999999999999999998 78899999998888889999999886 4999999999875332 3689999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC-----C-CCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-----S-PRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-----~-~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
+|.+.|+|.+++ +...++....++++..+++||+|||.- + ..|.|||||..||||..+|...|+|+|+
T Consensus 289 dYHe~GSL~DyL------~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 289 DYHEHGSLYDYL------NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred ecccCCcHHHHH------hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999 346788899999999999999999953 2 2399999999999999999999999999
Q ss_pred cccccCC--CcCCCCccccCcccccchhhhhhcC----C-C-cccceehhHHHHHHHHhC----------CCCCCCCCCC
Q 021441 156 RNFLGRT--DVAGPSSQVTADEIFLASEVKEFRR----F-S-EKSDVYSFGVFLLELVSG----------REASSSLSPD 217 (312)
Q Consensus 156 a~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~----~-~-~~sDiwslG~vl~~l~tg----------~~pf~~~~~~ 217 (312)
|-..... .........+||.+|||||++...- + + ..+||||||.|+||++-. ..||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9776543 2333345567999999999987532 1 1 258999999999998752 3677654433
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhh-hhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILD-ERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
+. .+..+.+.+. .++++.. ....-..+.++|+.||..+|.-|.|+--+-..|.++.+
T Consensus 443 DP-----------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DP-----------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CC-----------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 32 2233333222 1111222 22233678999999999999999999888888877764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=271.47 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=215.4
Q ss_pred CCcccccccCcceEEEeeee-CCc----eEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGLL-QDG----MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~-~~~----~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.+..++||+|+||+||++.| ..+ -+||+|.+... ...++.+|+..|..++|||++++++++..+. +-+|.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568899999999999984 323 36888865433 3467889999999999999999999998765 67899
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
+|++.|+|.+++. ..+..+.....+.|+.||++|+.|||. +++|||||-.+|+||..-..+|+.|||+++....
T Consensus 777 q~mP~G~LlDyvr----~hr~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVR----EHRDNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHH----HhhccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999994 355677888899999999999999998 7799999999999999999999999999999887
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.............+.|+|-|.+....|+.++||||||+++||++| |..||......++..+. +
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------E 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------h
Confidence 777776666777788999999999999999999999999999998 88999877654443333 2
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
...+-..|+.++-++.-++.+||..|+..||+++++.+.+.+++...
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 22234567777789999999999999999999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=242.43 Aligned_cols=234 Identities=26% Similarity=0.339 Sum_probs=187.3
Q ss_pred cceEEEeeeeC-CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcccccccC
Q 021441 21 KFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 95 (312)
Q Consensus 21 ~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 95 (312)
+||.||++... +++.+++|...... ...+.+|+..++.++|+|++++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999954 58899999876543 46788999999999999999999999988899999999999999988732
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcc
Q 021441 96 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175 (312)
Q Consensus 96 ~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~ 175 (312)
...++...+..++.+++.++.+||+ .+++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 81 -----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 -----RGRLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred -----ccCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2227888999999999999999999 679999999999999999999999999988765432 122344666
Q ss_pred cccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh--HHHH
Q 021441 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN--EGME 253 (312)
Q Consensus 176 ~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 253 (312)
.|++||...+..++.++|+||||+++++|++|..||...... ........ ......... ..+.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~-------------~~~~~~~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG-------------KPKPPFPPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh-------------ccCCCCccccccCCH
Confidence 799999999888899999999999999999999999763211 11111111 110011111 1457
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 254 EFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
++.+++.+||..+|.+||++.+++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhhC
Confidence 89999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=247.22 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=214.5
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCC------ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYC 71 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (312)
.++.+..++++....+.+|.||+||.+.|.. .+.+.+|..+... ...+..|..++..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3556677889999999999999999996542 3445566443322 23467788888888999999999987
Q ss_pred ee-CCeEEEEEEeccCCccccccc---CcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc
Q 021441 72 QE-NNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI 147 (312)
Q Consensus 72 ~~-~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~ 147 (312)
.. ....++++++...++|..|+. +......+.+.......++.|++.|+.|||. .|+||.||-.+|.++|+.-+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhhee
Confidence 54 456788899998899998885 1122334556667777899999999999999 66999999999999999999
Q ss_pred eEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHh
Q 021441 148 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 148 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~ 226 (312)
|||+|=.+++.....++......-..+..|++||.+..+.|+.++|+||||++||||+| |+.||...++.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------- 505 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------- 505 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---------
Confidence 99999999988776665544444445667999999999999999999999999999998 99999876653
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
++...+....+-..|-++|+++..+|..||..+|++||+++++..-|.+..-+
T Consensus 506 -------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 506 -------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 23444455666678899999999999999999999999999999988876543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=262.40 Aligned_cols=268 Identities=18% Similarity=0.237 Sum_probs=180.3
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-----------------CCceEEEEEeCCCCCh---h--------------HHH
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-----------------QDGMLVAIKKRPGAPT---Q--------------EFI 50 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~---~--------------~~~ 50 (312)
++..++|.+.++||+|+||.||++.. ..++.||+|.+..... . ...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34578999999999999999999852 2346799998653321 1 223
Q ss_pred HHHHHHhcCCCcc-----ceeeeeeeee--------CCeEEEEEEeccCCcccccccCccc-------------------
Q 021441 51 DEVCFLASIQHRN-----LVTLLGYCQE--------NNLQFLIYEYIPNGSVSIHLYGPSQ------------------- 98 (312)
Q Consensus 51 ~e~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~------------------- 98 (312)
.|+.++.+++|.+ ++++++++.. .+..|+||||+.+++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 3666666675544 4666776643 3467999999999999888753210
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCccccc
Q 021441 99 VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178 (312)
Q Consensus 99 ~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~ 178 (312)
......++..+..++.|++.+|.|+|+ .+|+||||||+||+++.++.++|+|||++........ ........++.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCccee
Confidence 011234677888999999999999999 6799999999999999999999999999865433221 1122233467899
Q ss_pred chhhhhhcC--------------------CC--cccceehhHHHHHHHHhCCC-CCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 179 ASEVKEFRR--------------------FS--EKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 179 aPE~~~~~~--------------------~~--~~sDiwslG~vl~~l~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
|||.+.... |+ .+.||||+||++|+|++|.. ||.......... .........++.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~~~~~~~~~r~- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQYDNDLNRWRM- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hhccchHHHHHh-
Confidence 999875432 22 24799999999999999886 665432111100 000000000110
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSS---ERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rpt~~~ll~~ 279 (312)
..............++..++++.+||..+| .+|+|++++|+|
T Consensus 456 --~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011111111223345789999999999866 689999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=244.70 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=200.9
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC-----CeEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQFL 79 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (312)
.+--+.||.|+||.||.+. -++++.|++|++.+. ....+.+|+++|..++|.|+...++..... ..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3445789999999999998 667999999987654 235688999999999999999988876543 23578
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
+.|.+.. +|..++ ...+.++...+..++.||+.||.|||+ .+|.||||||.|++++.+..+||||||+++.-
T Consensus 135 ~TELmQS-DLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEeccccccccc
Confidence 8888855 888888 455667788888999999999999999 77999999999999999999999999999865
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH-
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK- 237 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (312)
.... ..+......|..|+|||++.|.+ |+.+.||||.||++.|++..+..|....+.+..+++..+...+....+..
T Consensus 207 e~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 4332 22344456788899999999865 89999999999999999999999988777665555554444333332211
Q ss_pred -------Hhhhhcc-ccC--------ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 238 -------ILDERLW-STF--------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 238 -------~~~~~~~-~~~--------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
++..... +.. +..-..+...++..++..||.+|.+..+.+.++.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111110 001 1111245678888999999999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=240.27 Aligned_cols=251 Identities=19% Similarity=0.256 Sum_probs=199.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN 74 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 74 (312)
.|.+..++|.+++.||.|+|.+|.+++ .++.+.||+|+++.+ ..+=+..|-.+..+- +||.++.+..+|+..
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 456778999999999999999999999 677899999965432 222345566666665 699999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..+++|.||.+||+|.-.+ ..+..++++.+..+...|+.||.|||+ +||+.||+|.+|+++|..|++||+|+|
T Consensus 324 srlffvieyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred ceEEEEEEEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccc
Confidence 9999999999999998777 566789999999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+++..-. .....+...||+.|.|||++.|..|+.+.|.|+||++|+||+.|..||.....+..... .+ ..
T Consensus 397 mcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n------te--dy 466 (593)
T KOG0695|consen 397 MCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN------TE--DY 466 (593)
T ss_pred hhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc------hh--HH
Confidence 9876432 23345667899999999999999999999999999999999999999975332211110 00 00
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 271 (312)
+.+++-++ ...+|..++-....+++.-|++||.+|.
T Consensus 467 lfqvilek-qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 467 LFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 11111111 1234555556778899999999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=271.27 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=189.8
Q ss_pred CCcccccccCcce-EEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccCCc
Q 021441 11 FSDKNLIGEGKFG-EVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS 88 (312)
Q Consensus 11 y~~~~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (312)
|.-.+.+|.|+.| .||++... ++.||||.+-.+..+...+|+..|+.. +||||+++|+.-.+.+++|+..|.|.. +
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 3445778899987 56888876 679999998888888889999999988 599999999999999999999999965 9
Q ss_pred ccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---C--CceEEeeccccccccCCC
Q 021441 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---D--FIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~--~~vkl~Dfg~a~~~~~~~ 163 (312)
|.+++......... ..-........|+++||+|||+ .+||||||||+||||+. + ..++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~-~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEM-QSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhh-cccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99998553110000 1113346688999999999999 55999999999999976 3 478999999999886543
Q ss_pred c-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhC-CCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 164 V-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 164 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
. ........||-.|+|||.+....-+.++|||||||++|+.++| .+||.+.-..+.. ++.+.....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----Il~~~~~L~-------- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----ILTGNYTLV-------- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh----hhcCcccee--------
Confidence 2 2235566788899999999998888899999999999999996 8999864432211 111111000
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+..+||.+|++.||..||+|.++|.|
T Consensus 734 ----~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 ----HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0011111178999999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=238.74 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=190.4
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeeeeeeC------Ce
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL 76 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 76 (312)
.+|.-++.+|.|.- .|-.|. .-.++.|++|+.. ........+|..++..+.|+||++++.++... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777888888887 555555 3357889999643 23445678999999999999999999998654 34
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+|||++.. +|...+. -.++=.++..+..|+++|++|||+ .||+||||||+||++..++.+|+.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-------MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhh
Confidence 6999999965 8877762 345667888999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+.-... -..+.+..+..|.|||++.|..|.+.+||||+||++.||++|+..|.+.+.-+.-.........+....+.
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 754322 24556788899999999999999999999999999999999999998643222111111111111100000
Q ss_pred ----------------------HHhhhhcc---ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 ----------------------KILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ----------------------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+......+ .+.+..-...+++++.+||..||++|.+++++|.|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000 11111223578999999999999999999999977
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=222.97 Aligned_cols=206 Identities=20% Similarity=0.282 Sum_probs=164.7
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+++..++..-+..||+|++|.|-+.+ ..+|+..|+|.+.... .....+|+.+..+. ..|.++.|||.....+.+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44556677778999999999998888 5679999999755433 34456677766665 589999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+.||.|+. +|+.+-.... .....+++..+-+|+..+++||.|||+. -.++|||+||+|||++.+|+||+||||.+-
T Consensus 121 wIcME~M~t-Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999966 7766553222 2456788999999999999999999973 349999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhh----cCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLS 215 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~ 215 (312)
.+.+... .+-..|-..|+|||.+.. ..|+.+|||||||++|+||.++..||....
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 6643321 122345566999998664 378999999999999999999999997644
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=248.51 Aligned_cols=193 Identities=21% Similarity=0.357 Sum_probs=167.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--h---------HHHHHHHHHhcCC---Cccceeeeeeeee
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--Q---------EFIDEVCFLASIQ---HRNLVTLLGYCQE 73 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~---------~~~~e~~~l~~l~---h~~i~~~~~~~~~ 73 (312)
.+|+.++.+|+|+||.|++|. .++...|++|.+.++.. + .+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999 44567899997655432 1 2345899999997 9999999999999
Q ss_pred CCeEEEEEEec-cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEee
Q 021441 74 NNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD 152 (312)
Q Consensus 74 ~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~D 152 (312)
.+..|++||.- +|-+|.+++ ...+.+++.....|++|++.|+++||+ .||||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEee
Confidence 99999999976 456888888 455678899999999999999999999 7799999999999999999999999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCC
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASS 212 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~ 212 (312)
||.+.....+ +....+||..|.|||++.|..| +..-||||||+++|-+++...||.
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998876543 3455789999999999999999 888999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=218.81 Aligned_cols=208 Identities=35% Similarity=0.527 Sum_probs=178.6
Q ss_pred cccCcceEEEeeeeC-CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcccc
Q 021441 17 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 91 (312)
Q Consensus 17 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (312)
||+|.+|.||++... +++.+++|....... ..+.+|+..++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999954 488999998877654 678999999999999999999999999889999999999889998
Q ss_pred cccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeeccccccccCCCcCCCCcc
Q 021441 92 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQ 170 (312)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~ 170 (312)
++... ...++...+..++.+++.++.+||+ .|++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 87321 1357888999999999999999999 67999999999999999 89999999999876543321 1222
Q ss_pred ccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCCh
Q 021441 171 VTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249 (312)
Q Consensus 171 ~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (312)
..+...|.+||..... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3456679999999877 778999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 250 EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
..+.+++.+|+..||.+||++.+++.++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2578899999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=250.30 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=203.1
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+.++|.+.+.+|+|+||.||+++ ..+++..|+|.++-+ ...-+.+|+-+++.++||||+.+++.+.....+|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 46899999999999999999999 667888898876544 44456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
||.+|+|.+.- .....+++..+...++..+.||+|||+ .|=+|||||-.||++++.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy-----~~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIY-----HVTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCccccee-----eecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999998877 455678889999999999999999999 77999999999999999999999999998776543
Q ss_pred CcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 163 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.. ......||+.|+|||+.. ...|+..+||||+|+...|+---+.|.....+.....+. .+..
T Consensus 166 i~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm------------TkS~ 231 (829)
T KOG0576|consen 166 IA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM------------TKSG 231 (829)
T ss_pred hh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh------------hccC
Confidence 32 244567999999999854 346899999999999999997766665443332111111 1111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......-...+++.|.+|++.+|..+|.+||+++.+|.|
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1122223344556889999999999999999999988754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=227.96 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=194.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eC---CceEEEEEeCCCC-ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~---~~~~vaiK~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+....+.|..+++||+|.|+.||++. .. .++.||+|.+... ....+..|+++|..+ .+.||+++.+++..++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34556789999999999999999998 33 5788999976654 556789999999999 589999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeecccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLR 156 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a 156 (312)
.+||||++.....++. ..++...+..+++.++.||.++|. +|||||||||+|++.+. .+.-.|+|||+|
T Consensus 111 ~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhH
Confidence 9999999998887777 235678889999999999999999 78999999999999985 457799999998
Q ss_pred ccccCC--------------Cc-----------CC---C--------------CccccCcccccchhhhhhcC-CCcccc
Q 021441 157 NFLGRT--------------DV-----------AG---P--------------SSQVTADEIFLASEVKEFRR-FSEKSD 193 (312)
Q Consensus 157 ~~~~~~--------------~~-----------~~---~--------------~~~~~~~~~y~aPE~~~~~~-~~~~sD 193 (312)
...... .. .. + .....||+.|+|||++..-+ -+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 732100 00 00 0 11224899999999987654 488999
Q ss_pred eehhHHHHHHHHhCCCCCCCCCCCChh-hHHHHhhhhhhh----------------------------hhh-hHHhhh-h
Q 021441 194 VYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDF----------------------------SNL-LKILDE-R 242 (312)
Q Consensus 194 iwslG~vl~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~----------------------------~~~-~~~~~~-~ 242 (312)
|||.|+++.-++++..||-....+-.. ..+..+...... ..+ .....+ +
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998653322211 111000000000 000 000000 0
Q ss_pred ---cccc-CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 ---LWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ---~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+ ...-.+..+.+++.+|+..||.+|.|++++|.|
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111 112223478999999999999999999999965
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=210.31 Aligned_cols=246 Identities=18% Similarity=0.299 Sum_probs=179.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcC-CCccceeeeee-eeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASI-QHRNLVTLLGY-CQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e 82 (312)
.+.|.+.+.||+|.||.+-++. ..+++.+++|..+... ..+|.+|...--.| .|.||+.-|+. |+..+..++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4789999999999999999999 5568899999876553 46788888766666 48999998875 566677789999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC--CCCceEEeecccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLG 160 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~--~~~~vkl~Dfg~a~~~~ 160 (312)
|++.|+|.+-+. ...+.+.....++.|+++||.|||+ +.+||||||.+|||+- +...|||||||++...+
T Consensus 103 ~aP~gdL~snv~------~~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVE------AAGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcC------cccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999987762 2456777888999999999999999 7799999999999993 34489999999987654
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-----CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
.. .........|.+||+.... ...+.+|+|.||+++|.++||.+||........... .+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--------~~~~w 241 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--------EWEQW 241 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--------HHHHH
Confidence 32 2223344458999986532 236789999999999999999999975432222111 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (312)
.+....... ..-...++.+..+.++-|..++++|=.+.+
T Consensus 242 ~~rk~~~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 242 LKRKNPALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred hcccCccCc-hhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 111111111 111222356778888999999999943333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=209.84 Aligned_cols=195 Identities=32% Similarity=0.459 Sum_probs=165.5
Q ss_pred CCcccccccCcceEEEeeeeC-CceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
|.+.+.||+|++|.||++... +++.+++|..... ....+.+|++.++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999954 4789999987655 34577889999999999999999999988888999999999
Q ss_pred CCcccccccCcccccccc-cCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 86 NGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~-~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
+++|.+++.. ... +++..+..++.+++.++.+||+ .|++|+||+|.|++++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRK-----KGGKLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999988832 222 6788999999999999999999 6799999999999999999999999999887654320
Q ss_pred CCCCccccCcccccchhhh-hhcCCCcccceehhHHHHHHHHhCCCCCCC
Q 021441 165 AGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSS 213 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~vl~~l~tg~~pf~~ 213 (312)
. ......++..|++||.. ....++.++|+||||+++++|++|..||..
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 12233466679999998 666778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=246.28 Aligned_cols=196 Identities=16% Similarity=0.164 Sum_probs=134.5
Q ss_pred CCC-ccceeeeeee-------eeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021441 59 IQH-RNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130 (312)
Q Consensus 59 l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~gi 130 (312)
++| +||.++++++ .....++.++|++ +++|.+++.. ....++...+..++.||+.||.|||+ +||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS--QGI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh--CCe
Confidence 445 5777777776 2334567788887 5599988832 23458899999999999999999999 779
Q ss_pred EecCCCCCceEeCCCCc-------------------eEEeeccccccccCCC---------cC-----CCCccccCcccc
Q 021441 131 VHKDFKTANVLVDEDFI-------------------AKVADAGLRNFLGRTD---------VA-----GPSSQVTADEIF 177 (312)
Q Consensus 131 vH~dikp~Nil~~~~~~-------------------vkl~Dfg~a~~~~~~~---------~~-----~~~~~~~~~~~y 177 (312)
+||||||+|||++..+. +|++|||+++...... .. .......+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 4555555554321100 00 000113477889
Q ss_pred cchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHH
Q 021441 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQ 257 (312)
Q Consensus 178 ~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (312)
+|||++.+..|+.++|||||||+||||++|..|+..... ........ ...+. .. .......+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~--------~~~~~----~~-~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR--------VLPPQ----IL-LNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh--------hcChh----hh-hcCHHHHH
Confidence 999999999999999999999999999998887643110 00000000 00000 00 11234578
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q 021441 258 LIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 258 li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
++.+||..||.+||++.++++|
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=196.81 Aligned_cols=172 Identities=20% Similarity=0.230 Sum_probs=126.9
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
|+|.+++.. ....+++..+..++.|++.||.|||+ ++ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 466666621 23458999999999999999999998 55 999999999999999 99987654321
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
..+++.|+|||++.+..|+.++|||||||++|||++|..||......... ........... .. ....
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~-------~~-~~~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPAD-------DP-RDRS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhccC-------Cc-cccc
Confidence 25678899999999999999999999999999999999999654322111 11111110000 00 0001
Q ss_pred CChHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 247 FTNEGME--EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 247 ~~~~~~~--~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.+...++ ++.+++.+||..||.+||++.++++++.....+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~ 174 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL 174 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence 1222333 69999999999999999999999999988876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=198.88 Aligned_cols=263 Identities=17% Similarity=0.248 Sum_probs=219.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC-CCChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.-.|++.++||+|.||.+|.+. .-+++.||||..+ ...+.++..|...++.|. .+.|...|-+...+-+..+|+|++
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 4579999999999999999998 5578999999654 456678899999999885 689999998888887788999988
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-----ceEEeeccccccc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-----IAKVADAGLRNFL 159 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-----~vkl~Dfg~a~~~ 159 (312)
|-+|.++. ..+...++..++..++.|++.-++++|+ +.+|.|||||+|+||...+ .+.++|||+|+.+
T Consensus 107 -GPSLEDLF----D~CgR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLF----DLCGRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHH----HHhcCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77888887 4678889999999999999999999999 5699999999999997543 6899999999988
Q ss_pred cCCCcCCC-----CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 160 GRTDVAGP-----SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 160 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
.+.....+ .....||.+||+=....|..-+.+.|+=|||-++++++-|.+||.+.........++.+....+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 65544433 3345699999999999999999999999999999999999999999887777777776665554333
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+. +++.+.|+++...+...-+.+-.+-|..+-+...+..+++.
T Consensus 260 i~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 IE---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HH---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 32 23445677888899988888888999998888887777765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=193.08 Aligned_cols=265 Identities=17% Similarity=0.210 Sum_probs=212.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCC-ccceeeeeeeeeCCeEEEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (312)
+...+|.++++||+|+||.+|++. ..+|..||||..... ....+..|..+.+.+++ ..|..+..+..+.....+||+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 346789999999999999999999 778999999975544 44678889999999965 667777777778888889999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFL 159 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~~~ 159 (312)
.+ |-+|.++.. .+...++..+++-++-|++.-++|+|. ++++||||||+|++..- ...+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfn----fC~R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFN----FCSRRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHH----HHhhhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 778888873 566789999999999999999999999 77999999999999963 457899999999987
Q ss_pred cCCCcCCC-----CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 160 GRTDVAGP-----SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 160 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
-+.....+ .....||.+|.+-....+..-+.+.|+=|+|.++.++--|..||.+.......+.++.+....-. .
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-T 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-C
Confidence 55433322 33456999999998888888888999999999999999999999998877766666555433211 1
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
. ....+...|.++.-.+..|-..--++-|...-+.+.+.-++..
T Consensus 244 ~--------ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 244 P--------IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred C--------HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1 1223445567889999999999888999988777777666654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=206.06 Aligned_cols=260 Identities=20% Similarity=0.205 Sum_probs=199.1
Q ss_pred CCCcccccccCcceEEEeeeeCC--ceEEEEEeCCCCC---hhHHHHHHHHHhcCC----Cccceeeeeee-eeCCeEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAP---TQEFIDEVCFLASIQ----HRNLVTLLGYC-QENNLQFL 79 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~---~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 79 (312)
+|++.+.||+|+||.||.|.... ...+|+|...... ...+..|..++..+. .+++..+++.+ ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999543 3578999654332 226777888888886 26899999998 47778899
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-----CceEEeecc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAG 154 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-----~~vkl~Dfg 154 (312)
||+.+ |.+|.++.... ....++..++.+++.|++.+|.++|+ .|++||||||+|+++... ..+.+.|||
T Consensus 99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 77888876322 24678999999999999999999999 779999999999999865 469999999
Q ss_pred ccc--cccCCCc-----CCC-CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 155 LRN--FLGRTDV-----AGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 155 ~a~--~~~~~~~-----~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
+++ ....... ... .....||..|++++...+...+.+.|+||++.++.++..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3322111 111 23456999999999999999999999999999999999999999765543332211111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..... ........+.++.++...+-..+...+|....+...+.......
T Consensus 253 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLL------------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhc------------cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11100 00022333467888888888899999999999999999888775
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=195.61 Aligned_cols=174 Identities=18% Similarity=0.218 Sum_probs=130.7
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC--CceEEEEEeCCCC--------ChhHHHHHHHHHhcCCCcccee-eeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVT-LLGYCQ 72 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~h~~i~~-~~~~~~ 72 (312)
......+|.+.+.||+|+||.||+|... +++.+|+|..... ....+.+|+++++.++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 4455688999999999999999999843 5777899975422 1345789999999999999885 4432
Q ss_pred eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEeCCCCceEEe
Q 021441 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVA 151 (312)
Q Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~di-kp~Nil~~~~~~vkl~ 151 (312)
+..|+||||++|++|.... ... ...++.+++.+|.|||+ +||+|||| ||+||+++.++.++|+
T Consensus 91 --~~~~LVmE~~~G~~L~~~~------~~~------~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR------PHG------DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC------ccc------hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEE
Confidence 4579999999998886221 001 13578899999999999 77999999 9999999999999999
Q ss_pred eccccccccCCCcCCC------CccccCcccccchhhhhhcCC------Cccccee
Q 021441 152 DAGLRNFLGRTDVAGP------SSQVTADEIFLASEVKEFRRF------SEKSDVY 195 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~------~~~sDiw 195 (312)
|||+++.......... .....++..|.|||.+..... +..+|-|
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999987754332111 123346677899998775532 3346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=214.30 Aligned_cols=251 Identities=21% Similarity=0.219 Sum_probs=182.3
Q ss_pred CcccccccCcceEEEeee-eCCceEEEEEeCC----C-CChh----HHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 12 SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP----G-APTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~----~-~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.....+|.|++|.|+.+. ......++.|... . .... .+..|..+-..+.|+|++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 457889999999888776 3333334444322 1 1111 1445667777789999988887776665555669
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||++ +|..++. ....+....+.-++.|++.|+.|+|. .|+.|||+||+|++++.+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9988883 22356667777899999999999999 6699999999999999999999999999877643
Q ss_pred CCcC--CCCccccCcccccchhhhhhcCCCc-ccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVA--GPSSQVTADEIFLASEVKEFRRFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.... .......|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+..... ..... +.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~~~~~------~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--NNYSD------QR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--hcccc------cc
Confidence 3222 3344567888899999999999965 589999999999999999999876554332200 00000 00
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
-............+..-+.+|.+||+.||.+|.|++++++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111112233445567899999999999999999999885
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=184.35 Aligned_cols=258 Identities=26% Similarity=0.342 Sum_probs=192.0
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCc-cceeeeeeeeeCCeEEEEEEe
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 83 (312)
|.+.+.||.|+||.||.+... ..+++|.+... ....+.+|..++..+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999966 66788865432 244578899999999887 799999999777778999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+.++++.+++...... ..+.......+..|++.++.++|. .|++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999998666221110 367888899999999999999999 6799999999999999988 7999999998855443
Q ss_pred CcCC----CCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCC-ChhhHHHHhhhhhhhhh
Q 021441 163 DVAG----PSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSN 234 (312)
Q Consensus 163 ~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 234 (312)
.... ......++..|++||...+ ..++...|+||+|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3221 2355678889999999998 57789999999999999999999997665432 011111111110000
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223578999999999999999999888776
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=176.22 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=190.9
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..+..+.-+|.+...|..|+++|+.+. ++.|++.. ....+|..|.-.|+.+.||||.++++.|.....+.++..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 345566788999999999999988554 45565432 223467888888999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|++.++|...+.... .--.+-....+++.+++.|++|||++..-|----+....+++|++.+.+|+-- -+++..+
T Consensus 268 ~mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarisma-d~kfsfq- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMA-DTKFSFQ- 342 (448)
T ss_pred eccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecc-cceeeee-
Confidence 999999999885432 34456677888999999999999998544555568889999999988776531 1111100
Q ss_pred CcCCCCccccCcccccchhhhhhcCC---CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.....-++.|++||.+..++- -.++|+|||++++||+.|...||.+..+.+-... +.
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------ia 402 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IA 402 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hh
Confidence 111123345999999887654 3468999999999999999999998776433221 12
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
-+.++..+|+..+..+..||.-|++.||.+||.+..++-.||.+.
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 234445678888899999999999999999999999999988763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=193.44 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=194.1
Q ss_pred ccccCcceEEEeeeeC----CceEEEEEeCCCCC-----hhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEecc
Q 021441 16 LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.+|+|+||.|++++.- .+..+++|...... ......|..++..++ ||.++++...++....+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999999732 36678877543221 113345677777776 9999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
++.+...+ .....+.+.....+...++-++.++|+ .|++++|+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l-----~~~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRL-----SKEVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcc-----ccCCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 98888777 345567778888899999999999999 55999999999999999999999999999876543322
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (312)
.|+..|+|||++. ....++|.||||+++|+|+||..||.. +....+. .. ..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il------------~~--~~ 204 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRIL------------KA--EL 204 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHh------------hh--cc
Confidence 6788899999998 667789999999999999999999976 1111111 11 12
Q ss_pred cCChHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHHHHHHhccccccccc
Q 021441 246 TFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVTELDRTLDKEMNLTTVMGE 296 (312)
Q Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~--~~ll~~l~~~~~~~~~~~~~~~~ 296 (312)
..|...+..+.+++.+++..+|.+|.-. ..+.++++...-....|+.....
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r 257 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEAR 257 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhc
Confidence 4677778899999999999999999755 68888888888888887754443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=172.35 Aligned_cols=169 Identities=12% Similarity=0.125 Sum_probs=129.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh--h----------HHHHHHHHHhcCCCccceeeeeeeee
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--Q----------EFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
+...+|+.++.||+|+||.||++.. ++..+|+|.+.+... + .+.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999776 366799998764322 1 14688889999999999999888653
Q ss_pred C--------CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 74 N--------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 74 ~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
. +..++||||++|.+|.+.. ..+. ....+++.++..+|. .|++|+|++|+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCC
Confidence 2 3578999999999887653 1122 245699999999999 779999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 205 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~ 205 (312)
| ++|+|||......... ....++....|+.++|+||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchh--------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 8 9999999775432111 1112455566788999999999877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=177.35 Aligned_cols=232 Identities=21% Similarity=0.262 Sum_probs=143.1
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCC--CCCh----hHHHHHHHHHhcCC----------Cccceeeeeee
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT----QEFIDEVCFLASIQ----------HRNLVTLLGYC 71 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~--~~~~----~~~~~e~~~l~~l~----------h~~i~~~~~~~ 71 (312)
..+...+.||.|+++.||.+. ..+++.+|+|.+. .... +++.+|.-....+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345667899999999999999 5579999999632 2211 23444443333322 11222223322
Q ss_pred e---------eC---C-----eEEEEEEeccCCcccccccC---cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 021441 72 Q---------EN---N-----LQFLIYEYIPNGSVSIHLYG---PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131 (312)
Q Consensus 72 ~---------~~---~-----~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~giv 131 (312)
. .. + ..+++|+-+.+ +|..++.. ... ............+..|++..+++||. .|++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHS--YGLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhh--cceE
Confidence 1 11 1 23567887744 77666521 111 12233445556677899999999999 6799
Q ss_pred ecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhc--------CCCcccceehhHHHHHH
Q 021441 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--------RFSEKSDVYSFGVFLLE 203 (312)
Q Consensus 132 H~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~sDiwslG~vl~~ 203 (312)
|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999877655432211 2333558999987553 46889999999999999
Q ss_pred HHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCC
Q 021441 204 LVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270 (312)
Q Consensus 204 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (312)
|+++..||........... ....+.++|+.++.||.++|+.||++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986543322111 112333788999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=165.30 Aligned_cols=136 Identities=18% Similarity=0.111 Sum_probs=104.0
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCCh------------h-----------------HHHHHHHHHhcCCCccc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------------Q-----------------EFIDEVCFLASIQHRNL 64 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------~-----------------~~~~e~~~l~~l~h~~i 64 (312)
.+.||+|++|.||+|...+|+.||+|....... . ....|...+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 578999999999999966899999997643211 1 12348888999877776
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEeC
Q 021441 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDFKTANVLVD 143 (312)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~l-H~~~~givH~dikp~Nil~~ 143 (312)
.....+... ..++||||+.++++.... .....++...+..++.|++.+|.++ |. .||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPR-----LKDAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchh-----hhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE
Confidence 443332222 238999999987665443 1234577888999999999999999 67 6799999999999998
Q ss_pred CCCceEEeeccccccc
Q 021441 144 EDFIAKVADAGLRNFL 159 (312)
Q Consensus 144 ~~~~vkl~Dfg~a~~~ 159 (312)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=194.36 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=189.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 79 (312)
.+.+....|.|.+.||+|+||.||.|...+++.||+|.-.+....+|.--..++.+|+ -+.|..+...+.-.+.-++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3556778999999999999999999996669999999988888877766666666766 2345555555555555679
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-------CCCceEEee
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------EDFIAKVAD 152 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-------~~~~vkl~D 152 (312)
|++|.+.|+|.+++ +....+++.....+..|++.-+.+||. .||||+||||+|+++. ..-.++|+|
T Consensus 772 v~ey~~~Gtlld~~-----N~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLI-----NTNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhh-----ccCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999 356778889999999999999999999 6799999999999994 344789999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
||.+-.+.-............|..+-=+|...|..++..+|.|.|+.+++-|+.|+.-- ..+...+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~ 910 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSW 910 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcce
Confidence 99886653322222333445666688899999999999999999999999999987421 0000000
Q ss_pred hhhhHHhhhhccccCChHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 233 SNLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
.. ... ++... .+-+.+++..+|+.|-..=|...+|...+++.+.++..
T Consensus 911 ~~-----~~~----~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 911 MV-----KTN----FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ec-----ccc----chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 00 000 01111 13456777888884444447888888888888877653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-23 Score=171.17 Aligned_cols=197 Identities=18% Similarity=0.208 Sum_probs=138.8
Q ss_pred CCccceeeeeeeee---------------------------CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHH
Q 021441 60 QHRNLVTLLGYCQE---------------------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112 (312)
Q Consensus 60 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i 112 (312)
.||||+++.+.|.+ +..+|+||.-+.. +|..++. .+ ..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~-~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TR-HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cC-CCchHHHHHH
Confidence 49999999877632 2357899988865 8887772 22 2345566678
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceEeC--CCC--ceEEeeccccccccCCC----cCCCCccccCcccccchhhhh
Q 021441 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDF--IAKVADAGLRNFLGRTD----VAGPSSQVTADEIFLASEVKE 184 (312)
Q Consensus 113 ~~~i~~~L~~lH~~~~givH~dikp~Nil~~--~~~--~vkl~Dfg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~ 184 (312)
+.|+++|..|||+ +|+.|||+|.+||++. +|+ .+.++|||.+-...... +....-..-|....+|||+..
T Consensus 347 laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 6799999999999994 333 68999999765433221 111122233666789999987
Q ss_pred hcCC------CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHH
Q 021441 185 FRRF------SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL 258 (312)
Q Consensus 185 ~~~~------~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (312)
..+- -.++|.|+.|.+.||+++...||....+..... +. ..+...+..+..+++.++++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-----------r~----Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-----------RT----YQESQLPALPSRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-----------hh----hhhhhCCCCcccCChHHHHH
Confidence 5431 237999999999999999999997733221110 00 11122244667777899999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHH
Q 021441 259 IVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 259 i~~~l~~dp~~Rpt~~~ll~~l 280 (312)
+...|+.||++|+++.=....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876444433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=194.44 Aligned_cols=245 Identities=19% Similarity=0.236 Sum_probs=171.7
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCCCC----ChhHHHH---HHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----PTQEFID---EVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+|...+.||++.|=+|.+++.+.|. |++|.+-.. ..+.+.+ |++ ....++||+.++.-+.....--|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777899999999999999987676 888864332 2233333 344 444589999999888766666788888
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc--c
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--G 160 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~--~ 160 (312)
|..+ +|.+++ ..++-+......-|+.|++.||..+|. .||+|+|||.+|||++.=+-+.|+||..-+-. +
T Consensus 102 yvkh-nLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 8866 888888 455566677778899999999999999 67999999999999999889999999764321 1
Q ss_pred CCCcCCCCccc----cCcccccchhhhhhcC-----------CCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHH
Q 021441 161 RTDVAGPSSQV----TADEIFLASEVKEFRR-----------FSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224 (312)
Q Consensus 161 ~~~~~~~~~~~----~~~~~y~aPE~~~~~~-----------~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~ 224 (312)
..... ...++ ..-.+|.|||.+.... .+++.||||+||+++|+++ |.+||.- -++..
T Consensus 174 eDNPa-df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a 246 (1431)
T KOG1240|consen 174 EDNPA-DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA 246 (1431)
T ss_pred CCCcc-cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh
Confidence 11100 01111 1223599999876522 4678899999999999998 4666642 11111
Q ss_pred Hhhh-hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 225 LVQN-SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 225 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.-.+ ......+.+.+.. ..+++++..|++.||++|.++++.|+.-++
T Consensus 247 Yr~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1111 1111111111111 257999999999999999999999987433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=156.27 Aligned_cols=185 Identities=19% Similarity=0.101 Sum_probs=136.4
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCCh--h-----HHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEec
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--Q-----EFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+...|++|+||+|+.+.. .+.+++.+.+..... . .+.+|+++|+++. ++++++++++ ...|++|+|+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 467899999999998776 467788665544332 2 4678999999995 5889999886 3468999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEeCCCCceEEeeccccccccCCC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~di-kp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
.|.+|.... ... ...++.|++.+|.++|+ +||+|+|| ||+||+++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~------~~~------~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRP------PRG------DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhh------hhh------hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 998886433 001 13467899999999999 77999999 7999999999999999999998554322
Q ss_pred cC----CC-------CccccCcccccchhhhhhc-CCC-cccceehhHHHHHHHHhCCCCCCCCCC
Q 021441 164 VA----GP-------SSQVTADEIFLASEVKEFR-RFS-EKSDVYSFGVFLLELVSGREASSSLSP 216 (312)
Q Consensus 164 ~~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~sDiwslG~vl~~l~tg~~pf~~~~~ 216 (312)
.. .. ......++.|++|+..... ..+ ...+.++-|+-+|.++|+..++.+..+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 00 1112245567777764433 233 567889999999999999998776543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=157.81 Aligned_cols=139 Identities=18% Similarity=0.129 Sum_probs=105.6
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCCh-----------------------------hHHHHHHHHHhcCCCcc
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----------------------------QEFIDEVCFLASIQHRN 63 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----------------------------~~~~~e~~~l~~l~h~~ 63 (312)
+.+.||+|++|.||+|...+|+.||+|....... .....|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999966899999997554311 11246788888888887
Q ss_pred ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC
Q 021441 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 143 (312)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~ 143 (312)
+.....+.... .|+||||+.|+++.... .....++......++.|++.++.++|+. .||+|+||||+||+++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~-----l~~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPR-----LKDVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhh-----hhhccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE
Confidence 74444333322 48999999887554322 1223456778889999999999999971 3599999999999999
Q ss_pred CCCceEEeecccccccc
Q 021441 144 EDFIAKVADAGLRNFLG 160 (312)
Q Consensus 144 ~~~~vkl~Dfg~a~~~~ 160 (312)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=177.03 Aligned_cols=220 Identities=24% Similarity=0.349 Sum_probs=164.5
Q ss_pred HhcCCCccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 021441 56 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF 135 (312)
Q Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~di 135 (312)
|+.+.|.|+.+|+|.+.++...+.|.+||..|+|.+.+.. ....+++......+++++.||.|+|... .-.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeee
Confidence 3567899999999999999999999999999999999953 3456888899999999999999999833 2399999
Q ss_pred CCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcC-------CCcccceehhHHHHHHHHhCC
Q 021441 136 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-------FSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 136 kp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDiwslG~vl~~l~tg~ 208 (312)
+..|.+++....+|++|||+.................-...|.|||.+.+.. .+.+.|+||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987664311111112222344699999988742 356799999999999999999
Q ss_pred CCCCCCCCCChh-hHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 209 EASSSLSPDSSQ-DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 209 ~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.||......... .....+.... .....+...... ..++++..++.+||..+|++||+++.+-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHhcC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999875433322 2222222200 000011111111 33457899999999999999999999999999888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=187.94 Aligned_cols=237 Identities=19% Similarity=0.203 Sum_probs=164.0
Q ss_pred HhcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
...+|..++.+..|+||.||.++++ +.+++|+|+.+....- +. ++.....|.++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lil---Rn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLIL---RN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhh---hc--cccccCCccee--------------------
Confidence 4578999999999999999999844 5678898644332110 00 22222233333
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC--
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-- 163 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~-- 163 (312)
|+-...+. +...++. +++.+++|+|. .||+|||+||+|.+++.-|++|+.|||+++......
T Consensus 136 -gDc~tllk-----~~g~lPv--------dmvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLK-----NIGPLPV--------DMVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcc-----cCCCCcc--------hhhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 23333331 1122222 23789999999 559999999999999999999999999976542110
Q ss_pred -----------cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 164 -----------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 164 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
.........+|+.|+|||++....|+..+|.|++|+++|+.+.|..||.+.++++.......
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis------- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh-------
Confidence 00112245799999999999999999999999999999999999999988766543221111
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCC
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGT 298 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~ 298 (312)
+...|.+-....+.+.++++.++|+.+|..|.-....++.-++-+-..+.|..++..+-
T Consensus 273 -------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqka 331 (1205)
T KOG0606|consen 273 -------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKA 331 (1205)
T ss_pred -------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhc
Confidence 12223333444557899999999999999997555666666666666777776555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=151.52 Aligned_cols=133 Identities=19% Similarity=0.236 Sum_probs=101.9
Q ss_pred CcccccccCcceEEEeeeeCCceEEEEEeCCCC---ChhHHHHHHHHHhcC-----CCccceeeeeeeeeCC---eEE-E
Q 021441 12 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-----QHRNLVTLLGYCQENN---LQF-L 79 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-l 79 (312)
.-.+.||+|+||.||. ...++.+ +||..... ....+.+|+.+++.+ .||||+++++++.+.. .++ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4467899999999996 4334444 68876543 456789999999999 5799999999998763 434 7
Q ss_pred EEEe--ccCCcccccccCcccccccccCHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCceEeCCC----CceEEee
Q 021441 80 IYEY--IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL-AHLHSLSPRVVHKDFKTANVLVDED----FIAKVAD 152 (312)
Q Consensus 80 v~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L-~~lH~~~~givH~dikp~Nil~~~~----~~vkl~D 152 (312)
|+|| +.+++|.+++.. ..+++. ..++.+++.++ .|||+ ++|+||||||+||+++.. +.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 557899999832 224444 35678888888 89999 679999999999999743 3899999
Q ss_pred cccc
Q 021441 153 AGLR 156 (312)
Q Consensus 153 fg~a 156 (312)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=153.85 Aligned_cols=138 Identities=18% Similarity=0.134 Sum_probs=106.9
Q ss_pred CCCcccccccCcceEEEeee--eCCceEEEEEeCCCCCh---------------------------hHHHHHHHHHhcCC
Q 021441 10 NFSDKNLIGEGKFGEVYKGL--LQDGMLVAIKKRPGAPT---------------------------QEFIDEVCFLASIQ 60 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~---------------------------~~~~~e~~~l~~l~ 60 (312)
-|.+.+.||+|++|.||+|. ..+++.||+|....... ..+.+|...+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 56789999997553210 12457889998886
Q ss_pred C--ccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 021441 61 H--RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKT 137 (312)
Q Consensus 61 h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g-ivH~dikp 137 (312)
+ ..+++++++ . ..|+||||+.+.++..... ............++.|++.++.+||. .| ++|+||||
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCCh
Confidence 4 234444443 2 3489999999988866541 22234455667899999999999999 88 99999999
Q ss_pred CceEeCCCCceEEeeccccccc
Q 021441 138 ANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 138 ~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999987654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6e-19 Score=143.62 Aligned_cols=132 Identities=20% Similarity=0.290 Sum_probs=107.2
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++.||+|++|.||++.+ .+..+++|...... ...+.+|+.++..+.|+++.....++......+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 46678889644322 1246678899999988888777767666677899999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
|++|++|.+.+.. .. . ....++.+++.+|.++|+ .|++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~-----~~---~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINS-----NG---M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHh-----cc---H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888721 11 1 677899999999999999 7799999999999999 78999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-19 Score=141.05 Aligned_cols=136 Identities=21% Similarity=0.145 Sum_probs=105.5
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-------------------------hhHHHHHHHHHhcCCC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLASIQH 61 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~e~~~l~~l~h 61 (312)
....|.+.+.||+|+||.||++...+++.+|+|...... ......|..++..+.+
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 334488999999999999999997778999999644321 1124567888888866
Q ss_pred c--cceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 021441 62 R--NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 139 (312)
Q Consensus 62 ~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~N 139 (312)
+ .+...++. ...++||||+++++|..... . .....++.+++.++.++|+ .|++|+||+|+|
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----~------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV-----L------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFN 155 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhccc-----c------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCccc
Confidence 6 34444432 34589999999988876541 0 2245688899999999999 779999999999
Q ss_pred eEeCCCCceEEeeccccccc
Q 021441 140 VLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 140 il~~~~~~vkl~Dfg~a~~~ 159 (312)
|+++.++.++|+|||.+...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=139.13 Aligned_cols=127 Identities=22% Similarity=0.324 Sum_probs=100.1
Q ss_pred ccccCcceEEEeeeeCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 16 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.||+|++|.||++.+. +..+++|...... ...+.+|.+++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999954 6778999743221 134567999999998876555444555556678999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|++|.+++.. ... .++.+++.+|.++|+ .|++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~-----~~~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEE-----GND-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhh-----cHH-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999877621 110 689999999999999 7799999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=157.16 Aligned_cols=173 Identities=22% Similarity=0.326 Sum_probs=127.2
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+.|++|...+|.+++.... .....++.....++.|++.++.| +|.+|+|+||.||+...+..++|.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999996443 33445677788999999999998 5699999999999999999999999999
Q ss_pred cccccCCC----cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhC-CCCCCCCCCCChhhHHHHhhhhh
Q 021441 156 RNFLGRTD----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 156 a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
........ .........+|..|++||.+.|..|+.++||||||++++|+++- ..+|...
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------------- 466 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------------- 466 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------
Confidence 88765544 12234455799999999999999999999999999999999872 1111110
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
..+..+-+..+.+.+..++ ++-..|+.+++.+.|.+||++.
T Consensus 467 --~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 467 --ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 0000111111111111121 2446899999999999999443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=155.62 Aligned_cols=132 Identities=23% Similarity=0.285 Sum_probs=105.2
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEe-CCC----C------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPG----A------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~-~~~----~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
.|...+.||+|+||.||++.+.... +++|. ... . ....+.+|+++++.++|++++....+.......+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456789999999999999865333 33332 111 1 1234678999999999999988777777766788
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++. ....++.+++.+|.+||+ .|++||||||+||++ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999987762 245689999999999999 779999999999999 577899999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=165.43 Aligned_cols=253 Identities=19% Similarity=0.194 Sum_probs=188.0
Q ss_pred hcCCCcccccccCcceEEEeeee--CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (312)
...|.+.+.||+|+|+.|-.+.. .....++.|.+.... ......|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 46789999999999999998874 335566666544332 122334666666665 9999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEeCCCC-ceEEeeccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRN 157 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH-~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~ 157 (312)
++++..++++.+.+. .......+......++.|+..++.|+| . .++.|+||||+|.+++.++ .++++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999998887772 111123455666789999999999999 7 7799999999999999999 99999999999
Q ss_pred cccC-CCcCCCCccccC-cccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGR-TDVAGPSSQVTA-DEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
.+.. ...........+ ++.|.|||...+..| .+..|+||.|+++.-+++|..|+............ +...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~--~~~~----- 246 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS--WKSN----- 246 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee--eccc-----
Confidence 8866 444444444556 889999999998655 88899999999999999999998765544321100 0000
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (312)
..+..............+++.+++..+|..|.+.+++-
T Consensus 247 -----~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 247 -----KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----ccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00001112223335678899999999999999988765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-16 Score=121.69 Aligned_cols=132 Identities=23% Similarity=0.263 Sum_probs=109.6
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCCC--ccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
+.+.||+|.++.||.+...+ ..+++|...... ...+..|...++.+.+ .++++++.+....+..|++|||+.+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46789999999999999754 678999876544 3568889999999976 5889998888877889999999988766
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
..+ +......++.+++.++..+|... .+++|+|++|+||++++.+.++++|||.+.
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 532 44556778999999999999742 369999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=125.60 Aligned_cols=135 Identities=22% Similarity=0.222 Sum_probs=92.9
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCChh-----HH----------------------HHHHHHHhcCCCc--c
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-----EF----------------------IDEVCFLASIQHR--N 63 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----~~----------------------~~e~~~l~~l~h~--~ 63 (312)
+.+.||+|+||.||+|...+++.||+|........ .. ..|...+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 35789999999999999767899999975543211 11 2344444444322 2
Q ss_pred ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC
Q 021441 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 143 (312)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~ 143 (312)
+.+.++. ...++||||++++.+...... .... ...+..++.+++.++.++|.. .|++|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~-----~~~~-~~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLK-----DVRL-LEDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhh-----hhhh-cccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE
Confidence 3444433 235899999998544321100 0000 155678999999999999972 4599999999999999
Q ss_pred CCCceEEeeccccccc
Q 021441 144 EDFIAKVADAGLRNFL 159 (312)
Q Consensus 144 ~~~~vkl~Dfg~a~~~ 159 (312)
++.++++|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=129.01 Aligned_cols=131 Identities=17% Similarity=0.149 Sum_probs=97.5
Q ss_pred cccc-cCcceEEEeeeeCCceEEEEEeCCC----------------CChhHHHHHHHHHhcCCCccc--eeeeeeeee-C
Q 021441 15 NLIG-EGKFGEVYKGLLQDGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNL--VTLLGYCQE-N 74 (312)
Q Consensus 15 ~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~----------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-~ 74 (312)
..|| .|+.|+||.+... +..+++|.+.. .....+.+|+.++..+.|++| +..+++... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 7888899998865 56788886532 122456789999999988774 666665433 2
Q ss_pred Ce---EEEEEEeccC-CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEE
Q 021441 75 NL---QFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 150 (312)
Q Consensus 75 ~~---~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl 150 (312)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.++.+||+ +||+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688777621 223332 36789999999999 77999999999999999999999
Q ss_pred eecccccc
Q 021441 151 ADAGLRNF 158 (312)
Q Consensus 151 ~Dfg~a~~ 158 (312)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.6e-15 Score=130.80 Aligned_cols=248 Identities=22% Similarity=0.221 Sum_probs=179.9
Q ss_pred HhcCCCccccccc--CcceEEEeeee---CCceEEEEEeCCC-----CChhHHHHHHHHHhcC-CCccceeeeeeeeeCC
Q 021441 7 ATKNFSDKNLIGE--GKFGEVYKGLL---QDGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~--G~~g~V~~~~~---~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 75 (312)
-...+.+.+.+|. |.+|.||.+.. .+...+|+|.-.. .....-.+|+...+.+ .|++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456677888999 99999999985 3577888885221 1122234566666666 4899999888889999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHH----HHHHHhcCCCCeEecCCCCCceEeCCC-CceEE
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK----GLAHLHSLSPRVVHKDFKTANVLVDED-FIAKV 150 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl 150 (312)
.+|+=.|++. .++..+... ...-++...++.+..+... ||.++|. +.++|-|+||+||+...+ ...++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceeec
Confidence 9999999985 577766632 2233566777888888888 9999999 779999999999999999 89999
Q ss_pred eeccccccccCCCcCCCC---ccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 151 ADAGLRNFLGRTDVAGPS---SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
+|||+...+......... ....+...|++||+.. +.++..+|++|+|.++.+-..+..++...-...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------- 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------- 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC---------
Confidence 999998887655432221 1225677899999987 567889999999999999999887765431111
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
|..+.+.. ...++....+..+...+..|++.+|..|++.+.+..
T Consensus 335 ----W~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----WSQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----cccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111100 123344444456777999999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=128.15 Aligned_cols=138 Identities=18% Similarity=0.180 Sum_probs=92.8
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHH--------------------------------------
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF-------------------------------------- 55 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~-------------------------------------- 55 (312)
.+.||+|++|.||+|+.++|+.||||+..+...+.+..++.+
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999988899999998766544333333222
Q ss_pred -----HhcC----CCccceeeeeee-eeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHH-HHHHHh
Q 021441 56 -----LASI----QHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK-GLAHLH 124 (312)
Q Consensus 56 -----l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~-~L~~lH 124 (312)
+.++ .+..-+.+-.++ ...+..++||||++|.+|.+..... ....+ ...++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCCC---HHHHHHHHHHHHHHHHH
Confidence 2222 121112222222 1223468999999999998765211 11112 2335555555 367888
Q ss_pred cCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 125 ~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
. .|++|+|++|.||+++.++.++++|||++....
T Consensus 275 ~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 R--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred h--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 779999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.2e-15 Score=120.91 Aligned_cols=203 Identities=20% Similarity=0.263 Sum_probs=141.0
Q ss_pred HhcCCCccceeeeeeeeeC-----CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021441 56 LASIQHRNLVTLLGYCQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130 (312)
Q Consensus 56 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~gi 130 (312)
+-.+.|.||++++.|+.+. ....++.||+..+++..++..-. .++..+....+.+|+-||+.||.|||+-...|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3445699999999987543 34678999999999999985433 35667888889999999999999999977789
Q ss_pred EecCCCCCceEeCCCCceEEeeccccccc--cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC
Q 021441 131 VHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 131 vH~dikp~Nil~~~~~~vkl~Dfg~a~~~--~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~ 208 (312)
+|+++..+.|++..+|-+|+.--.-.... .............+.+.|.+||.-.....+.++|||+||+...+|.-+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999988887642211111 0111111123344566799999877777788999999999999998877
Q ss_pred CCCCCCC-CCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 209 EASSSLS-PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 209 ~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.--...+ ..... ....+....+... .=++++.+|++-.|..||++.+++-|
T Consensus 280 iq~tnseS~~~~e---------e~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 280 IQSTNSESKVEVE---------ENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eccCCCcceeehh---------hhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 5322111 00000 0001111111111 12568999999999999999999865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.1e-13 Score=121.20 Aligned_cols=181 Identities=18% Similarity=0.163 Sum_probs=127.1
Q ss_pred CCcccccccCcceEEEe-e-eeCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEecc
Q 021441 11 FSDKNLIGEGKFGEVYK-G-LLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~-~-~~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
|.+ ...+-++.+ +|. + +..++.+|.+....... .....+.++.|+.++||||+++++.+...+.+|+|.|-+.
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 444 333334433 454 3 35556777777544433 3557788999999999999999999999999999999873
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~ 165 (312)
.|...+. .+......-.+.||+.||.+||. .++++|++|.-+-++++..|..||++|.++.........
T Consensus 93 --Pl~~~lk--------~l~~~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 93 --PLETVLK--------ELGKEEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred --cHHHHHH--------HhHHHHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 3443331 12245566789999999999985 267999999999999999999999999887654332211
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~ 208 (312)
.....--..|..|+.+.... ...|.|-|||++++++.|.
T Consensus 162 --~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 11111112366666554333 3479999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-13 Score=106.76 Aligned_cols=127 Identities=17% Similarity=0.059 Sum_probs=93.2
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEeccCCccc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVS 90 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (312)
++.|+.|.++.||++... +..|++|...... ......|..+++.+.+..+ .+++.+.. ...++|||+++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 467889999999999865 6789999876543 2346788888888854443 44554433 2347999999998775
Q ss_pred ccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 91 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~---~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
... .....+..+++.+|+.||..+ .+++|+|++|.||+++ ++.++++||+.+.
T Consensus 80 ~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 321 001235678999999999832 1259999999999999 6689999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=124.35 Aligned_cols=143 Identities=14% Similarity=0.082 Sum_probs=87.3
Q ss_pred hcCCCcccccccCcceEEEeeeeCC-ceEEEEEeCCCCChhHH-------------------------------------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF------------------------------------- 49 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~------------------------------------- 49 (312)
...|.. +.||+|++|.||.|+.++ |+.||||...+...+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 355665 799999999999999665 99999998765432211
Q ss_pred ------HHHHHHHhcC----CCccceeeeeeeee-CCeEEEEEEeccCCcccccccCcc-cccccccCHHHHHHHHHHHH
Q 021441 50 ------IDEVCFLASI----QHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAA 117 (312)
Q Consensus 50 ------~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~i~ 117 (312)
.+|...+.++ .+...+.+-.++.+ ....++||||+.|+.+.+...-.. ......+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1222222222 12222222222211 234569999999999876421000 0011122222233333333
Q ss_pred HHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEeecccccccc
Q 021441 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAGLRNFLG 160 (312)
Q Consensus 118 ~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~Dfg~a~~~~ 160 (312)
.. .|++|+|++|.||+++.+| .++++|||++....
T Consensus 277 ------f~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FR--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------Hh--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34 6699999999999999988 99999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.8e-13 Score=121.37 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=172.9
Q ss_pred hcCCCcccccccCcceEEEeeee--CCceEEEEEeCCCCChhH-----HHHHHHHHhcC-CCccceeeeeeeeeCCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRPGAPTQE-----FIDEVCFLASI-QHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~-----~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (312)
..+|..+..||.|.|+.|+.+.. .++..|++|...+..... -..|+.+...+ .|.+++..+..+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 35788899999999999999873 357889988654433322 23355555555 47778887766666666779
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeecccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNF 158 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg~a~~ 158 (312)
=.|||.++++.... .....++....+++..|++.++.++|+ ..++|+|+||+||++.++ +.-++.|||.++.
T Consensus 344 p~e~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccccc
Confidence 99999998887666 233456677788899999999999999 669999999999999986 7789999998865
Q ss_pred ccCCCcCCCCccccCcccc-cchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..-.. ......+..| .+++......+..+.|++|||..+.+.+++...-+..... . .
T Consensus 417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~----------~--- 474 (524)
T KOG0601|consen 417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----L----------T--- 474 (524)
T ss_pred cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----e----------e---
Confidence 32111 1222333445 4666666677899999999999999999877543221110 0 0
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
+........+.. ..++..+.+.+...++..||.+.++..+.+..
T Consensus 475 -i~~~~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 -IRSGDTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -eecccccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 011111222222 26788899999999999999999888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.8e-12 Score=99.21 Aligned_cols=134 Identities=16% Similarity=0.070 Sum_probs=93.0
Q ss_pred ccccccCcceEEEeeeeCC-------ceEEEEEeCCC--------------C----------C-hhHH----HHHHHHHh
Q 021441 14 KNLIGEGKFGEVYKGLLQD-------GMLVAIKKRPG--------------A----------P-TQEF----IDEVCFLA 57 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~--------------~----------~-~~~~----~~e~~~l~ 57 (312)
...||.|.-+.||.|...+ +..+|+|+... + . ...+ .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998442 47899994110 0 0 1122 36888888
Q ss_pred cCC--CccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHH-hcCCCCeEecC
Q 021441 58 SIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKD 134 (312)
Q Consensus 58 ~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~l-H~~~~givH~d 134 (312)
++. .-+++..+++ ...++||||+.+..+..-. .....++......+..+++.++..+ |. .|++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-----LKDAKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-----hhccccCHHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence 884 3456666654 3457999999764332111 1112233445667789999999988 88 7799999
Q ss_pred CCCCceEeCCCCceEEeeccccccc
Q 021441 135 FKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 135 ikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|++.||++++ +.+.++|||.+-..
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-14 Score=132.20 Aligned_cols=253 Identities=19% Similarity=0.205 Sum_probs=175.8
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeC------CCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR------PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+...+.+.+.+.+.+|.++.++.+. ...+...+.|.. .....+....+-.++..-.+|.++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 4556788888899999999999998 334533343321 111122222333333333456666665555666778
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++|++|..+++|...+.+.. ..+..........+..++++||. ..++|+|++|+|++...++..++.||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCcccccc
Confidence 99999999988887774332 33444445567788899999997 448999999999999999999999998422
Q ss_pred cccCC---------------------C--------cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC
Q 021441 158 FLGRT---------------------D--------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208 (312)
Q Consensus 158 ~~~~~---------------------~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~ 208 (312)
..+-. . .........+|+.|.+||...+..-...+|.|+.|+++++.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 21100 0 001122446888999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 209 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 209 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
.||...+++.....+ ... ...|..-+...+...++++...+..+|.+|..+....+
T Consensus 1033 pp~na~tpq~~f~ni--~~~------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENI--LNR------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred CCCCCcchhhhhhcc--ccC------------CCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence 999987765443211 111 12234455666678999999999999999988764333
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-10 Score=100.13 Aligned_cols=269 Identities=16% Similarity=0.167 Sum_probs=164.0
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeee------eeeCCe-EEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGY------CQENNL-QFLIY 81 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~~~-~~lv~ 81 (312)
....+.||+|+-+.+|-.- ..+ .|| |+...-....-.+.+..|... .||-+..-+.| ..+.+. .-++|
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred cCCCccccCCccceeeecchhhc--hhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3457889999999999765 322 233 654433332223334444443 56654442222 122222 55778
Q ss_pred EeccCCc-ccccccCc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 82 EYIPNGS-VSIHLYGP-SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 82 e~~~~~~-L~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
+.+.+.- ...+.... .......+.|...++.++.++.+.+-||. .|.+-+|+.++|+|+++++.|.|.|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEEEEcccceeec
Confidence 8776632 22222111 12234557899999999999999999999 67999999999999999999999985433322
Q ss_pred cCCCcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhC-CCCCCCCCCCChh--hHH-HHhhhhh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQ--DLV-ELVQNSR 230 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg-~~pf~~~~~~~~~--~~~-~~~~~~~ 230 (312)
..+.. .---++...|.+||.-. +-..+...|.|.||+++|+++.| .+||++....... -.. .+...
T Consensus 168 ~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g-- 242 (637)
T COG4248 168 ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG-- 242 (637)
T ss_pred cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc--
Confidence 11111 11124667799999855 33456789999999999999987 8999874311100 000 00000
Q ss_pred hhhhhhHHhhhhcc----ccCC-hHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 231 DFSNLLKILDERLW----STFT-NEGMEEFIQLIVRCLDP--SSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 231 ~~~~~~~~~~~~~~----~~~~-~~~~~~l~~li~~~l~~--dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
.+....+ ..+.. ...+ .-.++++..+..+|+.. ++.-|||++.++..|..+.++...|.
T Consensus 243 ~f~ya~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 243 RFAYASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred eeeechh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000000 00000 0011 12346788899999985 46789999999999999988766554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.9e-11 Score=97.64 Aligned_cols=138 Identities=22% Similarity=0.327 Sum_probs=101.0
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCC--ccceeeeeeeeeC---CeEEEEEEec
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQH--RNLVTLLGYCQEN---NLQFLIYEYI 84 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~ 84 (312)
.+.|+.|..+.||++...+++.+++|..... ....+..|.++++.+.+ ..+.+++.+.... +..|+|||++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3678999999999998765678999976543 24567889999999865 3456677666553 2568999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------------------------------------- 126 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~-------------------------------------- 126 (312)
+|.++...+.. ..++......++.+++.+|..||+.
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765510 2244455556666666666666642
Q ss_pred ----------------CCCeEecCCCCCceEeCC--CCceEEeeccccc
Q 021441 127 ----------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRN 157 (312)
Q Consensus 127 ----------------~~givH~dikp~Nil~~~--~~~vkl~Dfg~a~ 157 (312)
...++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 6678999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.8e-11 Score=91.00 Aligned_cols=126 Identities=21% Similarity=0.301 Sum_probs=90.2
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCC--h---------hHHHHHHHHHhcCCCcc--ceeeeeeeeeCCeEEEEE
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--T---------QEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~---------~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~ 81 (312)
..+++|+-+.++.+.+. +..+++|.-.+.. . ..-.+|..++.++..-. .+.++++ +...-.++|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence 46789999999999765 3447778532211 1 23455788888775333 3444444 444455999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
||++|..|.+.+... ...++..+-.-+.-||. +||+|+||.++||+++.++ +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA------------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888777321 13467777778889999 7799999999999998875 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6e-11 Score=90.60 Aligned_cols=140 Identities=20% Similarity=0.222 Sum_probs=97.2
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
....+.+|+-++|+.+.+. |+.+.||.-.... .....+|...|.++.--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5778899999999999986 6778888533221 123566888888875333333333444444556899
Q ss_pred EeccC-CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEeeccccc
Q 021441 82 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRN 157 (312)
Q Consensus 82 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~Dfg~a~ 157 (312)
||++| .++.+++.... ............+..+-..+.-||. ++|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM---EDESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc---cCcccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 46666663221 1222223336788888889999999 6799999999999997655 45899999976
Q ss_pred c
Q 021441 158 F 158 (312)
Q Consensus 158 ~ 158 (312)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-11 Score=110.00 Aligned_cols=149 Identities=20% Similarity=0.186 Sum_probs=104.5
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC-------CccccCcccccchhhhhhcC
Q 021441 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP-------SSQVTADEIFLASEVKEFRR 187 (312)
Q Consensus 115 ~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~ 187 (312)
+++.|+.++|.. .++||++|.|++|.++..+..||+.|+.+..........- ..-......|.|||++.+..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 445899999974 6899999999999999999999999998655433111100 11112445699999999988
Q ss_pred CCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCC
Q 021441 188 FSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 266 (312)
Q Consensus 188 ~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 266 (312)
.+.++|+||+|+++|.+.. |+..+............... ..-.....+.++++++++=+.+++..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-------------~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-------------LNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-------------cccccccccccCcHHHHHHHHHHhcCC
Confidence 8999999999999999994 54444433222211111111 111122344667789999999999999
Q ss_pred CCCCCCHHHHH
Q 021441 267 SERRPSMSDVV 277 (312)
Q Consensus 267 p~~Rpt~~~ll 277 (312)
+.-||++..++
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999776554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.3e-09 Score=91.40 Aligned_cols=218 Identities=17% Similarity=0.213 Sum_probs=149.3
Q ss_pred ceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeee----eCCeEEEEEEeccC-Cccccc
Q 021441 22 FGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQ----ENNLQFLIYEYIPN-GSVSIH 92 (312)
Q Consensus 22 ~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 92 (312)
..+.|++. ..+|..|++|.+.... ......-+++.+++.|+|++++.+++. ....+++|++|.++ .+|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 5578899999874332 223445678889999999999998875 23467899999976 344433
Q ss_pred ccCcc----------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 93 LYGPS----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 93 ~~~~~----------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
-.... .......++..+|.++.|+..||.++|+ .|..-+-+.|.+|+++.+.+++|+.-|........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 32211 1234557789999999999999999999 77999999999999999999999877765443222
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. + + -+. --.+-|.=.||.++..|.||..--...+. .... .
T Consensus 447 ~---------~-----~--~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--~~~s--~----------------- 486 (655)
T KOG3741|consen 447 P---------T-----E--PLE---SQQQNDLRDLGLLLLALATGTENSNRTDS--TQSS--H----------------- 486 (655)
T ss_pred C---------C-----c--chh---HHhhhhHHHHHHHHHHHhhcccccccccc--hHHH--H-----------------
Confidence 1 0 0 011 12356888999999999998642111110 0000 0
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
...+...++.++++++......++++ -++.+++.++-.-
T Consensus 487 -~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ 525 (655)
T KOG3741|consen 487 -LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSR 525 (655)
T ss_pred -HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHH
Confidence 01234445678888998888888887 6788887665443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3e-09 Score=88.88 Aligned_cols=129 Identities=14% Similarity=0.084 Sum_probs=88.6
Q ss_pred eEEEeeeeCCceEEEEEeCCCCCh--------------hHHHHHHHHHhcCCCcc--ceeeeeeeee-----CCeEEEEE
Q 021441 23 GEVYKGLLQDGMLVAIKKRPGAPT--------------QEFIDEVCFLASIQHRN--LVTLLGYCQE-----NNLQFLIY 81 (312)
Q Consensus 23 g~V~~~~~~~~~~vaiK~~~~~~~--------------~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~lv~ 81 (312)
..|+.+... |+.|.+|....... ....+|...+..+.... .+..+.+... ...-++|+
T Consensus 36 rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 445665554 67899995433221 13667888777774222 2334444432 23468999
Q ss_pred EeccCC-cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-------CCceEEeec
Q 021441 82 EYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DFIAKVADA 153 (312)
Q Consensus 82 e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-------~~~vkl~Df 153 (312)
|++++. +|.+++..- .....+......++.+++..+..||. +||+|+|+++.|||++. +..+.++||
T Consensus 115 e~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 115 EDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 999875 677776211 12234456677899999999999999 77999999999999975 468999999
Q ss_pred cccc
Q 021441 154 GLRN 157 (312)
Q Consensus 154 g~a~ 157 (312)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=85.02 Aligned_cols=122 Identities=20% Similarity=0.197 Sum_probs=76.5
Q ss_pred EEEeeeeCCceEEEEEeCCC---------------CC--------------hhHHHHHHHHHhcCCCc--cceeeeeeee
Q 021441 24 EVYKGLLQDGMLVAIKKRPG---------------AP--------------TQEFIDEVCFLASIQHR--NLVTLLGYCQ 72 (312)
Q Consensus 24 ~V~~~~~~~~~~vaiK~~~~---------------~~--------------~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 72 (312)
.||.|...++..+|+|.... .. .....+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999987788999995211 00 01246699999998644 566776553
Q ss_pred eCCeEEEEEEecc--CCcccccccCcccccccccCHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEeCCCCceE
Q 021441 73 ENNLQFLIYEYIP--NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LHSLSPRVVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 73 ~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~-lH~~~~givH~dikp~Nil~~~~~~vk 149 (312)
...+||||+. |..+..+.. ..++......++.+++..+.. +|. .|++|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-------~~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-------VDLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-------CGGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-------ccccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEE
Confidence 2359999998 644443321 111122334567777775555 577 779999999999999988 899
Q ss_pred Eeeccccccc
Q 021441 150 VADAGLRNFL 159 (312)
Q Consensus 150 l~Dfg~a~~~ 159 (312)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999977543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-09 Score=86.40 Aligned_cols=130 Identities=21% Similarity=0.147 Sum_probs=92.5
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCC------------------C-------ChhHHHHHHHHHhcCCCc--c
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG------------------A-------PTQEFIDEVCFLASIQHR--N 63 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~------------------~-------~~~~~~~e~~~l~~l~h~--~ 63 (312)
+.+...||-|.-|.||.|....+.++++|.-.. . ......+|.++|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999988899999993110 0 012356788999888543 6
Q ss_pred ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC
Q 021441 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 143 (312)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~ 143 (312)
+.+.+++ +...+|||+++|..|...-. +......++..|+..+..+-. .||||+|+++=||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEe
Confidence 7777765 34569999999866653321 122223344555555544444 7799999999999999
Q ss_pred CCCceEEeecccc
Q 021441 144 EDFIAKVADAGLR 156 (312)
Q Consensus 144 ~~~~vkl~Dfg~a 156 (312)
++|.+.++||--+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.7e-08 Score=76.49 Aligned_cols=134 Identities=12% Similarity=0.057 Sum_probs=95.2
Q ss_pred ccCcceEEEeeeeCCceEEEEEeCC---------CCChhHHHHHHHHHhcCCCc--cceeeeeeee---eC--CeEEEEE
Q 021441 18 GEGKFGEVYKGLLQDGMLVAIKKRP---------GAPTQEFIDEVCFLASIQHR--NLVTLLGYCQ---EN--NLQFLIY 81 (312)
Q Consensus 18 g~G~~g~V~~~~~~~~~~vaiK~~~---------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~--~~~~lv~ 81 (312)
+.|+.|.|+..... |+.+.+|.-. +.....+.+|...+..+... .+.+.. ++. .+ ..-++|.
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 45888999998765 3468889532 33557899999999988432 244444 222 11 1347899
Q ss_pred EeccC-CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc--eEEeecccccc
Q 021441 82 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~--vkl~Dfg~a~~ 158 (312)
|-+.+ .+|.+++.. ......+......++.+++..+.-||+ .|+.|+|+-+.||+++.++. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 467666521 122344666677899999999999999 77999999999999987677 99999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.6e-08 Score=79.04 Aligned_cols=106 Identities=22% Similarity=0.238 Sum_probs=77.8
Q ss_pred hhHHHHHHHHHhcCCC--ccceeeeeeeeeC----CeEEEEEEeccCC-cccccccCcccccccccCHHHHHHHHHHHHH
Q 021441 46 TQEFIDEVCFLASIQH--RNLVTLLGYCQEN----NLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118 (312)
Q Consensus 46 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 118 (312)
.....+|...+..+.. =..+..+++.... ...++|+|++++. +|.+++... ...+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 3456778777777642 2244555555432 2348999999874 677777321 11455566789999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEeecccccc
Q 021441 119 GLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNF 158 (312)
Q Consensus 119 ~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~Dfg~a~~ 158 (312)
.++-||. +||+|+|+++.|||++.++ .+.++||+.+..
T Consensus 130 ~i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 7799999999999999887 899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-07 Score=74.05 Aligned_cols=135 Identities=15% Similarity=0.140 Sum_probs=87.4
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChh------------HHHHHHHHHhcCC---Cccceeeeee
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ------------EFIDEVCFLASIQ---HRNLVTLLGY 70 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------~~~~e~~~l~~l~---h~~i~~~~~~ 70 (312)
+...+|.+.+.+.......|.+.... ++.+++|...+.... ...+.+..+..+. -...+.++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34577888888888777777766665 578999976654331 1222333333332 2233333333
Q ss_pred eee-----CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 71 CQE-----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 71 ~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
... ....+++|||++|..|.+.. .++. .+...+..++..+|. .|+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECC
Confidence 221 22346899999998776543 1121 244567788999999 679999999999999966
Q ss_pred CceEEeeccccc
Q 021441 146 FIAKVADAGLRN 157 (312)
Q Consensus 146 ~~vkl~Dfg~a~ 157 (312)
+ ++++||+...
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 5 9999997644
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.9e-07 Score=74.60 Aligned_cols=139 Identities=17% Similarity=0.088 Sum_probs=83.7
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCCCc--cceeeeeeeeeCCeEEEEEEeccCCc-cc
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHR--NLVTLLGYCQENNLQFLIYEYIPNGS-VS 90 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~-L~ 90 (312)
..||+|..+.||... +..+++|...... .....+|.++++.+..- -+.+.+++....+...+|||+++|.+ +.
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 568999999999842 4457889866543 45678899999888532 25677777777777889999999863 21
Q ss_pred ccccCc-----------------ccc-cccccCHHHH-HHHHH----------HHHHH-HHHHh--cCCCCeEecCCCCC
Q 021441 91 IHLYGP-----------------SQV-SRQKLEFKHR-LSIAL----------GAAKG-LAHLH--SLSPRVVHKDFKTA 138 (312)
Q Consensus 91 ~~~~~~-----------------~~~-~~~~~~~~~~-~~i~~----------~i~~~-L~~lH--~~~~givH~dikp~ 138 (312)
..+... .+. .......... ..+.. .+... ..+|. .....++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111000 000 0000111100 00000 00111 11221 22245799999999
Q ss_pred ceEeCCCCceEEeeccccc
Q 021441 139 NVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~ 157 (312)
||++++++ +.++||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999988 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.4e-07 Score=74.91 Aligned_cols=76 Identities=18% Similarity=0.230 Sum_probs=55.0
Q ss_pred ccccCcc-eEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEeccCCccccc
Q 021441 16 LIGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 92 (312)
Q Consensus 16 ~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (312)
.|..|.+ ..||++... +..+.+|.........+.+|+.+++.+. +--+.+++++....+..++||++++|.++...
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4455555 789999865 3678999877655556778998888873 33456677777666667899999999777543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.4e-07 Score=81.77 Aligned_cols=136 Identities=18% Similarity=0.161 Sum_probs=86.1
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHH-----------------------------------------
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE----------------------------------------- 52 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e----------------------------------------- 52 (312)
...|+.++-|.||.|..++|+.||||+..+...+.+...
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 377889999999999988899999997555444333322
Q ss_pred --HHHHhcCC-----Ccc--ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHH-HHH
Q 021441 53 --VCFLASIQ-----HRN--LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG-LAH 122 (312)
Q Consensus 53 --~~~l~~l~-----h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~-L~~ 122 (312)
...+.++. .++ |.+++ ..-.+...++|||++|..+.+..... ....+...+ +..++.+ +..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k~i---a~~~~~~f~~q 280 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALK----SAGIDRKEL---AELLVRAFLRQ 280 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHH----hcCCCHHHH---HHHHHHHHHHH
Confidence 22222221 122 11211 11223456999999998888775211 123343332 2222222 222
Q ss_pred HhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 123 lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
+=. .|+.|+|..|.||+++.+|.+.+.|||+.....
T Consensus 281 ~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHh--cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 222 569999999999999999999999999976654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.6e-07 Score=72.73 Aligned_cols=77 Identities=18% Similarity=0.274 Sum_probs=55.2
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCc--cceeeeeee---eeCCeEEEEEEeccCC
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR--NLVTLLGYC---QENNLQFLIYEYIPNG 87 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~ 87 (312)
++.|+.|..+.||.+...+ ..+++|..... ....+..|..+++.+... -+.+++... ......+++|++++|.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 4678999999999999776 58999987665 445677888888887422 245666533 2334578999999997
Q ss_pred cccc
Q 021441 88 SVSI 91 (312)
Q Consensus 88 ~L~~ 91 (312)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.1e-06 Score=69.48 Aligned_cols=135 Identities=19% Similarity=0.223 Sum_probs=85.9
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChh----------------------H-----HHHHHHHHhcCC--Cccc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------------------E-----FIDEVCFLASIQ--HRNL 64 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~-----~~~e~~~l~~l~--h~~i 64 (312)
...|++|.-+.||.|...++..+|+|++...... . ..+|...|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3467778888999999777889999974422110 1 233555555552 3344
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC
Q 021441 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 144 (312)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~ 144 (312)
.+.+++.. ..+|||++..... - ................+..+++..+.-|-. ..|+||+||+.=|||+.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~---p--AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGL---P--APRLKDVPLELEEAEGLYEDVVEYMRRLYK-EAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeecC----CeEEEEeccCCCC---C--CCCcccCCcCchhHHHHHHHHHHHHHHHHH-hcCcccccchhhheEEE-
Confidence 55554433 3489999955311 1 011111222222456677777777766654 25799999999999999
Q ss_pred CCceEEeeccccccc
Q 021441 145 DFIAKVADAGLRNFL 159 (312)
Q Consensus 145 ~~~vkl~Dfg~a~~~ 159 (312)
++.+.++|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 889999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.4e-08 Score=86.25 Aligned_cols=187 Identities=21% Similarity=0.128 Sum_probs=132.7
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEEEeccCC-c
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPNG-S 88 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~ 88 (312)
|.....+++|+++++++.+....+....+.+... ....-++++|.+++||| .+..++-+......+++++++.++ +
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 4445567789999999888443444445544333 44456789999999999 555555566667789999999876 3
Q ss_pred ccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCC
Q 021441 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168 (312)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 168 (312)
....+. .....+.......+.+.-..+++++|+.. =+|+| ||+.++ +..+..||+....+.+.. ..
T Consensus 322 ~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 322 SALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred ccccCC----hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 332221 22233444555667778888999999732 48888 777665 678999999887765443 23
Q ss_pred ccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCC
Q 021441 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 213 (312)
Q Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~ 213 (312)
....+++.++|||+...+.+....|.||+|.-..+|.-|.+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 445678889999999999999999999999887888887776443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=8e-06 Score=79.56 Aligned_cols=77 Identities=17% Similarity=0.336 Sum_probs=56.4
Q ss_pred ccccccCcceEEEeeeeCCc---eEEEEEeCCCC----ChhHHHHHHHHHhcCC-Cccc--eeeeeeeeeC---CeEEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNL--VTLLGYCQEN---NLQFLI 80 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~----~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 80 (312)
.+.++.|.+..+|++....+ ..+++|+.+.. ....+.+|..+++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57788899999999885443 46888876542 2346789999999985 6654 7777777654 457899
Q ss_pred EEeccCCccc
Q 021441 81 YEYIPNGSVS 90 (312)
Q Consensus 81 ~e~~~~~~L~ 90 (312)
||+++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999986543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.7e-06 Score=65.17 Aligned_cols=129 Identities=19% Similarity=0.234 Sum_probs=89.7
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCC-CCChhHHHHHHHHHhcCCCcccee-eeeeeeeCCeEEEEEEeccCCc
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVT-LLGYCQENNLQFLIYEYIPNGS 88 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~-~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~ 88 (312)
.+..+.|++|.+|.||++.+. +..+|+|.-. ......+..|.++|..+..-.+.+ +|.+..+ ++.|||+.|-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 355789999999999999987 4578888644 445678999999999987666544 4544333 36699999977
Q ss_pred ccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceEeCCCCceEEeecccccc
Q 021441 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK-TANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dik-p~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
|.+.-... +. .-...+++.-.-|-. .||-|..|. |...++-.++.+.|+||..|+.
T Consensus 99 L~~~~~~~--------~r----k~l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG--------DR----KHLLRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc--------cH----HHHHHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 76444111 12 233445555444555 568888875 5666666666999999988763
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-05 Score=66.17 Aligned_cols=74 Identities=9% Similarity=0.157 Sum_probs=46.6
Q ss_pred ccccccCcce-EEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCc---cceeeeeeeeeC---CeEEEEEEecc
Q 021441 14 KNLIGEGKFG-EVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQEN---NLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~ 85 (312)
++.|+.|+.. .||.+. ..+++|..... ....+.+|.+++..+... -+..+++..... ...|++|++++
T Consensus 2 ~~~~~~gG~~n~vy~~~----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 2 IEPVDSGGTDNATFRLG----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred ceeccCCCcccceEEcC----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 3557766655 689762 24778876553 345688899999887532 234444443322 23488999999
Q ss_pred CCcccc
Q 021441 86 NGSVSI 91 (312)
Q Consensus 86 ~~~L~~ 91 (312)
|.++..
T Consensus 78 G~~l~~ 83 (235)
T cd05155 78 GETATA 83 (235)
T ss_pred CCCCCc
Confidence 977753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.8e-05 Score=61.60 Aligned_cols=102 Identities=24% Similarity=0.194 Sum_probs=76.5
Q ss_pred HHHHHHhcCCC-ccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-
Q 021441 51 DEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP- 128 (312)
Q Consensus 51 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~- 128 (312)
.|.-+++.+.+ +++++++|+|.. ++|.||...+++....... ..-...+|..+..++.+++..+.+++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888865 699999999853 3688999765553211000 112345799999999999999999986322
Q ss_pred CeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 129 givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
.+.-.|++|+|+.+++++.+|++|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 388899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=62.21 Aligned_cols=123 Identities=20% Similarity=0.286 Sum_probs=85.0
Q ss_pred hcCCCcccccccCcc-eEEEeeeeCCceEEEEEeCCC------------------------CChhHHHHHHHHHhcCC--
Q 021441 8 TKNFSDKNLIGEGKF-GEVYKGLLQDGMLVAIKKRPG------------------------APTQEFIDEVCFLASIQ-- 60 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~------------------------~~~~~~~~e~~~l~~l~-- 60 (312)
..+++.++.||.|.- |.||++... ++.||+|.+.. ...+.|..|-....+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 478889999999999 999999986 67899997110 01123566766666663
Q ss_pred -Cccc--eeeeeeeeeCC------------------eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHH
Q 021441 61 -HRNL--VTLLGYCQENN------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119 (312)
Q Consensus 61 -h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~ 119 (312)
+.++ ++++||..-.. ..-||.||.+... .+. .+-+.+|.+-
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~d 176 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRD 176 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHH
Confidence 4455 88999873220 1135666554321 111 2345677888
Q ss_pred HHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 120 L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+..+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 177 l~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence 889999 67999999999997 5599999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-05 Score=64.54 Aligned_cols=73 Identities=18% Similarity=0.158 Sum_probs=47.9
Q ss_pred ccccccCcceEEEeeeeCC--ceEEEEEeCCCCChh--HHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEEEeccCCc
Q 021441 14 KNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPNGS 88 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (312)
++.|..|-...+|++...+ ++.|++|........ ...+|..+++.+.... .++++.... + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 3567778889999998653 568899976544322 2346888888874323 344444332 2 37999999876
Q ss_pred cc
Q 021441 89 VS 90 (312)
Q Consensus 89 L~ 90 (312)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.1e-05 Score=64.85 Aligned_cols=135 Identities=13% Similarity=0.114 Sum_probs=76.2
Q ss_pred ccccCcceEEEeeeeCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEeccCCcccc
Q 021441 16 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVSI 91 (312)
Q Consensus 16 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (312)
.+..|-.+.+|++... ++.+++|....... ....+|..+++.+....+ .+++... . -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 4556888899998843 56788997554322 135778888888853323 3344332 2 258999999876643
Q ss_pred cc-----------------cCcccccccccCHH-HHHHHHHHH---------HHHHHHHhc------CCCCeEecCCCCC
Q 021441 92 HL-----------------YGPSQVSRQKLEFK-HRLSIALGA---------AKGLAHLHS------LSPRVVHKDFKTA 138 (312)
Q Consensus 92 ~~-----------------~~~~~~~~~~~~~~-~~~~i~~~i---------~~~L~~lH~------~~~givH~dikp~ 138 (312)
.. +.. .......+.. .+..+..++ ...+..+-. ....++|+|+.|.
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQ-PRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 20 000 0011111111 111111111 111111111 1135899999999
Q ss_pred ceEeCCCCceEEeeccccc
Q 021441 139 NVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~ 157 (312)
||++++++ +.++||+.+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.1e-05 Score=65.55 Aligned_cols=143 Identities=15% Similarity=0.085 Sum_probs=83.7
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCc--cceeeeee------eeeCCeEEEEEEecc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~ 85 (312)
++.+..|....+|++...+ ..+++|............|..++..+.+. .+.+++.. ....+..++|+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 5677778888999987554 46888987765556677788888877432 24444332 123455689999999
Q ss_pred CCcccccc--------------cCcc-cccc-----cccCHHHH----------HHHHHHHHHHHHHHhc-----CCCCe
Q 021441 86 NGSVSIHL--------------YGPS-QVSR-----QKLEFKHR----------LSIALGAAKGLAHLHS-----LSPRV 130 (312)
Q Consensus 86 ~~~L~~~~--------------~~~~-~~~~-----~~~~~~~~----------~~i~~~i~~~L~~lH~-----~~~gi 130 (312)
|..+...- +... .... ....+... ......+..++.++.. ...++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 87654310 0000 0000 00010000 0011112222333332 23569
Q ss_pred EecCCCCCceEeCCCCceEEeeccccc
Q 021441 131 VHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 131 vH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
+|+|+.|.|++++.++.+.|+||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhc
Confidence 999999999999998778999998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.5e-05 Score=63.25 Aligned_cols=79 Identities=15% Similarity=0.105 Sum_probs=58.4
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCC---ccceeeeeeeee---CCeEEEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH---RNLVTLLGYCQE---NNLQFLIYE 82 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e 82 (312)
...-.+.||+|..+.||.....++ ++.+|..... ....+..|.+.++.+.. -.+.++++++.. .+..++|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 344467899999999999986545 4666765542 45688899999998842 357788877654 355799999
Q ss_pred eccCCcc
Q 021441 83 YIPNGSV 89 (312)
Q Consensus 83 ~~~~~~L 89 (312)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.4e-05 Score=59.91 Aligned_cols=125 Identities=17% Similarity=0.180 Sum_probs=83.6
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCC-------------------hhHHHHHHHHHhcCC------Cccceeee
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------TQEFIDEVCFLASIQ------HRNLVTLL 68 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------------~~~~~~e~~~l~~l~------h~~i~~~~ 68 (312)
...||+|+.-.||.--... ...||...... ..+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~HP~dp--~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDP--NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEECCCCC--CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4679999999999765432 35677665555 456667777666655 78899999
Q ss_pred eeeeeCCeEEEEEEeccC--C----cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 69 GYCQENNLQFLIYEYIPN--G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 69 ~~~~~~~~~~lv~e~~~~--~----~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
|+...+-..-+|+|.+.. | +|.+++ ....++. . +...+-.-..+|-. ..|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l------~~~~~~~-~---~~~~L~~f~~~l~~--~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL------KEGGLTE-E---LRQALDEFKRYLLD--HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH------HcCCccH-H---HHHHHHHHHHHHHH--cCCeecCCCcccEEE
Confidence 999998888899998743 2 344444 1222333 2 22233333456666 559999999999999
Q ss_pred CCCC----ceEEee
Q 021441 143 DEDF----IAKVAD 152 (312)
Q Consensus 143 ~~~~----~vkl~D 152 (312)
.... .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 6432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.2e-05 Score=69.50 Aligned_cols=136 Identities=16% Similarity=0.185 Sum_probs=84.6
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChh----------------------------------------HHHHHH
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------------------------------------EFIDEV 53 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------------------------~~~~e~ 53 (312)
.+.||.-+.|.|++|+.++|+.||+|.-.+...+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4788999999999999888999999953322211 122232
Q ss_pred HHHhc----CCCcc------ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHH-
Q 021441 54 CFLAS----IQHRN------LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH- 122 (312)
Q Consensus 54 ~~l~~----l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~- 122 (312)
+-..+ +.|-+ |.++|-.+. ....++|||++|..+.+.-. .....++.. .++..+.++...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~----i~~~gi~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDA----IDKRGISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHH----HHHcCCCHH---HHHHHHHHHHHHH
Confidence 22222 22333 444443322 24569999999987765531 122233433 344444444322
Q ss_pred HhcCCCCeEecCCCCCceEeCC----CCceEEeecccccccc
Q 021441 123 LHSLSPRVVHKDFKTANVLVDE----DFIAKVADAGLRNFLG 160 (312)
Q Consensus 123 lH~~~~givH~dikp~Nil~~~----~~~vkl~Dfg~a~~~~ 160 (312)
+=. .|++|+|-.|.||++.. ++.+.+-|||+.....
T Consensus 317 If~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHh--cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 222 56999999999999983 6799999999977653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=62.99 Aligned_cols=143 Identities=17% Similarity=0.086 Sum_probs=81.2
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCc--cceeeeeee------eeCCeEEEEEEec
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR--NLVTLLGYC------QENNLQFLIYEYI 84 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~--~i~~~~~~~------~~~~~~~lv~e~~ 84 (312)
++.++.|....+|++...++ .+++|..... ....+..|.+++..|... .+++++... ...+..+++++|+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 56777787789999886544 5788976543 245566677777776321 234444321 2245678999999
Q ss_pred cCCcccccc--------------cCccc---ccc-c---ccCHHHHH------------HHHHHHHHHHHHHh-----cC
Q 021441 85 PNGSVSIHL--------------YGPSQ---VSR-Q---KLEFKHRL------------SIALGAAKGLAHLH-----SL 126 (312)
Q Consensus 85 ~~~~L~~~~--------------~~~~~---~~~-~---~~~~~~~~------------~i~~~i~~~L~~lH-----~~ 126 (312)
+|..+.... +.... ... . ...+.... .....+...+.++. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 886543110 00000 000 0 00000000 00111222333342 22
Q ss_pred CCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 127 ~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
..+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3679999999999999998877899998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.5e-06 Score=78.70 Aligned_cols=200 Identities=23% Similarity=0.217 Sum_probs=132.0
Q ss_pred HHHHHHHHhcCCCccceeeeeeeeeCCe----EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh
Q 021441 49 FIDEVCFLASIQHRNLVTLLGYCQENNL----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124 (312)
Q Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH 124 (312)
...|.+.+..+.|+|+..++.|...... ..+..+++...++...+ ..-...+..+...+..++.+||.++|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3457778888899999999988755432 23456777777776666 34556788899999999999999999
Q ss_pred cCCCCeEecCCCCC---ceEeCCCCceEEe--eccccccccCCCcCCCCccccCcccccchhhhhhcCCCc--ccceehh
Q 021441 125 SLSPRVVHKDFKTA---NVLVDEDFIAKVA--DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE--KSDVYSF 197 (312)
Q Consensus 125 ~~~~givH~dikp~---Nil~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~sDiwsl 197 (312)
... ..|.-+..+ +.-.+..+.+..+ ||+.+......... .....+..+-++|....+.+.. ..|+|.+
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc--cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 843 444444444 4444555666666 88877765443221 1122333467787777666544 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 021441 198 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277 (312)
Q Consensus 198 G~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (312)
|.....+..|..+-.-... .. ...+........+...+|+.-++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~------------------~~--------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV------------------PV--------SLLDVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccc------------------hh--------hhhccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999887654211000 00 001111112567888999999999999999999
Q ss_pred HHHHHHH
Q 021441 278 TELDRTL 284 (312)
Q Consensus 278 ~~l~~~~ 284 (312)
.+.---.
T Consensus 433 ~~~f~~~ 439 (1351)
T KOG1035|consen 433 THPFLRF 439 (1351)
T ss_pred hchhccc
Confidence 8754433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00033 Score=60.67 Aligned_cols=143 Identities=13% Similarity=0.046 Sum_probs=77.7
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCc--cceeeeee------eeeCCeEEEEEEecc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~ 85 (312)
++.|+.|....+|.+...++ .+++|.........+..+..++..|... .+.+++.. ....+..++++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 45677777789999986655 5888987533444555566666655311 13333321 223456789999999
Q ss_pred CCcccccc--------------cCccc----ccccccCHHHHH---------------HHHHHHH-HHHHHHhc-----C
Q 021441 86 NGSVSIHL--------------YGPSQ----VSRQKLEFKHRL---------------SIALGAA-KGLAHLHS-----L 126 (312)
Q Consensus 86 ~~~L~~~~--------------~~~~~----~~~~~~~~~~~~---------------~i~~~i~-~~L~~lH~-----~ 126 (312)
|..+...- +.... ............ ....+.+ ..+..+.. .
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 86542110 00000 000000110000 0111111 11222221 3
Q ss_pred CCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 127 ~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
..|+||+|+.|+||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3579999999999999977666899998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00013 Score=62.63 Aligned_cols=72 Identities=25% Similarity=0.259 Sum_probs=47.4
Q ss_pred cccccCcceEEEeeeeCC-------ceEEEEEeCCCCC--hhHHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEEEec
Q 021441 15 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGAP--TQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+.+..|-...+|++.... ++.+++|...... ......|.+++..+.... ..++++.+.. ..|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 456667778999998543 4789999866542 235677888888874322 3345554432 2589999
Q ss_pred cCCccc
Q 021441 85 PNGSVS 90 (312)
Q Consensus 85 ~~~~L~ 90 (312)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00068 Score=60.02 Aligned_cols=72 Identities=17% Similarity=0.155 Sum_probs=51.0
Q ss_pred ccccccCcceEEEeeeeCCc-eEEEEEeCCC----------CChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQDG-MLVAIKKRPG----------APTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~----------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 79 (312)
.+.||.|....||++...++ +.+++|...+ ...+....|.+.|..+. ..++++++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 56899999999999997655 5899997431 13345667888887762 245677776643 44679
Q ss_pred EEEeccCC
Q 021441 80 IYEYIPNG 87 (312)
Q Consensus 80 v~e~~~~~ 87 (312)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=7.8e-05 Score=62.90 Aligned_cols=129 Identities=17% Similarity=0.155 Sum_probs=89.6
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCC----------CCC---------------hhHHHHHHHHHhcCC-Ccc
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP----------GAP---------------TQEFIDEVCFLASIQ-HRN 63 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~----------~~~---------------~~~~~~e~~~l~~l~-h~~ 63 (312)
-+.++..||-|.-+.+|.+....|+..++|.-. ... +-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467789999999999999998888899998310 000 012455777777773 322
Q ss_pred -ceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 64 -LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 64 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
+++.+++ +..++|||++.+..|...- .-.+.. .+...+..-+.-|-. +|+||+|..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~--------~v~d~~---~ly~~lm~~Iv~la~--~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR--------HVEDPP---TLYDDLMGLIVRLAN--HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee--------ecCChH---HHHHHHHHHHHHHHH--cCceecccchheeEE
Confidence 3444543 4567999999998776443 111222 234445555566666 779999999999999
Q ss_pred CCCCceEEeeccc
Q 021441 143 DEDFIAKVADAGL 155 (312)
Q Consensus 143 ~~~~~vkl~Dfg~ 155 (312)
++++.++++||--
T Consensus 236 ~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQ 248 (465)
T ss_pred ecCCCEEEeechH
Confidence 9999999999964
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=55.84 Aligned_cols=30 Identities=27% Similarity=0.376 Sum_probs=25.0
Q ss_pred CeEecCCCCCceEeCCCCc-eEEeecccccc
Q 021441 129 RVVHKDFKTANVLVDEDFI-AKVADAGLRNF 158 (312)
Q Consensus 129 givH~dikp~Nil~~~~~~-vkl~Dfg~a~~ 158 (312)
.++|+|+.|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997554 56999987753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00062 Score=57.72 Aligned_cols=76 Identities=17% Similarity=0.264 Sum_probs=49.8
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
.+-.+.++.|....+|++.. +++.+-+|.........+..|.+-|+.|. --.+++++++....+..|+||||++.+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~-~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT-DGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp --EEEEE--SSSSEEEEEET-TS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeeeEecCCCChhheEEEEC-CCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34467888899999999884 46678999877656677888888888773 456788888887777779999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0049 Score=52.79 Aligned_cols=137 Identities=23% Similarity=0.285 Sum_probs=80.7
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCcc--ceeeeeeeeeCC--eEEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRN--LVTLLGYCQENN--LQFLIY 81 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~--~~~lv~ 81 (312)
..+.+.+..|....+|..... ++++++. .+. .......+|..+++.+..-- +...+++|.... ..|.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344555544555556666544 6778888 331 22344566778887764212 334455665544 568999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHH-HHHHHHHHHHhcC----------------------------------
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA-LGAAKGLAHLHSL---------------------------------- 126 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~-~~i~~~L~~lH~~---------------------------------- 126 (312)
+++.|..+........ .. .+.+ -.+...|+-||+.
T Consensus 105 ~~veGe~~~~~~~~~~------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~ 174 (321)
T COG3173 105 EWVEGEVVWSALPPES------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG 174 (321)
T ss_pred EEecceeccCcCCccc------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence 9999854332221000 00 0111 1333333333332
Q ss_pred ----------------------CCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 127 ----------------------SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 127 ----------------------~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
...++|+|+.+.|+++++++-+-+.||+++...
T Consensus 175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 134799999999999999999999999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0023 Score=55.99 Aligned_cols=140 Identities=16% Similarity=0.115 Sum_probs=77.4
Q ss_pred ccccccCcceEEEeeeeC-----CceEEEEEeCCCCChh--HHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEecc
Q 021441 14 KNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~ 85 (312)
+..|..|-...+|++... .++.|++|+....... ....|..+++.+....+ .++++.+..+ .|.+|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445556778899998743 2367999987654322 23568888887753333 3455555332 5789998
Q ss_pred CCcccccc-----------------cCccccccc-ccCHHHHHHHHHHH--------------------HHHHHH-Hhc-
Q 021441 86 NGSVSIHL-----------------YGPSQVSRQ-KLEFKHRLSIALGA--------------------AKGLAH-LHS- 125 (312)
Q Consensus 86 ~~~L~~~~-----------------~~~~~~~~~-~~~~~~~~~i~~~i--------------------~~~L~~-lH~- 125 (312)
+.++...- +........ ...+..+..+..++ +..|.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 76664210 000000000 11122222222111 111111 111
Q ss_pred -CCCCeEecCCCCCceEeCC-CCceEEeeccccc
Q 021441 126 -LSPRVVHKDFKTANVLVDE-DFIAKVADAGLRN 157 (312)
Q Consensus 126 -~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a~ 157 (312)
....++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1235899999999999986 4689999997654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=4e-05 Score=76.25 Aligned_cols=157 Identities=14% Similarity=0.061 Sum_probs=111.2
Q ss_pred HHHHHhcCCCccceeeeeeeee--CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC---
Q 021441 52 EVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--- 126 (312)
Q Consensus 52 e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--- 126 (312)
|..-++...|+++...+.-... +...|.+++++.+|.+.+.+.++... ....+...+.....+.+.+..-+|..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3334445578877665544432 23458899999999999888766543 33344444444444446666666643
Q ss_pred CCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh
Q 021441 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 206 (312)
Q Consensus 127 ~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t 206 (312)
++--+|+++|+-|-++..+-.++++++|+.+.... ...-.+...+++.|++|+..+.-.++.++|+|..|+.+|...-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 34479999999999999999999999999883211 1112334457778999999998899999999999999999888
Q ss_pred CCCCC
Q 021441 207 GREAS 211 (312)
Q Consensus 207 g~~pf 211 (312)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.013 Score=50.48 Aligned_cols=29 Identities=21% Similarity=0.276 Sum_probs=25.2
Q ss_pred CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 128 ~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999988 678999998643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0092 Score=51.45 Aligned_cols=31 Identities=19% Similarity=0.189 Sum_probs=27.7
Q ss_pred CCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 128 ~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
.+++|+|+.++|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 5799999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.015 Score=50.47 Aligned_cols=138 Identities=17% Similarity=0.141 Sum_probs=86.2
Q ss_pred CcccccccCcceEEEeeeeCCceEEEEEeCCCCC------------------------hhH-----HHHHHHHHhcCCCc
Q 021441 12 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------------------------TQE-----FIDEVCFLASIQHR 62 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------------------------~~~-----~~~e~~~l~~l~h~ 62 (312)
.+.+.|..|.-.-||.|...+|..+|||+++... ... ..+|..-|+++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456677888889999998888999999633110 000 23466667776544
Q ss_pred cceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
.|...--+... ...|||+++.......-. .....++...+..+..+++.-+.-|-+ .+++||.||.-=|+|+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHH-HhceeccchhhhhheE
Confidence 33322222222 245899999654332111 222334445566666777776665554 2679999999999988
Q ss_pred CCCCceEEeecccccc
Q 021441 143 DEDFIAKVADAGLRNF 158 (312)
Q Consensus 143 ~~~~~vkl~Dfg~a~~ 158 (312)
- +|.+.++|.+-+-.
T Consensus 299 h-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVE 313 (520)
T ss_pred E-CCEEEEEEcccccc
Confidence 5 56899999876543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.029 Score=49.81 Aligned_cols=71 Identities=13% Similarity=0.116 Sum_probs=48.6
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCC----------ChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEE
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----------PTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----------~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 79 (312)
..+.||.|....||++... ++.++||.-... ...+-..|.+.|+.+. -.++++++.++.+. .++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 4678899999999999865 456899964411 2233344566666553 24778888887744 458
Q ss_pred EEEeccC
Q 021441 80 IYEYIPN 86 (312)
Q Consensus 80 v~e~~~~ 86 (312)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0014 Score=58.93 Aligned_cols=166 Identities=20% Similarity=0.265 Sum_probs=92.2
Q ss_pred hHHHHHHHHHhcCCCccceeeeeeeee-CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhc
Q 021441 47 QEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125 (312)
Q Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~ 125 (312)
.++.-...+++.+.|+|....+++... .....+|||++.. ++.+..... . .-.. ++. .
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~-----~-l~~~-------s~~-------~ 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG-----N-LKDE-------SLL-------A 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc-----c-cchh-------hhc-------c
Confidence 345566788889999999998887643 3457789999844 777666211 1 1100 000 1
Q ss_pred CCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHH
Q 021441 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 205 (312)
Q Consensus 126 ~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~ 205 (312)
+|+.|-.+ +..+| .++.. | | ...++++||||+|.++.++.
T Consensus 86 --~~~~~~~~------------~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 86 --HGVLHLNI------------IYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELY 125 (725)
T ss_pred --cccceehh------------hhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHH
Confidence 33444222 22222 00000 0 0 11124999999999999999
Q ss_pred hCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 021441 206 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 278 (312)
Q Consensus 206 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (312)
-|...+......+...........+ .......... .+.-.+++.+.++...|+...|..||...++.+
T Consensus 126 L~~~l~~~~~~s~~l~~i~k~~~~d--~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEILLKYYTDD--QELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HhhHHHHHHHHHHHHHHHHHhccCc--hhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 9887665433322221111111111 0111111111 233344567889999999999999998777664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.011 Score=51.40 Aligned_cols=72 Identities=15% Similarity=0.175 Sum_probs=44.0
Q ss_pred ccccccCcceEEEeeeeCC----ceEEEEEeCCCCCh--hHHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEeccC
Q 021441 14 KNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~--~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
++.|..|=...+|++.... +..|++|+...... -.-.+|..+++.+....+ .++++++. ++ +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 3445557778899987432 23789997654332 223567888888754444 34555543 22 58888877
Q ss_pred Ccc
Q 021441 87 GSV 89 (312)
Q Consensus 87 ~~L 89 (312)
..+
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.026 Score=49.22 Aligned_cols=70 Identities=13% Similarity=0.181 Sum_probs=44.3
Q ss_pred cccccCcceEEEeeeeCCc-eEEEEEeCC----------CCChhHHHHHHHHHhcCC--Cc-cceeeeeeeeeCCeEEEE
Q 021441 15 NLIGEGKFGEVYKGLLQDG-MLVAIKKRP----------GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~-~~vaiK~~~----------~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 80 (312)
+.||.|....||++....+ +.++||.-. +...++..-|.+.|+... -| +++++|.+ +.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3589999999999996543 579999422 122344556777777653 24 45555544 33344589
Q ss_pred EEeccC
Q 021441 81 YEYIPN 86 (312)
Q Consensus 81 ~e~~~~ 86 (312)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.09 Score=42.71 Aligned_cols=80 Identities=14% Similarity=0.242 Sum_probs=59.1
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC---CCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.+..+.+..|.--..|.+... ...+-+|.........+..|+.-|+.+ +.-.+.+++.+....+..|+||||++.
T Consensus 17 ~i~er~~v~gG~inea~~v~dg-~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDG-TDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred hhhcccccCCccccceeEeecC-CcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 4445567777777777877765 356888987777667777777666655 345688888888899999999999987
Q ss_pred Cccc
Q 021441 87 GSVS 90 (312)
Q Consensus 87 ~~L~ 90 (312)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.044 Score=47.47 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=80.0
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCC---cccee---eeeee--eeCC--eEEEEEEe
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH---RNLVT---LLGYC--QENN--LQFLIYEY 83 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h---~~i~~---~~~~~--~~~~--~~~lv~e~ 83 (312)
..|.+ .-..+|++...+++. ++|..... ...++..|...+..+.- +-.++ .-|-. .-.+ ..+.+++|
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 34444 446789998776654 99988775 55677788888888731 21122 11111 1123 67889999
Q ss_pred ccCCcccc-cccC------------------cc--c-ccccccCHHH-------------HHHHHHHHHHHHHHHhcC--
Q 021441 84 IPNGSVSI-HLYG------------------PS--Q-VSRQKLEFKH-------------RLSIALGAAKGLAHLHSL-- 126 (312)
Q Consensus 84 ~~~~~L~~-~~~~------------------~~--~-~~~~~~~~~~-------------~~~i~~~i~~~L~~lH~~-- 126 (312)
++|..+.. .... .. + .......+.. ......++...+..+...
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987763 1100 00 0 0000111110 001222233333333321
Q ss_pred ----CCC--eEecCCCCCceEeCCCCc-eEEeeccccc
Q 021441 127 ----SPR--VVHKDFKTANVLVDEDFI-AKVADAGLRN 157 (312)
Q Consensus 127 ----~~g--ivH~dikp~Nil~~~~~~-vkl~Dfg~a~ 157 (312)
..+ +||+|+.|+||+++.+.. +.++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 133 999999999999999884 8999998653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.057 Score=54.22 Aligned_cols=143 Identities=15% Similarity=0.157 Sum_probs=77.9
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCC--Ccc--ceeeeee--------eee-CC--eEE
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQ--HRN--LVTLLGY--------CQE-NN--LQF 78 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~--h~~--i~~~~~~--------~~~-~~--~~~ 78 (312)
+.|+ |..-.+|++...+++.+++|+.+... ......|...+..|. ++. +.+++-. ... .+ ..+
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v 109 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL 109 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence 4564 45578899987777789999987543 334445656665552 122 2222211 111 12 456
Q ss_pred EEEEeccCCccccccc-C--------------------cccc-cccccCH-----------------HHHHHHHHHHHHH
Q 021441 79 LIYEYIPNGSVSIHLY-G--------------------PSQV-SRQKLEF-----------------KHRLSIALGAAKG 119 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~-~--------------------~~~~-~~~~~~~-----------------~~~~~i~~~i~~~ 119 (312)
.+++|++|..+.+... . .... ....+.| .....++.+++..
T Consensus 110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~ 189 (1013)
T PRK06148 110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR 189 (1013)
T ss_pred EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence 7899999976654110 0 0000 0011111 0111222223222
Q ss_pred HH-----HHhcCCCCeEecCCCCCceEeCCCC--ce-EEeecccccc
Q 021441 120 LA-----HLHSLSPRVVHKDFKTANVLVDEDF--IA-KVADAGLRNF 158 (312)
Q Consensus 120 L~-----~lH~~~~givH~dikp~Nil~~~~~--~v-kl~Dfg~a~~ 158 (312)
.. .+..+..++||+|+.+.||+++.++ .+ -|+|||-+..
T Consensus 190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 21 2334446799999999999999875 45 4999997643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.14 Score=44.42 Aligned_cols=69 Identities=17% Similarity=0.222 Sum_probs=43.6
Q ss_pred cceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCcc--ceeee---e--eeeeCCeEEEEEEeccCCcc
Q 021441 21 KFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRN--LVTLL---G--YCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 21 ~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e~~~~~~L 89 (312)
.-..||.+...++..+++|..... ....+..|...+..+.... ++... | ....++..+.|+++++|...
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 346799998776778999987543 3456677888777763211 22211 1 12234567889999987644
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.046 Score=48.51 Aligned_cols=73 Identities=21% Similarity=0.300 Sum_probs=44.1
Q ss_pred ccccccCcceEEEeeeeCCc-------eEEEEEeCCCCCh--hHHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEe
Q 021441 14 KNLIGEGKFGEVYKGLLQDG-------MLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~-------~~vaiK~~~~~~~--~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 83 (312)
.+.|..|-...+|++....+ +.|.+........ -.-.+|..+++.+...++ .++++.+.. +++.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 44565688889999974321 1255554322221 123568888888865444 445555543 489999
Q ss_pred ccCCccc
Q 021441 84 IPNGSVS 90 (312)
Q Consensus 84 ~~~~~L~ 90 (312)
++|.++.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.1 Score=42.16 Aligned_cols=129 Identities=20% Similarity=0.202 Sum_probs=88.0
Q ss_pred cccCcc-eEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCC--ccceeeeeeeeeCCeEEEEEEeccCCcccccc
Q 021441 17 IGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL 93 (312)
Q Consensus 17 lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (312)
+..|.. +.||+....+.--+.+|+........+..|.+.++-+.- --+.++.++..+.+.-|++|+-++|.++...-
T Consensus 26 v~~geS~~~v~rl~a~~r~g~~~k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~ 105 (266)
T COG3231 26 VTEGESGAGVFRLFADSRPGLYLKIASSGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPR 105 (266)
T ss_pred eeccCCCCeEEEEeccCCCceEEEEecCcchhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchh
Confidence 334443 578887744444467787777777888999999988742 23455666666677889999999998776332
Q ss_pred cCcccccccccCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 021441 94 YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---------------------------------------------- 127 (312)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~---------------------------------------------- 127 (312)
..++. .+.+--++.+|..||.+.
T Consensus 106 --------~~~~p---~r~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~ 174 (266)
T COG3231 106 --------YALDP---KRAVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDE 174 (266)
T ss_pred --------hcCCH---HHHHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHH
Confidence 12222 224455667777777641
Q ss_pred ----------CCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 128 ----------PRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 128 ----------~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
--+.|+|-+.=|++++...---++|+|-.
T Consensus 175 L~~~rp~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrl 213 (266)
T COG3231 175 LEARRPAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRL 213 (266)
T ss_pred HHhcCCchhhceeecCcccCcceEecCCceEEeeecCcc
Confidence 12589999999999998877778888753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.061 Score=46.70 Aligned_cols=102 Identities=14% Similarity=0.143 Sum_probs=65.7
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|++|++- |+.+.. + ....++....++.+.+.-+.-+... -..-|||+..+||+++ .|+|.|+||.+
T Consensus 300 y~yl~~kdh-gt~is~-i--------k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I--------KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e--------ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeee
Confidence 456777765 445532 1 2235677778888888777777752 3589999999999999 99999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 197 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 197 (312)
++...... .......-.|-.+.|.. +.+-|||-+
T Consensus 368 sRl~~~q~-------~isy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 368 SRLSYSQG-------IISYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred eecccCCc-------eeeccccCchhhhcCcc-ceeeeHHHH
Confidence 87432211 11111234455565444 556666654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.2 Score=45.47 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=44.1
Q ss_pred cccccccCcceEEEeeeeCC---------ceEEEEEeCCCCChh--HHHHHHHHHhcCCCccce-eeeeeeeeCCeEEEE
Q 021441 13 DKNLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLV-TLLGYCQENNLQFLI 80 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 80 (312)
-++.|..|=.-.+|++.... ++.|.+++....... ....|..+++.+....|. ++++.+. + +.|
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 35566667778899987431 357889876543322 234577777776433333 4555443 2 357
Q ss_pred EEeccCCcc
Q 021441 81 YEYIPNGSV 89 (312)
Q Consensus 81 ~e~~~~~~L 89 (312)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899988654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.13 Score=45.58 Aligned_cols=71 Identities=14% Similarity=0.145 Sum_probs=45.9
Q ss_pred ccccccCcceEEEeeeeC-CceEEEEEeCC---------CCChhHHHHHHHHHhcCC--Cc-cceeeeeeeeeCCeEEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---------GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~---------~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 80 (312)
++.||.|.-..||++... .++.++||.-. +...++..-|.+.|+... .| +++++|.+- .....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 678999999999999864 25679999421 122345566778887663 24 455565443 3334578
Q ss_pred EEeccC
Q 021441 81 YEYIPN 86 (312)
Q Consensus 81 ~e~~~~ 86 (312)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888853
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.025 Score=44.53 Aligned_cols=29 Identities=14% Similarity=0.115 Sum_probs=25.3
Q ss_pred CeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 129 givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
..+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 379999999999998887 89999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 312 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = e-100
Identities = 110/285 (38%), Positives = 163/285 (57%), Gaps = 12/285 (4%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLAS 58
+L AT NF K LIG G FG+VYKG+L+DG VA+K+R +Q EF E+ L+
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+H +LV+L+G+C E N LIY+Y+ NG++ HLYG + ++ RL I +GAA+
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAAR 150
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPSSQVTADE 175
GL +LH+ ++H+D K+ N+L+DE+F+ K+ D G+ + L +T + S+ V
Sbjct: 151 GLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL---STVVKGTL 205
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235
++ E R +EKSDVYSFGV L E++ R A P +L E S + L
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+I+D L E + +F V+CL SSE RPSM DV+ +L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 2e-94
Identities = 110/295 (37%), Positives = 165/295 (55%), Gaps = 25/295 (8%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLA 57
EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+ TQ +F EV ++
Sbjct: 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
HRNL+ L G+C + L+Y Y+ NGSV+ L + S+ L++ R IALG+A
Sbjct: 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSA 141
Query: 118 KGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR------TDVAGPSSQ 170
+GLA+LH P+++H+D K AN+L+DE+F A V D GL + T V G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---- 197
Query: 171 VTADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--SSSLSPDSSQDLVELV 226
T +A E + SEK+DV+ +GV LLEL++G+ A + L+ D L++ V
Sbjct: 198 -T----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ L ++D L + +E +E+ IQ+ + C S RP MS+VV L+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-86
Identities = 89/300 (29%), Positives = 139/300 (46%), Gaps = 35/300 (11%)
Query: 2 EELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-------QE 48
EL T NF ++ N +GEG FG VYKG + + VA+KK Q+
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQ 76
Query: 49 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 108
F E+ +A QH NLV LLG+ + + L+Y Y+PNGS+ L L +
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHM 134
Query: 109 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
R IA GAA G+ LH +H+D K+AN+L+DE F AK++D GL + +
Sbjct: 135 RCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 169 SQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 222
S++ A E + KSD+YSFGV LLE+++G A Q L
Sbjct: 193 SRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLL 243
Query: 223 VELVQNS-RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+++ + + + +D+++ + + +E + +CL +RP + V L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-69
Identities = 71/316 (22%), Positives = 119/316 (37%), Gaps = 35/316 (11%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLAS 58
E L + + G+FG V+K L VA+K P Q + +E V L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 59 IQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
++H N++ +G + +LI + GS+S L + + IA
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHIAE 128
Query: 115 GAAKGLAHLHS--------LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA 165
A+GLA+LH P + H+D K+ NVL+ + A +AD GL F
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 166 GPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ 220
QV A E+ L + R + D+Y+ G+ L EL S A+ +
Sbjct: 189 DTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 221 DLVELVQNSRDFSNLLKILDERLW------STFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
E + ++ +++ + + GM + I C D +E R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 275 DVVTELDRTLDKEMNL 290
V + + + N+
Sbjct: 308 CVGERIT-QMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-58
Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 39/292 (13%)
Query: 10 NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 61
+ D K IG G FG V++ G VA+K EF+ EV + ++H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N+V +G + ++ EY+ GS+ L+ +R++L+ + RLS+A AKG+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMN 151
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEI 176
+LH+ +P +VH++ K+ N+LVD+ + KV D GL FL AG T
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG-----TP--E 204
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
++A EV +EKSDVYSFGV L EL + ++ +L+P +Q + +
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFK-------- 254
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288
+RL + +I C +RPS + ++ L R L K
Sbjct: 255 ---CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL-RPLIKSA 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-58
Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 55
++L+ TK + E GE++KG Q G + +K + + ++F +E
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 56 LASIQHRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
L H N++ +LG CQ I ++P GS+ L+ + ++ + A
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFA 117
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
L A+G+A LH+L P + + +V++DED A+++ A ++ + A
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-APAWVA 176
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
E + K +D++SF V L ELV+ + LS + +++
Sbjct: 177 PEAL---QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALE----- 226
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
R T +L+ C++ +RP +V L++ DK
Sbjct: 227 ------GLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-56
Identities = 75/342 (21%), Positives = 123/342 (35%), Gaps = 49/342 (14%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASI 59
E SL N LIG G++G VYKG L D VA+K A Q FI+E + + +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLM 64
Query: 60 QHRNLVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
+H N+ + + L+ EY PNGS+ +L S ++ +A
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRLAH 118
Query: 115 GAAKGLAHLHS-------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167
+GLA+LH+ P + H+D + NVLV D ++D GL L + P
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 168 SSQVTAD------------EIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 214
+ A E+ A +++ ++ D+Y+ G+ E+
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 215 SPDSS-----QDLVELVQNSRDFSNLLKILDERL-----WSTFTNEGMEEFIQLIVRCLD 264
Q V D L+ +R W + + + I C D
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS-LAVRSLKETIEDCWD 297
Query: 265 PSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 306
+E R + + + M + +PT H
Sbjct: 298 QDAEARLTAQXAE----ERMAELMMIWERNKSVSPTAHHHHH 335
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-56
Identities = 69/297 (23%), Positives = 122/297 (41%), Gaps = 51/297 (17%)
Query: 10 NFSD---KNLIGEGKFGEVYKG-LLQDGMLVAIKK----------RPGAPTQEFIDEVCF 55
++ + IG+G FG V+KG L++D +VAIK QEF EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 56 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
++++ H N+V L G ++ E++P G + L + +++ +L + L
Sbjct: 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLD 130
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGRTDVAGPSSQ 170
A G+ ++ + +P +VH+D ++ N+ + AKVAD G L + V S
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGL 186
Query: 171 V-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225
+ A E A E ++EK+D YSF + L +++G S + + +
Sbjct: 187 LGNFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+ R T + +I C ++RP S +V EL
Sbjct: 243 REE-----------GLRP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 8e-55
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 27/269 (10%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75
+G G FG V K + VAIK+ + + FI E+ L+ + H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74
Query: 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKD 134
L+ EY GS+ L+G + H +S L ++G+A+LHS+ P+ ++H+D
Sbjct: 75 --CLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 135 FKTANVLVDEDF-IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 193
K N+L+ + K+ D G + S ++A EV E +SEK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-----AWMAPEVFEGSNYSEKCD 185
Query: 194 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 253
V+S+G+ L E+++ R+ + + ++ V N R +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIG-GPAFRIMWAVHN-----------GTRP--PLIKNLPK 231
Query: 254 EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
L+ RC +RPSM ++V +
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-55
Identities = 76/290 (26%), Positives = 135/290 (46%), Gaps = 35/290 (12%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 55
++++ + IG G FG VYKG VA+K APT Q F +EV
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 56 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
L +H N++ +GY L ++ ++ S+ HL S K E K + IA
Sbjct: 74 LRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQ 128
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175
A+G+ +LH+ ++H+D K+ N+ + ED K+ D GL R + Q++
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 176 IFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
+++A EV ++ +S +SDVY+FG+ L EL++G+ S+++ ++E+V
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS 244
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+L K+ + +L+ CL + RPS ++ E++
Sbjct: 245 PDLSKVRSNCP---------KRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 14 KNLIGEGKFGEVYKGLL-QDGMLVAIKK--RPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 69
++G+G FG+ K + G ++ +K+ R TQ F+ EV + ++H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 70 YC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
++ L I EYI G++ + + + + R+S A A G+A+LHS++
Sbjct: 75 VLYKDKRL-NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-------- 180
++H+D + N LV E+ VAD GL + +
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 181 ----EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
E+ R + EK DV+SFG+ L E++ A P + + +
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-----R 242
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
F + VRC D E+RPS + L+
Sbjct: 243 YC---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------QEFIDEV 53
EL+L IG G FG+VY+ G VA+K R + E
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
A ++H N++ L G C + L+ E+ G ++ L S +++ ++ A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWA 111
Query: 114 LGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDV 164
+ A+G+ +LH + ++H+D K++N+L+ + I K+ D GL RT
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 165 ---AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221
AG + ++A EV FS+ SDV+S+GV L EL++G +
Sbjct: 172 MSAAGAYA-------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAV 222
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ N L + E F +L+ C +P RPS ++++ +L
Sbjct: 223 AYGVAMN-----------KLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-51
Identities = 65/302 (21%), Positives = 129/302 (42%), Gaps = 35/302 (11%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 72
IG+G++GEV+ G + G VA+K + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 73 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 127
+ +LI +Y NGS+ +L L+ K L +A + GL HLH+
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 128 -----PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA--GPSSQV-----TAD 174
P + H+D K+ N+LV ++ +AD GL F+ T+ P+++V
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
E+ S + + +D+YSFG+ L E+ R S + + +LV + + +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 235 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288
+ + + ++L ++E + + +L+ C + R + V L + +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL-AKMSESQ 333
Query: 289 NL 290
++
Sbjct: 334 DI 335
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-51
Identities = 63/302 (20%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 72
IG+G+FGEV++G + G VA+K + + E + ++H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 73 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS--- 125
++N +L+ +Y +GS+ +L +R + + + +AL A GLAHLH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 126 ---LSPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 174
P + H+D K+ N+LV ++ +AD GL + T P+ +V A
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
E+ S + +++D+Y+ G+ E+ R + + D +LV +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 235 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288
+ K + +++L + E + +++ C + R + + L + L ++
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ-LSQQE 338
Query: 289 NL 290
+
Sbjct: 339 GI 340
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-50
Identities = 61/302 (20%), Positives = 118/302 (39%), Gaps = 50/302 (16%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 72
+G+G++GEV++G Q G VA+K + + E + ++H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 73 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 127
+ +LI Y GS+ +L L+ L I L A GLAHLH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 128 -----PRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 174
P + H+D K+ N+LV ++ +AD GL + G + +V A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDL 222
E+ + + ++ D+++FG+ L E+ ++ + S +D+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 223 VELV--QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
++V R I + W ++ + +L+ C + R + + L
Sbjct: 247 RKVVCVDQQR-----PNIPNR--WF--SDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 281 DR 282
+
Sbjct: 298 TK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 44/293 (15%)
Query: 10 NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 61
F LIG+G+FG+VY G VAI+ + F EV +H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N+V +G C +I ++ + + L+ IA KG+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMG 144
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD------- 174
+LH + ++HKD K+ NV D + + D GL + G ++
Sbjct: 145 YLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 175 --EIF---LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229
EI ++ FS+ SDV++ G EL + + + ++ +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT- 257
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+ L + +E +++ C E RP+ + ++ L++
Sbjct: 258 ----GMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-42
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 43/294 (14%)
Query: 17 IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 68
+G+G FG V G +VA+KK + +F E+ L S+QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 69 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
G C + LI EY+P GS+ +L Q +++++ L KG+ +L +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 179
R +H+D T N+LV+ + K+ D GL + + E IF A
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY------KVKEPGESPIFWYA 216
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E +FS SDV+SFGV L EL + E S S + + + Q +L+++L
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 240 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
N + E ++ C + + +RPS D+ +D+ D+
Sbjct: 277 KN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 43/294 (14%)
Query: 17 IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 68
+G+G FG V G +VA+KK + +F E+ L S+QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 69 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
G C + LI EY+P GS+ +L Q +++++ L KG+ +L +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 179
R +H+D T N+LV+ + K+ D GL + + E IF A
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF------KVKEPGESPIFWYA 185
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E +FS SDV+SFGV L EL + E S S + + + Q +L+++L
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 240 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
N + E ++ C + + +RPS D+ +D+ D
Sbjct: 246 KN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 51/294 (17%)
Query: 17 IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 67
+GEG FG+V G VA+K +P + + E+ L ++ H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 68 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G C E+ LI E++P+GS+ +L ++ K+ K +L A+ KG+ +L S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 184
+ VH+D NVLV+ + K+ D GL + +F A E
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 185 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD-----------SSQDLVELVQNSRDF 232
+F SDV+SFGV L EL++ SS ++ + LV ++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE---- 258
Query: 233 SNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+RL E QL+ +C + R S +++ +
Sbjct: 259 -------GKRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 80/299 (26%), Positives = 122/299 (40%), Gaps = 46/299 (15%)
Query: 17 IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 68
+G+G FG V G LVA+K+ + P Q +F E+ L ++ +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 69 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
G Q L+ EY+P+G + L Q R +L+ L + KG+ +L S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 179
R VH+D N+LV+ + K+AD GL + D E IF A
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY------VVREPGQSPIFWYA 198
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
E FS +SDV+SFGV L EL + ++ S + E + S LL++
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL--SRLLEL 256
Query: 239 LDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290
L+E + + E +L+ C PS + RPS S + +LD
Sbjct: 257 LEE-------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-40
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 42/284 (14%)
Query: 17 IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 71
IG G FGEV+ G L+ D LVA+K R P +F+ E L H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ +++ E + G L + +L K L + AA G+ +L S +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCI 235
Query: 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 188
H+D N LV E + K++D G+ ++ ++ + A E + R+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRY 292
Query: 189 SEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDERLW 244
S +SDV+SFG+ L E S G P S+Q E V+ RL
Sbjct: 293 SSESDVWSFGILLWETFSLGAS------PYPNLSNQQTREFVEK-----------GGRLP 335
Query: 245 STFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
E + + +L+ +C +RPS S + EL +
Sbjct: 336 CP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 64/291 (21%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 71
IG G+FG V+ G + VAIK R GA + ++FI+E + + H LV L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
E L+ E++ +G +S +L + R + L + L +G+A+L V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVI 126
Query: 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS----------- 180
H+D N LV E+ + KV+D G+ ++ D+ + +S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGM-------------TRFVLDDQYTSSTGTKFPVKWAS 173
Query: 181 -EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNL 235
EV F R+S KSDV+SFGV + E+ S G+ P S+ ++VE +
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSEVVEDIST------- 220
Query: 236 LKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
RL Q++ C E RP+ S ++ +L
Sbjct: 221 ----GFRL------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 50/289 (17%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 71
+G G+FG V G + VAIK + G+ + EFI+E + ++ H LV L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+ F+I EY+ NG + +L + R + + + L + + + +L S + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK--QFL 142
Query: 132 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 186
H+D N LV++ + KV+D GL R L + S+ + E+ + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM------YS 196
Query: 187 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 242
+FS KSD+++FGV + E+ S G+ P ++ + E + R
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQ-----------GLR 239
Query: 243 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
L + ++ C ++ RP+ +++ + +D+E
Sbjct: 240 L------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 64/295 (21%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FG V G + VA+K + G+ + EF E + + H LV G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+++ EYI NG + +L + + LE L + +G+A L S + +H+D
Sbjct: 76 YPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRD 129
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 182
N LVD D KV+D G+ ++ D+ +++S EV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGM-------------TRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKI 238
+ ++S KSDV++FG+ + E+ S G+ P ++ ++V V
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGK------MPYDLYTNSEVVLKVSQ---------- 220
Query: 239 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
RL Q++ C E+RP+ +++ ++ +K+ +
Sbjct: 221 -GHRL------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-39
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 58/294 (19%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 71
IG+G+FG+V G + G VA+K + A Q F+ E + ++H NLV LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+E +++ EY+ GS+ +L R L L +L + + +L V
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 139
Query: 132 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 184
H+D NVLV ED +AKV+D GL + + + TA E
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 187
Query: 185 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILD 240
++FS KSDV+SFG+ L E+ S GR P +D+V V+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPRVEK-----------G 230
Query: 241 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290
++ + + +++ C + RPS + +L+ E++L
Sbjct: 231 YKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 15 NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 71
+ +G G++GEVY+G+ + + VA+K + E F+ E + I+H NLV LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
++I E++ G++ +L + +RQ++ L +A + + +L +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 340
Query: 132 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 190
H++ N LV E+ + KVAD GL R G T A ++ + A E + +FS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSI 398
Query: 191 KSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
KSDV++FGV L E+ + G + + EL++ D R
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEK-----------DYR------- 437
Query: 250 EGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 296
M E+ +L+ C + RPS +++ + + V E
Sbjct: 438 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 64/297 (21%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 71
IG+G+FG+V G + G VA+K + A Q F+ E + ++H NLV LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
+E +++ EY+ GS+ +L R L L +L + + +L V
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 311
Query: 132 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 184
H+D NVLV ED +AKV+D GL + + + TA E
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 359
Query: 185 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILD 240
++FS KSDV+SFG+ L E+ S GR P +D+V V+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPRVEK-----------G 402
Query: 241 ERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290
+ M+ ++ C + RP+ + +L+ E++L
Sbjct: 403 YK---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 68/300 (22%), Positives = 126/300 (42%), Gaps = 58/300 (19%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDE 52
E +G G FG VYKGL + VAIK+ R + E +DE
Sbjct: 15 TEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
+AS+ + ++ LLG C + +Q LI + +P G + ++ + + + ++ L+
Sbjct: 68 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNW 122
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
+ AKG+ +L R+VH+D NVLV K+ D GL LG + +
Sbjct: 123 CVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYH 175
Query: 173 ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 226
A+ + A E R ++ +SDV+S+GV + EL++ G + + ++ ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL 232
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+ ERL + ++ +C ++ RP +++ E +
Sbjct: 233 EK-----------GERL------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 49/297 (16%)
Query: 17 IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 67
+GEG FG+V G +VA+K + A + E+ L ++ H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 68 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G C++ L+ EY+P GS+ +L R + L A +G+A+LH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-L 178
+H+D NVL+D D + K+ D GL + + E +F
Sbjct: 153 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVREDGDSPVFWY 204
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
A E + +F SDV+SFGV L EL++ + S + + Q L +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTVLRLTE 262
Query: 238 ILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
+L+ E + E L+ C + + RP+ +++ L +K
Sbjct: 263 LLER-------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 58/287 (20%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQ 72
+G G+FGEV+ VA+K +PG+ + + F+ E + ++QH LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
+ + ++I E++ GS+ L K + + A+G+A + +H
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR--NYIH 307
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 180
+D + AN+LV + K+AD GL ++V D + A
Sbjct: 308 RDLRAANILVSASLVCKIADFGL-------------ARVIEDNEYTAREGAKFPIKWTAP 354
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E F F+ KSDV+SFG+ L+E+V+ GR + S+ +++ ++
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALER----------- 400
Query: 240 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
R+ E E +++RC E RP+ + + LD
Sbjct: 401 GYRM------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 72
+G+G FGEV+ G VAIK +PG + E F+ E + ++H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
E + +++ EY+ GS+ L G + + L + +A A G+A++ + VH
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 303
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 180
+D + AN+LV E+ + KVAD GL +++ D + A
Sbjct: 304 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 350
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E + RF+ KSDV+SFG+ L EL + GR + ++++++ V+
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 396
Query: 240 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
R+ E L+ +C E RP+ + L+
Sbjct: 397 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 72
+G+G FGEV+ G VAIK +PG + E F+ E + ++H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
E + +++ EY+ GS+ L G + + L + +A A G+A++ + VH
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 386
Query: 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 180
+D + AN+LV E+ + KVAD GL +++ D + A
Sbjct: 387 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 433
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E + RF+ KSDV+SFG+ L EL + GR + ++++++ V+
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 479
Query: 240 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
R+ E L+ +C E RP+ + L+
Sbjct: 480 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-37
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 74
+G G+FGEV+ G VA+K + G+ + F+ E + +QH+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 134
+ ++I EY+ NGS+ L PS KL L +A A+G+A + +H+D
Sbjct: 81 PI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 135 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 182
+ AN+LV + K+AD GL +++ D + A E
Sbjct: 135 LRAANILVSDTLSCKIADFGL-------------ARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS 206
+ F+ KSDV+SFG+ L E+V+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-37
Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 64/306 (20%)
Query: 14 KNLIGEGKFGEVYKGLLQDG-MLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGY 70
K+ +G G++GEVY+G+ + + VA+K + +EF+ E + I+H NLV LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
C ++I E++ G++ +L + +RQ++ L +A + + +L
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NF 132
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---------- 180
+H+D N LV E+ + KVAD GL S++ + + A
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGL-------------SRLMTGDTYTAHAGAKFPIKWT 179
Query: 181 --EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSN 234
E + +FS KSDV++FGV L E+ + G SP + EL++
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEK------ 227
Query: 235 LLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290
D R+ E E + +L+ C + RPS +++ + +
Sbjct: 228 -----DYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
Query: 291 TTVMGE 296
V E
Sbjct: 277 DEVEKE 282
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 53/306 (17%)
Query: 14 KNLIGEGKFGEVYKGLLQDGML-----VAIKK-RPGAPTQ---EFIDEVCFLASIQHRNL 64
++G G FG V+KG+ V IK + Q D + + S+ H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V LLG C ++LQ L+ +Y+P GS+ H+ + R L + L+ + AKG+ +L
Sbjct: 78 VRLLGLCPGSSLQ-LVTQYLPLGSLLDHV----RQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV------TADEIFL 178
+VH++ NVL+ +VAD G+ + L D S+ A E
Sbjct: 133 EH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
F +++ +SDV+S+GV + EL++ G E + L ++ +L++
Sbjct: 191 ------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEK--------- 232
Query: 238 ILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 293
ERL + + ++V+C RP+ ++ E R +
Sbjct: 233 --GERL------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284
Query: 294 MGEGTP 299
E P
Sbjct: 285 KRESGP 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 76/289 (26%), Positives = 117/289 (40%), Gaps = 58/289 (20%)
Query: 17 IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 68
IG G GEV G L+ + VAIK + G ++ F+ E + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G L ++ EY+ NGS+ L + + + + G G+ +L L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 181
VH+D NVLVD + + KV+D GL R D A ++ TA E
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--- 227
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLK 237
FR FS SDV+SFGV + E+++ G P +++D++ V+
Sbjct: 228 ---FRTFSSASDVWSFGVVMWEVLAYGE------RPYWNMTNRDVISSVEE--------- 269
Query: 238 ILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
RL QL++ C +RP S +V+ LD
Sbjct: 270 --GYRL------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 51/306 (16%)
Query: 17 IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 67
+G G FG VYKGL + VAIK+ R + E +DE +AS+ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
LG C + +Q LI + +P G + ++ + + + ++ L+ + AKG+ +L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 182
R+VH+D NVLV K+ D GL LG + + A+ + A E
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALES 190
Query: 183 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
R ++ +SDV+S+GV + EL++ G + + ++ +++ E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEK-----------GE 236
Query: 242 RLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEG 297
RL + ++V+C ++ RP +++ E + + G+
Sbjct: 237 RL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 290
Query: 298 TPTVTL 303
+
Sbjct: 291 RMHLPS 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 17 IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTL 67
IG G+FGEVYKG+L+ + VAIK + G ++ F+ E + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
G + +I EY+ NG++ L + + + + G A G+ +L ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 186
VH+D N+LV+ + + KV+D GL L A ++ I + A E +R
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 187 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 242
+F+ SDV+SFG+ + E+++ G P S+ ++++ + + R
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHEVMKAIND-----------GFR 268
Query: 243 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 296
L QL+++C RRP +D+V+ LD+ + +L T+
Sbjct: 269 L------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 52/288 (18%)
Query: 14 KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVT 66
+G G FG V +G+ + + VAIK + G T+E + E + + + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L+G CQ L L+ E G + L R+++ + + + G+ +L
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 179
VH+D NVL+ AK++D GL LG D A + + A E
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN- 186
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
FR+FS +SDV+S+GV + E +S G++ + +++ ++
Sbjct: 187 -----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQ---------- 228
Query: 239 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+R+ E E L+ C E RP V +
Sbjct: 229 -GKRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 46/294 (15%)
Query: 14 KNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLV 65
+IG+G FG VY G D + AIK Q+ F+ E + + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 66 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
L+G L ++ Y+ +G + + + ++ K +S L A+G+ +L
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LAS 180
+ VH+D N ++DE F KVAD GL + + A A
Sbjct: 142 EQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA--RLPVKWTAL 197
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E + RF+ KSDV+SFGV L EL++ G + P DL + R
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGR--------- 245
Query: 240 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
RL E Q++ +C + RP+ +V E+++ + +
Sbjct: 246 --RL------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 54/295 (18%)
Query: 17 IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 66
+G+G FG V +G + VA+K +P +Q +FI EV + S+ HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L G ++ ++ E P GS+ L + + A+ A+G+ +L S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 179
R +H+D N+L+ + K+ D GL L + D V +V A E
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
R FS SD + FGV L E+ + G+E L+ ++ +
Sbjct: 198 -----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEG-------- 241
Query: 239 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
ERL E + ++V+C E RP+ + L +M
Sbjct: 242 --ERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-36
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 15 NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+IG G FG VY G L D + A+K E F+ E + H N+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 67 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C + ++ Y+ +G + + + K + L AKG+ +L S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 180
+ VH+D N ++DE F KVAD GL + + S L A
Sbjct: 147 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMAL 201
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E + ++F+ KSDV+SFGV L EL++ G ++ D+ + R L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGR-------RL 251
Query: 240 D------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
+ L+ +++++C P +E RPS S++V+ +
Sbjct: 252 LQPEYCPDPLY------------EVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 54/297 (18%)
Query: 15 NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+IG G FG VY G L D + A+K E F+ E + H N+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 67 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LLG C + ++ Y+ +G + + + K + L AKG+ L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 180
+ VH+D N ++DE F KVAD GL + + S L A
Sbjct: 211 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---FDSVHNKTGAKLPVKWMAL 265
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E + ++F+ KSDV+SFGV L EL++ G ++ D+ +
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQ----------- 311
Query: 240 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
R + +++++C P +E RPS S++V+ + +
Sbjct: 312 GRR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 68/305 (22%), Positives = 130/305 (42%), Gaps = 69/305 (22%)
Query: 14 KNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNL 64
K +GEG FG+V+ +D MLVA+K + ++F E L ++QH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 65 VTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 113
V G C + + +++EY+ +G I + G + ++ +L L IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV 171
A G+ +L S VH+D T N LV + + K+ D G+ + TD G + +
Sbjct: 140 SQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 172 ----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLV 223
E + +R+F+ +SDV+SFGV L E+ + G+ P S+ +++
Sbjct: 198 PIRWMPPESIM------YRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVI 245
Query: 224 ELVQNSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
E + R +L+ + ++ +++ C ++R ++ ++
Sbjct: 246 ECITQGR-------VLERPRVCPKEVY------------DVMLGCWQREPQQRLNIKEIY 286
Query: 278 TELDR 282
L
Sbjct: 287 KILHA 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 17 IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTL 67
+GEG FG+V+ + MLVA+K + + + +F E L +QH+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 68 LGYCQENNLQFLIYEYIPNGS----------VSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
G C E +++EY+ +G + L G V+ L L++A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV---- 171
G+ +L L VH+D T N LV + + K+ D G+ + TD G + +
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQ 227
E L +R+F+ +SDV+SFGV L E+ + G+ P S+ + ++ +
Sbjct: 227 MPPESIL------YRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDCIT 274
Query: 228 NSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
R L+ ++ ++ C ++R S+ DV L
Sbjct: 275 QGR-------ELERPRACPPEVY------------AIMRGCWQREPQQRHSIKDVHARLQ 315
Query: 282 RTLDKEMNLTTVMG 295
V+G
Sbjct: 316 ALAQAPPVYLDVLG 329
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 69/319 (21%), Positives = 115/319 (36%), Gaps = 84/319 (26%)
Query: 17 IGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 65
+G G FG+V + M VA+K +P A E + E+ L+ + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 66 TLLGYCQENNLQFLIYEYIPNGS-------------VSIHLYGPSQVSRQKLEFKHRLSI 112
LLG C +I EY G S + L+ + LS
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
+ AKG+A L S +H+D N+L+ I K+ D GL + +
Sbjct: 151 SYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGL------------ARDIK 196
Query: 173 ADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 219
D ++ VK ++ +SDV+S+G+FL EL S G + D
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254
Query: 220 QDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERR 270
++++ EG M E ++ C D +R
Sbjct: 255 SKFYKMIK----------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 271 PSMSDVVTELDRTLDKEMN 289
P+ +V +++ + + N
Sbjct: 293 PTFKQIVQLIEKQISESTN 311
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-35
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 52/302 (17%)
Query: 17 IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 68
+G G+FGEV G L+ + VAIK + G + +F+ E + H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G ++ ++ EY+ NGS+ L + + + + G A G+ +L +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 181
VH+D N+L++ + + KV+D GL R + A + T+ E
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--- 223
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+R+F+ SDV+S+G+ L E++S G + S+QD+++ V
Sbjct: 224 ---YRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDE-----------G 266
Query: 241 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 296
RL QL++ C RP +V+ LD+ + +L +
Sbjct: 267 YRL------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
Query: 297 GT 298
Sbjct: 321 AA 322
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 76/308 (24%), Positives = 118/308 (38%), Gaps = 76/308 (24%)
Query: 14 KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRN 63
+GE +FG+VYKG L VAIK + A EF E A +QH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSI 112
+V LLG ++ +I+ Y +G + + + LE + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQ 170
A G+ +L S VVHKD T NVLV + K++D GL + D +S
Sbjct: 134 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 171 V----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDL 222
+ A E + + +FS SD++S+GV L E+ S G P S+QD+
Sbjct: 192 LPIRWMAPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQDV 239
Query: 223 VELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSM 273
VE+++ + L++ C + RRP
Sbjct: 240 VEMIR----------------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277
Query: 274 SDVVTELD 281
D+ + L
Sbjct: 278 KDIHSRLR 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 17 IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 68
+GEG FGEVY+G+ + + VA+K + +F+ E + ++ H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G +E ++I E P G + +L + ++ L+ + +L K +A+L S+
Sbjct: 80 GIIEEEPT-WIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 183
VH+D N+LV K+ D GL ++ D +++ + E
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN----- 187
Query: 184 EFRRFSEKSDVYSFGVFLLELVS 206
FRRF+ SDV+ F V + E++S
Sbjct: 188 -FRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 17 IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 68
IGEG+FG+V++G+ + VAIK + +F+ E + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G EN + ++I E G + L QV + L+ + A + LA+L S
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 183
R VH+D NVLV + K+ D GL ++ + ++ A E
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN----- 190
Query: 184 EFRRFSEKSDVYSFGVFLLELVS 206
FRRF+ SDV+ FGV + E++
Sbjct: 191 -FRRFTSASDVWMFGVCMWEILM 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 69/308 (22%)
Query: 14 KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 65
+++IGEG FG+V K ++ M AIK+ + A + F E+ L + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 66 TLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIAL 114
LLG C+ +L EY P+G+ + + + + L + L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 173
A+G+ +L + +H+D N+LV E+++AK+AD GL R +V
Sbjct: 150 DVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKT 199
Query: 174 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN 228
+A E + ++ SDV+S+GV L E+VS G ++ +L E +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP- 255
Query: 229 SRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTE 279
+G +E E L+ +C RPS + ++
Sbjct: 256 ---------------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
Query: 280 LDRTLDKE 287
L+R L++
Sbjct: 295 LNRMLEER 302
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 33/219 (15%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQ----EFIDEV 53
+ L+L K +G G FG V KG Q VA+K + A E + E
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
+ + + +V ++G C+ + L+ E G ++ +L V + + + +
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
+ G+ +L VH+D NVL+ AK++D GL L + + A
Sbjct: 124 HQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKA 176
Query: 174 DEI------FLASEVKEFRRFSEKSDVYSFGVFLLELVS 206
+ A E + +FS KSDV+SFGV + E S
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 61/322 (18%), Positives = 109/322 (33%), Gaps = 88/322 (27%)
Query: 14 KNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 62
+G G FG+V + + VA+K + A E + E+ ++ + QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLSIA 113
N+V LLG C +I EY G + L ++ + L +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
A+G+A L S +H+D NVL+ +AK+ D GL + +
Sbjct: 171 SQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGL------------ARDIMN 216
Query: 174 DEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---- 216
D ++ VK ++ +SDV+S+G+ L E+ S G +P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYPGI 270
Query: 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSS 267
+ +LV+ +G M ++ C
Sbjct: 271 LVNSKFYKLVK----------------------DGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 268 ERRPSMSDVVTELDRTLDKEMN 289
RP+ + + L ++
Sbjct: 309 THRPTFQQICSFLQEQAQEDRR 330
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 58/301 (19%)
Query: 17 IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+G+G FG VY+G+ + VAIK A +E F++E + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFKHRLSIALGAAKGLA 121
LLG + +I E + G + +L + + +A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 175
+L++ + VH+D N +V EDF K+ D G+ + TD G + + E
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234
F+ SDV+SFGV L E+ + + LS + ++ V
Sbjct: 211 SLK------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVMEGG---- 257
Query: 235 LLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288
+LD + L+ +L+ C + + RPS ++++ + ++
Sbjct: 258 ---LLDKPDNCPDMLF------------ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 289 N 289
Sbjct: 303 R 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 62/304 (20%), Positives = 122/304 (40%), Gaps = 66/304 (21%)
Query: 14 KNLIGEGKFGEVYKGLLQDG----MLVAIK--KRPGAPTQE---FIDEVCFLASIQHRNL 64
++GEG+FG V +G L+ + VA+K K + +E F+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 65 VTLLGYC-----QENNLQFLIYEYIPNGSVSIHL-YGPSQVSRQKLEFKHRLSIALGAAK 118
+ LLG C Q +I ++ G + +L Y + + + + L + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV----T 172
G+ +L + +H+D N ++ +D VAD GL + D G +++
Sbjct: 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQN 228
A E R ++ KSDV++FGV + E+ + G +P + ++ + + +
Sbjct: 217 AIESLA------DRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYDYLLH 264
Query: 229 SRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELD 281
R ++ E +++ C RP+ S + +L+
Sbjct: 265 GH-----------R---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 282 RTLD 285
+ L+
Sbjct: 305 KLLE 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 17 IGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTLLG 69
+G G FG V +G+ + + VAIK + G T+E + E + + + +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
CQ L L+ E G + L R+++ + + + G+ +L
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--N 456
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEVK 183
VH++ NVL+ AK++D GL LG D S TA + A E
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECI 511
Query: 184 EFRRFSEKSDVYSFGVFLLELVS 206
FR+FS +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 48/292 (16%)
Query: 17 IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+G G FGEVY+G + + VA+K Q+ F+ E ++ H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+G ++ +F++ E + G + L P L L +A A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 125 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 175
+H+D N L+ +AK+ D G+ + R G + + E
Sbjct: 158 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234
F+ F+ K+D +SFGV L E+ S G S S+Q+++E V +
Sbjct: 216 AFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTSGG---- 262
Query: 235 LLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
R+ + +++ +C E RP+ + ++ ++
Sbjct: 263 -------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 56/303 (18%), Positives = 114/303 (37%), Gaps = 61/303 (20%)
Query: 14 KNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNL 64
++G+G+FG V + L+ + VA+K + +EF+ E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 65 VTLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAA 117
L+G + +I ++ +G + L + L + + + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV---- 171
G+ +L S +H+D N ++ ED VAD GL + D G +S++
Sbjct: 148 CGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 230
A E ++ SDV++FGV + E+++ G+ + + ++ +
Sbjct: 206 LALESLA------DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNYLIGGN 256
Query: 231 DFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRT 283
R ++ E L+ +C ++RPS + + EL+
Sbjct: 257 -----------R---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
Query: 284 LDK 286
L
Sbjct: 297 LGH 299
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 70/314 (22%), Positives = 114/314 (36%), Gaps = 75/314 (23%)
Query: 17 IGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 65
+G G FG+V + VA+K + GA E + E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 66 TLLGYC-QENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 113
LLG C + +I E+ G+ + P + + L +H + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
AKG+ L S + +H+D N+L+ E + K+ D GL + +
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKG 208
Query: 174 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP----DSSQDLVE 224
D +A E R ++ +SDV+SFGV L E+ S G SP ++
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFCR 262
Query: 225 LVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSD 275
++ EG M E Q ++ C +RP+ S+
Sbjct: 263 RLK----------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 276 VVTELDRTLDKEMN 289
+V L L
Sbjct: 301 LVEHLGNLLQANAQ 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 65/312 (20%)
Query: 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 60
+GEG FG+V + VA+K + A ++ + E+ + I +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 109
H+N++ LLG C ++ ++I EY G+ + Y ++V +++ FK
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
+S A+G+ +L S + +H+D NVLV E+ + K+AD GL + D
Sbjct: 160 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 170 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224
+ T + +A E R ++ +SDV+SFGV + E+ + G + ++L +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK 270
Query: 225 LVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVV 277
L++ R M+ E ++ C +RP+ +V
Sbjct: 271 LLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 278 TELDRTLDKEMN 289
+LDR L N
Sbjct: 311 EDLDRILTLTTN 322
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 65/312 (20%)
Query: 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 60
+GEG FG+V + VA+K + A ++ + E+ + I +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 109
H+N++ LLG C ++ ++I EY G+ + Y ++V +++ FK
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
+S A+G+ +L S + +H+D NVLV E+ + K+AD GL + D
Sbjct: 206 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 170 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224
+ T + +A E R ++ +SDV+SFGV + E+ + G + ++L +
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK 316
Query: 225 LVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVV 277
L++ R M+ E ++ C +RP+ +V
Sbjct: 317 LLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 278 TELDRTLDKEMN 289
+LDR L N
Sbjct: 357 EDLDRILTLTTN 368
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 45/286 (15%)
Query: 17 IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 68
IGEG+FG+V++G+ M VAIK + +F+ E + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
G EN + ++I E G + L QV + L+ + A + LA+L S
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVK 183
R VH+D NVLV + K+ D GL ++ + A + L A E
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESI 564
Query: 184 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
FRRF+ SDV+ FGV + E++ G + + D++ ++N ER
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN-----------GER 610
Query: 243 LWSTFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
L + L+ +C RRP +++ +L L++E
Sbjct: 611 LPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 48/292 (16%)
Query: 17 IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+G G FGEVY+G + + VA+K Q+ F+ E ++ H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+G ++ +F++ E + G + L P L L +A A G +L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 125 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 175
+H+D N L+ +AK+ D G+ + R G + + E
Sbjct: 199 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234
F+ F+ K+D +SFGV L E+ S G S S Q+++E V +
Sbjct: 257 AFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSGG---- 303
Query: 235 LLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
R+ + +++ +C E RP+ + ++ ++
Sbjct: 304 -------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 74/314 (23%)
Query: 17 IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 66
+GEG+FG+V K VA+K + A E + E L + H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 67 LLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKLEFK 107
L G C ++ LI EY GS S + + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 108 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167
+S A ++G+ +L + ++VH+D N+LV E K++D GL + D
Sbjct: 151 DLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-- 206
Query: 168 SSQVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 222
+ +A E ++ +SDV+SFGV L E+V+ G + P + L
Sbjct: 207 --VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP---ERL 261
Query: 223 VELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSM 273
L++ G ME E +L+++C ++RP
Sbjct: 262 FNLLK----------------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 274 SDVVTELDRTLDKE 287
+D+ +L++ + K
Sbjct: 300 ADISKDLEKMMVKR 313
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 68/331 (20%), Positives = 111/331 (33%), Gaps = 97/331 (29%)
Query: 14 KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 62
++G G FG+V + VA+K + A + E + E+ + + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGS------------------VSIHLYGPSQVSRQKL 104
N+V LLG C + +LI+EY G + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164
F+ L A AKG+ L VH+D NVLV + K+ D GL
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGL--------- 218
Query: 165 AGPSSQVTADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREAS 211
+ + +D ++ VK ++ KSDV+S+G+ L E+ S G
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--- 272
Query: 212 SSLSP----DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQL 258
+P + +L+Q G M+ E +
Sbjct: 273 ---NPYPGIPVDANFYKLIQ----------------------NGFKMDQPFYATEEIYII 307
Query: 259 IVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
+ C S +RPS ++ + L L
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 72/323 (22%), Positives = 114/323 (35%), Gaps = 86/323 (26%)
Query: 14 KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRN 63
IGEG FG V++ +VA+K + A F E +A + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKL 104
+V LLG C L++EY+ G S L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 163
+L IA A G+A+L + VH+D T N LV E+ + K+AD GL RN + D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRN-IYSAD 228
Query: 164 --VAGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP 216
A + + E + R++ +SDV+++GV L E+ S G P
Sbjct: 229 YYKADGNDAIPIRWMPPESIF------YNRYTTESDVWAYGVVLWEIFSYGL------QP 276
Query: 217 ---DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLD 264
+ ++++ V+ +G + E L+ C
Sbjct: 277 YYGMAHEEVIYYVR----------------------DGNILACPENCPLELYNLMRLCWS 314
Query: 265 PSSERRPSMSDVVTELDRTLDKE 287
RPS + L R ++
Sbjct: 315 KLPADRPSFCSIHRILQRMCERA 337
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 69/314 (21%)
Query: 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 60
+GEG FG+V VA+K + A ++ I E+ + I +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 109
H+N++ LLG C ++ ++I EY G+ + Y PS ++L K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
+S A A+G+ +L S + +H+D NVLV ED + K+AD GL + D
Sbjct: 194 VSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---- 247
Query: 170 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224
+ T + +A E R ++ +SDV+SFGV L E+ + G + ++L +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFK 304
Query: 225 LVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSD 275
L++ EG M+ E ++ C +RP+
Sbjct: 305 LLK----------------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342
Query: 276 VVTELDRTLDKEMN 289
+V +LDR + N
Sbjct: 343 LVEDLDRIVALTSN 356
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 54/300 (18%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 17 IGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLV 65
+G+G F +++KG+ ++ V +K F + ++ + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
G C + L+ E++ GS+ +L + ++ + +L +A A + L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 126 LSPRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
++H + N+L+ + K++D G+ S V +I
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------SITVLPKDIL 177
Query: 178 ------LASE-VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS 229
+ E ++ + + +D +SFG L E+ S G + S+L SQ ++ ++
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQRKLQFYED- 233
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
+L + E LI C+D + RPS ++ +L+ ++
Sbjct: 234 ----------RHQL---PAPKAAELA-NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-31
Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 36/279 (12%)
Query: 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQE---FIDEVCFLAS 58
S ++F + +G G +GEV+K +DG L A+K P ++ + EV
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 59 I-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+ QH V L +E + +L E S+ H + L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTL 167
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
LAHLHS +VH D K AN+ + K+ D GL LG Q D +
Sbjct: 168 LALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRY 222
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
+A E+ + + +DV+S G+ +LE+ E P + +L Q
Sbjct: 223 MAPELLQ-GSYGTAADVFSLGLTILEVACNMEL-----PHGGEGWQQLRQ---------G 267
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L + + E ++V L+P + R + +
Sbjct: 268 YLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEAL 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 61/290 (21%), Positives = 117/290 (40%), Gaps = 43/290 (14%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT---QEFIDEVCFLASI-Q 60
T F + IG G+FG V+K + DG + AIK+ +P A + Q + EV A + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
H ++V E++ + EY GS++ + + + L +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLA-DAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-------GPSSQVTA 173
++HS+ +VH D K +N+ + I A ++ G +++++
Sbjct: 129 RYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 174 DEIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
++ LA+EV +E K+D+++ + ++ P + E+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQWHEIR 241
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
Q + ++ S +EF +L+ + P ERRPS +
Sbjct: 242 QG--RLPRI-----PQVLS-------QEFTELLKVMIHPDPERRPSAMAL 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 55/302 (18%), Positives = 104/302 (34%), Gaps = 43/302 (14%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFID-EVCFLAS 58
+ + K++ +GEG F V L DG A+K+ +E E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 59 IQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
H N++ L+ YC +L+ + G++ + + L L + L
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLL 141
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 174
G +GL +H+ H+D K N+L+ ++ + D G N + D
Sbjct: 142 GICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 175 EI-------FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQ 220
+ A E+ + E++DV+S G L ++ G P
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKG 253
Query: 221 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
D V L ++ L + QL+ + +RP + ++++L
Sbjct: 254 DSVALAVQNQ--------LSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 281 DR 282
+
Sbjct: 302 EA 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 51/276 (18%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IG G F VYKGL + + VA K + Q F +E L +QH N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 70 Y----CQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 117
+ L+ E + +G++ + + RQ L+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK------------ 140
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
GL LH+ +P ++H+D K N+ + K+ D GL + + T +
Sbjct: 141 -GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPE-- 195
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
F+A E+ E ++ E DVY+FG+ +LE+ + S + + V +
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS-------- 244
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
+ E ++E I+ C+ + + R S
Sbjct: 245 GVKPASFDKVAIPE-VKEIIE---GCIRQNKDERYS 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 33/279 (11%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT----QEFIDEVCFLASIQH 61
NF + IG G+F EVY+ L DG+ VA+KK + I E+ L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKG 119
N++ E+N ++ E G +S + +QK R +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIF 177
L H+HS RV+H+D K ANV + + K+ D GL R F +T A S V T +
Sbjct: 149 LEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTP--YY 202
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
++ E ++ KSD++S G L E+ + + +L L + K
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCK---------K 249
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
I ++ EE QL+ C++P E+RP ++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 54/279 (19%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
+ + IGEG FG+ +DG IK+ +E EV LA+++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N+V +EN +++ +Y G + + + + L + L H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLAS 180
+H +++H+D K+ N+ + +D ++ D G+ R ++A + + T +L+
Sbjct: 141 VHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTP--YYLSP 194
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
E+ E + ++ KSD+++ G L EL + + + + LV KI+
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVL---------KIIS 239
Query: 241 ---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ ++ + L+ + + RPS++ +
Sbjct: 240 GSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 49/295 (16%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 63
+F +G G FG V++ D AIK+ ++ + EV LA ++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 64 LVTLLGYCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
+V E N ++ + ++ + + + ++ E L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLH 122
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 171
I L A+ + LHS ++H+D K +N+ D + KV D GL + + +
Sbjct: 123 IFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 172 TADEIFLAS----------EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221
E +S K D++S G+ L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER------- 233
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L + + + ++ L PS RP ++
Sbjct: 234 -----------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 49/286 (17%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+F + LIG G FG+V+K DG IK+ ++ EV LA + H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHY 69
Query: 68 LGYCQENNLQ----------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
G + F+ E+ G++ + + +KL+ L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALE 126
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 171
+ KG+ ++HS +++++D K +N+ + + K+ D GL L +
Sbjct: 127 LFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182
Query: 172 -TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
T +++ E + + ++ D+Y+ G+ L EL+ + + +
Sbjct: 183 GTLR--YMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFT------ 229
Query: 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ D + F ++ L+ + L E RP+ S++
Sbjct: 230 ------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 44/286 (15%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
+++ IG G +G K DG ++ K+ A Q + EV L ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 63 NLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAK 118
N+V + N +++ EY G ++ + ++ ++++ L +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122
Query: 119 GLAHLHS---LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQV-TA 173
L H V+H+D K ANV +D K+ D GL L A + V T
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
+++ E ++EKSD++S G L EL + P ++ EL
Sbjct: 181 --YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------ 226
Query: 234 NLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
KI + R+ ++ +E ++I R L+ RPS+ ++
Sbjct: 227 ---KIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEI 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 62/312 (19%), Positives = 104/312 (33%), Gaps = 58/312 (18%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLA 57
+ + L + ++ EG F VY+ + G A+K + I EVCF+
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 58 SIQ-HRNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 109
+ H N+V +FL+ + G + L SR L
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESRGPLSCDTV 138
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
L I + + H+H P ++H+D K N+L+ K+ D G + P
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI----SHYPDY 194
Query: 170 QVTADEIFLASEVKE---------------FRRF--SEKSDVYSFGVFLLELVSGREASS 212
+A L E + F EK D+++ G L L +
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ---- 250
Query: 213 SLSPDSSQDLVELVQNSRDF--SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
P F L+I++ + + F LI L + E R
Sbjct: 251 --HP---------------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 271 PSMSDVVTELDR 282
S+++VV +L
Sbjct: 294 LSIAEVVHQLQE 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 66
+ + +G G FGEV++ Q G A+KK + +E+ A + +V
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLSSPRIVP 114
Query: 67 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAK 118
L G +E + E + GS+ I G Q LE
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE------------- 161
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-----RNFLGRTDVAGPSSQVT 172
GL +LH+ R++H D K NVL+ D A + D G + LG++ + G T
Sbjct: 162 GLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E +A EV + K D++S +L +++G
Sbjct: 220 --ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 56/301 (18%), Positives = 102/301 (33%), Gaps = 56/301 (18%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNL 64
+F + ++G+G FG+V K D AIK + + EV LAS+ H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 65 VTLLGYCQENNLQ-------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
V E F+ EY NG++ + +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWR 120
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ 170
+ + L+++HS ++H+D K N+ +DE K+ D GL +N D+ SQ
Sbjct: 121 LFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 171 VTADEIFLAS-----------EVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDS 218
+ EV + +EK D+YS G+ E++ +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230
Query: 219 SQDLVELVQNSRDFSNLLKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
+ V + L + + ++I +D +RP
Sbjct: 231 GMERVNI------LKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGART 280
Query: 276 V 276
+
Sbjct: 281 L 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 59/287 (20%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHR 62
+ F+ IG+G FGEV+KG+ + +VAIK ++ I+ E+ L+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 63 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ G Y ++ L ++I EY+ GS L P L+ +I KGL
Sbjct: 81 YVTKYYGSYLKDTKL-WIIMEYLGGGSAL-DLLEP-----GPLDETQIATILREILKGLD 133
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGLRNFLGR--TDVAGPSSQVTADE 175
+LHS + +H+D K ANVL+ E K+AD L + + T V P
Sbjct: 134 YLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP-------- 183
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235
++A EV + + K+D++S G+ +EL G S L P L
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---------------MKVL 228
Query: 236 LKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
I L+ +S + + + CL+ RP+ +
Sbjct: 229 FLIPKNNPPTLEGN-YS-------KPLKEFVEACLNKEPSFRPTAKE 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 50/283 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 63
K ++ IG+G G VY + + G VAI++ + + I+E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 64 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+V L Y + L +++ EY+ GS++ V+ ++ ++ + L
Sbjct: 79 IVNYLDSYLVGDEL-WVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEF 131
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 176
LHS +V+H+D K+ N+L+ D K+ D G +Q+T ++
Sbjct: 132 LHSN--QVIHRDIKSDNILLGMDGSVKLTDFGF------------CAQITPEQSKRSTMV 177
Query: 177 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A EV + + K D++S G+ +E++ G + +P + L + N
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTP- 234
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
++ + S F + RCL+ E+R S +
Sbjct: 235 ----ELQNPEKLS-------AIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 35/290 (12%)
Query: 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 59
S+ ++ + +IG G V VAIK+ + E + E+ ++
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 60 QHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALG 115
H N+V+ + ++ L +L+ + + GSV H+ + L+ +I
Sbjct: 71 HHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTAD 174
+GL +LH +H+D K N+L+ ED ++AD G+ FL D+ + T
Sbjct: 130 VLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185
Query: 175 EIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227
F +A EV ++ R + K+D++SFG+ +EL +G P + L+ +Q
Sbjct: 186 --FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--MKVLMLTLQ 241
Query: 228 NS--RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
N + + + + + F ++I CL E+RP+ ++
Sbjct: 242 NDPPSLETGVQDKEMLKKYG-------KSFRKMISLCLQKDPEKRPTAAE 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 57/290 (19%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 63
+ + +G+G FG+VYK + G L A K + +++I E+ LA+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 64 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+V LLG Y + L +++ E+ P G+V + + L + + L
Sbjct: 78 IVKLLGAYYHDGKL-WIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNF 132
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLG-RTDVAGPSSQVT----A 173
LHS R++H+D K NVL+ + ++AD G L R G T A
Sbjct: 133 LHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-----TPYWMA 185
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
E+ + +K+ + K+D++S G+ L+E+ L+P
Sbjct: 186 PEVVMCETMKD-TPYDYKADIWSLGITLIEMAQIEPPHHELNP---------------MR 229
Query: 234 NLLKI--------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
LLKI L WS EF + LD + E RPS +
Sbjct: 230 VLLKIAKSDPPTLLTPSKWS-------VEFRDFLKIALDKNPETRPSAAQ 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 59/294 (20%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPTQEFIDEVCFLASI-QHRN 63
F L+G G +G+VYKG ++ G L AIK G +E E+ L HRN
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 64 LVTLLG-YCQENNLQF-----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+ T G + ++N L+ E+ GSV+ L ++ L+ + I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTK--GNTLKEEWIAYICREIL 139
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGLRNFLG-RTDVAGPSSQVT 172
+GL+HLH +V+H+D K NVL+ E+ K+ D A L +G R G T
Sbjct: 140 RGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG-----T 192
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
A E+ E + + KSD++S G+ +E+ G + P
Sbjct: 193 PYWMAPEVIACDENPD-ATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------------ 239
Query: 229 SRDFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
L I L + WS ++F I CL + +RP+
Sbjct: 240 ---MRALFLIPRNPAPRLKSKKWS-------KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 34/312 (10%), Positives = 73/312 (23%), Gaps = 53/312 (16%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK------KRPGAPTQEFIDEVCF 55
LS + + G V+ ++ A+K + + + +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 56 LASIQHRNLVTLLGYCQENNLQ--------------------------FLIYEYIP-NGS 88
A + + + L+ +
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 89 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148
+ V R + + A+L S +VH F N+ + D
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRL 233
Query: 149 KVADAGLRNFLG-RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
+ D +G R + E AS F+ + + G+ + +
Sbjct: 234 MLGDVSALWKVGTRGPASSVPVTYAPREFLNAST----ATFTHALNAWQLGLSIYRVWCL 289
Query: 208 REASSSLSP--DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDP 265
P + + + L + + LI R L+
Sbjct: 290 F------LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNF 339
Query: 266 SSERRPSMSDVV 277
RR + +
Sbjct: 340 DRRRRLLPLEAM 351
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-23
Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 46/281 (16%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLV 65
+ F +GEG +G VYK + + G +VAIK+ P QE I E+ + ++V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87
Query: 66 TLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
G Y + +L +++ EY GSVS + ++ + L +I KGL +LH
Sbjct: 88 KYYGSYFKNTDL-WIVMEYCGAGSVS-DII---RLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-------- 176
+ R +H+D K N+L++ + AK+AD F G + Q+T
Sbjct: 143 FM--RKIHRDIKAGNILLNTEGHAKLAD-----F-------GVAGQLTDTMAKRNTVIGT 188
Query: 177 --FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234
++A EV + ++ +D++S G+ +E+ G+ + + P + + + N
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAIFMIPTNPPP--- 243
Query: 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
LWS + F + +CL S E+R + +
Sbjct: 244 --TFRKPELWS-------DNFTDFVKQCLVKSPEQRATATQ 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 35/214 (16%)
Query: 13 DKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLL 68
D+ ++G+G +G VY G L + + +AIK +R +Q +E+ ++H+N+V L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 69 GYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVS--------RQKLEFKHRLSIALGAA 117
G EN + E +P GS+S +GP + + +Q LE
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE------------ 133
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
GL +LH ++VH+D K NVL++ + K++D G L + + T
Sbjct: 134 -GLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL--Q 188
Query: 177 FLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 208
++A E+ K R + + +D++S G ++E+ +G+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-23
Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 50/280 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 63
IGEG G V G VA+K R + +EV + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 64 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+V + Y L +++ E++ G+++ VS+ +L + ++ + LA+
Sbjct: 104 VVEMYKSYLVGEEL-WVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 176
LH+ V+H+D K+ ++L+ D K++D G +Q++ D
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLV 202
Query: 177 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A EV ++ + D++S G+ ++E+V G S SP Q + L +
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP- 259
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
K+ + S + R L + R +
Sbjct: 260 ----KLKNSHKVS-------PVLRDFLERMLVRDPQERAT 288
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 55/323 (17%), Positives = 101/323 (31%), Gaps = 63/323 (19%)
Query: 1 MEELSLATKNFSDKNLIGEG--KFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDE 52
M + +IG+G V G V ++ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 53 VCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 111
+ H N+V + +N L +++ ++ GS L F ++
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAK-DLI--------CTHFMDGMN 126
Query: 112 ---IAL---GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGR 161
IA G K L ++H + VH+ K +++L+ D ++ + + R
Sbjct: 127 ELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 162 TDVAGPSSQVTADEIF-LASEV--KEFRRFSEKSDVYSFGVFLLELVSG----------- 207
V + + + L+ EV + + + KSD+YS G+ EL +G
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244
Query: 208 ------REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------- 253
L S+ EL + + D ST +
Sbjct: 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304
Query: 254 ----EFIQLIVRCLDPSSERRPS 272
F + +CL + + RPS
Sbjct: 305 TFSPHFHHFVEQCLQRNPDARPS 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 55/287 (19%), Positives = 107/287 (37%), Gaps = 43/287 (14%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 63
+ +S IG G +V++ L + + AIK + + +E+ +L +Q +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 64 L--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ L Y + +++ E N ++ L ++ ++ R S + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 122
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADE 175
+H +VH D K AN L+ + + K+ D G+ T SQV T E
Sbjct: 123 TIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 176 IFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNS 229
K + S KSDV+S G L + G+ +P + +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---- 229
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L I+D F + ++ ++ CL ++R S+ ++
Sbjct: 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 66/292 (22%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 60
K FSD IG G FG VY +++ +VAIKK + Q+ I EV FL ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 61 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 119
H N + G Y +E+ +L+ EY + + +V ++ L+ ++ GA +G
Sbjct: 113 HPNTIQYRGCYLREHTA-WLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQG 166
Query: 120 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-- 177
LA+LHS ++H+D K N+L+ E + K+ D F G +S + F
Sbjct: 167 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGD-----F-------GSASIMAPANSFVG 212
Query: 178 ----LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
+A EV + ++ K DV+S G+ +EL + +++
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------- 258
Query: 231 DFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
S L I L WS E F + CL + RP+
Sbjct: 259 -MSALYHIAQNESPALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 56/294 (19%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 56
+ +S+ + +S IG G +V++ L + + AIK + + +E+ +L
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 80
Query: 57 ASIQHRNL--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
+Q + + L Y + +++ E N ++ L ++ ++ R S
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWK 134
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T 172
+ + +H +VH D K AN L+ + + K+ D G+ T SQV T
Sbjct: 135 NMLEAVHTIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 173 ----ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDL 222
E K + S KSDV+S G L + G+ +P +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQ 245
Query: 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ L I+D F + ++ ++ CL ++R S+ ++
Sbjct: 246 ISK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 9e-22
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 54/282 (19%)
Query: 16 LIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLVTLLG 69
I G G +Y +G V +K + E E FLA + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 70 YCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+ + + + +++ EY+ S+ + QKL ++ L L++LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-------RSKGQKLPVAEAIAYLLEILPALSYLH 199
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVK 183
S+ +V+ D K N+++ E+ + K+ D G + + + G T F A E+
Sbjct: 200 SI--GLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLYG-----TPG--FQAPEIV 249
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+ +D+Y+ G L L + D + +++ +
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR--------- 299
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL 284
L+ R +DP +R + ++ +L L
Sbjct: 300 --------------LLRRAIDPDPRQRFTTAEEMSAQLTGVL 327
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 70/306 (22%)
Query: 16 LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 66
+G G VY +D +L VAIK P +E + EV + + H+N+V+
Sbjct: 18 KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 67 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
++ +E++ +L+ EYI ++S I +GP L ++ G+ H H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGIKHAH 128
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 180
+ R+VH+D K N+L+D + K+ D G+ A + +T L +
Sbjct: 129 DM--RIVHRDIKPQNILIDSNKTLKIFDFGIA-------KALSETSLTQTNHVLGTVQYF 179
Query: 181 --EVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------EASSSLSPD 217
E + E +D+YS G+ L E++ G ++ + D
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
Q L ++ + K R + ++E + L R +
Sbjct: 240 IPQSLSNVILRA-----TEKDKANRYKT------IQEMKDDLSSVLHE---NRANEDVYE 285
Query: 278 TELDRT 283
+ +T
Sbjct: 286 LDKMKT 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 54/287 (18%), Positives = 106/287 (36%), Gaps = 43/287 (14%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 63
+ +S IG G +V++ L + + AIK + + +E+ +L +Q +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 64 L--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ L Y + +++ E N ++ L ++ ++ R S + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 169
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADE 175
+H +VH D K AN L+ + + K+ D G+ T SQV E
Sbjct: 170 TIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 176 IFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNS 229
K + S KSDV+S G L + G+ +P + +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---- 276
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L I+D F + ++ ++ CL ++R S+ ++
Sbjct: 277 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 43/273 (15%)
Query: 15 NLIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVT 66
+G+GKFG VY Q ++A+K ++ G Q EV + ++H N++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L GY + +LI EY P G+V L K + + + A L++ HS
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSK 128
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQVTADEIFLASEVK 183
RV+H+D K N+L+ K+AD G RTD+ G T D +L E+
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD--YLPPEMI 179
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
E R EK D++S GV E + G+ P + E + +I
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK---------RISRVEF 224
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
TF + E LI R L + +RP + +V
Sbjct: 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 45/308 (14%), Positives = 97/308 (31%), Gaps = 42/308 (13%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKG------LLQDGMLVAIKK-RPGAPTQEFI--DE 52
E L +K +L+GEG F +VY+ ++ +K +P P + +I
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
+ L + N L+ E G++ + + + +S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--------V 164
A+ + +H ++H D K N ++ F+ + + L L D +
Sbjct: 178 AMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 165 AGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221
+ TA F E+ + ++ + D + + ++ G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT------YMKVKNE 289
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ L RL + EF +++ P PS+ + +L
Sbjct: 290 ---------GGECKPEGLFRRLPHL---DMWNEFFHVMLNI--PDCHHLPSLDLLRQKLK 335
Query: 282 RTLDKEMN 289
+ +
Sbjct: 336 KVFQQHYT 343
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 59/282 (20%)
Query: 16 LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G F + ++ + A K +P + E+ S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 126
G+ ++N+ F++ E S+ R+ L E + R G +LH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 178
RV+H+D K N+ ++ED K+ D GL +++V D
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 206
Query: 179 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
A EV + S + DV+S G + L+ G+ P + L E
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 251
Query: 237 KILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+I N LI + L RP++++++
Sbjct: 252 RIKKNEYSIPKHINPVAAS---LIQKMLQTDPTARPTINELL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 57/281 (20%)
Query: 16 LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+G F + ++ + A K +P + E+ S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 126
G+ ++N+ F++ E S+ R+ L E + R G +LH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 134
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 178
RV+H+D K N+ ++ED K+ D GL +++V D
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 180
Query: 179 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
A EV + S + DV+S G + L+ G+ P + L E
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 225
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+I + LI + L RP++++++
Sbjct: 226 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 34/321 (10%), Positives = 85/321 (26%), Gaps = 75/321 (23%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQE-------- 48
EL + ++G+ + + G + +RP + +
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 49 ------------------FIDEVCFLASIQHRNLVTLLGYCQ---ENNLQFLIYEYIPNG 87
FI + Q + ++ + + + FL N
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI 147
+ + + L RL + L + LA LH +VH + ++++D+
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGG 244
Query: 148 AKVADAGL-------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF 200
+ P ++ A ++ + D ++ G+
Sbjct: 245 VFLTGFEHLVRDGARVVSSVSRGFEPP--ELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 201 LLELVSGREASSSLSP---DSSQDLVELV-QNSRDFSNLLKILDERLWSTFTNEGMEEFI 256
+ + P D++ E + ++ ++ ++
Sbjct: 303 IYWIWCAD------LPITKDAALGGSEWIFRSCKNIPQPVR------------------- 337
Query: 257 QLIVRCLDPSSERRPSMSDVV 277
L+ L E R +
Sbjct: 338 ALLEGFLRYPKEDRLLPLQAM 358
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 34/285 (11%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----F 55
+ ++ D IG G +G V K + G ++A+K+ ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 56 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
+ S +V G ++ E + + S V + + I L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 171
K L HL + +++H+D K +N+L+D K+ D G L + + +T AG
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-- 190
Query: 172 TADEIFLASEV----KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227
++A E + + +SDV+S G+ L EL +GR + Q L Q
Sbjct: 191 -----YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQ 241
Query: 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
+ L +ER +S FI + CL +RP
Sbjct: 242 VVKGDPPQLSNSEEREFS-------PSFINFVNLCLTKDESKRPK 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 32/303 (10%), Positives = 78/303 (25%), Gaps = 66/303 (21%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDE-------------------- 52
++G+ + + G + P I +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 53 --------VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK- 103
L + + + + + + P ++ +G +S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 104 ---LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160
L RL + L + LA LH +VH + ++++D+ + G
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 161 RTDVAGPSSQVTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLS 215
+ V+ E A + F + + D ++ G+ + +
Sbjct: 263 ASAVSPIGRGFAPPE-TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------L 315
Query: 216 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMS 274
P++ + + I + + + L+ L E R
Sbjct: 316 PNTDDAALGGSE---------WIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPL 359
Query: 275 DVV 277
+
Sbjct: 360 QAM 362
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 52/288 (18%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLL 68
+F K+++G G G + + D VA+K+ EV L S +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSL 126
++ Q++ E V ++ +++ GLAHLHSL
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEY-------VEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 127 SPRVVHKDFKTANVLVDE------------DF-IAKVADAGLRNFLGRTDVAGPSSQVTA 173
+VH+D K N+L+ DF + K G +F R+ V G
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG---- 191
Query: 174 DEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN 228
++A E+ + D++S G ++S P S Q ++
Sbjct: 192 ---WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLG 243
Query: 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ L E+ +LI + + ++RPS V
Sbjct: 244 ACSLDCL---HPEKHED-------VIARELIEKMIAMDPQKRPSAKHV 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 43/295 (14%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTL 67
+ ++G G G V G VA+K+ + E+ L S H N++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 68 LGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
+ ++ E N ++ + S + + + + +S+ A G+AHLHS
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 126 LSPRVVHKDFKTANVLVD-------------EDFIAKVADAGLRNFLGRTDVAGPSSQVT 172
L +++H+D K N+LV E+ ++D GL L + ++
Sbjct: 134 L--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 173 --------ADEIFLAS-EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQD 221
A E+ S ++ RR + D++S G ++S + P D
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----PFGDKYSR 246
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++ + + E LI + +D +RP+ V
Sbjct: 247 ESNIIRGIFSLDE----MKCLHDRSLIAEA----TDLISQMIDHDPLKRPTAMKV 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 47/274 (17%)
Query: 16 LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G+GKFG VY Q+ ++A+K ++ G Q E+ + ++H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
Y + +L+ E+ P G + L + + + + A L + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEELADALHYCHER- 133
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEIFLASEV 182
+V+H+D K N+L+ K+AD G V PS + T D +L E+
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRRRTMCGTLD--YLPPEM 183
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
E + EK D++ GV E + G P S E + +I++
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTETHR---------RIVNVD 228
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L F + LI + L +R + V
Sbjct: 229 L--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 55
M S + + +++G+G V++G + G L AIK P + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 56 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
L + H+N+V L +E + LI E+ P GS+ L PS + L L +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 169
G+ HL +VH++ K N++ D + K+ D G L + S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174
Query: 170 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 221
+++ +++ D++S GV +G P +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 222 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 270
++ + + + + + + + ++ L+ E+
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 271 PSMSDVVTELDRTLDK 286
E L +
Sbjct: 295 WGFDQFFAETSDILHR 310
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 66/285 (23%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
L+G+G F VY+ + G+ VAIK + G + +EV ++H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 121
Y +++N +L+ E NG ++ +L +R K S G+
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYL-----KNRVK-----PFSENEARHFMHQIITGML 126
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 178
+LHS ++H+D +N+L+ + K+AD GL ++Q+
Sbjct: 127 YLHSH--GILHRDLTLSNLLLTRNMNIKIADFGL------------ATQLKMPHEKHYTL 172
Query: 179 -------ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231
+ E+ +SDV+S G L+ GR P + +
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNT------ 220
Query: 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L K++ + E LI + L + R S+S V
Sbjct: 221 ---LNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+ + +GEG +G VYK G +VA+K+ G P+ I E+ L + H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHP 79
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N+V+L+ L++E++ L ++ L+ +G+AH
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--VT----ADE 175
H R++H+D K N+L++ D K+AD GL R F + VT A +
Sbjct: 135 CHQH--RILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPD 189
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ + S +++S D++S G E+++G+
Sbjct: 190 VLMGS-----KKYSTSVDIWSIGCIFAEMITGK 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 55
M S + + +++G+G V++G + G L AIK P + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 56 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
L + H+N+V L +E + LI E+ P GS+ L PS + L L +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 169
G+ HL +VH++ K N++ D + K+ D G L + S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174
Query: 170 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 221
+++ +++ D++S GV +G P +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 222 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 270
++ + + + + + + + ++ L+ E+
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 271 PSMSDVVTELDRTLDK 286
E L +
Sbjct: 295 WGFDQFFAETSDILHR 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 59/346 (17%), Positives = 121/346 (34%), Gaps = 72/346 (20%)
Query: 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVC----FLASI 59
L +F + +G G G V+K G+++A K +++ L
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 60 QHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+V G + + + + E++ GS+ L ++ Q L +++ K
Sbjct: 89 NSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIK 142
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTAD 174
GL +L +++H+D K +N+LV+ K+ D G L + + + V S
Sbjct: 143 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS------ 195
Query: 175 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-------------------------- 208
+++ E + +S +SD++S G+ L+E+ GR
Sbjct: 196 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 209 -EASSSLSPDSSQDLVELVQNSRDFSNLLKI-------LDERLWSTFTNEGMEEFIQLIV 260
+ ++ ++ F L I L ++S EF +
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS-------LEFQDFVN 306
Query: 261 RCLDPSSERRPSMSD------VVTELDRTLDKEMNLTTVMGEGTPT 300
+CL + R + + +D L + +G P+
Sbjct: 307 KCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPS 352
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 63/310 (20%), Positives = 110/310 (35%), Gaps = 73/310 (23%)
Query: 16 LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 66
++G G EV+ +D VA+K + A F E A++ H +V
Sbjct: 19 ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 67 LLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
+ + L +++ EY+ ++ +H GP + K + + A + L
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLA 179
H ++H+D K AN+++ KV D G+ R +A + VT +
Sbjct: 130 NFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIAR------AIADSGNSVTQTAAVIG 181
Query: 180 S------EVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSS 213
+ E +SDVYS G L E+++G S+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241
Query: 214 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
S DL +V + L K + R + E +VR + P
Sbjct: 242 RHEGLSADLDAVVLKA-----LAKNPENRYQT------AAEMRADLVRVHNG---EPPEA 287
Query: 274 SDVVTELDRT 283
V+T+ +RT
Sbjct: 288 PKVLTDAERT 297
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 53/287 (18%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFL 56
+ + + +G G G+V+K + G ++A+K+ + +E ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 57 -ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
S +V G + ++ F+ E + + + + E + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIP----ERILG-KMTV 131
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQ 170
K L +L V+H+D K +N+L+DE K+ D G L + + AG ++
Sbjct: 132 AIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA- 189
Query: 171 VTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225
++A E + + ++DV+S G+ L+EL +G+ + D L ++
Sbjct: 190 ------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKV 242
Query: 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
+Q LL +S +F + CL +RP
Sbjct: 243 LQEE---PPLLP--GHMGFS-------GDFQSFVKDCLTKDHRKRPK 277
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
F +G G + VYKGL G+ VA+K+ G P+ I E+ + ++H N
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELKHEN 64
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+V L N L++E++ N + + LE +GLA
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT----A 173
H +++H+D K N+L+++ K+ D GL R F P + VT A
Sbjct: 125 HEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAF------GIPVNTFSSEVVTLWYRA 176
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++ + S R +S D++S G L E+++G+
Sbjct: 177 PDVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 40/271 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----FLASIQHRNLVTLLG- 69
+G G +G V K + G ++A+K+ + + + ++ VT G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
+E ++ ++ E + + S+ Y Q + IA+ K L HLHS
Sbjct: 75 LFREGDV-WICMELM-DTSLD-KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130
Query: 130 VVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEV--- 182
V+H+D K +NVL++ K+ D G L + + + AG ++A E
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-------YMAPERINP 183
Query: 183 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
+ +S KSD++S G+ ++EL R S ++ V L
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSPQ-----LPA 236
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
+S EF+ +CL +S+ RP+
Sbjct: 237 DKFS-------AEFVDFTSQCLKKNSKERPT 260
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+ + IGEG +G VYK G A+KK G P+ I E+ L ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHS 60
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N+V L L++E++ L V LE S L G+A+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT--------- 172
H RV+H+D K N+L++ + K+AD GL R F P + T
Sbjct: 116 CHDR--RVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYR 167
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A ++ + S +++S D++S G E+V+G
Sbjct: 168 APDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 35/210 (16%)
Query: 16 LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 66
L+G G G+VY+ +D + VA+K + F E +Q ++V
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 67 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
+ + + + ++ I ++ + GP L ++I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-------LAPPRAVAIVRQIGSALDAAH 151
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 180
+ H+D K N+LV D A + D G+ A ++T + +
Sbjct: 152 AA--GATHRDVKPENILVSADDFAYLVDFGIA-------SATTDEKLTQLGNTVGTLYYM 202
Query: 181 --EVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E + ++D+Y+ L E ++G
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 28/202 (13%), Positives = 50/202 (24%), Gaps = 49/202 (24%)
Query: 16 LIGEGKFGEVYKGLLQDGML---VAIK------KRPGAPTQEFIDEVCFLASIQHRNLVT 66
G + ++ D L VA+ P QE + L+ I +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+L ++ E+I GS+ +V+ + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ-------EVADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
V + V V D +A ++
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYPA---------TMPDANP---------------- 181
Query: 187 RFSEKSDVYSFGVFLLELVSGR 208
+ D+ G L L+ R
Sbjct: 182 ----QDDIRGIGASLYALLVNR 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 58/230 (25%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
+ + IGEG +G V+K + +VA+K+ G P+ + E+C L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKH 60
Query: 62 RNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQV---SRQKLEFKHRL 110
+N+V L + L++E+ + + + P V Q L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLL------ 111
Query: 111 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSS 169
KGL HS V+H+D K N+L++ + K+A+ GL R F P
Sbjct: 112 -------KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF------GIPVR 156
Query: 170 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 210
+ ++ + + +S D++S G EL +
Sbjct: 157 CYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 57/229 (24%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF-------IDEVCFLASI 59
K + + +GEG+F VYK +VAIKK + G ++ + E+ L +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 60 QHRNLVTLLG-YCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQKLEFKHR 109
H N++ LL + ++N+ L+++++ S+ L PS + L
Sbjct: 70 SHPNIIGLLDAFGHKSNI-SLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTL----- 122
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGP- 167
+GL +LH ++H+D K N+L+DE+ + K+AD GL ++F P
Sbjct: 123 --------QGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPN 166
Query: 168 ---SSQV-T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ QV T A E+ + R + D+++ G L EL+
Sbjct: 167 RAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRV 210
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 63/300 (21%), Positives = 117/300 (39%), Gaps = 65/300 (21%)
Query: 4 LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEV 53
++ + S+ +G G +GEV + AIK + + ++EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
L + H N++ L + ++ +L+ E G L+ ++ + + +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LF-------DEIIHRMKFNEV 136
Query: 114 LGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR--- 161
A G+ +LH + +VH+D K N+L+ ++D + K+ D GL
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 162 -TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---D 217
+ G TA ++A EV +++ EK DV+S GV L L++G P
Sbjct: 195 MKERLG-----TAY--YIAPEVLR-KKYDEKCDVWSIGVILFILLAGY------PPFGGQ 240
Query: 218 SSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ Q+++ V+ + F D W + LI + L S+RR S
Sbjct: 241 TDQEILRKVEKGKYTF-------DSPEWKNVSEGA----KDLIKQMLQFDSQRRISAQQA 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+ + L+GEG +G V K G +VAIKK + E+ L ++H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-MREIKLLKQLRHE 84
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
NLV LL C++ +L++E+ V + ++ L+++ G+
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 158
HS ++H+D K N+LV + + K+ D G R
Sbjct: 140 CHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 68
IGEG +G V+K G +VAIKK P + E+ L ++H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
+ L++EY + + ++ + SI + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121
Query: 129 RVVHKDFKTANVLVDEDFIAKVADAGL-RNF 158
+H+D K N+L+ + + K+ D G R
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 65/296 (21%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 57
F+++ ++G+G FGEV K A+K T + EV L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+ H N++ L ++++ +++ E G L+ ++ + R S A
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LF-------DEIIKRKRFSEHDAAR 125
Query: 118 ------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDV 164
G+ ++H +VH+D K N+L+ ++D K+ D GL + D
Sbjct: 126 IIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQD 221
G TA ++A EV + EK DV+S GV L L+SG P + D
Sbjct: 184 IG-----TAY--YIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYD 229
Query: 222 LVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++ V+ + F D W T +++ LI + L R + +
Sbjct: 230 ILKRVETGKYAF-------DLPQWRTISDDA----KDLIRKMLTFHPSLRITATQC 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 59/303 (19%), Positives = 111/303 (36%), Gaps = 68/303 (22%)
Query: 2 EELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEV 53
+ + + + D +G G FG V++ G A + + + E+
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKL 104
++ ++H LV L +++N +IYE++ G + + RQ
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR 161
+ GL H+H + VH D K N++ + + K+ D GL L
Sbjct: 266 K-------------GLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDP 309
Query: 162 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 216
G TA+ F A EV E + +D++S GV L+SG LSP
Sbjct: 310 KQSVKVTTG-----TAE--FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG------LSPF 356
Query: 217 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
++ + + V++ + D+ +S + +G + I + L R ++
Sbjct: 357 GGENDDETLRNVKSCDWNM-------DDSAFSGISEDGKD----FIRKLLLADPNTRMTI 405
Query: 274 SDV 276
Sbjct: 406 HQA 408
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 66/301 (21%)
Query: 4 LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----E 52
+ +T FSD+ ++G+G FGEV G A+K + + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
V L + H N++ L + ++ +L+ E G L+ ++ + R S
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LF-------DEIISRKRFSE 125
Query: 113 ALGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 161
A G+ ++H +VH+D K N+L+ +D ++ D GL
Sbjct: 126 VDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 162 --TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--- 216
D G TA ++A EV + EK DV+S GV L L+SG P
Sbjct: 184 KMKDKIG-----TAY--YIAPEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNG 229
Query: 217 DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
+ D+++ V+ + F + W + LI + L R S D
Sbjct: 230 ANEYDILKKVEKGKYTF-------ELPQWKKVSESA----KDLIRKMLTYVPSMRISARD 278
Query: 276 V 276
Sbjct: 279 A 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 51/307 (16%), Positives = 102/307 (33%), Gaps = 72/307 (23%)
Query: 17 IGEGKFGEVYKGLLQDGMLVAIK----------KRPGAPTQEFID----------EVCFL 56
+ +GKF ++ +D A+K + + I E+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 57 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
I++ +T G + ++IYEY+ N S+ L+ + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-----EYFFVLDKNYTCFIPIQV 152
Query: 117 AK--------GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
K +++H+ + H+D K +N+L+D++ K++D G
Sbjct: 153 IKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE------------- 198
Query: 169 SQVTADEI---------FLASEVKEFRRF--SEKSDVYSFGVFLLELVSGR---EASSSL 214
S+ D+ F+ E K D++S G+ L + SL
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 215 SPDSSQDLVELVQNSR-----DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 269
+L ++ D ++ L L + + N E I + L +
Sbjct: 259 -----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 270 RPSMSDV 276
R + D
Sbjct: 314 RITSEDA 320
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 58/302 (19%), Positives = 107/302 (35%), Gaps = 66/302 (21%)
Query: 2 EELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEV 53
+ + + + D +G G FG V++ + G + I +E+
Sbjct: 40 QPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEI 99
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG------SVSIHLYGPSQVS---RQKL 104
+ + H L+ L ++ LI E++ G + + ++V RQ
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR- 161
E GL H+H +VH D K N++ + K+ D GL L
Sbjct: 160 E-------------GLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 162 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 216
TA+ F A E+ + +D+++ GV L+SG LSP
Sbjct: 205 EIVKVTTA-----TAE--FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG------LSPFA 251
Query: 217 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
+ + ++ V+ +F DE +S+ + E + I L +R ++
Sbjct: 252 GEDDLETLQNVKRCDWEF-------DEDAFSSVSPEAKD----FIKNLLQKEPRKRLTVH 300
Query: 275 DV 276
D
Sbjct: 301 DA 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 29/217 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNL 64
+ K +G G FG V + + G VAIK + +E E+ + + H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 65 VTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLS-IALGA 116
V+ N+L L EY G + +L K + LS I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA- 133
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
L +LH R++H+D K N+++ + I K+ D G L + ++
Sbjct: 134 ---LRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-----TEF 183
Query: 174 --DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+LA E+ E ++++ D +SFG E ++G
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 51/224 (22%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
+ + + +GEG + VYKG LVA+K+ GAP I EV L ++H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHA 60
Query: 63 NLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
N+VTL L++EY+ + I+ V KL L
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN---MHNV---KLFLFQLL---- 110
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--- 170
+GLA+ H +V+H+D K N+L++E K+AD GL R + P+
Sbjct: 111 ---RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK------SIPTKTYDN 159
Query: 171 --VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
VT +I L S +S + D++ G E+ +GR
Sbjct: 160 EVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 78/308 (25%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----------------KRPGAPT 46
+ +G G +GEV AIK K
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 47 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 106
+E +E+ L S+ H N++ L ++ +L+ E+ G L+ +++
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LF-------EQIIN 139
Query: 107 KHRLSIALGAAK-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 156
+H+ AA G+ +LH + +VH+D K N+L+ + K+ D GL
Sbjct: 140 RHKFDEC-DAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 157 NFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS 212
+F + D G TA ++A EV + ++++EK DV+S GV + L+ G
Sbjct: 197 SFFSKDYKLRDRLG-----TAY--YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY---- 244
Query: 213 SLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 268
P + QD+++ V+ + F D W ++E +LI L
Sbjct: 245 --PPFGGQNDQDIIKKVEKGKYYF-------DFNDWKNISDEA----KELIKLMLTYDYN 291
Query: 269 RRPSMSDV 276
+R + +
Sbjct: 292 KRCTAEEA 299
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 37/240 (15%), Positives = 78/240 (32%), Gaps = 32/240 (13%)
Query: 47 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 106
++ + +N V L ++ + ++ + + S + E
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--RRCSLEDREH 163
Query: 107 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA 165
L I + A+ + LHS ++H+D K +N+ D + KV D GL +
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 166 GPSSQVTADEIF---------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
+ + A ++ E +S K D++S G+ L EL+
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-- 279
Query: 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++ + + + + ++ L PS RP +D+
Sbjct: 280 ----------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 19/109 (17%), Positives = 33/109 (30%), Gaps = 5/109 (4%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 63
+F +G G FG V++ D AIK+ ++ + EV LA ++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
+V E + E P ++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 69
IG+G FGEV+K + G VA+KK + G P + E+ L ++H N+V L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 83
Query: 70 YCQENNLQ--------FLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKGL 120
C+ +L++++ H L G K + GL
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPSSQV-T---- 172
++H +++H+D K ANVL+ D + K+AD GL R F + +++V T
Sbjct: 138 YYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
E+ L R + D++ G + E+ +
Sbjct: 196 PPELLLGE-----RDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 17 IGEGKFGEVYKGLLQD---GMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
+G G +G VYK +D A+K+ G E+ L ++H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVF 87
Query: 72 QENNLQ--FLIYEYIPN---GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ + +L+++Y + + H + +L S+ G+ +LH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 127 SPRVVHKDFKTANVLVDEDF----IAKVADAGL-RNF--LGRTDVAGPSSQVT----ADE 175
V+H+D K AN+LV + K+AD G R F + VT A E
Sbjct: 147 -NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ L + R +++ D+++ G EL++
Sbjct: 206 LLLGA-----RHYTKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 54/228 (23%), Positives = 83/228 (36%), Gaps = 56/228 (24%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+ +GEG +GEVYK + VAIK+ G P I EV L +QHR
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHR 93
Query: 63 NLVTLLGYCQENNLQFLIYEYIP-------NGSVSIHLYGPSQV---SRQKLEFKHRLSI 112
N++ L N+ LI+EY + + + + Q +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS---MRVIKSFLYQLI-------- 142
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA-----KVADAGL-RNFLGRTDVAG 166
G+ H S R +H+D K N+L+ + K+ D GL R F
Sbjct: 143 -----NGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIR 192
Query: 167 PSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ +T EI L S R +S D++S E++
Sbjct: 193 QFTHEIITLWYRPPEILLGS-----RHYSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 51/330 (15%), Positives = 98/330 (29%), Gaps = 83/330 (25%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID----EVC 54
K IG+G +G V + Q + AIK + + ++ EV
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 112
+ + H N+ L ++ L+ E G + ++++ + ++
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 113 ALG--------------------------AAK-------GLAHLHSLSPRVVHKDFKTAN 139
+ L +LH+ + H+D K N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPEN 198
Query: 140 VLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEV--KEFRRFSE 190
L ++ F K+ D GL + + F+A EV +
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLN---NGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 191 KSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWST 246
K D +S GV L L+ G P + D + V N + F + ++
Sbjct: 256 KCDAWSAGVLLHLLLMGA------VPFPGVNDADTISQVLNKKLCF-------ENPNYNV 302
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ L+ L+ + + R
Sbjct: 303 LSPLA----RDLLSNLLNRNVDERFDAMRA 328
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 67/291 (23%), Positives = 109/291 (37%), Gaps = 64/291 (21%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLV 65
S ++G G+FG+V+K G+ +A IK R +E +E+ + + H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 66 TLLGYCQENNLQFLIYEYIPNGSV------SIHLYGPSQVS---RQKLEFKHRLSIALGA 116
L + N L+ EY+ G + + +Q E
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE----------- 198
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSS 169
G+ H+H + ++H D K N+L D I K+ D GL G
Sbjct: 199 --GIRHMHQM--YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG--- 250
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELV 226
T + FLA EV + S +D++S GV L+SG LSP D+ + + +
Sbjct: 251 --TPE--FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG------LSPFLGDNDAETLNNI 300
Query: 227 QNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
R D ++ + + E E I + L R S S+
Sbjct: 301 LACRWDL-------EDEEFQDISEEAKE----FISKLLIKEKSWRISASEA 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 67/299 (22%)
Query: 5 SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFL 56
S+ T N ++G G F EV+ G L A+K K P +E+ L
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 57 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYG------PSQVSRQKLEFKH 108
I+H N+VTL + +L+ + + G + I G S V +Q L
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS--- 117
Query: 109 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---T 162
+ +LH +VH+D K N+L +E+ + D GL +
Sbjct: 118 ----------AVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 163 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 218
G P ++A EV + +S+ D +S GV L+ G P ++
Sbjct: 166 TACGTPG--------YVAPEVLAQKPYSKAVDCWSIGVITYILLCGY------PPFYEET 211
Query: 219 SQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L E ++ +F + W + + I L+ R +
Sbjct: 212 ESKLFEKIKEGYYEF-------ESPFWDDISESAKD----FICHLLEKDPNERYTCEKA 259
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 60/310 (19%), Positives = 111/310 (35%), Gaps = 75/310 (24%)
Query: 3 ELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEF 49
+++ F D +IG+G F V + + + G A+K PG T++
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 50 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG---------SVSIHLYG---PS 97
E ++H ++V LL + + ++++E++ + + +Y S
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 98 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAG 154
RQ LE L + H ++H+D K VL+ + K+ G
Sbjct: 134 HYMRQILE-------------ALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 155 LRNFLGR-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 209
+ LG G T F+A EV + + + DV+ GV L L+SG
Sbjct: 179 VAIQLGESGLVAGGRVG-----TPH--FMAPEVVKREPYGKPVDVWGCGVILFILLSGC- 230
Query: 210 ASSSLSP--DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 266
P + + L E + + + R WS + + L+ R L
Sbjct: 231 -----LPFYGTKERLFEGIIKGKYKM-------NPRQWSHISESAKD----LVRRMLMLD 274
Query: 267 SERRPSMSDV 276
R ++ +
Sbjct: 275 PAERITVYEA 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 59/293 (20%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 57
F+++ ++G+G FGEV K A+K T + EV L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 115
+ H N++ L ++++ +++ E G + I + R++ I
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-------IKRKRFSEHDAARIIKQ 129
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPS 168
G+ ++H + +VH+D K N+L+ ++D K+ D GL + D G
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG-- 185
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQDLVE 224
TA ++A EV + EK DV+S GV L L+SG +P + D+++
Sbjct: 186 ---TA--YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG-------TPPFYGKNEYDILK 232
Query: 225 LVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
V+ + F D W T +++ + LI + L R + +
Sbjct: 233 RVETGKYAF-------DLPQWRTISDDAKD----LIRKMLTFHPSLRITATQC 274
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 73/306 (23%)
Query: 5 SLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFI 50
+ + D +G G+F V K G+ A K R G +E
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 51 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQ 102
EV L + H N++TL + LI E + G + + +Q
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 103 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNF 158
L+ G+ +LH+ + H D K N+++ K+ D GL +
Sbjct: 124 ILD-------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 159 LGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 214
+ ++ G T + F+A E+ + ++D++S GV L+SG
Sbjct: 169 IEDGVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------A 215
Query: 215 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
SP D+ Q+ + + DF DE +S + + I + L + +R
Sbjct: 216 SPFLGDTKQETLANITAVSYDF-------DEEFFSQTSELAKD----FIRKLLVKETRKR 264
Query: 271 PSMSDV 276
++ +
Sbjct: 265 LTIQEA 270
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 60/303 (19%), Positives = 109/303 (35%), Gaps = 73/303 (24%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 53
+ D +G G+F V K G+ A K R G +E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 105
L + H N++TL + LI E + G + + +Q L+
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 161
G+ +LH+ + H D K N+++ K+ D GL + +
Sbjct: 127 -------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 162 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 216
++ G T + F+A E+ + ++D++S GV L+SG SP
Sbjct: 172 GVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 218
Query: 217 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
D+ Q+ + + + DF DE +S + + I + L + +R ++
Sbjct: 219 LGDTKQETLANITSVSYDF-------DEEFFSHTSELAKD----FIRKLLVKETRKRLTI 267
Query: 274 SDV 276
+
Sbjct: 268 QEA 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 70
+GEG +GEV + VA+K + E I E+C + H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 123
+E N+Q+L EY G + + + F ++ G+ +L
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 178
H + + H+D K N+L+DE K++D GL + E L
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169
Query: 179 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
A E+ + R F E DV+S G+ L +++G L D D +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217
Query: 233 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++ W + + L+ + L + R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 64/303 (21%), Positives = 110/303 (36%), Gaps = 73/303 (24%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 53
+N D +G G+F V K G+ A K R G ++ EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 105
L IQH N++TL + LI E + G + + +Q L
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 161
G+ +LHSL + H D K N+++ K+ D GL + +
Sbjct: 126 -------------GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 162 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 216
++ G T + F+A E+ + ++D++S GV L+SG SP
Sbjct: 171 GNEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 217
Query: 217 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
D+ Q+ + V +F ++ +S + + I R L ++R ++
Sbjct: 218 LGDTKQETLANVSAVNYEF-------EDEYFSNTSALAKD----FIRRLLVKDPKKRMTI 266
Query: 274 SDV 276
D
Sbjct: 267 QDS 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 65/294 (22%)
Query: 9 KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 61
K +K +G G+FG V++ + K K G E+ L +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSI 112
RN++ L + +I+E+I + + L Q E
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAG 166
L LHS + + H D + N++ K+ + G L +
Sbjct: 114 ------ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLV 223
+ + A EV + S +D++S G + L+SG ++P +++Q ++
Sbjct: 166 -----APE--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG------INPFLAETNQQII 212
Query: 224 ELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
E + N+ F DE + + E M+ + R L + R + S+
Sbjct: 213 ENIMNAEYTF-------DEEAFKEISIEAMD----FVDRLLVKERKSRMTASEA 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 40/288 (13%)
Query: 8 TKNFSDKNLIGE-GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 66
TK +I E KFG + L K GA ++ D V + R L +
Sbjct: 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ + F+ + + S P + + L +H + + AKG+ L S
Sbjct: 156 ITSSQSSASSGFVEEKSL---SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+ +H+D N+L+ E + K+ D GL + + ++A E R
Sbjct: 213 --KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 187 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245
++ +SDV+SFGV L E+ S G SP V+ +F LK
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGA------SPYPG------VKIDEEFCRRLK-------- 310
Query: 246 TFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
EG M E Q ++ C +RP+ S++V L L
Sbjct: 311 ----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+++D +IG G FG VY+ L D G LVAIKK D E+ + +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD 105
Query: 61 HRNLVTLLGYCQENNLQF------LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
H N+V L + + + L+ +Y+P +Y +V+R K L +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-----TVY---RVARHYSRAKQTLPVIY 157
Query: 115 G------AAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP 167
+ LA++HS + H+D K N+L+D D + K+ D G + V G
Sbjct: 158 VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVRGE 211
Query: 168 SSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ + A E+ + ++ DV+S G L EL+ G+
Sbjct: 212 PNVSYICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 53/305 (17%), Positives = 110/305 (36%), Gaps = 61/305 (20%)
Query: 2 EELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQE----- 48
++ S+ K D+ +G G GEV + VAI+ KR A
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 183
Query: 49 ---FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQK 103
E+ L + H ++ + + + +++ E + G + + V ++
Sbjct: 184 ALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV-------VGNKR 235
Query: 104 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG 160
L+ + +LH ++H+D K NVL+ +ED + K+ D G LG
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 161 R----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216
+ G + + A E+ ++ D +S GV L +SG P
Sbjct: 294 ETSLMRTLCGTPTYL-APEVL---VSVGTAGYNRAVDCWSLGVILFICLSGY------PP 343
Query: 217 ----DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
+ L + + + + +F +W+ + + ++ L+ + L + R
Sbjct: 344 FSEHRTQVSLKDQITSGKYNF-------IPEVWAEVSEKALD----LVKKLLVVDPKARF 392
Query: 272 SMSDV 276
+ +
Sbjct: 393 TTEEA 397
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 59/232 (25%), Positives = 87/232 (37%), Gaps = 60/232 (25%)
Query: 10 NFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ- 60
+ IGEG +G+V+K L G VA+K+ G P I EV L ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLET 70
Query: 61 --HRNLVTLL------GYCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQK 103
H N+V L +E L L++E++ V + Q
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 104 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT 162
L +GL LHS RVVH+D K N+LV K+AD GL R +
Sbjct: 130 L-------------RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIY---- 170
Query: 163 DVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ VT A E+ L S ++ D++S G E+ +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRK 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 55/290 (18%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASI 59
+ + N IG G +GEV + + A K K F E+ + S+
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAA 117
H N++ L ++N +L+ E G + + V ++ I
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-------VHKRVFRESDAARIMKDVL 116
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 170
+A+ H L V H+D K N L D K+ D GL G
Sbjct: 117 SAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---- 170
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 227
T +++ +V E + + D +S GV + L+ G P + +++ ++
Sbjct: 171 -TP--YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY------PPFSAPTDSEVMLKIR 220
Query: 228 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
F E+ W + + LI R L S ++R +
Sbjct: 221 EGTFTF-------PEKDWLNVSPQAES----LIRRLLTKSPKQRITSLQA 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 60/233 (25%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASI 59
+ IG G +G VYK G VA+K G P + EV L +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST-VREVALLRRL 68
Query: 60 Q---HRNLVTLLGYCQENNLQ-----FLIYEYIPN------GSVSIHLYGPSQV---SRQ 102
+ H N+V L+ C + L++E++ + RQ
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 103 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGR 161
L +GL LH+ +VH+D K N+LV K+AD GL R +
Sbjct: 129 FL-------------RGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIY--- 170
Query: 162 TDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ VT A E+ L S ++ D++S G E+ +
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 38/219 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
K + +G G +G V + + G VAIKK P Q I E+ L +Q
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81
Query: 61 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
H N++ LL + +L+ ++ + ++ K + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQ-----KIMGLKFSEEKIQYLVY 133
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 172
KGL ++HS VVH+D K N+ V+ED K+ D G L R A + V
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTR 187
Query: 173 ---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ L+ + +++ D++S G + E+++G+
Sbjct: 188 WYRAPEVILS-----WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 9e-14
Identities = 62/290 (21%), Positives = 108/290 (37%), Gaps = 69/290 (23%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRNLVT 66
+G G+F V K G A K R G +E EV L I+H N++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 67 LLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLEFKHRLSIALGAAK 118
L + LI E + G + + +Q L+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD------------- 119
Query: 119 GLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 170
G+ +LHS R+ H D K N+++ + K+ D G+ + + ++ G
Sbjct: 120 GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG---- 173
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 227
T + F+A E+ + ++D++S GV L+SG SP ++ Q+ + +
Sbjct: 174 -TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPFLGETKQETLTNIS 224
Query: 228 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
DF DE +S + + I R L +RR +++
Sbjct: 225 AVNYDF-------DEEYFSNTSELAKD----FIRRLLVKDPKRRMTIAQS 263
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 34/225 (15%)
Query: 7 ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT---------QEF 49
+T F + ++G G V + + A+K G +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 50 IDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEF 106
+ EV L + H N++ L + N FL+++ + G + + + L
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-------TEKVTLSE 123
Query: 107 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----T 162
K I + + LH L +VH+D K N+L+D+D K+ D G L
Sbjct: 124 KETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
+V G S + A EI S + ++ D++S GV + L++G
Sbjct: 182 EVCGTPSYL-APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 70
+GEG +GEV + VA+K + E I E+C + H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 123
+E N+Q+L EY G + + + F ++ G+ +L
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 178
H + + H+D K N+L+DE K++D GL + E L
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169
Query: 179 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
A E+ + R F E DV+S G+ L +++G L D D +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217
Query: 233 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++ W + + L+ + L + R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 39/220 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
K + + IG G G V VAIKK P Q E+ + +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 61 HRNLVTLLG-YCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
H+N+++LL + + L+ +Y + ++ QV + +L+ + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQML 174
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----- 172
G+ HLHS ++H+D K +N++V D K+ D G L RT AG S +T
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVT 226
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ L + E D++S G + E+V +
Sbjct: 227 RYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHK 260
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 65/300 (21%), Positives = 109/300 (36%), Gaps = 72/300 (24%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 57
+ FSD +G+G F V + + G+ A K K Q+ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGP---SQVSRQKLEFKHR 109
+QH N+V L QE + +L+++ + G V+ Y S +Q LE
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---- 116
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 162
+A+ HS +VH++ K N+L+ + K+AD GL +
Sbjct: 117 ---------SIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 163 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----D 217
AG P +L+ EV + +S+ D+++ GV L L+ G P +
Sbjct: 166 GFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVG-------YPPFWDE 210
Query: 218 SSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
L ++ D+ W T T E LI L + ++R +
Sbjct: 211 DQHRLYAQIKAGAYDY-------PSPEWDTVTPEA----KSLIDSMLTVNPKKRITADQA 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 96/316 (30%)
Query: 14 KNLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID------------- 51
K+ IG+G +G V D A+K ++ G P +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 52 --------EVCFLASIQHRNLVTL---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 100
E+ L + H N+V L L E++L ++++E + G V +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVM------EVPT 130
Query: 101 RQKLE-------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153
+ L F+ + G+ +LH +++H+D K +N+LV ED K+AD
Sbjct: 131 LKPLSEDQARFYFQDLIK-------GIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 154 GLRNFLGRTDV-----AG-PSSQVTADEIFLASEV--KEFRRFS-EKSDVYSFGVFLLEL 204
G+ N +D G P+ F+A E + + FS + DV++ GV L
Sbjct: 182 GVSNEFKGSDALLSNTVGTPA--------FMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 205 VSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL----WSTFTNEGMEEFIQLIV 260
V G+ P + ++ L KI + L E+ LI
Sbjct: 234 VFGQ------CPFMDERIMCL---------HSKIKSQALEFPDQPDIA----EDLKDLIT 274
Query: 261 RCLDPSSERRPSMSDV 276
R LD + E R + ++
Sbjct: 275 RMLDKNPESRIVVPEI 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 60/302 (19%), Positives = 108/302 (35%), Gaps = 69/302 (22%)
Query: 5 SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVC 54
++ F+++ +G+G F V + + + G A K Q+ E
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEF 106
++H N+V L E +LI++ + G + I S +Q LE
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE- 121
Query: 107 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 161
+ H H + VVH++ K N+L+ + K+AD GL +
Sbjct: 122 ------------AVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 162 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 216
AG T +L+ EV + + D+++ GV L L+ G P
Sbjct: 168 QAWFGFAG-----TPG--YLSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFW 214
Query: 217 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
+ L + ++ DF W T T E + LI + L + +R + +
Sbjct: 215 DEDQHRLYQQIKAGAYDF-------PSPEWDTVTPEAKD----LINKMLTINPSKRITAA 263
Query: 275 DV 276
+
Sbjct: 264 EA 265
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 67/298 (22%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLAS 58
D +G G FG+V+ G+ IK R P ++ E+ L S
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEY---------IPNGSVSIHLYGPSQVSRQKLEFKHR 109
+ H N++ + ++ + +++ E I + V+ K
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL---MKQM 133
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 162
++ LA+ HS VVHKD K N+L K+ D GL T
Sbjct: 134 MN-------ALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSS 219
+ AG TA +++A EV + R + K D++S GV + L++G P S
Sbjct: 185 NAAG-----TA--LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSL 230
Query: 220 QDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++ + ++ T + ++ L+ + L ERRPS + V
Sbjct: 231 EEVQQKATYKEPNY--------AVECRPLTPQAVD----LLKQMLTKDPERRPSAAQV 276
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 66/313 (21%), Positives = 117/313 (37%), Gaps = 70/313 (22%)
Query: 8 TKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 58
+ F D ++++GEG V + L A+K K+PG EV L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 59 IQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHR 109
Q HRN++ L+ + +E + +L++E + GS+ IH S V +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---- 122
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAG 166
L LH+ + H+D K N+L ++ K+ D L + +
Sbjct: 123 ---------ALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 167 PSSQVTADEI-----FLASEV-----KEFRRFSEKSDVYSFGVFLLELVSG--------- 207
P S ++A EV +E + ++ D++S GV L L+SG
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 208 ---REASSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL 263
P L E +Q + +F ++ W+ + + LI + L
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEF-------PDKDWAHISCAAKD----LISKLL 280
Query: 264 DPSSERRPSMSDV 276
+++R S + V
Sbjct: 281 VRDAKQRLSAAQV 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 44/220 (20%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFID-EVCFLASIQHRNLVTLL 68
+++ +IG G FG V++ L + VAIKK F + E+ + ++H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLK 98
Query: 69 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG------A 116
+ N + L+ EY+P +Y + SR + K + + L
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-----TVY---RASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQ---VT 172
+ LA++HS+ + H+D K N+L+D + K+ D G + +AG + +
Sbjct: 151 LRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFG----SAKILIAGEPNVSYICS 204
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ + ++ D++S G + EL+ G+
Sbjct: 205 RYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 65/289 (22%), Positives = 97/289 (33%), Gaps = 73/289 (25%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFL----ASIQH 61
L+G+G FG V+ G L D + VAIK EV L A H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--- 118
++ LL + + L+ E L+ + K L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLF-------DYITEKGPLGEGPSRCFFGQ 147
Query: 119 ---GLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGR---TDVAG-PSSQ 170
+ H HS VVH+D K N+L+D AK+ D G L TD G
Sbjct: 148 VVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-- 203
Query: 171 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229
+ E ++ + V+S G+ L ++V G P
Sbjct: 204 ------YSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IP------------- 238
Query: 230 RDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
F +IL+ L + + + LI RCL P RPS+ ++
Sbjct: 239 --FERDQEILEAELHFPAHVSPDC----CALIRRCLAPKPSSRPSLEEI 281
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 70/306 (22%)
Query: 1 MEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFI 50
E + A+ FSD +G+G F V + + G+ A K K Q+
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 51 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYG---PSQVSRQ 102
E +QH N+V L QE + +L+++ + G V+ Y S +Q
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136
Query: 103 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 159
LE +A+ HS +VH++ K N+L+ + K+AD GL +
Sbjct: 137 ILE-------------SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 160 GR----TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 214
AG P +L+ EV + +S+ D+++ GV L L+ G
Sbjct: 182 NDSEAWHGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVGY------ 227
Query: 215 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
P + L ++ D+ W T T E LI L + ++R
Sbjct: 228 PPFWDEDQHRLYAQIKAGAYDY-------PSPEWDTVTPEAKS----LIDSMLTVNPKKR 276
Query: 271 PSMSDV 276
+
Sbjct: 277 ITADQA 282
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 70/285 (24%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 70
IG+G F +V + G VAIK + + + + EV + + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 123
+ +LI EY G V +L V+ +++ F+ +S + +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVS-------AVQYC 130
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------- 176
H R+VH+D K N+L+D D K+AD G S++ T
Sbjct: 131 HQK--RIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176
Query: 177 --FLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
+ A E+ + +++ + DV+S GV L LVSG P Q+L EL +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKELRE------ 224
Query: 234 NLLKILDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++L R+ + + L+ R L + +R ++ +
Sbjct: 225 ---RVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQI 262
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 41/225 (18%)
Query: 8 TKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQHRNL 64
F + + G+G FG V G GM VAIKK P + + LA + H N+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 65 VTLL------GYCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG-- 115
V L G ++ ++ EY+P+ ++H + R + L
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD---TLH-----RCCRNYYRRQVAPPPILIKV 133
Query: 116 ----AAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQ 170
+ + LH S V H+D K NVLV+ D K+ D G + +
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNV 189
Query: 171 ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ A E+ + + ++ D++S G E++ G
Sbjct: 190 AYICSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 72/302 (23%)
Query: 8 TKNFSDK-----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFL 56
+NF++ +G GKF V + + G A K +R E + E+ L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 57 ASIQHR-NLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHLYGPSQVS---RQKLE 105
+ ++ L + + LI EY G + + V +Q LE
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG-- 160
G+ +LH +VH D K N+L+ K+ D G+ +G
Sbjct: 143 -------------GVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 161 --RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 216
++ G T + +LA E+ + + +D+++ G+ L++ SP
Sbjct: 188 CELREIMG-----TPE--YLAPEILNYDPITTATDMWNIGIIAYMLLTH------TSPFV 234
Query: 217 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
+ +Q+ + D+ E +S+ + + I L + E+RP+
Sbjct: 235 GEDNQETYLNISQVNVDY-------SEETFSSVSQLATD----FIQSLLVKNPEKRPTAE 283
Query: 275 DV 276
Sbjct: 284 IC 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 46/231 (19%), Positives = 94/231 (40%), Gaps = 47/231 (20%)
Query: 7 ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID------- 51
A K F K ++IG G V + + G A+K + E ++
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 52 -EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E- 105
E L + H +++TL+ + ++ FL+++ + G + + + L E
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-------TEKVALSEK 200
Query: 106 -----FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160
+ L ++ LH+ +VH+D K N+L+D++ +++D G L
Sbjct: 201 ETRSIMRSLLE-------AVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 161 R----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
++ G + A EI S + + ++ D+++ GV L L++G
Sbjct: 252 PGEKLRELCGTPGYL-APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 75/289 (25%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFLASIQHR--N 63
L+G G FG VY G+ + D + VAIK P + EV L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 64 LVTLLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALG 115
++ LL + + + LI E P + + R L+ F L
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLE---- 160
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGR---TDVAG-PSSQ 170
+ H H+ V+H+D K N+L+D + K+ D G L TD G
Sbjct: 161 ---AVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV-- 213
Query: 171 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229
+ E + R+ + V+S G+ L ++V G P
Sbjct: 214 ------YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IP------------- 248
Query: 230 RDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
F + +I+ +++ ++E LI CL RP+ ++
Sbjct: 249 --FEHDEEIIRGQVFFRQRVSSECQ----HLIRWCLALRPSDRPTFEEI 291
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
K + + IG G G V VAIKK P Q E+ + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 61 HRNLVTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
H+N++ LL + + +L+ +++ E + ++ QV + +L+ + +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLC-----QVIQMELDHERMSYLLY 134
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 172
G+ HLHS ++H+D K +N++V D K+ D G L RT AG S +T
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPY 186
Query: 173 -------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ L + E D++S G + E++ G
Sbjct: 187 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGG 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 40/216 (18%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
L+GEG +G+V + L + A+K +R E+ L ++H+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 68 LG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAK 118
+ Y +E +++ EY G + V ++ F +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDS----VPEKRFPVCQAHGYFCQLID------- 120
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP------SSQVT 172
GL +LHS +VHKD K N+L+ K++ G+ L S
Sbjct: 121 GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
EI + + F F K D++S GV L + +G
Sbjct: 179 PPEIA--NGLDTFSGF--KVDIWSAGVTLYNITTGL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 49/236 (20%), Positives = 89/236 (37%), Gaps = 53/236 (22%)
Query: 4 LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQE------- 48
+S+ K D+ +G G GEV + VAIK KR A
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 49 -FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLE 105
E+ L + H ++ + + + +++ E + G + + V ++L+
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV-------VGNKRLK 112
Query: 106 -------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGL 155
F L + +LH ++H+D K NVL+ +ED + K+ D G
Sbjct: 113 EATCKLYFYQMLL-------AVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 156 RNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 207
LG + G + + A E+ ++ ++ D +S GV L +SG
Sbjct: 164 SKILGETSLMRTLCGTPTYL-APEVLVS---VGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ ++LIG G +G V + + +VAIKK ++ ID E+ L +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLN 110
Query: 61 HRNLVTLLG-YCQENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 113
H ++V +L ++ +F ++ E ++ + L H ++
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFK-----KLFRTPVYLTELHIKTLL 162
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
G+ ++HS ++H+D K AN LV++D KV D GL
Sbjct: 163 YNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 75/289 (25%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID----EVCFLASIQHRNL 64
+G G FG V+ + + V +K + E+ L+ ++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK------ 118
+ +L + L+ E +G + L+ ++ RL L +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLF-------AFIDRHPRLDEPLASYIFRQLVS 141
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPS 168
+ +L ++H+D K N+++ EDF K+ D G +L G + P
Sbjct: 142 AVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP- 198
Query: 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+V + E+ +++S GV L LV +P
Sbjct: 199 -EVLMGNPYRGPEL----------EMWSLGVTLYTLVFEE------NP------------ 229
Query: 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
F L + ++ + +E + L+ L P ERR ++ +V
Sbjct: 230 ---FCELEETVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+++ + IGEG +G V + + VAIKK +P + E+ L +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 83
Query: 61 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIAL 114
H N++ + ++ +++ + + ++ ++ + Q L H
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLME---TDLY-----KLLKTQHLSNDHICYFLY 135
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 171
+GL ++HS + V+H+D K +N+L++ K+ D GL R D G ++
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 172 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
T A EI L + +++ D++S G L E++S R
Sbjct: 194 TRWYRAPEIMLN-----SKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 54/297 (18%), Positives = 94/297 (31%), Gaps = 69/297 (23%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASI 59
SD + +G G VY+ A +KK + E+ L +
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRL 105
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHRLS 111
H N++ L + L+ E + G + I G + +Q LE
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE------ 159
Query: 112 IALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDV 164
+A+LH +VH+D K N+L D K+AD GL + V
Sbjct: 160 -------AVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQ 220
G T + A E+ + + D++S G+ L+ G P Q
Sbjct: 211 CG-----TPG--YCAPEILRGCAYGPEVDMWSVGIITYILLCGF------EPFYDERGDQ 257
Query: 221 DLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ + N F W + + L+ + + ++R +
Sbjct: 258 FMFRRILNCEYYF-------ISPWWDEVSLNAKD----LVRKLIVLDPKKRLTTFQA 303
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 42/227 (18%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK--------RPGAPTQEFID------EV 53
++ + I G +G V G+ +G+ VAIK+ R + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 54 CFLASIQHRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 108
L H N++ L + +L+ E + L R + +H
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-----DLAQVIHDQRIVISPQH 135
Query: 109 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168
GL LH VVH+D N+L+ ++ + D L R D A +
Sbjct: 136 IQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFN----LAREDTADAN 189
Query: 169 SQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ + F+ F++ D++S G + E+ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQ-----FKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 61/304 (20%), Positives = 107/304 (35%), Gaps = 69/304 (22%)
Query: 6 LATKNFSD-------KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVC 54
+ F +GEG F K + + A+K KR A TQ+ E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57
Query: 55 FLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLE 105
L + H N+V L + FL+ E + G + I S + R+ +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR- 161
++H+H + VVH+D K N+L +++ K+ D G
Sbjct: 118 -------------AVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 162 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG----REASSS 213
T + A E+ + E D++S GV L ++SG + S
Sbjct: 163 NQPLKTPCF-----TLH--YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215
Query: 214 LSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
L+ S+ ++++ ++ F + W + E LI L +R
Sbjct: 216 LTCTSAVEIMKKIKKGDFSF-------EGEAWKNVSQEA----KDLIQGLLTVDPNKRLK 264
Query: 273 MSDV 276
MS +
Sbjct: 265 MSGL 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 56/302 (18%), Positives = 113/302 (37%), Gaps = 62/302 (20%)
Query: 1 MEELSLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDE 52
+++L + F+D K IG G + + + M A+K K PT+E I+
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEI 68
Query: 53 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKL 104
+ QH N++TL + +++ E + G + I S V
Sbjct: 69 LLRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG 160
+ + +LH+ VVH+D K +N+L ++ D G L
Sbjct: 127 K-------------TVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 161 R-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 215
TA+ F+A EV E + + D++S GV L +++G ++
Sbjct: 172 AENGLLMTPCY-----TAN--FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224
Query: 216 PDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
D+ ++++ + + + W++ ++ L+ + L +R + +
Sbjct: 225 DDTPEEILARIGSGKFSL-------SGGYWNSVSDTA----KDLVSKMLHVDPHQRLTAA 273
Query: 275 DV 276
V
Sbjct: 274 LV 275
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ + + + +G G +G V + G+ VA+KK P Q I E+ L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86
Query: 61 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 113
H N++ LL +E N +L+ + ++ + + QKL H +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLN-----NIVKCQKLTDDHVQFLI 138
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 172
+GL ++HS ++H+D K +N+ V+ED K+ D G L R + V
Sbjct: 139 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVAT 192
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A EI L + +++ D++S G + EL++GR
Sbjct: 193 RWYRAPEIMLN-----WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ D +G G +G V + + G VAIKK P Q + E+ L ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82
Query: 61 HRNLVTLLG--YCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 113
H N++ LL E F L+ ++ + ++ + +KL +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMG---TDLG-----KLMKHEKLGEDRIQFLV 134
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 172
KGL ++H+ ++H+D K N+ V+ED K+ D G L R + + V
Sbjct: 135 YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVT 188
Query: 173 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
A E+ L + R+++ D++S G + E+++G+
Sbjct: 189 RWYRAPEVILN-----WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 47/245 (19%), Positives = 91/245 (37%), Gaps = 46/245 (18%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
N+ K+LIG G +G VY VAIKK ++ ID E+ L ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLK 83
Query: 61 HRNLVTLLGYCQ-ENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 113
++ L ++ L+F ++ E + ++ + L +H +I
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIAD---SDLK-----KLFKTPIFLTEEHIKTIL 135
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 172
G +H ++H+D K AN L+++D KV D GL R D +
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 173 ADEIFLASEVKE--------------------FRRFSEKSDVYSFGVFLLELVSGREASS 212
+E ++ + +++ D++S G EL++ ++
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
Query: 213 SLSPD 217
+ +
Sbjct: 254 NDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 44/228 (19%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ +F K+L+GEG +G V G +VAIKK P + + E+ L +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFK 67
Query: 61 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQV-SRQKLEFKHRLSIAL 114
H N++T+ + N ++I E + +H +V S Q L H
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQ---TDLH-----RVISTQMLSDDHIQYFIY 119
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSS 169
+ + LH + V+H+D K +N+L++ + KV D GL + ++ G S
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 170 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ A E+ L S ++S DV+S G L EL R
Sbjct: 178 GMVEFVATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAELFLRR 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 54/219 (24%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+G G FG+V G G VA+K + + E+ L +H +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL 76
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 120
F++ EY+ G + ++ ++E F+ LS +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQILS-------AV 124
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 178
+ H VVH+D K NVL+D AK+AD GL N + +D FL
Sbjct: 125 DYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRT 169
Query: 179 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 208
A EV R ++ + D++S GV L L+ G
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 32/223 (14%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ D +G G G V+ + VAIKK + E+ + +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK---IVLTDPQSVKHALREIKIIRRLD 66
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP------SQVSR-QKLEFKHRLSIA 113
H N+V + + Q S+++ + V L +H
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGL-RNFLGRTDVAGPSSQ- 170
+GL ++HS + V+H+D K AN+ ++ ED + K+ D GL R G S+
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 171 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
VT + + L+ +++ D+++ G E+++G+
Sbjct: 185 LVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 50/303 (16%), Positives = 110/303 (36%), Gaps = 62/303 (20%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQ-HRNL 64
++ +G GK+ EV++ + + + V +K +P ++ E+ L +++ N+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNI 93
Query: 65 VTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+TL + L++E++ N Q L K L +
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDY 145
Query: 123 LHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVT--------- 172
HS+ ++H+D K NV++D E ++ D GL F P +
Sbjct: 146 CHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYNVRVASRYFK 197
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--------------SSSLSPDS 218
E+ + +++ + D++S G L ++ +E + L +
Sbjct: 198 GPELLV-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 219 SQDLVEL--VQNSRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCL--DPSSER 269
D ++ ++ F+++L + W F + E + + + L D
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ--S 310
Query: 270 RPS 272
R +
Sbjct: 311 RLT 313
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 52/218 (23%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLL 68
+G G FG+V G G VA+K R + + + E+ L +H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLA 121
+ F++ EY+ G + ++ +L+ F+ LS G+
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQILS-------GVD 130
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 178
+ H VVH+D K NVL+D AK+AD GL N + +D FL
Sbjct: 131 YCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRTS 175
Query: 179 -------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 208
A EV R ++ + D++S GV L L+ G
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 16/217 (7%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC----- 54
+E + F D ++G G FGEV+ ++ G L A KK ++
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 55 -FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
LA + R +V+L Y + L+ + G + H+Y + + E +
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV- 171
A GL HLH ++++D K NVL+D+D +++D GL +
Sbjct: 296 A-QIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAG 351
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
T F+A E+ + D ++ GV L E+++ R
Sbjct: 352 TPG--FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 44/247 (17%), Positives = 83/247 (33%), Gaps = 59/247 (23%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV 65
+K +S +G G FG V + + G A+KK + E+ + + H N++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--NRELDIMKVLDHVNII 63
Query: 66 TLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK------------ 107
L+ G + Q G + V + K
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 108 -HRLSIALGAAK-----------------GLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 148
H++ + + + +HSL + H+D K N+LV+ +D
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTL 181
Query: 149 KVADAGLRNFLGRTDVAGPSSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFL 201
K+ D G + + S + A E+ L + ++ D++S G
Sbjct: 182 KLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVF 232
Query: 202 LELVSGR 208
EL+ G+
Sbjct: 233 GELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 42/232 (18%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 60
+ + +G+G +G V+K + + G +VA+KK Q D E+ L +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELS 66
Query: 61 -HRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIALGA 116
H N+V LL + +N + +L+++Y+ +H V R LE H+ +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYME---TDLH-----AVIRANILEPVHKQYVVYQL 118
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE 175
K + +LHS ++H+D K +N+L++ + KVAD GL R+F+ V +
Sbjct: 119 IKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 176 IFLASEVKEF-------------------RRFSEKSDVYSFGVFLLELVSGR 208
+ + ++++ D++S G L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 58/220 (26%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID-----------EVCFLASIQHRN 63
IG G FG LVA+K +I+ E+ S++H N
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVK---------YIERGAAIDENVQREIINHRSLRHPN 77
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGA 116
+V +I EY G + + + + F+ LS
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERI-----CNAGRFSEDEARFFFQQLLS----- 127
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA--KVADAGLRNF-----LGRTDVAGPSS 169
G+++ HS+ ++ H+D K N L+D K+ D G ++ V P+
Sbjct: 128 --GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 182
Query: 170 QVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 208
++A EV + + + +DV+S GV L ++ G
Sbjct: 183 -------YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-08
Identities = 51/347 (14%), Positives = 98/347 (28%), Gaps = 122/347 (35%)
Query: 24 EVYKGLLQDG--------MLVAIKKRPGAPTQEFIDEVC-----FLAS-IQHRNLVTLLG 69
E ++ + + + Q+F++EV FL S I+
Sbjct: 49 EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE------- 101
Query: 70 YCQENNLQFLIYEY----IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
++ ++ +Y + N + ++ VSR + K R L
Sbjct: 102 -QRQPSMMTRMYIEQRDRLYNDN---QVFAKYNVSRLQPYLKLR-----------QALLE 146
Query: 126 LSPR---VVH------KDFKTANVLVDEDFIAKVAD-----------------AGLRNFL 159
L P ++ K + +V + K+ L+ L
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 160 GRTDVAGPSSQVTADEIFLASEV--KEFRR-FSEKS---------DVYS---FGVFLLE- 203
+ D S + I L E RR K +V + + F L
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 204 --LVSGREAS-------------------SSLSPDSSQDLVELVQNSRDFS--------N 234
L++ R +L+PD + L+ + R N
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 235 --LLKILDERL---------WSTFTNEGMEEFIQLIVRCLDPSSERR 270
L I+ E + W + + I+ + L+P+ R+
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 48/228 (21%), Positives = 92/228 (40%), Gaps = 41/228 (17%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC----- 54
+E + F ++G+G FGEV ++ G + A KK ++ E
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 55 -FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 112
L + R +V+L Y + + L+ + G + H+Y + F ++
Sbjct: 236 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-----HMGQAGFPEARAV 289
Query: 113 ALGA--AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL----------RNFLG 160
A GL LH R+V++D K N+L+D+ +++D GL + +G
Sbjct: 290 FYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV + R++ D ++ G L E+++G+
Sbjct: 348 TVG-------------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 55/219 (25%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 67
+GEG FG+V + VA+K K+ + E+ +L ++H +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL 74
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 120
++ EY G + ++ V ++++ F+ + +
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYI-----VEKKRMTEDEGRRFFQQIIC-------AI 121
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 178
+ H ++VH+D K N+L+D++ K+AD GL N + D FL
Sbjct: 122 EYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------------TDGNFLKT 166
Query: 179 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 208
A EV + ++ + DV+S G+ L ++ GR
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 64/294 (21%), Positives = 97/294 (32%), Gaps = 55/294 (18%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK--------KRPGAPTQE 48
++E+ L +F +IG G F EV K G + A+K KR
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKR--GEVSC 107
Query: 49 FIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK 107
F +E L + R + L + Q+ N +L+ EY G + L S+
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL------SKFGERIP 160
Query: 108 HRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161
++ I + + +H L VH+D K N+L+D ++AD G L
Sbjct: 161 AEMARFYLAEIVM----AIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 162 TDVAGPSSQV-TAD----EIFLASEVKEFRRFSEKS-DVYSFGVFLLELVSGREASSSLS 215
V T D EI A D ++ GVF E+ G +
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG------QT 268
Query: 216 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 269
P + E + L + EE I R L P R
Sbjct: 269 PFYADSTAETYGKIVHYKEHLSLPLVDEGVP------EEARDFIQRLLCPPETR 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 51/300 (17%), Positives = 100/300 (33%), Gaps = 68/300 (22%)
Query: 8 TKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 58
+D K ++G G G+V + + G A+K P A + +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH----HWQA 78
Query: 59 IQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGP--------SQVSRQKL 104
++V +L + + +I E + G + I G +++ R
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR 161
+ LHS + + H+D K N+L ++D + K+ D G +
Sbjct: 139 T-------------AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 162 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPD 217
T ++A EV ++ + D++S GV + L+ G S+
Sbjct: 184 NALQTPCY-----TPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236
Query: 218 SSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
S + ++ + F WS + + QLI L R +++
Sbjct: 237 ISPGMKRRIRLGQYGF-------PNPEWSEVSEDA----KQLIRLLLKTDPTERLTITQF 285
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 4e-08
Identities = 35/194 (18%), Positives = 57/194 (29%), Gaps = 46/194 (23%)
Query: 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----------GAPTQEFIDEVC 54
L T+ IGEG FGEV++ + D VAIK +E + E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 55 FL---------ASIQHRNLVTLLGY--CQENNLQFLIYEYI----PNGSVSIHL--YGPS 97
+ + L Q + L+ + GS + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 98 QV----------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL 141
Q+ + SI LA + S R H+D NVL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVL 194
Query: 142 VDEDFIAKVADAGL 155
+ + + K+
Sbjct: 195 LKKTSLKKLHYTLN 208
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASIQH 61
++F ++GEG F V L AIK KR + E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG---AAK 118
V L Q++ + Y NG + ++ +K A+
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--------RK---IGSFDETCTRFYTAE 138
Query: 119 ---GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TA 173
L +LH ++H+D K N+L++ED ++ D G + + A +S V TA
Sbjct: 139 IVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 174 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+++ E+ + + SD+++ G + +LV+G
Sbjct: 197 Q--YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 65/294 (22%), Positives = 117/294 (39%), Gaps = 59/294 (20%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK--------KRPGAPTQEF 49
+++ L ++F +IG G FGEV K + A+K KR A T F
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKR--AETACF 121
Query: 50 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 109
+E L + + + TL Q++N +L+ +Y G + L S+ +
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL------SKFEDRLPEE 175
Query: 110 LS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNF 158
++ + + + +H L VH+D K N+L+D + ++AD G +
Sbjct: 176 MARFYLAEMVI----AIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229
Query: 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218
++ VA + + EI A E + R+ + D +S GV + E++ G +P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGK-GRYGPECDWWSLGVCMYEMLYG------ETPFY 282
Query: 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM---EEFIQLIVRCLDPSSER 269
++ LVE KI++ + F + E LI R + R
Sbjct: 283 AESLVETYG---------KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHR 327
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK--------KRPGAPTQE 48
+ +L + +++ +IG G FGEV K + A+K KR + +
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKR--SDSAF 115
Query: 49 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 108
F +E +A +V L Q++ +++ EY+P G + + S + K
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM------SNYDVPEKW 169
Query: 109 -RLSIA-LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166
R A + A L +HS+ +H+D K N+L+D+ K+AD G + + +
Sbjct: 170 ARFYTAEVVLA--LDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 167 PSSQV-TADEIFLASEV----KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221
+ V T D +++ EV + + D +S GVFL E++ G +P +
Sbjct: 226 CDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADS 277
Query: 222 LVELVQN 228
LV
Sbjct: 278 LVGTYSK 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLA---------S 58
+FS +IG G FGEVY D G + A+K + E L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 59 IQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+V + Y + I + + G + HL S + F + I LG
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILG-- 304
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQV-TAD 174
L H+H+ VV++D K AN+L+DE +++D GL + + V T
Sbjct: 305 --LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHG 355
Query: 175 EIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 208
++A EV ++ + +D +S G L +L+ G
Sbjct: 356 --YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 49/297 (16%), Positives = 101/297 (34%), Gaps = 76/297 (25%)
Query: 13 DKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV-CFLASIQHRNLVTL 67
++G G G+V + + A+K P + EV + Q ++V +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRI 120
Query: 68 LGYCQENNLQ----FLIYEYIPNGSV--SIHLYGP--------SQVSRQKLEFKHRLSIA 113
+ + ++ E + G + I G S++ + E
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE-------- 172
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQ 170
+ +LHS++ + H+D K N+L + I K+ D G + +
Sbjct: 173 -----AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------AKE 213
Query: 171 VTADEIF---------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQ 220
T+ +A EV ++ + D++S GV + L+ G S+ S
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 221 DLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ ++ + +F WS + E LI L +R ++++
Sbjct: 274 GMKTRIRMGQYEF-------PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 319
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 73
IG G FG++Y G + G VAIK + E +Q + T+ E
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 74 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
+ ++ E L GPS +K K L +A + ++HS +
Sbjct: 77 GDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 129 RVVHKDFKTANVLV 142
+H+D K N L+
Sbjct: 126 -FIHRDVKPDNFLM 138
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 62/239 (25%), Positives = 93/239 (38%), Gaps = 59/239 (24%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAIK---KRPGAPTQEFI---DEV-------CFLASIQH 61
L+G+G FG+V + G A+K K E I DEV L + +H
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKK-------EVIVAKDEVAHTLTENRVLQNSRH 207
Query: 62 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
L L Y Q ++ + EY G + HL R E + R A L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGA-EIVSAL 261
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSS 169
+LHS VV++D K N+++D+D K+ D GL + F G +
Sbjct: 262 DYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE------ 314
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
+LA EV E + D + GV + E++ GR P +QD +L +
Sbjct: 315 -------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFEL 360
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 20/134 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQE 73
IG G FGE+Y G +Q VAIK + + E +Q + + + E
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 74 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
+ L+ + L GPS +KL K L +A + +HS S
Sbjct: 75 GDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 129 RVVHKDFKTANVLV 142
+H+D K N L+
Sbjct: 124 -FLHRDIKPDNFLM 136
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQ 60
F +G G FG V L++ G A+K K+ ++ ++E L ++
Sbjct: 42 QFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IAL 114
LV L ++N+ +++ EY+ G + HL R+ F + I L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVL 152
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVT 172
+LHSL ++++D K N+L+D+ +V D G + GRT + G T
Sbjct: 153 ----TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----T 201
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ LA E+ + +++ D ++ GV + E+ +G
Sbjct: 202 PE--ALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 65/242 (26%)
Query: 16 LIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLASIQ 60
++G+G FG+V KG L A+K ++ + D+V +
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVK----ILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 61 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--A 117
L L C Q + + + EY+ G + H+ Q FK ++ A A
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAAEIA 452
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAG 166
GL L S ++++D K NV++D + K+AD G+ + F G D
Sbjct: 453 IGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD--- 507
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
++A E+ ++ + + D ++FGV L E+++G+ +P +D EL
Sbjct: 508 ----------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELF 551
Query: 227 QN 228
Q+
Sbjct: 552 QS 553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 73
IGEG FG +++G L + VAIK + + DE + + + + QE
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 74 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 128
L+ + L GPS + +K K A + +H S
Sbjct: 78 GLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 129 RVVHKDFKTANVLV 142
+V++D K N L+
Sbjct: 127 -LVYRDIKPDNFLI 139
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 49/256 (19%)
Query: 16 LIGEGKFGEVYKGLLQD-GMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLL 68
IG+G FG+V D + A+K K+ E E+ + ++H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 69 GYCQ-ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIA-LGAAKGLAHL 123
Q E ++ F++ + + G + HL +Q + FK +L I L A L +L
Sbjct: 82 YSFQDEEDM-FMVVDLLLGGDLRYHL-------QQNVHFKEETVKLFICELVMA--LDYL 131
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--------ADE 175
+ R++H+D K N+L+DE + D + + + T A E
Sbjct: 132 QNQ--RIIHRDMKPDNILLDEHGHVHITDFNI-----AAMLPRETQITTMAGTKPYMAPE 184
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN------- 228
+F + ++ +S D +S GV EL+ GR S SS+++V +
Sbjct: 185 MFSS---RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 229 --SRDFSNLLKILDER 242
S++ +LLK L E
Sbjct: 242 AWSQEMVSLLKKLLEP 257
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 70/244 (28%)
Query: 16 LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV-------CFLAS 58
L+G+G FG+V K G A+K K E I DEV L +
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRK-------EVIIAKDEVAHTVTESRVLQN 61
Query: 59 IQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA- 116
+H L L Y Q ++ + EY G + HL ++ F + GA
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGAE 113
Query: 117 -AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDV 164
L +LHS VV++D K N+++D+D K+ D GL + F G +
Sbjct: 114 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE- 170
Query: 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 224
+LA EV E + D + GV + E++ GR P +QD
Sbjct: 171 ------------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHER 212
Query: 225 LVQN 228
L +
Sbjct: 213 LFEL 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 9e-05
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 10 NFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASI 59
+F +G G FG V+ + +G A+K K ++ DE L+ +
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IA 113
H ++ + G Q+ F+I +YI G + L R+ F + ++ +
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVC 116
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155
L L +LHS ++++D K N+L+D++ K+ D G
Sbjct: 117 L----ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF 152
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 30/135 (22%), Positives = 49/135 (36%), Gaps = 22/135 (16%)
Query: 17 IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQ 72
IG G FGE+ G L VAIK Q E F + + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
++ E L GPS + + K L IA+ + ++HS +
Sbjct: 76 CGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 128 PRVVHKDFKTANVLV 142
++++D K N L+
Sbjct: 126 --LIYRDVKPENFLI 138
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 47/281 (16%), Positives = 93/281 (33%), Gaps = 67/281 (23%)
Query: 14 KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV-CFLASIQHRNLVTLL 68
++G G G+V + + A+K + EV + Q ++V ++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 77
Query: 69 GYCQENNLQ----FLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHR--LSIALGAAKGL 120
+ ++ E + G + I R F R I + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEIMKSIGEAI 130
Query: 121 AHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
+LHS++ + H+D K N+L + I K+ D G
Sbjct: 131 QYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSR-DFSNL 235
A E ++ + D++S GV + L+ G S+ S + ++ + +F
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF--- 221
Query: 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
WS + E LI L +R ++++
Sbjct: 222 ----PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 69/314 (21%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
+G G F V+ + + VA+K + T+ DE+ L + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 73 ENNLQFLIYEYIPNGSVSIH------LYGPSQVSRQKLEFKHRLSIALGAA------KGL 120
+ L+ L + G +H + G + ++ K + + GL
Sbjct: 86 NHILKLLDHFNH-KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 121 AHLHSLSPRVVHKDFKTANVLVDE------DFIAKVADAGLRNFLGR---TDVAGPSSQV 171
++H ++H D K NVL++ K+AD G + + + +
Sbjct: 145 DYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREY 201
Query: 172 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD------- 221
+ E+ L + + +D++S + EL++G E S D
Sbjct: 202 RSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 222 --------LVELVQNSRDF----SNLLKILDERLWST---------FTNEGMEEFIQLIV 260
L+ + +R F L I + W F+ + +E +
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 261 RCL--DPSSERRPS 272
L DP +R
Sbjct: 316 PMLQLDP--RKRAD 327
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 53/219 (24%)
Query: 16 LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 57
++G+G FG+V K G L A+K K + I D+V
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKK-------DVILQDDDVECTMTEKRILSL 79
Query: 58 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
+ H L L C Q + F + E++ G + H+ + F + A
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFDEARARFYAA 131
Query: 117 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPSS 169
L LH ++++D K NVL+D + K+AD G+ + + G
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG--- 186
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
T D ++A E+ + + D ++ GV L E++ G
Sbjct: 187 --TPD--YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 66/226 (29%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ------------ 60
+IG+G FG+V K + VA+K + ++ +E+ L ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 61 ------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHR 109
RN + LL NL YE I N L + + L+
Sbjct: 164 MLENFTFRNHICMTFELLSM----NL----YELIKKNKFQGFSLPLVRKFAHSILQ---- 211
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGP 167
L LH R++H D K N+L+ + KV D G + +
Sbjct: 212 ---------CLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----V 256
Query: 168 SSQVT-----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
+ + A E+ L + R+ D++S G L EL++G
Sbjct: 257 YTYIQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGY 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 6e-04
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 68/227 (29%)
Query: 16 LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV------CFLASI 59
++G+G FG+V+ L A+K K + D V L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-------ATLKVRDRVRTKMERDILVEV 83
Query: 60 QHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------I 112
H +V L Y Q +LI +++ G + L S++ + F +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVM-FTEEDVKFYLAEL 135
Query: 113 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGR 161
AL L HLHSL ++++D K N+L+DE+ K+ D GL +F G
Sbjct: 136 ALA----LDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG- 188
Query: 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 208
T + ++A EV R ++ +D +SFGV + E+++G
Sbjct: 189 ----------TVE--YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 312 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.24 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.93 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.28 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-63 Score=418.70 Aligned_cols=271 Identities=16% Similarity=0.230 Sum_probs=225.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++++.||+|+||.||+|+ ..+++.||+|.+. ......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999 5678999999764 33456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||++||+|.+++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 111 mEy~~gG~L~~~i-----~~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 111 LSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp ECCCTTEEHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999998 344578999999999999999999999 779999999999999999999999999998875
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
............||+.|+|||++.+..|+.++|||||||++|+|++|..||...+. ......+. .
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~------------~ 248 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKII------------K 248 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------H
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH------------c
Confidence 44433344556899999999999999999999999999999999999999976432 11111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HHHHHHHhcccccccccCCCccc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE---LDRTLDKEMNLTTVMGEGTPTVT 302 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~---l~~~~~~~~~~~~~~~~~~~~~~ 302 (312)
.. ..++..+++++++||.+||..||++|||++|++.+ ++.-.-+.++|+.+....+|..|
T Consensus 249 ~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~lt 311 (311)
T 4aw0_A 249 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 311 (311)
T ss_dssp TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCCC
Confidence 11 13455567889999999999999999999997644 33344456788888777666543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=411.20 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=216.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|.+.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+|++++++++||||+++++++.+.+.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45678999999999999999999843 467899998876543 458899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcc--------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 77 QFLIYEYIPNGSVSIHLYGPS--------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
+|+|||||++|+|.+++.... ......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcE
Confidence 999999999999999985321 1234568999999999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~ 227 (312)
||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||...+.. .....+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i- 243 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI- 243 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH-
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-
Confidence 9999999987654433333344568889999999999999999999999999999998 89999865432 111111
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++++.+||.+||+.||++|||++++.+.|+++.+..
T Consensus 244 ------------~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 244 ------------TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111223456667789999999999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-61 Score=412.82 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=210.1
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|.+.++||+|+||.||+|.++ +++.||||.+..... +.+.+|++++++++||||+++++++.+.+.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567888899999999999999853 478899998875543 458899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCccc----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
+|+|||||++|+|.+++..... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCC
Confidence 9999999999999998854321 123468999999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||......+ ....
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~ 272 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDC 272 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999987655444444455678999999999999999999999999999999999 899998654321 1111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
+ ........+..+++++.+||.+||+.||++|||+.+++++|+.+.+..
T Consensus 273 i-------------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 I-------------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp H-------------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred H-------------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 111223456667789999999999999999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=409.48 Aligned_cols=259 Identities=21% Similarity=0.219 Sum_probs=213.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
.+.|++.++||+|+||.||+|+ ..+++.||||.+..... ..+|+.+++.++||||+++++++.+.+.+|+|||||+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 3557788899999999999999 55789999998764432 24799999999999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCCCcC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTDVA 165 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~~~~ 165 (312)
|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.+| .+||+|||+|+........
T Consensus 135 g~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 135 GSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999983 34568999999999999999999999 7799999999999999988 6999999999876543221
Q ss_pred ---CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 166 ---GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 166 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.......||+.|+|||++.+..|+.++|||||||++|||+||..||............ .....
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~------------ 273 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI--ASEPP------------ 273 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH--HHSCC------------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--HcCCC------------
Confidence 1223457999999999999999999999999999999999999999876554332211 11111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
.....+..+++++.++|.+||..||.+|||+.|++++|...+.+...
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 11234566678999999999999999999999999999998876443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=407.24 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=216.0
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+...++++.++||+|+||.||+|.+. +++.||||.+... ..+.+.+|+.++++++||||++++|++...+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 34567788999999999999999852 4678999987543 3467899999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 144 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~ 144 (312)
.+|+|||||++|+|.+++..... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECC
Confidence 99999999999999999854321 123468899999999999999999999 77999999999999999
Q ss_pred CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHH
Q 021441 145 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 223 (312)
Q Consensus 145 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~ 223 (312)
++++||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+.. ...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 99999999999987655444444455678999999999999999999999999999999998 89999865432 111
Q ss_pred HHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 224 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
..+ ........+..+++++.+||.+||+.||++|||+.+++++|+.+
T Consensus 258 ~~i-------------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMI-------------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH-------------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 12222345667778999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=403.62 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=206.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.|++..+++++.++||+|+||.||+|.++. .||||.++... .+.+.+|+.++++++||||+++++++.. +.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 367778899999999999999999999653 48999875332 2458899999999999999999998865 468
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|||||++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 107 ~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp EEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred EEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCce
Confidence 999999999999998842 23568999999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhc---CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
...............||+.|+|||++.+. .|+.++|||||||++|||+||..||....... .....+....
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~~---- 254 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGY---- 254 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTTC----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCC----
Confidence 76544333334456799999999999753 58999999999999999999999997654321 1111111110
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
........+.++++++.+||.+||+.||++|||+.+++++|+.+.
T Consensus 255 -----~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 255 -----ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp -----CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 011112345566789999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-61 Score=414.17 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=201.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|++++.||+|+||.||+|+ ..+++.||||.+.... ...+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3689999999999999999999 5578999999865432 246789999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||+||+|.+++.. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999832 223456888999999999999999999 7799999999999999999999999999987643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... ......||+.|+|||++.+..|+.++|||||||++|||+||..||...+. ......+ ...
T Consensus 178 ~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i------------~~~ 240 (350)
T 4b9d_A 178 TVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKI------------ISG 240 (350)
T ss_dssp HHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH------------HHT
T ss_pred Ccc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHH------------HcC
Confidence 211 11234699999999999999999999999999999999999999976432 1111111 111
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....+..+++++.+||.+||..||++|||++++++|
T Consensus 241 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 241 S-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 123445567899999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=409.28 Aligned_cols=248 Identities=18% Similarity=0.315 Sum_probs=207.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.+.|++.++||+|+||.||+|. ..+++.||||++. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3579999999999999999999 5579999999764 33456688999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
|+||+|.+++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 153 ~~gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999882 2458999999999999999999999 779999999999999999999999999998764332
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......||+.|+|||++.+..|+.++|||||||++|||++|..||...+.. .....+.... ..
T Consensus 225 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~-----------~~ 288 (346)
T 4fih_A 225 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL-----------PP 288 (346)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSS-----------CC
T ss_pred C--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCC-----------CC
Confidence 1 233467999999999999999999999999999999999999999764321 1111111110 01
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+++++.+||.+||..||++|||++|+++|
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112334556889999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=407.46 Aligned_cols=270 Identities=24% Similarity=0.372 Sum_probs=220.3
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCC-ccceeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQH-RNLVTLLGY 70 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h-~~i~~~~~~ 70 (312)
++|++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+|+.++.++.| |||++++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 357888999999999999999999999832 246899998765433 357889999999965 899999999
Q ss_pred eee-CCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 71 CQE-NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 71 ~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
|.. ++.+|+|||||++|+|.+++..... .....+++..+..++.||+.||.|||+ ++||||||||+
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK~~ 214 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 214 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccCcc
Confidence 866 4568999999999999999854221 123458899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
|||++.++.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||......
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433222344568889999999999999999999999999999998 89999875432
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.. ... .+........+..+++++.++|.+||+.||++|||+.+++++|+++++...
T Consensus 295 ~~--~~~-------------~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 295 EE--FCR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HH--HHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HH--HHH-------------HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 21 111 122222334566677899999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-59 Score=411.87 Aligned_cols=248 Identities=18% Similarity=0.315 Sum_probs=207.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.+.|+++++||+|+||.||+|. ..+++.||||++. ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4679999999999999999999 5579999999754 33456688999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
|+||+|.+++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 230 ~~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999882 3458899999999999999999999 779999999999999999999999999998764332
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.... .....+.... ..
T Consensus 302 --~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~-----------~~ 365 (423)
T 4fie_A 302 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL-----------PP 365 (423)
T ss_dssp --CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSC-----------CC
T ss_pred --ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCC-----------CC
Confidence 1233467999999999999999999999999999999999999999764321 1111111100 01
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+++++.+||.+||..||++|||+.|+|+|
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112334556889999999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-59 Score=389.59 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=192.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999 557899999976432 235688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+ +|+|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l-----~~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYI-----VQRDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHH-----HHSCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 56888887 234568999999999999999999999 779999999999999999999999999998754
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......||+.|+|||++.+..| +.++|||||||++|+|+||..||...+ .......+.+
T Consensus 164 ~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~----------- 226 (275)
T 3hyh_A 164 DGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISN----------- 226 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH-----------
T ss_pred CCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHc-----------
Confidence 332 2234579999999999999887 689999999999999999999997533 1222211111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ...++..+++++.+||.+||+.||++|||++|+++|
T Consensus 227 -~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 -G--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -C--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 122445567889999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-59 Score=391.58 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=195.7
Q ss_pred CCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee----CCeEEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLI 80 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 80 (312)
|++.++||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3677889999999999999 557889999976432 23458899999999999999999999865 3458999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEEeeccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFL 159 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~~~ 159 (312)
||||++|+|.+++. ....+++..+..++.||+.||.|||+.+.+|+||||||+|||++ .+|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999983 44568899999999999999999998333399999999999998 4799999999999754
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......||+.|+|||++.+ .|+.++|||||||++|||+||..||..... .......+....
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~--------- 246 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV--------- 246 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC---------
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCC---------
Confidence 322 2334579999999999875 699999999999999999999999975432 122222221111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...++++.+||.+||..||++|||++++++|
T Consensus 247 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111222334689999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=395.07 Aligned_cols=258 Identities=19% Similarity=0.247 Sum_probs=202.6
Q ss_pred hcCCCcccccccCcceEEEeeee----CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
.++|++++.||+|+||.||+|+. .+++.||+|.+... ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999974 24788999976532 2235788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+|||||+||+|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.
T Consensus 103 ivmEy~~gg~L~~~l-----~~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 103 LILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEECCCTTCEEHHHH-----HHHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEcCCCCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999998 344568999999999999999999999 7799999999999999999999999999986
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......||+.|+|||++.+..|+.++|||||||++|||+||..||...+.. .....+.
T Consensus 176 ~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~----------- 239 (304)
T 3ubd_A 176 SIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMIL----------- 239 (304)
T ss_dssp -------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-----------
T ss_pred ccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHH-----------
Confidence 54322 1233457999999999999999999999999999999999999999764321 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHHHHHHhccccccc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTELDRTLDKEMNLTTVM 294 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~~ll~~l~~~~~~~~~~~~~~ 294 (312)
.. ...++..+++++.+||.+||+.||++|||+ +|+++| -.-+.++|+.+.
T Consensus 240 -~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H---p~f~~idw~~l~ 294 (304)
T 3ubd_A 240 -KA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH---SFFSTIDWNKLY 294 (304)
T ss_dssp -HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS---GGGTTCCHHHHH
T ss_pred -cC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC---ccccCCCHHHHH
Confidence 11 123455567899999999999999999985 455443 233445555553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=387.60 Aligned_cols=272 Identities=21% Similarity=0.353 Sum_probs=202.6
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHH--HhcCCCccceeeeeeeeeCC----eEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF--LASIQHRNLVTLLGYCQENN----LQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~----~~~lv~ 81 (312)
.++|.+.+.||+|+||.||+|.++ ++.||||.+.......+..|.++ +..++||||+++++++...+ .+|+||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 357889999999999999999975 78999999877666665555554 45679999999999997653 579999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
||+++|+|.+++. ...+++..+.+++.|++.||+|||+. ..+|+||||||+|||++.++++||+|||+
T Consensus 81 Ey~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999983 24578999999999999999999973 12799999999999999999999999999
Q ss_pred cccccCCCc--CCCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 156 RNFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 156 a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
|+....... ........||+.|+|||++.+. .|+.++|||||||++|||+||..||............ ...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~-~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh-ccc
Confidence 987654322 1223345799999999999764 4678999999999999999998877543322111000 000
Q ss_pred hhhhhhhhhH-HhhhhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 228 NSRDFSNLLK-ILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 228 ~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..+....+.. .......+.. ....++.+.+|+.+||+.||++|||+.++++.|+++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 0000011111 1111222222 2345678999999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=379.09 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=184.7
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCC--------
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-------- 75 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 75 (312)
++|++++.||+|+||.||+|+ ..+++.||+|.+.... .+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468999999999999999999 4578999999764332 245788999999999999999999986543
Q ss_pred ----eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 76 ----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 76 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
.+|+|||||.+++|.+++.... .....+...+..++.|++.||.|||+ +||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEc
Confidence 3799999999999999985332 22334567788999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCC----------CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh
Q 021441 152 DAGLRNFLGRTDVAG----------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~ 221 (312)
|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||++ ||.... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence 999998765432211 1223469999999999999999999999999999999996 764311 1
Q ss_pred HHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... ..... .+......++.+.+||.+||+.||++|||+.++++|
T Consensus 233 ~~~~~~~---------~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTLTD---------VRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHH---------HHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHH---------HhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 00000 011112233567899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=388.39 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=201.8
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee------CCe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL 76 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 76 (312)
++|++++.||+|+||.||+|. ..+++.||||++.... ...+.+|+.+|+.++||||+++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999 5579999999876432 2357789999999999999999998753 367
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+|||||. |+|.+++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i-----~~~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQII-----HSSQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHH-----TSSSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 5788887 345678999999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCC--cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 157 NFLGRTD--VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+...... .........||+.|+|||++.+.. |+.++||||+||++|||++|..||.+.+..+....+......+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 122334567999999999998865 5999999999999999999999998754433222222221111111
Q ss_pred hhhH--------Hhh---h---hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLK--------ILD---E---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~--------~~~---~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ... . ..+.......++++.+||.+||..||.+|||+.|+|+|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1000 000 0 00011112345789999999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=375.91 Aligned_cols=262 Identities=23% Similarity=0.233 Sum_probs=198.9
Q ss_pred HhcCCCcccccccCcceEEEeeee----CCceEEEEEeCCC-CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+++++.+ +||||+++++++.+.+.+|+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 357899999999999999999973 2578999997644 3456788999999988 699999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeeccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFL 159 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg~a~~~ 159 (312)
|||+++++|.+++ ..+++..+..++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 99 mE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 99 MPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999887 247889999999999999999999 779999999999999876 79999999999765
Q ss_pred cCCCcC--------------------------CCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCC
Q 021441 160 GRTDVA--------------------------GPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASS 212 (312)
Q Consensus 160 ~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~ 212 (312)
...... .......||+.|+|||++.+.. |+.++||||+||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 1112346999999999998764 8999999999999999999999996
Q ss_pred CCCCCChhhHHHHh--hhhhhhhhh----------------------hHHhh------h---------hccccCChHHHH
Q 021441 213 SLSPDSSQDLVELV--QNSRDFSNL----------------------LKILD------E---------RLWSTFTNEGME 253 (312)
Q Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~----------------------~~~~~------~---------~~~~~~~~~~~~ 253 (312)
..... ...+..+. ...+..... ..... + ..........++
T Consensus 249 ~~~~~-~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 249 KASDD-LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp CCSSH-HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCH-HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54322 11111111 111000000 00000 0 000011223457
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 254 EFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
++.+||.+||..||++|||++|+|+|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 89999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=393.39 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=209.9
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHH---HHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDE---VCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++++.||+|+||.||+|+ ..+++.||+|++.. .......+| +.+++.++||||+++++++.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 456889999999999999999999 55799999997642 222233333 56677789999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+.||+|..++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 266 ~lylVmEy~~GGdL~~~l-----~~~~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEEECCCCSCBHHHHH-----HHHCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccce
Confidence 999999999999999998 344568999999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
|+...... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||................
T Consensus 339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~------- 407 (689)
T 3v5w_A 339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------- 407 (689)
T ss_dssp CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-------
T ss_pred eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-------
Confidence 98765432 234579999999999964 579999999999999999999999997654433222111111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHHHHHHhccccccc
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTELDRTLDKEMNLTTVM 294 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~l~~~~~~~~~~~~~~ 294 (312)
. ....++..+++++.+||.+||..||.+|++ ++++++ .-.-+.++|..+.
T Consensus 408 -----~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~---HpfF~~idW~~l~ 462 (689)
T 3v5w_A 408 -----T--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE---SPFFRSLDWQMVF 462 (689)
T ss_dssp -----H--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT---SGGGTTCCHHHHH
T ss_pred -----C--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc---CccccCCCHHHHH
Confidence 1 112345566789999999999999999998 455554 3455566776654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=388.37 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=205.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++++.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4689999999999999999999 56799999997655433 4578899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC--CceEEeeccccccccC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGR 161 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~--~~vkl~Dfg~a~~~~~ 161 (312)
|+||+|.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999988832 33568899999999999999999999 779999999999999854 8999999999987654
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... .....+.... .
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~----------~ 373 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCD----------W 373 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTC----------C
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCC----------C
Confidence 321 23346999999999999999999999999999999999999999764422 1111111110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.+||.+||..||.+|||+.|+|+|
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111223446789999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=353.42 Aligned_cols=278 Identities=39% Similarity=0.627 Sum_probs=226.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
...++|++.+.||+|+||.||+|..++++.||+|...... ...+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 3458999999999999999999997778999999876543 3567899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++.... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999885432 123458899999999999999999999 77999999999999999999999999999865443
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
..........+++.|+|||++.+..++.++|||||||++|+|++|..||....+..................+....++.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 33333334457889999999999999999999999999999999999998765544333222211111111122233344
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.....+...++.+.+++.+||..||++|||+.+++++|+.+++.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 44556788889999999999999999999999999999998854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=355.40 Aligned_cols=268 Identities=25% Similarity=0.443 Sum_probs=218.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeeee--------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeee
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGY 70 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~ 70 (312)
+.+..++|++.+.||+|+||.||+|.. .++..||+|.+..... ..+.+|+.+++.+ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345668899999999999999999973 2456899998876533 3578899999999 89999999999
Q ss_pred eeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 021441 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 139 (312)
Q Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~N 139 (312)
+...+.+|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~N 233 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARN 233 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhh
Confidence 9999999999999999999998853221 122457889999999999999999999 779999999999
Q ss_pred eEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCC
Q 021441 140 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDS 218 (312)
Q Consensus 140 il~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~ 218 (312)
|+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999987654443333444567788999999999999999999999999999999 999997644321
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
. .. .+........+..+++++.++|.+||..||.+|||+.+++++|+.++....+
T Consensus 314 ~---~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 L---FK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp H---HH-------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H---HH-------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1 11 1122222345556678999999999999999999999999999999875443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=340.16 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=216.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..++|++.+.||+|+||.||++...+++.||+|.+... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 467788999999999999999999999777888999987654 346788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999998832 23457899999999999999999999 779999999999999999999999999998654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~------------- 220 (269)
T 4hcu_A 158 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI------------- 220 (269)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH-------------
T ss_pred ccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH-------------
Confidence 33211 1223445677999999999999999999999999999999 99999764321 111111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+...++++.+++.+||+.||++|||+.+++++|+++.+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 221 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 111122334445678999999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=348.32 Aligned_cols=274 Identities=25% Similarity=0.324 Sum_probs=214.7
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChh--HHHHHHHHHhcCCCccceeeeeeeeeCC----eE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENN----LQ 77 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 77 (312)
+.+..++|++.+.||+|+||.||+|... ++.||+|.+...... ....|+.+++.++||||+++++++.... ..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 4456789999999999999999999876 789999988655443 3455788889999999999999997743 46
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCceEeCCCCc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP----------RVVHKDFKTANVLVDEDFI 147 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~----------givH~dikp~Nil~~~~~~ 147 (312)
|+||||+++++|.+++. ...+++..+..++.|++.||.|||+ . ||+|+||||+||+++.++.
T Consensus 98 ~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEEecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 99999999999999983 2348899999999999999999998 6 7999999999999999999
Q ss_pred eEEeeccccccccCCCcCCCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH
Q 021441 148 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 222 (312)
Q Consensus 148 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~ 222 (312)
+||+|||++................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999987755444333444578999999999987 3567789999999999999999999987655433332
Q ss_pred HHHhhhhhhhhhhhHHhh-hhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 223 VELVQNSRDFSNLLKILD-ERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.......+....+..... ....... ....++++.++|.+||+.||++|||+.++++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 222222222222222111 1111111 224457799999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=346.24 Aligned_cols=277 Identities=38% Similarity=0.611 Sum_probs=221.1
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.++.+..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+|+.+++.++||||+++++++...+..
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 567788899999999999999999999977789999998765432 3688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC---CeEecCCCCCceEeCCCCceEEeecc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP---RVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~---givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
++||||+.+++|.+++.... .....+++..+..++.|++.||.|||+ + ||+|+||||+||+++.++.++|+|||
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred EEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999885432 233458899999999999999999999 5 79999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCC--CCChhhHHHHhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--PDSSQDLVELVQNSRDF 232 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~--~~~~~~~~~~~~~~~~~ 232 (312)
++........ .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.... .................
T Consensus 180 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 180 LAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred cccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9986643221 11233458889999999999999999999999999999999999996311 01111111111111111
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
.......+.......+...++.+.+++.+||+.||.+|||+.+++++|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 12222333344455677888999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=341.72 Aligned_cols=249 Identities=21% Similarity=0.360 Sum_probs=206.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+. ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999998 5678999999753 3345668899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999998883 2357889999999999999999999 77999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ...
T Consensus 170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~------------~~~ 233 (297)
T 3fxz_A 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT------------NGT 233 (297)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH------------HCS
T ss_pred cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh------------CCC
Confidence 21 23345688999999999999999999999999999999999999976432111 111110 011
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+..+++.+.++|.+||+.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122344566789999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=357.94 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=215.7
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.|.+..++|++.+.||+|+||.||+|... +++.||+|.+..... ..+.+|+.+++.++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45667789999999999999999999954 788999998765432 3577899999999999999999999998899
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus 188 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 999999999999988832 23457889999999999999999999 779999999999999999999999999988
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~------------ 326 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---RE------------ 326 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HH------------
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH------------
Confidence 6543322222223345667999999999999999999999999999998 9999976542211 11
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.+........+..+++++.++|.+||+.||++|||+.++++.|+.+.++
T Consensus 327 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 327 -FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1111122234555678899999999999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=339.07 Aligned_cols=262 Identities=24% Similarity=0.423 Sum_probs=215.4
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..++|++.+.||+|+||.||++...++..||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 466778899999999999999999999888889999987654 456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+....
T Consensus 98 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999998842 23458899999999999999999999 779999999999999999999999999998664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... +
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~-------------~ 234 (283)
T 3gen_A 172 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEH-------------I 234 (283)
T ss_dssp CHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH-------------H
T ss_pred ccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHH-------------H
Confidence 33211 1223345677999999999999999999999999999998 999997644211 1111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+...++.+.+++.+||+.||.+|||+.+++++|++++++.
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111122234444578999999999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=351.76 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=216.6
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGY 70 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~ 70 (312)
..|.+..++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+|+.++..+ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 46778899999999999999999999962 3468999998765432 3478899999999 78999999999
Q ss_pred eeeCC-eEEEEEEeccCCcccccccCcccc--------------------------------------------------
Q 021441 71 CQENN-LQFLIYEYIPNGSVSIHLYGPSQV-------------------------------------------------- 99 (312)
Q Consensus 71 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~-------------------------------------------------- 99 (312)
+...+ ..|+||||+.+++|.+++......
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 87754 489999999999999888543210
Q ss_pred -----------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCC
Q 021441 100 -----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 168 (312)
Q Consensus 100 -----------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 168 (312)
....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++............
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 01228889999999999999999999 77999999999999999999999999999866443322233
Q ss_pred ccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 169 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
....+|..|+|||++.+..++.++|||||||++|+|++ |..||......... .. ..........
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~-------------~~~~~~~~~~ 317 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR-------------RLKEGTRMRA 317 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH-------------HHHHTCCCCC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH-------------HHHcCCCCCC
Confidence 34557788999999999999999999999999999998 99999765433211 11 1111222334
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
+...++++.+++.+||..||++|||+.+++++|+.+++..
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 4555678999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=343.04 Aligned_cols=263 Identities=29% Similarity=0.418 Sum_probs=206.3
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+.+..++|++.+.||+|+||.||+|... ++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45667789999999999999999999874 7789999865443 23577899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEeCCCCceEEeeccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g--ivH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
|+||||+.+++|.+++.... ....+++..+..++.|++.||.|||+ +| |+||||||+||+++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999884321 12348899999999999999999999 77 99999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+....... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~--------- 251 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAV--------- 251 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHH---------
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---------
Confidence 87543322 12234568889999999999999999999999999999999999997643211 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.........+..+++++.++|.+||..||.+|||+.++++.|+.+++..
T Consensus 252 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 252 ---GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0111223455666788999999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=343.09 Aligned_cols=266 Identities=26% Similarity=0.421 Sum_probs=217.7
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 72 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (312)
.+.+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4567789999999999999999999974 2357899998865432 45778999999999999999999999
Q ss_pred eCCeEEEEEEeccCCcccccccCcccc-------------------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 021441 73 ENNLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133 (312)
Q Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~ 133 (312)
..+..|+||||+.+++|.+++...... ....+++..+..++.|++.||.|||+ +||+|+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~ 174 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHR 174 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCccc
Confidence 999999999999999999888532210 12347899999999999999999999 779999
Q ss_pred CCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCC
Q 021441 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASS 212 (312)
Q Consensus 134 dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~ 212 (312)
||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433323344556778999999999999999999999999999999 999997
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
....... ... +........+..+++++.+++.+||+.||++|||+.+++++|++++.+
T Consensus 255 ~~~~~~~---~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERL---FNL-------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGH---HHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHH---HHH-------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 6543221 111 111122334555678899999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=341.18 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=214.2
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.+..++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 3457899999999999999999999 45688999997654433 4578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 86 TEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999842 24568899999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCC------------CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 161 RTDVAG------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 161 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----- 234 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----- 234 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----
Confidence 332211 011346888999999999999999999999999999999999998764432221100
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
....... ...+..+++.+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 235 -----~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 235 -----NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -----CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0000111 122344556899999999999999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=349.87 Aligned_cols=270 Identities=27% Similarity=0.426 Sum_probs=220.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee--------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|.+..++|++.+.||+|+||.||+|.. ..+..||+|.+..... ..+.+|+++++.+ +||||+++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 3566778999999999999999999983 2346799998765433 4577899999999 8999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++...+..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+||||||+
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~ 220 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAAR 220 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGG
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcc
Confidence 99999999999999999999998843221 112458899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655443334445567788999999999999999999999999999999 99999754321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~ 290 (312)
... ..+........+..+++++.+++.+||+.||++|||+.+++++|+.++....+.
T Consensus 301 ---~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 301 ---ELF-------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp ---HHH-------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred ---HHH-------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 111 111222223345556788999999999999999999999999999999765433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=343.76 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=211.2
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|... .+..||+|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44678999999999999999999853 34569999876542 24578899999999999999999999998899
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999998832 23468899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----------- 265 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VIS----------- 265 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH-----------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHH-----------
Confidence 76443211 11223345667999999999999999999999999999999 999997644211 111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
.+........+..+++.+.++|.+||..||.+|||+.++++.|+.+++....
T Consensus 266 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 266 --SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1111222334556678999999999999999999999999999999876443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=336.08 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=214.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.+.+..++|++.+.||+|+||.||++...++..||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 456778999999999999999999999887888999987654 456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 82 TEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEccCCCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999999988832 23458899999999999999999999 779999999999999999999999999988664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....
T Consensus 156 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~------------- 218 (268)
T 3sxs_A 156 DDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKV------------- 218 (268)
T ss_dssp TTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHH-------------
T ss_pred hhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHH-------------
Confidence 432211 223345667999999999999999999999999999999 9999975432111 1111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
........+...++.+.+++.+||+.||++|||+.+++++|+.+.++
T Consensus 219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111223344467899999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=344.71 Aligned_cols=273 Identities=23% Similarity=0.364 Sum_probs=200.4
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC-Cce---EEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGM---LVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQ 72 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~---~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (312)
+++.+..++|++.+.||+|+||.||+|... ++. .||+|.+... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 345567789999999999999999999844 332 7999987643 2356889999999999999999999997
Q ss_pred eCCeE------EEEEEeccCCcccccccCccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 73 ENNLQ------FLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 73 ~~~~~------~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
..... |+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCC
Confidence 76554 899999999999988843221 122358899999999999999999999 779999999999999999
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHH
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 224 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~ 224 (312)
+.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--- 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN--- 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---
Confidence 9999999999987654443333444556778999999999999999999999999999999 999998654322111
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccccc
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 292 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~ 292 (312)
. +........+..+++++.+++.+||..||++|||+.++++.|+++++.......
T Consensus 251 ~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 251 Y-------------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp H-------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred H-------------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1 111112234455668899999999999999999999999999999988654443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=342.04 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=205.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4789999999999999999998 4478899999764332 3567899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++ .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l-----~~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGS-----BTTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999988 344568899999999999999999999 77999999999999999999999999999866433
Q ss_pred CcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
..........+|+.|+|||++.+..+ +.++|||||||++|+|++|..||............ ... .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~--~~~------------~ 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--WKE------------K 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH--HHT------------T
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--Hhc------------c
Confidence 33333445678999999999988776 78899999999999999999999865543221111 110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++.+.+||.+||..||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00111123345788999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=346.05 Aligned_cols=246 Identities=25% Similarity=0.313 Sum_probs=205.1
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999994 67899999976432 224577899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999998883 34568899999999999999999999 779999999999999999999999999997654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~------------ 227 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVL------------ 227 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH------------
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH------------
Confidence 332 2334568899999999998887 48999999999999999999999764321 1111111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ....+...++++.+++.+||..||.+|||++++++|
T Consensus 228 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 RG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred hC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 112344456789999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=340.62 Aligned_cols=264 Identities=16% Similarity=0.201 Sum_probs=215.7
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++......|+||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 45789999999999999999999 467899999976533 345688999999999 899999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc-----eEEeecccccc
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNF 158 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~-----vkl~Dfg~a~~ 158 (312)
+ +++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++. ++|+|||++..
T Consensus 87 ~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDL----CDRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 8899988832 24568999999999999999999999 77999999999999999887 99999999987
Q ss_pred ccCCCcCC-----CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 159 LGRTDVAG-----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||..............+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64432211 1235578999999999999999999999999999999999999998876555444333332211100
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.. .......+ ++.+++.+||+.||.+||++.++++.|+++.++.
T Consensus 240 ~~---------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 240 PI---------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CH---------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CH---------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00 01112234 8999999999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=339.62 Aligned_cols=270 Identities=24% Similarity=0.388 Sum_probs=219.0
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.|.+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 5677789999999999999999999973 357889999876543 24578899999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
...+..|+||||+++++|.+++..... .....+++..+..++.|++.||.|||+ +|++|+||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccc
Confidence 999999999999999999988843221 112348899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++|+|||.+................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987654432222333456678999999999999999999999999999999 99999765432
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
... .. ..........+...++++.+++.+||..||.+|||+.+++++|++++.+..+
T Consensus 255 ~~~--~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 255 SKF--YK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHH--HH-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hHH--HH-------------HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 211 11 1111222233445568899999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=341.78 Aligned_cols=273 Identities=26% Similarity=0.408 Sum_probs=211.2
Q ss_pred hhHHhcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeee--
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE-- 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (312)
..+..++|++.+.||+|+||.||+|++ .+++.||+|.+..... ..+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 346678999999999999999999973 3578999998776544 357789999999999999999999854
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
....|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCceEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccC
Confidence 3568999999999999998832 23458899999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh--
Q 021441 154 GLRNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-- 230 (312)
Q Consensus 154 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 230 (312)
|++......... .......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~ 234 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQG 234 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCT
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCcccc
Confidence 999876443211 222334466779999999999999999999999999999999999864221 1111111100
Q ss_pred --hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 231 --DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.................+..+++++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 01112222233333445667778999999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=348.42 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=214.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+|+.+++.++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 44678999999999999999999842 467899998865432 34778999999999999999999999988
Q ss_pred eEEEEEEeccCCcccccccCccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEE
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKV 150 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl 150 (312)
..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999998853221 122458899999999999999999999 7799999999999999655 5999
Q ss_pred eeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhh
Q 021441 151 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~---- 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF---- 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----
Confidence 99999986544333333444567888999999999999999999999999999998 99999764321 11111
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
+........+..+++.+.+++.+||+.||++|||+.+++++|+.+.+..-.
T Consensus 299 ---------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 299 ---------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ---------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111112234455667899999999999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=345.63 Aligned_cols=267 Identities=26% Similarity=0.411 Sum_probs=214.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 72 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (312)
.+.+..++|++.+.||+|+||.||+|... +++.||+|.+..... ..+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34566789999999999999999999853 358899998875532 45788999999999999999999999
Q ss_pred eCCeEEEEEEeccCCcccccccCcccc-------------------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 021441 73 ENNLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133 (312)
Q Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~ 133 (312)
..+..|+||||+++++|.+++...... ....+++..++.++.|++.||.|||+ +||+|+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 999999999999999999888532110 12568899999999999999999999 779999
Q ss_pred CCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCC
Q 021441 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASS 212 (312)
Q Consensus 134 dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~ 212 (312)
||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987654433333344567788999999999999999999999999999999 999997
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..... .....+ ........+..+++++.+++.+||..||++|||+.+++++|+++.++.
T Consensus 279 ~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAHE---EVIYYV-------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCHH---HHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCChH---HHHHHH-------------hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 64321 111111 111112344556688999999999999999999999999999987553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=338.40 Aligned_cols=263 Identities=22% Similarity=0.359 Sum_probs=203.7
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 57899999999999999999998779999999765332 2457889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.+ +|.+.+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLD----ENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHH----TCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9986 6666652 233458899999999999999999999 77999999999999999999999999999876432
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh--
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL-- 239 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (312)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..................+.........
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2 12233467888999999887 468999999999999999999999998766655443332222211111100000
Q ss_pred -----------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 -----------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+.......++++.+||.+||..||++|||++++++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000111123345789999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=342.93 Aligned_cols=248 Identities=23% Similarity=0.271 Sum_probs=206.2
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|+ ..+++.||+|.+. ......+.+|..+++.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 346789999999999999999999 4578999999764 334566888999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||++..
T Consensus 82 lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 82 FVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 9999999999988872 34568899999999999999999999 7799999999999999999999999999875
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 155 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~----------- 218 (337)
T 1o6l_A 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELIL----------- 218 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH-----------
T ss_pred cccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHH-----------
Confidence 42221 123345688999999999999999999999999999999999999975432 11111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.. ...++..+++++.++|.+||..||++|| +++++++|
T Consensus 219 -~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 -ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -cC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11 1224455678899999999999999999 89988876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=346.02 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=203.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5789999999999999999999 456899999975432 235688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEeec
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA 153 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~Df 153 (312)
|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .++|+||
T Consensus 91 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999983 34568899999999999999999999 7799999999999998877 7999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|++....... ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||...... .....+....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~~~~--- 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANITAVS--- 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTC---
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC---
Confidence 9998765432 223456899999999999999999999999999999999999999764321 1111111100
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........++++.+||.+||..||.+|||+.++++|
T Consensus 235 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 -------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000112335689999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=343.88 Aligned_cols=267 Identities=24% Similarity=0.362 Sum_probs=214.2
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCC----ChhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.|.+..++|++.+.||+|+||.||+|.. .++..||+|.+... ....+.+|+.+++.+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4667788999999999999999999984 24678999986543 345688999999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCcccc------------------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQV------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~ 133 (312)
...+..|+||||+++++|.+++...... ....+++..+..++.|++.||.|||+ +||+|+
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence 9999999999999999999988543210 11347889999999999999999999 779999
Q ss_pred CCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCC
Q 021441 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASS 212 (312)
Q Consensus 134 dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~ 212 (312)
||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987654332222333456778999999999999999999999999999998 999997
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
........ .. ..........+...++++.+++.+||..||.+|||+.+++++|+.++..
T Consensus 277 ~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANF--YK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHH--HH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHH--HH-------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 75433211 11 1111222234455568899999999999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=341.50 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=208.6
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCce----EEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|++.+.||+|+||.||+|.. .+++ ++++|.+... ....+.+|+.+++.++||||+++++++.. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 3467899999999999999999984 3444 3788865432 23457789999999999999999999864 56
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cEEEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcc
Confidence 8899999999999988842 23467888899999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
................++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------ 230 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL------------ 230 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH------------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH------------
Confidence 88755444334445567778999999999999999999999999999999 99999875543222111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
........+..++.++.+++.+||..||.+|||+.+++++|+.+......
T Consensus 231 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~ 280 (325)
T 3kex_A 231 ----EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280 (325)
T ss_dssp ----HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred ----HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 11112233444556789999999999999999999999999999866543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=341.21 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=206.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCce----EEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|++.+.||+|+||.||+|.+ .+++ +||+|.+.. .....+.+|+.+++.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 457899999999999999999984 3443 468887643 23457889999999999999999999998764 7
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++|++++.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 889999999999988832 23568899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---------------- 229 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------------- 229 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------
Confidence 7755443333444556778999999999999999999999999999999 99999765432211
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
..+........+...+.++.+++.+||..||.+|||+.+++++|+.+.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 1111222223445566789999999999999999999999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=331.13 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=215.5
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+|.+..++|++.+.||+|+||.||++...+++.||+|.+... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 466778999999999999999999999777889999987654 346788999999999999999999999998899999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp ECCCTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EeCCCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccccccc
Confidence 999999999998832 23457899999999999999999999 779999999999999999999999999987654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .....+
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i------------- 218 (267)
T 3t9t_A 156 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI------------- 218 (267)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH-------------
T ss_pred ccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHH-------------
Confidence 32211 1223346677999999999999999999999999999999 89999764321 111111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+...++.+.+++.+||+.||++|||+.+++++|+++.++.
T Consensus 219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111112234445678999999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=344.34 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=201.9
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34578999999999999999999843 57789999876543 24578899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999842 23468899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~----------- 261 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK----------- 261 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHH-----------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-----------
Confidence 7643321 111222234667999999999999999999999999999998 99999764321 1111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.+........+..+++.+.+++.+||+.||++||++.++++.|+.++....
T Consensus 262 --~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 262 --AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp --HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred --HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 111222223345566889999999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=338.69 Aligned_cols=269 Identities=26% Similarity=0.458 Sum_probs=216.5
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee--------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLG 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~ 69 (312)
.|.+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.+ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 4667789999999999999999999984 2467899998875433 3577899999999 8999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
++...+..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+|+||||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~ 186 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAAR 186 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccc
Confidence 99999999999999999999998853321 012347889999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654433223334456778999999999999999999999999999999 99999764321
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
..... +........+..+++++.+++.+||..||.+|||+.+++++|++++....+
T Consensus 267 ---~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ---ELFKL-------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ---HHHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---HHHHH-------------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11111 111122334555668899999999999999999999999999999976543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=350.59 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=213.5
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-eEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (312)
|.+..++|++.+.||+|+||.||++... ++.||+|.+... ....+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 4566789999999999999999999976 678999987654 4567899999999999999999999987654 789999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... ....++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999998422 22346888999999999999999999 7799999999999999999999999999875432
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. ....++..|+|||++.+..++.++|||||||++|||++ |..||......+..... .
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----------------~ 400 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----------------E 400 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----------------H
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------H
Confidence 21 12245677999999999999999999999999999998 99999876544322111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.......+..+++++.++|.+||+.||++|||+.++++.|+.+....+
T Consensus 401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 112234556667899999999999999999999999999999887654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=343.67 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=207.1
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+..++|++.+.||+|+||.||+|. ..+++.||+|.+. ......+.+|+.+++.++||||+++++++......
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3456889999999999999999999 5568899999754 33446788999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.++|+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEECCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceee
Confidence 99999999999998883 34568899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
...... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.................
T Consensus 164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------ 234 (384)
T 4fr4_A 164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------ 234 (384)
T ss_dssp ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------
T ss_pred eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------
Confidence 764332 2334568999999999874 4589999999999999999999999986554443332222111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVT 278 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~~ll~ 278 (312)
....++..+++++.++|.+||..||.+||+ ++++++
T Consensus 235 --------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 --------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112345556789999999999999999998 666654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=337.00 Aligned_cols=265 Identities=21% Similarity=0.331 Sum_probs=208.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---C---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---P---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... . ...+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 5789999999999999999998 456889999975321 1 24578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999883 34568899999999999999999999 779999999999999999999999999998664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
..... ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||....... ..........
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~~~~~~~~~~---------- 229 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--IAIKHIQDSV---------- 229 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--HHHHHHSSCC----------
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhhccC----------
Confidence 33211 1233468889999999999999999999999999999999999997643211 1111111100
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHHhccccc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEMNLTT 292 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~~ll~~l~~~~~~~~~~~~ 292 (312)
+.........+++.+.++|.+||..||++|| +++++.+.|+.++.+.....+
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 0111123344567899999999999999998 899999999988765544333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=335.03 Aligned_cols=272 Identities=20% Similarity=0.319 Sum_probs=211.5
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCC--eE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (312)
+...++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+++++.++||||+++++++.... ..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 4456889999999999999999999 44689999998764 23456789999999999999999999987654 77
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----CCCCceEEeec
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADA 153 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~----~~~~~vkl~Df 153 (312)
|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+ +||+|+||||+||++ +.++.+||+||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 99999999999999884322 22338899999999999999999999 779999999999999 88889999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhh--------hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh-hHH-
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE--------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLV- 223 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~-~~~- 223 (312)
|++........ .....++..|+|||++. +..++.++|||||||++|+|++|..||......... ...
T Consensus 161 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 99987644322 22346888999999987 467899999999999999999999999765432221 111
Q ss_pred HHhhhhhh--hhhhhHHh--------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 224 ELVQNSRD--FSNLLKIL--------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 224 ~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......+. +....... ........+...++.+.+++.+||+.||++|||++++++|..+-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111110 00000000 00111245677889999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=344.58 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=199.7
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (312)
.+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.. .....+..|..++..+ +||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3556899999999999999999999 45689999997653 2345577899999988 79999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+.+++|..++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l-----~~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccccce
Confidence 99999999999999888 334568899999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+...... .......+|+.|+|||++.+..|+.++|||||||++|+|++|..||...+.. .....+.
T Consensus 172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~--------- 237 (353)
T 3txo_A 172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAIL--------- 237 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---------
T ss_pred eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHH---------
Confidence 7533221 1233456899999999999999999999999999999999999999764321 1111111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~------~~ll~~ 279 (312)
.. ...++...++++.++|.+||..||++||++ +++++|
T Consensus 238 ---~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 ---ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ---HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ---cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11 112344566889999999999999999998 666653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=329.72 Aligned_cols=263 Identities=26% Similarity=0.457 Sum_probs=215.7
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
++|.+..++|++.+.||+|+||.||+|...+++.||+|.+... ..+.+.+|+++++.++||||+++++++.. +..|+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3577888999999999999999999999877888999976543 45678899999999999999999999874 45899
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+.+++|.+++... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+...
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999998321 12358899999999999999999999 77999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 160 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~------------ 223 (279)
T 1qpc_A 160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL------------ 223 (279)
T ss_dssp SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH------------
T ss_pred cCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH------------
Confidence 543221 1223345667999999998899999999999999999999 99999764321 111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++++.+++.+||..||++|||+.++++.|+++....
T Consensus 224 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 224 -ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 111122334556688999999999999999999999999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=326.40 Aligned_cols=267 Identities=17% Similarity=0.223 Sum_probs=217.5
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.+ +|++++++++++......|+|||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 456889999999999999999999 467899999976533 445688999999999 79999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc-----eEEeeccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRN 157 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~-----vkl~Dfg~a~ 157 (312)
|+ +++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++. ++|+|||++.
T Consensus 87 ~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 8899998832 23458899999999999999999999 77999999999999987776 9999999998
Q ss_pred cccCCCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 158 FLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
........ .......+|+.|+|||++.+..++.++|||||||++|+|++|..||..............+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543221 1234456889999999999999999999999999999999999999886655444333322221110
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.. .......+++++.+++.+||+.||++|||+.++++.|++++++..
T Consensus 240 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 240 TP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp SC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cc---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00 111222345789999999999999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=334.06 Aligned_cols=268 Identities=24% Similarity=0.424 Sum_probs=221.4
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+.|.+..++|++.+.||+|+||.||+|.. .++..||+|.+.... ...+.+|+.+++.++||||+++++++...+..|
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 46778889999999999999999999994 458899999876543 356889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+.+++|.+++.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+..
T Consensus 86 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999998842 234558899999999999999999999 6799999999999999999999999999986
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .
T Consensus 161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----------------~ 223 (288)
T 3kfa_A 161 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------E 223 (288)
T ss_dssp SCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------------H
T ss_pred ccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------H
Confidence 643321 11223345667999999999999999999999999999999 99999765432211 1
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
..........+..+++.+.+++.+||..||.+|||+.++++.|+.++.+.....
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~ 277 (288)
T 3kfa_A 224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277 (288)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 112222233455567889999999999999999999999999999998765433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=344.46 Aligned_cols=273 Identities=18% Similarity=0.242 Sum_probs=210.4
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (312)
.+..++|++++.||+|+||.||+|+ ..+++.||+|.+... ....+..|..++..+ +||||+++++++...+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 3456789999999999999999999 556889999975432 234577888988876 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+.+++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||++
T Consensus 128 ~~lV~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 999999999999988883 34568999999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||........... .....+.
T Consensus 201 ~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~ 271 (396)
T 4dc2_A 201 KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLF 271 (396)
T ss_dssp BCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHH
T ss_pred eecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHH
Confidence 753222 1223445789999999999999999999999999999999999999975432211000 0000000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHHHHHHhccccccc
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS---DVVTELDRTLDKEMNLTTVM 294 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~---~ll~~l~~~~~~~~~~~~~~ 294 (312)
..+. .....++..+++++.+||.+||+.||.+||++. .+.+.++.-.-+.++|..+.
T Consensus 272 ~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 272 QVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp HHHH-HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred HHHh-ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 1000 011235556678999999999999999999973 44455555555555655543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=331.96 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=198.9
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999999999 4568899999754322 2567889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.++.+..+. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~l~~~~~-----~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQDLKKYFD-----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHH-----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCCHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99874444333 234568899999999999999999999 77999999999999999999999999999876432
Q ss_pred CcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh-hh--hh---hhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-QN--SR---DFSNL 235 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~-~~--~~---~~~~~ 235 (312)
. .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ......+ .. .+ .+...
T Consensus 155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTG
T ss_pred c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhh
Confidence 2 2233456788899999998776 799999999999999999998886443221 1111111 10 00 00011
Q ss_pred hHHhh---------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILD---------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+ ...........++++.++|.+||+.||++|||++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 000111233456789999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=340.99 Aligned_cols=288 Identities=26% Similarity=0.355 Sum_probs=214.7
Q ss_pred HHhcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeee--eCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQ--ENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 75 (312)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++. ...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 3468999999999999999999983 3588999998776544 34788999999999999999999886 456
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred eEEEEEeecCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccccc
Confidence 78999999999999998832 23458899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh---hhhhh
Q 021441 156 RNFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---QNSRD 231 (312)
Q Consensus 156 a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~~ 231 (312)
+........ ........++..|+|||++.+..++.++|||||||++|+|++|..||...... ..... .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~ 249 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPA 249 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhccccccccc
Confidence 987643321 11223345777899999999999999999999999999999999998642211 00000 01111
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccccccccCCCcccc
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTL 303 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~ 303 (312)
................+..+++++.+++.+||+.||++|||+.+++++|+.+......+......++|..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~~~~ 321 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKH 321 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------------------
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcCccc
Confidence 122333334444455666778899999999999999999999999999999998887777665555554443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=329.97 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=201.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
++.+..++|++.+.||+|+||.||+|... .+..||+|....... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 35567789999999999999999999843 245799998765432 457789999999999999999999854
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+..|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred CccEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccc
Confidence 568999999999999988832 23457899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...+
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i------- 230 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI------- 230 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH-------
T ss_pred cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH-------
Confidence 99876433211 1223346678999999999999999999999999999997 9999976543221 1111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++.+.+++.+||..||++|||+.+++++|+.++++.
T Consensus 231 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 231 ------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111122345566788999999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=328.55 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=198.8
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
++..++|++.+.||+|+||.||++... ++.+|+|..... ....+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 345789999999999999999999975 788999986532 235678899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCceEeCC--------CC
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR---VVHKDFKTANVLVDE--------DF 146 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g---ivH~dikp~Nil~~~--------~~ 146 (312)
|+||||+++++|.+++. ...+++..+..++.|++.||.|||+ +| ++|+||||+||+++. ++
T Consensus 82 ~lv~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp EEEEECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred EEEEEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccCc
Confidence 99999999999988872 3468899999999999999999999 66 899999999999986 77
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
.++|+|||.+....... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus 154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------- 222 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------- 222 (271)
T ss_dssp CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------
T ss_pred ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 89999999987654332 2234678889999999999999999999999999999999999976432111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.............+..+++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 --------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111112222334556678899999999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=335.87 Aligned_cols=269 Identities=24% Similarity=0.370 Sum_probs=215.3
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.|.+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.++..+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 5677789999999999999999999972 3568999998765433 3577899999999 689999999998
Q ss_pred eeCC-eEEEEEEeccCCcccccccCcccc-----------cccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 021441 72 QENN-LQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 139 (312)
Q Consensus 72 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~N 139 (312)
...+ ..|+||||+++++|.+++...... ....+++..+..++.|++.||.|||+ +||+|+||||+|
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~N 178 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARN 178 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCccce
Confidence 7654 589999999999999988533211 01237889999999999999999999 779999999999
Q ss_pred eEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCC
Q 021441 140 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDS 218 (312)
Q Consensus 140 il~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~ 218 (312)
|+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999986644332222334456778999999999999999999999999999998 999997654322
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
. ..... ........+...++++.+++.+||+.||.+|||+.+++++|+.+++...
T Consensus 259 ~--~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 259 E--FCRRL-------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp H--HHHHH-------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H--HHHHh-------------ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1 11111 1111123344456789999999999999999999999999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=330.73 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=197.5
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----------------------------hhHHHHHHHH
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----------------------------TQEFIDEVCF 55 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----------------------------~~~~~~e~~~ 55 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+.... .+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345899999999999999999998 4578999999764322 2457889999
Q ss_pred HhcCCCccceeeeeeeee--CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 021441 56 LASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133 (312)
Q Consensus 56 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~ 133 (312)
++.++||||+++++++.. ....|+||||+++++|.++. ....+++..+..++.|++.||.|||+ +||+|+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHY--QKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecc
Confidence 999999999999999976 56789999999999998765 23468899999999999999999999 779999
Q ss_pred CCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcC---CCcccceehhHHHHHHHHhCCCC
Q 021441 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREA 210 (312)
Q Consensus 134 dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~vl~~l~tg~~p 210 (312)
||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987643321 123346888999999998765 37889999999999999999999
Q ss_pred CCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 211 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 211 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
|..... ......+. ...........+++++.++|.+||..||++|||+.++++|
T Consensus 240 f~~~~~---~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 240 FMDERI---MCLHSKIK------------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCCSSH---HHHHHHHH------------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCccH---HHHHHHHh------------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 975321 11111110 1111111223455789999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=337.31 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=203.6
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCce----EEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
..++|++.+.||+|+||.||+|.. .+++ +|++|.+.. .....+.+|+.+++.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 468899999999999999999984 3444 457776532 34567889999999999999999999998764 7
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++|++++.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 889999999999988832 23468899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---------------- 229 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------------- 229 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------
Confidence 7654443333444556778999999999999999999999999999999 99999765433211
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
..+........+..++.++.+++.+||..||.+|||+.++++.|+.+.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 1112222233445566789999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=332.03 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=199.8
Q ss_pred cCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999998778999999765432 35678999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+ +|.+++. .....++...+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 7777763 223567889999999999999999999 779999999999999999999999999987654321
Q ss_pred cCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh---hhhhhhHH-
Q 021441 164 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---DFSNLLKI- 238 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 238 (312)
. ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||................... .+......
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 1 12234578889999999765 58999999999999999999999997654322111111110000 00000000
Q ss_pred --------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 --------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..+..+.......++++.++|.+||..||++|||++++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00011122234456889999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=337.39 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=203.2
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34679999999999999999999 456889999965432 24568899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEee
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVAD 152 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~D 152 (312)
.|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999883 34568899999999999999999999 7799999999999999887 899999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~-- 233 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVN-- 233 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHTC--
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHhcC--
Confidence 99998764332 123456888999999999999999999999999999999999999764321 1111111000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........++.+.++|.+||..||++|||+.++++|
T Consensus 234 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000001112234689999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=353.45 Aligned_cols=260 Identities=24% Similarity=0.437 Sum_probs=213.6
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..++|++.+.||+|+||.||+|..+++..||+|.+... ..+.+.+|+.+++.++||||+++++++. ....|+|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 456778899999999999999999999877889999987643 4567899999999999999999999986 5578999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999998422 22357788899999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .... +
T Consensus 336 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~-------------i 398 (454)
T 1qcf_A 336 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA-------------L 398 (454)
T ss_dssp CHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH-------------H
T ss_pred CCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------H
Confidence 32211 1222345677999999999999999999999999999999 999997644221 1111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
........+..+++++.++|.+||+.||++|||+.++++.|+.+..
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1112223455667899999999999999999999999999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=335.38 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=205.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.. .....+.+|..+++.++||||+++++++.+....|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 346789999999999999999999 45789999997643 34456788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||++..
T Consensus 83 lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 83 MIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEECCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCccee
Confidence 9999999999999883 34568899999999999999999999 7799999999999999999999999999986
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i------------ 215 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKI------------ 215 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH------------
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH------------
Confidence 5432 2335688899999999999999999999999999999999999976432 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.... ..++...++++.++|.+||..||++|| +++++++|
T Consensus 216 ~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 216 LNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111 124455668899999999999999999 88888765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=330.87 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=204.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhc--CCCccceeeeeeeee----CCeEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQE----NNLQFL 79 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~l 79 (312)
...++|++.+.||+|+||.||++.. +++.||+|.+.......+..|.+++.. ++||||+++++++.. ....|+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 3468999999999999999999987 478899999887777777777777776 789999999998654 345799
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH--------~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
||||+++++|.+++. ...+++..+..++.|++.||.||| + +||+||||||+||+++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999982 345889999999999999999999 7 779999999999999999999999
Q ss_pred eccccccccCCCcC--CCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhC----------CCCCCC
Q 021441 152 DAGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REASSS 213 (312)
Q Consensus 152 Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg----------~~pf~~ 213 (312)
|||++......... .......+|+.|+|||++.+. .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99998765433211 112334688999999999877 455799999999999999999 788866
Q ss_pred CCCCChhhH-HHHhhhhhhhhhhhHHhhhhc-cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 214 LSPDSSQDL-VELVQNSRDFSNLLKILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
......... ......... ..... ....+...++++.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQ-------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSC-------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccC-------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 443322111 110000000 00000 0112344678899999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=339.32 Aligned_cols=268 Identities=21% Similarity=0.343 Sum_probs=215.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-Cc-----eEEEEEeCCCCC----hhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DG-----MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~vaiK~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.+.+..++|++.+.||+|+||.||+|... ++ ..||+|.+.... ...+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 46677889999999999999999999843 23 479999876543 24578899999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc---------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
...+..|+||||+++++|.+++..... .....++...+..++.|++.||.|||+ +||+|+||||+||++
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLL 197 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEE
Confidence 999999999999999999988843211 013457889999999999999999999 779999999999999
Q ss_pred CCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhh
Q 021441 143 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD 221 (312)
Q Consensus 143 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~ 221 (312)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986644332222233446678999999999999999999999999999998 99999765432211
Q ss_pred HHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.. ..........+...++.+.+++.+||+.||.+|||+.+++++|+++..+.
T Consensus 277 -~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 -YK-------------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -HH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HH-------------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11 11112222334445678999999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=335.72 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=203.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.++|++.+.||+|+||.||+|. ..+++.+|+|.+..... ..+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 4789999999999999999999 45688999998765433 45778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC--CCceEEeeccccccccCC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~--~~~vkl~Dfg~a~~~~~~ 162 (312)
++++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999988832 23468899999999999999999999 77999999999999997 789999999999876433
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... .
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~----------~ 221 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEY----------T 221 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCC----------C
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCC----------C
Confidence 2 123346888999999999888999999999999999999999999764321 11111111100 0
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
........+++++.+++.+||..||.+|||+.++++|-
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00000112357899999999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=341.38 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=200.3
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCC--ccceeeeeeeeeCCe
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQH--RNLVTLLGYCQENNL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 76 (312)
+++..++|++.+.||+|+||.||++...+++.||+|.+.... ...+.+|+.+++.+.| |||+++++++...+.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 456778999999999999999999997778999999765332 2457889999999976 999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+|||+ .+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++ ++.+||+|||++
T Consensus 84 ~~lv~e~-~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEEECC-CSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEEeC-CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 9999995 5779988883 34568889999999999999999999 7799999999999997 578999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-----------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHH
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~ 225 (312)
................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------- 226 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------- 226 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--------
Confidence 87654433323344568999999999976 67899999999999999999999999753321
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
................+...++++.+++.+||..||.+|||+.++++|-
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 227 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 0111122222333344555567899999999999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=348.56 Aligned_cols=251 Identities=19% Similarity=0.223 Sum_probs=202.4
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
-.++|++.+.||+|+||.||+|. ..+++.+|+|.+.... ...+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999998 5578999999765443 24578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~Dfg~a~ 157 (312)
|||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~-----~~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999988883 34568899999999999999999999 7799999999999998 56789999999997
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
....... ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||..... ......+....
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~------- 229 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGA------- 229 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTC-------
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCC-------
Confidence 6643321 12335689999999999999999999999999999999999999976432 11111111100
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.++|.+||..||.+|||+.++++|
T Consensus 230 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 ---YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000111123445789999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=357.65 Aligned_cols=262 Identities=24% Similarity=0.437 Sum_probs=217.0
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
.|.+..++|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+|+.+++.++||||+++++++......|+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 35666788999999999999999999954 5789999987654 45678999999999999999999999999889999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+.+++|.+++.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus 294 v~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999998842 223457889999999999999999999 77999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||........ . ..
T Consensus 369 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~-------------~~ 431 (495)
T 1opk_A 369 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y-------------EL 431 (495)
T ss_dssp TTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H-------------HH
T ss_pred cCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HH
Confidence 433221 1223345677999999999999999999999999999999 9999986543221 1 11
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+........+..+++++.+||.+||+.||++|||+.++++.|+.++.+
T Consensus 432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 122222344556678999999999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=340.99 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=203.0
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcC-CCccceeeeeeeeeCC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN 75 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 75 (312)
..+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.. .....+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 45667899999999999999999999 45789999997643 3445677888888876 8999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999998883 33568899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+..
T Consensus 165 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~------- 232 (345)
T 1xjd_A 165 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM------- 232 (345)
T ss_dssp CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH-------
T ss_pred hhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHh-------
Confidence 87543221 1234457899999999999999999999999999999999999999764321 11111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT 278 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-~ll~ 278 (312)
. ...++..+++++.++|.+||..||++||++. ++++
T Consensus 233 -----~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 -----D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----C--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 1224445668899999999999999999997 6654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=326.87 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=214.7
Q ss_pred HhhHHhcCCCccc-ccccCcceEEEeeeeC---CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 3 ELSLATKNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 3 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
++.+..++|.+.+ .||+|+||.||+|... ++..||+|.+.... ...+.+|+.+++.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 3456678888887 9999999999999742 57889999876543 24578899999999999999999999 45
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+..|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECccc
Confidence 568999999999999998832 33558899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 155 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 155 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
.+........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i------ 226 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI------ 226 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH------
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH------
Confidence 9987643321 122233446778999999998899999999999999999998 999997654321 11111
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
........+..+++++.++|.+||..||++||++.+++++|+++..+...
T Consensus 227 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 227 -------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -------hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11112334556678999999999999999999999999999999977553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=329.81 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=210.6
Q ss_pred HhhHHhcCCCccc-ccccCcceEEEeee---eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee
Q 021441 3 ELSLATKNFSDKN-LIGEGKFGEVYKGL---LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 3 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~---~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
++.+..++|++.+ .||+|+||.||++. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3455678898888 99999999999995 3357889999876442 35688899999999999999999999 5
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
.+..|+||||+.+++|.+++. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHH-----hCcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccC
Confidence 567899999999999999883 33458899999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 154 GLRNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 154 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
|++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~------ 232 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM------ 232 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH------
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH------
Confidence 998776433211 11222345677999999999899999999999999999999 99999764421 11111
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
+........+..+++++.+++.+||+.||.+||++.++++.|++++.....
T Consensus 233 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 233 -------LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 111122334556678999999999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=339.62 Aligned_cols=252 Identities=20% Similarity=0.216 Sum_probs=194.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
..++|++.+.||+|+||.||+++ ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 45789999999999999999999 447899999976543 346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc--eEEeeccccccccC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNFLGR 161 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~--vkl~Dfg~a~~~~~ 161 (312)
+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++.....
T Consensus 98 ~~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999998883 34568899999999999999999999 77999999999999987775 99999999874322
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcc-cceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEK-SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. ......+|+.|+|||++.+..++.+ +|||||||++|+|++|..||............ .. .+..
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~---------~~~~ 236 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQ---------RILS 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HH---------HHHT
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HH---------HHhc
Confidence 21 2233468889999999998888655 89999999999999999999875543322111 00 0111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.+||.+||..||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111122345789999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=331.05 Aligned_cols=267 Identities=22% Similarity=0.384 Sum_probs=204.0
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-C---CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-Q---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQ 72 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~---~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (312)
+.+.+..++|++.+.||+|+||.||+|.. . ++..||+|.+.... ...+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 45667788999999999999999999973 2 45689999876432 245788999999999999999999987
Q ss_pred eCC-----eEEEEEEeccCCcccccccCcc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 73 ENN-----LQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 73 ~~~-----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
... ..|+||||+.+++|.+++.... ......+++..++.++.|++.||.|||+ +||+|+||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTS
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCC
Confidence 654 3499999999999998873221 1234568899999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence 999999999987654433333334456778999999999999999999999999999999 8899976543221 111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
. ........+..+++++.+++.+||..||.+|||+.+++++|+.++++
T Consensus 262 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 L-------------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp H-------------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11112234455567899999999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=333.32 Aligned_cols=269 Identities=25% Similarity=0.390 Sum_probs=212.3
Q ss_pred cCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeee--CCeE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ 77 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (312)
+.|++.+.||+|+||.||++.+ .+++.||+|.+..... ..+.+|+.+++.++||||+++++++.. ....
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 4459999999999999988753 2578999998775542 457889999999999999999999987 4678
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++. ...+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999883 2347899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh---hhhhhhh
Q 021441 158 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---QNSRDFS 233 (312)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~~~~ 233 (312)
....... ........++..|+|||++.+..++.++|||||||++|+|++|..||...... ..... .......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK----FLELIGIAQGQMTVL 258 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh----hhhhhcccccchhHH
Confidence 7654321 11233345777899999999999999999999999999999999998642210 00000 0011111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
.....+........+..+++++.++|.+||+.||++|||+.++++.|+.+.++--.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 22333334444456667778999999999999999999999999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=333.85 Aligned_cols=269 Identities=26% Similarity=0.388 Sum_probs=212.0
Q ss_pred HHhcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeC--
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-- 74 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (312)
+..++|++.+.||+|+||.||+|.+ .+++.||+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4467799999999999999999983 36889999986543 336688999999999999999999999776
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ceEEEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccc
Confidence 668999999999999998832 23458899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh---hhh
Q 021441 155 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ---NSR 230 (312)
Q Consensus 155 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~---~~~ 230 (312)
.+........ ........++..|+|||++.+..++.++|||||||++|+|++|..|+.... ........ ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQM 247 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCccccc
Confidence 9987644321 122334457778999999999999999999999999999999998864321 00000000 001
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
.................+..+++++.+++.+||+.||.+|||+.++++.|+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111222223333344456677789999999999999999999999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=338.60 Aligned_cols=269 Identities=23% Similarity=0.383 Sum_probs=216.2
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 71 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (312)
++|.+..++|++.+.||+|+||.||+|... +++.||+|.+..... ..+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 457778899999999999999999999743 467899998865433 3477899999999999999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-----ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
...+..|+||||+.+++|.+++..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCC
Confidence 998899999999999999988843211 012346889999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~ 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRF 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHHH
Confidence 999999999886644332222233445778999999999999999999999999999999 88999764321 11111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
. ........+..+++.+.+++.+||..||++|||+.+++++|++.+....
T Consensus 253 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 253 V-------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp H-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred H-------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 1 1111123445566889999999999999999999999999998766543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=338.09 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=203.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35789999999999999999999 56789999997642 334578899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+ +++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus 87 v~E~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 87 VIEYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EECCC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEECC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 99999 567877772 34568899999999999999999999 67999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||...........
T Consensus 159 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------- 219 (336)
T 3h4j_B 159 TDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------- 219 (336)
T ss_dssp TTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------
T ss_pred cCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------
Confidence 44332 233468889999999998877 7899999999999999999999976443221110
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+. ......+...++++.++|.+||..||.+|||++++++|
T Consensus 220 i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 220 VN-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CC-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HH-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 01122345566889999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=337.08 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=204.5
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|..+++.++||||+++++++.+....|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 45789999999999999999999 45789999997642 344568889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.++|+|||++...
T Consensus 119 v~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccceec
Confidence 999999999998883 33468899999999999999999999 77999999999999999999999999999865
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~------------ 251 (350)
T 1rdq_E 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIV------------ 251 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------
T ss_pred cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHH------------
Confidence 432 2334688899999999999999999999999999999999999975432 11111111
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
.. ...++..+++++.++|.+||..||.+||+ ++++++|
T Consensus 252 ~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11 12244556688999999999999999998 7777765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=332.73 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=205.7
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC--CCccceeeeeeeeeC----CeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN----NLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv 80 (312)
..++|++.+.||+|+||.||+|... ++.||+|.+..........|.+++... +||||+++++++... ...|+|
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 4578999999999999999999976 789999988766666667777777765 899999999999877 788999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
|||+++++|.+++. ...+++..+..++.|++.||.|||+. ..||+||||||+||+++.++.+||+|||
T Consensus 114 ~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 114 TDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp ECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 99999999999882 23588999999999999999999983 1179999999999999999999999999
Q ss_pred ccccccCCCcC--CCCccccCcccccchhhhhhcCCCcc------cceehhHHHHHHHHhC----------CCCCCCCCC
Q 021441 155 LRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEK------SDVYSFGVFLLELVSG----------REASSSLSP 216 (312)
Q Consensus 155 ~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------sDiwslG~vl~~l~tg----------~~pf~~~~~ 216 (312)
++......... .......+|+.|+|||++.+..++.. +|||||||++|+|++| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99765433221 11224468899999999988777665 9999999999999999 566655433
Q ss_pred CChhhHHHHhhhhhhhhhhhHHh-hhhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 217 DSSQDLVELVQNSRDFSNLLKIL-DERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
....... ..... ........ ...+++++.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 268 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYED-----------MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSCCHHH-----------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCchhh-----------hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 2211100 00000 01111112 2367788999999999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=350.41 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=209.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..++|++.+.||+|+||.||++.+..+..||+|.+... ..+.+.+|+.+++.++||||+++++++.. +..|+|
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 456777889999999999999999999877788999987653 34678999999999999999999999876 568999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 257 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999998321 23457889999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ .... +
T Consensus 332 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~-------------i 394 (452)
T 1fmk_A 332 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ-------------V 394 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH-------------H
T ss_pred CCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------H
Confidence 32211 1223345678999999999999999999999999999999 999997644211 1111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
........+..+++.+.++|.+||+.||++|||++++++.|+.+..
T Consensus 395 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1112223455667899999999999999999999999999988763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=334.81 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=199.4
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.... ...+.+|..++..+ +||||+++++++...+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 346789999999999999999999 4568999999765321 23467899999887 899999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|..++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp EEEECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccc
Confidence 99999999999998883 33568899999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||............ ....+..
T Consensus 159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~~ 229 (345)
T 3a8x_A 159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLFQ 229 (345)
T ss_dssp CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHH
T ss_pred cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-------cHHHHHH
Confidence 543221 2234457899999999999999999999999999999999999999753322110000 0000001
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (312)
.+.. ....++...+.++.++|.+||+.||.+||++
T Consensus 230 ~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 VILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHH-CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHc-CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111 1123455667899999999999999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=339.68 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=201.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4679999999999999999998 4568899999865432 245778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~Dfg~a~~ 158 (312)
||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999988883 34568899999999999999999999 7799999999999998654 599999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||..... ......+....
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~-------- 246 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGA-------- 246 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC--------
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC--------
Confidence 64332 12345688899999999999999999999999999999999999976432 11111111100
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.++|.+||..||++|||+.++++|
T Consensus 247 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 --YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001112345789999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=336.34 Aligned_cols=268 Identities=16% Similarity=0.177 Sum_probs=205.3
Q ss_pred HhcCCCcccccccCcceEEEeeeeCC------ceEEEEEeCCCCChh--------------HHHHHHHHHhcCCCcccee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ--------------EFIDEVCFLASIQHRNLVT 66 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~--------------~~~~e~~~l~~l~h~~i~~ 66 (312)
..++|++.+.||+|+||.||+|.... ++.||+|........ ....|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998543 478999987654421 2334555667778999999
Q ss_pred eeeeeeeC----CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 67 LLGYCQEN----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 67 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
+++++... ...|+||||+ +++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence 99998764 4579999999 8899988832 33568999999999999999999999 779999999999999
Q ss_pred C--CCCceEEeeccccccccCCCcCC-----CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 021441 143 D--EDFIAKVADAGLRNFLGRTDVAG-----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 215 (312)
Q Consensus 143 ~--~~~~vkl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~ 215 (312)
+ .++.+||+|||++.......... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999997764332211 1233458999999999999999999999999999999999999998644
Q ss_pred CCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 216 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
............... .+....+... ....+++++.+++..||..||.+||++.++++.|++++++.
T Consensus 266 ~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 266 KDPKYVRDSKIRYRE---NIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp TCHHHHHHHHHHHHH---CHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHHhhh---hHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 332221111111111 1112222221 11334578999999999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=326.05 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=205.0
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----------hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----------QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 446899999999999999999999 45789999998653221 5678899999999999999999998766
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEeCCCCc-----
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFI----- 147 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g--ivH~dikp~Nil~~~~~~----- 147 (312)
. ++||||+++++|.+.+.. ....+++..+..++.|++.||.|||+ +| |+|+||||+||+++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred C--eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCCCcee
Confidence 5 699999999999877732 34468899999999999999999999 67 999999999999988876
Q ss_pred eEEeeccccccccCCCcCCCCccccCcccccchhhhh--hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHH
Q 021441 148 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 148 vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~ 225 (312)
++|+|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|..||.............
T Consensus 168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~- 241 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM- 241 (287)
T ss_dssp EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-
T ss_pred EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-
Confidence 99999999875432 223456788899999984 4457899999999999999999999998655432211111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
..........+..+++++.++|.+||+.||++|||+.++++.|+++
T Consensus 242 ------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 ------------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1122223345566678999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=328.50 Aligned_cols=262 Identities=19% Similarity=0.266 Sum_probs=197.6
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 47899999999999999999994 5689999997654432 34678999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|..++ .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELD-----RYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHH-----HTSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHH-----hhhcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999988877 234568899999999999999999999 7799999999999999999999999999977543
Q ss_pred CCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................... ........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (311)
T 4agu_A 155 PSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI-PRHQQVFS 231 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-HHHHHHHH
T ss_pred ccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc-cccccccc
Confidence 221 1233467888999999987 5679999999999999999999999976543322221111100000 00000000
Q ss_pred -hhcc--------------ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 -ERLW--------------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 -~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ......+++++.+++.+||+.||.+|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00012345779999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=322.25 Aligned_cols=264 Identities=31% Similarity=0.486 Sum_probs=209.1
Q ss_pred CcccccccCcceEEEeeeeCCceEEEEEeCCCC-------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 12 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
...+.||+|+||.||+|... ++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 33489999999999999874 778999975432 2356889999999999999999999999988999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++++|.+++... .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+........
T Consensus 113 ~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 113 PNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp TTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred CCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 999999888432 123458899999999999999999999 7799999999999999999999999999886654332
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHH-HhhhhhhhhhhhHHhhhhc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE-LVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (312)
........+++.|+|||.+.+ .++.++|||||||++|+|++|..||............. ..... ...+...++. .
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~ 264 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE--EKTIEDYIDK-K 264 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT--SCCHHHHSCS-S
T ss_pred cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh--hhhhhhhccc-c
Confidence 222334568889999999875 47889999999999999999999998765443222111 11111 0111111222 2
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
....+...++.+.+++.+||..||.+|||+.+++++|+++.
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 23456778889999999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=345.33 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=204.7
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+.+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.. .....+.+|..+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 44566899999999999999999999 45688999997643 334457889999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+++++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||++
T Consensus 144 ~~lV~E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEECCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999998873 2357899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcC----CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
......... ......||+.|+|||++.+.. |+.++|||||||++|+|++|..||...+.. .....+....
T Consensus 216 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~-- 289 (410)
T 3v8s_A 216 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHK-- 289 (410)
T ss_dssp EECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH--
T ss_pred EeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhcc--
Confidence 765433211 122456899999999998765 789999999999999999999999764321 1111111100
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~ 279 (312)
..........+++++.+||.+||..+|.+ ||+++++++|
T Consensus 290 --------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 --------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00111112235678999999999999988 9999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=336.42 Aligned_cols=249 Identities=19% Similarity=0.279 Sum_probs=202.6
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (312)
.+..++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+..|..++..+ +||+|+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 35568999999999999999999995 4588999997643 3445678899999888 79999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 999999999999998883 33568899999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~--------- 234 (353)
T 2i0e_A 169 KENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM--------- 234 (353)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---------
T ss_pred cccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHH---------
Confidence 7542221 123345689999999999999999999999999999999999999976432 11111111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
.. ...++..+++++.++|.+||..||.+||+ ++++++|
T Consensus 235 ---~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 ---EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---HC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---hC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 12345566789999999999999999996 4565544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=330.19 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=197.5
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+++..++|++.+.||+|+||.||++.... .+|+|.+.... ...+.+|+.+++.++||||++++++.. ....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCcc
Confidence 346678999999999999999999998653 48999765432 245788999999999999999999654 4567
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
++||||+.+++|.+++. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.
T Consensus 95 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp EEEEECCCEEEHHHHHT----TC---CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred EEEEEecCCCcHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceecc
Confidence 99999999999988883 234568899999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
...............+++.|+|||++. +..++.++|||||||++|+|++|..||....... ..........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~---- 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGS---- 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTS----
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcccc----
Confidence 654433333334456888999999986 5678889999999999999999999997654321 1111111110
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
...........+++++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 243 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 -----LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0011122344566889999999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=330.62 Aligned_cols=268 Identities=20% Similarity=0.327 Sum_probs=188.8
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35789999999999999999998 456899999975432 3356889999999999999999999999999999999
Q ss_pred EeccCCcccccccCcc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
||+.+ +|.+++.... ......+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 99985 8877774321 1122458899999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---hhhhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNLL 236 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~ 236 (312)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||..................+. +....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 322 122344678889999999874 589999999999999999999999986543222111111111000 00000
Q ss_pred HHh--------------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KIL--------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ............++++.++|.+||+.||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0000111122345789999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=336.49 Aligned_cols=253 Identities=18% Similarity=0.258 Sum_probs=201.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC--------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG--------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4679999999999999999998 45789999997531 24567889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc---eEEeeccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGL 155 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~---vkl~Dfg~ 155 (312)
+||||+++++|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999987773221 123357889999999999999999999 77999999999999987654 99999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.... ......+..... .
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~-~-- 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKY-K-- 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCC-C--
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCC-C--
Confidence 987654321 1234468899999999999999999999999999999999999997632 111111111000 0
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... ...+++++.++|.+||..||++|||+.++++|
T Consensus 251 ---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 ---MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01235789999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=342.23 Aligned_cols=269 Identities=16% Similarity=0.185 Sum_probs=204.5
Q ss_pred hhHHhcCCCcccccccC--cceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 4 LSLATKNFSDKNLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+....++|++.+.||+| +||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34467899999999999 9999999994 478999999765332 245678999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999999888421 23558899999999999999999999 7799999999999999999999999998
Q ss_pred cccccCCC-----cCCCCccccCcccccchhhhhh--cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 156 RNFLGRTD-----VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 156 a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
+....... .........++..|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~ 252 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNG 252 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcC
Confidence 76542211 1122333468888999999988 57899999999999999999999999875543322111 000
Q ss_pred hhh-hhh---------------------hhHH---------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 021441 229 SRD-FSN---------------------LLKI---------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277 (312)
Q Consensus 229 ~~~-~~~---------------------~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (312)
... ... .... .........+..+++++.+||.+||+.||++|||+.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000 000 0000 000001113344567899999999999999999999999
Q ss_pred HH
Q 021441 278 TE 279 (312)
Q Consensus 278 ~~ 279 (312)
+|
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 76
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=339.49 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=203.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++.+.||+|+||.||+|. ..+++.+|+|.+..... ..+.+|+.+++.++||||+++++++......|+||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4689999999999999999998 45788999998765432 4578899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC--CCceEEeeccccccccC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~--~~~vkl~Dfg~a~~~~~ 161 (312)
+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999988832 23468899999999999999999999 77999999999999974 56899999999987643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+... ..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~----------~~ 267 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC----------DW 267 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC----------CC
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----------CC
Confidence 22 123346888999999999999999999999999999999999999764321 111111100 00
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.++|.+||..||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112234456789999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=330.26 Aligned_cols=267 Identities=27% Similarity=0.472 Sum_probs=208.0
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-C----ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..++|++.+.||+|+||.||+|... + +..||+|.+..... ..+.+|+.+++.++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 34578888999999999999999843 2 34699998765432 357789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+
T Consensus 121 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999988832 23568899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 157 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~-------- 263 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAI-------- 263 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH--------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH--------
Confidence 87643321 111223345678999999999999999999999999999999 99999764321 111111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccccccc
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 294 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~~~~ 294 (312)
........+..+++.+.+++.+||+.||++||++.+++++|+.+++......++.
T Consensus 264 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~ 318 (333)
T 1mqb_A 264 -----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318 (333)
T ss_dssp -----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBC
T ss_pred -----HCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhc
Confidence 1111223344566889999999999999999999999999999998765555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=332.97 Aligned_cols=249 Identities=18% Similarity=0.257 Sum_probs=196.3
Q ss_pred hHHhcCCCcccccccCcceEEEeeee----CCceEEEEEeCCCC-------ChhHHHHHHHHHhcCCCccceeeeeeeee
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQE 73 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (312)
.+..++|++.+.||+|+||.||+|+. .+++.||+|.+... ....+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34568899999999999999999985 46889999986543 22446789999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
.+..|+||||+.+++|.+++. ....++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeC
Confidence 999999999999999998883 34457889999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|++....... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 166 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i------- 233 (327)
T 3a62_A 166 GLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKI------- 233 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH-------
T ss_pred CcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHH-------
Confidence 9987543221 1123446888999999999999999999999999999999999999764321 111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
... ....+...++++.++|.+||..||++|| ++.++++|
T Consensus 234 -----~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 -----LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 1234455668899999999999999999 66677654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=324.24 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=207.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC--Ce
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 76 (312)
..+..++|++.+.||+|+||.||+|... ++.+|+|.+.... ...+.+|+.+++.++||||+++++++... +.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 4566789999999999999999999976 7889999866443 24578899999999999999999999876 77
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEeCCCCceEEeecc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g--ivH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
.|+||||+++++|.+++... ....+++..+..++.|++.||.|||+ +| ++|+||||+||+++.++.++++|||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred eEeeecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEEecc
Confidence 89999999999999998432 22358899999999999999999998 66 9999999999999999999999998
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCc---ccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE---KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
.+.... .....+|+.|+|||++.+..++. ++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------------ 219 (271)
T 3kmu_A 159 VKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------------ 219 (271)
T ss_dssp SCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------------
T ss_pred ceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------------
Confidence 765432 22345778899999998765544 79999999999999999999975432111
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
.............+..+++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 ---GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111112222334556667899999999999999999999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=333.18 Aligned_cols=277 Identities=25% Similarity=0.332 Sum_probs=205.1
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHh--cCCCccceeeeeeeee-----CC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLA--SIQHRNLVTLLGYCQE-----NN 75 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~-----~~ 75 (312)
+..+..++|++.+.||+|+||.||++.. +++.||+|.+.......+..|.+++. .++||||+++++.+.. ..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3456779999999999999999999987 47899999987666666666666655 4789999999985532 23
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCceEeCCCC
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP---------RVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~---------givH~dikp~Nil~~~~~ 146 (312)
..|+||||+++++|.+++. ....++..+..++.|++.||.|||+ + ||+||||||+||+++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHh------hcccchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccceEEEcCCC
Confidence 5689999999999999883 2334788889999999999999998 5 799999999999999999
Q ss_pred ceEEeeccccccccCCCc------CCCCccccCcccccchhhhhh-------cCCCcccceehhHHHHHHHHhCCCCCCC
Q 021441 147 IAKVADAGLRNFLGRTDV------AGPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVSGREASSS 213 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~vl~~l~tg~~pf~~ 213 (312)
.+||+|||++........ ........+|..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999987643321 111223468899999999987 4567899999999999999999777644
Q ss_pred CCCCCh-hhHHH-HhhhhhhhhhhhHHhh-hhccccC------ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 214 LSPDSS-QDLVE-LVQNSRDFSNLLKILD-ERLWSTF------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 214 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
...... ..... .....+.......... ......+ ....++++.++|.+||+.||++|||+.++++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 332211 11111 1111111111111111 1111111 2346678999999999999999999999999999999
Q ss_pred HHhc
Q 021441 285 DKEM 288 (312)
Q Consensus 285 ~~~~ 288 (312)
..-.
T Consensus 318 ~~~~ 321 (336)
T 3g2f_A 318 MIWE 321 (336)
T ss_dssp HCCC
T ss_pred HHHH
Confidence 6544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=327.62 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=204.8
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+..++|++.+.||+|+||.||++... ++.||+|.+.... ...+.+|+.+++.++||||+++++++.+ ..|+||||+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 35678999999999999999999976 6789999886544 3568899999999999999999998874 378999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceEeCCCCc-eEEeeccccccccCC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGRT 162 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~-~givH~dikp~Nil~~~~~~-vkl~Dfg~a~~~~~~ 162 (312)
++++|.+++.... ....++...+..++.|++.||.|||+.. +||+|+||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp TTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999884321 2234678889999999999999999843 46999999999999998886 799999998755322
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
.....++..|+|||++.+..++.++|||||||++|+|++|..||.............. ...
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------------~~~ 220 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV--------------HNG 220 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH--------------HTT
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH--------------hcC
Confidence 2234578889999999999999999999999999999999999976543321111100 111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
.....+..+++.+.+++.+||+.||++|||+.+++++|+.+.+......
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 1223344556789999999999999999999999999999986644433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=339.99 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=196.2
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCC--CccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||++...+++.||+|.+.... ...+.+|+.+++.+. ||||+++++++...+..|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 345699999999999999999997678899999764332 245788999999996 5999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||| +.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 56779988883 33467888899999999999999999 7799999999999996 589999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhh-----------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~------- 275 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--IS------- 275 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HH-------
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HH-------
Confidence 54332222334568999999999875 36889999999999999999999999754321 00
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+..+.........+...++++.++|.+||..||.+|||+.++++|
T Consensus 276 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111222222223344445789999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.57 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=205.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeC-CeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-NLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 81 (312)
|.+..++|++.+.||+|+||.||++... ++.||+|.+... ..+.+.+|+.+++.++||||+++++++... +..|+||
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4566789999999999999999999875 788999987755 446688999999999999999999987544 4689999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++... ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999888321 12237888899999999999999999 7799999999999999999999999999875533
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... +.
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~-------------~~ 228 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR-------------VE 228 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH-------------HT
T ss_pred cc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------------Hh
Confidence 21 22345677999999999999999999999999999998 9999976442211 111 11
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.......+..+++.+.++|.+||+.||++|||+.++++.|+++.....
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 112233455667899999999999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=323.94 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=203.0
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+..++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4567899999999999999999998 55678899997643 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++. ....++...+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EEEECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 99999999999988883 33568899999999999999999999 779999999999999999999999999886
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .......
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---------- 220 (279)
T 3fdn_A 158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRIS---------- 220 (279)
T ss_dssp CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----------
T ss_pred cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHH----------
Confidence 543322 23346788899999999999999999999999999999999999754321 1111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+...++.+.++|.+||+.||.+|||+.++++|
T Consensus 221 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 221 ----RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01123444556789999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=339.83 Aligned_cols=277 Identities=20% Similarity=0.312 Sum_probs=215.9
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCC--eE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (312)
+...++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+++++.++||||+++++++.... ..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44568899999999999999999994 4689999998764 23456789999999999999999999987654 77
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----CCCCceEEeec
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADA 153 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~----~~~~~vkl~Df 153 (312)
|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+ +||+||||||+||++ +.++.+||+||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred EEEEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 99999999999999884321 22338899999999999999999999 779999999999999 78888999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhh--------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh-h-HH
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-D-LV 223 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~-~-~~ 223 (312)
|++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......... . ..
T Consensus 161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 99987644332 223458889999999876 56788999999999999999999999764432221 1 12
Q ss_pred HHhhhhhhh--hhhhHHh--------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 224 ELVQNSRDF--SNLLKIL--------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 224 ~~~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
......+.. ....... ........+...++.+.+++.+||+.||++||++.++++.++.++++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~ 312 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence 222211100 0000000 0011223557788999999999999999999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=330.80 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=197.7
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--------ChhHHHHHHHHHhcCC---Cccceeeeeeeee
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQ---HRNLVTLLGYCQE 73 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--------~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 73 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+... ......+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 446899999999999999999999 467899999975421 2346677888777764 9999999999977
Q ss_pred CC-----eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCce
Q 021441 74 NN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 148 (312)
Q Consensus 74 ~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~v 148 (312)
.. ..++|||++.+ +|.+++... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCE
Confidence 54 57999999975 888887322 22348899999999999999999999 779999999999999999999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
||+|||.+....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999997654322 23445688899999999999999999999999999999999999976543222111111111
Q ss_pred hhhhhhh---hHHhhh-------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNL---LKILDE-------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~---~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... ...... .........+++++.++|.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 000000 00001122345789999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=323.35 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=207.8
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+.+..++|++.+.||+|+||.||+|... ++..||+|...... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 4566789999999999999999999832 24569999877542 34578899999999999999999998754
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.+++|.+++.. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred CCEEEEecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCC
Confidence 56899999999999988832 23457889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......... ..
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~---~~-------- 227 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG---VL-------- 227 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---HH--------
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---HH--------
Confidence 8876433211 1233456778999999999999999999999999999998 999997644322111 11
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++.+.+++.+||..||++|||+.+++++|+.+.+..
T Consensus 228 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 228 -----EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 111112234445678999999999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=319.59 Aligned_cols=265 Identities=17% Similarity=0.237 Sum_probs=208.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-CChhHHHHHHHHHhcCCCccceeeeeee-eeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~ 84 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.... .....+.+|+.+++.+.|++++..+..+ ......++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 5789999999999999999999 46789999996433 3345688999999999887766666554 6677889999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeeccccccccC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a~~~~~ 161 (312)
+++|.+++. .....+++..+..++.|++.||.|||+ +||+|+||||+||++ +.++.+||+|||++.....
T Consensus 88 -~~~L~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 88 -GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHH----HTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 889998883 123468899999999999999999999 779999999999999 7889999999999987654
Q ss_pred CCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 3321 123345688999999999999999999999999999999999999987665544333322221110000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.......+++++.+++.+||+.||++|||+.++++.|++++.+..
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 011122335789999999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=344.64 Aligned_cols=275 Identities=21% Similarity=0.246 Sum_probs=213.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
++.+..++|++.+.||+|+||.||+|+ ..+++.||+|.+.. .....+.+|..++..++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 344567899999999999999999999 44688999997643 23344788999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999832 23568899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
+......... ......||+.|+|||++. ...|+.++|||||||++|||++|..||...... .....+....
T Consensus 222 a~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~ 297 (437)
T 4aw2_A 222 CLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHK 297 (437)
T ss_dssp CEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH
T ss_pred hhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcc
Confidence 9765432211 122356899999999987 456899999999999999999999999764322 1111111100
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHHHHHHHHhcccccccccCCC
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTELDRTLDKEMNLTTVMGEGTP 299 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~ 299 (312)
.....+.....+++++.+||.+||..+|.+ |++++++++| -.-+.++|..+....+|
T Consensus 298 ---------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H---pff~~i~w~~l~~~~~p 356 (437)
T 4aw2_A 298 ---------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH---PFFSGIDWDNIRNCEAP 356 (437)
T ss_dssp ---------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS---GGGTTCCTTTGGGSCCS
T ss_pred ---------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC---CccCCCCHHHHhhCCCC
Confidence 000111222335688999999999998888 9999998765 23345566666554444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=321.59 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=204.2
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 57899999999999999999994 46889999976422 23568889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+......
T Consensus 86 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999998883 34568899999999999999999999 77999999999999999999999999998765433
Q ss_pred CcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
..........++..|+|||++.+..+ +.++|||||||++|+|++|..||.......... .......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~----------- 225 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKK----------- 225 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHHTTC-----------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhhhcc-----------
Confidence 22223344568888999999988775 788999999999999999999998755432211 1111100
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........++.+.++|.+||..||.+|||+.++++|
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011123345789999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=336.88 Aligned_cols=262 Identities=13% Similarity=0.167 Sum_probs=214.2
Q ss_pred hhHHhcCCCcccccccCcceEEEeee------eCCceEEEEEeCCCCChhHHHHHHHHHhcCC---CccceeeeeeeeeC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQEN 74 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 74 (312)
+.+..++|++.+.||+|+||.||+|. ..+++.||+|.+.......+..|..+++.+. |+||+++++++...
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34556789999999999999999993 4468899999998888888999999999887 89999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC----------
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---------- 144 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---------- 144 (312)
+..|+||||+++++|.+++..........+++..+..++.|++.||.|||+ +||+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999854332345678999999999999999999999 77999999999999998
Q ss_pred -CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHH
Q 021441 145 -DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 223 (312)
Q Consensus 145 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~ 223 (312)
++.+||+|||++................+|..|+|||++.+..|+.++|||||||++|+|+||..||.........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--- 294 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--- 294 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence 8999999999997654322222233456899999999999999999999999999999999999998653321100
Q ss_pred HHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHhc
Q 021441 224 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR-PSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-pt~~~ll~~l~~~~~~~~ 288 (312)
. .. ..... ..++.+.+++..||+.+|.+| |+++++.+.|+.++.+..
T Consensus 295 -----------~----~~-~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 295 -----------P----EG-LFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----------E----CS-CCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----------e----ch-hcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 00 00011 124678999999999999998 688999999999987743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=326.97 Aligned_cols=245 Identities=20% Similarity=0.290 Sum_probs=200.9
Q ss_pred CCcccccccCcceEEEeeee-CCceEEEEEeCCC---CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 11 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
|...+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 67778999999999999994 4789999997543 3345688999999999999999999999999999999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCC
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~ 166 (312)
++|.+++. ...+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++........
T Consensus 127 ~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 196 (321)
T 2c30_A 127 GALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 196 (321)
T ss_dssp CBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred CCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--
Confidence 99998872 2458899999999999999999999 7799999999999999999999999999876643321
Q ss_pred CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcccc
Q 021441 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246 (312)
Q Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (312)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... .....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~-----------~~~~~ 262 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSP-----------PPKLK 262 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSS-----------CCCCT
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCC-----------CCCcC
Confidence 223456889999999999999999999999999999999999999754321 1111111100 00011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....++.+.+++.+||..||++|||+.++++|
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223445789999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=332.11 Aligned_cols=250 Identities=20% Similarity=0.338 Sum_probs=193.9
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCC-------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------- 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 75 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46799999999999999999995 47899999976422 2356889999999999999999999885543
Q ss_pred --------------------------------------------------eEEEEEEeccCCcccccccCcccccccccC
Q 021441 76 --------------------------------------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 105 (312)
Q Consensus 76 --------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 105 (312)
..|+||||+++++|.+++.... ......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchh
Confidence 3799999999999999985432 233456
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcC----------CCCccccCcc
Q 021441 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA----------GPSSQVTADE 175 (312)
Q Consensus 106 ~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~~~~ 175 (312)
...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......... .......+|+
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 66788999999999999999 77999999999999999999999999999876543211 1223346889
Q ss_pred cccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHH
Q 021441 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF 255 (312)
Q Consensus 176 ~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (312)
.|+|||++.+..++.++|||||||++|+|++|..|+.. ....... .............++++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~----------~~~~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITD----------VRNLKFPLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHH----------HHTTCCCHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHH----------hhccCCCcccccCChhH
Confidence 99999999999999999999999999999998765421 0000000 00001111123334678
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 256 IQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.++|.+||+.||++|||+.++++|
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=332.32 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=201.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEecc
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP 85 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..... ...+|++++.++ +||||+++++++.+....|+||||+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 4679999999999999999999 45789999998765433 345688888877 79999999999999999999999999
Q ss_pred CCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC----CceEEeeccccccccC
Q 021441 86 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGR 161 (312)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~----~~vkl~Dfg~a~~~~~ 161 (312)
+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||++... +.+||+|||++.....
T Consensus 100 gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 100 GGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp SCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999998883 34568899999999999999999999 779999999999998543 3599999999986543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. .......+|+.|+|||++.+..|+.++|||||||++|+|++|..||..............+.... .
T Consensus 173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~----------~ 240 (342)
T 2qr7_A 173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK----------F 240 (342)
T ss_dssp TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC----------C
T ss_pred CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC----------c
Confidence 22 12233467888999999998889999999999999999999999998654333333222221110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.++|.+||..||++|||+.++++|
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01112234456789999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=328.31 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=209.3
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEE--EEEeCCC----CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLV--AIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~v--aiK~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|. ..++..+ ++|.+.. .....+.+|+.+++.+ +||||+++++++...+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 345789999999999999999998 4456544 8886543 2345688899999999 899999999999999999
Q ss_pred EEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
|+||||+++++|.+++..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCC
Confidence 999999999999998853320 123468899999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~ 225 (312)
.++|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~ 253 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK 253 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHH
Confidence 9999999998743221 11223345677999999999899999999999999999998 99999764321 11111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
+........+..+++++.+++.+||..||.+|||+.+++++|+.++.+..
T Consensus 254 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 254 -------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11112223455566889999999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=350.18 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=207.5
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 456789999999999999999999 45789999997642 33456788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++..
T Consensus 261 lVmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999888432 23448899999999999999999999 7799999999999999999999999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH-HHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL-VELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (312)
..... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||........... ...+.
T Consensus 336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~---------- 402 (576)
T 2acx_A 336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---------- 402 (576)
T ss_dssp CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----------
T ss_pred cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----------
Confidence 64332 12234789999999999999999999999999999999999999987543322111 11111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.....++..+++++.+||.+||..||.+|| +++++++|
T Consensus 403 ----~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 ----EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111234555678999999999999999999 67777765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=342.07 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=205.5
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.. .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999994 4789999998643 234568899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999999883 34568899999999999999999999 77999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.
T Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~----------- 229 (476)
T 2y94_A 167 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKIC----------- 229 (476)
T ss_dssp CTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHH-----------
T ss_pred ccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHh-----------
Confidence 44322 233468889999999998876 78999999999999999999999764321 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ...+...++++.++|.+||..||.+|||+.++++|
T Consensus 230 -~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 230 -DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 110 12334456789999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=331.78 Aligned_cols=264 Identities=16% Similarity=0.146 Sum_probs=198.0
Q ss_pred HhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCCh--------------hHHHHHHHHHhcCCCccceeee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT--------------QEFIDEVCFLASIQHRNLVTLL 68 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--------------~~~~~e~~~l~~l~h~~i~~~~ 68 (312)
..++|++.+.||+|+||.||+|... ++..+|+|....... ..+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3578999999999999999999954 578899997654421 2355678888899999999999
Q ss_pred eeeee----CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC
Q 021441 69 GYCQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 144 (312)
Q Consensus 69 ~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~ 144 (312)
+++.. ....|+||||+ +++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISG-----QNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCB-----GGGBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEcc
Confidence 99887 67889999999 889999883 33378899999999999999999999 77999999999999998
Q ss_pred CC--ceEEeeccccccccCCCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 021441 145 DF--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 217 (312)
Q Consensus 145 ~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~ 217 (312)
++ .++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 9999999999776432211 1113446888999999999999999999999999999999999999653322
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
.............. ......... ....+++++.++|.+||..||++|||++++++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVAVQTAKTNLLDE---LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHHT---TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHHHHHHHHhhccc---ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 22111111110010 000000000 01134578999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=320.54 Aligned_cols=265 Identities=17% Similarity=0.235 Sum_probs=210.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-CChhHHHHHHHHHhcCCCccceeeeeee-eeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~ 84 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.+.|++++..+..+ ......|+||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 5789999999999999999999 46789999997543 3345788999999999988766655554 6677889999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEeeccccccccC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~Dfg~a~~~~~ 161 (312)
+++|.+++. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++ .++.++|+|||.+.....
T Consensus 88 -~~~L~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 88 -GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 889998883 123468899999999999999999999 7799999999999994 888999999999987654
Q ss_pred CCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... .......++..|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 237 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--- 237 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC---
Confidence 3321 12344568889999999999999999999999999999999999998765444333332221111000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
.....+..+++++.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus 238 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 238 ------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0011123345789999999999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=340.80 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=190.2
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCC-CccceeeeeeeeeCC--eE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENN--LQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~ 77 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+... ......+|+.+++.+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 46899999999999999999998 557899999976432 2245678999999997 999999999997543 68
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+ +|..++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus 87 ~lv~e~~~~-~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCSE-EHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccCc-CHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999975 7877772 2457888899999999999999999 779999999999999999999999999997
Q ss_pred cccCCCc-------------------CCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 021441 158 FLGRTDV-------------------AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPD 217 (312)
Q Consensus 158 ~~~~~~~-------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~ 217 (312)
....... ........+|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6533110 111234568999999999987 57899999999999999999999999875432
Q ss_pred ChhhHHHHhhhhhhhhhh-----------hHHhhhh------cc-------------ccCChHHHHHHHHHHHHhcCCCC
Q 021441 218 SSQDLVELVQNSRDFSNL-----------LKILDER------LW-------------STFTNEGMEEFIQLIVRCLDPSS 267 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~------~~-------------~~~~~~~~~~l~~li~~~l~~dp 267 (312)
............+....+ ....... .. .......++++.+|+.+||..||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 222111111111100000 0000000 00 00111345789999999999999
Q ss_pred CCCCCHHHHHHH
Q 021441 268 ERRPSMSDVVTE 279 (312)
Q Consensus 268 ~~Rpt~~~ll~~ 279 (312)
++|||++++++|
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=335.71 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=201.6
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC--hhHHHHHHHHHhcCC-----CccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----HRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......|..+++.+. ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3468899999999999999999994 578899999876433 345677999999886 99999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-------------
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE------------- 144 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~------------- 144 (312)
|+||||+ +++|.+++.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITR---NNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEECCC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred EEEEcCC-CCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccccccchhcc
Confidence 9999999 8899888842 222358899999999999999999999 77999999999999975
Q ss_pred ------------CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCC
Q 021441 145 ------------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS 212 (312)
Q Consensus 145 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~ 212 (312)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999764332 234567889999999999999999999999999999999999998
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhh---------hhc---ccc-----------------CChHHHHHHHHHHHHhc
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILD---------ERL---WST-----------------FTNEGMEEFIQLIVRCL 263 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~---~~~-----------------~~~~~~~~l~~li~~~l 263 (312)
..................+......... ... +.. .....++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 6543222221111111111000000000 000 000 00111267889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 021441 264 DPSSERRPSMSDVVTE 279 (312)
Q Consensus 264 ~~dp~~Rpt~~~ll~~ 279 (312)
+.||++|||+.++++|
T Consensus 341 ~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 341 QIDPTLRPSPAELLKH 356 (360)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=333.16 Aligned_cols=239 Identities=21% Similarity=0.309 Sum_probs=200.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4689999999999999999998 557899999976543 2335678999999999999999999999999
Q ss_pred eEEEEEEeccCC-cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 LQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..++||||+.++ +|.+++ .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFI-----DRHPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHH-----HTCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999766 888887 334568899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 998764332 2233568889999999998887 88999999999999999999999652210
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ....+..+++++.++|.+||..||++|||+.++++|
T Consensus 237 -----~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011222345789999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=333.26 Aligned_cols=251 Identities=18% Similarity=0.200 Sum_probs=189.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 346799999999999999999994 46889999987644 3355778999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccccccC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~~~~~ 161 (312)
++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|||++.....
T Consensus 131 ~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 131 TGGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CSCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999998883 34558899999999999999999999 77999999999999975 88999999999886543
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~~~~----------~ 268 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRILNCE----------Y 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHHTTC----------C
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHHhCC----------C
Confidence 22 1233467889999999999999999999999999999999999997644321 1111111100 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+.++.++|.+||..||++|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223456789999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=334.55 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=183.1
Q ss_pred cCCCcc---cccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDK---NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~---~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|.+. +.||+|+||.||+|. ..+++.||+|.+.........+|+.+++.+. ||||+++++++.+....|+||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 345543 789999999999999 4568999999987777778889999999996 99999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEeecccccccc
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLG 160 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~Dfg~a~~~~ 160 (312)
+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .++|+|||++....
T Consensus 88 ~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 88 LNGGELFERIK-----KKKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCSCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999883 34568999999999999999999999 7799999999999998766 89999999997654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCCh----hhHHHHhhhhhhhhhhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS----QDLVELVQNSRDFSNLL 236 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~ 236 (312)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+.
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~--------- 229 (325)
T 3kn6_A 161 PDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--------- 229 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---------
T ss_pred CCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---------
Confidence 3221 12334568889999999999999999999999999999999999986543211 11111111
Q ss_pred HHhhhhc--cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... .......+++++.++|.+||..||.+|||++++++|
T Consensus 230 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 230 ---KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1100 000112345789999999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=330.17 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=202.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 5679999999999999999999 456889999975432 245688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEeec
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA 153 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~Df 153 (312)
|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .++|+||
T Consensus 91 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999883 34568899999999999999999999 7799999999999999888 7999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~--- 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANITSVS--- 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTC---
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcc---
Confidence 9998764432 223446888999999999999999999999999999999999999764321 1111111100
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........++.+.++|.+||..||++|||+.++++|
T Consensus 235 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001112334689999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=328.67 Aligned_cols=268 Identities=22% Similarity=0.345 Sum_probs=210.0
Q ss_pred hHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
.+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 35578999999999999999999983 2467899998864432 3577899999999999999999999998
Q ss_pred CeEEEEEEeccCCcccccccCccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceE
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAK 149 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vk 149 (312)
...|+||||+++++|.+++..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++. +..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEE
Confidence 889999999999999998853321 122457889999999999999999999 77999999999999994 44699
Q ss_pred EeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhh
Q 021441 150 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~-- 258 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV-- 258 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH--
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH--
Confidence 999999876644433333444567888999999999999999999999999999998 99999764321 111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhccc
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 290 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~ 290 (312)
........+..+++.+.++|.+||+.||.+|||+.+++++|+.+....-..
T Consensus 259 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 259 -----------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred -----------hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 111122334456678999999999999999999999999999988765433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=324.68 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=203.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCC-Cccceeeeeeeee--CCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~ 83 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.......+.+|+.+++.+. ||||+++++++.. ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 4789999999999999999998 5678999999998888889999999999996 9999999999987 6678999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+.+++|.+++ ..++...+..++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|||++......
T Consensus 115 ~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 115 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred cCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999998777 237788899999999999999999 7799999999999999777 8999999999865433
Q ss_pred CcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hhhhhhhhH--
Q 021441 163 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SRDFSNLLK-- 237 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~-- 237 (312)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ......... .........
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHh
Confidence 2 2233467888999999987 568999999999999999999999996543221 111111110 011000000
Q ss_pred ----------Hh--------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ----------IL--------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ----------~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ...........+++++.+||.+||+.||++|||++++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000111223356889999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=322.04 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=204.6
Q ss_pred HhcCCCcccccccCcceEEEeeeeCC----ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeee-eeCCeE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC-QENNLQ 77 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 77 (312)
...+|++.+.||+|+||.||+|.... ...+|+|....... ..+.+|+.+++.++||||+++++++ ...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34678899999999999999998432 33689998665433 4577899999999999999999985 445678
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.
T Consensus 103 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999842 33457889999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCc--CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 158 FLGRTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 158 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----------- 245 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----------- 245 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-----------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----------
Confidence 7644322 112233456778999999999999999999999999999999 56666654433221111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++.+.+++.+||..||.+|||+.++++.|+.+++..
T Consensus 246 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 246 -----LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111112234445678999999999999999999999999999998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=320.16 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=204.0
Q ss_pred CCCcccccccCcceEEEeeee-CC---ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE-EEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL-QD---GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ-FLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~-~~---~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 80 (312)
.|.+.+.||+|+||.||+|.. .+ +..+|+|....... ..+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 345569999999999999983 22 34799998765433 4577899999999999999999999766555 899
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+....
T Consensus 102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999998842 24567889999999999999999999 779999999999999999999999999997654
Q ss_pred CCC--cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 161 RTD--VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 161 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
... .........++..|+|||.+.+..++.++|||||||++|+|++|..|+...... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~------------ 241 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL------------ 241 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH------------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh------------
Confidence 332 122233446778899999999999999999999999999999966554332211 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
........+..+++.+.+++.+||..||.+|||+.++++.|+++++...
T Consensus 242 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 242 -AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111223344556789999999999999999999999999999997754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=331.45 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=193.6
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
...++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++......|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 345789999999999999999998 55789999998764432 346789999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe-----CCCCceEEeecc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-----DEDFIAKVADAG 154 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~-----~~~~~vkl~Dfg 154 (312)
||||+.+ +|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||++ +..+.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 8888872 34458899999999999999999999 779999999999999 455569999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++........ ......+|..|+|||++.+.. ++.++|||||||++|+|++|..||..................+...
T Consensus 183 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 183 LARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9987643221 123345688899999998754 7999999999999999999999997644322111111110000000
Q ss_pred hhhHHhhh-------------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDE-------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........ ..........++++.+||.+||+.||++|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000 00000111245789999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=352.54 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=212.7
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.|.+..++|++.+.||+|+||.||++.+..+..||+|.+... ..+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 466778899999999999999999999877788999987643 44678999999999999999999999876 568999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 340 ~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999998321 22457889999999999999999999 779999999999999999999999999998664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .... +
T Consensus 415 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~-------------i 477 (535)
T 2h8h_A 415 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ-------------V 477 (535)
T ss_dssp CHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHH-------------H
T ss_pred CCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------H
Confidence 32211 1222345677999999999999999999999999999999 999997644211 1111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
........+..+++++.+||.+||+.||++|||++++++.|+.++
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111222344566788999999999999999999999999998775
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=325.42 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=195.6
Q ss_pred hcCCCcc-cccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDK-NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.+.|++. +.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.++.++ +||||+++++++...+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578875 789999999999998 557889999976433 346788999999885 7999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc---eEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~---vkl~Dfg~a~~ 158 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999998883 33567899999999999999999999 77999999999999998776 99999999876
Q ss_pred ccCCCcC-----CCCccccCcccccchhhhhh-----cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 159 LGRTDVA-----GPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 242 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC- 242 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC-
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc-
Confidence 5322111 11123358889999999875 568899999999999999999999998765432110000000
Q ss_pred hhhhhhhhHHhhhhccccCC----hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFT----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+...+.... ...+ ..+++++.++|.+||..||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000011100 1111 1245789999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=345.32 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=192.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeC------C
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++... ....+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999998 557899999987542 234577899999999999999999998654 4
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.++ +...+. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 579999999874 444441 237888999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh--
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-- 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 233 (312)
+....... ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......+...
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 2334578899999999999999999999999999999999999998654322111111111100000
Q ss_pred -hh----hHHhhhh---------------ccc---cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 -NL----LKILDER---------------LWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 -~~----~~~~~~~---------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+ ....... ... ......++++.+||.+||..||++|||++|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000 000 0011225789999999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=342.49 Aligned_cols=274 Identities=21% Similarity=0.222 Sum_probs=211.3
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
++.+..++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3456678999999999999999999994 57899999987532 2234778999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999998832 22468899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
+......... ......||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... .....+..
T Consensus 209 a~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~ 284 (412)
T 2vd5_A 209 CLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVH 284 (412)
T ss_dssp CEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred heeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 9876432211 1223468999999999883 46899999999999999999999999764321 11111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHHHHHHhcccccccccCCC
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSMSDVVTELDRTLDKEMNLTTVMGEGTP 299 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---pt~~~ll~~l~~~~~~~~~~~~~~~~~~~ 299 (312)
.. ...........+++++.+||.+||. +|.+| |+++++++| -.-+.++|..+....+|
T Consensus 285 ~~---------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H---pff~~i~w~~l~~~~~p 345 (412)
T 2vd5_A 285 YK---------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH---PFFFGLDWDGLRDSVPP 345 (412)
T ss_dssp HH---------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS---GGGTTCCSTTSTTSCCS
T ss_pred cc---------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC---CCcCCCCHHHHhhcCCC
Confidence 00 0000111223456789999999999 99998 478777654 34456677766554443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=327.67 Aligned_cols=261 Identities=22% Similarity=0.399 Sum_probs=209.8
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhc--CCCccceeeeeeeeeCC----eEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQFL 79 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~l 79 (312)
...++|++.+.||+|+||.||++... ++.||+|.+.......+.+|.+++.. ++||||+++++++.... ..|+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred cccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 34578999999999999999999975 78999999887777778889998887 68999999999998765 7899
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH--------~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
||||+.+++|.+++. ...+++..+..++.|++.||.||| + +||+|+||||+||+++.++.++|+
T Consensus 118 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECTTSCEEEC
T ss_pred EEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECCCCCEEEE
Confidence 999999999999883 235789999999999999999999 7 779999999999999999999999
Q ss_pred eccccccccCCCcC--CCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhC----------CCCCCC
Q 021441 152 DAGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REASSS 213 (312)
Q Consensus 152 Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg----------~~pf~~ 213 (312)
|||++......... .......+++.|+|||++.+. .++.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999776443211 123345688899999999876 234689999999999999999 778866
Q ss_pred CCCCChh--hHHHHhhhhhhhhhhhHHhhhhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 214 LSPDSSQ--DLVELVQNSRDFSNLLKILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 214 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
....... ....... ........ ....++.+.+++.+||..||++|||+.+++++|+++.++
T Consensus 270 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVC------------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TSCSSCCHHHHHHHHT------------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCcCcccHHHHHHHHH------------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 5432211 1111110 11111111 235668899999999999999999999999999999876
Q ss_pred h
Q 021441 287 E 287 (312)
Q Consensus 287 ~ 287 (312)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=332.07 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=195.0
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCC---
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENN--- 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (312)
...++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 346789999999999999999999 46789999998765422 35778999999999999999999986543
Q ss_pred -eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred cccEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 3499999999999999883 34568899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++......... .......+++.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~-- 237 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPI-- 237 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCCC--
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCC--
Confidence 99766433211 122334578899999999999999999999999999999999999976432111 1111111000
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV-TELDRTL 284 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll-~~l~~~~ 284 (312)
........+++++.++|.+||+.||++||++.+++ +.+....
T Consensus 238 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 ---------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00011223457899999999999999999666555 5555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=331.04 Aligned_cols=272 Identities=26% Similarity=0.417 Sum_probs=211.9
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-----CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCC-
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENN- 75 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (312)
.+..++|++.+.||+|+||.||++.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34567899999999999999999983 3588999998765433 45788999999999999999999886543
Q ss_pred -eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 76 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 67999999999999998832 23457889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh--
Q 021441 155 LRNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-- 231 (312)
Q Consensus 155 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-- 231 (312)
++......... .......++..|+|||.+.+..++.++|||||||++|+|++|..||.... ............
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH----HHHHHHHCTTCCTH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH----HHHHHhhccccchh
Confidence 99876443211 11223456677999999999999999999999999999999999886421 011111110000
Q ss_pred --hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 232 --FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
...+...+........+..+++++.++|.+||..||++|||+.++++.|+++.++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111222222223344566778999999999999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=320.30 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=205.4
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.+..++|++.+.||+|+||.||+|.. .+++.||+|.+. ......+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 34568999999999999999999994 468899999764 23346688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.
T Consensus 90 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EEEECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 99999999999998883 33457899999999999999999999 779999999999999999999999999986
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .....++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+.
T Consensus 163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~---------- 225 (284)
T 2vgo_A 163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRIV---------- 225 (284)
T ss_dssp ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----------
T ss_pred cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHHh----------
Confidence 554322 23346788899999999999999999999999999999999999764321 1111110
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ...++...++++.++|.+||..||.+|||+.++++|
T Consensus 226 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 226 --NV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --TT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --cc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 10 112344556789999999999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=348.93 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=206.2
Q ss_pred cCCCccc-ccccCcceEEEeeee---CCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 9 KNFSDKN-LIGEGKFGEVYKGLL---QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 9 ~~y~~~~-~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
+++.+.+ .||+|+||.||+|.+ .++..||+|.+... ....+.+|+.+++.++||||+++++++.. +..|+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3344444 799999999999974 24678999987653 34678999999999999999999999976 468999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999998842 34568899999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 161 RTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~------------- 551 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF------------- 551 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHH-------------
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHH-------------
Confidence 33211 11222335567999999999999999999999999999998 9999987554221 111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 291 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~~~ 291 (312)
+........+..+++++.++|.+||..||++||++.++++.|+.+........
T Consensus 552 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 552 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 11122234556677899999999999999999999999999999987755433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=329.40 Aligned_cols=260 Identities=19% Similarity=0.192 Sum_probs=199.7
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC--------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
....++|++.+.||+|+||.||+|. ..+++.||+|.+. ......+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 3446789999999999999999998 4568899999753 234467889999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCccc-----------------------------------ccccccCHHHHHHHHHHHHHHH
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQ-----------------------------------VSRQKLEFKHRLSIALGAAKGL 120 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~-----------------------------------~~~~~~~~~~~~~i~~~i~~~L 120 (312)
..|+||||+++++|.+++..... .....+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999888742100 0122345777889999999999
Q ss_pred HHHhcCCCCeEecCCCCCceEeCCCC--ceEEeeccccccccCCCc--CCCCccccCcccccchhhhhh--cCCCcccce
Q 021441 121 AHLHSLSPRVVHKDFKTANVLVDEDF--IAKVADAGLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF--RRFSEKSDV 194 (312)
Q Consensus 121 ~~lH~~~~givH~dikp~Nil~~~~~--~vkl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi 194 (312)
.|||+ +||+|+||||+||+++.++ .++|+|||++........ ........+++.|+|||++.+ ..++.++||
T Consensus 182 ~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999 7799999999999998777 899999999986543221 112334568889999999976 578999999
Q ss_pred ehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 195 YSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 195 wslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
|||||++|+|++|..||........ .......... ........+++++.++|.+||..||.+|||+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADT--ISQVLNKKLC-----------FENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCC-----------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcccc-----------cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999976443211 1111111000 00111123457899999999999999999999
Q ss_pred HHHHH
Q 021441 275 DVVTE 279 (312)
Q Consensus 275 ~ll~~ 279 (312)
++++|
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=336.97 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=200.7
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHH-HhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|+ ..+++.||+|.+... ....+..|..+ ++.++||||+++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345789999999999999999999 456889999976432 22345556665 4667999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.+|.+||+|||+++
T Consensus 115 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 99999999999998883 34567888999999999999999999 779999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .......||+.|+|||++.+..|+.++|||||||++|||++|..||..... ......+
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i----------- 251 (373)
T 2r5t_A 188 ENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNI----------- 251 (373)
T ss_dssp GGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHH-----------
T ss_pred ccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHH-----------
Confidence 643221 223455789999999999999999999999999999999999999975432 1111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHHHHHHhcccccc
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD-VVTELDRTLDKEMNLTTV 293 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~-ll~~l~~~~~~~~~~~~~ 293 (312)
... ...++..+++++.++|.+||..||.+||++.+ +.+.+..-.-+.++|..+
T Consensus 252 -~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 252 -LNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp -HHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred -Hhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 111 11234456678999999999999999999853 333344444445555554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=332.28 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=194.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC------C
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4789999999999999999999 4578999999875432 24577899999999999999999998765 3
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+ +++|.+++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 779988873 2457889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh-
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS- 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 233 (312)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..............+...
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9865432 234567889999999887 678999999999999999999999998654322111111111111000
Q ss_pred ----------hhhHHh---hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 ----------NLLKIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ----------~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...... ............++++.+|+.+||..||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 0111122334556889999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=331.79 Aligned_cols=262 Identities=20% Similarity=0.281 Sum_probs=194.3
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCChh----HHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... .+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999994 47889999976543322 345799999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.+ +|.+++. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLD----DCGNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 975 7777663 233458889999999999999999999 779999999999999999999999999987653222
Q ss_pred cCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh-
Q 021441 164 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE- 241 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 241 (312)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+...........+...........
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 12233457888999999887 56799999999999999999999999875433222222111111110000000000
Q ss_pred -----hc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 -----RL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 -----~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. .......+++++.+||.+||+.||++|||++++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000112345789999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=320.88 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=201.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5789999999999999999998 4568899999764322 245778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc---eEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~---vkl~Dfg~a~~ 158 (312)
||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++. ++|+|||.+..
T Consensus 85 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999987772 34568899999999999999999999 77999999999999987665 99999999976
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~-------- 223 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGA-------- 223 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTC--------
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhcc--------
Confidence 643322 23356888999999999999999999999999999999999999764321 1111111100
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.+++.+||+.||++|||+.++++|
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 --YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111123445789999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=344.34 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=196.2
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 345789999999999999999999 55789999997542 23345678999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++ .....+++..+..++.|++.||.|||+. +||+||||||+||+++.++.+||+|||++..
T Consensus 225 lv~e~~~~~~L~~~l-----~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHH-----HHHSCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999998888 2345688999999999999999999961 4599999999999999999999999999875
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......+|+.|+|||++.+..|+.++|||||||++|+|++|..||...... .....+.
T Consensus 299 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~----------- 362 (446)
T 4ejn_A 299 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL----------- 362 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-----------
T ss_pred ccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHH-----------
Confidence 43222 1233457899999999999999999999999999999999999999764321 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
.. ...++...++++.++|.+||+.||.+|| +++++++|
T Consensus 363 -~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 -ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 1124455668899999999999999999 99998865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=328.08 Aligned_cols=265 Identities=19% Similarity=0.275 Sum_probs=197.8
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee--------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE-------- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 73 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 57899999999999999999994 678999999764332 3467899999999999999999999876
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
.+..|+||||+.+ ++...+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 5555552 233458899999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCc--CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 154 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 154 g~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|++........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987643221 1222344678899999999874 57999999999999999999999998754332222221111111
Q ss_pred hhhhhhHHhhhhcccc----------CCh-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKILDERLWST----------FTN-----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~----------~~~-----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
................ ... ..++++.+||.+||..||++|||+.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000000000000000 000 013568999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=334.87 Aligned_cols=252 Identities=17% Similarity=0.220 Sum_probs=192.5
Q ss_pred hcCCCcc-cccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHh-cCCCccceeeeeeeee----CCeEEEE
Q 021441 8 TKNFSDK-NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQE----NNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~lv 80 (312)
.++|.+. +.||+|+||.||++. ..+++.||+|++.. ...+.+|+.++. ..+||||+++++++.. ...+|+|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 3567666 789999999999998 45789999998753 356678888774 4589999999999865 5678999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~ 157 (312)
|||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 138 ~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 138 MECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999988421 23458899999999999999999999 77999999999999997 7899999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh-HHHHhhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRDFSNLL 236 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (312)
...... ......+|+.|+|||++.+..|+.++|||||||++|+|++|..||.......... ....+....
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~------ 283 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 283 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC------
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc------
Confidence 654322 1234467888999999999999999999999999999999999998755433211 111111000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.+||.+||..||++|||+.++++|
T Consensus 284 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000011113456789999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=333.31 Aligned_cols=264 Identities=19% Similarity=0.245 Sum_probs=212.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCC-ccceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.++|++.+.||+|+||.||+|. ..+++.||||..... ....+.+|+++++.+.| +++..+..++......|+||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 5789999999999999999999 467899999975433 34568899999999976 55666666677888899999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeeccccccccC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a~~~~~ 161 (312)
+++|.+++. .....+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 -g~sL~~ll~----~~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 889998883 224568999999999999999999999 779999999999999 5889999999999987654
Q ss_pred CCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... .......+|..|+|||++.+..++.++|||||||++|+|++|..||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3321 12235568999999999999999999999999999999999999998876655444443332221111110
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..+..+++++.++|.+||..||++||++.+|++.|++++.+.
T Consensus 239 ---------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 ---------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ---------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111233578999999999999999999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=334.57 Aligned_cols=262 Identities=20% Similarity=0.260 Sum_probs=203.3
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 457899999999999999999994 478899999865442 245788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
||+++++|.+++. ....+++..+..++.|++.||.|||+ + ||+|+||||+||+++.++.++|+|||++....
T Consensus 111 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999883 33467899999999999999999998 4 69999999999999999999999999987553
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh------------
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN------------ 228 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~------------ 228 (312)
... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 184 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 221 2234678889999999999999999999999999999999999976442221111000000
Q ss_pred -----------hh---hhhh-hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 -----------SR---DFSN-LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 -----------~~---~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. .... ................+++++.+||.+||+.||++|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 0000 011111111111223356789999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.48 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=204.0
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|+. .+++.||+|.+.. .....+..|..+++.++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999994 5789999997643 33456788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||++|++|..++.... .....+++..+..++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999998874322 123468899999999999999999999 7799999999999999999999999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh-hHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (312)
...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||......... .....+
T Consensus 339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i----------- 405 (543)
T 3c4z_A 339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----------- 405 (543)
T ss_dssp CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH-----------
T ss_pred ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH-----------
Confidence 643321 123347899999999999999999999999999999999999999875432211 111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (312)
... ...++..+++++.++|.+||..||++||++
T Consensus 406 -~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 406 -LEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -hhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 111 123455667899999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=329.42 Aligned_cols=243 Identities=28% Similarity=0.406 Sum_probs=197.0
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+.|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 558899999999999999999 4678999999765332 135778999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+ ++.+++. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCSE-EHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCC-CHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99975 6666652 223568899999999999999999999 7799999999999999999999999999876532
Q ss_pred CCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
. ....+|+.|+|||++. +..++.++|||||||++|+|++|..||....... .....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~------------- 265 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI------------- 265 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH-------------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH-------------
Confidence 2 2346888999999985 4568999999999999999999999997643211 11111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+++.+.++|.+||+.||++|||++++++|
T Consensus 266 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111112234456789999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=342.13 Aligned_cols=264 Identities=20% Similarity=0.275 Sum_probs=182.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee-----CCe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3789999999999999999998 5578999999765432 2457789999999999999999999843 356
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+. ++|..++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLF-----RTPVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHH-----HSSCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhc-----ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 5888777 234568899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcC-------------------------CCCccccCcccccchhhh-hhcCCCcccceehhHHHHHHHHh----
Q 021441 157 NFLGRTDVA-------------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVS---- 206 (312)
Q Consensus 157 ~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~vl~~l~t---- 206 (312)
+........ .......+|+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 876432111 112344678999999986 45668999999999999999999
Q ss_pred -------CCCCCCCCCCCCh------------------hhHHHH--hhhhhhhhhhh-----------HHhh---hhccc
Q 021441 207 -------GREASSSLSPDSS------------------QDLVEL--VQNSRDFSNLL-----------KILD---ERLWS 245 (312)
Q Consensus 207 -------g~~pf~~~~~~~~------------------~~~~~~--~~~~~~~~~~~-----------~~~~---~~~~~ 245 (312)
|..+|.+...... ..+... ....+....+. .... .....
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6666654331100 000000 00000000000 0000 00001
Q ss_pred cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 246 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......++++.+||.+||..||++|||++|+|+|
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1122346789999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=320.51 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=205.9
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..+.|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++++......|+||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 34679999999999999999998 45688999997643 23467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+.+++|.+++. ...++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus 100 e~~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999998882 2457899999999999999999999 7799999999999999999999999999877643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... ..... +..
T Consensus 172 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~-------------~~~ 233 (303)
T 3a7i_A 172 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL-------------IPK 233 (303)
T ss_dssp TBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH-------------HHH
T ss_pred ccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH-------------hhc
Confidence 321 223456888899999999999999999999999999999999999754321 11111 111
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
......+..+++.+.+++.+||..||++|||+.+++++.
T Consensus 234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112234445567899999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=317.80 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=200.9
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||+|+||.||+|. ..++..+|+|.+. ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999999 4467789999754 3445678899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeeccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 159 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a~~~ 159 (312)
|+++++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||++ +.++.++|+|||.+...
T Consensus 87 ~~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999988873 34558899999999999999999999 779999999999999 78899999999998766
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.... ......+++.|+|||++.+. ++.++|||||||++|+|++|..||....... .........
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~--------- 223 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIREGT--------- 223 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC---------
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCC---------
Confidence 4332 22334688889999998754 8999999999999999999999997644211 111111100
Q ss_pred hhhccccCCh----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+. .+++++.+++.+||..||++|||+.++++|
T Consensus 224 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 224 -----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 235789999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=328.08 Aligned_cols=264 Identities=21% Similarity=0.351 Sum_probs=197.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++...+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 357899999999999999999994 5688999997643322 3467899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|..+. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+....
T Consensus 103 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 103 FEFVDHTILDDLE-----LFPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EECCSEEHHHHHH-----HSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EecCCcchHHHHH-----hhccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999998888776 234568899999999999999999999 779999999999999999999999999987654
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh--hhhhhhhH
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSNLLK 237 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 237 (312)
.... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.................. +.......
T Consensus 176 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 176 APGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred CCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 3221 12334578889999999876 6799999999999999999999999765432221111111000 00000000
Q ss_pred ---Hhhh---------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ---ILDE---------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ---~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... .........+++.+.+||.+||..||++|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000112346789999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=330.77 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=196.1
Q ss_pred CCCcccccccCcceEEEeeee--CC--ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeee-eCCeEEEE
Q 021441 10 NFSDKNLIGEGKFGEVYKGLL--QD--GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLI 80 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~--~~--~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 80 (312)
.|++.+.||+|+||.||+|.. .+ ...+|+|.+.... ...+.+|+.+++.++||||+++++++. ..+..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 466789999999999999984 22 3468999875432 246788999999999999999999865 44578999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999842 23457788899999999999999999 779999999999999999999999999998654
Q ss_pred CCCcC--CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 161 RTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 161 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+..... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~--------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQ--------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HT---------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---Hc---------
Confidence 33211 11223456678999999999999999999999999999999 67788765543322111 11
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
......+..+++.+.++|.+||..||++|||+.+++++|+.++....
T Consensus 312 ----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 312 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11122344556789999999999999999999999999999997644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=332.95 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=192.5
Q ss_pred ccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 14 KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5679999999999998 4578999999876543 35678999999999999999999999999999999999999999
Q ss_pred cccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe--CCCCceEEeeccccccccCCCcCCC
Q 021441 90 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~--~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||++ +.++.+||+|||++........
T Consensus 174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 887732 23457888999999999999999999 779999999999999 5678999999999987644322
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ........... .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~-----------~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNNILACRWD-----------LEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCCC-----------SCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCC-----------CChhh
Confidence 223458889999999999999999999999999999999999997643211 11111111100 00111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+++++.+||.+||..||.+|||+.++++|
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12345789999999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=335.06 Aligned_cols=268 Identities=20% Similarity=0.275 Sum_probs=198.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeee---------
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------- 73 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 73 (312)
+....++|++.+.||+|+||.||+|. ..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 45567899999999999999999998 5678999999765432 233579999999999999999999843
Q ss_pred -----------------------------CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHh
Q 021441 74 -----------------------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124 (312)
Q Consensus 74 -----------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH 124 (312)
...+++||||+++ +|.+.+.... .....+++..+..++.|++.||.|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 7665553211 23456889999999999999999999
Q ss_pred cCCCCeEecCCCCCceEeC-CCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHH
Q 021441 125 SLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLL 202 (312)
Q Consensus 125 ~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~ 202 (312)
+ +||+||||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|
T Consensus 159 ~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 S--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp T--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred H--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9 7799999999999997 68899999999998664332 223346788899999988755 899999999999999
Q ss_pred HHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh------------hhhccccCChHHHHHHHHHHHHhcCCCCCCC
Q 021441 203 ELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270 (312)
Q Consensus 203 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (312)
+|++|..||......+...........+....+...- .......++...++++.+||.+||..||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999998754322211111111111111111000 0011112344456789999999999999999
Q ss_pred CCHHHHHHH
Q 021441 271 PSMSDVVTE 279 (312)
Q Consensus 271 pt~~~ll~~ 279 (312)
||+.++++|
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.22 Aligned_cols=266 Identities=16% Similarity=0.202 Sum_probs=206.3
Q ss_pred hcCCCcccccccCcceEEEeeeeC---------CceEEEEEeCCCCChhHHHHHHHHHhcCCCcccee------------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ---------DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT------------ 66 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~------------ 66 (312)
.++|++.+.||+|+||.||+|... .++.||+|..... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 578999999999999999999954 3788999987644 56789999999999999887
Q ss_pred ---eeeeeee-CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 67 ---LLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 67 ---~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
+++++.. .+..|+||||+ +++|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+||++
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE
Confidence 5666665 67889999999 88999998421 23568999999999999999999999 779999999999999
Q ss_pred CCCC--ceEEeeccccccccCCCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 021441 143 DEDF--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 215 (312)
Q Consensus 143 ~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~ 215 (312)
+.++ .++|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999776433211 11233468889999999999999999999999999999999999998654
Q ss_pred CCChhhHHHHhhh-hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 216 PDSSQDLVELVQN-SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 216 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
...... ...... ....... ... ......+++++.+++.+||..||++|||++++++.|++++++.-
T Consensus 273 ~~~~~~-~~~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNTEDI-MKQKQKFVDKPGPF---VGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCHHHH-HHHHHHHHHSCCCE---ECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHHHH-HHHHHhccCChhhh---hhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 322111 111100 0000000 000 00011235789999999999999999999999999999997754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=321.92 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=199.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4689999999999999999999 457899999976532 124578899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++.... .....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999998884221 123557889999999999999999999 779999999999999999999999999987654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||....... .........
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------------ 252 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQ------------ 252 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHT------------
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhc------------
Confidence 3221 1223457888999999999999999999999999999999999997543221 111111110
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
..........+++++.+++.+||..||.+|||+.+++++|+++.....
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 111111223456789999999999999999999999999999987643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.41 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=201.5
Q ss_pred cccccCcceEEEeeee---CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLL---QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
+.||+|+||.||+|.+ .+++.||+|++.... ...+.+|+.+++.++||||+++++++.. ...++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999953 356889999876432 3578899999999999999999999865 457899999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc-C
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A 165 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~-~ 165 (312)
++|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus 454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999983 34568899999999999999999999 7799999999999999999999999999987644322 1
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......++..|+|||++.+..++.++|||||||++|||++ |..||........ . ..+.....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~-------------~~i~~~~~ 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T-------------AMLEKGER 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H-------------HHHHTTCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHHcCCC
Confidence 12223345678999999999999999999999999999998 9999976543211 1 11122222
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
...+..+++++.++|.+||+.||++|||+.++++.|+++..+-.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 34556677899999999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=321.50 Aligned_cols=257 Identities=20% Similarity=0.264 Sum_probs=203.1
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC---------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 3457899999999999999999994 46889999965422 2467889999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEe
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVA 151 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~ 151 (312)
..|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 9999999999999999883 34568899999999999999999999 7799999999999999887 89999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
|||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 155 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~- 227 (283)
T 3bhy_A 155 DFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISAVN- 227 (283)
T ss_dssp CCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTC-
T ss_pred ecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHhcc-
Confidence 999987654322 123345788899999999999999999999999999999999999764321 1111111100
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD 285 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~~ 285 (312)
...........++.+.+++.+||..||++|||+.++++| ++.+..
T Consensus 228 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 228 ---------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000001112234689999999999999999999999974 444443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=323.34 Aligned_cols=243 Identities=25% Similarity=0.308 Sum_probs=188.0
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh-----hHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT-----QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.++||+|+||.||+|.. .+++.||+|++..... .....|+..+..+ .||||+++++++...+..|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999995 4789999997643321 2234455544444 899999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+ +++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA----WGASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 5578777632 23468999999999999999999999 779999999999999999999999999987664
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.... . ......
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~-~~~~~~------------ 266 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G-WQQLRQ------------ 266 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H-HHHHTT------------
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H-HHHHhc------------
Confidence 332 2233458889999999886 78999999999999999999977664311 1 111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+..+++++.++|.+||..||++|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000111122345789999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=318.44 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=203.8
Q ss_pred hcCCCcccccccCcceEEEeeeeC-CceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeee-------------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE------------- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------- 73 (312)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 467999999999999999999954 78999999876543 567899999999999999999998754
Q ss_pred ---CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEE
Q 021441 74 ---NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 150 (312)
Q Consensus 74 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl 150 (312)
....|+||||+++++|.+++.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHH---GGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred ccCcceEEEEEeccCCCCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEE
Confidence 3457999999999999998842 123568889999999999999999999 77999999999999999999999
Q ss_pred eeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 151 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
+|||.+....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||... .....
T Consensus 164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~------ 229 (284)
T 2a19_B 164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT------ 229 (284)
T ss_dssp CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH------
T ss_pred Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH------
Confidence 9999987764432 123346788899999999999999999999999999999999886321 00000
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.+.. ...+..+++.+.++|.+||..||++|||+.+++++|..+.+..
T Consensus 230 -------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 -------DLRD---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------HHHT---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------Hhhc---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0001 1123344578999999999999999999999999999886543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=327.25 Aligned_cols=264 Identities=20% Similarity=0.314 Sum_probs=195.4
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--------hhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
....++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 4456899999999999999999999 4568899999875322 245778999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.+ +|..++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999987 77766632 23457778889999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hh--
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SR-- 230 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~-- 230 (312)
+....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ....... .+
T Consensus 159 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTE 234 (346)
T ss_dssp GSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCT
T ss_pred ceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCCh
Confidence 98764322 122344678889999999765 479999999999999999999999976442211 1111111 00
Q ss_pred -hhhhhhHHhhh---hccc-----cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 -DFSNLLKILDE---RLWS-----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 -~~~~~~~~~~~---~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+.......+. .... ......++++.++|.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000 0000 0113345789999999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=324.98 Aligned_cols=258 Identities=17% Similarity=0.205 Sum_probs=198.7
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999999994 478999999875432 2457889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999883 33468899999999999999999999 77999999999999999999999999998765
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
...... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~---------- 250 (309)
T 2h34_A 185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQA---------- 250 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSC----------
T ss_pred cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccC----------
Confidence 433211 123345788899999999989999999999999999999999999753211 111111110
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDK 286 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~~ll~~l~~~~~~ 286 (312)
.......+..+++++.++|.+||+.||++|| +++++++.|+..+..
T Consensus 251 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 251 -IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0011223445567899999999999999999 999999999987644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=342.08 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=200.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+. ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999994 578999999753 34556788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~Dfg~a~ 157 (312)
|||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999988873 34568899999999999999999999 7799999999999995 45679999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... ......+|+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .....+.....
T Consensus 173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~------ 239 (486)
T 3mwu_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKY------ 239 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCC------
T ss_pred ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC------
Confidence 664332 2234468899999999875 5899999999999999999999999764321 11111111100
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.++|.+||..||.+|||+.++++|
T Consensus 240 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 ----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112345789999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=324.33 Aligned_cols=252 Identities=20% Similarity=0.368 Sum_probs=200.5
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc-------eEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG-------MLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-------~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
+..++|++.+.||+|+||.||+|... ++ ..||+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 45789999999999999999999843 33 57999987543 235688999999999999999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc-------
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI------- 147 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~------- 147 (312)
+..|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999999842 23348899999999999999999999 77999999999999998887
Q ss_pred -eEEeeccccccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHH
Q 021441 148 -AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 148 -vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~ 225 (312)
++|+|||.+...... ....++..|+|||++.+ ..++.++|||||||++|+|++|..|+...... ......
T Consensus 159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH
T ss_pred eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHH
Confidence 999999998654321 22346677999999987 67899999999999999999965544332211 111111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
... ....+...++++.+++.+||+.||.+|||+.+++++|++++..
T Consensus 231 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YED---------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHT---------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hhc---------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 110 1122233346789999999999999999999999999988753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=340.91 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=199.4
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC----------------CChhHHHHHHHHHhcCCCccceeeee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNLVTLLG 69 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~----------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (312)
..++|++++.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999 45688999997543 22456889999999999999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF--- 146 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~--- 146 (312)
++......|+||||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999988883 34568899999999999999999999 7799999999999999876
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
.+||+|||++....... ......+|+.|+|||++. ..|+.++|||||||++|+|++|..||...... .....+
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i 259 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKV 259 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 69999999998764332 223446888999999987 46899999999999999999999999864432 111111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... ... ....+++++.++|.+||..||.+|||+.++++|
T Consensus 260 ~~~~~~~------~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYF------DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCC------CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCC------Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110000 000 012235789999999999999999999999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=316.27 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=184.8
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
...++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3457899999999999999999994 5788999997643 23466889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+..
T Consensus 88 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999988832 23567899999999999999999999 7799999999999999999999999999876
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
...... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~------------ 224 (278)
T 3cok_A 162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---KV------------ 224 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------C------------
T ss_pred ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---HH------------
Confidence 543221 1223457888999999999899999999999999999999999997654322110 00
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ....+...+.++.++|.+||..||++|||+.++++|
T Consensus 225 ~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 225 VLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000 012344456789999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=318.10 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=195.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|.+.+.||+|+||.||+|. ..++..+|+|.+.. .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4789999999999999999999 45688999997543 344678899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeeccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 159 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a~~~ 159 (312)
|+++++|.+.+.... .....+++..+..++.|++.||.|||+ +||+|+||||+||++ +.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999988874321 123568899999999999999999999 779999999999999 55678999999999765
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.... ......+++.|+|||++. ..++.++|||||||++|+|++|..||........ .......
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~~~~~~---------- 240 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQKATYK---------- 240 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHC----------
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---HhhhccC----------
Confidence 4322 223456888899999986 5689999999999999999999999976432111 1111000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........++++.+++.+||..||++|||+.++++|
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 241 -EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011111235789999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=321.11 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=189.1
Q ss_pred hhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChh-----HHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+++..++|++.+.||+|+||.||+|. ..+++.||+|.+...... .+.++...++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 46678999999999999999999999 457899999987654322 233445557778999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeecccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
|+||||+.+ +|.+++.... .....+++..+..++.|++.||.|||+ + |++|+||||+||+++.++.++|+|||++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999975 7766553211 134568899999999999999999998 5 7999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhh----hhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
....... ......+++.|+|||++ .+..++.++|||||||++|+|++|..||....... ...
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~---------- 223 (290)
T 3fme_A 158 GYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL---------- 223 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH----------
T ss_pred ccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH----------
Confidence 7664332 12234678889999996 55678999999999999999999999997533211 111
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...............+++++.+++.+||+.||++|||+.++++|
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 224 ---KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111111122233456789999999999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=326.93 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=201.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC-----CeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4689999999999999999998 45788999998764332 4577899999999999999999998654 368
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+|||++.+ +|.+++. ...+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+.
T Consensus 106 ~iv~e~~~~-~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCSE-EHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccCc-CHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 999999975 8877772 2358899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCc-CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
....... ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||..................+.....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7653322 1223445788999999987654 4899999999999999999999999876544333222211111111110
Q ss_pred hHH--------hh------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKI--------LD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~--------~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... .. ...+.......++++.+||.+||+.||++|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00 000111123345789999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=329.10 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=202.9
Q ss_pred HhcCCCcccccccCcceEEEeeee----CCceEEEEEeCCC-------CChhHHHHHHHHHhcC-CCccceeeeeeeeeC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~-------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 74 (312)
..++|++.+.||+|+||.||+|+. .+++.||+|.+.. .....+.+|+.+++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999985 3688999997653 2335567899999999 699999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 99999999999999998883 33468899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc--CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
++......... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.............. .
T Consensus 205 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~---- 277 (355)
T 1vzo_A 205 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--R---- 277 (355)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--H----
T ss_pred CCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--H----
Confidence 99765432211 12334688999999999863 468899999999999999999999976543322211110 0
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTEL 280 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~l 280 (312)
... .....+..+++.+.++|.+||..||.+|| ++.++++|.
T Consensus 278 -----~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 -----ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 11234555668899999999999999999 888888764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=341.49 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=199.2
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC-----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.++|++++.||+|+||.||+|.. .++..||+|.+.. .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999994 4788999997543 33467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC---CceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~---~~vkl~Dfg~a~~ 158 (312)
||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999988772 34568899999999999999999999 779999999999999764 4599999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... ......+|+.|+|||++. ..|+.++|||||||++|+|++|..||...... .....+.....
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~------- 254 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKY------- 254 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCC-------
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC-------
Confidence 65432 223356889999999986 56899999999999999999999999764432 11111111100
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTL 284 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~ 284 (312)
.........+++++.++|.+||..||.+|||+.++++| +.+..
T Consensus 255 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 255 ---TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 00001112345789999999999999999999999976 44443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=336.13 Aligned_cols=196 Identities=21% Similarity=0.325 Sum_probs=162.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC-----Ce
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5789999999999999999998 5578999999876432 24578899999999999999999998765 56
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+.+ +|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCSE-EHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCc-CHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 8999999865 8888873 34568899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcC--------------------CCCccccCcccccchhhh-hhcCCCcccceehhHHHHHHHHhCCCCC
Q 021441 157 NFLGRTDVA--------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREAS 211 (312)
Q Consensus 157 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~vl~~l~tg~~pf 211 (312)
+........ .......+|+.|+|||++ .+..|+.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876433211 112455789999999986 4556899999999999999999855444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=343.76 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=202.3
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+. ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34679999999999999999999 4478999999753 2345678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeecccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 156 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a 156 (312)
||||+.+++|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999988883 34568899999999999999999999 779999999999999 56789999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... ......+|+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .....+.....
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~----- 244 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVEKGKY----- 244 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC-----
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCC-----
Confidence 7664322 2234468899999999976 6899999999999999999999999764422 11111111100
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.++|.+||..||.+|||+.++++|
T Consensus 245 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 -----TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -----CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00001112345789999999999999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=322.90 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=201.9
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457899999999999999999994 47889999976543 33567899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe---CCCCceEEeeccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 159 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~---~~~~~vkl~Dfg~a~~~ 159 (312)
|+++++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||++ +.++.++|+|||.+...
T Consensus 87 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999988873 33467899999999999999999999 779999999999999 78889999999998654
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~--------- 223 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGY--------- 223 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCC---------
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCC---------
Confidence 322 123345788899999999999999999999999999999999999764321 1111111100
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.++|.+||..||++|||+.++++|
T Consensus 224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 224 -YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001112234456789999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=316.66 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=197.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-------ChhHHHHHHHHHhcCCCccceeeeeee--eeCCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYC--QENNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 77 (312)
.++|++.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999 456889999986532 335688999999999999999999998 445678
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.++ +.+++.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 5554421 234568899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCC--CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRF--SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
...............++..|+|||++.+... +.++|||||||++|+|++|..||..... ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~------- 227 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGK------- 227 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH-------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHhc-------
Confidence 7644332323334568889999999987543 7899999999999999999999975331 111111110
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 228 -----~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 -----G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 112344556789999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=330.56 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=183.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeC------C
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999998 5678999999875432 24577899999999999999999998653 5
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+|+|++ +++|.+++. ...++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 678988872 2458899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+...... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+................+....
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8765322 233567888999999987 6789999999999999999999999987543222111111111110000
Q ss_pred -----------hhHHhhh---hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 -----------LLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 -----------~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+.. ..........++++.+||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 00001112335789999999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=331.48 Aligned_cols=268 Identities=19% Similarity=0.287 Sum_probs=196.1
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--------------hhHHHHHHHHHhcCCCccceee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLVTL 67 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~ 67 (312)
.++....++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+|+.+++.++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 35566779999999999999999999997779999999754321 1568899999999999999999
Q ss_pred eeeeee-----CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 68 LGYCQE-----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 68 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
++++.. ....|+||||+.+ +|.+.+. .....+++..+..++.|++.||.|||+ +||+|+||||+||++
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILL 167 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCSE-EHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE
T ss_pred eeeEEeccCCCcceEEEEEccCCC-CHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHHEEE
Confidence 999843 3468999999985 6766663 233468899999999999999999999 779999999999999
Q ss_pred CCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh
Q 021441 143 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221 (312)
Q Consensus 143 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~ 221 (312)
+.++.++|+|||.+....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999987543322 2234467888999999887 678999999999999999999999998654322211
Q ss_pred HHHHhhhhhhhhhhh--------HHhh-------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 222 LVELVQNSRDFSNLL--------KILD-------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 222 ~~~~~~~~~~~~~~~--------~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+...... .... ...+.......++.+.++|.+||+.||++|||+.++++|
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111111000 0000 000111223345789999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=332.89 Aligned_cols=261 Identities=18% Similarity=0.224 Sum_probs=198.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh--hHHHHHHHHHhcC------CCccceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT--QEFIDEVCFLASI------QHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 78 (312)
..+|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.+ .|+||+++++++...+..|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4579999999999999999998 55689999998876533 4566788887776 5779999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc--eEEeecccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLR 156 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~--vkl~Dfg~a 156 (312)
+||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++
T Consensus 176 lv~e~~~~-~L~~~l~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLSM-NLYELIKK---NKFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCCC-BHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccCC-CHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999965 78777732 223458899999999999999999999 67999999999999999987 999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh-
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL- 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 235 (312)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......+...........+.....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 754322 23346788899999999999999999999999999999999999875432222111111111100000
Q ss_pred -----hHHhhhhc------------------------------------cccCChHHHHHHHHHHHHhcCCCCCCCCCHH
Q 021441 236 -----LKILDERL------------------------------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274 (312)
Q Consensus 236 -----~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (312)
........ ........++++.+||.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 00000000 0001112246799999999999999999999
Q ss_pred HHHHH
Q 021441 275 DVVTE 279 (312)
Q Consensus 275 ~ll~~ 279 (312)
++|+|
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=330.93 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=191.0
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----------ChhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
..++|.+.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 35789999999999999999998 556889999975421 12247889999999999999999999754
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC---ceEEe
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVA 151 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~---~vkl~ 151 (312)
+..|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999998883 44568899999999999999999999 7799999999999997554 59999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|||++....... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++|..||......... ......
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~ 359 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 359 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc
Confidence 999998764332 1233568889999999854 56788999999999999999999999864433211 111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... . ........+++.+.++|.+||..||++|||+.++++|
T Consensus 360 ~~~-~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 GKY-N---------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TCC-C---------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-C---------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0 0000111235789999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=324.12 Aligned_cols=246 Identities=19% Similarity=0.305 Sum_probs=203.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||++. ..+++.+|+|.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999999 446789999975432 235678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++....
T Consensus 120 ~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999988872 34568899999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ....... .
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~------------~ 255 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIK------------K 255 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------H
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHh------------c
Confidence 322 1223456788899999999999999999999999999999999999754321 1111110 0
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....+..+++++.++|.+||..||++|||+.+++++
T Consensus 256 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 256 N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 112344556789999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=317.57 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=203.7
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||++.. .+++.+|+|.+... ....+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 357899999999999999999994 46888999975432 23457789999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+.+++|.+++ .....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+...
T Consensus 93 v~e~~~~~~L~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999998887 234568899999999999999999999 77999999999999999999999999998875
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .......
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~------------ 228 (294)
T 2rku_A 166 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIK------------ 228 (294)
T ss_dssp CSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------
T ss_pred ccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh------------
Confidence 4322 1223356788899999999888999999999999999999999999764321 1111110
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ....+...++.+.+++.+||..||++|||+.+++++
T Consensus 229 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 229 KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 112344556789999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=321.34 Aligned_cols=268 Identities=22% Similarity=0.313 Sum_probs=188.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
++.+..++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 466778999999999999999999998 456889999987543 235677899999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcc---cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 78 FLIYEYIPNGSVSIHLYGPS---QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
|+||||+++++|.+++.... ......+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999998874211 1124558899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCc---CCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 155 LRNFLGRTDV---AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 155 ~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
.+........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQNDP 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSSC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccCC
Confidence 9876543211 111233468888999999876 56899999999999999999999999875432211 11111110
Q ss_pred hhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. .. ...........+++++.+++.+||..||.+|||+.++++|
T Consensus 245 ~~--~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 PS--LE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CC--TT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Cc--cc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 00 0000112233445789999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=317.51 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=196.0
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee----CCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (312)
..+.|++.+.||+|+||.||+|. ..++..||+|.+... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 44568889999999999999998 456888999975432 23457889999999999999999998865 356
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEeC-CCCceEEeec
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVD-EDFIAKVADA 153 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g--ivH~dikp~Nil~~-~~~~vkl~Df 153 (312)
.|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +| ++|+||||+||+++ .++.++|+||
T Consensus 104 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEEEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 899999999999999883 33567899999999999999999999 66 99999999999998 7899999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|++...... ......+++.|+|||++. ..++.++|||||||++|+|++|..||...... ..........
T Consensus 177 g~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~---- 245 (290)
T 1t4h_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG---- 245 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT----
T ss_pred CCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhcc----
Confidence 998654322 123346788899999887 45899999999999999999999999764321 1111111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+...++++.++|.+||..||.+|||+.++++|
T Consensus 246 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 --------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00111222234679999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=349.90 Aligned_cols=242 Identities=19% Similarity=0.282 Sum_probs=200.8
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++++.||+|+||.||+|. ..+++.||+|++. ......+..|..++..+ +||+|+++++++...+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 456789999999999999999999 5568899999764 23445677899999887 699999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+++|..++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999998883 33568899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .......||+.|+|||++.+..|+.++|||||||++|||++|..||...+. ......+.
T Consensus 491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~---------- 555 (674)
T 3pfq_A 491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM---------- 555 (674)
T ss_dssp ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----------
T ss_pred ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHH----------
Confidence 643222 123445789999999999999999999999999999999999999976432 11111111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (312)
.. ...++..+++++.+||.+||+.||++||++
T Consensus 556 --~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 556 --EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --SS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --hC--CCCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11 123455667899999999999999999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=330.95 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=194.5
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeCC------eEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 81 (312)
..+|++.+.||+|+||.||+|....+..+|+|++.... ....+|+.+++.++||||+++++++...+ .+|+||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 35799999999999999999997655668888654322 22347999999999999999999985543 378999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~~~~ 160 (312)
||+.++.+..... . ......+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~~~~~~-~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVYRASRH-Y-AKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHHHHHHH-H-HHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHHHHHHH-H-HhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9998754432221 0 1124568899999999999999999999 7799999999999999 79999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......+|+.|+|||++.+. .|+.++|||||||++|+|++|..||.+................+....+...
T Consensus 194 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~- 269 (394)
T 4e7w_A 194 AGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM- 269 (394)
T ss_dssp TTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-
T ss_pred CCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-
Confidence 332 22345678889999999775 4899999999999999999999999875432221111111111111111000
Q ss_pred hhh-------------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DER-------------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+. ....++...++++.+||.+||..||.+|||+.++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 0111233456789999999999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=324.89 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=199.2
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC-----------hhHHHHHHHHHhcC-CCccceeeeeeeeeC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----------TQEFIDEVCFLASI-QHRNLVTLLGYCQEN 74 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 74 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|+..... ...+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36799999999999999999995 478999999765432 24567899999998 799999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+..|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999998883 34568899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+..
T Consensus 246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~ 319 (365)
T 2y7j_A 246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRMIME 319 (365)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh
Confidence 987764332 22345688899999998754 578899999999999999999999976332 111111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... . . ....+ ...++.+.++|.+||..||++|||+.++++|
T Consensus 320 ~~~-~-~----~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQY-Q-F----SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp TCC-C-C----CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-C-C----CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0 0 00000 1234679999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=320.43 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=201.6
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeee--eCCeEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (312)
..++|++.+.||+|+||.||++.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++. .....|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 357899999999999999999994 478899999765332 245788999999999999999999874 356889
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceEeCCCCceEEeec
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-----VVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g-----ivH~dikp~Nil~~~~~~vkl~Df 153 (312)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+ +| ++|+||||+||+++.++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999998884321 123448899999999999999999999 66 999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|.+........ ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i------- 228 (279)
T 2w5a_A 161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI------- 228 (279)
T ss_dssp CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH-------
T ss_pred chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHH-------
Confidence 99876543211 112235778899999999999999999999999999999999999764321 111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~ 281 (312)
........+..+++++.++|.+||+.||++|||+.++++++.
T Consensus 229 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 229 ------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ------hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111122345556788999999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=336.87 Aligned_cols=242 Identities=12% Similarity=0.119 Sum_probs=185.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC------CChhHHHHHHH---HHhcCCCccceeee-------ee
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVC---FLASIQHRNLVTLL-------GY 70 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~------~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 70 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5779999999999999999999 46789999997542 22356788994 45555799999998 55
Q ss_pred eeeCC-----------------eEEEEEEeccCCcccccccCcccc--cccccCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 021441 71 CQENN-----------------LQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131 (312)
Q Consensus 71 ~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~L~~lH~~~~giv 131 (312)
+...+ ..|+||||+ +|+|.+++...... ....+++..+..++.|++.||.|||+ +||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence 55443 278999999 56999888432111 12234457888899999999999999 7799
Q ss_pred ecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhc-----------CCCcccceehhHHH
Q 021441 132 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----------RFSEKSDVYSFGVF 200 (312)
Q Consensus 132 H~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDiwslG~v 200 (312)
||||||+||+++.++.+||+|||++...... .....+ +.|+|||++.+. .++.++|||||||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999864321 122345 779999999988 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 201 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 201 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+|+|++|..||........... . ......+++++.++|.+||..||++|||+.++++|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~------------~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW------------I---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCSGG------------G---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccchhh------------h---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999976443221110 0 00112345789999999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=323.42 Aligned_cols=272 Identities=21% Similarity=0.226 Sum_probs=190.4
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC--CChhHHHHHHHHHhcCCCccceeeeeeeeeCCe---
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--- 76 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 76 (312)
......++|++.+.||+|+||.||+|.. .+++.||+|.+.. .......+++..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3456678999999999999999999994 5688999997533 334566778888888999999999999865433
Q ss_pred ----EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEe
Q 021441 77 ----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVA 151 (312)
Q Consensus 77 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~ 151 (312)
.|+||||+.++ +...+.... .....++...+..++.|++.||.|||.+.+||+|+||||+||+++. ++.+||+
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cceeEEEEeeccccc-HHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 78999999874 333221110 2345678889999999999999999922278999999999999997 8999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||..................+
T Consensus 175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 999998764332 223446788899999997665 7999999999999999999999998754322221111111111
Q ss_pred hhhhhhHHh---------------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKIL---------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......... ............++++.+||.+||+.||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 100000000 0111122333457899999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=320.62 Aligned_cols=252 Identities=16% Similarity=0.207 Sum_probs=199.8
Q ss_pred HhcCCCcc-cccccCcceEEEeee-eCCceEEEEEeCCC-----CChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEE
Q 021441 7 ATKNFSDK-NLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 7 ~~~~y~~~-~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (312)
-.++|.+. +.||+|+||.||+|. ..+++.||+|.+.. .....+.+|+.++..+ .||||+++++++...+..|
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34567776 899999999999998 44689999997543 2346788999999999 4699999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGL 155 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~ 155 (312)
+||||+.+++|.+++.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||+
T Consensus 106 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999988832 223568899999999999999999999 77999999999999998 78999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+........ .....+++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+...
T Consensus 181 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~------ 248 (327)
T 3lm5_A 181 SRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQV------ 248 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT------
T ss_pred ccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHhc------
Confidence 987643321 2334688899999999999999999999999999999999999976432111 1111100
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+++.+.++|.+||..||++|||++++++|
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 ----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111122334456789999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=317.56 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=199.8
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 457899999999999999999984 46889999976543 4567889999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+++|.+++. .....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 107 ~~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHH----HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999998883 134568899999999999999999999 7799999999999999999999999999876543321
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ....... .....
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-----------~~~~~ 244 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIPT-----------NPPPT 244 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH-----------SCCCC
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhc-----------CCCcc
Confidence 2234467888999999999899999999999999999999999997543211 1100000 00011
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12234456789999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=315.06 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=196.3
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC-----ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+..+..+ +||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999994 47899999976532 234577889999988 899999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC---------------
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--------------- 145 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~--------------- 145 (312)
|||+++++|.+++..... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999998843211 12557899999999999999999999 779999999999999844
Q ss_pred ----CceEEeeccccccccCCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChh
Q 021441 146 ----FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ 220 (312)
Q Consensus 146 ----~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~ 220 (312)
..++|+|||.+...... ....++..|+|||++.+. .++.++|||||||++|+|++|..|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 47999999998765432 223578889999999876 56789999999999999999987764321
Q ss_pred hHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 221 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. .... ........+..+++++.+++.+||..||++|||+.++++|
T Consensus 236 ~-~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 Q-WHEI-------------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H-HHHH-------------HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H-HHHH-------------HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1000 1111223445566889999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=326.92 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=200.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCC--------Cccceeeeeeee----
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ--------HRNLVTLLGYCQ---- 72 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 72 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 4789999999999999999998 5578999999886543 356778999999885 788999999987
Q ss_pred eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCC-----
Q 021441 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDF----- 146 (312)
Q Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~----- 146 (312)
.....|+||||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+ + ||+||||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhh
Confidence 45678999999955 55444421 223468899999999999999999999 6 799999999999999876
Q ss_pred --------------------------------------------ceEEeeccccccccCCCcCCCCccccCcccccchhh
Q 021441 147 --------------------------------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182 (312)
Q Consensus 147 --------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (312)
.++|+|||.+...... .....+|+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999865432 233467889999999
Q ss_pred hhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh----hhh-hhh----------------------
Q 021441 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS----RDF-SNL---------------------- 235 (312)
Q Consensus 183 ~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~----~~~-~~~---------------------- 235 (312)
+.+..++.++|||||||++|+|++|..||.................. ... ...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999876544322111111000 000 000
Q ss_pred ------hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 ------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... .....+...++.+.+||.+||..||++|||+.++++|
T Consensus 345 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLV--EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHH--HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhh--hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 0123456778899999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=315.22 Aligned_cols=250 Identities=19% Similarity=0.284 Sum_probs=195.2
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 35789999999999999999998 4568999999765322 23478899999999999999999998765
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc---eEEe
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVA 151 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~---vkl~ 151 (312)
. .|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++. ++|+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999988873 34568899999999999999999999 77999999999999987664 9999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
|||.+........ .....+++.|+|||++. ...++.++|||||||++|+|++|..||......... ......
T Consensus 160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~ 234 (322)
T 2ycf_A 160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 234 (322)
T ss_dssp CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHH
T ss_pred cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHh
Confidence 9999876543211 12345788899999975 456889999999999999999999999765433211 111111
Q ss_pred hhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. . ..........++++.+++.+||..||++|||+.++++|
T Consensus 235 ~~-~---------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 GK-Y---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TC-C---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Cc-c---------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00 0 00000112235789999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=320.25 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=197.0
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCC--CccceeeeeeeeeCCe
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ--HRNLVTLLGYCQENNL 76 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 76 (312)
+.+..++|++.+.||+|+||.||++...+++.||+|.+.... ...+.+|+.+++.+. ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 455678899999999999999999997778899999764332 245788999999996 5999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||| +.+++|.+++. ....++...+..++.|++.||.|||+ +||+|+||||+||++++ +.++|+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 55779988883 33467888999999999999999999 77999999999999965 89999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-----------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHH
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~ 225 (312)
................+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~---- 247 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--S---- 247 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--H----
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--H----
Confidence 87654332222334568889999999876 467889999999999999999999997543211 0
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l 280 (312)
..............+...++++.++|.+||..||.+|||+.+++++-
T Consensus 248 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 248 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp --------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11111222222234444467899999999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=320.30 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=196.3
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC--CChhHHHHHHHHHhcC-CCccceeeeeeeee------C
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--APTQEFIDEVCFLASI-QHRNLVTLLGYCQE------N 74 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~ 74 (312)
....++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34568899999999999999999994 5788999997543 3456788999999998 79999999999876 4
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|+||||+.+++|.+++... ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6789999999999999888422 23567889999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
++....... .......++..|+|||++. +..++.++|||||||++|+|++|..||....... .....
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~--- 246 (326)
T 2x7f_A 175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLI--- 246 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---
T ss_pred CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh---
Confidence 987654321 1123346788899999987 4568999999999999999999999997543211 11100
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
............+++.+.++|.+||..||.+|||+.++++|
T Consensus 247 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 ---------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ---------HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---------hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111112233456789999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=327.25 Aligned_cols=257 Identities=19% Similarity=0.291 Sum_probs=189.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------ 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999998 4568999999865422 245778999999999999999999987654
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.+ +|.+.+. ..++...+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999976 6666652 247788899999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh-h---
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-D--- 231 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~--- 231 (312)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .......... +
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 97654322 1233567888999999999999999999999999999999999997644221 1111111000 0
Q ss_pred -hhhh----hHHhhh---------------hcc---ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 -FSNL----LKILDE---------------RLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 -~~~~----~~~~~~---------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+ ...... ... .......++++.+||.+||..||++|||++++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000000 000 00112336789999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=326.57 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=187.6
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC---hhHHHHHHHHHhcCC-Cccceeeeeeee-------
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-HRNLVTLLGYCQ------- 72 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~------- 72 (312)
.+...+|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.++..+. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 4456789999999999999999999 4578999999764433 345788999999995 999999999984
Q ss_pred -eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEeCCCCceE
Q 021441 73 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 73 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~g--ivH~dikp~Nil~~~~~~vk 149 (312)
.....++||||+. ++|.+++... .....+++..+..++.|++.||.|||+ +| |+|+||||+||+++.++.++
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECCCCCEE
Confidence 3345799999996 5787776321 123458899999999999999999999 66 99999999999999999999
Q ss_pred EeeccccccccCCCcCC----------CCccccCcccccchhhh---hhcCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 021441 150 VADAGLRNFLGRTDVAG----------PSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~ 216 (312)
|+|||++.......... ......+++.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432111 11133478889999998 566789999999999999999999999965332
Q ss_pred CChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
... . ............++.+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 259 ~~~------~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LRI------V-------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHh------h-------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 110 0 000111112222356899999999999999999999999999998763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.55 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=207.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeC----CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+.+..++|++.+.||+|+||.||+|... .+..||+|....... ..+.+|+.+++.++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 4455678999999999999999999843 246799998765432 457889999999999999999999854 5
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCC
Confidence 68999999999999998832 23457889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i-------- 605 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI-------- 605 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH--------
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH--------
Confidence 9876433211 1223456678999999999999999999999999999997 99999764321 111111
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++.+.++|.+||..||++|||+.++++.|+.++++.
T Consensus 606 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 606 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111122345566789999999999999999999999999999998763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=313.63 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=199.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|.....||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 34556667799999999999999 456889999976543 34568899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeeccccccccC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Dfg~a~~~~~ 161 (312)
|+++++|.+++... ......++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+.....
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999888432 122345688889999999999999999 77999999999999987 89999999999876543
Q ss_pred CCcCCCCccccCcccccchhhhhhcC--CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.......... ....
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------------~~~~ 239 (295)
T 2clq_A 176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--------------FKVG 239 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--------------HHHH
T ss_pred CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--------------Hhhc
Confidence 221 123446788899999998754 8899999999999999999999996533211100 0000
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+..+++++.++|.+||..||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112234455667899999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=311.42 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCC------CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.++||||+++++++...+..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 4468899999999999999999995 4788999997643 33457889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+.+++|.+++. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+..
T Consensus 88 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 88 MVMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 9999999999998883 33457889999999999999999999 6799999999999999999999999999876
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ......+..
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~--------- 225 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRG--------- 225 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---------
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhc---------
Confidence 643321 223457788999999988776 6899999999999999999999975321 111111110
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....+...++.+.+++.+||+.||.+|||+.++++|
T Consensus 226 ----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 ----G-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----C-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 112344456789999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=317.87 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=198.0
Q ss_pred HHhcCCCcccccccCcceEEEeeee-C-Cc--eEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-Q-DG--MLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~-~~--~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|.+ . ++ ..||+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 4568899999999999999999983 2 22 36899986543 2346788999999999999999999998765
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.++||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred -ceeeEecccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccc
Confidence 7899999999999988832 23457899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 156 RNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 156 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~------- 237 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI------- 237 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH-------
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH-------
Confidence 8776433211 11223346667999999999899999999999999999999 99999764321 111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
.........+..+++++.+++.+||..||++|||+.+++++|+++...
T Consensus 238 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 238 -----DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111111223445668899999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=332.36 Aligned_cols=260 Identities=25% Similarity=0.322 Sum_probs=194.0
Q ss_pred cCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeC------CeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 81 (312)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+|+++++.++||||+++++++... ..+++||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 4699999999999999999995 568999999765432 2345799999999999999999988532 2367999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-CceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-~~vkl~Dfg~a~~~~ 160 (312)
||+.+ ++...+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 5544442111 234568899999999999999999999 779999999999999965 578999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh--hhhhhhhhH
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SRDFSNLLK 237 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 237 (312)
... ......+|+.|+|||++.+. .|+.++|||||||++|||++|..||...... ......... .+....+..
T Consensus 209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHH
T ss_pred cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence 332 12335678899999999775 6899999999999999999999999874432 222222211 111111111
Q ss_pred Hhhhh-------------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDER-------------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. .+. ....++...++++.+||.+||..||.+|||+.++++|
T Consensus 284 ~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 M-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp H-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred h-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000 0011233456789999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=314.45 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=200.5
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC------------hhHHHHHHHHHhcCC-Cccceeeeeeee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQ 72 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------------~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 72 (312)
-.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999994 568999999865432 245678999999995 999999999999
Q ss_pred eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEee
Q 021441 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD 152 (312)
Q Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~D 152 (312)
..+..|+||||+++++|.+++. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999883 34568899999999999999999999 7799999999999999999999999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhh------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
||.+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ......
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~ 241 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMI 241 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHHH
Confidence 99987654332 2233467888999999863 45788999999999999999999999754321 111111
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ..........+++.+.+++.+||..||++|||+.++++|
T Consensus 242 ~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGN----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTC----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCC----------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1100 000011123456789999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=321.92 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=201.3
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCC---hhHHHHHHHHHhcCCCccceeeeeeeee----CCe
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNL 76 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (312)
.+..++|++.+.||+|+||.||++.. .+++.||+|.+.... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34568899999999999999999994 678999999764333 3457889999999999999999999862 346
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+.+++|.+++.... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 799999999999988884321 134568899999999999999999999 77999999999999999999999999987
Q ss_pred ccccCCCcCC-------CCccccCcccccchhhhhhcC---CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 157 NFLGRTDVAG-------PSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 157 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
.......... ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||......... ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA--- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH---
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh---
Confidence 6543211000 001224578899999987554 688999999999999999999998532111000 00
Q ss_pred hhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
...........+...++++.++|.+||+.||.+|||+.+++++|+.+.
T Consensus 258 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 258 ----------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ----------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000111112223445678999999999999999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=321.35 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=201.5
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
.++.+..++|++.+.||+|+||.||++.... .+++|.+... ....+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4567788999999999999999999999753 4899976532 23457789999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++||||+.+++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++ ++.++|+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999832 23457889999999999999999999 7799999999999998 679999999997
Q ss_pred ccccCCC---cCCCCccccCcccccchhhhhh---------cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHH
Q 021441 157 NFLGRTD---VAGPSSQVTADEIFLASEVKEF---------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 224 (312)
Q Consensus 157 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~ 224 (312)
....... .........++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~ 253 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIW 253 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 7653211 1122233457888999999875 34788999999999999999999999764321 1111
Q ss_pred HhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 225 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
.... ..........+++++.+++.+||..||++|||+.++++.|+.+.++...
T Consensus 254 ~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 254 QMGT------------GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHT------------TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred Hhcc------------CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1110 0111111223456799999999999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=316.34 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=201.5
Q ss_pred HhcCCCcccccccCcceEEEeeee--CCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCc------cceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHR------NLVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~ 76 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.+++.++|+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 357899999999999999999984 368899999876543 24577889988888655 49999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC------------
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE------------ 144 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~------------ 144 (312)
.|+||||+ +++|.+++... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 77888887321 22357889999999999999999999 77999999999999987
Q ss_pred -------CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 021441 145 -------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 217 (312)
Q Consensus 145 -------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~ 217 (312)
++.++|+|||.+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999998764322 23456788999999999999999999999999999999999999865433
Q ss_pred ChhhHHHHhhhhhhhhhhhH----------------------Hhh-----hhccccCChHHHHHHHHHHHHhcCCCCCCC
Q 021441 218 SSQDLVELVQNSRDFSNLLK----------------------ILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~----------------------~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (312)
+............+...... ... ...........++++.++|.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 22222211111100000000 000 000112344567889999999999999999
Q ss_pred CCHHHHHHH
Q 021441 271 PSMSDVVTE 279 (312)
Q Consensus 271 pt~~~ll~~ 279 (312)
||+.++++|
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=319.26 Aligned_cols=264 Identities=17% Similarity=0.218 Sum_probs=202.6
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh--------------------hHHHHHHHHHhcCCCccceee
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--------------------QEFIDEVCFLASIQHRNLVTL 67 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~e~~~l~~l~h~~i~~~ 67 (312)
.++|++.+.||+|+||.||+|.. +++.||+|.+..... ..+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999998 789999997542211 678899999999999999999
Q ss_pred eeeeeeCCeEEEEEEeccCCcccccccCc---ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC
Q 021441 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 144 (312)
Q Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~ 144 (312)
++++...+..|+||||+++++|.+++... .......+++..+..++.|++.||.|||+ .+|++|+||||+||+++.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcC
Confidence 99999999999999999999999983210 11124678899999999999999999997 145999999999999999
Q ss_pred CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhc-CCCc-ccceehhHHHHHHHHhCCCCCCCCCCCChhhH
Q 021441 145 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDL 222 (312)
Q Consensus 145 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~ 222 (312)
++.++|+|||.+...... ......++..|+|||++.+. .++. ++|||||||++|+|++|..||...... ...
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 999999999998875433 22345678889999999887 5666 999999999999999999999865442 111
Q ss_pred HHHhhhh-hhhhhh----hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 223 VELVQNS-RDFSNL----LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 223 ~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+... ..+... ...............+++++.+++.+||..||.+|||+.++++|
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 000000 00000000011114456789999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=316.18 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=197.3
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
..++|++.+.||+|+||.||+|.. .+++.+|+|.+... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 457899999999999999999995 46889999976533 34678889999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999888732 23458899999999999999999999 77999999999999999999999999987543221
Q ss_pred CcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 163 DVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
.. ......++..|+|||++. +..++.++|||||||++|+|++|..||....... ........
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-------- 237 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKS-------- 237 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS--------
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhcc--------
Confidence 11 122346788899999984 5568899999999999999999999997643211 11110000
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+..++.++.++|.+||..||.+|||+.++++|
T Consensus 238 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 238 ---DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000112234456789999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=329.29 Aligned_cols=251 Identities=12% Similarity=0.034 Sum_probs=177.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHH---HHHhcCCCccceeee-------ee
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEV---CFLASIQHRNLVTLL-------GY 70 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~---~~l~~l~h~~i~~~~-------~~ 70 (312)
..+|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3569999999999999999999 45789999998765432 3455674 45555 799988755 44
Q ss_pred eeeC-----------------CeEEEEEEeccCCcccccccCcccccccccCHHHH------HHHHHHHHHHHHHHhcCC
Q 021441 71 CQEN-----------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR------LSIALGAAKGLAHLHSLS 127 (312)
Q Consensus 71 ~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~~L~~lH~~~ 127 (312)
+... ...|+||||+. ++|.+++... ...+....+ ..++.|++.||.|||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-- 212 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQS-- 212 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHH--
Confidence 4332 33799999998 7999888432 112233334 5677999999999999
Q ss_pred CCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhh--cCCCcccceehhHHHHHHHH
Q 021441 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELV 205 (312)
Q Consensus 128 ~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~ 205 (312)
+||+||||||+||+++.++.+||+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 779999999999999999999999999998654321 13455688999999987 78999999999999999999
Q ss_pred hCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 206 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 206 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+|..||............ ...................+++++.++|.+||+.||++|||+.++++|
T Consensus 288 tg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred hCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999876433211000 000000001111111223556889999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.98 Aligned_cols=200 Identities=23% Similarity=0.265 Sum_probs=167.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCC-Cc-----cceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-HR-----NLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~ 78 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+..|+.+++.+. |+ +|+++++++...+..|
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 4789999999999999999998 4568899999886543 245667888887774 44 4999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC--CCCceEEeecccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLR 156 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~--~~~~vkl~Dfg~a 156 (312)
+||||+.+ +|.+++... ....+++..+..++.|++.||.|||.+..||+||||||+||+++ .++.+||+|||++
T Consensus 133 lv~e~~~~-~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEECCCC-BHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEecCCC-CHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999965 888877322 22457899999999999999999996447899999999999995 4778999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 216 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~ 216 (312)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 876432 2345678889999999999999999999999999999999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.35 Aligned_cols=268 Identities=19% Similarity=0.272 Sum_probs=182.4
Q ss_pred cCCCc-ccccccCcceEEEeeeeC---CceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeee--CCeEEEEE
Q 021441 9 KNFSD-KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIY 81 (312)
Q Consensus 9 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (312)
+.|++ .++||+|+||.||+|... +++.||+|.+.... ...+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44666 458999999999999844 57889999877543 4578899999999999999999999954 67899999
Q ss_pred EeccCCcccccccCcc----cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe----CCCCceEEeec
Q 021441 82 EYIPNGSVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADA 153 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~----~~~~~vkl~Df 153 (312)
||+.+ +|.+++.... ......+++..+..++.|++.||.|||+ +||+||||||+||++ +.++.+||+||
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99976 6665553111 1122348899999999999999999999 779999999999999 77889999999
Q ss_pred cccccccCCCc-CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCC-------hhhHHH
Q 021441 154 GLRNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDS-------SQDLVE 224 (312)
Q Consensus 154 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~-------~~~~~~ 224 (312)
|++........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... ...+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987643211 1223345688899999999875 48999999999999999999999997654321 111111
Q ss_pred Hhhhh--h---hhhhhh---------HHhhhhccc---------cCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 225 LVQNS--R---DFSNLL---------KILDERLWS---------TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 225 ~~~~~--~---~~~~~~---------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... + .+.... ......... ......++++.+||.+||..||.+|||++++|+|
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11100 0 000000 000000000 0011114678999999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=321.82 Aligned_cols=257 Identities=20% Similarity=0.308 Sum_probs=193.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE----
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ---- 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 77 (312)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4789999999999999999998 5578999999876432 24577899999999999999999999876554
Q ss_pred --EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 78 --FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 78 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
|+||||+.+ +|.+.+ ...+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||+
T Consensus 121 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCCE-EHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEccccc-cHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 999999975 776665 2347899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+...........+....
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 8765332 233467888999999987 6789999999999999999999999986443221111111111000000
Q ss_pred -----------hhHHhhhh---ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 -----------LLKILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 -----------~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........ .........++++.+||.+||+.||++|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 0011122345789999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=317.19 Aligned_cols=257 Identities=20% Similarity=0.311 Sum_probs=194.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCe-----
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL----- 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 76 (312)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4789999999999999999998 4578999999875432 2457789999999999999999999876643
Q ss_pred -EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 77 -QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 77 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.|+||||+.+ +|.+++. ..+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCSE-EGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEeccccC-CHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 4999999974 7776662 247889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh-
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS- 233 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 233 (312)
+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..................+...
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8765322 233467888999999887 578999999999999999999999998654321111111100000000
Q ss_pred ----------hhhHHhh---hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 ----------NLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ----------~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... ...........++++.++|.+||..||++|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 001122334557899999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=315.07 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=198.6
Q ss_pred HhcCCCcccccccCcceEEEeeee--CCceEEEEEeCCC-----CChhHHHHHHHHHhcC---CCccceeeeeeee----
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRPG-----APTQEFIDEVCFLASI---QHRNLVTLLGYCQ---- 72 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---- 72 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+.. .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 358899999999999999999985 4678999996532 2234566777777766 8999999999986
Q ss_pred -eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 73 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 73 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
.....++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCSC-BHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCCC-CHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEe
Confidence 45678999999985 88887732 123447899999999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh-
Q 021441 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR- 230 (312)
Q Consensus 152 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~- 230 (312)
|||.+....... ......++..|+|||++.+..++.++|||||||++|+|++|..||..................+
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999987654322 1233467888999999999999999999999999999999999998654322111111100000
Q ss_pred --hhhhhhH-------HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 --DFSNLLK-------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 --~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+..... .............+++.+.++|.+||..||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 000001122334556889999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=320.19 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=196.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC-----CeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5789999999999999999999 45789999998764432 3467899999999999999999987653 678
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+.+ +|.+++. ...++...+..++.|++.||.|||+ +||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~lv~e~~~~-~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQT-DLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCSE-EHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccCc-cHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 999999975 7877762 2457899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCC--------CCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhh
Q 021441 158 FLGRTDVAG--------PSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228 (312)
Q Consensus 158 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~ 228 (312)
......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 764322111 1223467889999998765 6689999999999999999999999986542211111111100
Q ss_pred hhhhhh---------hhHHhhh------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 229 SRDFSN---------LLKILDE------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 229 ~~~~~~---------~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.+.... ....... .........+++++.++|.+||..||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000000 00001123456789999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=314.38 Aligned_cols=261 Identities=19% Similarity=0.287 Sum_probs=190.4
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeee-----------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQ----------- 72 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~----------- 72 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 57899999999999999999994 4689999997655443 45778999999999999999998873
Q ss_pred ---eCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCce
Q 021441 73 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 148 (312)
Q Consensus 73 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~v 148 (312)
.....|+||||+.+ +|.+++. ...++...+..++.|++.||.|||+ +||+|+||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMET-DLANVLE------QGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCSE-EHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccCC-CHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeE
Confidence 34678999999974 8888872 2457889999999999999999999 7799999999999997 56799
Q ss_pred EEeeccccccccCCC-cCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHh
Q 021441 149 KVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~ 226 (312)
||+|||.+....... .........++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 999999988654321 1122334456788999999876 6789999999999999999999999986543211 11111
Q ss_pred hhhhhh-----hhhhH----Hhhhh------ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 227 QNSRDF-----SNLLK----ILDER------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 227 ~~~~~~-----~~~~~----~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...+.. ..+.. ..... ........+++++.++|.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 111000 00000 00000 0011123456789999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=319.28 Aligned_cols=260 Identities=17% Similarity=0.260 Sum_probs=197.9
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCC-----------Cccceeeeeeee
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQ 72 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 72 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.+. ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45789999999999999999999 4678999999886543 345778888888875 789999999987
Q ss_pred eCC----eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeC----
Q 021441 73 ENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVD---- 143 (312)
Q Consensus 73 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~---- 143 (312)
..+ ..++|||++ +++|.+++.. .....+++..+..++.|++.||.|||+ + ||+|+||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHH---hhccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCC
Confidence 643 689999999 7799888732 223458899999999999999999999 6 799999999999994
Q ss_pred --CCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChh-
Q 021441 144 --EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ- 220 (312)
Q Consensus 144 --~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~- 220 (312)
..+.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999765432 23346788999999999999999999999999999999999999865432211
Q ss_pred ---hHHHHhhhhhhhhh-----------------------------hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCC
Q 021441 221 ---DLVELVQNSRDFSN-----------------------------LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 268 (312)
Q Consensus 221 ---~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 268 (312)
.............. ...... ....++...++++.+||.+||+.||+
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCcc
Confidence 11111110000000 000001 11235677889999999999999999
Q ss_pred CCCCHHHHHHH
Q 021441 269 RRPSMSDVVTE 279 (312)
Q Consensus 269 ~Rpt~~~ll~~ 279 (312)
+|||+.++++|
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=309.25 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=199.5
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCC-----CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
...++|++.+.||+|+||.||+|.. .+++.||+|.+. ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3457899999999999999999994 468899999753 2345678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC---CceEEeecccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLR 156 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~---~~vkl~Dfg~a 156 (312)
|||++.+++|.+.+. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.+ +.++|+|||++
T Consensus 99 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999988773 33467899999999999999999999 779999999999999764 47999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||...... .....+.....
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~----- 239 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKY----- 239 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC-----
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC-----
Confidence 7654332 1223357788999999876 4899999999999999999999999764321 11111111000
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.++|.+||..||++|||+.+++++
T Consensus 240 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 -----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -----CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000112345789999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=314.51 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=197.5
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCc-eEEEEEeCCCCC--hhHHHHHHHHHhcCCCcc------ceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDG-MLVAIKKRPGAP--TQEFIDEVCFLASIQHRN------LVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~-~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~ 76 (312)
..++|++.+.||+|+||.||+|.. .++ +.||+|.+.... ...+.+|+.+++.+.|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 357899999999999999999984 344 789999886543 345778999999887655 8999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe--------------
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-------------- 142 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~-------------- 142 (312)
.|+||||+.+ ++.+.+.. .....+++..+..++.|++.||.|||+ +||+|+||||+||++
T Consensus 97 ~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELLGK-NTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECCCC-BHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEeccCC-ChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999955 55555521 222458899999999999999999999 779999999999999
Q ss_pred -----CCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 021441 143 -----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 217 (312)
Q Consensus 143 -----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~ 217 (312)
+.++.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999998764322 23456888999999999999999999999999999999999999865432
Q ss_pred ChhhHHHHhhhhhhhhhhhH----------------------Hhhh-----hccccCChHHHHHHHHHHHHhcCCCCCCC
Q 021441 218 SSQDLVELVQNSRDFSNLLK----------------------ILDE-----RLWSTFTNEGMEEFIQLIVRCLDPSSERR 270 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (312)
.............+...... .... ..........+.++.+||.+||..||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 22211111111100000000 0000 00111233446789999999999999999
Q ss_pred CCHHHHHHH
Q 021441 271 PSMSDVVTE 279 (312)
Q Consensus 271 pt~~~ll~~ 279 (312)
||+.++++|
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=315.95 Aligned_cols=253 Identities=17% Similarity=0.214 Sum_probs=173.1
Q ss_pred hcCCCccc-ccccCcceEEEeeee-CCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeee----CCeEEEEE
Q 021441 8 TKNFSDKN-LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 81 (312)
.++|.+.+ .||+|+||.||+|.. .+++.||+|.+... .....+....++.+.||||+++++++.. ....|+||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 57788854 699999999999994 47899999987543 2222333344566789999999999875 44589999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeecccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF 158 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~~ 158 (312)
||+.+++|.+++... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||.+..
T Consensus 106 e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 106 ECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred eccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999988422 23468899999999999999999999 77999999999999986 44599999999876
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .....+++.|+|||++.+..++.++|||||||++|+|++|..||................. .
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~ 247 (336)
T 3fhr_A 181 TTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR---------L 247 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh---------c
Confidence 54322 2334568889999999888899999999999999999999999976543322110000000 0
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
............+++++.++|.+||..||.+|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00011111223456789999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=309.28 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=190.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeee-----------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQE----------- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 73 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4679999999999999999999 457899999987543 23467889999999999999999998754
Q ss_pred --CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEe
Q 021441 74 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151 (312)
Q Consensus 74 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~ 151 (312)
....|+||||+++++|.+++.. ....++...+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999842 23456788899999999999999999 779999999999999999999999
Q ss_pred eccccccccCCCc------------CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCC
Q 021441 152 DAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDS 218 (312)
Q Consensus 152 Dfg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~ 218 (312)
|||.+........ ........++..|+|||++.+. .++.++|||||||++|+|++ ||.... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence 9999876542210 1112334578889999999865 68999999999999999998 443211 0
Q ss_pred hhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 219 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......... ..........+...++.+.+++.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR----------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH----------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc----------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 000010000 011122233455566789999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=317.20 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=197.8
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCC--Cccceeeeeeee
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQ 72 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 72 (312)
....++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.+. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999998 557899999975432 2245677999999986 599999999999
Q ss_pred eCCeEEEEEEeccC-CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEE
Q 021441 73 ENNLQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKV 150 (312)
Q Consensus 73 ~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl 150 (312)
..+..++|||++.+ ++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++ .++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999975 78988873 34567899999999999999999999 7799999999999999 7899999
Q ss_pred eeccccccccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh
Q 021441 151 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229 (312)
Q Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 229 (312)
+|||++....... .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~-- 257 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIR-- 257 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH--
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhhc--
Confidence 9999988765332 233468888999999988776 788999999999999999999996421 0000
Q ss_pred hhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ....+..+++++.++|.+||..||++|||+++++++
T Consensus 258 -----------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 -----------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------c--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011233455789999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=317.01 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=180.8
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh----hHHHHHHH-HHhcCCCccceeeeeeeeeCCe
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT----QEFIDEVC-FLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~----~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
.|.+..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+..|+. +++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 3556778999999999999999999994 5789999998754432 23444555 6777899999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeeccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.|+||||+.+ +|.+++..........+++..+..++.|++.||.|||+ + |++|+||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 9999999986 76666532111224568899999999999999999999 6 799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhh----hhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 231 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 231 (312)
+....... ......++..|+|||++ .+..++.++|||||||++|+|++|..||........ ...
T Consensus 173 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~---- 240 (327)
T 3aln_A 173 SGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT---- 240 (327)
T ss_dssp SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C----
T ss_pred ceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH----
Confidence 87654322 12233678889999998 456789999999999999999999999976432110 000
Q ss_pred hhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.................+++++.+++.+||..||++|||+.+++++
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 --QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000000111111223456789999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=312.46 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=190.6
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---------hHHHHHHHHHhcC----CCccceeeeee
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---------QEFIDEVCFLASI----QHRNLVTLLGY 70 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---------~~~~~e~~~l~~l----~h~~i~~~~~~ 70 (312)
....++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999998 45688999998754422 2345688888888 89999999999
Q ss_pred eeeCCeEEEEEEe-ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCce
Q 021441 71 CQENNLQFLIYEY-IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 148 (312)
Q Consensus 71 ~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~v 148 (312)
+...+..++|||+ +.+++|.+++. ....+++..+..++.|++.||.|||+ +||+|+||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeE
Confidence 9988889999999 78889998883 34458899999999999999999999 6799999999999999 88999
Q ss_pred EEeeccccccccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 149 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 149 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
+|+|||.+....... .....++..|+|||++.+..+ +.++|||||||++|+|++|..||.... ...
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL- 246 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH-
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh-
Confidence 999999988765432 233457888999999987776 458999999999999999999996421 000
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ...++..+++++.++|.+||..||++|||+.++++|
T Consensus 247 ------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ------------EA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------------HT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------hh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 112344556789999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=322.81 Aligned_cols=256 Identities=19% Similarity=0.254 Sum_probs=188.6
Q ss_pred cCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEeccCC
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNG 87 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (312)
+.|.+.+.||+|+||+||.+...+++.||+|.+.....+.+.+|+.+++.+ +||||+++++++...+..|+||||+. +
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 344557889999999998777667899999987766667788999999876 89999999999999999999999996 5
Q ss_pred cccccccCcccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-------------CceEEee
Q 021441 88 SVSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-------------FIAKVAD 152 (312)
Q Consensus 88 ~L~~~~~~~~~~~~--~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-------------~~vkl~D 152 (312)
+|.+++........ ....+..+..++.|++.||.|||+ +||+||||||+||+++.+ +.++|+|
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99888843321110 111223356799999999999999 779999999999999754 4899999
Q ss_pred ccccccccCCCcC--CCCccccCcccccchhhhhh-------cCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhH
Q 021441 153 AGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 222 (312)
Q Consensus 153 fg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~ 222 (312)
||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 9999876543211 11234468889999999976 568999999999999999999 999996543211
Q ss_pred HHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......... ...........++++.++|.+||..||.+|||+.++++|
T Consensus 248 ~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111111000 011112245667899999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.52 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=188.8
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEEEec
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
+...+|.+.+.||+|+||.||.....+++.||+|.+.........+|+.+++.+ +||||+++++++.+....|+||||+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 445678999999999999977655666889999998777667778999999999 7999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC-----CceEEeeccccccc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAGLRNFL 159 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~-----~~vkl~Dfg~a~~~ 159 (312)
.+ +|.+++.... .......+..++.|++.||.|||+ +||+||||||+||+++.+ ..++|+|||++...
T Consensus 101 ~g-~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 AA-TLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp SE-EHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 75 8888874322 122333456799999999999999 779999999999999532 25789999999876
Q ss_pred cCCCc-CCCCccccCcccccchhhhh---hcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 160 GRTDV-AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 160 ~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
..... ........+|+.|+|||++. +..++.++|||||||++|+|++ |..||....... ..........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~~~~~-- 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSL-- 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTTCCCC--
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhccCCc--
Confidence 53321 12233456899999999987 4567889999999999999999 999996432211 1111000000
Q ss_pred hhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+.+||.+||+.||.+|||+.++++|
T Consensus 248 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 --------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp --------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0011123445678999999999999999999999954
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.39 Aligned_cols=231 Identities=13% Similarity=0.036 Sum_probs=183.7
Q ss_pred HhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+|+.++..++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 347899999999999999999994 4689999998765432 567889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++++|.+++.. . .....+..++.|++.||.|||+ +||+||||||+||+++.+|.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999998831 1 2445678899999999999999 779999999999999999999998653
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhH-HHHhhhhhhhhhhhHH
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL-VELVQNSRDFSNLLKI 238 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (312)
|++ .++.++|||||||++|+|++|..||........... .......
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------- 221 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ--------- 221 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC---------
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC---------
Confidence 222 368899999999999999999999987554321100 0000000
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..........+++++.++|.+||..||.+| |+.++++.|++.....
T Consensus 222 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 222 --PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000011223445789999999999999999 9999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=306.58 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=179.2
Q ss_pred hHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCCChh-----HHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
....++|++.+.||+|+||.||+|.. .+++.||+|.+...... .+.++..+++.++||||+++++++...+..|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 34567899999999999999999994 47889999987544321 2334445677889999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~-givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
+||||+ ++++..+.. .....+++..+..++.|++.||.|||+ + |++|+||||+||+++.++.++|+|||.+.
T Consensus 101 lv~e~~-~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEECCC-SEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEecc-CCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 999999 445544431 123567899999999999999999998 4 69999999999999999999999999987
Q ss_pred cccCCCcCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
...... ......+++.|+|||++. +..++.++|||||||++|+|++|..||...... ..........
T Consensus 174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~--- 245 (318)
T 2dyl_A 174 RLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQE--- 245 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHS---
T ss_pred hccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhcc---
Confidence 654322 122345788899999984 456889999999999999999999999753321 1111111000
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..........+++++.++|.+||..||.+|||+.++++|
T Consensus 246 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 --------EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000011112345789999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.00 Aligned_cols=272 Identities=19% Similarity=0.232 Sum_probs=201.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeee------CC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NN 75 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 75 (312)
..++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+|+.+++.++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 45889999999999999999999 4568999999876542 2457789999999999999999998754 66
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCc---eEEee
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVAD 152 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~---vkl~D 152 (312)
..|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++. ++|+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred eEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 7799999999999999885322 22357788899999999999999999 77999999999999997764 99999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh---
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--- 229 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~--- 229 (312)
||.+....... ......++..|+|||++.+..++.++|||||||++|+|++|..||....... .........
T Consensus 168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~--~~~~~i~~~~~~ 242 (676)
T 3qa8_A 168 LGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--QWHGKVREKSNE 242 (676)
T ss_dssp CCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH--HSSTTCC-----
T ss_pred ccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh--hhhhhhhcccch
Confidence 99998764432 2234568889999999999999999999999999999999999996532100 000000000
Q ss_pred --hhhhhhhHH----hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHHHHHHh
Q 021441 230 --RDFSNLLKI----LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD-----VVTELDRTLDKE 287 (312)
Q Consensus 230 --~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~-----ll~~l~~~~~~~ 287 (312)
......... ............+++.+.++|.+||..||++|||+.+ +.+.++.+++..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000000 0001123355667899999999999999999999988 567777777654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=322.34 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=193.0
Q ss_pred hcCCCcccccccCcceEEEeeeeC--CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe-----
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL----- 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 76 (312)
.++|++.+.||+|+||.||++... +++.||+|.+..... ..+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999853 588999998764332 346789999999999999999999987655
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||+++++|.+++. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999987762 258899999999999999999999 779999999999999985 8999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...... ....+|+.|+|||++.+. ++.++|||||||++|+|++|..||..........
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~--------------- 286 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE--------------- 286 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT---------------
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc---------------
Confidence 865432 345688899999998765 4889999999999999999999886532211100
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHHHh
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKE 287 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~~ll~~l~~~~~~~ 287 (312)
.......++.+.++|.+||..||.+|| +++++.+.|...+.+.
T Consensus 287 --------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 287 --------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp --------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred --------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 000011236789999999999999999 5677778888777554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=293.55 Aligned_cols=228 Identities=18% Similarity=0.234 Sum_probs=177.7
Q ss_pred hcCCCcc-cccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHH-hcCCCccceeeeeeeee----CCeEEEE
Q 021441 8 TKNFSDK-NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLLGYCQE----NNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv 80 (312)
.++|.+. +.||+|+||.||+|. ..+++.||+|.+.. .....+|+.++ +..+||||+++++++.. ....|+|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4667776 789999999999998 45788999998754 45667888887 55689999999999876 6678999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~ 157 (312)
|||+++++|.+++.. .....+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++.
T Consensus 94 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 94 MECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp ECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999988842 223468899999999999999999999 77999999999999998 7899999999886
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
... +..++.++|||||||++|+|++|..||............ ..
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------~~ 212 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------KT 212 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------CC
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------HH
Confidence 432 134677899999999999999999999764432110000 00
Q ss_pred HhhhhccccCC----hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFT----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
..... ....+ ..+++++.+++.+||..||++|||+.++++|
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 00111 2345789999999999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.30 Aligned_cols=241 Identities=12% Similarity=0.091 Sum_probs=177.2
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHHHHHHHhcCCC-ccceee---------e---
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQH-RNLVTL---------L--- 68 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h-~~i~~~---------~--- 68 (312)
++|++.+.||+|+||.||+|. ..+++.||||++... ..+.+.+|+.+++.+.| +|.... .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457788999999999999999 567899999976522 23568889999999876 321111 1
Q ss_pred ---------eeeee-----CCeEEEEEEeccCCcccccccCcc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 021441 69 ---------GYCQE-----NNLQFLIYEYIPNGSVSIHLYGPS--QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132 (312)
Q Consensus 69 ---------~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH 132 (312)
.++.. ....+++|+.+ +++|.+++.... ......+++..+..++.|++.||.|||+ +||+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiH 234 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVH 234 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccc
Confidence 11111 22356777766 568887773110 1124457788889999999999999999 77999
Q ss_pred cCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhh----------hhcCCCcccceehhHHHHH
Q 021441 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK----------EFRRFSEKSDVYSFGVFLL 202 (312)
Q Consensus 133 ~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDiwslG~vl~ 202 (312)
|||||+|||++.++.+||+|||++...... .....+ +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998765433 122345 779999999 4555788999999999999
Q ss_pred HHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 203 ELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 203 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+|++|..||.......... .+.. ....+++++.++|.+||+.||++|||+.+++++
T Consensus 309 elltg~~Pf~~~~~~~~~~---------------~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE---------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG---------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhhHH---------------HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999997643221110 0000 111335789999999999999999999988754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.36 Aligned_cols=240 Identities=18% Similarity=0.180 Sum_probs=180.9
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCC---------Cccce-
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQ---------HRNLV- 65 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~---------h~~i~- 65 (312)
..++|++.+.||+|+||.||+|+. +++.||+|.+.... ...+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 457899999999999999999998 57999999765332 267888999988885 55554
Q ss_pred ----------------eeeeeeee-------------CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHH
Q 021441 66 ----------------TLLGYCQE-------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116 (312)
Q Consensus 66 ----------------~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i 116 (312)
++++++.. .+..|+||||+.+|++.+.+. ...+++..+..++.|+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHH
Confidence 44444443 678999999999987666552 2457899999999999
Q ss_pred HHHHHHHh-cCCCCeEecCCCCCceEeCCCC--------------------ceEEeeccccccccCCCcCCCCccccCcc
Q 021441 117 AKGLAHLH-SLSPRVVHKDFKTANVLVDEDF--------------------IAKVADAGLRNFLGRTDVAGPSSQVTADE 175 (312)
Q Consensus 117 ~~~L~~lH-~~~~givH~dikp~Nil~~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~ 175 (312)
+.||.||| + +||+||||||+|||++.++ .+||+|||+++..... ...+|+
T Consensus 171 ~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 99999999 8 6799999999999999887 9999999999876432 346888
Q ss_pred cccchhhhhhcCCCcccceehhHHH-HHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH--hhhhccccCChHHH
Q 021441 176 IFLASEVKEFRRFSEKSDVYSFGVF-LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI--LDERLWSTFTNEGM 252 (312)
Q Consensus 176 ~y~aPE~~~~~~~~~~sDiwslG~v-l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 252 (312)
.|+|||++.+.. +.++||||||++ .+++++|..||... ....... ..+... ............++
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLT-----DKMLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHH-----HHHHHTCCCSSCCCSHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHH-----HhhhhhhccCcccchhhhhhcC
Confidence 999999998776 899999998777 78889999888320 0000000 000000 00111112234577
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHH-HH
Q 021441 253 EEFIQLIVRCLDPSSERRPSMSDVV-TE 279 (312)
Q Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll-~~ 279 (312)
+++.+||.+||..| |+.+++ +|
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHHhccC-----CHHHHHhcC
Confidence 89999999999987 999988 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-34 Score=261.79 Aligned_cols=181 Identities=17% Similarity=0.047 Sum_probs=124.9
Q ss_pred cccCcceEEEeee-eCCceEEEEEeCCCCC-------------hhHHHHHHHHHhcC-CCccceeeeeeeeeCCeEEEEE
Q 021441 17 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-------------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 17 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-------------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
.+.|+.|.+..++ ...++.+++|.+.... ..++.+|+++|+++ .|+||+++++++.+.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666665 3457789999754321 13588899999999 6999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||++|++|.+++. ....++.. +|+.||+.||.|+|+ +|||||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~-----~~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLA-----AGEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHH-----TTCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHH-----hCCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999994 33445543 588999999999999 7799999999999999999999999999986643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCC
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 210 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~p 210 (312)
.. .......||+.|+|||++.+. +..++|+||+|+++++|.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 32 123345699999999999864 56789999999998887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-29 Score=228.74 Aligned_cols=182 Identities=19% Similarity=0.196 Sum_probs=139.3
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCC-----------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
..+.||+|+||.||++... ++.+++|...... .+.+.+|+++++.++||||+++..++......|+||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3568999999999999644 5678888643221 123688999999999999996655555666779999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++++|.+++.. +..++.|++.+|.|||+ +||+||||||+||+++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999998832 45799999999999999 77999999999999999 999999999987654
Q ss_pred CCcCC-----CCccccCcccccchhhhhh--cCCCcccceehhHHHHHHHHhCCCCCC
Q 021441 162 TDVAG-----PSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASS 212 (312)
Q Consensus 162 ~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~vl~~l~tg~~pf~ 212 (312)
..... ......+|+.|+|||++.+ ..|+..+|+||..+-..+.+.+..+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 22110 0124568899999999987 678889999999888888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=191.52 Aligned_cols=156 Identities=17% Similarity=0.077 Sum_probs=121.3
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---------------------hhHHHHHHHHHhcCCCccce
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQHRNLV 65 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~e~~~l~~l~h~~i~ 65 (312)
....|.+.+.||+|+||.||+|...+++.||+|...... ...+.+|+.+++.++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 345566779999999999999998778999999865321 235789999999998 4 6
Q ss_pred eeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC
Q 021441 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 145 (312)
Q Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~ 145 (312)
++.+++.. +..|+||||+++++|.+ +. . .....++.|++.||.|||+ .||+||||||+||+++ +
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VR-----V------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CC-----C------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE-T
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cc-----h------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHEEEE-C
Confidence 66665544 45699999999999987 41 1 1134689999999999999 7799999999999999 9
Q ss_pred CceEEeeccccccccCCCcCCCCccccCcccccchhhhhh----------cCCCcccceeh
Q 021441 146 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----------RRFSEKSDVYS 196 (312)
Q Consensus 146 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~sDiws 196 (312)
+.++|+|||++... ..+.|||++.. ..|+..+|+|+
T Consensus 229 ~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999998632 12688998764 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-21 Score=162.84 Aligned_cols=133 Identities=18% Similarity=0.115 Sum_probs=100.5
Q ss_pred CCcccccccCcceEEEeeee-CCceE--EEEEeCCCCCh---------------------------hHHHHHHHHHhcCC
Q 021441 11 FSDKNLIGEGKFGEVYKGLL-QDGML--VAIKKRPGAPT---------------------------QEFIDEVCFLASIQ 60 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~---------------------------~~~~~e~~~l~~l~ 60 (312)
|.+.+.||+|+||.||+|.. .+++. ||+|....... ..+.+|..++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999996 67888 99997433210 24678999999998
Q ss_pred Cccc--eeeeeeeeeCCeEEEEEEeccC-C----cccccccCcccccccccCHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 021441 61 HRNL--VTLLGYCQENNLQFLIYEYIPN-G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVH 132 (312)
Q Consensus 61 h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH-~~~~givH 132 (312)
|+++ +.+++. ...++||||+.+ | +|.+... ..+...+..++.|++.+|.+|| . .||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~--~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQE--AELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence 7753 334432 245899999942 3 3433321 1123346789999999999999 8 77999
Q ss_pred cCCCCCceEeCCCCceEEeeccccccc
Q 021441 133 KDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 133 ~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=154.39 Aligned_cols=131 Identities=15% Similarity=0.145 Sum_probs=93.4
Q ss_pred CCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----------------hhHH--------HHHHHHHhcCCCccc
Q 021441 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------------TQEF--------IDEVCFLASIQHRNL 64 (312)
Q Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------------~~~~--------~~e~~~l~~l~h~~i 64 (312)
=|.+.+.||.|++|.||+|...+|+.||||+..... .... .+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999998789999999643210 0111 234455555533222
Q ss_pred --eeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEe
Q 021441 65 --VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 142 (312)
Q Consensus 65 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~ 142 (312)
...++. . ..++||||+.|.+|..+.. . .....++.|++.+|.+||+ +|||||||||.|||+
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-----~------~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-----V------PDPASLYADLIALILRLAK--HGLIHGDFNEFNILI 238 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCC-----C------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcc-----c------HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEE
Confidence 112221 1 2369999999988865541 1 1124578999999999999 779999999999999
Q ss_pred CCCC----------ceEEeeccccc
Q 021441 143 DEDF----------IAKVADAGLRN 157 (312)
Q Consensus 143 ~~~~----------~vkl~Dfg~a~ 157 (312)
++++ .+.|+||+-+-
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCE
T ss_pred eCCCCcccccccccceEEEEeCCcc
Confidence 8877 48999998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-13 Score=114.54 Aligned_cols=142 Identities=13% Similarity=0.077 Sum_probs=111.1
Q ss_pred hHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCC---CChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (312)
.-....|++...++.|+.+.||++... ++.+++|.... .....+.+|..+++.+. +..+.++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334578988899998999999999855 57899998764 34456889999999884 66788899999888899999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS--------------------------------- 127 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--------------------------------- 127 (312)
||+++|.++.+.... ......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999888765310 0112357888999999999721
Q ss_pred ------------------------CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 128 ------------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 128 ------------------------~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876667799998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.41 E-value=6.5e-13 Score=110.26 Aligned_cols=136 Identities=17% Similarity=0.162 Sum_probs=99.3
Q ss_pred cCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCCcc--ceeeeeeeeeCCeEEEEEEeccC
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
.+|.+....+.|..+.||++...+++.+++|.........+..|..+++.+.+.. +.+++++....+..|+|||+++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3455444434566799999987667789999876655566788999998885433 56688888877788999999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS--------------------------------------- 127 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--------------------------------------- 127 (312)
.++. .. . .. ...++.+++..|..||+..
T Consensus 100 ~~l~--~~-----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 100 QDLL--SS-----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp EETT--TS-----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cccC--cC-----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 8874 21 0 01 1245677777777777632
Q ss_pred -----------------CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 128 -----------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 128 -----------------~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999887667799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.2e-11 Score=105.01 Aligned_cols=140 Identities=14% Similarity=0.222 Sum_probs=104.8
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCC--CCC----hhHHHHHHHHHhcCC--CccceeeeeeeeeC---CeEEE
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAP----TQEFIDEVCFLASIQ--HRNLVTLLGYCQEN---NLQFL 79 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~----~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~l 79 (312)
....+.|+.|.++.||++...+ ..+++|... ... ...+.+|..+++.+. +..+++++.++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3446788999999999998654 578889776 322 346788999999886 34578888887765 44789
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--------------------------------- 126 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~--------------------------------- 126 (312)
|||+++|..+.+.. ...++......++.+++..|..||+.
T Consensus 119 vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 99999998775422 12345677778899999999999973
Q ss_pred -----------------------CCCeEecCCCCCceEeCCCCc--eEEeecccccc
Q 021441 127 -----------------------SPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF 158 (312)
Q Consensus 127 -----------------------~~givH~dikp~Nil~~~~~~--vkl~Dfg~a~~ 158 (312)
..+++|+|++|.||+++.++. +.++||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=3.9e-11 Score=101.98 Aligned_cols=184 Identities=18% Similarity=0.177 Sum_probs=114.0
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCC-Ccc--ceeeeeeeeeCC---eEEEEEEeccC
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ-HRN--LVTLLGYCQENN---LQFLIYEYIPN 86 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~ 86 (312)
++.++.|....||++. ..+++|..... ....+.+|..+++.+. +.. +.+++....... ..|+||++++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 5668999999999885 35888975543 2356788999998873 322 344444433332 34899999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---------------------------------------- 126 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~---------------------------------------- 126 (312)
.++..... ..++......++.+++..+..||+.
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88764321 2234445555666666666666641
Q ss_pred ----------------CCCeEecCCCCCceEeCC--CCceEEeeccccccccCCCcCCCCccccCcccccchhhhhh--c
Q 021441 127 ----------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--R 186 (312)
Q Consensus 127 ----------------~~givH~dikp~Nil~~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~ 186 (312)
...++|+|++|.||+++. ++.+.++||+.+................ . -..|+.... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~--~-~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD--E-EYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT--T-SCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc--c-ccCHHHHHHHHH
Confidence 124899999999999998 5667999999876542211000000000 0 012221110 0
Q ss_pred CC------------CcccceehhHHHHHHHHhCCCCC
Q 021441 187 RF------------SEKSDVYSFGVFLLELVSGREAS 211 (312)
Q Consensus 187 ~~------------~~~sDiwslG~vl~~l~tg~~pf 211 (312)
.| ....+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 12358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=2.8e-08 Score=82.71 Aligned_cols=133 Identities=22% Similarity=0.227 Sum_probs=92.7
Q ss_pred ccccCcce-EEEeeee-CCceEEEEEeCCCCChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEeccCCccccc
Q 021441 16 LIGEGKFG-EVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 92 (312)
Q Consensus 16 ~lg~G~~g-~V~~~~~-~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (312)
.+..|..+ .||+... ..+..+++|.........+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34445544 6898874 446679999877766777889999998884 32367788888888899999999999776543
Q ss_pred ccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 021441 93 LYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS--------------------------------------------- 127 (312)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~--------------------------------------------- 127 (312)
... .......+..++...|..||...
T Consensus 111 ~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 111 LEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 310 00111234445555555555320
Q ss_pred -----------CCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 128 -----------PRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 128 -----------~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999988777899998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=8.9e-08 Score=81.21 Aligned_cols=74 Identities=12% Similarity=0.057 Sum_probs=53.2
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCc---cceeeeeeee-eCCeEEEEEEeccCCc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQ-ENNLQFLIYEYIPNGS 88 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~ 88 (312)
++.++.|....||++ +..+++|..... ....+..|..+++.+.+. .+.+++.+.. ..+..|+||++++|..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 567888988999998 456888875332 235678899999998642 2556666653 3455789999999987
Q ss_pred ccc
Q 021441 89 VSI 91 (312)
Q Consensus 89 L~~ 91 (312)
+..
T Consensus 100 l~~ 102 (306)
T 3tdw_A 100 LGE 102 (306)
T ss_dssp CHH
T ss_pred Cch
Confidence 764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=1.9e-07 Score=80.90 Aligned_cols=78 Identities=9% Similarity=0.026 Sum_probs=55.8
Q ss_pred cccc-ccCcceEEEeeeeC-------CceEEEEEeCCCCC------hhHHHHHHHHHhcCC-C--ccceeeeeeeeeC--
Q 021441 14 KNLI-GEGKFGEVYKGLLQ-------DGMLVAIKKRPGAP------TQEFIDEVCFLASIQ-H--RNLVTLLGYCQEN-- 74 (312)
Q Consensus 14 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~------~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~-- 74 (312)
.+.| +.|....+|++... +++.+++|...... ...+..|..+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998753 25678999765432 256788888888874 2 3467777776554
Q ss_pred -CeEEEEEEeccCCcccc
Q 021441 75 -NLQFLIYEYIPNGSVSI 91 (312)
Q Consensus 75 -~~~~lv~e~~~~~~L~~ 91 (312)
+..|+|||+++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.38 E-value=2.7e-06 Score=72.99 Aligned_cols=74 Identities=18% Similarity=0.352 Sum_probs=44.1
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCC--ccceeeee------eeeeCCeEEEEEEecc
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLG------YCQENNLQFLIYEYIP 85 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~------~~~~~~~~~lv~e~~~ 85 (312)
.+.|+.|..+.||++...++ .+++|.... ....+..|..+++.+.. -.+.+++. +....+..|++|+|++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 34566677889999987655 489998765 33444556666665531 12334433 1234567899999999
Q ss_pred CCcc
Q 021441 86 NGSV 89 (312)
Q Consensus 86 ~~~L 89 (312)
|..+
T Consensus 115 G~~~ 118 (346)
T 2q83_A 115 GRPF 118 (346)
T ss_dssp CBCC
T ss_pred CccC
Confidence 8655
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4e-06 Score=73.64 Aligned_cols=73 Identities=14% Similarity=0.076 Sum_probs=48.0
Q ss_pred cccccccCcceEEEeeeeC-CceEEEEEeCCCC----------ChhHHHHHHHHHhcCCC--c-cceeeeeeeeeCCeEE
Q 021441 13 DKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----------PTQEFIDEVCFLASIQH--R-NLVTLLGYCQENNLQF 78 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~----------~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~ 78 (312)
-.+.||.|..+.||++... +++.+++|..... .......|.++++.+.. + .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3578999999999999743 4678999964321 23456778888887632 3 34455544 334457
Q ss_pred EEEEeccCC
Q 021441 79 LIYEYIPNG 87 (312)
Q Consensus 79 lv~e~~~~~ 87 (312)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.24 E-value=7.4e-06 Score=69.36 Aligned_cols=76 Identities=18% Similarity=0.159 Sum_probs=60.7
Q ss_pred cccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCC---CccceeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 13 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
-.+.|+.|....+|++... +..+++|.........+..|...|+.+. ...+++++.+....+..|+|||++++..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3577899999999999864 5678899876555667888988888873 35678888888777889999999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.8e-05 Score=65.12 Aligned_cols=79 Identities=16% Similarity=0.203 Sum_probs=56.4
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC---hhHHHHHHHHHhcCCC---ccceeeeeeeeeCCeEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQH---RNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv 80 (312)
......-++.+|.|..+.||++...+|+.|.+|...... ...+..|...|+.+.. --+.+++++. . -++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 345566678899999999999998889999999865433 3457889998888742 1244455442 2 3689
Q ss_pred EEeccCCcc
Q 021441 81 YEYIPNGSV 89 (312)
Q Consensus 81 ~e~~~~~~L 89 (312)
||++.+...
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999976543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.02 E-value=3.4e-05 Score=65.56 Aligned_cols=143 Identities=10% Similarity=0.008 Sum_probs=77.7
Q ss_pred ccccccCcceEEEeeeeCCceEEEEEeCCC-CChhHHHHHHHHHhcCCCcc--ceeeeee------eeeCCeEEEEEEec
Q 021441 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRN--LVTLLGY------CQENNLQFLIYEYI 84 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~ 84 (312)
.+.|+.|....+|++...++ .+++|.... .....+..|..++..+.... +.+++.. ....+..+++++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 35566788889999986545 588998765 24456677888777763211 3333321 12345678999999
Q ss_pred cCCccccc--------------ccCc----ccccccccCHHHHHHH---------------HHHHHHHHHHHhc-----C
Q 021441 85 PNGSVSIH--------------LYGP----SQVSRQKLEFKHRLSI---------------ALGAAKGLAHLHS-----L 126 (312)
Q Consensus 85 ~~~~L~~~--------------~~~~----~~~~~~~~~~~~~~~i---------------~~~i~~~L~~lH~-----~ 126 (312)
+|..+... ++.. ................ ...+...+..+.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 98665321 0000 0000000011100000 0012233344432 1
Q ss_pred CCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 127 ~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
..+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2469999999999999987666899998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.2e-05 Score=67.12 Aligned_cols=75 Identities=5% Similarity=-0.019 Sum_probs=40.2
Q ss_pred ccccccCcceE-EEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCC-C-ccceeeeeeeeeCCeEEEEEEeccCCccc
Q 021441 14 KNLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-H-RNLVTLLGYCQENNLQFLIYEYIPNGSVS 90 (312)
Q Consensus 14 ~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (312)
.+.|+.|.... +|++...++..+++|.........+..|..+++.+. + -.+.+++.+....+ +++||++.+..+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 45566665444 677765435667888765543244556677766663 2 23556665543333 6899998765553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.3e-05 Score=67.00 Aligned_cols=30 Identities=27% Similarity=0.513 Sum_probs=26.9
Q ss_pred CCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 128 ~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
..++|+|++|.||+++.++ +.++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 6799999999999999877 99999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=65.11 Aligned_cols=73 Identities=19% Similarity=0.209 Sum_probs=50.1
Q ss_pred ccccccCcceEEEeeeeCC--------ceEEEEEeCCCCCh-hHHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEEEe
Q 021441 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT-QEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~-~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 83 (312)
++.|+.|....+|++...+ +..+++|+...... ..+..|..+++.+...+ ..++++.+.+ .+|++|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 4567788889999998542 46899998754233 66678988888874323 3556665442 289999
Q ss_pred ccCCccc
Q 021441 84 IPNGSVS 90 (312)
Q Consensus 84 ~~~~~L~ 90 (312)
++|.++.
T Consensus 154 l~G~~l~ 160 (429)
T 1nw1_A 154 IPSRPLS 160 (429)
T ss_dssp CCEEECC
T ss_pred eCCcccC
Confidence 9875553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00053 Score=58.24 Aligned_cols=74 Identities=9% Similarity=0.154 Sum_probs=49.2
Q ss_pred cccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCC--ccceeeeee-----eeeCCeEEEEEEecc
Q 021441 15 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQH--RNLVTLLGY-----CQENNLQFLIYEYIP 85 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~-----~~~~~~~~lv~e~~~ 85 (312)
..++ |....||++...+++.+++|..... ....+..|..+++.+.. -.+++++.. ....+..+++|++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 7778999988766767999987643 45567778888877732 123444432 223456688999998
Q ss_pred CCcc
Q 021441 86 NGSV 89 (312)
Q Consensus 86 ~~~L 89 (312)
|..+
T Consensus 111 G~~~ 114 (328)
T 1zyl_A 111 GRQF 114 (328)
T ss_dssp CEEC
T ss_pred CCCC
Confidence 8654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00014 Score=61.24 Aligned_cols=73 Identities=10% Similarity=0.057 Sum_probs=45.2
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh--hHHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEec-cC
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYI-PN 86 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~ 86 (312)
+.-.+.|+.|....+|++ ..+++|....... .....|..+++.+....+ .+++....+ .-++++||+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 333788888999999999 3588897654321 223567777776632222 455554332 345899999 76
Q ss_pred Cccc
Q 021441 87 GSVS 90 (312)
Q Consensus 87 ~~L~ 90 (312)
.++.
T Consensus 93 ~~l~ 96 (301)
T 3dxq_A 93 QTMS 96 (301)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00023 Score=63.43 Aligned_cols=73 Identities=14% Similarity=0.043 Sum_probs=47.2
Q ss_pred ccccccCcceEEEeeeeCC-ceEEEEEeCCCCChh--HHHHHHHHHhcCCCccc-eeeeeeeeeCCeEEEEEEeccCCcc
Q 021441 14 KNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSV 89 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 89 (312)
++.|+.|-...+|++...+ +..+++|+....... ....|..++..+...++ .++++.+. +. .|++|++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence 4567788889999998654 477899976443221 22578888888854444 55666653 22 59999988655
Q ss_pred c
Q 021441 90 S 90 (312)
Q Consensus 90 ~ 90 (312)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=9.8e-05 Score=58.14 Aligned_cols=142 Identities=15% Similarity=0.079 Sum_probs=89.1
Q ss_pred cccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCcCCC
Q 021441 88 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 167 (312)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~ 167 (312)
+|.+++. ....+++++.+|.++.|.+.+|.-.-.. +.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~----~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILR----LYNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHH----HcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 5666662 3457899999999999999998776210 1112334567899999999988875 1111
Q ss_pred CccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccC
Q 021441 168 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247 (312)
Q Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (312)
.....+.+||... ...+.+.=|||||+++|.-+-...|- ..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e----------------------------------~e 138 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE----------------------------------NE 138 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------------------TE
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc----------------------------------cc
Confidence 0111266777653 33456778999999999988755442 11
Q ss_pred ChHHHHHHHHHHHHhcCC-------------------------CCCCCCCHHHHHHHHHHHH
Q 021441 248 TNEGMEEFIQLIVRCLDP-------------------------SSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 248 ~~~~~~~l~~li~~~l~~-------------------------dp~~Rpt~~~ll~~l~~~~ 284 (312)
...+++.|..||..|.+- .+..|++.+++++.-+.-+
T Consensus 139 E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 139 ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 222346778888888755 2457888888887665443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00022 Score=61.95 Aligned_cols=144 Identities=13% Similarity=0.112 Sum_probs=82.0
Q ss_pred cCCCcccccccCcceEEEeeeeC--------CceEEEEEeCCCC--ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (312)
+..+ .+.|..|-...+|++... +++.+++|+.... ......+|..+++.+. +.-..++++.+.++
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--- 126 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--- 126 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE---
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc---
Confidence 3344 456767888899999853 2468999986442 3456678988888774 32335666655432
Q ss_pred EEEEEeccCCcccccc-cC----------------ccccccccc--CHHHHHHHHHHHHH-------------------H
Q 021441 78 FLIYEYIPNGSVSIHL-YG----------------PSQVSRQKL--EFKHRLSIALGAAK-------------------G 119 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~-~~----------------~~~~~~~~~--~~~~~~~i~~~i~~-------------------~ 119 (312)
+||||++|.++..-- .. ......... .+..+.++..++.. .
T Consensus 127 -~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 127 -RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp -EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred -cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 899999986664211 00 000001111 13344444443321 1
Q ss_pred HH----HHhcC--CCCeEecCCCCCceEeCCC----CceEEeeccccc
Q 021441 120 LA----HLHSL--SPRVVHKDFKTANVLVDED----FIAKVADAGLRN 157 (312)
Q Consensus 120 L~----~lH~~--~~givH~dikp~Nil~~~~----~~vkl~Dfg~a~ 157 (312)
+. +|... ...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12 22221 2358999999999999876 789999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0009 Score=57.27 Aligned_cols=31 Identities=23% Similarity=0.212 Sum_probs=27.3
Q ss_pred CCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 128 ~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
.+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00043 Score=60.00 Aligned_cols=72 Identities=15% Similarity=0.110 Sum_probs=43.5
Q ss_pred ccccccCcceEEEeeeeCC---------ceEEEEEeCCCCChh--HHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 81 (312)
.+.|+.|....+|++...+ ++.+++|+....... ....|..+++.+.... ..++++.. .+ ++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 4567778888999998543 267899986543221 2356777777774222 44565443 22 5899
Q ss_pred EeccCCcc
Q 021441 82 EYIPNGSV 89 (312)
Q Consensus 82 e~~~~~~L 89 (312)
+|++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.012 Score=51.74 Aligned_cols=72 Identities=8% Similarity=-0.023 Sum_probs=47.3
Q ss_pred ccccccCcceEEEeeeeCC--------ceEEEEEeCCCCCh--hHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT--QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++.+..|-...+|++.... ++.++++....... ....+|..+++.+. +.-..++++.+ .+ +.|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 4567778888999998542 47799998654322 23457888887774 22345555433 22 58999
Q ss_pred eccCCcc
Q 021441 83 YIPNGSV 89 (312)
Q Consensus 83 ~~~~~~L 89 (312)
|++|..+
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.017 Score=50.47 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=24.4
Q ss_pred eEecCCCCCceEe------CCCCceEEeecccccc
Q 021441 130 VVHKDFKTANVLV------DEDFIAKVADAGLRNF 158 (312)
Q Consensus 130 ivH~dikp~Nil~------~~~~~vkl~Dfg~a~~ 158 (312)
++|+|+.+.||++ +.++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999987653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.97 E-value=1.2 Score=34.90 Aligned_cols=91 Identities=9% Similarity=0.057 Sum_probs=61.2
Q ss_pred HHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 021441 52 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131 (312)
Q Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~giv 131 (312)
|+.+|.. .||+.++. .+-...+.+.+.++. ......+- .-...+....++++.+|+....+++. -+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~~----r~ 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNRT----RY 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGGS----SE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEc--CcccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhcC----ce
Confidence 3444433 57888766 455555554444333 32333222 23456788889999999987766654 67
Q ss_pred ecCCCCCceEeCCCCceEEeecccc
Q 021441 132 HKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 132 H~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
|--+.|+|++++.++.+++.-.|..
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEET
T ss_pred EEEEecceEEEcCCCCEEEEEccCc
Confidence 8889999999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.28 E-value=1.3 Score=34.75 Aligned_cols=83 Identities=7% Similarity=0.019 Sum_probs=56.1
Q ss_pred CCccceeeeeeeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCC
Q 021441 60 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA-HLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~-~lH~~~~givH~dikp~ 138 (312)
.||++ . ..+-...+.+.+.++.-++ ...+- .-...+....++.+.+++.... +++. -+|--+.|+
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~--~~~f~------~i~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSS--FLTFA------AIRKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE 113 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTT--CEEHH------HHHTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcc--cCcHH------HHHhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence 57887 3 3344555565454444322 22111 1234677888889999888776 5554 678889999
Q ss_pred ceEeCCCCceEEeecccc
Q 021441 139 NVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a 156 (312)
|++++.++.+++.-.|.-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 312 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-59
Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 28/289 (9%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFL 56
++ + + IG G FG VYKG VA+K APT Q F +EV L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 57 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
+H N++ +GY L ++ ++ S+ HL+ K E + IA
Sbjct: 59 RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQT 113
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
A+G+ +LH+ ++H+D K+ N+ + ED K+ D GL R + Q++ +
Sbjct: 114 AQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 177 FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233
++A EV ++ +S +SDVY+FG+ L EL++G+ S+++ ++ +V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSP 229
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282
+L K+ + +L+ CL + RP ++ ++
Sbjct: 230 DLSKVRSNCP---------KAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-57
Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 66
+ IG G+FG V+ G + VAIK + ++FI+E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L G C E L++E++ +G L + R + L + L +G+A+L
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
V+H+D N LV E+ + KV+D G+ F+ + + + + EV F
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFS 177
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
R+S KSDV+SFGV + E+ S + P ++ E+V+ D S ++ RL S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVE---DISTGFRLYKPRLAS- 228
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
Q++ C E RP+ S ++ +L +
Sbjct: 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-56
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 24/275 (8%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 66
+ +G G+FGEV+ G VA+K K+ F+ E + +QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L + + ++I EY+ NGS+ L P S KL L +A A+G+A +
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
+ +H+D + AN+LV + K+AD GL + + + A E +
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG 185
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
F+ KSDV+SFG+ L E+V+ P E++QN L+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQN----------LERGYRMV 230
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+ EE QL+ C E RP+ + + L+
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (445), Expect = 5e-54
Identities = 68/288 (23%), Positives = 128/288 (44%), Gaps = 24/288 (8%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLAS 58
++ + + + K+ +G G++GEVY+G+ + + VA+K K +EF+ E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
I+H NLV LLG C ++I E++ G++ +L + +RQ++ L +A +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISS 126
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
+ +L +H+D N LV E+ + KVAD GL + D + +
Sbjct: 127 AMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 183
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
A E + +FS KSDV++FGV L E+ + D S + ++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYG---------------MSPYPGIDLSQVYEL 228
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
L++ E+ +L+ C + RPS +++ + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 8e-54
Identities = 64/274 (23%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 66
K+ + +G G+FG V G + VAIK K EFI+E + ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L G C + F+I EY+ NG + +L R + + + L + + + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
S + +H+D N LV++ + KV+D GL ++ + + EV +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYS 176
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
+FS KSD+++FGV + E+ S + P E ++ + L++ L S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEH---IAQGLRLYRPHLAS- 227
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
E+ ++ C ++ RP+ +++ +
Sbjct: 228 ------EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (444), Expect = 1e-53
Identities = 67/309 (21%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 2 EELSLATKNFSDK---------NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPT-- 46
E+ + A + F+ + +IG G+FGEV G L + + VAIK T
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 47 --QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL 104
++F+ E + H N++ L G ++ +I E++ NGS L + + +
Sbjct: 70 QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS----LDSFLRQNDGQF 125
Query: 105 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164
+ + G A G+ +L VH+D N+LV+ + + KV+D GL FL
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 165 AGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 221
+ + A E ++R+F+ SDV+S+G+ + E++S E
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-------- 235
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
+++ +++ + QL++ C RP +V LD
Sbjct: 236 -------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 282 RTLDKEMNL 290
+ + +L
Sbjct: 289 KMIRNPNSL 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 76/288 (26%), Positives = 118/288 (40%), Gaps = 30/288 (10%)
Query: 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH 61
L++ K IG+G+FG+V G G VA+K + A Q F+ E + ++H
Sbjct: 3 ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRH 59
Query: 62 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
NLV LLG +E +++ EY+ GS+ +L R L L +L + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAM 116
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
+L VH+D NVLV ED +AKV+D GL T G + A
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAP 169
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
E ++FS KSDV+SFG+ L E+ S P L ++V + K
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYK 218
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288
+++ C + RPS + +L+ E+
Sbjct: 219 MDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-52
Identities = 60/301 (19%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 14 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID--EVCFLASIQHRNLVTLLGYC 71
+ IG+G+FGEV++G G VA+K + + E+ ++H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 72 QENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL- 126
++N +L+ +Y +GS+ +L +R + + + +AL A GLAHLH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 127 -----SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---------RTDVAGPSSQVT 172
P + H+D K+ N+LV ++ +AD GL G +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM- 179
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
A E+ S + +++D+Y+ G+ E+ + + D +LV +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSV 238
Query: 233 SNLLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
+ K++ E+ + E + +++ C + R + + L + +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
Query: 287 E 287
E
Sbjct: 299 E 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-52
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 24/275 (8%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 66
++ + +G+G FGEV+ G VAIK K + F+ E + ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
L E + +++ EY+ GS+ L G + + L + +A A G+A++
Sbjct: 77 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 127 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 186
VH+D + AN+LV E+ + KVAD GL + + + + A E +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYG 189
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
RF+ KSDV+SFG+ L EL + P E +L ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNRE----------VLDQVERGYRMP 234
Query: 247 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 281
E E L+ +C E RP+ + L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 31/294 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQ 60
+ + +IG G+FGEVYKG+L+ + VAIK T+ +F+ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
H N++ L G + +I EY+ NG++ L + + + G A G+
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGM 123
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLA 179
+L + VH+D N+LV+ + + KV+D GL L A ++ I + A
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
E +R+F+ SDV+SFG+ + E+++ E ++K +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 293
++ + QL+++C RRP +D+V+ LD+ + +L T+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-51
Identities = 54/306 (17%), Positives = 112/306 (36%), Gaps = 44/306 (14%)
Query: 4 LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLA 57
+ L +F + +G G G V+K G+++A K +P + I E+ L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLH 59
Query: 58 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
+V G + + E++ GS+ L ++ + +++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVI 114
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
KGL +L +++H+D K +N+LV+ K+ D G+ L + ++ +
Sbjct: 115 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 169
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------------EA 210
++ E + +S +SD++S G+ L+E+ GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 211 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 270
+ S ++ F L I++E + EF + +CL + R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 271 PSMSDV 276
+ +
Sbjct: 290 ADLKQL 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 5e-51
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 60
K FSD IG G FG VY +++ +VAIKK + Q+ I EV FL ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
H N + G + +L+ EY + + ++ L+ ++ GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGL 128
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
A+LHS ++H+D K N+L+ E + K+ D G + + + + A E+ LA
Sbjct: 129 AYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+ ++ K DV+S G+ +EL + P + + + L I
Sbjct: 187 DEG---QYDGKVDVWSLGITCIELAERK------PPLFNMNAMSA---------LYHIAQ 228
Query: 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+ + E F + CL + RP+ ++
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-50
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 40/304 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI 59
S +G G FG+V + M VA+K +P A E + E+ L+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-------------GPSQVSRQKLE 105
H N+V LLG C +I EY G + L + L+
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165
+ LS + AKG+A L S +H+D N+L+ I K+ D GL +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225
++A E ++ +SDV+S+G+FL EL S + P S+
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256
Query: 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285
K++ E E ++ C D +RP+ +V +++ +
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 286 KEMN 289
+ N
Sbjct: 308 ESTN 311
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 5e-50
Identities = 71/311 (22%), Positives = 111/311 (35%), Gaps = 46/311 (14%)
Query: 1 MEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK----RPGAPTQEFI 50
+ L N IGEG FG V++ + +VA+K +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 51 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--------------- 95
E +A + N+V LLG C L++EY+ G ++ L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 96 ----PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 151
S L +L IA A G+A+L + VH+D T N LV E+ + K+A
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIA 182
Query: 152 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 211
D GL + D ++ E + R++ +SDV+++GV L E+ S
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG--- 239
Query: 212 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
L P E++ + D + E L+ C RP
Sbjct: 240 --LQPYYGMAHEEVIY---------YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRP 287
Query: 272 SMSDVVTELDR 282
S + L R
Sbjct: 288 SFCSIHRILQR 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 8e-50
Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 31/288 (10%)
Query: 2 EELSLATKNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKK----RPGAPTQEFIDEV 53
++L L N ++ +G G FG V +G+ + + VAIK A T+E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
+ + + +V L+G CQ L L+ E G + L G R+++ + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
+ G+ +L VH+D NVL+ AK++D GL LG D +
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 174 DEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
+ + A E FR+FS +SDV+S+GV + E +S + +++ ++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGKRM 231
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
E E L+ C E RP V +
Sbjct: 232 E-------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 30/279 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
++ IG G +G K DG ++ K+ A Q + EV L ++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 64 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+V + N +++ EY G ++ + ++ RQ L+ + L + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALK 123
Query: 122 HLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 178
H S V+H+D K ANV +D K+ D GL L + T ++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP--YYM 181
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
+ E ++EKSD++S G L EL + P ++ EL + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------KIREG 229
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
R+ ++ +E ++I R L+ RPS+ +++
Sbjct: 230 KFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-49
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 34/291 (11%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPTQ----EFIDEVCFLASIQH 61
+F +IG G FG VY G L D + A+K +F+ E + H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 62 RNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
N+++LLG C ++ Y+ +G L + K + L AKG+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP--SSQVTADEIFL 178
L S + VH+D N ++DE F KVAD GL + + + ++
Sbjct: 144 KFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 179 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238
A E + ++F+ KSDV+SFGV L EL++ P + ++ ++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLL---QGRRL 253
Query: 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289
L + +++++C P +E RPS S++V+ + +
Sbjct: 254 LQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 6e-48
Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 39/298 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGAPT----QEFIDEVCFLASI-Q 60
+ +++IGEG FG+V K ++ M AIK+ + ++F E+ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 61 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHR 109
H N++ LLG C+ +L EY P+G++ L + + + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
L A A+G+ +L + +H+D N+LV E+++AK+AD GL + V
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMG 186
Query: 170 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 229
++ ++A E + ++ SDV+S+GV L E+VS +P EL +
Sbjct: 187 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK- 238
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
L + +E L+ +C RPS + ++ L+R L++
Sbjct: 239 -----LPQGYRLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 31/301 (10%)
Query: 11 FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPT----QEFIDEVCFLASIQH 61
F ++G G FG VYKGL + VAIK+ A + +E +DE +AS+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
++ LLG C + + LI + +P G L + + + ++ L+ + AKG+
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+L R+VH+D NVLV K+ D GL LG + + ++A E
Sbjct: 126 YLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
R ++ +SDV+S+GV + EL++ + S + IL++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEK 228
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTV 301
+ ++V+C ++ RP +++ E + + G+ +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 302 T 302
Sbjct: 289 P 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-47
Identities = 58/274 (21%), Positives = 109/274 (39%), Gaps = 27/274 (9%)
Query: 9 KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRN 63
+++ +GEG +GEV VA+K KR + E+C + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+V G+ +E N+Q+L EY G + + + G+ +L
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 183
H + + H+D K N+L+DE K++D GL + +++ ++A E+
Sbjct: 120 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 184 EFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
+ R F +E DV+S G+ L +++G P S + + + N K +D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEKKTYLNPWKKID-- 233
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ L+ + L + R ++ D+
Sbjct: 234 ----------SAPLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-47
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 16 LIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 67
IGEG+FG+V++G+ + VAIK + F+ E + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 68 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 127
+G EN + ++I E G L QV + L+ + A + LA+L S
Sbjct: 74 IGVITENPV-WIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 128 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 187
R VH+D NVLV + K+ D GL ++ + S + ++A E FRR
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRR 185
Query: 188 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 247
F+ SDV+ FGV + E++ P +++ + +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGR------IENGERLPMPPNC 234
Query: 248 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
L+ +C RRP +++ +L L++E
Sbjct: 235 P----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-47
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 41/299 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPTQ----EFIDEVCFLA 57
+GEG FG+V VA+K T+ + I E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 SI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLE 105
I +H+N++ LLG C ++ ++I EY G++ +L Y PS ++L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 106 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 165
K +S A A+G+ +L S + +H+D NVLV ED + K+AD GL + D
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 225
++ ++A E R ++ +SDV+SFGV L E+ + SP + E
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEE- 245
Query: 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
L K+L E + E ++ C +RP+ +V +LDR +
Sbjct: 246 ---------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-47
Identities = 62/300 (20%), Positives = 124/300 (41%), Gaps = 32/300 (10%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPTQ----EFID 51
+E +A + + +G+G FG VY+G+ + VAIK A + EF++
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 52 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEF 106
E + ++V LLG + +I E + G + +L +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 107 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166
+ +A A G+A+L++ + VH+D N +V EDF K+ D G+ + TD
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
+ +++ E + F+ SDV+SFGV L E+ + E P +++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVL 245
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286
+ +++ L + + +L+ C + + RPS ++++ + ++
Sbjct: 246 R---------FVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-46
Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 32/277 (11%)
Query: 13 DKNLIGEGKFGEVYKGLLQD---GMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 64
+ +G G FG V KG Q VA+K A E + E + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V ++G C+ + L+ E G ++ +L + ++ K+ + + + G+ +L
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 183
VH+D NVL+ AK++D GL + + + + A E
Sbjct: 125 E--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+ +FS KSDV+SFGV + E S + P E+ +L++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEV----------TAMLEKGE 227
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
E L+ C E RP + V L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-46
Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 35/272 (12%)
Query: 17 IGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
IG G F VYKGL + + VA + + Q F +E L +QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 71 CQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ L+ E + +G++ +L + ++ K S KGL LH+
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 127 SPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 185
+P ++H+D K N+ + K+ D GL + + V F+A E+ E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE- 186
Query: 186 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 245
++ E DVY+FG+ +LE+ + Q+ ++ + ++ +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSE-----YPYSECQNAAQIYR---------RVTSGVKPA 232
Query: 246 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
+F + E ++I C+ + + R S+ D++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-46
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 9 KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
++F +G+GKFG VY Q ++A+K + EV + ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
N++ L GY + +LI EY P G+V L K + + + A L+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALS 120
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+ HS RV+H+D K N+L+ K+AD G + + + +L E
Sbjct: 121 YCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 174
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
+ E R EK D++S GV E + G+ P + E + +I
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK---------RISRV 219
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 277
TF + E LI R L + +RP + +V+
Sbjct: 220 EF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-46
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 15 NLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 70
+G+G FG+VYK + +L A K + ++++ E+ LAS H N+V LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 71 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 130
N +++ E+ G+V + + L + L +LH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN--KI 131
Query: 131 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 186
+H+D K N+L D K+AD G+ RT S A E+ + K+ R
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD-R 190
Query: 187 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 246
+ K+DV+S G+ L+E+ P + + + LLKI +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE------PPHHELNPMRV---------LLKIAKSEPPTL 235
Query: 247 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 276
F + +CL+ + + R + S +
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 45/301 (14%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASI 59
N ++G G FG+V + VA+K + E+ + +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG------------------PSQVS 100
H N+V LLG C + +LI+EY G + +L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 101 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160
L F+ L A AKG+ L VH+D NVLV + K+ D GL +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ 220
++A E ++ KSDV+S+G+ L E+ S P
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGI 270
Query: 221 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
+ N K++ EE ++ C S +RPS ++ + L
Sbjct: 271 PVDA---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 281 D 281
Sbjct: 322 G 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-45
Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 28/273 (10%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRN 63
K ++ IG+G G VY + + G VAI+ + + I+E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+V L + +++ EY+ GS++ + ++ ++ + L L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 183
HS +V+H+D K+ N+L+ D K+ D G + S + ++A EV
Sbjct: 133 HSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVV 188
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
+ + K D++S G+ +E++ G P +++ + + +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYL--------IATNGTP 234
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ F + RCLD E+R S ++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-45
Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 32/283 (11%)
Query: 9 KNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK------RPGAPTQEFIDEVCFLAS 58
K+ +G+G FG V +G + VA+K +FI EV + S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
+ HRNL+ L G + ++ E P GS L + + A+ A+
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 119 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 177
G+ +L S R +H+D N+L+ + K+ D GL R D +
Sbjct: 123 GMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
A E + R FS SD + FGV L E+ + + P + +++ K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILH---------K 226
Query: 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 280
I E + ++ ++V+C E RP+ + L
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 6e-43
Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 28/273 (10%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLV 65
++ +G G FG V++ G A K + + E+ ++ ++H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
L +++N +IYE++ G + + K+ + KGL H+H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 126 LSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 183
VH D K N++ K+ D GL L T F A EV
Sbjct: 143 N--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243
E + +D++S GV L+SG SP ++ E ++N + + +D+
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVK---SCDWNMDDSA 248
Query: 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+S + E+ I + L R ++
Sbjct: 249 FSGIS----EDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-42
Identities = 46/274 (16%), Positives = 94/274 (34%), Gaps = 31/274 (11%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
+F ++GEG F V L AIK E ++ + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
V L Q++ + Y NG + ++ + L +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEY 123
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182
LH ++H+D K N+L++ED ++ D G L ++ +++ E+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
+ + SD+++ G + +LV+G P + + + Q KI+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQ---------KIIKLE 226
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
F + + L+ + L + +R ++
Sbjct: 227 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 39/298 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 59
+G G FG+V + VA+K + + + E+ L I
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 60 QHR-NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG-----------PSQVSRQKLEF 106
H N+V LLG C + +I E+ G++S +L P + + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 107 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 166
+H + + AKG+ L S + +H+D N+L+ E + K+ D GL + +
Sbjct: 134 EHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 167 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 226
++A E R ++ +SDV+SFGV L E+ S SP + E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE- 245
Query: 227 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284
+ L E + E Q ++ C +RP+ S++V L L
Sbjct: 246 --------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 53/277 (19%), Positives = 101/277 (36%), Gaps = 31/277 (11%)
Query: 9 KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 61
K +K +G G+FG V++ + K K G E+ L +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
RN++ L + +I+E+I + + S +L + +S + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQ 116
Query: 122 HLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 179
LHS + H D + N++ K+ + G L D + A
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---YYA 171
Query: 180 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239
EV + S +D++S G + L+SG + +++Q ++E + N+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNAE------YTF 222
Query: 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
DE + + E + + R L + R + S+
Sbjct: 223 DEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (355), Expect = 1e-40
Identities = 52/284 (18%), Positives = 103/284 (36%), Gaps = 37/284 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------------QEFIDEVCFL 56
N+ K ++G G V + + A+K + + EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 ASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 115
+ H N++ L + N FL+++ + G + +L + L K I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRA 118
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP---SSQVT 172
+ + LH L +VH+D K N+L+D+D K+ D G L + +
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
A EI S + ++ D++S GV + L++G P + + +++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMIMSG 230
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ + +S + L+ R L ++R + +
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (351), Expect = 3e-39
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 28/267 (10%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 71
+G G FG V++ + G + K +E+ + + H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 72 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 131
++ LI E++ G + + K+ ++ A +GL H+H +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH--SIV 149
Query: 132 HKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 189
H D K N++ + + K+ D GL L ++ TA F A E+ +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVG 206
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
+D+++ GV L+SG SP + +D +E +QN + DE +S+ +
Sbjct: 207 FYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK---RCDWEFDEDAFSSVS- 256
Query: 250 EGMEEFIQLIVRCLDPSSERRPSMSDV 276
E I L +R ++ D
Sbjct: 257 ---PEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-38
Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 25/285 (8%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
NF IGEG +G VYK G +VA+KK I E+ L + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
+V LL N +L++E++ + S +GLA
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118
Query: 124 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 183
H S RV+H+D K N+L++ + K+AD GL G V + +V +
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175
Query: 184 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDLVELVQNSRD 231
+ +S D++S G E+V+ R S + + V + D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 232 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ + +S E+ L+ + L +R S
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (333), Expect = 2e-37
Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 25/284 (8%)
Query: 10 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 64
+ IGEG +G VYK G A+KK I E+ L ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 65 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 124
V L L++E++ L V LE S L G+A+ H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 125 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
RV+H+D K N+L++ + K+AD GL G + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMG 174
Query: 185 FRRFSEKSDVYSFGVFLLELVSGR------------EASSSLSPDSSQDLVELVQNSRDF 232
+++S D++S G E+V+G + + V +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ + W +F E I L+ + L +R +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 2e-37
Identities = 46/283 (16%), Positives = 89/283 (31%), Gaps = 27/283 (9%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-Q 72
IG G FG++Y G + G VAIK + E +Q + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 73 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132
E + ++ E + + + +K K L +A + ++HS +H
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSK--NFIH 126
Query: 133 KDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKE 184
+D K N L+ + + + D GL + + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244
S + D+ S G L+ G L + + E + + + E L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEVLC 241
Query: 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
+ EF + C + +P S + ++
Sbjct: 242 KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (337), Expect = 3e-37
Identities = 55/281 (19%), Positives = 99/281 (35%), Gaps = 38/281 (13%)
Query: 4 LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---------KRPGAPTQEFIDEV 53
L++ +FS +IG G FGEVY G + A+K K+ +
Sbjct: 1 LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 54 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
+++ +V + + I + + G + HL A
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYA 113
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 173
GL H+H + VV++D K AN+L+DE +++D GL +
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167
Query: 174 DEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
++A EV ++ + +D +S G L +L+ G ++D E+ + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTM 224
Query: 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
L +F+ E L+ L RR
Sbjct: 225 -------AVELPDSFS----PELRSLLEGLLQRDVNRRLGC 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-37
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 27/287 (9%)
Query: 10 NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 68
+++D +IG G FG VY+ L G LVAIKK + E+ + + H N+V L
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLR 79
Query: 69 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
+ + + L+ +Y+P + + ++Q L + + LA+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137
Query: 123 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+H S + H+D K N+L+D D + K+ D G L R + S + +
Sbjct: 138 IH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPEL 193
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS------------SQDLVELVQNS 229
+ ++ DV+S G L EL+ G+ S +++ + + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+I F E I L R L+ + R + +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 57/283 (20%), Positives = 102/283 (36%), Gaps = 30/283 (10%)
Query: 15 NLIGEGKFGEVYKG-LLQDGMLVAIKK--------RPGAPTQEFIDEVCFLASIQHRNLV 65
+ +GEG+F VYK +VAIKK + + E+ L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 66 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
LL + L+++++ I + + L H + L +GL +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 126 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KE 184
++H+D K N+L+DE+ + K+AD GL G + A VT + A E+
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR--WYRAPELLFG 174
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-----------QNSRDFS 233
R + D+++ G L EL+ S + S
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
K + ++ + LI + R + +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (329), Expect = 2e-36
Identities = 54/281 (19%), Positives = 97/281 (34%), Gaps = 35/281 (12%)
Query: 8 TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLAS 58
++ D +++G G F EV + LVAIK +E+ L
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 59 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 118
I+H N+V L + +LI + + G + + + + +
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLD 118
Query: 119 GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175
+ +LH +VH+D K N+L DED ++D GL V S
Sbjct: 119 AVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTP 173
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235
++A EV + +S+ D +S GV L+ G P ++ +L +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQ---ILKA 224
Query: 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
D W + + I ++ E+R +
Sbjct: 225 EYEFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 55/290 (18%), Positives = 112/290 (38%), Gaps = 25/290 (8%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHR 62
+++ + IGEG +G V + + VAIKK Q + E+ L +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N++ + + ++ + Y+ + LY + Q L H +GL +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASE 181
+HS V+H+D K +N+L++ K+ D GL D G ++ A + A E
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 182 V-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240
+ + +++ D++S G L E++S R + + + S +L I++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 241 ERL--------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+ W+ + + L+ + L + +R +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 129 bits (326), Expect = 2e-36
Identities = 54/292 (18%), Positives = 116/292 (39%), Gaps = 39/292 (13%)
Query: 9 KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLA 57
+ SD+ ++G G EV+ L+ VA+K R + F E A
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 58 SIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 113
++ H +V + + L +++ EY+ ++ ++ + + K + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 117
Query: 114 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 172
A + L H ++H+D K AN+++ KV D G+ R + ++ V
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 173 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232
+L+ E +SDVYS G L E+++G P + V +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQ---- 225
Query: 233 SNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRP-SMSDVVTELDR 282
+ ++ + + +EG+ + ++++ L + E R + +++ +L R
Sbjct: 226 ----HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-35
Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 34/274 (12%)
Query: 10 NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-------RPGAPTQEFIDEVCFLASIQH 61
+F ++G+G FG+V+ + AIK +++ + +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
L + Q F + EY+ G + H+ S K + A GL
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQ 117
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
LH S +V++D K N+L+D+D K+AD G+ D + T D ++A E
Sbjct: 118 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD--YIAPE 173
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
+ ++++ D +SFGV L E++ G+ SP QD EL + R
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIR----------- 216
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275
+ +E L+V+ E+R +
Sbjct: 217 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-35
Identities = 57/291 (19%), Positives = 99/291 (34%), Gaps = 26/291 (8%)
Query: 7 ATKNFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQE--------FIDEVCFL 56
A + + IGEG +G+V+K L G VA+K+ +E + + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 57 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALG 115
+ +H N+V L C + + V +V + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 116 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 175
+GL LHS RVVH+D K N+LV K+AD GL + V
Sbjct: 125 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 179
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV----------EL 225
+ A EV ++ D++S G E+ + S + +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++ + F + E L+++CL + +R S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 6e-35
Identities = 45/291 (15%), Positives = 97/291 (33%), Gaps = 27/291 (9%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVT 66
++ IGEG FG +++G L + VAIK P + + DE + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 67 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 126
+ Y + L ++ + S+ L + +K K A + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 127 SPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFLGRTDVAGPSSQVTADEI----- 176
+V++D K N L+ V D G+ F +
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236
+++ R S + D+ + G + + G L +++ E + + + L
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287
++ + EEF + + + + + P + + L++
Sbjct: 239 ELCAG--FP-------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-34
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 41/286 (14%)
Query: 9 KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVC 54
+N D +G G+F V K G+ A K R G ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 55 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 114
L IQH N++TL + LI E + G + L ++ L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLK 120
Query: 115 GAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGRTDVAGPSSQ 170
G+ +LH S ++ H D K N+++ + K+ D GL + + +
Sbjct: 121 QILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 175
Query: 171 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230
+ F+A E+ + ++D++S GV L+SG D+ Q+ + V
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVN 232
Query: 231 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++ +S + I R L ++R ++ D
Sbjct: 233 ------YEFEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 7e-34
Identities = 54/271 (19%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
++F +G G FG V+ +G A+K + DE L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
++ + G Q+ F+I +YI G + L Q+ A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LH S ++++D K N+L+D++ K+ D G ++ + ++A E
Sbjct: 119 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE 171
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
V + +++ D +SFG+ + E+++G +P + ++ + KIL+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYE---------KILNA 216
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 272
L F E+ L+ R + +R
Sbjct: 217 EL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-33
Identities = 43/267 (16%), Positives = 89/267 (33%), Gaps = 22/267 (8%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQ- 72
++G G G+V + + A+K P + EV Q ++V ++ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYEN 76
Query: 73 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 129
++ E + G + + Q + I + + +LHS+
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHSI--N 131
Query: 130 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 189
+ H+D K N+L + F T + ++A EV ++
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191
Query: 190 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 249
+ D++S GV + L+ G S + ++ + WS +
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-----FPNPEWSEVS- 245
Query: 250 EGMEEFIQLIVRCLDPSSERRPSMSDV 276
EE LI L +R ++++
Sbjct: 246 ---EEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-32
Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 29/294 (9%)
Query: 10 NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 63
+ IG+G FGEV+K + G VA+KK + E+ L ++H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 64 LVTLLGYCQENNLQFLIYE---YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 120
+V L+ C+ + + Y+ L G K + GL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 121 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR---TDVAGPSSQVTADEIF 177
++H +++H+D K ANVL+ D + K+AD GL + +++V
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 178 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237
+ R + D++ G + E+ + + L+ + S
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 238 ILDERLWSTFTNEGM---------------EEFIQLIVRCLDPSSERRPSMSDV 276
+ + L+ + LI + L +R D
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 27/287 (9%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
+ + IGEG +G V+K + +VA+K+ + E+C L ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
N+V L + L++E+ L+ + S KGL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182
H S V+H+D K N+L++ + K+A+ GL G V S++V +
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVL 173
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGR-------------EASSSLSPDSSQDLVELVQNS 229
+ +S D++S G EL + + L +++ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 230 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
D+ + L+ L + +R S +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 60/272 (22%), Positives = 96/272 (35%), Gaps = 33/272 (12%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 61
+F L+G+G FG+V G A+K + E L + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 62 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
L L Q ++ + EY G + HL + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119
Query: 122 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 181
+LHS VV++D K N+++D+D K+ D GL + T + +LA E
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--YLAPE 175
Query: 182 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
V E + D + GV + E++ GR P +QD L + IL E
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFE---------LILME 220
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 273
+ F E L+ L ++R
Sbjct: 221 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 49/294 (16%), Positives = 111/294 (37%), Gaps = 39/294 (13%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
+ D +G G +G V + + G VAIKK + + E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 63 NLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
N++ LL + +L+ ++ + +KL +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-------KHEKLGEDRIQFLVYQM 130
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
KGL ++H+ ++H+D K N+ V+ED K+ D GL + V
Sbjct: 131 LKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 184
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE--------------ASSSLSPDSSQDL 222
+ + R+++ D++S G + E+++G+ + +P +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 223 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++++ L L+++ +++ + L+ + L +E+R + +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-30
Identities = 57/275 (20%), Positives = 96/275 (34%), Gaps = 47/275 (17%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASIQ--HRN 63
L+G G FG VY G+ + D + VAIK EV L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 64 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 123
++ LL + + + LI E R L+ + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHC 126
Query: 124 HSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182
H+ V+H+D K N+L+D + K+ D G L T + ++ E
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 183 KEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241
+ R+ + V+S G+ L ++V G P F + +I+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD------IP---------------FEHDEEIIRG 219
Query: 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
++ F E LI CL RP+ ++
Sbjct: 220 QV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-27
Identities = 46/293 (15%), Positives = 108/293 (36%), Gaps = 38/293 (12%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTL 67
++ +G GK+ EV++ + + + V +K ++ E+ L +++ N++TL
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 68 LGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 125
++ + L++E++ N Q L K L + HS
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 126 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 184
+ ++H+D K NV++D E ++ D GL F + +V + + +
Sbjct: 148 M--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD 203
Query: 185 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL----------------VELVQN 228
++ + D++S G L ++ +E + Q + ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 229 SRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCLDPSSERRPSMSDV 276
F+++L + W F + E + + + L + R + +
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 7e-27
Identities = 53/295 (17%), Positives = 116/295 (39%), Gaps = 39/295 (13%)
Query: 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQH 61
+ + + + +G G +G V + G+ VA+KK + + E+ L ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 62 RNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
N++ LL + ++ ++ + V QKL H +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN------NIVKCQKLTDDHVQFLIYQI 130
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADE 175
+GL ++H S ++H+D K +N+ V+ED K+ D GL +++ A E
Sbjct: 131 LRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 176 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE--------------ASSSLSPDSSQD 221
I L + +++ D++S G + EL++GR +P +
Sbjct: 189 IML-----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 222 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 276
+++R++ L + + ++ + L+ + L S++R + +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 58/286 (20%), Positives = 98/286 (34%), Gaps = 35/286 (12%)
Query: 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK-------RPGAPTQEFI 50
E++ + +NF ++G G +G+V+ G L A+K + T+
Sbjct: 19 EKVGI--ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76
Query: 51 DEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 109
E L I+ LVTL Q LI +YI G + HL R++
Sbjct: 77 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEV 131
Query: 110 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 169
L HLH L ++++D K N+L+D + + D GL +
Sbjct: 132 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 170 QVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 228
E V+ + D +S GV + EL++G + +SQ E+ +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR 247
Query: 229 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 274
+ + LI R L ++R
Sbjct: 248 ILKS-------EPPYPQEMS----ALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 7e-26
Identities = 51/269 (18%), Positives = 98/269 (36%), Gaps = 36/269 (13%)
Query: 10 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 62
F +G G FG V + G A+K + ++E L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 63 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 122
LV L ++N+ +++ EY+ G + HL + H A +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 123 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 182
LHSL ++++D K N+L+D+ +V D G V G + + LA E+
Sbjct: 157 LHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEI 209
Query: 183 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242
+ +++ D ++ GV + E+ +G P + +++ + R
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSG-------KVR 256
Query: 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
S F+ + L+ L +R
Sbjct: 257 FPSHFS----SDLKDLLRNLLQVDLTKRF 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.6 bits (244), Expect = 4e-24
Identities = 44/307 (14%), Positives = 92/307 (29%), Gaps = 47/307 (15%)
Query: 16 LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 72
+G G F V+ + + VA+K + T+ DE+ L + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 73 ENNLQFLIYEYIPNGSVSI-----------HLYGPSQVSRQKLEFKHRLSIALGAAKGLA 121
+ L+ L + + L + + + + I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 122 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 180
++H ++H D K NVL++ D + + + + + +
Sbjct: 140 YMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 181 EVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD---------------L 222
EV + +D++S + EL++G E S D L
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 223 VELVQNSRDFSNLLKILDE-------------RLWSTFTNEGMEEFIQLIVRCLDPSSER 269
+ + +R F N +L F+ + +E + L +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318
Query: 270 RPSMSDV 276
R +
Sbjct: 319 RADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 2e-23
Identities = 58/305 (19%), Positives = 105/305 (34%), Gaps = 50/305 (16%)
Query: 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 62
K + + IG G G V VAIKK + + E+ + + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 63 NLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 116
N+++LL +E +L+ E + + + +L+ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQM 128
Query: 117 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 176
G+ HLHS ++H+D K +N++V D K+ D GL G + +
Sbjct: 129 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 183
Query: 177 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSSLSPDSSQ 220
+ A EV + E D++S G + E+V + E + P+ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 221 DLVELVQN---------SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 271
L V+N F L S + L+ + L +R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 272 SMSDV 276
S+ D
Sbjct: 304 SVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.6 bits (185), Expect = 4e-17
Identities = 34/211 (16%), Positives = 63/211 (29%), Gaps = 47/211 (22%)
Query: 15 NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------------QEFIDEVCFLASIQH 61
L+GEGK V+ + +K + G + F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 62 RNLVTLLGYCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 117
R L L G + ++ E I + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 118 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 177
+ +A + +VH D NVLV E+ I + D + + E
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVSEEGI-WIIDFPQ---------SVEVGEEGWRE-I 160
Query: 178 LASEVKEF-----RRFSEKSDVYSFGVFLLE 203
L +V+ R + + D+ S +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 312 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.48 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=393.21 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=206.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ..+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4789999999999999999999 457899999976432 23468899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+++++|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l-----~~~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGS-----BTTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999998 344578999999999999999999999 77999999999999999999999999999876544
Q ss_pred CcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... ......
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~~~~~------------ 222 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEK------------ 222 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HHHHTT------------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HHHhcC------------
Confidence 33333445679999999999998876 678999999999999999999997654432211 111111
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.+||.+||+.||++|||++|+++|
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111123445788999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=393.41 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=208.7
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
++|++..++|++.+.||+|+||.||+|+.+. .||+|.+... ....+.+|+.++++++||||+++++++.. +.
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 4688889999999999999999999998653 4999986532 23568899999999999999999998765 46
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred EEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccce
Confidence 7999999999999998832 23458899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhc---CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+...............+|+.|+|||++.+. .|+.++|||||||++|||+||..||....... ..........
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~--- 226 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGY--- 226 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTS---
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCC---
Confidence 876544433334456789999999998753 47999999999999999999999998654322 1111111110
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
........+.++++++.++|.+||+.||.+|||+.+++++|+.+.+
T Consensus 227 ------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 ------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111123455567899999999999999999999999999998874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-60 Score=397.70 Aligned_cols=269 Identities=16% Similarity=0.218 Sum_probs=217.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++. ......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 4679999999999999999999 4578999999754 34456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++++|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+|+...
T Consensus 87 mEy~~gg~L~~~~-----~~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 87 LSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp ECCCTTEEHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEccCCCCHHHhh-----hccCCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 9999999999887 345678999999999999999999999 779999999999999999999999999998775
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
............||+.|+|||++.+..|+.++|||||||++|+|++|..||...+. ......+. .
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~------------~ 224 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKII------------K 224 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------T
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHH------------c
Confidence 44433334455799999999999999999999999999999999999999976432 11111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---HHHHHhcccccccccCCCc
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD---RTLDKEMNLTTVMGEGTPT 300 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~---~~~~~~~~~~~~~~~~~~~ 300 (312)
. ...++..+++++.+||.+||+.||.+|||++|++++-. .-.-+.++|+.+....+|-
T Consensus 225 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~ 285 (288)
T d1uu3a_ 225 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 285 (288)
T ss_dssp T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCC
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCC
Confidence 1 12344556788999999999999999999999876532 2222456777777766554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-59 Score=386.10 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=207.6
Q ss_pred hcCCCcccccccCcceEEEeeee-CCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++.+.||+|+||.||+|.. .+++.||+|.+. ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999994 578899999754 33456688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++|+|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|....
T Consensus 85 mEy~~~g~L~~~l-----~~~~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EeecCCCcHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999888 344568999999999999999999999 779999999999999999999999999997654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+. ......+.+
T Consensus 158 ~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~------------ 218 (263)
T d2j4za1 158 SS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISR------------ 218 (263)
T ss_dssp CC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT------------
T ss_pred CC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHHc------------
Confidence 32 23445789999999999999999999999999999999999999975432 111111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ...++..+++++.+||.+||+.||++|||++|+++|
T Consensus 219 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 V--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1 123445567899999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=390.57 Aligned_cols=248 Identities=22% Similarity=0.368 Sum_probs=207.2
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC---CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|++. ....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 3589999999999999999998 5678999999754 23456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 99 ~~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999998762 2458899999999999999999999 779999999999999999999999999998764332
Q ss_pred cCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
.......||+.|+|||++.+..|+.++|||||||++|+|++|..||...... ......... ...
T Consensus 171 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~------------~~~ 234 (293)
T d1yhwa1 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATN------------GTP 234 (293)
T ss_dssp --CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHH------------CSC
T ss_pred --ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhC------------CCC
Confidence 2234457999999999999999999999999999999999999999754321 111111111 111
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....+..+++++++||.+||+.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123345567889999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=385.41 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..++|++.+.||+|+||.||+|.+.+++.||||.+... ..+++.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 45789999999999999999999877888999987643 4467899999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999998732 33567889999999999999999999 7799999999999999999999999999987654332
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhC-CCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......+|..|+|||++.+..|+.++|||||||++|||+|+ .+||..... ......+ ....
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i-------------~~~~ 219 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI-------------STGF 219 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHH-------------HHTC
T ss_pred e-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHH-------------HhcC
Confidence 2 22335678889999999999999999999999999999995 555543221 1111111 1122
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
....+..+++++.++|.+||+.||++|||+++++++|+++.+.
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 2334555668899999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=385.67 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=215.6
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
++|++..++|++.+.||+|+||.||+|..++++.||||.+... ..+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4678888999999999999999999999888889999987543 45678999999999999999999998865 45799
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++|+|.+++.. .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~---~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTS---HHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEc
Confidence 9999999999987732 223458899999999999999999999 77999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
...... ......+++.|+|||++.+..|+.++|||||||++|||+||..|+..... ....... +
T Consensus 160 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~-------------i 223 (272)
T d1qpca_ 160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN-------------L 223 (272)
T ss_dssp SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH-------------H
T ss_pred cCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH-------------H
Confidence 543322 22345678889999999999999999999999999999996655443221 1111111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
........+..+++++.+|+.+||+.||++|||++++++.|+.++..
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 12223344566778999999999999999999999999999988753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-59 Score=392.85 Aligned_cols=264 Identities=24% Similarity=0.418 Sum_probs=218.3
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-CCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
++|++..++|++.+.||+|+||.||+|.+ .+++.||+|.+... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 35778889999999999999999999984 46889999987643 4567899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++|+|.+++.. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus 90 iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999988832 234568899999999999999999999 7799999999999999999999999999987
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
....... ......++..|+|||++.+..|+.++|||||||++|||++|..||..... ... +...
T Consensus 165 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~-------------~~~~ 228 (287)
T d1opja_ 165 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ-------------VYEL 228 (287)
T ss_dssp CCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH-------------HHHH
T ss_pred cCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHH-------------HHHH
Confidence 6433211 12233577889999999999999999999999999999997777644222 111 1122
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+........+..+++++.+||.+||+.||++|||++++++.|+.+.++
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 222333455666778999999999999999999999999999887644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=377.54 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=213.7
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCC--CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
..++|++.+.||+|+||.||+|++++++.||+|.++. ...+++.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3579999999999999999999988888999997653 45578999999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
++|+|..++. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHH----SGGGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhh----ccccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999988863 234567889999999999999999999 7799999999999999999999999999987654433
Q ss_pred CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhc
Q 021441 165 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 243 (312)
Q Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (312)
. ......+|..|+|||++.+..|+.++|||||||++|||+| |..||...+..+. ...+ ....
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~~~i-------------~~~~ 218 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHI-------------AQGL 218 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHH-------------HTTC
T ss_pred e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---HHHH-------------HhCC
Confidence 2 2334568889999999999999999999999999999998 8999976553221 1111 1122
Q ss_pred cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 244 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
....+...++++.+||.+||+.||++|||+++++++|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233455566899999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-58 Score=387.22 Aligned_cols=261 Identities=25% Similarity=0.464 Sum_probs=203.2
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC-Cc---eEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ-DG---MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|..+ ++ ..||+|.+..... ..+.+|+.++++++||||+++++++...+..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 34577889999999999999999853 33 3689998765432 3588999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++|+|.+++. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 103 ~iv~Ey~~~g~L~~~~~----~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EEEEECCTTEEHHHHHH----TTTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEecCCCcceeeec----cccCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999998873 234468899999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCcCC---CCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 158 FLGRTDVAG---PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
......... ......+|+.|+|||.+.+..|+.++|||||||++|||+| |..||...... .....+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i------- 246 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAI------- 246 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH-------
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHH-------
Confidence 765432211 1222357888999999999999999999999999999998 89999765432 111111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
........+..+++++.+||.+||+.||++|||+.++++.|+++++.+.
T Consensus 247 ------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 247 ------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ------HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 1222233455667899999999999999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=386.85 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=195.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeee--CCeEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL 79 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (312)
.++|++.+.||+|+||.||+|+ ..+++.||+|.+..... ..+.+|+++++.++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4789999999999999999998 55789999998654432 347789999999999999999999864 456899
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~---~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 vmEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999884322 13456899999999999999999999832 24999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
+....... ......+|+.|+|||++.+..|+.++|||||||++|+|+||..||...+. ......+
T Consensus 162 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i---------- 226 (269)
T d2java1 162 RILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI---------- 226 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH----------
T ss_pred eecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHH----------
Confidence 87643321 12345788999999999999999999999999999999999999976432 1111111
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........+..+++++.+||.+||+.||.+|||++|+++|
T Consensus 227 ---~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 ---REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111233455667899999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=396.77 Aligned_cols=270 Identities=19% Similarity=0.262 Sum_probs=209.4
Q ss_pred hHHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 5 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
++..++|++++.||+|+||+||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4567899999999999999999999 557899999976432 23568899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+++++|.+++. ....+++..+..++.|++.||.|||+. +||+||||||+|||++.+|.+||+|||+|...
T Consensus 82 VmEy~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999883 345688999999999999999999961 36999999999999999999999999999876
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-h--------
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-R-------- 230 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~-------- 230 (312)
.... .....||+.|+|||++.+..|+.++|||||||++|||++|..||...+.............. .
T Consensus 156 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 156 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 4322 23457899999999999999999999999999999999999999875433221110000000 0
Q ss_pred --------------h---hhhhhHHhhhhccccC-ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHH
Q 021441 231 --------------D---FSNLLKILDERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTL 284 (312)
Q Consensus 231 --------------~---~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~~ 284 (312)
. ................ ....+.++.+||.+||..||++|||++|+|+| +.+.-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0 0000000111111111 12245789999999999999999999999986 54443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=391.39 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=212.5
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-C-----ceEEEEEeCCCC----ChhHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-D-----GMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~-----~~~vaiK~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.|++..++|++.+.||+|+||.||+|++. . ...||+|.+... ....+.+|+.++.++ +||||+++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 46677889999999999999999999843 2 236899976432 335688899999988 899999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc------------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 133 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~ 133 (312)
.+.+.+|+||||+++|+|.+++..... .....+++..+..++.|++.||.|||+ ++|+||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeec
Confidence 999999999999999999999854321 112457889999999999999999999 779999
Q ss_pred CCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCC
Q 021441 134 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASS 212 (312)
Q Consensus 134 dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~ 212 (312)
||||+||+++.++.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433222334457889999999999999999999999999999998 899998
Q ss_pred CCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 021441 213 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 282 (312)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~ 282 (312)
+...... ... ++........+..+++++.+||.+||+.||++|||+++|+++|..
T Consensus 269 ~~~~~~~--~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVDAN--FYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCSHH--HHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHH--HHH-------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 6544321 111 122222334566677899999999999999999999999999963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-58 Score=385.88 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=204.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.+.|++++.||+|+||.||+|+ ..+++.||+|++... ..+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 4578999999999999999999 457899999976433 335688999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+++++|.+++. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus 91 ~~~g~L~~~~~----~~~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998873 223568999999999999999999999 779999999999999999999999999987653321
Q ss_pred cCCCCccccCcccccchhhhh-----hcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 164 VAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
. ......||+.|+|||++. +..|+.++|||||||++|+|+||..||......+.. .......
T Consensus 165 ~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~i~~~~--------- 231 (288)
T d2jfla1 165 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LKIAKSE--------- 231 (288)
T ss_dssp H--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHHSC---------
T ss_pred c--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHcCC---------
Confidence 1 122356889999999984 456899999999999999999999999865432211 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
......+..+++++.+||.+||+.||++|||++|+++|
T Consensus 232 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 ---PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345567899999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=376.85 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=211.8
Q ss_pred HHhcCCCcccc-cccCcceEEEeeeeC---CceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~-lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|.+.+. ||+|+||.||+|.++ ++..||||.+.... .+.+.+|++++++++||||+++++++... ..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 45567888874 999999999999743 35579999875433 24588899999999999999999998754 68
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
|+||||+++|+|.+++. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHT----TCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHhh----ccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhh
Confidence 99999999999998873 234568999999999999999999999 779999999999999999999999999998
Q ss_pred cccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 158 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
....... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||......+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i--------- 225 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI--------- 225 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH---------
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHH---------
Confidence 7754332 222334567889999999999999999999999999999998 899998754321 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++++.+||.+||+.||++|||+.++++.|+......
T Consensus 226 ----~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 226 ----EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 122223456677789999999999999999999999999999887553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-57 Score=384.92 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=200.5
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (312)
+.|++++.||+|+||.||+|+ ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 359999999999999999998 56789999997654321 35788999999999999999999999999999999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
|||.++++..+. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~-----~~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHH-----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999887655 234568999999999999999999999 7799999999999999999999999999976533
Q ss_pred CCcCCCCccccCcccccchhhhhh---cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...... ..... +
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~-------------i 226 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-------------I 226 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH-------------H
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHH-------------H
Confidence 234578999999999865 35899999999999999999999999754321 11111 1
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+..+++++.+||.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111122334456889999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-57 Score=386.72 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=192.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
.+.|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5679999999999999999999 457899999976533 23456789999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC---CCCceEEeeccccccc
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFL 159 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~---~~~~vkl~Dfg~a~~~ 159 (312)
|++|++|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l-----~~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHH-----HTCSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhh-----hcccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999998 344578999999999999999999999 7799999999999995 5789999999999865
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .....+...
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~---------- 224 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKA---------- 224 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTT----------
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhcc----------
Confidence 4332 223456899999999999999999999999999999999999999764321 111111110
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+++++.+||.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111122334566889999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=373.86 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=202.8
Q ss_pred cccccCcceEEEeeeeC---CceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEeccC
Q 021441 15 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 86 (312)
Q Consensus 15 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (312)
++||+|+||.||+|.++ +++.||+|.+.... .+.+.+|+.++++++||||+++++++... ..|+||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999732 35789999865432 24688999999999999999999998654 57899999999
Q ss_pred CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc-C
Q 021441 87 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A 165 (312)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~-~ 165 (312)
|+|.+++ .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... .
T Consensus 92 g~L~~~l-----~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHH-----HHCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHH-----hhccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999988 344568899999999999999999999 7799999999999999999999999999987643321 1
Q ss_pred CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhhcc
Q 021441 166 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 244 (312)
Q Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (312)
.......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... ..... +.....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~-------------i~~~~~ 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM-------------LEKGER 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH-------------HHTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHH-------------HHcCCC
Confidence 22334568889999999999999999999999999999998 89999864422 11111 112223
Q ss_pred ccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 245 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
...+..+++++.+||.+||+.||++|||++++++.|+....+-++
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 345666778999999999999999999999999999988765443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=375.68 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=195.7
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee----CCeEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF 78 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (312)
+-|++.++||+|+||.||+|. ..+++.||+|.+... ..+.+.+|+++++.++||||+++++++.. ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 334778899999999999999 457889999975432 22457899999999999999999999864 34679
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC-CCCceEEeeccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRN 157 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~-~~~~vkl~Dfg~a~ 157 (312)
+||||+++++|.+++ .....+++..+..++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||+|+
T Consensus 89 ivmE~~~~g~L~~~l-----~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEECCCSCBHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHH-----hccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999988 334568899999999999999999998333399999999999996 57899999999997
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .......+....
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~------- 229 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV------- 229 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC-------
T ss_pred eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCC-------
Confidence 64322 2234578999999999875 599999999999999999999999975432 122222211111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.....+...++++.++|.+||+.||++|||++|+++|
T Consensus 230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0111222334679999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=373.58 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=205.4
Q ss_pred HHhcCCCcccccccCcceEEEeeeeCC-----ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCCe
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
+..+.|++.+.||+|+||.||+|.++. ...||||.+..... ..+.+|+.+++.++||||+++++++...+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 445679999999999999999998432 24799998754432 357889999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.++||||+.++++.+.+. .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEEEEECCTTEEHHHHHH----HTTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEEecccCcchhhhh----cccccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999887763 233568899999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+....... ........+|..|+|||++.+..++.++|||||||++|||+++..||..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~------------ 223 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVM------------ 223 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHH------------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHH------------
Confidence 87644322 2223344678899999999999999999999999999999997666543221 11111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 288 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~ 288 (312)
..+........+..+++++.+||.+||+.||++|||+.++++.|+.+++..-
T Consensus 224 -~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 224 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp -HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 1122233344566677899999999999999999999999999999887543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-56 Score=385.15 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=205.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++++.||+|+||.||+|. ..+++.||+|.+..... +.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4689999999999999999999 45789999998765443 4577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC--CCceEEeeccccccccC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~--~~~vkl~Dfg~a~~~~~ 161 (312)
+++|+|.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999888732 33468999999999999999999999 77999999999999964 67899999999987643
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+. ......+.... .
T Consensus 179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~----------~ 242 (350)
T d1koaa2 179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD----------W 242 (350)
T ss_dssp TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC----------C
T ss_pred cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC----------C
Confidence 32 22345789999999999999999999999999999999999999975432 11111111110 0
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.+||.+||..||++|||++|+++|
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111223456789999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=373.41 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=204.5
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeeeC-C---ceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeC
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQEN 74 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (312)
+|++..++|++.+.||+|+||.||+|... + +..||+|.+..... ..+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 36778899999999999999999999843 2 35789998764433 357889999999999999999999864
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
+.+|+||||++++++.+++. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH----HTTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred CeEEEEEEeccCCcHHhhhh----ccCCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccch
Confidence 57899999999999988763 234567899999999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
+|+........ ......+|+.|+|||++.+..|+.++|||||||++|||++ |..||......+.. ..+
T Consensus 154 ~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i------- 222 (273)
T d1mp8a_ 154 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI------- 222 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH-------
T ss_pred hheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHH-------
Confidence 99876433222 2334567889999999999999999999999999999998 89999775543221 111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
........+..+++++.+||.+||+.||++|||+.+++++|+.++++.
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 223 ------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111223456667789999999999999999999999999999988763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=375.76 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=209.3
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC--hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEE
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (312)
++|++..++|++.+.||+|+||.||+|..++++.||+|.+.... .+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 46788889999999999999999999998777889999876543 4679999999999999999999999865 45799
Q ss_pred EEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccc
Q 021441 80 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 159 (312)
Q Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~ 159 (312)
||||+.+|+|..++... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++++||+|||+++..
T Consensus 89 v~Ey~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhc
Confidence 99999999998887422 23458999999999999999999999 77999999999999999999999999999866
Q ss_pred cCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 160 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
..... .......+|+.|+|||++.+..++.++|||||||++|||++|..||..... ....... +
T Consensus 164 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~-------------i 227 (285)
T d1fmka3 164 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQ-------------V 227 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH-------------H
T ss_pred cCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH-------------H
Confidence 43322 223345688899999999999999999999999999999997766654322 1111111 1
Q ss_pred hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 240 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
........+..+++++.++|.+||+.||++|||++++++.|+..+
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 122233456667789999999999999999999999998888765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-56 Score=385.12 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=206.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh---hHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++|++++.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3679999999999999999999 45799999998765433 3577899999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeC--CCCceEEeeccccccccC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~--~~~~vkl~Dfg~a~~~~~ 161 (312)
|++++|.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999987763 234468999999999999999999999 7799999999999998 678999999999987654
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 241 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (312)
.. ......+|+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+... ....+... ..
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~----------~~ 245 (352)
T d1koba_ 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKRC----------DW 245 (352)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHHC----------CC
T ss_pred CC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC----------CC
Confidence 32 2334568889999999999999999999999999999999999997644221 11111110 11
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.........+++++.+||.+||..||.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223344567889999999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=376.05 Aligned_cols=269 Identities=24% Similarity=0.364 Sum_probs=207.4
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGY 70 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~ 70 (312)
++|++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 468888899999999999999999999832 347899998765432 3466677777766 68999999998
Q ss_pred eeeC-CeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 71 CQEN-NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 71 ~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
+... ..+|+||||+++|+|.+++..... .....+++..+..++.|++.||.|||+ +||+||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCcc
Confidence 7654 468999999999999998853221 123457899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC-CCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~-~pf~~~~~~ 217 (312)
|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998765544444445567899999999999999999999999999999999875 577654432
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
. .... .+........+..+++++.++|.+||+.||++|||++++++||+++++..
T Consensus 244 ~--~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 E--EFCR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp H--HHHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H--HHHH-------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2 1111 11222233455566788999999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=379.82 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=209.1
Q ss_pred HHhcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
+..++|++++.||+|+||.||+|+ ..+++.||+|++. ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 356789999999999999999999 5679999999764 334567889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
+||||+++|+|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.
T Consensus 82 iv~ey~~gg~L~~~~-----~~~~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 82 FVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHH-----HHHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cceeccCCCchhhhh-----hcccCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999999888 345668899999999999999999999 7799999999999999999999999999986
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 238 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (312)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|..||...+.. .......
T Consensus 155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~----------- 218 (337)
T d1o6la_ 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL----------- 218 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-----------
T ss_pred cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHh-----------
Confidence 54322 2234467899999999999999999999999999999999999999864421 1111111
Q ss_pred hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 239 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
.. ...++..+++++.+||.+||+.||.+|++ ++++++|
T Consensus 219 -~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 219 -ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -cC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11 12345566788999999999999999995 7888775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=370.13 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=207.6
Q ss_pred hhHHhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-hhHHHHHHHHHhcCCCccceeeeeeeee-CCeEEEEE
Q 021441 4 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIY 81 (312)
Q Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 81 (312)
|.+..++|++.+.||+|+||.||+|..+ ++.||+|.+.... .+.+.+|++++++++||||+++++++.+ .+.+|+||
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 5677889999999999999999999985 6789999886554 4668999999999999999999998854 45689999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccC
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 161 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~ 161 (312)
||+++|+|.+++.. .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++++|||+++....
T Consensus 81 ey~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHH---HHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999832 122357899999999999999999999 7799999999999999999999999999986533
Q ss_pred CCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 162 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
. .....++..|+|||++.+..++.++|||||||++|||+| |..||...+..+. ... +.
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~-------------i~ 214 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR-------------VE 214 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH-------------HT
T ss_pred C-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHH-------------HH
Confidence 2 233456778999999999999999999999999999998 6777765443221 111 12
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
......++..+++++.+||.+||..||.+|||+.+++++|+++...+
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 22334566667789999999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=377.18 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=203.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (312)
.++|++.+.||+|+||.||+|+ ..+++.||+|.+... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999 457899999975321 245688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC----ceEEeec
Q 021441 78 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA 153 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~----~vkl~Df 153 (312)
|+||||+++++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999883 34568999999999999999999999 7799999999999998877 5999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
|++........ .....+|+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. .....+....
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~--- 232 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVN--- 232 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTC---
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcC---
Confidence 99987644322 23346788899999999999999999999999999999999999864322 1111111110
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+...++++.+||.+||+.||++|||++++++|
T Consensus 233 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 -------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011122345789999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=376.35 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=207.1
Q ss_pred hcCCCcccccccCcceEEEeeeeC-Cce----EEEEEeCCC----CChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (312)
..+|++++.||+|+||.||+|.+. +++ +||+|.+.. .....+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 357999999999999999999843 443 689997543 2345789999999999999999999999875 567
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++++++.+++|.+.+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHH----HTSSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEeccCCccccccc----ccccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeecccccee
Confidence 8889999999987773 234568899999999999999999999 7799999999999999999999999999988
Q ss_pred ccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 159 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
..............+|+.|+|||++.+..|+.++|||||||++|||+| |..||......+. ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~------------ 225 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI------------ 225 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHH------------
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHH------------
Confidence 765444444444568899999999999999999999999999999998 7888876543322 111
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
+........+..+++++.+|+.+||..||.+|||+.+++++|+.+.+..
T Consensus 226 -i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 226 -LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 1222223455666789999999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-55 Score=376.28 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=206.0
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++++.||+|+||.||+|+ ..+++.||+|++. ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4789999999999999999999 4578999999764 33456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.|++|..++ .....++...+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+...
T Consensus 83 mE~~~gg~l~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHH-----HHTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCccccccc-----cccccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999998887 345567888889999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. .....||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.. .....+. .
T Consensus 156 ~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~------------~ 215 (316)
T d1fota_ 156 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKIL------------N 215 (316)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------H
T ss_pred cc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHH------------c
Confidence 33 23457899999999999999999999999999999999999999764321 1111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
. ....+..+++++.+++.+||..||.+|+ |++++++|
T Consensus 216 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 216 A--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1234555668899999999999999996 89999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-55 Score=374.68 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=215.1
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 71 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (312)
.+++++.++|++.+.||+|+||.||+|+.+ +++.||||++..... ..+.+|+.+++.++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 457788899999999999999999999843 457899998865442 4588999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-------------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 132 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH 132 (312)
......+++|||+.+++|.+++..... .....+++..+..++.|++.||+|||+ ++++|
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence 999999999999999999988843211 122347888999999999999999999 77999
Q ss_pred cCCCCCceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC-CCC
Q 021441 133 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EAS 211 (312)
Q Consensus 133 ~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~-~pf 211 (312)
|||||+||+++.++.+||+|||+|+...............+++.|+|||.+.+..|+.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998765444333344456778899999999999999999999999999999986 567
Q ss_pred CCCCCCChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q 021441 212 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 284 (312)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~ 284 (312)
......+ ....+ ........+..+++++.+||.+||+.||++|||+.++++.|+++.
T Consensus 244 ~~~~~~e---~~~~v-------------~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE---VIYYV-------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH---HHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH---HHHHH-------------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6543221 11111 112223455666789999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-55 Score=380.55 Aligned_cols=248 Identities=20% Similarity=0.286 Sum_probs=202.6
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC------ChhHHHH---HHHHHhcCCCccceeeeeeeeeCCe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFID---EVCFLASIQHRNLVTLLGYCQENNL 76 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~------~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (312)
..++|++.+.||+|+||.||+|+ ..+++.||+|++... ....+.+ ++.+++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 35789999999999999999999 457899999986422 2222333 4667778889999999999999999
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
+|+||||+++++|.+++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|
T Consensus 82 ~~ivmE~~~gg~L~~~l-----~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEECCCCSCBHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEEecCCCcHHHHH-----HhcccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeecee
Confidence 99999999999999988 344567889999999999999999999 77999999999999999999999999999
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
+...... .....||+.|+|||++.. ..|+.++|||||||++|+|+||..||...............
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--------- 221 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------- 221 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---------
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 8765432 334579999999999864 56899999999999999999999999875544332211111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE 279 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~ 279 (312)
.......+..+++++.+||.+||..||++||| ++++++|
T Consensus 222 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 -----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01112344556788999999999999999999 6888765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=369.65 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=214.9
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeee-CC-------ceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QD-------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLL 68 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~-------~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~ 68 (312)
.+|.+..++|++++.||+|+||.||+|+. .+ +..||+|.+..... ..+.+|...+.++ +||||++++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 35778889999999999999999999983 22 35799998765543 3466788888887 799999999
Q ss_pred eeeeeCCeEEEEEEeccCCcccccccCccc-----------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 021441 69 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 137 (312)
Q Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp 137 (312)
+++.+.+..|+||||+.+|+|.+++..... .....+++..+..++.|++.||.|||+ ++|+||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecc
Confidence 999999999999999999999999853321 123568999999999999999999999 7799999999
Q ss_pred CceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCC
Q 021441 138 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP 216 (312)
Q Consensus 138 ~Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~ 216 (312)
+|||++.++.+||+|||.+................+++.|+|||.+.+..|+.++|||||||++|||++ |..||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999988766555445556678889999999999999999999999999999998 6888875442
Q ss_pred CChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 021441 217 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 285 (312)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~ 285 (312)
. .... .+........+..+++++.+||.+||+.||++|||+.++++.|++++.
T Consensus 244 ~---~~~~-------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 E---ELFK-------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---HHHH-------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHHH-------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 1111 122223344556667899999999999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=370.65 Aligned_cols=270 Identities=24% Similarity=0.397 Sum_probs=219.9
Q ss_pred HhhHHhcCCCcccccccCcceEEEeeee------CCceEEEEEeCCCCCh----hHHHHHHHHHhcC-CCccceeeeeee
Q 021441 3 ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYC 71 (312)
Q Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~ 71 (312)
.|++..++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4777889999999999999999999973 3467899998765432 3577899999998 699999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-------------ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 138 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~ 138 (312)
......|+||||+++++|.+++..... .....+++..+..++.||+.||+|||+ +|++||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccc
Confidence 999999999999999999988853221 123458899999999999999999999 77999999999
Q ss_pred ceEeCCCCceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 021441 139 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD 217 (312)
Q Consensus 139 Nil~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~ 217 (312)
||+++.++.++++|||.++...............+|+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765443333445678899999999999999999999999999999999 55555543332
Q ss_pred ChhhHHHHhhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 021441 218 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 289 (312)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~~~ 289 (312)
+. +..++........+...++++.+||.+||+.||.+|||++++++.|++.+.+..|
T Consensus 255 ~~---------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~~ 311 (311)
T d1t46a_ 255 SK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (311)
T ss_dssp HH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HH---------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCCC
Confidence 11 1112223333445556678999999999999999999999999999999887543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-55 Score=365.51 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=204.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC------------hhHHHHHHHHHhcCC-Cccceeeeeeeee
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQE 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~------------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 73 (312)
.++|++.+.||+|+||+||+|+ ..+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3789999999999999999999 4578999999754322 124778999999996 9999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
++..|+||||+++++|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccc
Confidence 999999999999999999983 44568999999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhc------CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
|+++...... ......||+.|.|||.+.+. .++.++||||+||++|+|++|..||...+... ....+.
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i~ 228 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIM 228 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHHHHH
Confidence 9998765432 23345789999999998754 35789999999999999999999998654211 111111
Q ss_pred hhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 228 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... ..........+++++.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~----------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGN----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTC----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCC----------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 110 011122334566899999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-55 Score=366.34 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=201.1
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh------hHHHHHHHHHhcCCCccceeeeeeeeeCC----e
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENN----L 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 76 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..... ..+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999 56799999998754322 35788999999999999999999987543 4
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.|+||||++|++|.+++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~-----~~~~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhh-----cccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhh
Confidence 79999999999998877 344568999999999999999999999 77999999999999999999999999988
Q ss_pred ccccCCCc-CCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhh
Q 021441 157 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 235 (312)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 235 (312)
........ ........||+.|+|||++.+..|+.++|||||||++|+|+||..||...+.. ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~~~----- 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDP----- 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCC-----
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhcCC-----
Confidence 76543321 22233456899999999999999999999999999999999999999754321 11111111111
Q ss_pred hHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHH
Q 021441 236 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL 284 (312)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~~ll~~l~~~~ 284 (312)
.........+++++.++|.+||..||.+|| |++++++.|.++.
T Consensus 232 ------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 ------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111123344567899999999999999999 8999999988775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=375.08 Aligned_cols=243 Identities=20% Similarity=0.266 Sum_probs=205.4
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
.++|++++.||+|+||.||+|. ..+++.||+|++. ......+.+|+.+++.++||||+++++++......|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4789999999999999999999 4579999999764 23445688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+.+++|..++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+...
T Consensus 120 ~e~~~~g~l~~~l-----~~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 120 MEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHH-----HHHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccccchhhhH-----hhcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999998888 334568999999999999999999999 779999999999999999999999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
.. .....||+.|+|||++.+..|+.++|||||||++|+|+||..||...+. ......+. .
T Consensus 193 ~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~------------~ 252 (350)
T d1rdqe_ 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIV------------S 252 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------H
T ss_pred cc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHh------------c
Confidence 32 2345689999999999999999999999999999999999999975432 11111111 1
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~~ll~~ 279 (312)
. ....+..+++++.++|.+||..||.+|+ |++++++|
T Consensus 253 ~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 1233455678899999999999999994 89999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=372.17 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=203.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCC------CCChhHHHHHHHHHh-cCCCccceeeeeeeeeCCeEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFLI 80 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~------~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (312)
++|++++.||+|+||+||+|. ..+++.||+|++. ......+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 689999999999999999999 5579999999864 334455666666655 68999999999999999999999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 160 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~ 160 (312)
|||+++|+|.+++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i-----~~~~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHh-----hccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999998 344568899999999999999999999 779999999999999999999999999998654
Q ss_pred CCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 240 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (312)
... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. .....+...
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~----------- 218 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMD----------- 218 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHC-----------
T ss_pred ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHcC-----------
Confidence 322 2234457899999999999999999999999999999999999999764422 212111111
Q ss_pred hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 021441 241 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE 279 (312)
Q Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-~ll~~ 279 (312)
...++..+++++.+||.+||..||++|||+. ++++|
T Consensus 219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1234555678899999999999999999996 77653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=371.39 Aligned_cols=249 Identities=20% Similarity=0.237 Sum_probs=203.6
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChh--HHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.++|++++.||+|+||.||+|. ..+++.||+|.+.....+ .+.+|+.+|+.++||||+++++++.+.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 4789999999999999999999 457899999988765543 4779999999999999999999999999999999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCC--CceEEeeccccccccCC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRT 162 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~--~~vkl~Dfg~a~~~~~~ 162 (312)
+|++|.+++. .....+++..+..++.||+.||.|||+ +||+||||||+||+++.+ +.++|+|||++......
T Consensus 84 ~gg~L~~~i~----~~~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHT----SSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999883 223468999999999999999999999 779999999999999854 48999999999876432
Q ss_pred CcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh-hhhhhhhHHhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFSNLLKILDE 241 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (312)
. ......+++.|+|||...+..|+.++|||||||++|+|++|..||...+.. .....+.+. ..+
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~--------- 222 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTF--------- 222 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCC---------
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCC---------
Confidence 2 123345788899999999999999999999999999999999999764432 111111111 000
Q ss_pred hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 242 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.......+++++.+||.+||..||.+|||++|+++|
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111235789999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=366.68 Aligned_cols=258 Identities=20% Similarity=0.245 Sum_probs=196.0
Q ss_pred cccccccCcceEEEeee-eCCceEEEEEeCCCCC--------hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 13 DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 13 ~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
.++.||+|+||+||+|. ..+++.||+|++.... ...+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999 5578999999865332 23578999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.++++..+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988777665 344567888899999999999999999 779999999999999999999999999998765432
Q ss_pred cCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh---hhHHh
Q 021441 164 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN---LLKIL 239 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 239 (312)
. ......+|+.|+|||++.+. .|+.++|||||||++|+|++|..||...+..+...........+.... .....
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2 22345688999999998755 579999999999999999999999976543222111111111100000 00000
Q ss_pred hh--------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 DE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.. ..........++++.+||.+||..||++|||++|+|+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00001112345789999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=362.05 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=198.8
Q ss_pred HHhcCCCcccccccCcceEEEeeeeC--C--ceEEEEEeCCCC------ChhHHHHHHHHHhcCCCccceeeeeeeeeCC
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLLQ--D--GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN 75 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~--~~~vaiK~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (312)
+..++|++.+.||+|+||.||+|... + ...||+|.+... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 34578999999999999999999832 2 347899976532 124688999999999999999999999764
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
..++||||++++++.+.+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~lv~e~~~~~~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp SCEEEEECCTTCBHHHHHH----HHGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred chheeeeeecCcchhhhhh----cccCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchh
Confidence 6789999999999987763 234568899999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcC-CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHh-CCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 156 RNFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 156 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
++........ .......++..|+|||++.+..++.++|||||||++|||+| |..||...+..+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~--------- 225 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH--------- 225 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHH---------
Confidence 9876543322 12233456778999999999999999999999999999998 899997644321 111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT 283 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~ 283 (312)
.+.........+..+++++.++|.+||+.||++|||+.++++.|++.
T Consensus 226 ---~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ---KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122223345566678999999999999999999999999888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=370.22 Aligned_cols=253 Identities=17% Similarity=0.202 Sum_probs=198.9
Q ss_pred hcCCCccc-ccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhc-CCCccceeeeeeeee----CCeEEEE
Q 021441 8 TKNFSDKN-LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLAS-IQHRNLVTLLGYCQE----NNLQFLI 80 (312)
Q Consensus 8 ~~~y~~~~-~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv 80 (312)
.++|.+.+ .||+|+||.||+|. ..+++.||||.+.. ...+.+|+.++.+ .+||||+++++++.+ ...+|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 57898875 59999999999999 46789999998754 4567789988655 489999999999865 4568999
Q ss_pred EEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccc
Q 021441 81 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN 157 (312)
Q Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~ 157 (312)
||||+||+|.+++.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++
T Consensus 88 mEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 88 MECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccceee
Confidence 999999999999842 123468999999999999999999999 77999999999999985 5579999999998
Q ss_pred cccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhH
Q 021441 158 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 237 (312)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (312)
...... ......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.................
T Consensus 163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~------- 232 (335)
T d2ozaa1 163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------- 232 (335)
T ss_dssp ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC-------
T ss_pred eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC-------
Confidence 765432 2334578999999999999999999999999999999999999997655433221111000000
Q ss_pred HhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 238 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...........+++++.+||.+||+.||++|||+.++++|
T Consensus 233 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000011113456789999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=361.28 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=209.9
Q ss_pred HHhcCCCcccccccCcceEEEeeee-CCce--EEEEEeCCCC----ChhHHHHHHHHHhcC-CCccceeeeeeeeeCCeE
Q 021441 6 LATKNFSDKNLIGEGKFGEVYKGLL-QDGM--LVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ 77 (312)
Q Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~--~vaiK~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 77 (312)
+..++|++.+.||+|+||.||+|.+ .++. .||||.+... ..+.+.+|++++..+ +||||+++++++...+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3457899999999999999999984 3444 4778865322 345689999999998 799999999999999999
Q ss_pred EEEEEeccCCcccccccCcc-----------cccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 78 FLIYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 78 ~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
|+||||+++|+|.+++.... ......+++..+..++.|++.||.|+|+ ++|+||||||+|||++.++
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCC
Confidence 99999999999999885331 1234568899999999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCC-CCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~-pf~~~~~~~~~~~~~~ 225 (312)
.+||+|||+++...... ......+|..|+|||.+.+..|+.++|||||||++|||++|.. ||...+. ......
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~ 238 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEK 238 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH
T ss_pred ceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHH
Confidence 99999999987654322 2234467888999999999999999999999999999999765 5654331 111111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
+ ........+..+++++.+||.+||+.||++|||+++++++|+.++++.
T Consensus 239 i-------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 239 L-------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp G-------------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H-------------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 222234456667789999999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=362.05 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=201.1
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++++.||+|+||.||+|. ..+++.||+|++... ....+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999999999 467899999986432 24568899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
|+.++++.... ......+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~~~~~~----~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMD----ASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHH----HTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhh----hhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99775444333 1234568999999999999999999999 77999999999999999999999999999876433
Q ss_pred CcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh--hh---hhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD---FSNLL 236 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~---~~~~~ 236 (312)
. .......+|+.|+|||+.....+ +.++|||||||++|+|++|..||...+..+ ......... +. +....
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGG
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccc
Confidence 2 22344578899999999887765 889999999999999999999997643221 112111111 00 00000
Q ss_pred HHhh--hhc-------cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 KILD--ERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 ~~~~--~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ... ........++++.+|+.+||..||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000 000112344789999999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=359.88 Aligned_cols=272 Identities=21% Similarity=0.351 Sum_probs=204.1
Q ss_pred hcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHH--hcCCCccceeeeeeeeeCC----eEEEEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL--ASIQHRNLVTLLGYCQENN----LQFLIY 81 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l--~~l~h~~i~~~~~~~~~~~----~~~lv~ 81 (312)
.++|.+.+.||+|+||.||+|+.+ ++.||||.+.........+|.+++ ..++||||+++++++...+ .+|+||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 467889999999999999999975 789999998776666666665555 4678999999999997643 579999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
||+++|+|.+++. ...+++..+..++.|++.||.|+|.. .+||+||||||+|||++.++.+||+|||+
T Consensus 81 Ey~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999983 23578999999999999999999963 25799999999999999999999999999
Q ss_pred cccccCCCc--CCCCccccCcccccchhhhhhcC------CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhh
Q 021441 156 RNFLGRTDV--AGPSSQVTADEIFLASEVKEFRR------FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 227 (312)
Q Consensus 156 a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~ 227 (312)
++....... ........||+.|+|||++.+.. ++.++|||||||++|||+||..||............ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccc
Confidence 987654321 22234457899999999987653 577899999999999999999887543322211100 000
Q ss_pred hhhhhhhhhH-HhhhhccccC-----ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 228 NSRDFSNLLK-ILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 228 ~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.......... .......+.. +...+..+.+|+.+||+.||++|||+.|++++|+++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0000001111 1111111111 2345567999999999999999999999999999988764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-53 Score=358.75 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=203.1
Q ss_pred cCCCcccccccCcceEEEeeeeCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEEe
Q 021441 9 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++|++++.||+|+||+||+|+.++++.||+|.+.... ...+.+|+.+++.++||||+++++++...+..|++|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998888999999875432 35688999999999999999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 163 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~ 163 (312)
+.++++..+. .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887776665 345678999999999999999999999 679999999999999999999999999998764432
Q ss_pred cCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---hhhhhHH-
Q 021441 164 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNLLKI- 238 (312)
Q Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 238 (312)
. ......+++.|+|||.+.+.. ++.++|||||||++|||++|..||.+....+...........+. +......
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 2 223345788899999987655 58999999999999999999999976543222111111111110 1111000
Q ss_pred --------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 --------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.............++++.+||.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111122334456789999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=363.52 Aligned_cols=267 Identities=24% Similarity=0.377 Sum_probs=217.4
Q ss_pred hHhhHHhcCCCcccccccCcceEEEeeeeC------CceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeee
Q 021441 2 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 71 (312)
Q Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (312)
++|++..++|++.+.||+|+||.||+|.++ +++.||||.+..... ..+.+|+.++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 457888899999999999999999999853 257899998865433 2478999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCccc-----ccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC
Q 021441 72 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 146 (312)
Q Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~ 146 (312)
......++||||+.+|+|.+++..... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCc
Confidence 998999999999999999988743211 122346788899999999999999999 7799999999999999999
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCC-CCCCCCCCCChhhHHHH
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVEL 225 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~-~pf~~~~~~~~~~~~~~ 225 (312)
++||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||+||. .||...... .....
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~~ 247 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRF 247 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHHH
Confidence 99999999998765544333344456788999999999999999999999999999999985 667553321 11111
Q ss_pred hhhhhhhhhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 021441 226 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 286 (312)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~ 286 (312)
+ ........+..+++.+.++|.+||+.||.+|||+++++++|++.++.
T Consensus 248 i-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 248 V-------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp H-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred H-------------HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 11222345566678999999999999999999999999999877653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=361.18 Aligned_cols=238 Identities=23% Similarity=0.366 Sum_probs=195.7
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC---------ChhHHHHHHHHHhcCC--CccceeeeeeeeeCC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENN 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 75 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.+... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999999 557899999975421 1234678999999986 899999999999999
Q ss_pred eEEEEEEeccC-CcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-CCceEEeec
Q 021441 76 LQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADA 153 (312)
Q Consensus 76 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-~~~vkl~Df 153 (312)
..|+||||+.+ +++.+++ .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~-----~~~~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 4666666 234568899999999999999999999 77999999999999985 479999999
Q ss_pred cccccccCCCcCCCCccccCcccccchhhhhhcCC-CcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 154 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 154 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
|+|....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .....
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~~---- 219 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRG---- 219 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHC----
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhhc----
Confidence 9998654332 234578999999999988776 677999999999999999999996421 00100
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
...++..+++++.+||.+||+.||++|||++|+++|
T Consensus 220 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112334456889999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=354.24 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=202.1
Q ss_pred ccccccCcceEEEeeeeCC----ceEEEEEeCCCCC----hhHHHHHHHHHhcCCCccceeeeeeeee-CCeEEEEEEec
Q 021441 14 KNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI 84 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 84 (312)
.++||+|+||+||+|.... ...||+|.++... ...+.+|++++++++||||+++++++.. .+..|+||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998432 2368999875432 2458899999999999999999999865 46889999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCCCc
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 164 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~~~ 164 (312)
.+++|.+++.. .....++..+..++.|++.||.|+|+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999988742 34456778889999999999999999 7799999999999999999999999999987654322
Q ss_pred C--CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHhhhh
Q 021441 165 A--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 242 (312)
Q Consensus 165 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (312)
. .......+|..|+|||.+.+..++.++|||||||++|||+||..||....... .....+ ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i-------------~~g 250 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL-------------LQG 250 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-------------HTT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH-------------HcC
Confidence 2 22334568889999999999999999999999999999999888876533211 111111 111
Q ss_pred ccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 243 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
.....+..+++++.+||.+||+.||++||++.|++++|+.+.+.-
T Consensus 251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 123345556789999999999999999999999999999998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=357.55 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=198.5
Q ss_pred hcCCCcccccccCcceEEEeeee-CC-ceEEEEEeCC-----CCChhHHHHHHHHHhcC---CCccceeeeeeeee----
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGLL-QD-GMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQE---- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~-~~~vaiK~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 73 (312)
.++|++++.||+|+||.||+|.. .+ ++.||+|++. ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999984 44 6779999753 22334567787777665 79999999999853
Q ss_pred -CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEee
Q 021441 74 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD 152 (312)
Q Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~D 152 (312)
....|++||++.++++..... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecc
Confidence 346799999999877654431 344567899999999999999999999 7799999999999999999999999
Q ss_pred ccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh-
Q 021441 153 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD- 231 (312)
Q Consensus 153 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~- 231 (312)
||.+....... ......||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+...........+.
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987654332 23445789999999999999999999999999999999999999986543222111111111000
Q ss_pred --hhhhh-------HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 232 --FSNLL-------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 232 --~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
+.... ...............++.+.+||.+||+.||++|||+.|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000111122344556789999999999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=351.95 Aligned_cols=265 Identities=19% Similarity=0.251 Sum_probs=196.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeee--------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-------- 73 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 73 (312)
.++|+++++||+|+||+||+|. ..+++.||||++... ....+.+|+++++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 5799999999999999999999 457899999976432 33568899999999999999999998754
Q ss_pred CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeec
Q 021441 74 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 153 (312)
Q Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Df 153 (312)
.+..|+||||+.++++.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeec
Confidence 34579999999887766544 345568889999999999999999999 77999999999999999999999999
Q ss_pred cccccccCCCc--CCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhh
Q 021441 154 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 230 (312)
Q Consensus 154 g~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 230 (312)
|++........ ........+|+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+...............
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99977653322 2223334689999999998866 68999999999999999999999997644322222222211111
Q ss_pred hhhhhhHH--------hhhhccccC-------ChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 231 DFSNLLKI--------LDERLWSTF-------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 231 ~~~~~~~~--------~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
........ ......... ....++++.+||.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 10000000 000000000 01113577899999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=348.57 Aligned_cols=259 Identities=18% Similarity=0.249 Sum_probs=201.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCC-Cccceeeeeeeee--CCeEEEEEEe
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEY 83 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~ 83 (312)
.++|+++++||+|+||+||+|+ ..+++.||+|++.......+.+|+.+|+.+. ||||+++++++.. ...+|+||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 4679999999999999999999 4679999999998888888999999999995 9999999999874 4568999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeeccccccccCC
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT 162 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~~~ 162 (312)
+.+++|.... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||+|......
T Consensus 114 ~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 114 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred cCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999987554 357899999999999999999999 7799999999999998655 6899999999876433
Q ss_pred CcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhh-HHHHhhhhhhhhhhhHH--
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRDFSNLLKI-- 238 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~-- 238 (312)
. ......+|+.|+|||.+.+.. ++.++||||+||++|+|++|..||.......... ........+........
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 234456888999999988764 7999999999999999999999997654322111 11111111100000000
Q ss_pred ------------------hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 239 ------------------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 239 ------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.............++++.+||.+||..||++|||++|+|+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111223456789999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=344.16 Aligned_cols=264 Identities=17% Similarity=0.214 Sum_probs=201.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-CChhHHHHHHHHHhcCCCcc-ceeeeeeeeeCCeEEEEEEec
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYI 84 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 84 (312)
.++|++.+.||+|+||.||+|. ..+++.||+|.... .....+..|+++++.++|++ |+.+.+++...+..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 3679999999999999999998 45789999997543 33456889999999998766 555566667888899999999
Q ss_pred cCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC---CCceEEeeccccccccC
Q 021441 85 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGR 161 (312)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~---~~~vkl~Dfg~a~~~~~ 161 (312)
.+ ++...+. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. +..++++|||+|+....
T Consensus 86 ~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 GP-SLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-BHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred CC-chhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 65 5544442 234568999999999999999999999 77999999999999864 45799999999988754
Q ss_pred CCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 162 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 162 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||..||....................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~----- 233 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----- 233 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-----
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-----
Confidence 3321 123345689999999999999999999999999999999999999987655443332222111110
Q ss_pred HHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 237 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
..........+|+++.++|.+||+.||++||+++++.+.|+++..+.
T Consensus 234 ----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00011123344578999999999999999999999999999887653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.2e-50 Score=338.11 Aligned_cols=265 Identities=17% Similarity=0.242 Sum_probs=213.5
Q ss_pred HhcCCCcccccccCcceEEEeee-eCCceEEEEEeCCC-CChhHHHHHHHHHhcCCC-ccceeeeeeeeeCCeEEEEEEe
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
..++|++.+.||+|+||.||+|+ ..+++.||+|.... .....+.+|++.++.+.| +|++.+++++......|+||||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 36789999999999999999999 55789999997643 334567889999999965 8999999999999999999999
Q ss_pred ccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCC-----CCceEEeecccccc
Q 021441 84 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNF 158 (312)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~-----~~~vkl~Dfg~a~~ 158 (312)
+ +++|.+++. .....++...+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+|+.
T Consensus 83 ~-~~~l~~~~~----~~~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHH----hhccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 568877763 234468899999999999999999999 77999999999999974 57899999999987
Q ss_pred ccCCCcC-----CCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhh
Q 021441 159 LGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 233 (312)
Q Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 233 (312)
....... .......||+.|+|||.+.+..++.++|||||||++|||+||..||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6533211 12334569999999999999999999999999999999999999998766655444333322221111
Q ss_pred hhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 021441 234 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 287 (312)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~l~~~~~~~ 287 (312)
. ....+..+|+++.+++..||..+|++||+++.+.+.|++++++.
T Consensus 236 ~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 P---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp C---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1 11123334578999999999999999999999999999988664
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=352.92 Aligned_cols=262 Identities=19% Similarity=0.300 Sum_probs=196.3
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeeeCC------
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------ 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (312)
.++|++++.||+|+||+||+|. ..+++.||+|++.... ...+.+|+.+|+.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5789999999999999999999 4578999999876432 235778999999999999999999987654
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+ +.+|...+ ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM------KHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHH------HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHH------HhccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccc
Confidence 469999999 55676655 23568999999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 234 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 234 (312)
+...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+...................
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9876432 23456888999999988754 58999999999999999999999987543222211111111110000
Q ss_pred -----------hhHH---hhhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHH
Q 021441 235 -----------LLKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRT 283 (312)
Q Consensus 235 -----------~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~--l~~~ 283 (312)
.... .............++++.+||.+||..||.+|||+.|+|+| ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 00111122334456789999999999999999999999987 5443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=353.97 Aligned_cols=263 Identities=23% Similarity=0.258 Sum_probs=195.6
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCChhHHHHHHHHHhcCCCccceeeeeeeeeC------CeEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLIY 81 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 81 (312)
-+|+..++||+|+||+||+|+ ..+++.||||++.... ....+|+.++++++||||+++++++... ..+|+||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 368899999999999999999 4578999999875433 2345799999999999999999998542 3579999
Q ss_pred EeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC-ceEEeecccccccc
Q 021441 82 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLG 160 (312)
Q Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~-~vkl~Dfg~a~~~~ 160 (312)
||++++++..+... ......+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 99 Ey~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 99 DYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp ECCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred eccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99987644333211 1234568999999999999999999999 7799999999999999775 89999999998764
Q ss_pred CCCcCCCCccccCcccccchhhhhhc-CCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhhHHh
Q 021441 161 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 239 (312)
Q Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (312)
.... .....+++.|+|||.+.+. .|+.++|||||||++|||++|..||......+...........+.........
T Consensus 175 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 175 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2335688899999998764 68999999999999999999999997654322111111111111111111000
Q ss_pred h------------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 240 D------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 240 ~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ...........++++.+||.+||..||++|||+.|+|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000111223456789999999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=353.33 Aligned_cols=264 Identities=20% Similarity=0.286 Sum_probs=195.5
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh----hHHHHHHHHHhcCCCccceeeeeeeeeCC----eEE
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENN----LQF 78 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 78 (312)
.++|++++.||+|+||+||+|. ..+++.||||++..... ..+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999998 56799999998765433 35778999999999999999999986543 234
Q ss_pred EEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccccc
Q 021441 79 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
++++++.+++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5556677889998883 2358899999999999999999999 7799999999999999999999999999987
Q ss_pred ccCCCc-CCCCccccCcccccchhhhhh-cCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhhhh
Q 021441 159 LGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 236 (312)
Q Consensus 159 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (312)
...... ........+++.|+|||++.. ..++.++||||+||++|+|++|..||.........................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 644322 222344568899999999854 457899999999999999999999997654322221111111111000000
Q ss_pred --------H-Hhh-----hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 237 --------K-ILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 237 --------~-~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
. ... ...+.......++++.+|+.+||+.||.+|||++++|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 000011122345689999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=348.47 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=210.6
Q ss_pred HhcCCCcccccccCcceEEEeeee----CCceEEEEEeCCC-------CChhHHHHHHHHHhcCCC-ccceeeeeeeeeC
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASIQH-RNLVTLLGYCQEN 74 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~-------~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 74 (312)
..++|++++.||+|+||.||+|.. .+++.||+|.++. ...+.+.+|++++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 357899999999999999999973 2478999997643 234567889999999966 8999999999999
Q ss_pred CeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecc
Q 021441 75 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 154 (312)
Q Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg 154 (312)
...|++|||+.+++|.+++ .....+++..+..++.|++.||.|+|+ ++|+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i-----~~~~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TEEEEEECCCCSCBHHHHH-----HHHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CceeeeeecccccHHHHHH-----HhcccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeecc
Confidence 9999999999999999888 344566788899999999999999999 779999999999999999999999999
Q ss_pred ccccccCCCcCCCCccccCcccccchhhhhhcC--CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhh
Q 021441 155 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 232 (312)
Q Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 232 (312)
+++........ ......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||................
T Consensus 175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~----- 248 (322)
T d1vzoa_ 175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----- 248 (322)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-----
T ss_pred chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-----
Confidence 99876433222 123456888999999998654 5889999999999999999999998765544332221111
Q ss_pred hhhhHHhhhhccccCChHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHHHHHHhcccccccccCCC
Q 021441 233 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTELDRTLDKEMNLTTVMGEGTP 299 (312)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~~ll~~l~~~~~~~~~~~~~~~~~~~ 299 (312)
......++...++++.++|.+||..||.+||| ++|+++| -.-+.+++.++.....|
T Consensus 249 --------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H---pff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 249 --------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH---LFFQKINWDDLAAKKVP 309 (322)
T ss_dssp --------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS---GGGTTCCHHHHHTTCSC
T ss_pred --------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC---HhhcCCCHHHHHhCCCC
Confidence 11122345566789999999999999999994 7888754 11233455554443333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=340.16 Aligned_cols=260 Identities=20% Similarity=0.257 Sum_probs=203.3
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCC-----ChhHHHHHHHHHhcCCCccceeeeeeeeeCCeEEEEEE
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (312)
++|++++.||+|+||+||+|+ ..+++.||+|++... ....+.+|+.+++.++||||+++++++......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999999999 567899999975322 23567899999999999999999999999999999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccccccccCC
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT 162 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~~~~~~ 162 (312)
++.++++..++ .....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFD-----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHH-----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccc-----ccccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99998887776 345667889999999999999999999 77999999999999999999999999999876543
Q ss_pred CcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhh---h---hhhhh
Q 021441 163 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS---R---DFSNL 235 (312)
Q Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~---~---~~~~~ 235 (312)
.. ......++..|.|||++.+.. ++.++|||||||++|+|++|..||....... .....+... . .+...
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTG
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhh
Confidence 32 223345677899999988776 5899999999999999999999976533221 111111110 0 00000
Q ss_pred hHHh---------hhhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 236 LKIL---------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 236 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
.... ............++.+.+|+.+||+.||.+|||++|+|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0111122334456789999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=346.30 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=188.9
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC-----hhHHHHHHHHHhcCCCccceeeeeeeee------CC
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NN 75 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 75 (312)
.++|+++++||+|+||+||+|. ..+++.||||++.... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3689999999999999999999 4579999999865432 2357789999999999999999999853 36
Q ss_pred eEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeeccc
Q 021441 76 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 155 (312)
Q Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~ 155 (312)
.+|+||||+.++++.... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++++|||.
T Consensus 96 ~~~iv~Ey~~~~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhh
Confidence 789999999876554332 357889999999999999999999 7799999999999999999999999999
Q ss_pred cccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhh---h
Q 021441 156 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---F 232 (312)
Q Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---~ 232 (312)
++...... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+..............+. +
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 87654332 23445688899999999999999999999999999999999999976442211111110000000 0
Q ss_pred hhh----hH---------------Hhhhhc---cccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 233 SNL----LK---------------ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 233 ~~~----~~---------------~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
... .. ...... ........++++.+||.+||..||++||||+|+|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 000000 011123456789999999999999999999999977
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=342.98 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=193.8
Q ss_pred hcCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCCh-----hHHHHHHHHHhcCCCccceeeeeeeeeC-----Ce
Q 021441 8 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL 76 (312)
Q Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (312)
.++|++++.||+|+||+||+|+ ..+++.||||++..... ..+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4789999999999999999999 56799999998764432 3577899999999999999999998532 33
Q ss_pred EEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceEEeecccc
Q 021441 77 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 156 (312)
Q Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vkl~Dfg~a 156 (312)
.+++|+++.+++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchh
Confidence 466777888999998882 2458999999999999999999999 77999999999999999999999999998
Q ss_pred ccccCCCcCCCCccccCcccccchhhhhhcC-CCcccceehhHHHHHHHHhCCCCCCCCCCCChhhHHHHhhhhhhhhh-
Q 021441 157 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN- 234 (312)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 234 (312)
...... .....+++.|+|||...+.. ++.++|||||||++|+|++|..||.+.+...................
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 765332 23346788899999987765 58999999999999999999999986543222221111111100000
Q ss_pred -------hhHHhhh------hccccCChHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 021441 235 -------LLKILDE------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 279 (312)
Q Consensus 235 -------~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (312)
....... ..........++++.+||.+||..||++|||+.|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000 00000112345789999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-43 Score=307.61 Aligned_cols=263 Identities=17% Similarity=0.214 Sum_probs=188.8
Q ss_pred cCCCcccccccCcceEEEeee-eCCceEEEEEeCCCCC--hhHHHHHHHHHhcCC-----------Cccceeeeeeeee-
Q 021441 9 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE- 73 (312)
Q Consensus 9 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~- 73 (312)
.+|+++++||+|+||+||+|+ ..+++.||||++.... .+...+|+.+++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 469999999999999999999 4679999999887653 255678888888764 5789999988754
Q ss_pred -CCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCC------
Q 021441 74 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF------ 146 (312)
Q Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~------ 146 (312)
....++++.++..+....... .......+++..+..++.|++.||.|||+. .||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccc
Confidence 345667777765543321111 123456678899999999999999999962 5699999999999998765
Q ss_pred ceEEeeccccccccCCCcCCCCccccCcccccchhhhhhcCCCcccceehhHHHHHHHHhCCCCCCCCCCCChhh----H
Q 021441 147 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD----L 222 (312)
Q Consensus 147 ~vkl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~vl~~l~tg~~pf~~~~~~~~~~----~ 222 (312)
.++++|||.+...... .....+|+.|+|||++.+..|+.++||||+||++++|++|+.||.......... .
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999998765322 344568889999999999999999999999999999999999997654322111 1
Q ss_pred HHHhhh--hhhhhhhhH------Hhh-------------------hhccccCChHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 021441 223 VELVQN--SRDFSNLLK------ILD-------------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 275 (312)
Q Consensus 223 ~~~~~~--~~~~~~~~~------~~~-------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ 275 (312)
...... ..+...... ... ...........++++.+|+.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 110000 000000000 000 00112345667889999999999999999999999
Q ss_pred HHHH
Q 021441 276 VVTE 279 (312)
Q Consensus 276 ll~~ 279 (312)
+|+|
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.9e-26 Score=178.84 Aligned_cols=160 Identities=18% Similarity=0.111 Sum_probs=115.8
Q ss_pred CCcccccccCcceEEEeeeeCCceEEEEEeCCCCCh---------------------hHHHHHHHHHhcCCCccceeeee
Q 021441 11 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---------------------QEFIDEVCFLASIQHRNLVTLLG 69 (312)
Q Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~e~~~l~~l~h~~i~~~~~ 69 (312)
+.+.++||+|+||.||+|...+++.||+|....... ....+|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999977889999996432110 12345778888999999988876
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEeCCCCceE
Q 021441 70 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK 149 (312)
Q Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~~~givH~dikp~Nil~~~~~~vk 149 (312)
+.. .+++||++.+..+..+ +......++.|++.++.|||+ +||+||||||+|||+++++ ++
T Consensus 82 ~~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETTE-EE
T ss_pred ecC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCCC-EE
Confidence 532 2699999987655432 222245689999999999999 7799999999999999764 89
Q ss_pred EeeccccccccCCCcCCCCccccCcccccchh-----hhhhcCCCcccceehhHH
Q 021441 150 VADAGLRNFLGRTDVAGPSSQVTADEIFLASE-----VKEFRRFSEKSDVYSFGV 199 (312)
Q Consensus 150 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~sDiwslG~ 199 (312)
|+|||.|........ ..|.... .+..+.|+.++|+||+.-
T Consensus 143 liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 143 IIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp ECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 999999865432210 1122211 122467889999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.7e-08 Score=79.51 Aligned_cols=140 Identities=14% Similarity=0.081 Sum_probs=92.9
Q ss_pred HhcCCCcccccccCcceEEEeeeeCCceEEEEEeCCCC---ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEE
Q 021441 7 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYE 82 (312)
Q Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 82 (312)
....|++.+..+.++.+.||++... ++.+++|..... ....+.+|..++..+. +--+.+++.+....+..|+||+
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 3567777777666666799998755 455778865432 3345678888887763 3336777888888888999999
Q ss_pred eccCCcccccccCcccccccccCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 021441 83 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------------------------------------ 126 (312)
Q Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~lH~~------------------------------------ 126 (312)
+++|.++....... .. ...++.++...+..||+.
T Consensus 91 ~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 91 EADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp CCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred eccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99997775433110 00 111233344444444431
Q ss_pred ---------------------CCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 127 ---------------------SPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 127 ---------------------~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987777899998664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.63 E-value=8.2e-08 Score=77.04 Aligned_cols=76 Identities=16% Similarity=0.149 Sum_probs=57.5
Q ss_pred ccccCc-ceEEEeeeeCCceEEEEEeCCCCChhHHHHHHHHHhcCCC--ccceeeeeeeeeCCeEEEEEEeccCCcccc
Q 021441 16 LIGEGK-FGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSVSI 91 (312)
Q Consensus 16 ~lg~G~-~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (312)
.+..|. ...||++....+..+++|.........+..|...++.+.. --+.+++.+..+.+..|+||++++|.++..
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444555 3678999977777899998877777778888888887742 235667877778788899999999876643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=1.3e-05 Score=68.07 Aligned_cols=73 Identities=15% Similarity=0.113 Sum_probs=46.6
Q ss_pred ccccccCcceEEEeeeeC-CceEEEEEeCCC----------CChhHHHHHHHHHhcCC-C--ccceeeeeeeeeCCeEEE
Q 021441 14 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----------APTQEFIDEVCFLASIQ-H--RNLVTLLGYCQENNLQFL 79 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~----------~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 79 (312)
.+.||.|....||++... +++.+++|...+ ...++...|.+.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999844 467889995321 12344556888777662 2 345556654 3334568
Q ss_pred EEEeccCCc
Q 021441 80 IYEYIPNGS 88 (312)
Q Consensus 80 v~e~~~~~~ 88 (312)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.48 E-value=0.00076 Score=54.96 Aligned_cols=154 Identities=12% Similarity=-0.014 Sum_probs=80.2
Q ss_pred HhhHHhcCCCcccc-----cccCcceEEEeeeeCCceEEEEEeCCCC-ChhHHHHHHHHHhcCCCcc--ceeeee-----
Q 021441 3 ELSLATKNFSDKNL-----IGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRN--LVTLLG----- 69 (312)
Q Consensus 3 ~~~~~~~~y~~~~~-----lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~e~~~l~~l~h~~--i~~~~~----- 69 (312)
++.-..++|.+.+. |..|---+.|++...++ ++++|+.... ....+..|.+++..+.... +...+.
T Consensus 7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~ 85 (316)
T d2ppqa1 7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGE 85 (316)
T ss_dssp HHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred HHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCC
Confidence 34444567776443 34566678899987655 4899987543 4556677787777764221 111111
Q ss_pred -eeeeCCeEEEEEEeccCCcccccccC------------------cccccccc------------------cCHHHHHHH
Q 021441 70 -YCQENNLQFLIYEYIPNGSVSIHLYG------------------PSQVSRQK------------------LEFKHRLSI 112 (312)
Q Consensus 70 -~~~~~~~~~lv~e~~~~~~L~~~~~~------------------~~~~~~~~------------------~~~~~~~~i 112 (312)
+....+....++.+..+......... ........ .........
T Consensus 86 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (316)
T d2ppqa1 86 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE 165 (316)
T ss_dssp SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred cceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHH
Confidence 11223445667777766433211100 00000000 000111112
Q ss_pred HHHHHHHHHHHhc--CCCCeEecCCCCCceEeCCCCceEEeeccccc
Q 021441 113 ALGAAKGLAHLHS--LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 157 (312)
Q Consensus 113 ~~~i~~~L~~lH~--~~~givH~dikp~Nil~~~~~~vkl~Dfg~a~ 157 (312)
+......+..... ...|+||+|+.++|++++.+...-++||+.+.
T Consensus 166 l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 166 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222233332221 34679999999999999998878999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.0006 Score=55.97 Aligned_cols=134 Identities=10% Similarity=0.100 Sum_probs=76.4
Q ss_pred eEEEeeeeCCceEEEEEeCCCC--ChhHHHHHHHHHhcCCCcc--ceeee-----eeeeeCCeEEEEEEeccCCcccccc
Q 021441 23 GEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRN--LVTLL-----GYCQENNLQFLIYEYIPNGSVSIHL 93 (312)
Q Consensus 23 g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~e~~~l~~l~h~~--i~~~~-----~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (312)
-.||++...+|+.|++|...+. ...++..|...+..|.... ++..+ ..+...+..+.+++++.|..+...-
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 5899999888999999987654 3466788888887764211 11111 1234456778999999875442110
Q ss_pred ------------------cCcccccccccC----------------------HHHHHHHHHHHHHHHHHH--hcCCCCeE
Q 021441 94 ------------------YGPSQVSRQKLE----------------------FKHRLSIALGAAKGLAHL--HSLSPRVV 131 (312)
Q Consensus 94 ------------------~~~~~~~~~~~~----------------------~~~~~~i~~~i~~~L~~l--H~~~~giv 131 (312)
...........+ .......+..+...+.-. .....++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 000000011111 111222333333333222 12235699
Q ss_pred ecCCCCCceEeCCCCceEEeecccccc
Q 021441 132 HKDFKTANVLVDEDFIAKVADAGLRNF 158 (312)
Q Consensus 132 H~dikp~Nil~~~~~~vkl~Dfg~a~~ 158 (312)
|+|+.+.||+++++ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999743 45899987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.00042 Score=58.58 Aligned_cols=73 Identities=16% Similarity=0.163 Sum_probs=48.7
Q ss_pred ccccccCcceEEEeeeeCC--------ceEEEEEeCCCC-ChhHHHHHHHHHhcCC-CccceeeeeeeeeCCeEEEEEEe
Q 021441 14 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGA-PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY 83 (312)
Q Consensus 14 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 83 (312)
++.|+.|-.-.+|++.... .+.|.+++.... ......+|..+++.+. +.-..++++++.. ..|++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4577778888999998432 356777775532 3344567888888774 3334567766643 479999
Q ss_pred ccCCccc
Q 021441 84 IPNGSVS 90 (312)
Q Consensus 84 ~~~~~L~ 90 (312)
++|..+.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9886553
|